Table S1.Annotation for the differentially expressed proteins																	A22	A2	A1	A4	A5	A3	A6	A7	A8	A9	A10	A13	A14	A15	A16	A17	A23	A20	A19	A21	A18	A12	B1	B2	B3	B4	B5	B6	B8	B9	B10	B11	B12	B13	B14	B15	B16	B17	B18	B19	B20	B21	B22	B23																																						
	Protein ID	FKBP1A	Symbol	Sameset	Description	Gene ID	NCBI RNA ID	NCBI Protein ID	Ensembl RNA ID	KEGG RNA ID	Uniq Peptide Number	Uniq Spectrum Number	Protein Sequence	Ratio(APE / BPE)	Log2FC(APE / BPE)	Qvalue(APE / BPE)	APE_1 expression	APE_2 expression	APE_3 expression	APE_4 expression	APE_5 expression	APE_6 expression	APE_7 expression	APE_8 expression	APE_9 expression	APE_10 expression	APE_11 expression	APE_12 expression	APE_13 expression	APE_14 expression	APE_15 expression	APE_16 expression	APE_17 expression	APE_18 expression	APE_19 expression	APE_20 expression	APE_21 expression	APE_22 expression	BPE_23 expression	BPE_24 expression	BPE_25 expression	BPE_26 expression	BPE_27 expression	BPE_28 expression	BPE_29 expression	BPE_30 expression	BPE_31 expression	BPE_32 expression	BPE_33 expression	BPE_34 expression	BPE_35 expression	BPE_36 expression	BPE_37 expression	BPE_38 expression	BPE_39 expression	BPE_40 expression	BPE_41 expression	BPE_42 expression	BPE_43 expression	BPE_44 expression	KEGG Pathway Desc	KEGG Disease Desc	KEGG Module Desc	KEGG Reaction Desc	GO_C Desc	GO_F Desc	GO_P Desc	cellmarker_desc	cr2cancer_desc	genebank_desc	TF Desc	Pfam Desc	Reactome Desc	Cog Desc	EggNOG Desc	TF Cofactors Desc	InterPro Desc	UniProt Desc	msigdb_c1_desc	msigdb_c2_cp_biocarta_desc	msigdb_c2_cp_kegg_desc	msigdb_c2_cp_reactome_desc	msigdb_c2_cp_desc	msigdb_c3_mir_mir_legacy_desc	msigdb_c3_mir_mirdb_desc	msigdb_c3_tft_tft_legacy_desc	msigdb_c3_tft_gtrd_desc	msigdb_c4_cgn_desc	msigdb_c4_cm_desc	msigdb_c6_desc	msigdb_c7_desc	msigdb_h_desc	ST RNA ID	Symbol				
Q9BWU5	tr|Q9BWU5|Q9BWU5_HUMAN	PRKCD	HBB		Mutant hemoglobin beta chain (Fragment) OS=Homo sapiens OX=9606 GN=HBB PE=3 SV=1	3043	URS0000D6E78A						MVHLTPVEKSAVTALWGKVNVDEVGGEALGRLLVVYPWTQRFFESFGDLSTPDAVMGNPKVKAHGKKVLGAFSDGLAHLDNLKGTFAKLSELHCDKLHVDPENFR	0.554901	-0.849697739	0.01634916	7.8688103	6.9459151	7.7290387	7.7351205	10.0936273	9.1767815	7.836802376	8.6386153	9.513591	7.7428884	6.9151373	7.0781161	9.61601082	7.4592974	5.838975	7.105868	7.7213727	9.62543	8.364033367	9.0523682	9.5957964	9.1195339	11.326161	9.6958252	10.36915366	7.68120754	9.2855502	9.380565	10.0234567	9.935721	9.7683012	7.685701	9.095805	9.0359848	9.4313251	9.9720542	8.9125836	9.6337903	9.554583	7.495905	8.19921983	6.8066086	8.1517975	8.02518028																																	URS0000D6E78A	HBB		P35052	GPC1	MAPRE2
Q7Z7B4	tr|Q7Z7B4|Q7Z7B4_HUMAN	SNCA			Truncated alpha 1 globin variant (Fragment) OS=Homo sapiens OX=9606 PE=3 SV=1								LLSHCLLVTLAAHLPAEFITPAVHASLDKFLASVSTVLTSKYR	2.0447554	1.031928278	0.01568652				3.7162305	2.8217603	5.4151466	5.055865782	4.4679224		5.1382887	5.0966699	4.796857			4.1410325	4.6090205		4.2323524	5.418984674	7.5655567	5.5566719	4.9400697	3.6863666	3.6015094										3.8228083				4.720454		3.6979856	3.00949639	4.1588538		3.96572906																																	C9606_107320			P02452	COL1A1	PGLS
Q5SQY0	tr|Q5SQY0|Q5SQY0_HUMAN	UBE2L3	TUBB8		Tubulin beta chain OS=Homo sapiens OX=9606 GN=TUBB8 PE=1 SV=1	347688	XM_017016193	XP_016871682		K07375			MNMPSTPLAPTTGTATCSWSASTCTTTRPAVRPPSFPHRPPGNAALPSLMPSRPTQVAGQCGAGNNWAKGHYTEGAELMESVMDVVRKEAESCDCLQGFQLTHSLGGGTGSGMGTLLLSKIREEYPDRIINTFSILPSPKVSDTVVEPYNATLSVHQLIENADETFCIDNEALYDICSKTLKLPTPTYGDLNHLVSATMSGVTTCLRFPGQLNADLRKLAVNMVPFPRLHFFMPGFAPLTSRGSQQYRALTVAELTQQMFDAKNMMAACDPRHGRYLTAAAIFRGRMPMREVDEQMFNIQDKNSSYFADWLPNNVKTAVCDIPPRGLKMSATFIGNNTAIQELFKRVSEQFTAMFRRKAFLHWYTGEGMDEMEFTEAESNMNDLVSEYQQYQDATAEEEEDEEYAEEEVA	0.4124345	-1.277763224	0.02913548		5.5185853	3.603576			6.0187843		5.3858396	6.1867529		6.9644886	9.003515		5.6718129	4.7946057	4.1647354					7.7983919	7.248596	6.7310394					5.186604	8.9621816		7.4933982		7.4026369	7.7539611	5.5553137	8.3943892	8.7192188	8.2677229	5.054071	7.4189973	8.28190789	9.2693141	5.1252968		04145///Phagosome+++04540///Gap junction+++05010///Alzheimer disease+++05012///Parkinson disease+++05014///Amyotrophic lateral sclerosis+++05016///Huntington disease+++05020///Prion disease+++05022///Pathways of neurodegeneration - multiple diseases+++05130///Pathogenic Escherichia coli infection+++05132///Salmonella infection	H00679///Hypomyelinating leukodystrophy+++H00831///Primary dystonia+++H00837///Leber congenital amaurosis+++H00838///Congenital fibrosis of the extraocular muscles+++H01579///Congenital symmetric circumferential skin creases+++H01740///Macrothrombocytopenia+++H01881///Complex cortical dysplasia with other brain malformations+++H01897///Oocyte maturation defect			GO:0005737///cytoplasm+++GO:0005819///spindle+++GO:0005856///cytoskeleton+++GO:0005874///microtubule+++GO:0070062///extracellular exosome+++GO:0072687///meiotic spindle	GO:0000166///nucleotide binding+++GO:0003674///molecular_function+++GO:0003924///GTPase activity+++GO:0005200///structural constituent of cytoskeleton+++GO:0005525///GTP binding	GO:0000226///microtubule cytoskeleton organization+++GO:0000278///mitotic cell cycle+++GO:0001556///oocyte maturation+++GO:0007010///cytoskeleton organization+++GO:0007017///microtubule-based process+++GO:0007056///spindle assembly involved in female meiosis	tissueType=Fetal gonad;cancerType=Normal;cellName=Oogenesis phase fetal germ cell		"PREDICTED: Homo sapiens tubulin beta 8 class VIII (TUBB8), transcript variant X2, mRNA."			"R-HSA-109582///Hemostasis+++R-HSA-112314///Neurotransmitter receptors and postsynaptic signal transmission+++R-HSA-112315///Transmission across Chemical Synapses+++R-HSA-112316///Neuronal System+++R-HSA-1266738///Developmental Biology+++R-HSA-1280218///Adaptive Immune System+++R-HSA-1445148///Translocation of SLC2A4 (GLUT4) to the plasma membrane+++R-HSA-157858///Gap junction trafficking and regulation+++R-HSA-162582///Signal Transduction+++R-HSA-1632852///Macroautophagy+++R-HSA-1640170///Cell Cycle+++R-HSA-1643685///Disease+++R-HSA-168256///Immune System+++R-HSA-1852241///Organelle biogenesis and maintenance+++R-HSA-190828///Gap junction trafficking+++R-HSA-190840///Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane+++R-HSA-190861///Gap junction assembly+++R-HSA-190872///Transport of connexons to the plasma membrane+++R-HSA-194315///Signaling by Rho GTPases+++R-HSA-195258///RHO GTPase Effectors+++R-HSA-199977///ER to Golgi Anterograde Transport+++R-HSA-199991///Membrane Trafficking+++R-HSA-2132295///MHC class II antigen presentation+++R-HSA-2262752///Cellular responses to stress+++R-HSA-2467813///Separation of Sister Chromatids+++R-HSA-2500257///Resolution of Sister Chromatid Cohesion+++R-HSA-2555396///Mitotic Metaphase and Anaphase+++R-HSA-2995410///Nuclear Envelope (NE) Reassembly+++R-HSA-3371497///HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand+++R-HSA-373760///L1CAM interactions+++R-HSA-380320///Recruitment of NuMA to mitotic centrosomes+++R-HSA-392499///Metabolism of proteins+++R-HSA-422475///Axon guidance+++R-HSA-437239///Recycling pathway of L1+++R-HSA-438064///Post NMDA receptor activation events+++R-HSA-442755///Activation of NMDA receptors and postsynaptic events+++R-HSA-446203///Asparagine N-linked glycosylation+++R-HSA-453274///Mitotic G2-G2/M phases+++R-HSA-5617833///Cilium Assembly+++R-HSA-5626467///RHO GTPases activate IQGAPs+++R-HSA-5653656///Vesicle-mediated transport+++R-HSA-5663205///Infectious disease+++R-HSA-5663220///RHO GTPases Activate Formins+++R-HSA-597592///Post-translational protein modification+++R-HSA-6807878///COPI-mediated anterograde transport+++R-HSA-6811434///COPI-dependent Golgi-to-ER retrograde traffic+++R-HSA-6811436///COPI-independent Golgi-to-ER retrograde traffic+++R-HSA-6811442///Intra-Golgi and retrograde Golgi-to-ER traffic+++R-HSA-68877///Mitotic Prometaphase+++R-HSA-68882///Mitotic Anaphase+++R-HSA-68886///M Phase+++R-HSA-69275///G2/M Transition+++R-HSA-69278///Cell Cycle, Mitotic+++R-HSA-8852276///The role of GTSE1 in G2/M progression after G2 checkpoint+++R-HSA-8856688///Golgi-to-ER retrograde transport+++R-HSA-8953897///Cellular responses to stimuli+++R-HSA-8955332///Carboxyterminal post-translational modifications of tubulin+++R-HSA-948021///Transport to the Golgi and subsequent modification+++R-HSA-9609646///HCMV Infection+++R-HSA-9609690///HCMV Early Events+++R-HSA-9609736///Assembly and cell surface presentation of NMDA receptors+++R-HSA-9612973///Autophagy+++R-HSA-9619483///Activation of AMPK downstream of NMDARs+++R-HSA-9646399///Aggrephagy+++R-HSA-9648025///EML4 and NUDC in mitotic spindle formation+++R-HSA-9663891///Selective autophagy+++R-HSA-9668328///Sealing of the nuclear envelope (NE) by ESCRT-III+++R-HSA-9675108///Nervous system development+++R-HSA-9716542///Signaling by Rho GTPases, Miro GTPases and RHOBTB3+++R-HSA-983189///Kinesins+++R-HSA-983231///Factors involved in megakaryocyte development and platelet production"						chr10p15///Ensembl 103 genes in cytogenetic band chr10p15		KEGG_GAP_JUNCTION///Gap junction+++KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION///Pathogenic Escherichia coli infection	"REACTOME_ACTIVATION_OF_AMPK_DOWNSTREAM_OF_NMDARS///Activation of AMPK downstream of NMDARs+++REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS///Activation of NMDA receptors and postsynaptic events+++REACTOME_ADAPTIVE_IMMUNE_SYSTEM///Adaptive Immune System+++REACTOME_AGGREPHAGY///Aggrephagy+++REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION///Asparagine N-linked glycosylation+++REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS///Assembly and cell surface presentation of NMDA receptors+++REACTOME_AUTOPHAGY///Autophagy+++REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN///Carboxyterminal post-translational modifications of tubulin+++REACTOME_CELL_CYCLE///Cell Cycle+++REACTOME_CELL_CYCLE_MITOTIC///Cell Cycle, Mitotic+++REACTOME_CELLULAR_RESPONSES_TO_EXTERNAL_STIMULI///Cellular responses to external stimuli+++REACTOME_CILIUM_ASSEMBLY///Cilium Assembly+++REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC///COPI-dependent Golgi-to-ER retrograde traffic+++REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC///COPI-independent Golgi-to-ER retrograde traffic+++REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT///COPI-mediated anterograde transport+++REACTOME_DEVELOPMENTAL_BIOLOGY///Developmental Biology+++REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT///ER to Golgi Anterograde Transport+++REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION///Factors involved in megakaryocyte development and platelet production+++REACTOME_GAP_JUNCTION_ASSEMBLY///Gap junction assembly+++REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION///Gap junction trafficking and regulation+++REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT///Golgi-to-ER retrograde transport+++REACTOME_HCMV_EARLY_EVENTS///HCMV Early Events+++REACTOME_HCMV_INFECTION///HCMV Infection+++REACTOME_HEMOSTASIS///Hemostasis+++REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR///HSP90 chaperone cycle for steroid hormone receptors (SHR)+++REACTOME_INFECTIOUS_DISEASE///Infectious disease+++REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC///Intra-Golgi and retrograde Golgi-to-ER traffic+++REACTOME_KINESINS///Kinesins+++REACTOME_L1CAM_INTERACTIONS///L1CAM interactions+++REACTOME_MEMBRANE_TRAFFICKING///Membrane Trafficking+++REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION///MHC class II antigen presentation+++REACTOME_MITOTIC_G2_G2_M_PHASES///Mitotic G2-G2/M phases+++REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE///Mitotic Metaphase and Anaphase+++REACTOME_MITOTIC_PROMETAPHASE///Mitotic Prometaphase+++REACTOME_M_PHASE///M Phase+++REACTOME_NERVOUS_SYSTEM_DEVELOPMENT///Nervous system development+++REACTOME_NEURONAL_SYSTEM///Neuronal System+++REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION///Neurotransmitter receptors and postsynaptic signal transmission+++REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY///Nuclear Envelope (NE) Reassembly+++REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE///Organelle biogenesis and maintenance+++REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION///Post-translational protein modification+++REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES///Recruitment of NuMA to mitotic centrosomes+++REACTOME_RECYCLING_PATHWAY_OF_L1///Recycling pathway of L1+++REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION///Resolution of Sister Chromatid Cohesion+++REACTOME_RHO_GTPASE_EFFECTORS///RHO GTPase Effectors+++REACTOME_RHO_GTPASES_ACTIVATE_FORMINS///RHO GTPases Activate Formins+++REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS///RHO GTPases activate IQGAPs+++REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III///Sealing of the nuclear envelope (NE) by ESCRT-III+++REACTOME_SELECTIVE_AUTOPHAGY///Selective autophagy+++REACTOME_SEPARATION_OF_SISTER_CHROMATIDS///Separation of Sister Chromatids+++REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3///Signaling by Rho GTPases, Miro GTPases and RHOBTB3+++REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT///The role of GTSE1 in G2/M progression after G2 checkpoint+++REACTOME_TRANSLOCATION_OF_SLC2A4_GLUT4_TO_THE_PLASMA_MEMBRANE///Translocation of SLC2A4 (GLUT4) to the plasma membrane+++REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES///Transmission across Chemical Synapses+++REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE///Transport of connexons to the plasma membrane+++REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION///Transport to the Golgi and subsequent modification+++REACTOME_VESICLE_MEDIATED_TRANSPORT///Vesicle-mediated transport"			MIR4722_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4722-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).		"PAX6_TARGET_GENES///Genes containing one or more binding sites for UniProt:P26367 (PAX6) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++PBXIP1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96AQ6 (PBXIP1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SUMO1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P63165 (SUMO1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF512B_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96KM6 (ZNF512B) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF512_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96ME7 (ZNF512) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."						XM_017016193	TUBB8		Q7Z7B4	0	IGF2
Q53G99	tr|Q53G99|Q53G99_HUMAN	SEPTIN5			Beta actin variant (Fragment) OS=Homo sapiens OX=9606 PE=2 SV=1								MDDDIAALVVDNGSGMCKAGFAGDDAPRAVFPSIVGRPRHQGVMVGMGQKDSYVGDEAQSKRGILTLKYPIEHGIVTNWDDMEKIWHHTFYNELRVAPEEHPVLLTEAPLNPKANREKMTQIMFETFNTPAMYVAIQAVLSLYASGRTTGIVMDSGDGVTHTVPIYEGYALPHAILRLDLAGRDLTDYLMKILTERGYSFTTTAEREIVRDIKEKLCYVALDFEQEMATAASSSSLEKSYELPDGQVITIGNERFRCPEALFQPSFLGMESCGIHETTFNSIMKCDVDIRKDLYANTVLSGGTTMYPGIADRMRKEITALAPSTMKIKIIAPPERKYSVWIGGSILASLSTFQQMWISKQEYDESGPSIVHRKCF	0.5872084	-0.768055602	0.03736167	9.6092048	10.6664246	11.3340354	11.7193778	11.8531263	11.9822713	10.7288793	12.437148	13.4738536	12.5610279	12.1499249	13.7071248	10.52175572	12.0007152	12.3297597	13.147381	10.3006316	11.5254297	10.00379381	10.2413331	12.4589048	12.7904007	12.3315071	10.1622191	10.80820345	9.61486361	10.6819661	14.850728	14.076232	12.801376	13.8361909	12.378531	12.3449855	13.2223197	12.3347773	12.5029393	12.0079964	13.1811467	14.13259	11.8414728	12.09487548	13.4689831	11.866883	13.89894066																																	C9606_115272			Q14767	LTBP2	PDLIM7
Q53FE8	tr|Q53FE8|Q53FE8_HUMAN	PSMD9	NSFL1C		NSFL1 cofactor p47 (Fragment) OS=Homo sapiens OX=9606 PE=2 SV=1	55968	NM_016143	NP_057227	ENST00000216879	K14012			MAAERQEALREFVAVTGAEEDRARFFLESAGWDLQIALASFYEDGGDEDIVTISQATPSSVSRGTAPSDNRVTSFRDLIHDQDEDEEEEEGQRFYAGGSERSGQQIVGPPRKKSPNELVDDLFKGAKEHGAVAVERVTKSPGETSKPRPFAGGGYRLGAAPEEESAYVAGEKRQHSSQDVHVVLKLWKSGFSLDNGELRSYQDPSNAQFLESIRRGEVPAELRRLAHGGQVNLDMEDHRDEDFVKPKGAFKAFTGEGQKLGSTAPQVLSTSSPAQQAENEAKASSSILINESEPTTNIQIRLADGGRLVQKFNHSHRISDIRLFIVDARPAMAATSFILMTTFPNKELADESQTLKEANLLNAVIVQRLT	0.5548105	-0.849933078	0.01002251		4.2302096				4.6652687		4.905135	6.4693879	6.3014905	5.5393726	7.064631		4.6414757	4.453919	6.2229482		4.7538295			6.4537002	6.4486201	6.885266					6.778366	6.9840784	6.89948	6.1924635	4.808339	4.7159439	6.9428605	6.6615892	6.8369337	6.3979076	6.295188	7.138573	5.3840055	5.78427301	7.9351498	5.2446549	7.31370695	04141///Protein processing in endoplasmic reticulum				GO:0005634///nucleus+++GO:0005654///nucleoplasm+++GO:0005694///chromosome+++GO:0005737///cytoplasm+++GO:0005794///Golgi apparatus+++GO:0005795///Golgi stack+++GO:0005815///microtubule organizing center+++GO:0005829///cytosol+++GO:0005856///cytoskeleton+++GO:0005886///plasma membrane+++GO:0031616///spindle pole centrosome+++GO:0045111///intermediate filament cytoskeleton+++GO:1990730///VCP-NSFL1C complex	GO:0005515///protein binding+++GO:0005543///phospholipid binding+++GO:0008289///lipid binding+++GO:0043130///ubiquitin binding+++GO:0051117///ATPase binding	GO:0000045///autophagosome assembly+++GO:0000132///establishment of mitotic spindle orientation+++GO:0007030///Golgi organization+++GO:0031468///nuclear envelope reassembly+++GO:0043161///proteasome-mediated ubiquitin-dependent protein catabolic process+++GO:0046604///positive regulation of mitotic centrosome separation+++GO:0061025///membrane fusion+++GO:1904780///negative regulation of protein localization to centrosome			"Homo sapiens NSFL1 cofactor (NSFL1C), transcript variant 1, mRNA."		PF00789///UBX domain+++PF08059///SEP domain+++PF14555///UBA-like domain	"R-HSA-162582///Signal Transduction+++R-HSA-194315///Signaling by Rho GTPases+++R-HSA-9012999///RHO GTPase cycle+++R-HSA-9013407///RHOH GTPase cycle+++R-HSA-9716542///Signaling by Rho GTPases, Miro GTPases and RHOBTB3"		KOG2086///nuclear envelope reassembly		"IPR001012///UBX domain+++IPR009060///UBA-like superfamily+++IPR012989///SEP domain+++IPR029071///Ubiquitin-like domain superfamily+++IPR036241///NSFL1 cofactor p47, SEP domain superfamily"	[NSF1C_HUMAN|Reviewed]RecName: Full=NSFL1 cofactor p47; AltName: Full=UBX domain-containing protein 2C; AltName: Full=p97 cofactor p47;+++[L8EBH2_HUMAN|Unreviewed]SubName: Full=Alternative protein NSFL1C {ECO:0000313|EMBL:CCQ43923.1};	chr20p13///Ensembl 103 genes in cytogenetic band chr20p13			"REACTOME_RHO_GTPASE_CYCLE///RHO GTPase cycle+++REACTOME_RHOH_GTPASE_CYCLE///RHOH GTPase cycle+++REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3///Signaling by Rho GTPases, Miro GTPases and RHOBTB3"			MIR138_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-138-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR29B_1_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-29b-1-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR335_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-335-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3678_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3678-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3934_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3934-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4471///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4471 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR450B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-450b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6507_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6507-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR769_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-769-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR8059///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-8059 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).		"ADA2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9NZK5 (ADA2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ASH1L_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9NR48 (ASH1L) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++CASP8AP2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9UKL3 (CASP8AP2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++CHAF1A_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q13111 (CHAF1A) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++CHAF1B_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q13112 (CHAF1B) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++FOXJ2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9P0K8 (FOXJ2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++FXR1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P51114 (FXR1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++GLI1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P08151 (GLI1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++GLI4_TARGET_GENES///Genes containing one or more binding sites for UniProt:P10075 (GLI4) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++GTF2E2_TARGET_GENES///Genes containing one or more binding sites for UniProt:P29084 (GTF2E2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HES2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9Y543 (HES2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HMBOX1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6NT76 (HMBOX1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HMG20B_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9P0W2 (HMG20B) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HMGB1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P09429 (HMGB1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++JDP2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8WYK2 (JDP2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++KAT2A_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q92830 (KAT2A) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++KLF14_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8TD94 (KLF14) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++MCRS1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96EZ8 (MCRS1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++MEF2C_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q06413 (MEF2C) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++MORC2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9Y6X9 (MORC2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NFRKB_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6P4R8 (NFRKB) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NR0B1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P51843 (NR0B1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NUP153_TARGET_GENES///Genes containing one or more binding sites for UniProt:P49790 (NUP153) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++RBM15_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96T37 (RBM15) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++RBM17_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96I25 (RBM17) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++RBM34_TARGET_GENES///Genes containing one or more binding sites for UniProt:P42696 (RBM34) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SETX_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q7Z333 (SETX) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SNRNP70_TARGET_GENES///Genes containing one or more binding sites for UniProt:P08621 (SNRNP70) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SRSF9_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q13242 (SRSF9) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SUMO1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P63165 (SUMO1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++TAF9B_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9HBM6 (TAF9B) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++WDHD1_TARGET_GENES///Genes containing one or more binding sites for UniProt:O75717 (WDHD1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++WRNIP1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96S55 (WRNIP1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZBED5_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q49AG3 (ZBED5) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF146_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q15072 (ZNF146) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF30_TARGET_GENES///Genes containing one or more binding sites for UniProt:P17039 (ZNF30) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF391_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9UJN7 (ZNF391) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF524_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96C55 (ZNF524) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF528_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q3MIS6 (ZNF528) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF561_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8N587 (ZNF561) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF592_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q92610 (ZNF592) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF596_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8TC21 (ZNF596) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF618_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q5T7W0 (ZNF618) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF660_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6AZW8 (ZNF660) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF677_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q86XU0 (ZNF677) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF711_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9Y462 (ZNF711) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF784_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8NCA9 (ZNF784) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZSCAN29_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8IWY8 (ZSCAN29) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZSCAN30_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q86W11 (ZSCAN30) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZSCAN31_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96LW9 (ZSCAN31) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."		MODULE_207///Genes in the cancer module 207.+++MODULE_26///Genes in the cancer module 26.+++MODULE_389///Breast cancer expression clusters.		"GSE10463_CD40L_AND_VA347_VS_CD40L_IN_DC_DN///Genes down-regulated in comparison of dendritic cells activated in the absense of VAF347 [PubChem=10172275] versus those activated in the presence of VAF347 [PubChem=10172275].+++GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_DN///Genes down-regulated in comparison of CD4 [GeneID=920] thymocytes versus naive CD4 [GeneID=920] T cells from cord blood.+++GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_DN///Genes down-regulated in comparison of CD4 [GeneID=920] CD8 thymocytes versus naive CD4 [GeneID=920] T cells from cord blood.+++GSE1460_NAIVE_CD4_TCELL_CORD_BLOOD_VS_THYMIC_STROMAL_CELL_UP///Genes up-regulated in naive CD4 [GeneID=920] T cells from cord blood versus thymic stromal cells.+++GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_12H_UP///Genes up-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 12 h.+++GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_14H_UP///Genes up-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 14 h.+++GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_16H_UP///Genes up-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 16 h.+++GSE18893_TCONV_VS_TREG_24H_TNF_STIM_DN///Genes down-regulated in lymphocytes treated with TNF [GeneID=7124] for 24h: T conv versus T reg cells.+++GSE20198_IL12_VS_IFNA_TREATED_ACT_CD4_TCELL_UP///Genes up-regulated in the activated CD4 [GeneID=920] T cells (48h): IL-12 versus interferon alpha.+++GSE22103_UNSTIM_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_UP///Genes up-regulated in neutrophils: untreated versus stimulated by CSF2 and IFNG [GeneID=1437;3458].+++GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_48H_UP///Genes up-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 and then stimulated by IL4 [GeneID=3565] (48h).+++GSE28726_ACT_CD4_TCELL_VS_ACT_NKTCELL_DN///Genes down-regulated in activated T cells: CD4 [GeneID=920] versus NKT.+++GSE34156_NOD2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_DN///Genes down-regulated in monocytes (24h): muramyl dipeptide [PubChem=11620162] versus muramyl dipeptide [PubChem=11620162] and M. tuberculosis 19 kDa lipopeptide.+++GSE37416_0H_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_UP///Genes up-regulated in comparison of control polymorphonuclear leukocytes (PMN) at 0 h versus PMN treated with F. tularensis vaccine at 3 h.+++GSE37416_0H_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_UP///Genes up-regulated in comparison of control polymorphonuclear leukocytes (PMN) at 0 h versus PMN treated with F. tularensis vaccine at 6 h.+++GSE37416_CTRL_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_UP///Genes up-regulated in comparison of control polymorphonuclear leukocytes (PMN) at 6 h versus PMN treated with F. tularensis vaccine at 6 h.+++GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH1_DN///Genes down-regulated in comparison of effective memory CD4 [GeneID=920] T cells versus Th1 cells.+++GSE3982_NEUTROPHIL_VS_TH1_UP///Genes up-regulated in comparison of neutrophils versus Th1 cells.+++GSE4984_GALECTIN1_VS_VEHICLE_CTRL_TREATED_DC_DN///Genes down-regulated in monocyte-derived dendritic cells: LGALS1 [GeneID=3956] versus vehicle.+++GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY7_UP///Genes up-regulated in unstimulated monocytes versus macrophages incubated with CSF1 [GeneID=435] at day 7.+++GSE6269_HEALTHY_VS_STAPH_AUREUS_INF_PBMC_DN///Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from patients with acute influenza infection versus PBMC from patients with acute S. aureus infection.+++GSE7568_IL4_TGFB_DEXAMETHASONE_VS_IL4_TGFB_TREATED_MACROPHAGE_UP///Genes up-regulated in macrophages: 5 days with IL4 [GeneID=3565] and dexamethasone [PubChem=5743] followed by TGFB1 [GeneID=7040] for 24h versus 5 days with IL4 [GeneID=3565] followed by TGFB1 [GeneID=7040] for 24h.+++NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE///Genes negatively correlated with HAI response at 28d in peripheral blood mononuclear cell in adults (18-50) after exposure to Fluarix/Fluvirin , time point 7D. Comment: Supplementary Table 5: All genes whose expression (d3/d0 or d7/d0) correlates to the fold increase in HAI titers (d28/d0)."		NM_016143	NSFL1C		Q9NR12	PDLIM7	CHGA
Q0ZCI2	tr|Q0ZCI2|Q0ZCI2_HUMAN	TUBA4A	IGHV3-30		Immunglobulin heavy chain variable region (Fragment) OS=Homo sapiens OX=9606 PE=4 SV=1	28439	id-IGHV3-30-3						PLVQLVESGGGVVQPGRSLRLSCAASGFPFNTYGMHWVRQAPGKGLEWVAGTTYDGRIKDYADSVKGRFTISRDNSKNTLYLQMNSLRLEDTAVYYCAKKWPGTVLAGPDYWGLGTLVTVSS	0.6299241	-0.666750096	0.02152316	3.4539689	4.6706683	4.2872766	4.3387443		3.8626027	6.078214062	4.6577462	3.4400523		3.7417601	3.9079127	3.48191035	4.2214551			4.1233385	2.4768445		2.4079221		2.4046312	5.2109031	5.2100256	4.48393587	4.99790987	4.6202981	6.093872	4.0926705					3.307949	4.5838572	4.5008718	4.2316439		4.368582	3.7986608	4.32088868	4.2736108	4.1273699																																		id-IGHV3-30-3	IGHV3-30		P01344	IGF2	0
D6RAM3	tr|D6RAM3|D6RAM3_HUMAN	DCTN2	DOK3		Docking protein 3 OS=Homo sapiens OX=9606 GN=DOK3 PE=1 SV=1	79930	NM_024872	NP_079148	ENST00000357198				MDPLETPIKDGILYQQHVKFGKKCWRKVWALLYAGGPSGVARLESWEVRDGGLGAAGDRSAGPGRRGERRVIRLADCVSVLPADGESCPRDTGAFLLTTTERSHLLAAQHRQAWMGPICQLAFPGTGEASSGSTDAQSPKRGLVPMEENSIYSSWQEVGEFPVVVQRTEAATRCQLKGPALLVLGPDAIQLREAKGTQALYSWPYHFLRKFGSDKGVFSFEAGRRCHSGEGLFAFSTPCAPDLCRAVAGAIARQRERLPELTRPQPCPLPRATSLPSLDTPGELREMPPGPEPPTSRKMHLAEPGPQSLPLLLGPEPNDLASGLYASVCKRASGPPGNEHLYENLCVLEASPTLHGGEPEPHEGPGSRSPTTSPIYHNGQDLSWPGPANDSTLEAQYRRLLELDQVEGTGRPDPQAGFKAKLVTLLSRERRKGPAPCDRP	0.4043236	-1.306417589	5.54E-05		4.8211979		4.9623037	4.4740235	5.024202	4.547587784	5.4085963	5.2886021	6.7936763	6.0562871	7.0606425		4.2917737	5.3969337	5.1436392	4.1588409	4.800003	4.733854412		4.9079179	5.7876816	7.1397783		4.25350708		4.6011324	8.027051	7.7034279	7.158178	8.2816978	5.854227	6.449499	6.1288594	6.6578174	5.5505903	6.9809348	5.70748	7.575493	6.7681766	6.35973462	7.253097	5.3262197	6.41563166					GO:0005737///cytoplasm+++GO:0005886///plasma membrane+++GO:0016020///membrane+++GO:0030667///secretory granule membrane+++GO:0101003///ficolin-1-rich granule membrane	GO:0005515///protein binding	GO:0007169///transmembrane receptor protein tyrosine kinase signaling pathway+++GO:0007265///Ras protein signal transduction	tissueType=Brain;cancerType=Glioma;cellName=Macrophage+++tissueType=Blood;cancerType=Normal;cellName=CD1C-CD141- dendritic cell+++tissueType=Brain;cancerType=Normal;cellName=Macrophage		"Homo sapiens docking protein 3 (DOK3), transcript variant 1, mRNA."			R-HSA-168249///Innate Immune System+++R-HSA-168256///Immune System+++R-HSA-6798695///Neutrophil degranulation					[DOK3_HUMAN|Reviewed]RecName: Full=Docking protein 3; AltName: Full=Downstream of tyrosine kinase 3;	chr5q35///Ensembl 103 genes in cytogenetic band chr5q35			REACTOME_INNATE_IMMUNE_SYSTEM///Innate Immune System+++REACTOME_NEUTROPHIL_DEGRANULATION///Neutrophil degranulation			MIR12131///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-12131 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3652///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3652 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4430///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4430 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4516///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4516 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4531///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4531 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4747_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4747-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5093///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5093 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5196_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5196-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6752_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6752-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6842_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6842-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7110_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7110-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR8064///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-8064 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).	CAGCTG_AP4_Q5///Genes having at least one occurence of the highly conserved motif M15 CAGCTG sites. The motif matches transcription factor binding site V$AP4_Q5 (v7.4 TRANSFAC).+++CEBPDELTA_Q6///Genes having at least one occurence of the transcription factor binding site V$CEBPDELTA_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++HEB_Q6///Genes having at least one occurence of the transcription factor binding site V$HEB_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++OCT1_01///Genes having at least one occurence of the transcription factor binding site V$OCT1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++OCT1_B///Genes having at least one occurence of the transcription factor binding site V$OCT1_B (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++OCT1_Q6///Genes having at least one occurence of the transcription factor binding site V$OCT1_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++STAT4_01///Genes having at least one occurence of the transcription factor binding site V$STAT4_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++STAT6_02///Genes having at least one occurence of the transcription factor binding site V$STAT6_02 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++YATGNWAAT_OCT_C///Genes having at least one occurence of the highly conserved motif M44 YATGNWAAT sites. The motif matches transcription factor binding site V$OCT_C (v7.4 TRANSFAC).	"CBFA2T2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O43439 (CBFA2T2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NFKBIA_TARGET_GENES///Genes containing one or more binding sites for UniProt:P25963 (NFKBIA) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NUP153_TARGET_GENES///Genes containing one or more binding sites for UniProt:P49790 (NUP153) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++POU2AF1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q16633 (POU2AF1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++WRNIP1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96S55 (WRNIP1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."			ALK_DN.V1_DN///Genes down-regulated in DAOY cells (medulloblastoma) upon knockdown of ALK [Gene ID=238] gene by RNAi.+++IL15_UP.V1_DN///Genes down-regulated in Sez-4 cells (T lymphocyte) that were first starved of IL2 [Gene ID=3558] and then stimulated with IL15 [Gene ID=3600].	"GSE13411_NAIVE_VS_IGM_MEMORY_BCELL_DN///Genes down-regulated in comparison of naive B cells versus IgM-memory B cells.+++GSE13411_NAIVE_VS_SWITCHED_MEMORY_BCELL_DN///Genes down-regulated in comparison of naive B cells versus Ig isotype switched memory B cells.+++GSE14000_UNSTIM_VS_16H_LPS_DC_TRANSLATED_RNA_UP///Genes up-regulated in comparison of polysome bound (translated) mRNA before and 16 h after LPS (TLR4 agonist) stimulation.+++GSE14000_UNSTIM_VS_4H_LPS_DC_TRANSLATED_RNA_UP///Genes up-regulated in comparison of polysome bound (translated) mRNA before and 4 h after LPS (TLR4 agonist) stimulation.+++GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_UP///Genes up-regulated in comparison of control microglia cells versus those 1 h after stimulation with IFNG [GeneID=3458].+++GSE16385_UNTREATED_VS_12H_IFNG_TNF_TREATED_MACROPHAGE_UP///Genes up-regulated in macrophages (12h): control versus IFNG and TNF [GeneID=3458;7124].+++GSE16755_CTRL_VS_IFNA_TREATED_MAC_UP///Genes up-regulated in comparison of control macrophages versus macrophages treated with interferon alpha.+++GSE22229_RENAL_TRANSPLANT_VS_HEALTHY_PBMC_UP///Genes up-regulated in periperal blood monocytes (PBMC): tolerant kidney transplants versus healthy controls.+++GSE22886_IGM_MEMORY_BCELL_VS_BM_PLASMA_CELL_DN///Genes down-regulated in comparison of memory IgM B cells versus plasma cells from bone marrow and blood.+++GSE25085_FETAL_LIVER_VS_ADULT_BM_SP4_THYMIC_IMPLANT_UP///Genes up-regulated in thymic implants from fetal liver versus those from adult bone marrow.+++GSE26351_UNSTIM_VS_WNT_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_DN///Genes down-regulated in CD34+ [GeneID=947] cells: control versus treated with GSK-3 Inhibitor IX (BIO) [PubChem=5287844].+++GSE26928_NAIVE_VS_EFF_MEMORY_CD4_TCELL_DN///Genes down-regulated in comparison of naive CD4 [GeneID=920] T cells versus CD4 [GeneID=920] effector memory T cells.+++GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_DN///Genes down-regulated in monocytes (6h): muramyl dipeptide [PubChem=11620162] versus M. tuberculosis 19 kDa lipopeptide.+++GSE34156_TLR1_TLR2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_UP///Genes up-regulated in monocytes (24h): M. tuberculosis 19 kDa lipopeptide versus M. tuberculosis 19 kDa lipopeptide and muramyl dipeptide [PubChem=11620162].+++GSE34156_UNTREATED_VS_24H_NOD2_LIGAND_TREATED_MONOCYTE_DN///Genes down-regulated in monocytes (24h): untreated versus muramyl dipeptide [PubChem=11620162].+++GSE34156_UNTREATED_VS_6H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP///Genes up-regulated in monocytes (6h): untreated versus M. tuberculosis 19 kDa lipopeptide.+++GSE34205_HEALTHY_VS_FLU_INF_INFANT_PBMC_DN///Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMCs from infanct with acute influenza infection.+++GSE44955_MCSF_VS_MCSF_AND_IL27_STIM_MACROPHAGE_UP///Genes up-regulated in macrophage differentiated by: CSF1 [GeneID=1435] versus CSF1 [GeneID=1435] and IL27 [GeneID=246778].+++GSE4748_CYANOBACTERIUM_LPSLIKE_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_DN///Genes down-regulated in monocyte-derived dendritic cells: LPS like antigen from O. planktothrix (3h) versus LPS and LPS like antigen from O. planktothrix (3h).+++GSE9988_LOW_LPS_VS_VEHICLE_TREATED_MONOCYTE_DN///Genes down-regulated in comparison of monocytes treated with 1 ng/ml LPS (TLR4 agonist) versus untreated monocytes.+++HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_POSITIVE///Genes positively correlated with memory B cell response at 28d in peripheral blood mononuclear cell in seniors (50-74) after exposure to Fluarix , time point 28D+++HOEK_NK_CELL_2011_2012_TIV_3D_VS_0DY_ADULT_3D_DN///Genes down-regulated in natural killer cell 3d vs 0d in adults after exposure to 2011-2012 trivalent inactivated vaccine (A/California/7/09 (H1N1), A/Perth /16/2009 (H3N2), B/Brisbane/60/2008) , time point 3D. Comment: Down-regulated DE RNA transcripts (down &gt;= 1.5x) shared between both TIV-vaccinated donors+++ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_UP///Genes up-regulated in peripheral blood mononuclear cell 1d vs 0d in adults (20-50) after exposure to MRKAd5 HIV-1 gag/pol/nef , time point 1D. Comment: Table includes specific cell types"		NM_024872	DOK3		P61970	0	0
B7Z9A0	tr|B7Z9A0|B7Z9A0_HUMAN	PDLIM7	GSN		Actin-depolymerizing factor OS=Homo sapiens OX=9606 PE=2 SV=1	2934	NM_001353055	NP_001339984		K05768			MPGVSPCQDPAPLRLCPVSSQPNSMVVEHPEFLKAGKEPGLQIWRVEKFDLVPVPTNLYGDFFTGDAYVILKTVQLRNGNLQYDLHYWLGNECSQDESGAAAIFTVQLDDYLNGRAVQHREVQGFESATFLGYFKSGLKYKKGGVASGFKHVVPNEVVVQRLFQVKGRRVVRATEVPVSWESFNNGDCFILDLGNNIHQWCGSNSNRYERLKATQVSKGIRDNERSGRARVHVSEEGTEPEAMLQVLGPKPALPAGTEDTAKEDAANRKLAKLYKVSNGAGTMSVSLVADENPFAQGALKSEDCFILDHGKDGKIFVWKGKQANTEERKAALKTASDFITKMDYPKQTQVSVLPEGGETPLFKQFFKNWRDPDQTDGLGLSYLSSHIANVERVPFDAATLHTSTAMAAQHGMDDDGTGQKQIWRIEGSNKVPVDPATYGQFYGGDSYIILYNYRHGGRQGQIIYNWQGAQSTQDEVAASAILTAQLDEELGGTPVQSRVVQGKEPAHLMSLFGGKPMIIYKGGTSREGGQTAPASTRLFQVRANSAGATRAVEVLPKAGALNSNDAFVLKTPSAAYLWVGTGASEAEKTGAQELLRVLRAQPVQVAEGSEPDGFWEALGGKAAYRTSPRLKDKKMDAHPPRLFACSNKIGRFVIEEVPGELMQEDLATDDVMLLDTWDQVFVWVGKDSQEEEKTEALTSAKRYIETDPANRDRRTPITVVKQGFEPPSFVGWFLGWDDDYWSVDPLDRAMAELAA	0.6392722	-0.645497698	0.01191857						4.2127843	3.918777672	3.9281376	3.7813692		3.8220722	3.3628702	3.73727393	3.0890754		2.2327445						2.9483497		3.677105		4.4358356		4.370782	4.3074565		3.4391727		4.8137673		3.8997122		4.3003506		3.654176	3.4823552		5.2565617			04666///Fc gamma R-mediated phagocytosis+++04810///Regulation of actin cytoskeleton+++05203///Viral carcinogenesis	"H02322///Amyloidosis, Finnish type"			GO:0001726///ruffle+++GO:0002102///podosome+++GO:0005576///extracellular region+++GO:0005615///extracellular space+++GO:0005634///nucleus+++GO:0005737///cytoplasm+++GO:0005829///cytosol+++GO:0005856///cytoskeleton+++GO:0005886///plasma membrane+++GO:0005925///focal adhesion+++GO:0015629///actin cytoskeleton+++GO:0016528///sarcoplasm+++GO:0030027///lamellipodium+++GO:0030478///actin cap+++GO:0030864///cortical actin cytoskeleton+++GO:0032991///protein-containing complex+++GO:0034774///secretory granule lumen+++GO:0042470///melanosome+++GO:0042995///cell projection+++GO:0043209///myelin sheath+++GO:0045335///phagocytic vesicle+++GO:0048471///perinuclear region of cytoplasm+++GO:0070062///extracellular exosome+++GO:0072562///blood microparticle+++GO:1904813///ficolin-1-rich granule lumen	"GO:0003779///actin binding+++GO:0005509///calcium ion binding+++GO:0005515///protein binding+++GO:0005546///phosphatidylinositol-4,5-bisphosphate binding+++GO:0036313///phosphatidylinositol 3-kinase catalytic subunit binding+++GO:0045159///myosin II binding+++GO:0046872///metal ion binding+++GO:0051015///actin filament binding"	"GO:0006911///phagocytosis, engulfment+++GO:0006915///apoptotic process+++GO:0007417///central nervous system development+++GO:0007568///aging+++GO:0008154///actin polymerization or depolymerization+++GO:0010628///positive regulation of gene expression+++GO:0014003///oligodendrocyte development+++GO:0014891///striated muscle atrophy+++GO:0016192///vesicle-mediated transport+++GO:0022617///extracellular matrix disassembly+++GO:0030030///cell projection organization+++GO:0030031///cell projection assembly+++GO:0030036///actin cytoskeleton organization+++GO:0030041///actin filament polymerization+++GO:0030042///actin filament depolymerization+++GO:0030155///regulation of cell adhesion+++GO:0031648///protein destabilization+++GO:0035994///response to muscle stretch+++GO:0042060///wound healing+++GO:0042246///tissue regeneration+++GO:0042989///sequestering of actin monomers+++GO:0045010///actin nucleation+++GO:0045471///response to ethanol+++GO:0046597///negative regulation of viral entry into host cell+++GO:0048015///phosphatidylinositol-mediated signaling+++GO:0051014///actin filament severing+++GO:0051016///barbed-end actin filament capping+++GO:0051127///positive regulation of actin nucleation+++GO:0051593///response to folic acid+++GO:0051693///actin filament capping+++GO:0055119///relaxation of cardiac muscle+++GO:0060271///cilium assembly+++GO:0071276///cellular response to cadmium ion+++GO:0071346///cellular response to interferon-gamma+++GO:0071801///regulation of podosome assembly+++GO:0086003///cardiac muscle cell contraction+++GO:0090527///actin filament reorganization+++GO:0097017///renal protein absorption+++GO:0097284///hepatocyte apoptotic process+++GO:1902174///positive regulation of keratinocyte apoptotic process+++GO:1903903///regulation of establishment of T cell polarity+++GO:1903906///regulation of plasma membrane raft polarization+++GO:1903909///regulation of receptor clustering+++GO:1903923///positive regulation of protein processing in phagocytic vesicle+++GO:1990000///amyloid fibril formation+++GO:2001269///positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway"	tissueType=Brain;cancerType=Normal;cellName=Oligodendrocyte+++tissueType=Fetal kidney;cancerType=Normal;cellName=Natural killer T (NKT) cell+++tissueType=Small intestine;cancerType=Normal;cellName=Goblet cell+++tissueType=Fetal gonad;cancerType=Normal;cellName=Mitotic fetal germ cell+++tissueType=Embryonic prefrontal cortex;cancerType=Normal;cellName=Microglial cell		"Homo sapiens gelsolin (GSN), transcript variant 13, mRNA."			R-HSA-109581///Apoptosis+++R-HSA-111465///Apoptotic cleavage of cellular proteins+++R-HSA-168249///Innate Immune System+++R-HSA-168256///Immune System+++R-HSA-264870///Caspase-mediated cleavage of cytoskeletal proteins+++R-HSA-392499///Metabolism of proteins+++R-HSA-5357801///Programmed Cell Death+++R-HSA-6798695///Neutrophil degranulation+++R-HSA-75153///Apoptotic execution phase+++R-HSA-9659379///Sensory processing of sound+++R-HSA-9662361///Sensory processing of sound by outer hair cells of the cochlea+++R-HSA-9709957///Sensory Perception+++R-HSA-977225///Amyloid fiber formation						chr9q33///Ensembl 103 genes in cytogenetic band chr9q33	BIOCARTA_ECM_PATHWAY///Erk and PI-3 Kinase Are Necessary for Collagen Binding in Corneal Epithelia+++BIOCARTA_HIVNEF_PATHWAY///HIV-I Nef: negative effector of Fas and TNF+++BIOCARTA_RHO_PATHWAY///Rho cell motility signaling pathway	KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS///Fc gamma R-mediated phagocytosis+++KEGG_REGULATION_OF_ACTIN_CYTOSKELETON///Regulation of actin cytoskeleton	REACTOME_AMYLOID_FIBER_FORMATION///Amyloid fiber formation+++REACTOME_APOPTOSIS///Apoptosis+++REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS///Apoptotic cleavage of cellular proteins+++REACTOME_APOPTOTIC_EXECUTION_PHASE///Apoptotic execution phase+++REACTOME_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS///Caspase-mediated cleavage of cytoskeletal proteins+++REACTOME_INNATE_IMMUNE_SYSTEM///Innate Immune System+++REACTOME_NEUTROPHIL_DEGRANULATION///Neutrophil degranulation+++REACTOME_PROGRAMMED_CELL_DEATH///Programmed Cell Death+++REACTOME_SENSORY_PERCEPTION///Sensory Perception+++REACTOME_SENSORY_PROCESSING_OF_SOUND_BY_OUTER_HAIR_CELLS_OF_THE_COCHLEA///Sensory processing of sound by outer hair cells of the cochlea+++REACTOME_SENSORY_PROCESSING_OF_SOUND///Sensory processing of sound			MIR124_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-124-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR141_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-141-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR200A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-200a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4307///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4307 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR450B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-450b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4698///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4698 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR506_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-506-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR8485///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-8485 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).	AP1FJ_Q2///Genes having at least one occurence of the transcription factor binding site V$AP1FJ_Q2 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++AP1_Q2///Genes having at least one occurence of the transcription factor binding site V$AP1_Q2 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++AP1_Q4///Genes having at least one occurence of the transcription factor binding site V$AP1_Q4 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++HSF1_01///Genes having at least one occurence of the transcription factor binding site V$HSF1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++HSF_Q6///Genes having at least one occurence of the transcription factor binding site V$HSF_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++NFAT_Q4_01///Genes having at least one occurence of the transcription factor binding site V$NFAT_Q4_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++P300_01///Genes having at least one occurence of the transcription factor binding site V$P300_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++RFX1_01///Genes having at least one occurence of the transcription factor binding site V$RFX1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++RGAANNTTC_HSF1_01///Genes having at least one occurence of the highly conserved motif M68 RGAANNTTC sites. The motif matches transcription factor binding site V$HSF1_01 (v7.4 TRANSFAC).+++STAT5A_02///Genes having at least one occurence of the transcription factor binding site V$STAT5A_02 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++TGGAAA_NFAT_Q4_01///Genes having at least one occurence of the highly conserved motif M55 TGGAAA sites. The motif matches transcription factor binding site V$NFAT_Q4_01 (v7.4 TRANSFAC).	"FOXN3_TARGET_GENES///Genes containing one or more binding sites for UniProt:O00409 (FOXN3) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++GREB1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q4ZG55 (GREB1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HBZ_TARGET_GENES///Genes containing one or more binding sites for UniProt:P02008 (HBZ) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HES2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9Y543 (HES2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++IGLV5_37_TARGET_GENES///Genes containing one or more binding sites for UniProt:A0A075B6J1 (IGLV5_37) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++LHX9_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9NQ69 (LHX9) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++MEF2C_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q06413 (MEF2C) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NCOA2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q15596 (NCOA2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NFE2L1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q14494 (NFE2L1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++RYBP_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8N488 (RYBP) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SNIP1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8TAD8 (SNIP1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++TCF7_TARGET_GENES///Genes containing one or more binding sites for UniProt:P36402 (TCF7) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++UBN1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9NPG3 (UBN1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++UBP1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9NZI7 (UBP1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF514_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96K75 (ZNF514) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF577_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9BSK1 (ZNF577) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF592_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q92610 (ZNF592) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."		MODULE_114///Protein biosynthesis and ribosomes.+++MODULE_151///Genes in the cancer module 151.+++MODULE_163///Genes in the cancer module 163.+++MODULE_179///Blood cells and cancer expression cancer.+++MODULE_202///Genes in the cancer module 202.+++MODULE_255///Genes in the cancer module 255.+++MODULE_317///Genes in the cancer module 317.+++MODULE_324///Metal / Ca ion binding.+++MODULE_330///Genes in the cancer module 330.+++MODULE_378///Genes in the cancer module 378.+++MODULE_419///Genes in the cancer module 419.+++MODULE_459///Genes in the cancer module 459.+++MODULE_48///Genes in the cancer module 48.+++MODULE_524///Actin cytoskeleton binding.+++MODULE_532///Blood cells and cancer expression clusters.+++MODULE_83///Genes in the cancer module 83.+++MODULE_95///Genes in the cancer module 95.+++MODULE_9///Genes in the cancer module 9.	CSR_LATE_UP.V1_DN///Genes down-regulated in late serum response of CRL 2091 cells (foreskin fibroblasts).	"FLETCHER_PBMC_BCG_10W_INFANT_BCG_STIMULATED_VS_UNSTIMULATED_10W_DN///Genes down-regulated in peripheral blood mononuclear cell stimulated vs unstimulated in infants (10w) after exposure to BCG (Danish strain BCG Statens Serum Institut, Denmark) , time point 10W. Comment: PBMCs drawn at 10 weeks following immunization at birth+++FLETCHER_PBMC_BCG_10W_INFANT_PPD_STIMULATED_VS_UNSTIMULATED_10W_DN///Genes down-regulated in peripheral blood mononuclear cell stimulated vs unstimulated in infants (10w) after exposure to BCG (Danish strain BCG Statens Serum Institut, Denmark) , time point 10W. Comment: PBMCs drawn at 10 weeks following immunization at birth+++GSE10325_CD4_TCELL_VS_MYELOID_DN///Genes down-regulated in comparison of healthy CD4 [GeneID=920] T cells versus healthy myeloid cells.+++GSE12845_IGD_POS_BLOOD_VS_NAIVE_TONSIL_BCELL_DN///Genes down-regulated in comparison of IgD+ peripheral blood B cells versus IgD- naive tonsil B cells.+++GSE12845_IGD_POS_BLOOD_VS_PRE_GC_TONSIL_BCELL_DN///Genes down-regulated in comparison of IgD+ B cells from peripheral blood versus CD19 pre-germinal center tonsil B cell+++GSE12845_IGD_POS_VS_NEG_BLOOD_BCELL_DN///Genes down-regulated in comparison of IgD+ B cells versus IgD- B cells.+++GSE13484_12H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_UP///Genes up-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) cultured for 12 h versus PBMC cultured for 12 h with YF17D vaccine.+++GSE14000_4H_VS_16H_LPS_DC_TRANSLATED_RNA_UP///Genes up-regulated in comparison of polysome bound (translated) mRNA in dendritic cells (DC) at 4 h after LPS (TLR4 agonist) stimulation versus those at 16 h after the stimulation.+++GSE14000_UNSTIM_VS_16H_LPS_DC_TRANSLATED_RNA_UP///Genes up-regulated in comparison of polysome bound (translated) mRNA before and 16 h after LPS (TLR4 agonist) stimulation.+++GSE15215_CD2_POS_VS_NEG_PDC_DN///Genes down-regulated in comparison of CD2+ plasmacytoid dendritic cells (DC) versus CD2- cells.+++GSE15735_2H_VS_12H_HDAC_INHIBITOR_TREATED_CD4_TCELL_DN///Genes down-regulated in CD4 [GeneID=920] T cells treated with HDAC inhibitors: 2h versus 12h.+++GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_UP///Genes up-regulated in the neuron cell line: immature versus mature.+++GSE17186_MEMORY_VS_CD21HIGH_TRANSITIONAL_BCELL_UP///Genes up-regulated in B lymphocytes: memory versus transitional CR2 [GeneID=1380] high.+++GSE1925_3H_VS_24H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_DN///Genes down-regulated in macrophages primed and then stimulated by IFNG [GeneID=3458]: 3h versus 24h.+++GSE19772_CTRL_VS_HCMV_INF_MONOCYTES_AND_PI3K_INHIBITION_DN///Genes down-regulated in monocytes pre-treated with Ly294002 [PubChem=3973]: control versus HCMV infection.+++GSE19888_ADENOSINE_A3R_INH_VS_ACT_IN_MAST_CELL_DN///Genes down-regulated in HMC-1 (mast leukemia) cells incubated with: the peptide ALL1 versus Cl-IB-MECA [PubChem=3035850].+++GSE22229_RENAL_TRANSPLANT_VS_HEALTHY_PBMC_DN///Genes down-regulated in periperal blood monocytes (PBMC): tolerant kidney transplants versus healthy controls.+++GSE22886_DAY0_VS_DAY7_MONOCYTE_IN_CULTURE_DN///Genes down-regulated in comparison of monocytes cultured for 0 days versus those cultured for 7 days.+++GSE22886_DC_VS_MONOCYTE_UP///Genes up-regulated in comparison of dendritic cells (DC) versus monocytes.+++GSE22886_NAIVE_BCELL_VS_DC_DN///Genes down-regulated in comparison of naive B cells versus unstimulated dendritic cells (DC).+++GSE22886_NAIVE_CD4_TCELL_VS_DC_DN///Genes down-regulated in comparison of naive CD4 [GeneID=920] T cells versus unstimulatd dendritic cells (DC).+++GSE22886_NAIVE_CD4_TCELL_VS_NEUTROPHIL_DN///Genes down-regulated in comparison of naive CD4 [GeneID=920] T cells versus unstimulated neutrophils.+++GSE22886_NAIVE_CD4_TCELL_VS_NKCELL_DN///Genes down-regulated in comparison of naive CD4 [GeneID=920] T cells versus unstimulated NK cells.+++GSE22886_NAIVE_CD8_TCELL_VS_DC_DN///Genes down-regulated in comparison of naive CD8 T cells versus unstimulated dendritic cells (DC).+++GSE22886_NAIVE_CD8_TCELL_VS_NKCELL_DN///Genes down-regulated in comparison of naive CD8 T cells versus unstimulated NK cells.+++GSE22886_NAIVE_TCELL_VS_NKCELL_DN///Genes down-regulated in comparison of naive CD4 [GeneID=920] CD8 T cells versus unstimulated NK cells.+++GSE22886_NEUTROPHIL_VS_DC_DN///Genes down-regulated in comparison of neutrophils versus dendritic cells (DC).+++GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY3_UP///Genes up-regulated in comparison of CD25- T cells treated with IL4 [GeneID=3565] at day 3 versus untreated CD25- T cells at day 3.+++GSE24634_TEFF_VS_TCONV_DAY7_IN_CULTURE_DN///Genes down-regulated in comparison of untreated CD25+ T effector cells at day 7 versus untreated CD25- T cells at day 7.+++GSE24634_TREG_VS_TCONV_POST_DAY10_IL4_CONVERSION_DN///Genes down-regulated in comparison of CD25+ regulatory T cell (Treg) treated with IL4 [GeneID=3565] at day 10 versus CD25- T cells treated with IL4 [GeneID=3565] at 10 h.+++GSE24634_TREG_VS_TCONV_POST_DAY7_IL4_CONVERSION_DN///Genes down-regulated in comparison of CD25+ regulatory T cell (Treg) treated with IL4 [GeneID=3565] at day 7 versus CD25- T cells treated with IL4 [GeneID=3565] at day 7.+++GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_6H_UP///Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: IL-12 (6h) versus untreated (6h).+++GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_UP///Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: IL-12 (48h) versus TGFB1 [GeneID=7040] and IL-12 (48h).+++GSE29618_BCELL_VS_MDC_DAY7_FLU_VACCINE_DN///Genes down-regulated in comparison of B cells from influenza vaccinee at day 7 post-vaccination versus myeloid dendritic cells (mDC) at day 7 post-vaccination.+++GSE29618_BCELL_VS_MDC_DN///Genes down-regulated in comparison of B cells versus myeloid dendritic cells (mDC).+++GSE29618_BCELL_VS_PDC_DAY7_FLU_VACCINE_DN///Genes down-regulated in comparison of B cells from influenza vaccinee at day 7 post-vaccination versus plasmacytoid dendritic cells (pDC) at day 7 post-vaccination.+++GSE29618_BCELL_VS_PDC_DN///Genes down-regulated in comparison of B cells versus plasmacytoid dendritic cells (pDC) .+++GSE29618_MONOCYTE_VS_MDC_DAY7_FLU_VACCINE_DN///Genes down-regulated in comparison of monocytes from influenza vaccinee at day 7 post-vaccination versus myeloid dendritic cells at day 7 post-vaccination.+++GSE29618_MONOCYTE_VS_MDC_DN///Genes down-regulated in comparison of monocytes versus myeloid dendritic cells (mDC).+++GSE32164_RESTING_DIFFERENTIATED_VS_CMYC_INHIBITED_MACROPHAGE_UP///Genes up-regulated in macrophages: resting differentiated versus MYC [GeneID=4609] inhibited.+++GSE33424_CD161_INT_VS_NEG_CD8_TCELL_DN///Genes down-regulated in CD8 T cells: KLRB1 int [GeneID=3820] versus KLRB1- [GeneID=3820].+++GSE33425_CD161_HIGH_VS_NEG_CD8_TCELL_UP///Genes up-regulated in CD8 T cells: KLRB1 high [GeneID=3820] versus KLRB1- [GeneID=3820].+++GSE33425_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_DN///Genes down-regulated in KLRB1 high [GeneID=3820] T cells: CD8A [GeneID=925] versus CD8A CD8B [GeneID=925;926].+++GSE33425_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_UP///Genes up-regulated in KLRB1 high [GeneID=3820] T cells: CD8A [GeneID=925] versus CD8A CD8B [GeneID=925;926].+++GSE3982_BASOPHIL_VS_CENT_MEMORY_CD4_TCELL_UP///Genes up-regulated in comparison of basophils versus central memory CD4 [GeneID=920] T cells.+++GSE3982_CENT_MEMORY_CD4_TCELL_VS_NKCELL_DN///Genes down-regulated in comparison of central memory CD4 [GeneID=920] T cells versus NK cells.+++GSE3982_DC_VS_NKCELL_UP///Genes up-regulated in comparison of dendritic cells (DC) versus NK cells.+++GSE3982_EOSINOPHIL_VS_MAC_DN///Genes down-regulated in comparison of eosinophils versus macrophages.+++GSE3982_EOSINOPHIL_VS_MAST_CELL_UP///Genes up-regulated in comparison of eosinophils versus mast cells.+++GSE3982_MAC_VS_BASOPHIL_UP///Genes up-regulated in comparison of macrophages versus basophils.+++GSE3982_MAC_VS_NKCELL_UP///Genes up-regulated in comparison of macrophages versus NK cells.+++GSE3982_MAST_CELL_VS_BCELL_UP///Genes up-regulated in comparison of mast cells versus B cells.+++GSE3982_MAST_CELL_VS_CENT_MEMORY_CD4_TCELL_UP///Genes up-regulated in comparison of mast cells versus central memory CD4 [GeneID=920] T cells.+++GSE3982_MEMORY_CD4_TCELL_VS_BCELL_DN///Genes down-regulated in comparison of memory CD4 [GeneID=920] T cells versus B cells.+++GSE3982_MEMORY_CD4_TCELL_VS_TH2_UP///Genes up-regulated in comparison of memory CD4 [GeneID=920] T cells versus Th2 cells.+++GSE42088_UNINF_VS_LEISHMANIA_INF_DC_8H_UP///Genes up-regulated in dendritic cells: untreated versus 8h after infection of Leishmania major.+++GSE4748_CTRL_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_DN///Genes down-regulated in monocyte-derived dendritic cells: untreated versus LPS and LPS like antigen from O. planktothrix (3h).+++GSE6092_IFNG_VS_IFNG_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_UP///Genes up-regulated in endothelial cells: IFNG [GeneID=3459] versus IFNG [GeneID=3459] and B. burgdoferi.+++GSE6269_E_COLI_VS_STREP_PNEUMO_INF_PBMC_DN///Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from patients with acute E. coli infection versus PBMC from patients with acute S. pneumoniae infection.+++GSE6269_FLU_VS_STREP_PNEUMO_INF_PBMC_DN///Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from patients with acute influenza infection versus PBMC from patients with acute S. pneumoniae infection.+++GSE6269_HEALTHY_VS_STAPH_PNEUMO_INF_PBMC_DN///Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMC from patients with acute S. pneumoniae infection.+++GSE6269_STAPH_AUREUS_VS_STREP_PNEUMO_INF_PBMC_DN///Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from patients with acute infection: S. aureus versus S. pneumoniae.+++GSE7460_CTRL_VS_TGFB_TREATED_ACT_FOXP3_MUT_TCONV_UP///Genes up-regulated in comparsion of sfActCD4 versus sfActCD4TGF (see Fig. 1 in the paper for details).+++GSE7460_TCONV_VS_TREG_LN_UP///Genes up-regulated in comparison of TconvLN versus TregLN (see Fig. 1 in the paper for details).+++GSE7509_DC_VS_MONOCYTE_UP///Genes up-regulated in dendritic cells versus monocytes.+++GSE9006_HEALTHY_VS_TYPE_2_DIABETES_PBMC_AT_DX_UP///Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMCs from patients with type 2 diabetes at the time of diagnosis.+++GSE9006_TYPE_1_DIABETES_AT_DX_VS_1MONTH_POST_DX_PBMC_UP///Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from patients with type 1 diabetes at the time of the diagnosis versus those at 1 month later.+++GSE9006_TYPE_1_DIABETES_AT_DX_VS_4MONTH_POST_DX_PBMC_UP///Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from patients with type 1 diabetes at the time of the diagnosis versus those at 4 months later.+++GSE9006_TYPE_1_VS_TYPE_2_DIABETES_PBMC_AT_DX_UP///Genes up-regulated in peripheral blood mononuclear cells (PBMC) from patients with type 1 diabetes at the time of diagnosis versus those with type 2 diabetes at the time of diagnosis.+++HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_DN///Genes down-regulated in peripheral blood mononuclear cell vaccinated vs unvaccinated in adolescent/young adults (11-22) after exposure to M-M-R II , time point 7Y+++NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_POSITIVE///Genes positively correlated with HAI response at 28d in peripheral blood mononuclear cell in adults (18-50) after exposure to Fluarix/Fluvirin , time point 3D. Comment: Supplementary Table 5: All genes whose expression (d3/d0 or d7/d0) correlates to the fold increase in HAI titers (d28/d0).+++NAKAYA_PBMC_FLUMIST_AGE_18_50YO_7DY_DN///Genes down-regulated in peripheral blood mononuclear cell 7d vs 0d in adults (18-50) after exposure to FluMist , time point 7D. Comment: Supplementary Table 1a: All the differentially expressed genes identified in PBMCs of TIV vaccinees.+++OSMAN_BLOOD_CHAD63_KH_AGE_18_50YO_HIGH_DOSE_SUBJECTS_24HR_UP///Genes up-regulated in blood 24hr vs 0hr in adults (18-50) (high dose subjects) after exposure to ChAd63-KH , time point 24H , administered Intramuscular injection. Comment: DE gene list for high dose subjects."	HALLMARK_APOPTOSIS///Genes mediating programmed cell death (apoptosis) by activation of caspases.+++HALLMARK_COAGULATION///Genes encoding components of blood coagulation system; also up-regulated in platelets.+++HALLMARK_MITOTIC_SPINDLE///Genes important for mitotic spindle assembly.+++HALLMARK_MYOGENESIS///Genes involved in development of skeletal muscle (myogenesis).	NM_001353055	GSN		P07108	DBI	COL1A1
B2RDY9	tr|B2RDY9|B2RDY9_HUMAN	PABPC1			Adenylyl cyclase-associated protein OS=Homo sapiens OX=9606 PE=2 SV=1								MADMQNLVERLERAVGRLEAVSHTSDMHRGYADSPSKAGAAPYVQAFDSLLAGPVAEYLKISKEIGGDVQKHAEMVHTGLKLERALLVTASQCQQPAENKLSDLLAPISEQIKEVITFREKNRGSKLFNHLSAVSESIQALGWVAMAPKPGPYVKEMNDAAMFYTNRVLKEYKDVDKKHVDWVKAYLSIWTELQAYIKEFHTTGLAWSKTGPVAKELSGLPSGPSAGSGPPPPPPGPPPPPVSTSSGSDESASRSALFAQINQGESITHALKHVSDDMKTHKNPALKAQSGPVRSGPKPFSAPKPQTSPSPKRATKKEPAVLELEGKKWRVENQENVSNLVIEDTELKQVAYIYKCVNTTLQIKGKINSITVDNCKKLGLVFGDVVGIVEIINSKDVKVQVMGKVPTISINKTDGCHAYLSKNSLDCEIVSAKSSEMNVLIPTEGGDFNEFPVPEQFKTLWNGQKLVTTVTEIAG	0.4009557	-1.318485096	0.03109745		6.7377093	5.6474803	6.5075005	6.8195729	8.1039597	6.11851597	7.8782809	8.4375158	8.9471956	8.3182398	9.1645587		6.8972672	7.0998998	8.2196808	4.6585604	4.75005			7.8207275	9.3349983	8.3626493	4.6055507	4.15665976	3.94942735	4.8417256	12.226543	10.7377467	11.373842	11.4380652	8.409648	9.2475637	9.6623507	8.9757069	7.9159434	9.3224418	8.4486173	10.625923	9.3742553	8.45356843	9.8425376	8.130311	9.58102317																																	C9606_53263			Q96C24	SYTL4	SYTL4
B1AH77	tr|B1AH77|B1AH77_HUMAN	HSP90AB1			Ras-related C3 botulinum toxin substrate 2 OS=Homo sapiens OX=9606 GN=RAC2 PE=1 SV=1								MVDSKPVNLGLWDTAGQEDYDRLRPLSYPQTDVFLICFSLVSPASYENVRAKWFPEVRHHCPSTPIILVGTKLDLRDDKDTIEKLKEKKLAPITYPQGLALAKEIDSVKYLECSALTQRGLKTVFDEAIRAVLCPQPTRQQKRACSLL	0.6178193	-0.694743159	0.04408885	5.7202836	7.2169147	6.1196248	8.4699196	5.3329922	7.5749108	7.303772895	7.0311297	8.7066247	8.2922351	8.1566877	8.5447812	6.54584893	8.1701507	7.8426578	7.6681996	6.8960953	8.1080534	3.781002044	5.2128723	4.9462095	7.601121	8.1927344	8.2597874	6.17311497	5.18146174	7.9774469	9.135397	7.9199	8.15846	8.5444723	7.258132	7.7881796	9.4431645	8.3853925	8.123264	7.5254083	7.1185711	8.385754	7.1615392	6.42670958	8.3680015	7.4434247	7.55612095																																	C9606_105272			A0A7T0LN43	IGHV3-7	IGHV3-7
A2N7P4	tr|A2N7P4|A2N7P4_HUMAN	CFL1	IGHV1-3		Immunoglobulin mu-chain D-J4-region (Fragment) OS=Homo sapiens OX=9606 GN=IGHM PE=4 SV=1	28473	id-IGHV1-3-2						AHSQVQLVQSGAEVKKPGASVKVSCKASGYTFTSYAMHWVRQAPGQRLEWMGWINAGNGNTKYSQKFQGRVTITRDTSASTAYMELSSLRSEDTAVYYCARGGYSGYDLRPHDYWGQGTL	0.6309052	-0.664504953	0.02952311	5.6073661	5.431102		5.50517	7.0135682	5.7861348	6.166400225	5.3402177			5.3086022	5.0313418	5.30874579	5.4985549	6.0262621	6.9527307	7.1581624	5.5740638	3.588046477	5.8201465		6.658153	5.7953925	7.5175135	6.51373922	5.38432383	7.2173311	7.63348		5.346839	5.2546322			5.9761593	5.8559001	6.5697798	6.1425777	7.3544667			5.90271558	6.9349511	7.5738235	6.33246256																																	id-IGHV1-3-2	IGHV1-3				
A2KBC4	tr|A2KBC4|A2KBC4_HUMAN	MYH9	ADAM6		Anti-TN-C scFv (Fragment) OS=Homo sapiens OX=9606 PE=2 SV=1	8755	URS00009C52CA						EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSAISGSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKRFVPFDYWGQGTLVTVSSGDGSSGGSGGASTGEIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQRGYAPTTFGQGTKVEIK	0.6433543	-0.636314577	0.01954916	7.1174522	7.1921787	9.0633229	7.9205634	6.4571955	8.8768705	8.728543741	9.2724975	7.5673677	8.8625104	7.1646228	8.3582635	9.23159835	9.235839	6.8193467	8.5898977	9.1093784	8.6888395	7.040087809	7.0971789	9.3318501	7.9736775	9.7863389	8.5500908	9.17416299	8.85397029	8.2024464	9.854266	7.5347199	9.695609	6.6464961	8.72278	8.1966066	7.9582739	9.234337	8.3167315	8.7529555	8.3011782	10.276578	8.8036258	9.31062701	9.6797294	8.4062873	9.44019338																																	URS00009C52CA	ADAM6				
A2KBC1	tr|A2KBC1|A2KBC1_HUMAN	VASP	ADAM6		Anti-(ED-B) scFV (Fragment) OS=Homo sapiens OX=9606 PE=1 SV=2	8755	URS00009C52CA						EVQLLESGGGLVQPGGSLRLSCAASGFTFSSFSMSWVRQAPGKGLEWVSSISGSSGTTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKPFPYFDYWGQGTLVTVSSGDGSSGGSGGASEIVLTQSPGTLSLSPGERATLSCRASQSVSSSFLAWYQQKPGQAPRLLIYYASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQTGRIPPTFGQGTKVEIK	1.7984687	0.846769076	0.03958837			8.1603483		7.9834553			7.4063713	6.7618		5.4824159	6.3488682	8.64577653	5.5917968	8.2107939	8.7107322	8.6298338	7.7429792	8.780459348	8.9771039	8.4579434	7.0050805	8.3356447	5.6983383	6.80984656	6.84368822	7.0475158	8.000699		6.099006	6.6413381	7.115698	7.4511943		7.8134926	5.1255526	6.7791491	5.1805514	9.082753	7.6436065	5.02268746	5.3318713	8.6641559	5.99752645																																	URS00009C52CA	ADAM6				
A0N5G7	tr|A0N5G7|A0N5G7_HUMAN		ADAM6		Rheumatoid factor D5 heavy chain (Fragment) OS=Homo sapiens OX=9606 GN=VH3 PE=2 SV=1	8755	URS00009C52CA						GGGVVQPGRSLRLSCAASGFTFSHYAMHWVRQAPGKGLEWVAVIASDGNNDYYIDSLKGRFTISRDNSNNTLYLQLSSLRIEDTAVYYCARGLSRVTTHTFDIWGQGTMVTVSSGSRSA	0.6014955	-0.733374146	0.01939419	5.5831467	7.8839754	6.9855836	7.9353145	7.2140507	5.4858337	6.044739378	6.2823263	6.3347216	7.0214936	4.9961209	8.1347546	6.53343146	6.8558948	7.1687488	5.4964018	6.7941396	5.4051877	5.193844933	5.3583043	5.7941174	6.0672138	7.5611762	6.8784723	6.87582201	7.94015322	7.5747985	8.856269	7.085917	8.473405		5.063679	6.7827101	7.9003724	6.6969068	5.5869286	7.6551998	7.6319676	7.996577	7.3316146	4.80171455	7.8269694	7.266514	5.79352008																																	URS00009C52CA	ADAM6				
A0A7T0PWY8	tr|A0A7T0PWY8|A0A7T0PWY8_HUMAN		ADAM6		Immunglobulin heavy chain variable region (Fragment) OS=Homo sapiens OX=9606 PE=2 SV=1	8755	URS00009C52CA						EVQLVESGGGLVQPGRSLRLSCAASGFNFDDYAMHWVRQAPGKGLEWVSGLSWNSGSIAYADSVKGRFTSSRDNAKNSLFLQMSSLRAEDTAFYYCAKGYGSGSSYPLAPTLDYWGQGTLVTVSS	0.6654673	-0.587560375	0.03604511	4.9577198	6.1289083	6.8125169	6.0970972	6.2850524	6.6549549	6.30030044	7.7554146	5.8229418	5.9532859	6.701775	6.1630447	5.84124574	6.3781428	5.8104377	4.8529153	5.1186177	4.9070971	3.918137149	3.8231441	4.4363351	5.7873041	5.9381152	6.8590416	4.96335744	6.70532895	6.6304574	8.11837	5.8792758	6.405114	5.1316456	5.16734	5.2204117	7.3485004	6.8950044	6.7630913	7.4620879	4.8573752	7.427037	7.0648711	6.48626108	6.5949922	5.5493557	5.96568395																																	URS00009C52CA	ADAM6				
A0A7T0PWX7	tr|A0A7T0PWX7|A0A7T0PWX7_HUMAN		IGHV3-48		Immunglobulin heavy chain variable region (Fragment) OS=Homo sapiens OX=9606 PE=2 SV=1	28424	id-IGHV3-48-2						EVQLVESGGGLIHPGGSLRLTCAVSGFTFSTYSMNWVRQAPGKGLEWVSYISDSTGTVYYADSVKGRFTITRDNADNSLYLQMSSLRDDDTAVYYCARGGTRYYYGSGSHMDVWGQGTTVTVSS	0.4453162	-1.167098084	0.001379737		6.7287443	7.3395222	5.456423	4.5147987	7.3007621		6.2437821	5.2601651		6.4838192		7.70694697	8.2800972	5.851302		7.7210148	6.9398003	5.800745262	7.0229449	7.0380518	6.8919006	9.6475147	7.7032805	6.46084582	7.80220009	7.1222875	8.237849		6.546708	8.082406		7.8870636	7.7038201	8.7785144		7.3451992	5.2475182	7.034947	7.7978527	9.06495985	8.4386838	9.2390909	7.85974571																																	id-IGHV3-48-2	IGHV3-48				
A0A7T0LNV7	tr|A0A7T0LNV7|A0A7T0LNV7_HUMAN		IGHV3-23		Immunglobulin heavy chain variable region (Fragment) OS=Homo sapiens OX=9606 PE=2 SV=1	28442	URS0000D5BE04						EVQLLESGGGLVHPGGSLRLSCAVSGFTLTNYAINWVRQAPGKGLEWVSYISATGGSTYYADSVKGRFTISRDTSKNTLFLQMNSLRAEDTALYYCAKDAIAGRVWLQGAFDSWGQGTLVTVSS	0.6237351	-0.680994597	0.01512193	3.6069028	5.4084901	6.3274166	4.7122362	5.6594078	4.8884453	6.042275103	5.7871623	4.2546398		6.2648178		7.005225	5.698965	5.0879963	4.676419	6.9073884	5.8343704	5.265006212	6.2759389	6.1419547	6.244793	6.8770574	6.836632	5.56694259	5.57999589	5.6401908	7.133534		5.787092			4.9135439	6.5804808	6.8768591		6.7899263	4.4742381	6.219136	6.8936075	5.50053765	7.1276316	7.3064732	7.03488958																																	URS0000D5BE04	IGHV3-23				
A0A7T0LNJ4	tr|A0A7T0LNJ4|A0A7T0LNJ4_HUMAN		IGLV2-8		Immunglobulin lambda chain variable region (Fragment) OS=Homo sapiens OX=9606 PE=2 SV=1	28817	id-IGLV2-8						QSALTQPPSASGSPGQSVTISCTGTSSDVGGYSYVSWYQQHPGKAPKLMIYEVTKRPSGVPDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYANSDTFVFGTGTKVTVL	1.6121048	0.688945492	0.0369048	5.0735834	6.2422118	6.0218615	6.1785271	7.2358833	5.169879	5.028789274	6.1305344	6.2813551	6.2997949	6.2308498	5.5912475	5.29420372	7.0330445	7.3719649	6.7708832	7.9440726	6.274667	5.522473288	6.0117825	4.690992	6.8232039	7.0468201	6.7231237	5.33055169	5.93139635	4.654642	5.529952	3.9620765	3.14325	3.5806989	3.854334	4.3988677	6.4638644	5.1986155	4.3408519	5.6387899	6.7829577	5.221393	5.6710477	5.25633667	5.4571157	7.5883137	8.2900045																																	id-IGLV2-8	IGLV2-8				
A0A7T0LN43	tr|A0A7T0LN43|A0A7T0LN43_HUMAN		IGHV3-7		Immunglobulin heavy chain variable region (Fragment) OS=Homo sapiens OX=9606 PE=2 SV=1	28452	id-IGHV3-7-2						EVQLVESGGGLAQPGGSLRLSCTASGFAFETYWMTWVRQAPGKGLEWVANINGAGSEKDYVDSLKGRFTISRDNDKKSLYLQMDSLRAADTAVYFCARAPTDIVVAPGAMAGNYFDYWGQGALVTVSS	3.2730807	1.710649187	0.002326951	6.1287918	9.3725167	9.0475622	9.5802919	11.9067045	5.8383773	9.039074772	8.4747896	7.6496998	8.1971171	11.3967273	8.5632395	6.09409493	9.3826555	10.4421604	8.0804499	11.6399925	11.7017265	12.28732843	8.799449	6.7089883	6.3111642	6.1047431	9.7648488	9.41086824	6.94975344	7.5303918	6.367097	5.812386	6.309861	7.5811707	6.025141	8.8716004	8.5292348	9.5036408	6.0586372	6.2804796	6.259998	6.460863	5.9993469	6.03012519	6.369021	10.2359729	6.55344002																																	id-IGHV3-7-2	IGHV3-7				
A0A1W6IYL8	tr|A0A1W6IYL8|A0A1W6IYL8_HUMAN		IGKV2D-28		N90-VRC38.08 light chain variable region (Fragment) OS=Homo sapiens OX=9606 PE=2 SV=1	28883	URS0000EC003D						LIVMTQSPLSLTVTPGEPASLSCRSSQSLLESNGYNYLDWFVQKPGQSPKLLIYRGSHRASGVPDRFSGSGSGTHFTLRISRVEPEDAGVYFCMQAVQTPRLSFGGGTRVEIK	0.6067633	-0.720794276	0.02097512	9.2243771	10.96042	10.6618574	10.8212127	8.7732166	10.1061331	9.712147168	11.0891463	10.0891445	10.4309926	10.3263227	10.6528599	10.81081252	10.805839	8.8496385	9.7500025	9.4801052	9.6425117	8.146040734	6.2781535	7.6267739	9.1859424	11.1457141	11.1374422	8.32278884	11.04316813	10.7731465	11.030073	11.0330559	11.216908	9.8904949	11.062082	10.3679431	10.5846562	10.8613774	10.3309796	11.4344211	8.4954536	10.9355	9.4143121	10.67658981	10.2631088	9.4194682	9.84244039																																	URS0000EC003D	IGKV2D-28				
A0A1W6IYL0	tr|A0A1W6IYL0|A0A1W6IYL0_HUMAN		IGKV2D-28		N90-VRC38.07 light chain variable region (Fragment) OS=Homo sapiens OX=9606 PE=2 SV=1	28883	URS0000EC003D						DLVMTQSPHSLAVTPGEPASISCRSSQSLLLNNGRNYLDWYVQKPGQSPQLLIYLGSNRAPGVPDRFSGSGSGTDFTLKISRVEAEDIGFYYCMEARQTPRLTFGGGTKLEIR	0.6542663	-0.612050037	0.02917497	8.9231858	10.6307798	10.3484665	10.4723159	10.0795179	9.8226225	9.327177007	10.6618479	9.9773041	10.0366043	9.9966064	10.0427655	10.43559465	10.7836336	8.715487	9.6511873	10.1659961	9.3741148	8.210171559	6.5967816	7.3056134	8.784705	10.9675887	10.9727963	7.77873162	10.40827421	10.58756	10.538212	10.714649	10.840818	10.0619009	10.806969	10.1379619	10.5878323	10.2704046	9.8243818	11.0707243	9.2885968	10.46257	8.9637115	10.38091027	9.9484793	9.4867664	9.70774024																																	URS0000EC003D	IGKV2D-28				
A0A1W6IYK6	tr|A0A1W6IYK6|A0A1W6IYK6_HUMAN		IGKV2D-28		N90-VRC38.09 light chain variable region (Fragment) OS=Homo sapiens OX=9606 PE=2 SV=1	28883	URS0000EC003D						DIVMTQSPLSLSVTPGEPASISCRSSQSLLESNGYNYLDWYLQKPGQSPQLLIYLGSNRASGVPDRFSGTGSGTAFTLKISRVEAEDVGIYYCMQARQTPRLSFGEGTKVEIR	0.5466155	-0.871401751	0.004384464	10.5141651	11.0894215	10.8371037	10.997702	8.9541784	10.2757216	9.848991298	11.1592346	10.0904561	10.4339287	10.4417453	10.7841548	10.83673199	10.8312619	9.0260434	9.9151538	9.4150605	9.5179018	8.293211071	6.4891501	7.7415704	9.2430734	11.7697741	11.9002025	9.39087977	11.14550356	11.4966542	11.43596	11.1959582	11.292611	10.2645653	11.141812	10.2370154	10.9050634	10.9981241	10.5551731	11.5962665	9.6837285	10.942214	9.3112828	10.78066924	10.293251	9.5087967	10.06129353																																	URS0000EC003D	IGKV2D-28				
A0A1W6IYK4	tr|A0A1W6IYK4|A0A1W6IYK4_HUMAN		IGKV2-28		N90-VRC38.11 light chain variable region (Fragment) OS=Homo sapiens OX=9606 PE=2 SV=1	28921	id-IGKV2-28-3						LIVMTQSPPSLIVTPGEPASISCRSSQSLLESNGYNYLDWFQQRPGQSPRLLFYRGSHRASGVPDRFTASGSGTDFRLKISRVESEDVGIYYCMQAVQTPRLSFGGGTKLEIK	0.5112013	-0.968036719	0.001140134	7.9039901	8.6725468	8.4878918	8.4837065	8.6135134	7.8794684	5.23384476	7.0101766	8.1568608	8.361494	8.057173	7.1661432	8.81362179	9.0802719	6.8334353	7.7976397	7.3080861	7.8303739	6.410131093	4.8637217	5.6813001	6.1523488	9.1381488	9.00525	7.02748074	8.18620421	8.5486076	8.792731	8.9461711	9.33365	8.496496	9.341221	8.6606693	8.5848472	8.5517076	7.9759606	9.3204517	7.4801066	8.854763	7.0323752	9.01177122	8.1290117	7.7828939	7.8940293																																	id-IGKV2-28-3	IGKV2-28				
A0A1W6IYJ9	tr|A0A1W6IYJ9|A0A1W6IYJ9_HUMAN		IGKV2D-28		N90-VRC38.01 light chain variable region (Fragment) OS=Homo sapiens OX=9606 PE=2 SV=1	28883	URS0000EC003D						DLLMTQSPHSLAVTPGEPASISCRSSQSLLLGNGRNYLDWYVQKPGQSPQLLIYLGSNRASGVPDRFSGSGSGTYFTLKISRVEAEDVGFYYCMEARQTPRLTFGGGTKLEIR	0.6508429	-0.619618729	0.02888646	8.2950581	9.2905495	10.3724435	9.8525153	10.5360247	8.7856959	8.424242357	10.1821908	10.2054769	9.4752147	9.4891957	10.3687164	10.18207957	9.8859688	8.4988206	9.3431325	8.9916979	8.836354	7.675759901	6.9021965	7.3366447	8.6332953	11.2539011	10.4139783	9.69938825	9.97637829	10.7524096	8.585994	10.5851695	9.442687	9.7633791	10.531518	10.0869229	9.4102738	8.57778	8.3353126	11.0317362	9.3403006	10.382639	9.0463326	10.76602732	9.8207714	9.2734308	8.11855611																																	URS0000EC003D	IGKV2D-28				
A0A1W6IYJ8	tr|A0A1W6IYJ8|A0A1W6IYJ8_HUMAN		IGKV2D-28		N90-VRC38.05 light chain variable region (Fragment) OS=Homo sapiens OX=9606 PE=2 SV=1	28883	URS0000EC003D						DVVMTQSPLSLAVTPGEPASISCRSSRSLLQYNGRNYLDWYWHKPGQPPQLLIYLGSHRASGVPDRFTGSGSGTAFTLKISRVEAEDVGVYYCMQSLETPRLSFGEGTKVEIK	0.6283718	-0.670309545	0.02976044	10.5024953	11.0651597	10.8878569	11.0199934	10.9488641	10.2873412	9.884866177	11.2001799	10.2508805	10.5999397	10.4950761	10.8203081	10.94201452	11.0284802	9.0934731	10.0006052	10.4125004	9.6575453	8.312695124	6.4563924	7.8608822	9.4187875	11.7601686	11.7878315	9.44974235	10.95151349	11.4788281	11.442667	11.1582404	11.346282	10.4385381	11.241341	10.6385982	10.9733424	10.7852172	10.4929301	11.6061996	9.8342999	11.097184	8.3520001	10.9215397	10.4416856	9.595747	10.09925143																																	URS0000EC003D	IGKV2D-28				
A0A1W6IYI5	tr|A0A1W6IYI5|A0A1W6IYI5_HUMAN		IGHV3-13		N90-VRC38.08 heavy chain variable region (Fragment) OS=Homo sapiens OX=9606 PE=2 SV=1	28449	id-IGHV3-13-2						EVQLVESGGALVQPGGSLRLSCAASGFSFRDHDMHWVRQVTGKGLEWISSIGGGGDTYYLDSVKGRFIISRQNGRSSLFLQINSLTVGDTGVYYCVRGPTSGWWYHDYYGLDVWGQGTTVTVSS	0.3723724	-1.425182057	0.03517523		7.7478994			6.8427282									7.8560881			8.0491824	5.5213423				8.9533704	6.936719	10.0463741		7.97246522	10.4593529		9.8027368	8.405557			8.8774428	7.249379							8.36044128	10.2698437	9.7428102																																		id-IGHV3-13-2	IGHV3-13				
A0A140T9L8	tr|A0A140T9L8|A0A140T9L8_HUMAN		MPIG6B		C6orf25 OS=Homo sapiens OX=9606 GN=MPIG6B PE=1 SV=1	80739	rna-NM_025260.4-4						MAVFLQLLPLLLSRAQGNPGASLDGRPGDRVNLSCGGVSHPIRWVWAPSFPACKGLSKGRRPILWASSSGTPTVPPLQPFVGRLRSLDSGIRRLELLLSAGDSGTFFCKGRHEDESRTVLHVLGDRTYCKAPGPTHGSVYPQLLIPLLGAGLVLGLGALGLVWWLHRRLPPQPIGPLPRFALSPPHSSTCENRAPEASKGGRAQDSRGPGPGTEPALCGSGPSSPQQAPPAVHSGPC	0.437631	-1.192213063	0.005769734	6.3532283	7.4784958	6.9371663	7.7702135	8.2470124	8.1820629	6.126282929	8.6448725	9.52273	9.5860186	8.9699394	10.1444434	5.58346032	9.328047	7.4927617	8.3534422	6.719777	7.1154365		6.1505305	8.2729331	8.5050173	9.2307035	6.740457	5.80767685	6.68933978	6.4792249	12.194792	10.8773815	10.496487	10.9144544	8.406694	9.0620774	9.8820271	9.4179731	9.3964856	9.2100194	8.8751607	10.19478	9.4184387	9.03177125	9.8671973	8.1492029	9.25039927																																	rna-NM_025260.4-4	MPIG6B				
A0A024RAJ6	tr|A0A024RAJ6|A0A024RAJ6_HUMAN				Beta-hexosaminidase OS=Homo sapiens OX=9606 GN=HEXB PE=2 SV=1								MELCGLGLPRPPMLLALLLATLLAAMLALLTQVALVVQVAEAARAPSVSAKPGPALWPLPLSVKMTPNLLHLAPENFYISHSPNSTAGPSCTLLEEAFRRYHGYIFGFYKWHHEPAEFQAKTQVQQLLVSITLQSECDAFPNISSDESYTLLVKEPVAVLKANRVWGALRGLETFSQLVYQDSYGTFTINESTIIDSPRFSHRGILIDTSRHYLPVKIILKTLDAMAFNKFNVLHWHIVDDQSFPYQSITFPELSNKGSYSLSHVYTPNDVRMVIEYARLRGIRVLPEFDTPGHTLSWGKGQKDLLTPCYSRQNKLDSFGPINPTLNTTYSFLTTFFKEISEVFPDQFIHLGGDEVEFKCWESNPKIQDFMRQKGFGTDFKKLESFYIQKVLDIIATINKGSIVWQEVFDDKAKLAPGTIVEVWKDSAYPEELSRVTASGFPVILSAPWYLDLISYGQDWRKYYKVEPLDFGGTQKQKQLFIGGEACLWGEYVDATNLTPRLWPRASAVGERLWSSKDVRDMDDAYDRLTRHRCRMVERGIAAQPLYAGYCNHENM	0.6275132	-0.672282243	0.004682102	5.7501337	5.6449273	4.5420655	6.0883474	6.253457	4.5459309	5.828287548	4.9629684	6.9700708	6.4172197	6.1100621	5.836928	5.38069426	5.4521725	4.6668776	5.757509	5.8103083	4.5861922	2.763740271	4.5364035	4.1676516	5.3003561	6.5357559	6.1692043	4.66784686	6.23540558	5.737847	7.441238	6.0499917	5.963876	5.6090044	5.614043	5.6018707	6.2818839	5.5675473	5.6430461	6.7080893	5.7346888	6.847662	5.9978521	6.34569253	6.5242539	5.1616303	5.72408394																																						
A0A024R674	tr|A0A024R674|A0A024R674_HUMAN		SPTB		Spectrin beta chain OS=Homo sapiens OX=9606 GN=SPTB PE=3 SV=1	6710	NM_001355436	NP_001342365	ENST00000644917				MTSATEFENVGNQPPYSRINARWDAPDDELDNDNSSARLFERSRIKALADEREVVQKKTFTKWVNSHLARVSCRITDLYKDLRDGRMLIKLLEVLSGEMLPKPTKGKMRIHCLENVDKALQFLKEQRVHLENMGSHDIVDGNHRLVLGLIWTIILRFQIQDIVVQTQEGRETRSAKDALLLWCQMKTAGYPHVNVTNFTSSWKDGLAFNALIHKHRPDLIDFDKLKDSNARHNLEHAFNVAERQLGIIPLLDPEDVFTENPDEKSIITYVVAFYHYFSKMKVLAVEGKRVGKVIDHAIETEKMIEKYSGLASDLLTWIEQTITVLNSRKFANSLTGVQQQLQAFSTYRTVEKPPKFQEKGNLEVLLFTIQSRMRANNQKVYTPHDGKLVSDINRAWESLEEAEYRRELALRNELIRQEKLEQLARRFDRKAAMRETWLSENQRLVAQDNFGYDLAAVEAAKKKHEAIETDTAAYEERVRALEDLAQELEKENYHDQKRITARKDNILRLWSYLQELLQSRRQRLETTLALQKLFQDMLHSIDWMDEIKAHLLSAEFGKHLLEVEDLLQKHKLMEADIAIQGDKVKAITAATLKFTEGKGYQPCDPQVIQDRISHLEQCFEELSNMAAGRKAQLEQSKRLWKFFWEMDEAESWIKEKEQIYSSLDYGKDLTSVLILQRKHKAFEDELRGLDAHLEQIFQEAHGMVARKQFGHPQIEARIKEVSAQWDQLKDLAAFCKKNLQDAENFFQFQGDADDLKAWLQDAHRLLSGEDVGQDEGATRALGKKHKDFLEELEESRGVMEHLEQQAQGFPEEFRDSPDVTHRLQALRELYQQVVAQADLRQQRLQEALDLYTVFGETDACELWMGEKEKWLAEMEMPDTLEDLEVVQHRFDILDQEMKTLMTQIDGVNLAANSLVESGHPRSREVKQYQDHLNTRWQAFQTLVSERREAVDSALRVHNYCVDCEETSKWITDKTKVVESTKDLGRDLAGIIAIQRKLSGLERDVAAIQARVDALERESQQLMDSHPEQKEDIGQRQKHLEELWQGLQQSLQGQEDLLGEVSQLQAFLQDLDDFQAWLSITQKAVASEDMPESLPEAEQLLQQHAGIKDEIDGHQDSYQRVKESGEKVIQGQTDPEYLLLGQRLEGLDTGWDALGRMWESRSHTLAQCLGFQEFQKDAKQAEAILSNQEYTLAHLEPPDSLEAAEAGIRKFEDFLGSMENNRDKVLSPVDSGNKLVAEGNLYSDKIKEKVQLIEDRHRKNNEKAQEASVLLRDNLELQNFLQNCQELTLWINDKLLTSQDVSYDEARNLHNKWLKHQAFVAELASHEGWLENIDAEGKQLMDEKPQFTALVSQKLEALHRLWDELQATTKEKTQHLSAARSSDLRLQTHADLNKWISAMEDQLRSDDPGKDLTSVNRMLAKLKALEDQVNVRKEELGELFAQVPSMGEEGGDADLSIEKRFLDLLEPLGRRKKQLESSRAKLQISRDLEDETLWVEERLPLAQSADYGTNLQTVQLFMKKNQTLQNEILGHTPRVEDVLQRGQQLVEAAEIDCQDLEERLGHLQSSWDRLREAAAGRLQRLRDANEAQQYYLDADEAEAWIGEQELYVISDEIPKDEEGAIVMLKRHLRQQRAVEDYGRNIKQLASRAQGLLSAGHPEGEQIIRLQGQVDKHYAGLKDVAEERKRKLENMYHLFQLKRETDDLEQWISEKELVASSPEMGQDFDHVTLLRDKFRDFARETGAIGQERVDNVNAFIERLIDAGHSEAATIAEWKDGLNEMWADLLELIDTRMQLLAASYDLHRYFYTGAEILGLIDEKHRELPEDVGLDASTAESFHRVHTAFERELHLLGVQVQQFQDVATRLQTAYAGEKAEAIQNKEQEVSAAWQALLDACAGRRTQLVDTADKFRFFSMARDLLSWMESIIRQIETQERPRDVSSVELLMKYHQGINAEIETRSKNFSACLELGESLLQRQHQASEEIREKLQQVMSRRKEMNEKWEARWERLRMLLEVCQFSRDASVAEAWLIAQEPYLASGDFGHTVDSVEKLIKRHEAFEKSTASWAERFAALEKPTTLELKERQIAERPAEETGPQEEEGETAGEAPVSHHAATERTSPGEEEGTWPQNLQQPPPPGQHKDGQKSTGDERPTTEPLFKVLDTPLSEGDEPATLPAPRDHGQSVQMEGYLGRKHDLEGPNKKASNRSWNNLYCVLRNSELTFYKDAKNLALGMPYHGEEPLALRHAICEIAANYKKKKHVFKLRLSNGSEWLFHGKDEEEMLSWLQGVSTAINESQSIRVKAQSLPLPSLSGPDASLGKKDKEKRFSFFPKKK	0.4419115	-1.17817051	0.02569976									4.2212293	4.7883696		4.8899076				5.3000412		5.1037825				5.7719919	5.2075661					8.571134	7.4421541	7.866684	7.2022051	4.480593		5.8710383	5.0063204	4.484326	6.3298566	4.83071	6.222113	6.2125229	5.78405004	6.4135197		7.1267929		H00230///Hereditary spherocytosis+++H00231///Hereditary elliptocytosis+++H01810///Congenital myopathy			GO:0005737///cytoplasm+++GO:0005829///cytosol+++GO:0005856///cytoskeleton+++GO:0005886///plasma membrane+++GO:0005938///cell cortex+++GO:0008091///spectrin+++GO:0009986///cell surface+++GO:0014731///spectrin-associated cytoskeleton+++GO:0015629///actin cytoskeleton+++GO:0030054///cell junction+++GO:0030864///cortical actin cytoskeleton+++GO:0031235///intrinsic component of the cytoplasmic side of the plasma membrane+++GO:0032991///protein-containing complex+++GO:0042995///cell projection	GO:0003779///actin binding+++GO:0005200///structural constituent of cytoskeleton+++GO:0005515///protein binding+++GO:0005543///phospholipid binding+++GO:0030506///ankyrin binding+++GO:0051015///actin filament binding	GO:0007010///cytoskeleton organization+++GO:0030036///actin cytoskeleton organization+++GO:0051693///actin filament capping			"Homo sapiens spectrin beta, erythrocytic (SPTB), transcript variant 1, mRNA."			R-HSA-1266738///Developmental Biology+++R-HSA-162582///Signal Transduction+++R-HSA-199977///ER to Golgi Anterograde Transport+++R-HSA-199991///Membrane Trafficking+++R-HSA-373760///L1CAM interactions+++R-HSA-375165///NCAM signaling for neurite out-growth+++R-HSA-392499///Metabolism of proteins+++R-HSA-422475///Axon guidance+++R-HSA-445095///Interaction between L1 and Ankyrins+++R-HSA-446203///Asparagine N-linked glycosylation+++R-HSA-5653656///Vesicle-mediated transport+++R-HSA-5673001///RAF/MAP kinase cascade+++R-HSA-5683057///MAPK family signaling cascades+++R-HSA-5684996///MAPK1/MAPK3 signaling+++R-HSA-597592///Post-translational protein modification+++R-HSA-6807878///COPI-mediated anterograde transport+++R-HSA-948021///Transport to the Golgi and subsequent modification+++R-HSA-9675108///Nervous system development					[A0A024R674_HUMAN|Unreviewed]RecName: Full=Spectrin beta chain {ECO:0000256|PIRNR:PIRNR002297};+++[A1YZ73_HUMAN|Unreviewed]SubName: Full=Beta-spectrin {ECO:0000313|EMBL:ABL96684.1}; Flags: Fragment;+++[B2RMN7_HUMAN|Unreviewed]RecName: Full=Spectrin beta chain {ECO:0000256|PIRNR:PIRNR002297};	chr14q23///Ensembl 103 genes in cytogenetic band chr14q23			REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION///Asparagine N-linked glycosylation+++REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT///COPI-mediated anterograde transport+++REACTOME_DEVELOPMENTAL_BIOLOGY///Developmental Biology+++REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT///ER to Golgi Anterograde Transport+++REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS///Interaction between L1 and Ankyrins+++REACTOME_L1CAM_INTERACTIONS///L1CAM interactions+++REACTOME_MAPK_FAMILY_SIGNALING_CASCADES///MAPK family signaling cascades+++REACTOME_MEMBRANE_TRAFFICKING///Membrane Trafficking+++REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH///NCAM signaling for neurite out-growth+++REACTOME_NERVOUS_SYSTEM_DEVELOPMENT///Nervous system development+++REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION///Post-translational protein modification+++REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION///Transport to the Golgi and subsequent modification+++REACTOME_VESICLE_MEDIATED_TRANSPORT///Vesicle-mediated transport		"AGGAAGC_MIR5163P///Genes having at least one occurence of the motif AGGAAGC in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-516-3p (v7.1 miRBase).+++CACCAGC_MIR138///Genes having at least one occurence of the motif CACCAGC in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-138 (v7.1 miRBase).+++CAGCCTC_MIR4855P///Genes having at least one occurence of the motif CAGCCTC in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-485-5p (v7.1 miRBase).+++CAGTATT_MIR200B_MIR200C_MIR429///Genes having at least one occurence of the motif CAGTATT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-200b, hsa-miR-200c and hsa-miR-429 (v7.1 miRBase).+++CTCAGGG_MIR125B_MIR125A///Genes having at least one occurence of the motif CTCAGGG in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-125b and hsa-miR-125a (v7.1 miRBase)."	LET_7A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-let-7a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++LET_7B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-let-7b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++LET_7F_1_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-let-7f-1-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR125A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-125a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR125B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-125b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1343_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1343-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR138_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-138-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR185_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-185-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR18A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-18a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1913///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1913 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3059_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3059-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3175///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3175 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4306///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4306 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4319///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4319 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR432_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-432-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4644///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4644 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4666A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4666a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4747_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4747-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR485_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-485-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5196_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5196-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6529_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6529-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6749_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6749-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6825_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6825-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6826_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6826-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6884_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6884-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6889_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6889-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR92A_2_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-92a-2-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR939_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-939-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR98_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-98-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).	AACTTT_UNKNOWN///Genes having at least one occurence of the highly conserved motif M17 AACTTT in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++AFP1_Q6///Genes having at least one occurence of the transcription factor binding site V$AFP1_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++AP2_Q6///Genes having at least one occurence of the transcription factor binding site V$AP2_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++CART1_01///Genes having at least one occurence of the transcription factor binding site V$CART1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++CREL_01///Genes having at least one occurence of the transcription factor binding site V$CREL_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++CTAWWWATA_RSRFC4_Q2///Genes having at least one occurence of the highly conserved motif M28 CTAWWWATA sites. The motif matches transcription factor binding site V$RSRFC4_Q2 (v7.4 TRANSFAC).+++DR4_Q2///Genes having at least one occurence of the transcription factor binding site V$DR4_Q2 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++E12_Q6///Genes having at least one occurence of the transcription factor binding site V$E12_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++E2F_02///Genes having at least one occurence of the transcription factor binding site V$E2F_02 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++E2F1DP1_01///Genes having at least one occurence of the transcription factor binding site V$E2F1DP1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++E2F1DP1RB_01///Genes having at least one occurence of the transcription factor binding site V$E2F1DP1RB_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++E2F1DP2_01///Genes having at least one occurence of the transcription factor binding site V$E2F1DP2_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++E2F1_Q3///Genes having at least one occurence of the transcription factor binding site V$E2F1_Q3 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++E2F1_Q6///Genes having at least one occurence of the transcription factor binding site V$E2F1_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++E2F4DP1_01///Genes having at least one occurence of the transcription factor binding site V$E2F4DP1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++E2F4DP2_01///Genes having at least one occurence of the transcription factor binding site V$E2F4DP2_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++E2F_Q4///Genes having at least one occurence of the transcription factor binding site V$E2F_Q4 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++E2F_Q6///Genes having at least one occurence of the transcription factor binding site V$E2F_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++EGR1_01///Genes having at least one occurence of the transcription factor binding site V$EGR1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++EGR2_01///Genes having at least one occurence of the transcription factor binding site V$EGR2_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++EGR_Q6///Genes having at least one occurence of the transcription factor binding site V$EGR_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++FREAC7_01///Genes having at least one occurence of the transcription factor binding site V$FREAC7_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++GATTGGY_NFY_Q6_01///Genes having at least one occurence of the highly conserved motif M5 GATTGGY sites. The motif matches transcription factor binding site V$NFY_Q6_01 (v7.4 TRANSFAC).+++GCANCTGNY_MYOD_Q6///Genes having at least one occurence of the highly conserved motif M35 GCANCTGNY sites. The motif matches transcription factor binding site V$MYOD_Q6 (v7.4 TRANSFAC).+++GGAMTNNNNNTCCY_UNKNOWN///Genes having at least one occurence of the highly conserved motif M74 GGAMTNNNNNTCCY in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++GGGTGGRR_PAX4_03///Genes having at least one occurence of the highly conserved motif M56 GGGTGGRR sites. The motif matches transcription factor binding site V$PAX4_03 (v7.4 TRANSFAC).+++GTGGGTGK_UNKNOWN///Genes having at least one occurence of the highly conserved motif M91 GTGGGTGK in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++GTTGNYNNRGNAAC_UNKNOWN///Genes having at least one occurence of the highly conserved motif M43 GTTGNYNNRGNAAC in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++HSF2_01///Genes having at least one occurence of the transcription factor binding site V$HSF2_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++LMO2COM_02///Genes having at least one occurence of the transcription factor binding site V$LMO2COM_02 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++MEF2_02///Genes having at least one occurence of the transcription factor binding site V$MEF2_02 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++MSX1_01///Genes having at least one occurence of the transcription factor binding site V$MSX1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++MYOD_Q6///Genes having at least one occurence of the transcription factor binding site V$MYOD_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++MYOGENIN_Q6///Genes having at least one occurence of the transcription factor binding site V$MYOGENIN_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++MZF1_01///Genes having at least one occurence of the transcription factor binding site V$MZF1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++NFKAPPAB_01///Genes having at least one occurence of the transcription factor binding site V$NFKAPPAB_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++NFKB_C///Genes having at least one occurence of the transcription factor binding site V$NFKB_C (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++NFKB_Q6///Genes having at least one occurence of the transcription factor binding site V$NFKB_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++NFY_C///Genes having at least one occurence of the transcription factor binding site V$NFY_C (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++NGFIC_01///Genes having at least one occurence of the transcription factor binding site V$NGFIC_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++NKX3A_01///Genes having at least one occurence of the transcription factor binding site V$NKX3A_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++POU1F1_Q6///Genes having at least one occurence of the transcription factor binding site V$POU1F1_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++POU3F2_01///Genes having at least one occurence of the transcription factor binding site V$POU3F2_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++RP58_01///Genes having at least one occurence of the transcription factor binding site V$RP58_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++TATAAA_TATA_01///Genes having at least one occurence of the highly conserved motif M51 TATAAA sites. The motif matches transcription factor binding site V$TATA_01 (v7.4 TRANSFAC).+++TBP_01///Genes having at least one occurence of the transcription factor binding site V$TBP_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++TGACAGNY_MEIS1_01///Genes having at least one occurence of the highly conserved motif M41 TGACAGNY sites. The motif matches transcription factor binding site V$MEIS1_01 (v7.4 TRANSFAC).+++TGGNNNNNNKCCAR_UNKNOWN///Genes having at least one occurence of the highly conserved motif M27 TGGNNNNNNKCCAR in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++TTANTCA_UNKNOWN///Genes having at least one occurence of the highly conserved motif M64 TTANTCA in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++WGGAATGY_TEF1_Q6///Genes having at least one occurence of the highly conserved motif M79 WGGAATGY sites. The motif matches transcription factor binding site V$TEF1_Q6 (v7.4 TRANSFAC).+++YAATNANRNNNCAG_UNKNOWN///Genes having at least one occurence of the highly conserved motif M147 YAATNANRNNNCAG in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++YTATTTTNR_MEF2_02///Genes having at least one occurence of the highly conserved motif M33 YTATTTTNR sites. The motif matches transcription factor binding site V$MEF2_02 (v7.4 TRANSFAC).	"CBFA2T2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O43439 (CBFA2T2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++CC2D1A_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6P1N0 (CC2D1A) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++COBLL1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q53SF7 (COBLL1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ID1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P41134 (ID1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++IGLV5_37_TARGET_GENES///Genes containing one or more binding sites for UniProt:A0A075B6J1 (IGLV5_37) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF134_TARGET_GENES///Genes containing one or more binding sites for UniProt:P52741 (ZNF134) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9BSG1 (ZNF2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF322_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6U7Q0 (ZNF322) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF423_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q2M1K9 (ZNF423) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."	GNF2_ANK1///Neighborhood of ANK1+++GNF2_BNIP3L///Neighborhood of BNIP3L+++GNF2_CDC27///Neighborhood of CDC27+++GNF2_MAP2K3///Neighborhood of MAP2K3+++GNF2_PCAF///Neighborhood of PCAF+++GNF2_PRDX2///Neighborhood of PRDX2+++GNF2_RAD23A///Neighborhood of RAD23A+++GNF2_SPTA1///Neighborhood of SPTA1+++GNF2_SPTB///Neighborhood of SPTB+++GNF2_TAL1///Neighborhood of TAL1+++MORF_DDX11///Neighborhood of DDX11+++MORF_FDXR///Neighborhood of FDXR+++MORF_PML///Neighborhood of PML+++MORF_RAGE///Neighborhood of RAGE+++MORF_TNFRSF25///Neighborhood of TNFRSF25	MODULE_111///Genes in the cancer module 111.+++MODULE_113///Genes in the cancer module 113.+++MODULE_157///Genes in the cancer module 157.+++MODULE_60///Heart genes.+++MODULE_7///Genes in the cancer module 7.	ALK_DN.V1_DN///Genes down-regulated in DAOY cells (medulloblastoma) upon knockdown of ALK [Gene ID=238] gene by RNAi.+++E2F3_UP.V1_DN///Genes down-regulated in primary epithelial breast cancer cell culture over-expressing E2F3 [Gene ID=1871] gene.+++MYC_UP.V1_DN///Genes down-regulated in primary epithelial breast cancer cell culture over-expressing MYC [Gene ID=4609] gene.+++PGF_UP.V1_DN///Genes down-regulated in HUVEC cells (endothelium) by treatment with PGF [Gene ID=5228].+++PRC2_SUZ12_UP.V1_UP///Genes up-regulated in TIG3 cells (fibroblasts) upon knockdown of SUZ12 [Gene ID=23512] gene.+++RPS14_DN.V1_DN///Genes down-regulated in CD34+ hematopoietic progenitor cells after knockdown of RPS14 [Gene ID=6208] by RNAi.	"GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_UP///Genes up-regulated in comparison of control microglia cells versus those 1 h after stimulation with IFNG [GeneID=3458].+++GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_DN///Genes down-regulated in comparison of CD4 [GeneID=920] thymocytes versus naive CD4 [GeneID=920] T cells from cord blood.+++GSE16385_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_DN///Genes down-regulated in macrophages (12h): IFNG and TNF [GeneID=3458;7124] versus IL4 [GeneID=3565].+++GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_2H_DN///Genes down-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 and IL4 [GeneID=7040;3565] (2h) versus IL4 [GeneID=3565] (2h).+++GSE34205_RSV_VS_FLU_INF_INFANT_PBMC_UP///Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from infancts with acute RSV infection versus PBMCs from infants with acute influenza infection.+++GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_DN///Genes down-regulated in comparison of dendritic cells (DC) exposed to 50 worms/well B. malayi versus DC exposed to M. tuberculosis+++GSE37416_CTRL_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_UP///Genes up-regulated in comparison of control polymorphonuclear leukocytes (PMN) at 3 h versus PMN treated with F. tularensis vaccine at 3 h.+++GSE7568_CTRL_VS_24H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_DN///Genes down-regulated in macrophages differentiated in the presence of IL4 [GeneID=3565] and dexamethasone [PubChem=5743] for 5 days versus those subsequently treated with TGFB1 [GeneID=7040] for 24h.+++NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN///Genes down-regulated in plasmacytoid dendritic cell 7d vs 0d in young adults (18-50) after exposure to FluMist , time point 7D"	HALLMARK_HEME_METABOLISM///Genes involved in metabolism of heme (a cofactor consisting of iron and porphyrin) and erythroblast differentiation.	NM_001355436	SPTB				
Q9Y5X9	sp|Q9Y5X9|LIPE_HUMAN		LIPG		Endothelial lipase OS=Homo sapiens OX=9606 GN=LIPG PE=1 SV=1 >tr|A0A024R2B5|A0A024R2B5_HUMAN Phospholipase A1 OS=Homo sapiens OX=9606 GN=LIPG PE=3 SV=1	9388	NM_006033	NP_006024	ENST00000261292	K22284			MSNSVPLLCFWSLCYCFAAGSPVPFGPEGRLEDKLHKPKATQTEVKPSVRFNLRTSKDPEHEGCYLSVGHSQPLEDCSFNMTAKTFFIIHGWTMSGIFENWLHKLVSALHTREKDANVVVVDWLPLAHQLYTDAVNNTRVVGHSIARMLDWLQEKDDFSLGNVHLIGYSLGAHVAGYAGNFVKGTVGRITGLDPAGPMFEGADIHKRLSPDDADFVDVLHTYTRSFGLSIGIQMPVGHIDIYPNGGDFQPGCGLNDVLGSIAYGTITEVVKCEHERAVHLFVDSLVNQDKPSFAFQCTDSNRFKKGICLSCRKNRCNSIGYNAKKMRNKRNSKMYLKTRAGMPFRVYHYQMKIHVFSYKNMGEIEPTFYVTLYGTNADSQTLPLEIVERIEQNATNTFLVYTEEDLGDLLKIQLTWEGASQSWYNLWKEFRSYLSQPRNPGRELNIRRIRVKSGETQRKLTFCTEDPENTSISPGRELWFRKCRDGWRMKNETSPTVELP	1.5727751	0.65331241	0.03010933				6.0671989	6.3701466			6.2596595										6.3189707					5.7833878			5.70766399	6.084218											4.8886149				5.9843833		5.15582134	00561///Glycerolipid metabolism+++04979///Cholesterol metabolism		M00098///Acylglycerol degradation	"R02250///triacylglycerol acylhydrolase   Triacylglycerol + H2O <=> 1,2-Diacyl-sn-glycerol + Fatty acid+++R02687///1,2-diacyl-sn-glycerol acylhydrolase   1,2-Diacyl-sn-glycerol + H2O <=> 1-Acylglycerol + Fatty acid"	GO:0005576///extracellular region+++GO:0005615///extracellular space+++GO:0005769///early endosome+++GO:0005794///Golgi apparatus+++GO:0009986///cell surface	GO:0004465///lipoprotein lipase activity+++GO:0004620///phospholipase activity+++GO:0004806///triglyceride lipase activity+++GO:0008201///heparin binding+++GO:0008970///phospholipase A1 activity+++GO:0016298///lipase activity+++GO:0016787///hydrolase activity+++GO:0046872///metal ion binding+++GO:0052689///carboxylic ester hydrolase activity+++GO:0052739///phosphatidylserine 1-acylhydrolase activity+++GO:0052740///1-acyl-2-lysophosphatidylserine acylhydrolase activity	GO:0006629///lipid metabolic process+++GO:0006633///fatty acid biosynthetic process+++GO:0007584///response to nutrient+++GO:0008283///cell proliferation+++GO:0009395///phospholipid catabolic process+++GO:0010983///positive regulation of high-density lipoprotein particle clearance+++GO:0016042///lipid catabolic process+++GO:0019433///triglyceride catabolic process+++GO:0032376///positive regulation of cholesterol transport+++GO:0034375///high-density lipoprotein particle remodeling+++GO:0042632///cholesterol homeostasis+++GO:0043691///reverse cholesterol transport+++GO:0050746///regulation of lipoprotein metabolic process+++GO:0055091///phospholipid homeostasis	tissueType=Large intestine;cancerType=Normal;cellName=LGR5+ stem cell		"Homo sapiens lipase G, endothelial type (LIPG), transcript variant 1, mRNA."		PF00151///Lipase+++PF01477///PLAT/LH2 domain	"R-HSA-174824///Plasma lipoprotein assembly, remodeling, and clearance+++R-HSA-382551///Transport of small molecules+++R-HSA-8963899///Plasma lipoprotein remodeling+++R-HSA-8964058///HDL remodeling"		ENOG502QU8P///No_INFO		"IPR000734///Triacylglycerol lipase family+++IPR001024///PLAT/LH2 domain+++IPR002330///Lipoprotein lipase+++IPR013818///Lipase+++IPR016272///Lipase, LIPH-type+++IPR029058///Alpha/Beta hydrolase fold+++IPR033906///Lipase, N-terminal+++IPR036392///PLAT/LH2 domain superfamily"	"[LIPE_HUMAN|Reviewed]RecName: Full=Endothelial lipase; EC=3.1.1.3 {ECO:0000269|PubMed:10192396, ECO:0000269|PubMed:10318835, ECO:0000269|PubMed:12032167}; AltName: Full=Endothelial cell-derived lipase; Short=EDL; Short=EL; AltName: Full=Phospholipase A1; EC=3.1.1.32 {ECO:0000269|PubMed:12032167}; Flags: Precursor;"	chr18q21///Ensembl 103 genes in cytogenetic band chr18q21		KEGG_GLYCEROLIPID_METABOLISM///Glycerolipid metabolism	"REACTOME_HDL_REMODELING///HDL remodeling+++REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY_REMODELING_AND_CLEARANCE///Plasma lipoprotein assembly, remodeling, and clearance+++REACTOME_PLASMA_LIPOPROTEIN_REMODELING///Plasma lipoprotein remodeling+++REACTOME_TRANSPORT_OF_SMALL_MOLECULES///Transport of small molecules"			LET_7A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-let-7a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++LET_7B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-let-7b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++LET_7F_1_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-let-7f-1-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR23A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-23a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR23B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-23b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4330///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4330 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4491///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4491 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4511///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4511 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4528///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4528 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4657///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4657 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4666A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4666a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4691_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4691-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5010_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5010-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6792_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6792-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR98_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-98-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).	AAANWWTGC_UNKNOWN///Genes having at least one occurence of the highly conserved motif M144 AAANWWTGC in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++CEBPDELTA_Q6///Genes having at least one occurence of the transcription factor binding site V$CEBPDELTA_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++CEBP_Q2_01///Genes having at least one occurence of the transcription factor binding site V$CEBP_Q2_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++CEBP_Q2///Genes having at least one occurence of the transcription factor binding site V$CEBP_Q2 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++CEBP_Q3///Genes having at least one occurence of the transcription factor binding site V$CEBP_Q3 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++DR4_Q2///Genes having at least one occurence of the transcription factor binding site V$DR4_Q2 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++GATA1_01///Genes having at least one occurence of the transcription factor binding site V$GATA1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++OCT1_01///Genes having at least one occurence of the transcription factor binding site V$OCT1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++OCT1_B///Genes having at least one occurence of the transcription factor binding site V$OCT1_B (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++OCT1_Q5_01///Genes having at least one occurence of the transcription factor binding site V$OCT1_Q5_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++OCT_Q6///Genes having at least one occurence of the transcription factor binding site V$OCT_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++POU3F2_02///Genes having at least one occurence of the transcription factor binding site V$POU3F2_02 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++POU6F1_01///Genes having at least one occurence of the transcription factor binding site V$POU6F1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++TCANNTGAY_SREBP1_01///Genes having at least one occurence of the highly conserved motif M18 TCANNTGAY sites. The motif matches transcription factor binding site V$SREBP1_01 (v7.4 TRANSFAC).+++YATGNWAAT_OCT_C///Genes having at least one occurence of the highly conserved motif M44 YATGNWAAT sites. The motif matches transcription factor binding site V$OCT_C (v7.4 TRANSFAC).	"ID2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q02363 (ID2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++PAX3_TARGET_GENES///Genes containing one or more binding sites for UniProt:P23760 (PAX3) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++PBXIP1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96AQ6 (PBXIP1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SMN1_SMN2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q16637 (SMN1_SMN2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++UBP1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9NZI7 (UBP1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF350_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9GZX5 (ZNF350) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF92_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q03936 (ZNF92) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZSCAN29_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8IWY8 (ZSCAN29) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."		MODULE_154///Intermediate filaments.+++MODULE_297///Genes in the cancer module 297.+++MODULE_342///Genes in the cancer module 342.+++MODULE_357///Intermediate filaments and keratins.	PTEN_DN.V2_UP///Genes up-regulated in HCT116 cells (colon carcinoma) upon knockdown of PTEN [Gene ID=5728] by RNAi.+++TBK1.DF_UP///Genes up-regulated in epithelial lung cancer cell lines upon over-expression of an oncogenic form of KRAS [Gene ID=3845] gene and knockdown of TBK1 [Gene ID=29110] gene by RNAi.+++TGFB_UP.V1_UP///Genes up-regulated in a panel of epithelial cell lines by TGFB1 [Gene ID=7040].	GSE10325_MYELOID_VS_LUPUS_MYELOID_UP///Genes up-regulated in comparison of healthy myeloid cells versus systemic lupus erythematosus myeloid cells.+++GSE14908_ATOPIC_VS_NONATOPIC_PATIENT_HDM_STIM_CD4_TCELL_DN///Genes down-regulated in CD4 [GeneID=920] T cells stimulated with allergen (house dust mite): atopy versus healthy.+++GSE1925_CTRL_VS_3H_IFNG_STIM_MACROPHAGE_DN///Genes down-regulated in macrophages: untreated versus stimulated by IFNG [GeneID=3458] for 3h.+++GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_TCELL_MEMBRANES_ACT_MAST_CELL_UP///Genes up-regulated in HMC-1 (mast leukemia) cells: incubated with the peptide ALL1 and then treated with Cl-IB-MECA [PubChem=3035850] versus stimulation by T cell membranes.+++GSE26928_NAIVE_VS_CXCR5_POS_CD4_TCELL_DN///Genes down-regulated in comparison of naive CD4 [GeneID=920] T cells versus CD4 [GeneID=920] CXCR5+ [GeneID=643] T cells.+++GSE2706_LPS_VS_R848_AND_LPS_8H_STIM_DC_DN///Genes down-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 8 h versus DCs stimulated with LPS (TLR4 agonist) and R848 for 8 h.+++GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_2H_DN///Genes down-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: IL4 [GeneID=3565] (2h) versus untreated (2h).+++GSE29617_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_2008_UP///Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from TIV influenza vaccinee pre-vaccination versus those at day 3 post-vaccination.+++GSE29617_CTRL_VS_TIV_FLU_VACCINE_PBMC_2008_UP///Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from TIV influenza vaccinee before vaccination versus that after the vaccination.+++GSE29617_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_UP///Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from TIV influenza vaccinee at day 3 post-vaccination versus those at day 7 post-vaccination.+++GSE34156_UNTREATED_VS_6H_NOD2_LIGAND_TREATED_MONOCYTE_DN///Genes down-regulated in monocytes (6h): untreated versus muramyl dipeptide [PubChem=11620162].+++GSE3982_DC_VS_MAC_DN///Genes down-regulated in comparison of dendritic cells (DC) versus macrophages.+++GSE3982_NKCELL_VS_TH1_UP///Genes up-regulated in comparison of NK cells versus Th1 cells.+++GSE9601_NFKB_INHIBITOR_VS_PI3K_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_DN///Genes down-regulated in monocytes after HCMV infection: BAY 11-7082 [PubChem=5353431] versus Ly294002 [PubChem=3973].		NM_006033	LIPG				
Q9Y5S2	sp|Q9Y5S2|MRCKB_HUMAN		CDC42BPB		Serine/threonine-protein kinase MRCK beta OS=Homo sapiens OX=9606 GN=CDC42BPB PE=1 SV=2 >tr|A0A024R6N2|A0A024R6N2_HUMAN Non-specific serine/threonine protein kinase OS=Homo sapiens OX=9606 GN=CDC42BPB PE=3 SV=1	9578	NM_006035	NP_006026	ENST00000361246				MSAKVRLKKLEQLLLDGPWRNESALSVETLLDVLVCLYTECSHSALRRDKYVAEFLEWAKPFTQLVKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGLNWENIRNLEAPYIPDVSSPSDTSNFDVDDDVLRNTEILPPGSHTGFSGLHLPFIGFTFTTESCFSDRGSLKSIMQSNTLTKDEDVQRDLEHSLQMEAYERRIRRLEQEKLELSRKLQESTQTVQSLHGSSRALSNSNRDKEIKKLNEEIERLKNKIADSNRLERQLEDTVALRQEREDSTQRLRGLEKQHRVVRQEKEELHKQLVEASERLKSQAKELKDAHQQRKLALQEFSELNERMAELRAQKQKVSRQLRDKEEEMEVATQKVDAMRQEMRRAEKLRKELEAQLDDAVAEASKERKLREHSENFCKQMESELEALKVKQGGRGAGATLEHQQEISKIKSELEKKVLFYEEELVRREASHVLEVKNVKKEVHDSESHQLALQKEILMLKDKLEKSKRERHNEMEEAVGTIKDKYERERAMLFDENKKLTAENEKLCSFVDKLTAQNRQLEDELQDLAAKKESVAHWEAQIAEIIQWVSDEKDARGYLQALASKMTEELEALRSSSLGSRTLDPLWKVRRSQKLDMSARLELQSALEAEIRAKQLVQEELRKVKDANLTLESKLKDSEAKNRELLEEMEILKKKMEEKFRADTGLKLPDFQDSIFEYFNTAPLAHDLTFRTSSASEQETQAPKPEASPSMSVAASEQQEDMARPPQRPSAVPLPTTQALALAGPKPKAHQFSIKSFSSPTQCSHCTSLMVGLIRQGYACEVCSFACHVSCKDGAPQVCPIPPEQSKRPLGVDVQRGIGTAYKGHVKVPKPTGVKKGWQRAYAVVCDCKLFLYDLPEGKSTQPGVIASQVLDLRDDEFSVSSVLASDVIHATRRDIPCIFRVTASLLGAPSKTSSLLILTENENEKRKWVGILEGLQSILHKNRLRNQVVHVPLEAYDSSLPLIKAILTAAIVDADRIAVGLEEGLYVIEVTRDVIVRAADCKKVHQIELAPREKIVILLCGRNHHVHLYPWSSLDGAEGSFDIKLPETKGCQLMATATLKRNSGTCLFVAVKRLILCYEIQRTKPFHRKFNEIVAPGSVQCLAVLRDRLCVGYPSGFCLLSIQGDGQPLNLVNPNDPSLAFLSQQSFDALCAVELESEEYLLCFSHMGLYVDPQGRRARAQELMWPAAPVACSCSPTHVTVYSEYGVDVFDVRTMEWVQTIGLRRIRPLNSEGTLNLLNCEPPRLIYFKSKFSGAVLNVPDTSDNSKKQMLRTRSKRRFVFKVPEEERLQQRREMLRDPELRSKMISNPTNFNHVAHMGPGDGMQVLMDLPLSAVPPSQEERPGPAPTNLARQPPSRNKPYISWPSSGGSEPSVTVPLRSMSDPDQDFDKEPDSDSTKHSTPSNSSNPSGPPSPNSPHRSQLPLEGLEQPACDT	0.5882713	-0.765446479	0.02429415									3.3561509	3.1412467						3.7847798						3.5740613	4.0002835						5.0413576		4.7307219								4.059922		3.56611425	3.9786381							GO:0005737///cytoplasm+++GO:0005829///cytosol+++GO:0005856///cytoskeleton+++GO:0005886///plasma membrane+++GO:0005911///cell-cell junction+++GO:0016020///membrane+++GO:0030027///lamellipodium+++GO:0030054///cell junction+++GO:0031252///cell leading edge+++GO:0042641///actomyosin+++GO:0042995///cell projection+++GO:0070062///extracellular exosome	GO:0000166///nucleotide binding+++GO:0000287///magnesium ion binding+++GO:0004672///protein kinase activity+++GO:0004674///protein serine/threonine kinase activity+++GO:0005515///protein binding+++GO:0005524///ATP binding+++GO:0016301///kinase activity+++GO:0016740///transferase activity+++GO:0031267///small GTPase binding+++GO:0044877///protein-containing complex binding+++GO:0046872///metal ion binding	GO:0006468///protein phosphorylation+++GO:0007010///cytoskeleton organization+++GO:0007163///establishment or maintenance of cell polarity+++GO:0007165///signal transduction+++GO:0016310///phosphorylation+++GO:0016477///cell migration+++GO:0018107///peptidyl-threonine phosphorylation+++GO:0030036///actin cytoskeleton organization+++GO:0031032///actomyosin structure organization+++GO:0031532///actin cytoskeleton reorganization+++GO:0035556///intracellular signal transduction			"Homo sapiens CDC42 binding protein kinase beta (CDC42BPB), mRNA."		PF00069///Protein kinase domain+++PF00130///Phorbol esters/diacylglycerol binding domain (C1 domain)+++PF00780///CNH domain+++PF08826///DMPK coiled coil domain like+++PF15796///KELK-motif containing domain of MRCK Ser/Thr protein kinase	"R-HSA-162582///Signal Transduction+++R-HSA-194315///Signaling by Rho GTPases+++R-HSA-9012999///RHO GTPase cycle+++R-HSA-9013148///CDC42 GTPase cycle+++R-HSA-9013406///RHOQ GTPase cycle+++R-HSA-9013409///RHOJ GTPase cycle+++R-HSA-9716542///Signaling by Rho GTPases, Miro GTPases and RHOBTB3"		KOG0612///protein serine/threonine kinase activity		"IPR000095///CRIB domain+++IPR000719///Protein kinase domain+++IPR000961///AGC-kinase, C-terminal+++IPR001180///Citron homology (CNH) domain+++IPR001849///Pleckstrin homology domain+++IPR002219///Protein kinase C-like, phorbol ester/diacylglycerol-binding domain+++IPR008271///Serine/threonine-protein kinase, active site+++IPR011009///Protein kinase-like domain superfamily+++IPR011993///PH-like domain superfamily+++IPR014930///Myotonic dystrophy protein kinase, coiled coil+++IPR017441///Protein kinase, ATP binding site+++IPR020454///Diacylglycerol/phorbol-ester binding+++IPR031597///KELK-motif containing domain+++IPR033232///Serine/threonine-protein kinase MRCK beta+++IPR042718///Serine/threonine-protein kinase MRCK beta, catalytic domain"	[MRCKB_HUMAN|Reviewed]RecName: Full=Serine/threonine-protein kinase MRCK beta; EC=2.7.11.1; AltName: Full=CDC42-binding protein kinase beta; Short=CDC42BP-beta; AltName: Full=DMPK-like beta; AltName: Full=Myotonic dystrophy kinase-related CDC42-binding kinase beta; Short=MRCK beta; Short=Myotonic dystrophy protein kinase-like beta;	chr14q32///Ensembl 103 genes in cytogenetic band chr14q32			"REACTOME_CDC42_GTPASE_CYCLE///CDC42 GTPase cycle+++REACTOME_RHO_GTPASE_CYCLE///RHO GTPase cycle+++REACTOME_RHOJ_GTPASE_CYCLE///RHOJ GTPase cycle+++REACTOME_RHOQ_GTPASE_CYCLE///RHOQ GTPase cycle+++REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3///Signaling by Rho GTPases, Miro GTPases and RHOBTB3"		"ACACTCC_MIR122A///Genes having at least one occurence of the motif ACACTCC in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-122a (v7.1 miRBase).+++ATGAAGG_MIR205///Genes having at least one occurence of the motif ATGAAGG in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-205 (v7.1 miRBase).+++CAGTGTT_MIR141_MIR200A///Genes having at least one occurence of the motif CAGTGTT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-141 and hsa-miR-200a (v7.1 miRBase).+++CTTTGTA_MIR524///Genes having at least one occurence of the motif CTTTGTA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-524* (v7.1 miRBase).+++GTGCCAA_MIR96///Genes having at least one occurence of the motif GTGCCAA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-96 (v7.1 miRBase).+++TTTGTAG_MIR520D///Genes having at least one occurence of the motif TTTGTAG in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-520d* (v7.1 miRBase)."	MIR1207_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1207-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1283///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1283 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1286///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1286 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR16_2_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-16-2-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR195_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-195-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR374A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-374a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR374B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-374b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3944_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3944-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4433A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4433a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4717_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4717-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4722_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4722-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4763_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4763-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR520D_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-520d-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR524_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-524-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AR_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548ar-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AZ_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548az-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548BC///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548bc in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548E_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548e-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548F_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548f-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5582_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5582-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR574_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-574-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6071///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6071 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6768_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6768-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7160_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7160-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR95_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-95-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).	AAGWWRNYGGC_UNKNOWN///Genes having at least one occurence of the highly conserved motif M63 AAGWWRNYGGC in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++CCAWNWWNNNGGC_UNKNOWN///Genes having at least one occurence of the highly conserved motif M165 CCAWNWWNNNGGC in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++CTTTGA_LEF1_Q2///Genes having at least one occurence of the highly conserved motif M73 CTTTGA sites. The motif matches transcription factor binding site V$LEF1_Q2 (v7.4 TRANSFAC).+++GGCNNMSMYNTTG_UNKNOWN///Genes having at least one occurence of the highly conserved motif M123 GGCNNMSMYNTTG in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++TCF4_Q5///Genes having at least one occurence of the transcription factor binding site V$TCF4_Q5 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++TGACAGNY_MEIS1_01///Genes having at least one occurence of the highly conserved motif M41 TGACAGNY sites. The motif matches transcription factor binding site V$MEIS1_01 (v7.4 TRANSFAC).+++ZF5_01///Genes having at least one occurence of the transcription factor binding site V$ZF5_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.	"FOXH1_TARGET_GENES///Genes containing one or more binding sites for UniProt:O75593 (FOXH1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++FXR1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P51114 (FXR1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HBZ_TARGET_GENES///Genes containing one or more binding sites for UniProt:P02008 (HBZ) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HMG20B_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9P0W2 (HMG20B) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++MAFG_TARGET_GENES///Genes containing one or more binding sites for UniProt:O15525 (MAFG) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF740_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8NDX6 (ZNF740) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."			MEK_UP.V1_UP///Genes up-regulated in MCF-7 cells (breast cancer) positive for ESR1 [Gene ID=2099] MCF-7 cells (breast cancer) stably over-expressing constitutively active MAP2K1 [Gene ID=5604] gene.	"GSE10500_ARTHRITIC_SYNOVIAL_FLUID_VS_HEALTHY_MACROPHAGE_DN///Genes down-regulated in macrophages from patients with synovial fluid rheumatoid arthritis versus monocyte-derived macrophages from healthy persons.+++GSE16385_IFNG_TNF_VS_ROSIGLITAZONE_STIM_MACROPHAGE_UP///Genes up-regulated in macrophages (12h): IFNG and TNF [GeneID=3458;7124] versus rosiglitazone [PubChem=77999].+++GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA5_STIM_CD8_TCELL_UP///Genes up-regulated in CD8 T cells activated by anti-CD3 and anti-CD28 versus those stimulated by IFNA5 [GeneID=3442].+++GSE18893_TCONV_VS_TREG_24H_CULTURE_UP///Genes up-regulated in lymphocytes treated with medium for 24h: T conv versus T reg cells.+++GSE19888_ADENOSINE_A3R_INH_VS_ACT_WITH_INHIBITOR_PRETREATMENT_IN_MAST_CELL_DN///Genes down-regulated in HMC-1 (mast leukemia) cells incubated the peptide ALL1 versus those followed by treatment with Cl-IB-MECA [PubChem=3035850].+++GSE22045_TREG_VS_TCONV_UP///Genes up-regulated in comparison of regulatory T cell (Treg) versus conventional T cells.+++GSE22103_LPS_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_DN///Genes down-regulated in neutrophils: LPS versus stimulated by CSF2 and IFNG [GeneID=1437;3458].+++GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH2_UP///Genes up-regulated in comparison of naive CD4 [GeneID=920] T cells versus stimulated CD4 [GeneID=920] Th2 cells at 48 h.+++GSE22886_NEUTROPHIL_VS_DC_DN///Genes down-regulated in comparison of neutrophils versus dendritic cells (DC).+++GSE22886_TH1_VS_TH2_48H_ACT_UP///Genes up-regulated in comparison of stimulated CD4 [GeneID=920] Th1 cells at 48 h versus stimulated CD4 [GeneID=920] Th2 cells at 48 h.+++GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_6H_DN///Genes down-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 and then stimulated by IL-12 (6h).+++GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_DN///Genes down-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 and then stimulated by TGFB1 [GeneID=7040] and IL-12 (2h).+++GSE3982_DC_VS_BASOPHIL_UP///Genes up-regulated in comparison of dendritic cells (DC) versus basophils.+++GSE3982_DC_VS_CENT_MEMORY_CD4_TCELL_UP///Genes up-regulated in comparison of dendritic cells (DC) versus central memory CD4 [GeneID=920] T cells.+++GSE3982_DC_VS_NEUTROPHIL_UP///Genes up-regulated in comparison of dendritic cells (DC) versus neutrophils.+++GSE3982_DC_VS_NKCELL_UP///Genes up-regulated in comparison of dendritic cells (DC) versus NK cells.+++GSE3982_DC_VS_TH1_UP///Genes up-regulated in comparison of dendritic cells (DC) versus Th1 cells.+++GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH1_UP///Genes up-regulated in comparison of effective memory CD4 [GeneID=920] T cells versus Th1 cells.+++GSE3982_EOSINOPHIL_VS_DC_DN///Genes down-regulated in comparison of eosinophils versus dendritic cells (DC).+++HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_POSITIVE///Genes positively correlated with memory B cell response at 28d in peripheral blood mononuclear cell in seniors (50-74) after exposure to Fluarix , time point 28D"		NM_006035	CDC42BPB				
Q9Y490	sp|Q9Y490|TLN1_HUMAN		TLN1		Talin-1 OS=Homo sapiens OX=9606 GN=TLN1 PE=1 SV=3	7094	NM_006289	NP_006280	ENST00000314888	K06271			MVALSLKISIGNVVKTMQFEPSTMVYDACRIIRERIPEAPAGPPSDFGLFLSDDDPKKGIWLEAGKALDYYMLRNGDTMEYRKKQRPLKIRMLDGTVKTIMVDDSKTVTDMLMTICARIGITNHDEYSLVRELMEEKKEEITGTLRKDKTLLRDEKKMEKLKQKLHTDDELNWLDHGRTLREQGVEEHETLLLRRKFFYSDQNVDSRDPVQLNLLYVQARDDILNGSHPVSFDKACEFAGFQCQIQFGPHNEQKHKAGFLDLKDFLPKEYVKQKGERKIFQAHKNCGQMSEIEAKVRYVKLARSLKTYGVSFFLVKEKMKGKNKLVPRLLGITKECVMRVDEKTKEVIQEWNLTNIKRWAASPKSFTLDFGDYQDGYYSVQTTEGEQIAQLIAGYIDIILKKKKSKDHFGLEGDEESTMLEDSVSPKKSTVLQQQYNRVGKVEHGSVALPAIMRSGASGPENFQVGSMPPAQQQITSGQMHRGHMPPLTSAQQALTGTINSSMQAVQAAQATLDDFDTLPPLGQDAASKAWRKNKMDESKHEIHSQVDAITAGTASVVNLTAGDPAETDYTAVGCAVTTISSNLTEMSRGVKLLAALLEDEGGSGRPLLQAAKGLAGAVSELLRSAQPASAEPRQNLLQAAGNVGQASGELLQQIGESDTDPHFQDALMQLAKAVASAAAALVLKAKSVAQRTEDSGLQTQVIAAATQCALSTSQLVACTKVVAPTISSPVCQEQLVEAGRLVAKAVEGCVSASQAATEDGQLLRGVGAAATAVTQALNELLQHVKAHATGAGPAGRYDQATDTILTVTENIFSSMGDAGEMVRQARILAQATSDLVNAIKADAEGESDLENSRKLLSAAKILADATAKMVEAAKGAAAHPDSEEQQQRLREAAEGLRMATNAAAQNAIKKKLVQRLEHAAKQAAASATQTIAAAQHAASTPKASAGPQPLLVQSCKAVAEQIPLLVQGVRGSQAQPDSPSAQLALIAASQSFLQPGGKMVAAAKASVPTIQDQASAMQLSQCAKNLGTALAELRTAAQKAQEACGPLEMDSALSVVQNLEKDLQEVKAAARDGKLKPLPGETMEKCTQDLGNSTKAVSSAIAQLLGEVAQGNENYAGIAARDVAGGLRSLAQAARGVAALTSDPAVQAIVLDTASDVLDKASSLIEEAKKAAGHPGDPESQQRLAQVAKAVTQALNRCVSCLPGQRDVDNALRAVGDASKRLLSDSLPPSTGTFQEAQSRLNEAAAGLNQAATELVQASRGTPQDLARASGRFGQDFSTFLEAGVEMAGQAPSQEDRAQVVSNLKGISMSSSKLLLAAKALSTDPAAPNLKSQLAAAARAVTDSINQLITMCTQQAPGQKECDNALRELETVRELLENPVQPINDMSYFGCLDSVMENSKVLGEAMTGISQNAKNGNLPEFGDAISTASKALCGFTEAAAQAAYLVGVSDPNSQAGQQGLVEPTQFARANQAIQMACQSLGEPGCTQAQVLSAATIVAKHTSALCNSCRLASARTTNPTAKRQFVQSAKEVANSTANLVKTIKALDGAFTEENRAQCRAATAPLLEAVDNLSAFASNPEFSSIPAQISPEGRAAMEPIVISAKTMLESAGGLIQTARALAVNPRDPPSWSVLAGHSRTVSDSIKKLITSMRDKAPGQLECETAIAALNSCLRDLDQASLAAVSQQLAPREGISQEALHTQMLTAVQEISHLIEPLANAARAEASQLGHKVSQMAQYFEPLTLAAVGAASKTLSHPQQMALLDQTKTLAESALQLLYTAKEAGGNPKQAAHTQEALEEAVQMMTEAVEDLTTTLNEAASAAGVVGGMVDSITQAINQLDEGPMGEPEGSFVDYQTTMVRTAKAIAVTVQEMVTKSNTSPEELGPLANQLTSDYGRLASEAKPAAVAAENEEIGSHIKHRVQELGHGCAALVTKAGALQCSPSDAYTKKELIECARRVSEKVSHVLAALQAGNRGTQACITAASAVSGIIADLDTTIMFATAGTLNREGTETFADHREGILKTAKVLVEDTKVLVQNAAGSQEKLAQAAQSSVATITRLADVVKLGAASLGAEDPETQVVLINAVKDVAKALGDLISATKAAAGKVGDDPAVWQLKNSAKVMVTNVTSLLKTVKAVEDEATKGTRALEATTEHIRQELAVFCSPEPPAKTSTPEDFIRMTKGITMATAKAVAAGNSCRQEDVIATANLSRRAIADMLRACKEAAYHPEVAPDVRLRALHYGRECANGYLELLDHVLLTLQKPSPELKQQLTGHSKRVAGSVTELIQAAEAMKGTEWVDPEDPTVIAENELLGAAAAIEAAAKKLEQLKPRAKPKEADESLNFEEQILEAAKSIAAATSALVKAASAAQRELVAQGKVGAIPANALDDGQWSQGLISAARMVAAATNNLCEAANAAVQGHASQEKLISSAKQVAASTAQLLVACKVKADQDSEAMKRLQAAGNAVKRASDNLVKAAQKAAAFEEQENETVVVKEKMVGGIAQIIAAQEEMLRKERELEEARKKLAQIRQQQYKFLPSELRDEH	0.407609	-1.294742092	0.004975673	6.9966998	9.1784449	8.5799345	8.6545786	9.2472889	10.1997173	8.471734478	9.8327419	11.2625845	11.3235026	11.0312573	11.6247404	7.46311815	9.4863846	10.0438991	10.6506026	7.6110221	8.2959087			10.2085934	10.9399757	11.0749989	7.4617962	8.21430367	8.19993205	7.4150853	12.75995	12.3585848	12.067873	12.8665728	10.711994	10.7476038	11.4237397	11.3871821	11.3486042	11.2608961	10.9527856	12.327583	11.1053242	10.9742879	11.982358	10.4078421	11.64803139	04015///Rap1 signaling pathway+++04510///Focal adhesion+++04611///Platelet activation+++05131///Shigellosis+++05166///Human T-cell leukemia virus 1 infection				GO:0001726///ruffle+++GO:0005576///extracellular region+++GO:0005737///cytoplasm+++GO:0005829///cytosol+++GO:0005856///cytoskeleton+++GO:0005886///plasma membrane+++GO:0005912///adherens junction+++GO:0005925///focal adhesion+++GO:0009986///cell surface+++GO:0016020///membrane+++GO:0030054///cell junction+++GO:0032587///ruffle membrane+++GO:0042995///cell projection+++GO:0070062///extracellular exosome	GO:0001786///phosphatidylserine binding+++GO:0003779///actin binding+++GO:0005178///integrin binding+++GO:0005200///structural constituent of cytoskeleton+++GO:0005515///protein binding+++GO:0017166///vinculin binding+++GO:0030274///LIM domain binding+++GO:0035091///phosphatidylinositol binding+++GO:0045296///cadherin binding+++GO:0051015///actin filament binding	GO:0002576///platelet degranulation+++GO:0006936///muscle contraction+++GO:0007010///cytoskeleton organization+++GO:0007043///cell-cell junction assembly+++GO:0007044///cell-substrate junction assembly+++GO:0007155///cell adhesion+++GO:0007229///integrin-mediated signaling pathway+++GO:0016032///viral process+++GO:0030866///cortical actin cytoskeleton organization+++GO:0033622///integrin activation+++GO:0036498///IRE1-mediated unfolded protein response+++GO:0070527///platelet aggregation+++GO:0098609///cell-cell adhesion	tissueType=Fetal kidney;cancerType=Normal;cellName=Natural killer T (NKT) cell+++tissueType=Embryonic prefrontal cortex;cancerType=Normal;cellName=Microglial cell		"Homo sapiens talin 1 (TLN1), mRNA."		"PF00373///FERM central domain+++PF01608///I/LWEQ domain+++PF08913///Vinculin Binding Site+++PF09141///Talin, middle domain+++PF16511///N-terminal or F0 domain of Talin-head FERM"	"R-HSA-109582///Hemostasis+++R-HSA-114608///Platelet degranulation +++R-HSA-1266738///Developmental Biology+++R-HSA-162582///Signal Transduction+++R-HSA-1643685///Disease+++R-HSA-2262752///Cellular responses to stress+++R-HSA-354192///Integrin signaling+++R-HSA-354194///GRB2:SOS provides linkage to MAPK signaling for Integrins +++R-HSA-372708///p130Cas linkage to MAPK signaling for integrins+++R-HSA-373755///Semaphorin interactions+++R-HSA-381038///XBP1(S) activates chaperone genes+++R-HSA-381070///IRE1alpha activates chaperones+++R-HSA-381119///Unfolded Protein Response (UPR)+++R-HSA-397014///Muscle contraction+++R-HSA-399955///SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion+++R-HSA-422475///Axon guidance+++R-HSA-445355///Smooth Muscle Contraction+++R-HSA-5663202///Diseases of signal transduction by growth factor receptors and second messengers+++R-HSA-5673001///RAF/MAP kinase cascade+++R-HSA-5674135///MAP2K and MAPK activation+++R-HSA-5683057///MAPK family signaling cascades+++R-HSA-5684996///MAPK1/MAPK3 signaling+++R-HSA-6802946///Signaling by moderate kinase activity BRAF mutants+++R-HSA-6802948///Signaling by high-kinase activity BRAF mutants+++R-HSA-6802949///Signaling by RAS mutants+++R-HSA-6802952///Signaling by BRAF and RAF1 fusions+++R-HSA-6802955///Paradoxical activation of RAF signaling by kinase inactive BRAF+++R-HSA-6802957///Oncogenic MAPK signaling+++R-HSA-76002///Platelet activation, signaling and aggregation+++R-HSA-76005///Response to elevated platelet cytosolic Ca2++++R-HSA-76009///Platelet Aggregation (Plug Formation)+++R-HSA-8953897///Cellular responses to stimuli+++R-HSA-9649948///Signaling downstream of RAS mutants+++R-HSA-9656223///Signaling by RAF1 mutants+++R-HSA-9675108///Nervous system development"		KOG4261///cytoskeletal anchoring at plasma membrane		"IPR000299///FERM domain+++IPR002558///I/LWEQ domain+++IPR011993///PH-like domain superfamily+++IPR014352///FERM/acyl-CoA-binding protein superfamily+++IPR015009///Vinculin-binding site-containing domain+++IPR015224///Talin, central+++IPR019747///FERM conserved site+++IPR019748///FERM central domain+++IPR019749///Band 4.1 domain+++IPR029071///Ubiquitin-like domain superfamily+++IPR032425///Talin, N-terminal F0 domain+++IPR035963///FERM superfamily, second domain+++IPR035964///I/LWEQ domain superfamily+++IPR036476///Talin, central domain superfamily+++IPR036723///Alpha-catenin/vinculin-like superfamily+++IPR037438///Talin-1/2, rod-segment"	[TLN1_HUMAN|Reviewed]RecName: Full=Talin-1;+++[A0A1S5UZ07_HUMAN|Unreviewed]SubName: Full=Talin-1 {ECO:0000313|EMBL:AQN67632.1};	chr9p13///Ensembl 103 genes in cytogenetic band chr9p13	BIOCARTA_CHEMICAL_PATHWAY///Apoptotic Signaling in Response to DNA Damage+++BIOCARTA_ECM_PATHWAY///Erk and PI-3 Kinase Are Necessary for Collagen Binding in Corneal Epithelia+++BIOCARTA_INTEGRIN_PATHWAY///Integrin Signaling Pathway+++BIOCARTA_MCALPAIN_PATHWAY///mCalpain and friends in Cell motility+++BIOCARTA_RHO_PATHWAY///Rho cell motility signaling pathway+++BIOCARTA_UCALPAIN_PATHWAY///uCalpain and friends in Cell spread	KEGG_FOCAL_ADHESION///Focal adhesion	"REACTOME_DEVELOPMENTAL_BIOLOGY///Developmental Biology+++REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS///Diseases of signal transduction by growth factor receptors and second messengers+++REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS///GRB2:SOS provides linkage to MAPK signaling for Integrins +++REACTOME_HEMOSTASIS///Hemostasis+++REACTOME_INTEGRIN_SIGNALING///Integrin signaling+++REACTOME_IRE1ALPHA_ACTIVATES_CHAPERONES///IRE1alpha activates chaperones+++REACTOME_MAP2K_AND_MAPK_ACTIVATION///MAP2K and MAPK activation+++REACTOME_MAPK_FAMILY_SIGNALING_CASCADES///MAPK family signaling cascades+++REACTOME_MUSCLE_CONTRACTION///Muscle contraction+++REACTOME_NERVOUS_SYSTEM_DEVELOPMENT///Nervous system development+++REACTOME_ONCOGENIC_MAPK_SIGNALING///Oncogenic MAPK signaling+++REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS///p130Cas linkage to MAPK signaling for integrins+++REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION///Platelet activation, signaling and aggregation+++REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION///Platelet Aggregation (Plug Formation)+++REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2///Response to elevated platelet cytosolic Ca2++++REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION///SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion+++REACTOME_SEMAPHORIN_INTERACTIONS///Semaphorin interactions+++REACTOME_SIGNALING_BY_BRAF_AND_RAF_FUSIONS///Signaling by BRAF and RAF fusions+++REACTOME_SIGNALING_BY_MODERATE_KINASE_ACTIVITY_BRAF_MUTANTS///Signaling by moderate kinase activity BRAF mutants+++REACTOME_SMOOTH_MUSCLE_CONTRACTION///Smooth Muscle Contraction+++REACTOME_UNFOLDED_PROTEIN_RESPONSE_UPR///Unfolded Protein Response (UPR)"		"ACCAAAG_MIR9///Genes having at least one occurence of the motif ACCAAAG in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-9 (v7.1 miRBase).+++CAGCACT_MIR5123P///Genes having at least one occurence of the motif CAGCACT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-512-3p (v7.1 miRBase).+++CCCAGAG_MIR326///Genes having at least one occurence of the motif CCCAGAG in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-326 (v7.1 miRBase).+++CTCCAAG_MIR432///Genes having at least one occurence of the motif CTCCAAG in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-432 (v7.1 miRBase).+++GAGACTG_MIR452///Genes having at least one occurence of the motif GAGACTG in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-452* (v7.1 miRBase).+++GTATTAT_MIR3693P///Genes having at least one occurence of the motif GTATTAT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-369-3p (v7.1 miRBase).+++GTGCCTT_MIR506///Genes having at least one occurence of the motif GTGCCTT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-506 (v7.1 miRBase).+++TCCCCAC_MIR491///Genes having at least one occurence of the motif TCCCCAC in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-491 (v7.1 miRBase)."	MIR1207_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1207-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR124_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-124-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR153_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-153-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR200B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-200b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR200C_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-200c-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR20A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-20a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3150A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3150a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR330_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-330-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4260///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4260 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4269///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4269 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR429///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-429 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR432_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-432-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR450A_2_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-450a-2-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4527///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4527 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4731_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4731-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4736///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4736 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4763_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4763-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR506_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-506-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR514A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-514a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5572///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5572 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6503_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6503-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6715B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6715b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6721_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6721-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6763_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6763-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7155_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7155-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).	AML_Q6///Genes having at least one occurence of the transcription factor binding site V$AML_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++AP2_Q3///Genes having at least one occurence of the transcription factor binding site V$AP2_Q3 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++AP2_Q6///Genes having at least one occurence of the transcription factor binding site V$AP2_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++CATRRAGC_UNKNOWN///Genes having at least one occurence of the highly conserved motif M134 CATRRAGC in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++CP2_02///Genes having at least one occurence of the transcription factor binding site V$CP2_02 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++CRGAARNNNNCGA_UNKNOWN///Genes having at least one occurence of the highly conserved motif M100 CRGAARNNNNCGA in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++ELF1_Q6///Genes having at least one occurence of the transcription factor binding site V$ELF1_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++ER_Q6_02///Genes having at least one occurence of the transcription factor binding site V$ER_Q6_02 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++ETS2_B///Genes having at least one occurence of the transcription factor binding site V$ETS2_B (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++GATA1_01///Genes having at least one occurence of the transcription factor binding site V$GATA1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++GATA4_Q3///Genes having at least one occurence of the transcription factor binding site V$GATA4_Q3 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++GGATTA_PITX2_Q2///Genes having at least one occurence of the highly conserved motif M93 GGATTA sites. The motif matches transcription factor binding site V$PITX2_Q2 (v7.4 TRANSFAC).+++GGGTGGRR_PAX4_03///Genes having at least one occurence of the highly conserved motif M56 GGGTGGRR sites. The motif matches transcription factor binding site V$PAX4_03 (v7.4 TRANSFAC).+++HIF1_Q5///Genes having at least one occurence of the transcription factor binding site V$HIF1_Q5 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++MGGAAGTG_GABP_B///Genes having at least one occurence of the highly conserved motif M11 MGGAAGTG sites. The motif matches transcription factor binding site V$GABP_B (v7.4 TRANSFAC).+++NERF_Q2///Genes having at least one occurence of the transcription factor binding site V$NERF_Q2 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++PAX4_03///Genes having at least one occurence of the transcription factor binding site V$PAX4_03 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++PITX2_Q2///Genes having at least one occurence of the transcription factor binding site V$PITX2_Q2 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++RACCACAR_AML_Q6///Genes having at least one occurence of the highly conserved motif M111 RACCACAR sites. The motif matches transcription factor binding site V$AML_Q6 (v7.4 TRANSFAC).+++RGAGGAARY_PU1_Q6///Genes having at least one occurence of the highly conserved motif M50 RGAGGAARY sites. The motif matches transcription factor binding site V$PU1_Q6 (v7.4 TRANSFAC).+++RYTTCCTG_ETS2_B///Genes having at least one occurence of the highly conserved motif M16 RYTTCCTG sites. The motif matches transcription factor binding site V$ETS2_B (v7.4 TRANSFAC).+++TGACCTY_ERR1_Q2///Genes having at least one occurence of the highly conserved motif M25 TGACCTY sites. The motif matches transcription factor binding site V$ERR1_Q2 (v7.4 TRANSFAC).+++ZID_01///Genes having at least one occurence of the transcription factor binding site V$ZID_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.	"ARNT2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9HBZ2 (ARNT2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++CDC73_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6P1J9 (CDC73) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++EWSR1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q01844 (EWSR1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++FOXD2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O60548 (FOXD2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++FOXG1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P55316 (FOXG1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++GCM2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O75603 (GCM2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HMGB1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P09429 (HMGB1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HOXD1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9GZZ0 (HOXD1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ID1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P41134 (ID1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NCOA4_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q13772 (NCOA4) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NPM1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P06748 (NPM1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++POU2AF1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q16633 (POU2AF1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++RYBP_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8N488 (RYBP) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SNIP1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8TAD8 (SNIP1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SQSTM1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q13501 (SQSTM1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SUPT16H_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9Y5B9 (SUPT16H) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++TCF7_TARGET_GENES///Genes containing one or more binding sites for UniProt:P36402 (TCF7) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++UBN1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9NPG3 (UBN1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++WRNIP1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96S55 (WRNIP1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZBTB12_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9Y330 (ZBTB12) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZBTB7B_TARGET_GENES///Genes containing one or more binding sites for UniProt:O15156 (ZBTB7B) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF10_TARGET_GENES///Genes containing one or more binding sites for UniProt:P21506 (ZNF10) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF134_TARGET_GENES///Genes containing one or more binding sites for UniProt:P52741 (ZNF134) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF423_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q2M1K9 (ZNF423) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF490_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9ULM2 (ZNF490) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF561_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8N587 (ZNF561) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF84_TARGET_GENES///Genes containing one or more binding sites for UniProt:P51523 (ZNF84) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZSCAN31_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96LW9 (ZSCAN31) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."		MODULE_136///Genes in the cancer module 136.+++MODULE_179///Blood cells and cancer expression cancer.+++MODULE_255///Genes in the cancer module 255.+++MODULE_317///Genes in the cancer module 317.+++MODULE_378///Genes in the cancer module 378.+++MODULE_37///Genes in the cancer module 37.+++MODULE_459///Genes in the cancer module 459.+++MODULE_532///Blood cells and cancer expression clusters.+++MODULE_69///Genes in the cancer module 69.	TBK1.DF_DN///Genes down-regulated in epithelial lung cancer cell lines upon over-expression of an oncogenic form of KRAS [Gene ID=3845] gene and knockdown of TBK1 [Gene ID=29110] gene by RNAi.	"GSE13887_ACT_CD4_VS_NO_TREATED_CD4_TCELL_DN///Genes down-regulated in CD4 [GeneID=920] T cells from healthy donors: activated by anti-CD3 and anti-CD28 versus nitric oxide [PubChem=145068] treatment.+++GSE16385_MONOCYTE_VS_12H_IL4_TREATED_MACROPHAGE_DN///Genes down-regulated in monocytes (12h) versus macrophages (12h) treated with IL4 [GeneID=3565].+++GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_6H_IFNA_STIM_DN///Genes down-regulated in neuron cell line treated with interferon alpha for 6h: immature versus mature.+++GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_IN_MAST_CELL_UP///Genes up-regulated in HMC-1 (mast leukemia) cells: Cl-IB-MECA [PubChem=3035850] versus T cell membranes.+++GSE22611_UNSTIM_VS_2H_MDP_STIM_NOD2_TRANSDUCED_HEK293T_CELL_UP///Genes up-regulated in HEK293 cells over-expressing wildtype NOD2 [GeneID=64127]: untreated versus muramyl dipeptide [PubChem=11620162] for 2h.+++GSE22886_UNSTIM_VS_IL2_STIM_NKCELL_DN///Genes down-regulated in comparison of unstimulated NK cells versus those stimulated with IL2 [GeneID=3558] at 16 h.+++GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MDC_UP///Genes up-regulated in comparison of myeloid dendritic cells from LAIV influenza vaccinee at day 7 post-vaccination vesus those from TIV influenza vaccinee at day 7.+++GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_PDC_DN///Genes down-regulated in comparison of plasmacytoid dendritic cells (pDC) from TIV influenza vaccinee pre-vaccination versus those at day 7 post-vaccination.+++GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_DN///Genes down-regulated in monocytes (6h): muramyl dipeptide [PubChem=11620162] versus M. tuberculosis 19 kDa lipopeptide.+++GSE34156_TLR1_TLR2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_UP///Genes up-regulated in monocytes (24h): M. tuberculosis 19 kDa lipopeptide versus M. tuberculosis 19 kDa lipopeptide and muramyl dipeptide [PubChem=11620162].+++GSE34156_UNTREATED_VS_24H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP///Genes up-regulated in monocytes (24h): untreated versus muramyl dipeptide [PubChem=11620162] andM. tuberculosis 19 kDa lipopeptide.+++GSE34156_UNTREATED_VS_24H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP///Genes up-regulated in monocytes (24h): untreated versus M. tuberculosis 19 kDa lipopeptide.+++GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_UP///Genes up-regulated in epithelial cells (6h): untreated versus interferon alpha.+++GSE6269_FLU_VS_E_COLI_INF_PBMC_UP///Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from patients with acute influenza infection versus PBMC from patients with acute E. coli infection.+++GSE6269_HEALTHY_VS_FLU_INF_PBMC_DN///Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMC from patients with acute influenza infection.+++GSE7568_IL4_TGFB_DEXAMETHASONE_VS_IL4_TGFB_TREATED_MACROPHAGE_DN///Genes down-regulated in macrophages: 5 days with IL4 [GeneID=3565] and dexamethasone [PubChem=5743] followed by TGFB1 [GeneID=7040] for 24h versus 5 days with IL4 [GeneID=3565] followed by TGFB1 [GeneID=7040] for 24h.+++GSE7568_IL4_VS_IL4_AND_TGFB_TREATED_MACROPHAGE_24H_UP///Genes up-regulated in macrophages differentiated in the presence of IL4 [GeneID=3565] for 5 days versus those subsequently treated with TGFB1 [GeneID=7040] for 24h.+++GSE9601_UNTREATED_VS_PI3K_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_UP///Genes up-regulated in monocytes after HCMV infection: untreated versus Ly294002 [PubChem=3973].+++SCHERER_PBMC_APSV_WETVAX_AGE_18_32YO_50_TO_60DY_DN///Genes down-regulated in peripheral blood mononuclear cell (50 to 60)d vs 0d in adults (18-32) after exposure to APSV Wetvax , time point 50 to 60D"		NM_006289	TLN1				
Q9Y3C8	sp|Q9Y3C8|UFC1_HUMAN		UFC1		Ubiquitin-fold modifier-conjugating enzyme 1 OS=Homo sapiens OX=9606 GN=UFC1 PE=1 SV=3	51506	NM_016406	NP_057490	ENST00000368003				MADEATRRVVSEIPVLKTNAGPRDRELWVQRLKEEYQSLIRYVENNKNADNDWFRLESNKEGTRWFGKCWYIHDLLKYEFDIEFDIPITYPTTAPEIAVPELDGKTAKMYRGGKICLTDHFKPLWARNVPKFGLAHLMALGLGPWLAVEIPDLIQKGVIQHKEKCNQ	0.3710471	-1.43032566	1.66E-04	3.6034082	4.0229224	3.2794494	4.3054152	3.9375784	6.5434391	4.250293731	4.6864369	4.9430249	6.0919015	6.1880053	5.3332675	3.70466329	4.9364975	4.6061325	4.9812497	3.4197786	5.0275561		4.550861	5.2143834	4.826121	7.1642079	3.8797423	4.74280407	3.93217339	4.0679775	8.999691	7.6162794	7.867766	7.4310358	4.626651	6.2637997	6.5500454	6.7794166	6.0703016	6.6750545	5.1533992	7.641912	6.599513	5.05743555	6.852026	4.5041021	6.13242566		H02459///Syndromic neurodevelopmental disorder			GO:0070062///extracellular exosome	GO:0005515///protein binding+++GO:0061657///UFM1 conjugating enzyme activity+++GO:0071568///UFM1 transferase activity	GO:0007420///brain development+++GO:0034976///response to endoplasmic reticulum stress+++GO:0061709///reticulophagy+++GO:0071569///protein ufmylation+++GO:1990592///protein K69-linked ufmylation	tissueType=Lung;cancerType=Normal;cellName=Ciliated cell+++tissueType=Fetal kidney;cancerType=Normal;cellName=Natural killer T (NKT) cell		"Homo sapiens ubiquitin-fold modifier conjugating enzyme 1 (UFC1), mRNA."		PF08694///Ubiquitin-fold modifier-conjugating enzyme 1			KOG3357///UFM1 transferase activity		IPR014806///Ubiquitin-fold modifier-conjugating enzyme 1+++IPR016135///Ubiquitin-conjugating enzyme/RWD-like	[UFC1_HUMAN|Reviewed]RecName: Full=Ubiquitin-fold modifier-conjugating enzyme 1 {ECO:0000305}; Short=Ufm1-conjugating enzyme 1 {ECO:0000303|PubMed:15071506};	chr1q23///Ensembl 103 genes in cytogenetic band chr1q23						MIR208A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-208a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR208B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-208b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR646///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-646 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR9902///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-9902 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).	AR_Q6///Genes having at least one occurence of the transcription factor binding site V$AR_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++ATF_01///Genes having at least one occurence of the transcription factor binding site V$ATF_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++CETS1P54_01///Genes having at least one occurence of the transcription factor binding site V$CETS1P54_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++E4F1_Q6///Genes having at least one occurence of the transcription factor binding site V$E4F1_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++ELK1_01///Genes having at least one occurence of the transcription factor binding site V$ELK1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++GTGACGY_E4F1_Q6///Genes having at least one occurence of the highly conserved motif M20 GTGACGY sites. The motif matches transcription factor binding site V$E4F1_Q6 (v7.4 TRANSFAC).+++HTF_01///Genes having at least one occurence of the transcription factor binding site V$HTF_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++MGGAAGTG_GABP_B///Genes having at least one occurence of the highly conserved motif M11 MGGAAGTG sites. The motif matches transcription factor binding site V$GABP_B (v7.4 TRANSFAC).+++NRF2_01///Genes having at least one occurence of the transcription factor binding site V$NRF2_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++SCGGAAGY_ELK1_02///Genes having at least one occurence of the highly conserved motif M3 SCGGAAGY sites. The motif matches transcription factor binding site V$ELK1_02 (v7.4 TRANSFAC).+++STAT1_02///Genes having at least one occurence of the transcription factor binding site V$STAT1_02 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.	"ASH1L_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9NR48 (ASH1L) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++BANP_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8N9N5 (BANP) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++CBX7_TARGET_GENES///Genes containing one or more binding sites for UniProt:O95931 (CBX7) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++CIITA_TARGET_GENES///Genes containing one or more binding sites for UniProt:P33076 (CIITA) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++DIDO1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9BTC0 (DIDO1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++DLX4_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q92988 (DLX4) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ELF2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q15723 (ELF2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++GLI3_TARGET_GENES///Genes containing one or more binding sites for UniProt:P10071 (GLI3) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HMBOX1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6NT76 (HMBOX1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HOXA2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O43364 (HOXA2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ID1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P41134 (ID1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ISL1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P61371 (ISL1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++KAT5_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q92993 (KAT5) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++LHX2_TARGET_GENES///Genes containing one or more binding sites for UniProt:P50458 (LHX2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++MXD1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q05195 (MXD1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++MZF1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P28698 (MZF1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NFE2L1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q14494 (NFE2L1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NFRKB_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6P4R8 (NFRKB) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NKX2_2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O95096 (NKX2_2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++RORA_TARGET_GENES///Genes containing one or more binding sites for UniProt:P35398 (RORA) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++RUVBL1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9Y265 (RUVBL1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SETX_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q7Z333 (SETX) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++TAF9B_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9HBM6 (TAF9B) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++THAP1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9NVV9 (THAP1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++UBP1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9NZI7 (UBP1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZFHX3_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q15911 (ZFHX3) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF213_TARGET_GENES///Genes containing one or more binding sites for UniProt:O14771 (ZNF213) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9BSG1 (ZNF2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF407_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9C0G0 (ZNF407) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF664_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8N3J9 (ZNF664) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."				"GSE12198_CTRL_VS_LOW_IL2_STIM_NK_CELL_DN///Genes down-regulated in NK cells: primary versus stimulated by low dose of IL2 [GeneID=3558].+++GSE12845_IGD_NEG_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_UP///Genes up-regulated in comparison of IgD- peripheral blood B cells versus dark zone germinal center B cells.+++GSE12845_IGD_NEG_BLOOD_VS_NAIVE_TONSIL_BCELL_UP///Genes up-regulated in comparison of IgD- peripheral blood B cells versus dark zone germinal center B cells.+++GSE12845_IGD_NEG_BLOOD_VS_PRE_GC_TONSIL_BCELL_UP///Genes up-regulated in comparison of IgD- peripheral blood B cells versus pre-germinal center B cells.+++GSE13484_UNSTIM_VS_12H_YF17D_VACCINE_STIM_PBMC_UP///Genes up-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) cultured for 0 h versus PBMC cultured for 12 h with YF17D vaccine.+++GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_DN///Genes down-regulated in comparison of control microglia cells versus those 1 h after stimulation with IFNG [GeneID=3458].+++GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_ATOPIC_PATIENT_UP///Genes up-regulated in CD4 [GeneID=920] T cells from atopic patients: resting versus stimulated with allergen (house dust mite).+++GSE22229_RENAL_TRANSPLANT_IMMUNOSUPP_THERAPY_VS_HEALTHY_PBMC_DN///Genes down-regulated in periperal blood monocytes (PBMC): kidney transplant recipients receiving immunosuppression therapy versus healthy controls.+++GSE22611_UNSTIM_VS_2H_MDP_STIM_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_UP///Genes up-regulated in HEK293 cells expressing mutant NOD2 [GeneID=64127]: untreated versus muramyl dipeptide [PubChem=11620162] for 2h.+++GSE22611_UNSTIM_VS_6H_MDP_STIM_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_UP///Genes up-regulated in HEK293 cells expressing mutant NOD2 [GeneID=64127]: untreated versus muramyl dipeptide [PubChem=11620162] for 6h.+++GSE22886_NAIVE_TCELL_VS_NEUTROPHIL_UP///Genes up-regulated in comparison of naive CD4 [GeneID=920] CD8 T cells versus unstimulated neutrophils.+++GSE22886_NEUTROPHIL_VS_DC_DN///Genes down-regulated in comparison of neutrophils versus dendritic cells (DC).+++GSE22886_NEUTROPHIL_VS_MONOCYTE_DN///Genes down-regulated in comparison of neutrophils versusl monocytes.+++GSE2706_UNSTIM_VS_8H_LPS_AND_R848_DC_UP///Genes up-regulated in comparison of unstimulated dendritic cells (DC) at 0 h versus DCs stimulated with LPS (TLR4 agonist) and R848 for 8 h.+++GSE2706_UNSTIM_VS_8H_LPS_DC_UP///Genes up-regulated in comparison of unstimulated dendritic cells (DC) at 0 h versus DCs stimulated with LPS (TLR4 agonist) for 8 h.+++GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_2H_UP///Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 and IL4 [GeneID=7040;3565] (2h) versus IL-12 (2h).+++GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_48H_UP///Genes up-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 and then stimulated by IL4 [GeneID=3565] (48h).+++GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_2H_UP///Genes up-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 and then stimulated by TGFB1 and IL4 [GeneID=7040;3565] (2h).+++GSE33424_CD161_INT_VS_NEG_CD8_TCELL_DN///Genes down-regulated in CD8 T cells: KLRB1 int [GeneID=3820] versus KLRB1- [GeneID=3820].+++GSE34515_CD16_NEG_VS_POS_MONOCYTE_DN///Genes down-regulated in monocytes: CD16- versus CD16+.+++GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH1_DN///Genes down-regulated in comparison of central memory CD4 [GeneID=920] T cells versus Th1 cells.+++GSE3982_CTRL_VS_IGE_STIM_MAST_CELL_UP///Genes up-regulated in comparison of untreated mast cells versus mast cells treated with IgE at 2 h.+++GSE5142_CTRL_VS_HTERT_TRANSDUCED_CD8_TCELL_EARLY_PASSAGE_CLONE_DN///Genes down-regulated in CD8 T cells: control versus over-expressing TERT [GeneID=7015].+++GSE5679_PPARG_LIGAND_ROSIGLITAZONE_VS_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_UP///Genes up-regulated in monocyte-derived dendritic cells: rosiglitazone [PubChem=77999] versus rosiglitazone and AM580 [PubChem=77999;2126].+++GSE5679_RARA_AGONIST_AM580_VS_AM580_AND_ROSIGLITAZONE_TREATED_DC_UP///Genes up-regulated in monocyte-derived dendritic cells: AM580 [PubChem=2126] versus rosiglitazone and AM580 [PubChem=77999;2126].+++GSE9960_HEALTHY_VS_SEPSIS_PBMC_UP///Genes up-regulated in peripheral blood monocytes (PMBC): healthy versus sepsis.+++NAKAYA_B_CELL_FLUMIST_AGE_18_50YO_7DY_UP///Genes up-regulated in B cell 7d vs 0d in young adults (18-50) after exposure to FluMist , time point 7D"		NM_016406	UFC1				
Q9Y3C5	sp|Q9Y3C5|RNF11_HUMAN		RNF11		RING finger protein 11 OS=Homo sapiens OX=9606 GN=RNF11 PE=1 SV=1	26994	NM_014372	NP_055187	ENST00000242719				MGNCLKSPTSDDISLLHESQSDRASFGEGTEPDQEPPPPYQEQVPVPVYHPTPSQTRLATQLTEEEQIRIAQRIGLIQHLPKGVYDPGRDGSEKKIRECVICMMDFVYGDPIRFLPCMHIYHLDCIDDWLMRSFTCPSCMEPVDAALLSSYETN	0.4267229	-1.228628429	7.84E-04		4.0491229		4.2521403		6.4441309		5.4234904	6.061305	5.0521974	4.6566174	6.3664154		3.5182439	4.3540632	6.1207317		5.1056008			5.0740239	6.0525489	6.1364105					7.558969	8.0491884	7.810564	6.5270771	5.690072	6.2024435	6.7954319	5.7340016	5.2136282	6.5458758	6.0503415	7.339538	5.5170334	4.30594609	7.6152383	5.1612881	7.11593322					GO:0000151///ubiquitin ligase complex+++GO:0005634///nucleus+++GO:0005737///cytoplasm+++GO:0005768///endosome+++GO:0005769///early endosome+++GO:0055037///recycling endosome+++GO:0070062///extracellular exosome	GO:0003677///DNA binding+++GO:0005515///protein binding+++GO:0008270///zinc ion binding+++GO:0046872///metal ion binding+++GO:0061630///ubiquitin protein ligase activity	GO:0006511///ubiquitin-dependent protein catabolic process+++GO:0051865///protein autoubiquitination	tissueType=Fetal kidney;cancerType=Normal;cellName=Natural killer T (NKT) cell		"Homo sapiens ring finger protein 11 (RNF11), mRNA."		PF13639///Ring finger domain			KOG0800///ubiquitin-protein transferase activity		"IPR001841///Zinc finger, RING-type+++IPR013083///Zinc finger, RING/FYVE/PHD-type+++IPR042981///RING finger protein 11, RING-H2 finger"	[RNF11_HUMAN|Reviewed]RecName: Full=RING finger protein 11;	chr1p32///Ensembl 103 genes in cytogenetic band chr1p32					"AAAGGAT_MIR501///Genes having at least one occurence of the motif AAAGGAT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-501 (v7.1 miRBase).+++ACACTGG_MIR199A_MIR199B///Genes having at least one occurence of the motif ACACTGG in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-199a and hsa-miR-199b (v7.1 miRBase).+++ATAACCT_MIR154///Genes having at least one occurence of the motif ATAACCT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-154 (v7.1 miRBase).+++ATAGGAA_MIR202///Genes having at least one occurence of the motif ATAGGAA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-202* (v7.1 miRBase).+++ATGTTAA_MIR302C///Genes having at least one occurence of the motif ATGTTAA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-302c* (v7.1 miRBase).+++ATTCTTT_MIR186///Genes having at least one occurence of the motif ATTCTTT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-186 (v7.1 miRBase).+++CTCTATG_MIR368///Genes having at least one occurence of the motif CTCTATG in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-368 (v7.1 miRBase).+++CTGAGCC_MIR24///Genes having at least one occurence of the motif CTGAGCC in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-24 (v7.1 miRBase).+++GCTTGAA_MIR498///Genes having at least one occurence of the motif GCTTGAA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-498 (v7.1 miRBase).+++GTATTAT_MIR3693P///Genes having at least one occurence of the motif GTATTAT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-369-3p (v7.1 miRBase).+++TGCCTTA_MIR124A///Genes having at least one occurence of the motif TGCCTTA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-124a (v7.1 miRBase).+++TTTGCAC_MIR19A_MIR19B///Genes having at least one occurence of the motif TTTGCAC in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-19a and hsa-miR-19b (v7.1 miRBase).+++TTTGCAG_MIR518A2///Genes having at least one occurence of the motif TTTGCAG in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-518a-2* (v7.1 miRBase)."	"MIR10400_3P_MIR4674///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-10400-3p, hsa-miR-4674 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1184///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1184 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR12129///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-12129 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR153_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-153-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR192_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-192-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR196A_1_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-196a-1-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR199A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-199a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR199B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-199b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR19A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-19a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR19B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-19b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR202_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-202-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR203A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-203a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR208A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-208a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR208B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-208b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR2115_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-2115-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR297///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-297 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR302C_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-302c-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3143///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3143 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3149///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3149 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR32_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-32-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR33B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-33b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR361_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-361-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3922_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3922-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4283///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4283 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4437///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4437 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4503///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4503 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4731_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4731-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4799_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4799-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4801///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4801 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR498_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-498-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR515_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-515-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5190///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5190 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR519E_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-519e-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR551B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-551b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5580_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5580-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5696///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5696 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR580_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-580-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR642A_3P_MIR642B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-642a-3p, hsa-miR-642b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6508_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6508-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR651_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-651-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR8067///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-8067 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR8069///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-8069 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR8485///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-8485 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR92A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-92a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR92B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-92b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets)."	CTTTGA_LEF1_Q2///Genes having at least one occurence of the highly conserved motif M73 CTTTGA sites. The motif matches transcription factor binding site V$LEF1_Q2 (v7.4 TRANSFAC).+++DR4_Q2///Genes having at least one occurence of the transcription factor binding site V$DR4_Q2 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++EVI1_06///Genes having at least one occurence of the transcription factor binding site V$EVI1_06 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++GGGTGGRR_PAX4_03///Genes having at least one occurence of the highly conserved motif M56 GGGTGGRR sites. The motif matches transcription factor binding site V$PAX4_03 (v7.4 TRANSFAC).+++LEF1_Q2///Genes having at least one occurence of the transcription factor binding site V$LEF1_Q2 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++NCX_01///Genes having at least one occurence of the transcription factor binding site V$NCX_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++NKX25_02///Genes having at least one occurence of the transcription factor binding site V$NKX25_02 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++OCT1_03///Genes having at least one occurence of the transcription factor binding site V$OCT1_03 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++PAX2_02///Genes having at least one occurence of the transcription factor binding site V$PAX2_02 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++S8_01///Genes having at least one occurence of the transcription factor binding site V$S8_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++TGACATY_UNKNOWN///Genes having at least one occurence of the highly conserved motif M42 TGACATY in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++TGAYRTCA_ATF3_Q6///Genes having at least one occurence of the highly conserved motif M9 TGAYRTCA sites. The motif matches transcription factor binding site V$ATF3_Q6 (v7.4 TRANSFAC).+++VDR_Q6///Genes having at least one occurence of the transcription factor binding site V$VDR_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.	"ATF6_TARGET_GENES///Genes containing one or more binding sites for UniProt:P18850 (ATF6) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++BACH2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9BYV9 (BACH2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++DACH1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9UI36 (DACH1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++FOXP2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O15409 (FOXP2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HOXA2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O43364 (HOXA2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++MAFG_TARGET_GENES///Genes containing one or more binding sites for UniProt:O15525 (MAFG) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SKIL_TARGET_GENES///Genes containing one or more binding sites for UniProt:P12757 (SKIL) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF322_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6U7Q0 (ZNF322) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF768_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9H5H4 (ZNF768) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF84_TARGET_GENES///Genes containing one or more binding sites for UniProt:P51523 (ZNF84) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZSCAN30_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q86W11 (ZSCAN30) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."		MODULE_147///GPCR.+++MODULE_195///Breast cancer expression clusters.+++MODULE_356///Genes in the cancer module 356.+++MODULE_503///Genes in the cancer module 503.+++MODULE_576///Genes in the cancer module 576.	HOXA9_DN.V1_UP///Genes up-regulated in MOLM-14 cells (AML) with knockdown of HOXA9 [Gene ID=3205] gene by RNAi vs controls.+++P53_DN.V1_UP///Genes up-regulated in NCI-60 panel of cell lines with mutated TP53 [Gene ID=7157].	"GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_7DY_DN///Genes down-regulated in peripheral blood mononuclear cell 7d vs 0d in unknown after exposure to YF-Vax/Stamaril , time point 7D+++GSE11864_UNTREATED_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP///Genes up-regulated in comparison of untreated macrophages versus those cultured with M-CSF [GeneID=1435], IFNG [GeneID=3458] and Pam3Cys (TLR2 agonist).+++GSE12845_IGD_NEG_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_UP///Genes up-regulated in comparison of IgD- peripheral blood B cells versus dark zone germinal center B cells.+++GSE13887_HEALTHY_VS_LUPUS_RESTING_CD4_TCELL_DN///Genes down-regulated in resting CD4 [GeneID=920] T cells: healthy versus systemic lupus erythrematosus (SLE).+++GSE14000_TRANSLATED_RNA_VS_MRNA_16H_LPS_DC_DN///Genes down-regulated in comparison of polysome bound (translated) mRNA versus total mRNA 16 h after LPS (TLR4 agonist) stimulation.+++GSE14908_ATOPIC_VS_NONATOPIC_PATIENT_RESTING_CD4_TCELL_UP///Genes up-regulated in resting CD4 [GeneID=920] T cells: atopy versus healthy.+++GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_ATOPIC_PATIENT_UP///Genes up-regulated in CD4 [GeneID=920] T cells from atopic patients: resting versus stimulated with allergen (house dust mite).+++GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_NONATOPIC_PATIENT_DN///Genes down-regulated in CD4 [GeneID=920] T cells from non-atopic donors: resting versus stimulated with allergen (house dust mite).+++GSE17974_0H_VS_48H_IN_VITRO_ACT_CD4_TCELL_UP///Genes up-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the untreated cells at 48 h.+++GSE17974_0H_VS_72H_IN_VITRO_ACT_CD4_TCELL_UP///Genes up-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the untreated cells at 72 h.+++GSE1925_CTRL_VS_24H_IFNG_STIM_MACROPHAGE_DN///Genes down-regulated in macrophages: untreated versus stimulated by IFNG [GeneID=3458] for 24h.+++GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_A3R_INH_AND_TCELL_MEMBRANES_ACT_MAST_CELL_UP///Genes up-regulated in HMC-1 (mast leukemia) cells incubated with the peptide ALL1 followed by treatment with: Cl-IB-MECA [PubChem=3035850] versus T cell membranes.+++GSE19888_CTRL_VS_A3R_INHIBITOR_TREATED_MAST_CELL_DN///Genes down-regulated in HMC-1 (mast leukemia) cells: untreated versus incubated with the peptide ALL1.+++GSE20198_IL12_IL18_VS_IFNA_TREATED_ACT_CD4_TCELL_DN///Genes down-regulated in the activated CD4 [GeneID=920] T cells (48h): IL-12 and IL18 [GeneID=3606] versus interferon alpha.+++GSE22103_UNSTIM_VS_LPS_STIM_NEUTROPHIL_UP///Genes up-regulated in neutrophils: untreated versus LPS.+++GSE22601_CD4_SINGLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_UP///Genes up-regulated in single positive thymocytes: CD4 [GeneID=920] versus CD8.+++GSE22601_DOUBLE_NEGATIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_UP///Genes up-regulated in thymocytes: double negative versus CD4 [GeneID=920] single positive.+++GSE22886_TH1_VS_TH2_48H_ACT_DN///Genes down-regulated in comparison of stimulated CD4 [GeneID=920] Th1 cells at 48 h versus stimulated CD4 [GeneID=920] Th2 cells at 48 h.+++GSE23321_CD8_STEM_CELL_MEMORY_VS_EFFECTOR_MEMORY_CD8_TCELL_DN///Genes down-regulated in CD8 T cells: stem cell memory versus effector memory.+++GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_6H_DN///Genes down-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 and IL4 [GeneID=7040;3565] (6h) versus IL-12 (6h).+++GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_2H_DN///Genes down-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 and then stimulated by IL-12 (2h).+++GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_48H_DN///Genes down-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 and then stimulated by IL-12 (48h).+++GSE29618_BCELL_VS_PDC_DN///Genes down-regulated in comparison of B cells versus plasmacytoid dendritic cells (pDC) .+++GSE29618_PDC_VS_MDC_UP///Genes up-regulated in comparison of plasmacytoid dendritic cells (DC) versus myeloid DCs.+++GSE32164_RESTING_DIFFERENTIATED_VS_ALTERNATIVELY_ACT_M2_MACROPHAGE_DN///Genes down-regulated in macrophages: resting differentiated versus alternatively activated M2.+++GSE33425_CD161_INT_VS_NEG_CD8_TCELL_DN///Genes down-regulated in CD8 T cells: KLRB1 int [GeneID=3820] versus KLRB1- [GeneID=3820].+++GSE33425_CD161_INT_VS_NEG_CD8_TCELL_UP///Genes up-regulated in CD8 T cells: KLRB1 int [GeneID=3820] versus KLRB1- [GeneID=3820].+++GSE34205_RSV_VS_FLU_INF_INFANT_PBMC_UP///Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from infancts with acute RSV infection versus PBMCs from infants with acute influenza infection.+++GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_UP///Genes up-regulated in comparison of dendritic cells (DC) exposed to 50 worms/well B. malayi versus DC exposed to M. tuberculosis+++GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_YOUNG_UP///Genes up-regulated in comparison of untreated CD4 [GeneID=920] memory T cells from young donors versus those treated with TSST at 72 h.+++GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_WITH_PMA_STIM_DN///Genes down-regulated in gamma delta T cells stimulated by phorbol myristate acetate and ionomycin [PubChem=4792;3733]: Vd1 versus Vd2.+++GSE3982_EOSINOPHIL_VS_TH1_UP///Genes up-regulated in comparison of eosinophils versus Th1 cells.+++GSE5542_UNTREATED_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_DN///Genes down-regulated in epithelial cells (24h): untreated versus interferon alpha and IFNG [GeneID=3458].+++GSE8515_CTRL_VS_IL6_4H_STIM_MAC_UP///Genes up-regulated in comparison of untreated macrophages versus those treated with IL6 [GeneID=3569].+++GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_3H_DN///Genes down-regulated in monocytes (3h): untreated versus M. tuberculosis 19 kDa lipopeptide.+++GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_1MONTH_POST_DX_UP///Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMCs from patients with type 1 diabetes at 1 month after the diagnosis.+++GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_4MONTH_POST_DX_UP///Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMCs from patients with type 1 diabetes at 4 month after the diagnosis.+++NAKAYA_B_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP///Genes up-regulated in B cell 7d vs 0d in young adults (18-50) after exposure to Fluarix/Fluvirin , time point 7D+++NAKAYA_PBMC_FLUMIST_AGE_18_50YO_7DY_DN///Genes down-regulated in peripheral blood mononuclear cell 7d vs 0d in adults (18-50) after exposure to FluMist , time point 7D. Comment: Supplementary Table 1a: All the differentially expressed genes identified in PBMCs of TIV vaccinees.+++NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP///Genes up-regulated in plasmacytoid dendritic cell 7d vs 0d in young adults (18-50) after exposure to FluMist , time point 7D+++THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_UP///Genes up-regulated in peripheral blood mononuclear cell 28d vs 0d in young adults (21-30) (responders) after exposure to Inactivated influenza vaccine , time point 28D"	HALLMARK_ADIPOGENESIS///Genes up-regulated during adipocyte differentiation (adipogenesis).	NM_014372	RNF11				
Q9ULV4	sp|Q9ULV4|COR1C_HUMAN		CORO1C		Coronin-1C OS=Homo sapiens OX=9606 GN=CORO1C PE=1 SV=1 >tr|A0A024RBI5|A0A024RBI5_HUMAN Coronin OS=Homo sapiens OX=9606 GN=CORO1C PE=3 SV=1	23603	XM_024448914	XP_024304682					MRRVVRQSKFRHVFGQAVKNDQCYDDIRVSRVTWDSSFCAVNPRFVAIIIEASGGGAFLVLPLHKTGRIDKSYPTVCGHTGPVLDIDWCPHNDQVIASGSEDCTVMVWQIPENGLTLSLTEPVVILEGHSKRVGIVAWHPTARNVLLSAGCDNAIIIWNVGTGEALINLDDMHSDMIYNVSWNRNGSLICTASKDKKVRVIDPRKQEIVAEKEKAHEGARPMRAIFLADGNVFTTGFSRMSERQLALWNPKNMQEPIALHEMDTSNGVLLPFYDPDTSIIYLCGKGDSSIRYFEITDESPYVHYLNTFSSKEPQRGMGYMPKRGLDVNKCEIARFFKLHERKCEPIIMTVPRKSDLFQDDLYPDTAGPEAALEAEEWFEGKNADPILISLKHGYIPGKNRDLKVVKKNILDSKPTANKKCDLISIPKKTTDTASVQNEAKLDEILKEIKSIKDTICNQDERISKLEQQMAKIAA	0.3998496	-1.322470741	0.00119318				5.0335118	4.1078753	5.2397438		5.766547	5.3523631	5.3280222	5.6299266	6.4359927		5.5270257	4.1880761	4.2889812					5.4353396	6.0140307	7.2761359					8.935849	7.236557	7.758241	5.9245514	3.47577	5.5900072	6.2527078	6.0627515	6.8912976	7.5714684	7.1045109	7.274395	6.7671553	5.28545944	7.7925399	4.4984305	6.74155645					GO:0005737///cytoplasm+++GO:0005768///endosome+++GO:0005856///cytoskeleton+++GO:0005886///plasma membrane+++GO:0005925///focal adhesion+++GO:0005938///cell cortex+++GO:0010008///endosome membrane+++GO:0015629///actin cytoskeleton+++GO:0016020///membrane+++GO:0016328///lateral plasma membrane+++GO:0016600///flotillin complex+++GO:0030017///sarcomere+++GO:0030027///lamellipodium+++GO:0030054///cell junction+++GO:0031982///vesicle+++GO:0032587///ruffle membrane+++GO:0042383///sarcolemma+++GO:0042995///cell projection+++GO:0045202///synapse	GO:0003779///actin binding+++GO:0005515///protein binding+++GO:0031267///small GTPase binding+++GO:0051015///actin filament binding	GO:0001755///neural crest cell migration+++GO:0001932///regulation of protein phosphorylation+++GO:0001933///negative regulation of protein phosphorylation+++GO:0006909///phagocytosis+++GO:0007015///actin filament organization+++GO:0007165///signal transduction+++GO:0010632///regulation of epithelial cell migration+++GO:0010633///negative regulation of epithelial cell migration+++GO:0010762///regulation of fibroblast migration+++GO:0016197///endosomal transport+++GO:0016477///cell migration+++GO:0030036///actin cytoskeleton organization+++GO:0044387///negative regulation of protein kinase activity by regulation of protein phosphorylation+++GO:0045184///establishment of protein localization+++GO:0051893///regulation of focal adhesion assembly+++GO:0051895///negative regulation of focal adhesion assembly+++GO:0090148///membrane fission+++GO:0090630///activation of GTPase activity+++GO:0097750///endosome membrane tubulation+++GO:1900024///regulation of substrate adhesion-dependent cell spreading+++GO:1900025///negative regulation of substrate adhesion-dependent cell spreading+++GO:1900027///regulation of ruffle assembly+++GO:2000394///positive regulation of lamellipodium morphogenesis	tissueType=Stomach;cancerType=Normal;cellName=Pit progenitor cell		"PREDICTED: Homo sapiens coronin 1C (CORO1C), transcript variant X1, mRNA."									chr12q24///Ensembl 103 genes in cytogenetic band chr12q24					"AAAGGGA_MIR204_MIR211///Genes having at least one occurence of the motif AAAGGGA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-204 and hsa-miR-211 (v7.1 miRBase).+++ACATTCC_MIR1_MIR206///Genes having at least one occurence of the motif ACATTCC in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-1 and hsa-miR-206 (v7.1 miRBase).+++CACTGCC_MIR34A_MIR34C_MIR449///Genes having at least one occurence of the motif CACTGCC in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-34a, hsa-miR-34c and hsa-miR-449 (v7.1 miRBase).+++CACTGTG_MIR128A_MIR128B///Genes having at least one occurence of the motif CACTGTG in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-128a and hsa-miR-128b (v7.1 miRBase).+++CAGCACT_MIR5123P///Genes having at least one occurence of the motif CAGCACT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-512-3p (v7.1 miRBase).+++CAGTATT_MIR200B_MIR200C_MIR429///Genes having at least one occurence of the motif CAGTATT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-200b, hsa-miR-200c and hsa-miR-429 (v7.1 miRBase).+++CTTTGCA_MIR527///Genes having at least one occurence of the motif CTTTGCA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-527 (v7.1 miRBase).+++TTGCCAA_MIR182///Genes having at least one occurence of the motif TTGCCAA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-182 (v7.1 miRBase).+++TTTGCAG_MIR518A2///Genes having at least one occurence of the motif TTTGCAG in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-518a-2* (v7.1 miRBase)."	LET_7A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-let-7a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++LET_7B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-let-7b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++LET_7F_1_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-let-7f-1-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR12133///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-12133 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR12136///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-12136 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1271_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1271-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1298_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1298-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR146A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-146a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR182_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-182-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR196A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-196a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR200B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-200b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR200C_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-200c-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR206///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-206 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR2116_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-2116-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR217_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-217-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR224_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-224-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR300///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-300 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR30C_1_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-30c-1-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR30C_2_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-30c-2-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3652///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3652 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR381_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-381-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3913_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3913-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4273///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4273 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR429///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-429 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4317///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4317 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4418///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4418 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4430///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4430 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4505///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4505 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4694_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4694-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR509_3_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-509-3-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR509_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-509-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR562///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-562 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5787///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5787 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6079///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6079 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR607///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-607 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR613///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-613 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR619_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-619-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6506_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6506-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6508_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6508-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6513_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6513-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR651_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-651-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR664A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-664a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6731_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6731-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6780A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6780a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6788_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6788-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6828_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6828-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6832_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6832-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6842_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6842-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6854_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6854-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6878_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6878-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7156_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7156-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7976///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7976 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR8067///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-8067 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR8085///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-8085 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR8485///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-8485 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR887_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-887-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR98_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-98-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).	AML1_01///Genes having at least one occurence of the transcription factor binding site V$AML1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++AML1_Q6///Genes having at least one occurence of the transcription factor binding site V$AML1_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++AP1FJ_Q2///Genes having at least one occurence of the transcription factor binding site V$AP1FJ_Q2 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++AP1_Q2///Genes having at least one occurence of the transcription factor binding site V$AP1_Q2 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++AP1_Q4///Genes having at least one occurence of the transcription factor binding site V$AP1_Q4 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++CCAWWNAAGG_SRF_Q4///Genes having at least one occurence of the highly conserved motif M121 CCAWWNAAGG sites. The motif matches transcription factor binding site V$SRF_Q4 (v7.4 TRANSFAC).+++CTTTGA_LEF1_Q2///Genes having at least one occurence of the highly conserved motif M73 CTTTGA sites. The motif matches transcription factor binding site V$LEF1_Q2 (v7.4 TRANSFAC).+++E47_01///Genes having at least one occurence of the transcription factor binding site V$E47_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++EGR1_01///Genes having at least one occurence of the transcription factor binding site V$EGR1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++EGR_Q6///Genes having at least one occurence of the transcription factor binding site V$EGR_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++ETS2_B///Genes having at least one occurence of the transcription factor binding site V$ETS2_B (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++LEF1_Q6///Genes having at least one occurence of the transcription factor binding site V$LEF1_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++MAF_Q6///Genes having at least one occurence of the transcription factor binding site V$MAF_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++MAZR_01///Genes having at least one occurence of the transcription factor binding site V$MAZR_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++MGGAAGTG_GABP_B///Genes having at least one occurence of the highly conserved motif M11 MGGAAGTG sites. The motif matches transcription factor binding site V$GABP_B (v7.4 TRANSFAC).+++NGFIC_01///Genes having at least one occurence of the transcription factor binding site V$NGFIC_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++OSF2_Q6///Genes having at least one occurence of the transcription factor binding site V$OSF2_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++RGAGGAARY_PU1_Q6///Genes having at least one occurence of the highly conserved motif M50 RGAGGAARY sites. The motif matches transcription factor binding site V$PU1_Q6 (v7.4 TRANSFAC).+++RNGTGGGC_UNKNOWN///Genes having at least one occurence of the highly conserved motif M140 RNGTGGGC in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++RYAAAKNNNNNNTTGW_UNKNOWN///Genes having at least one occurence of the highly conserved motif M151 RYAAAKNNNNNNTTGW in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++SCGGAAGY_ELK1_02///Genes having at least one occurence of the highly conserved motif M3 SCGGAAGY sites. The motif matches transcription factor binding site V$ELK1_02 (v7.4 TRANSFAC).+++SP1_Q2_01///Genes having at least one occurence of the transcription factor binding site V$SP1_Q2_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++SP1_Q4_01///Genes having at least one occurence of the transcription factor binding site V$SP1_Q4_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++SP1_Q6_01///Genes having at least one occurence of the transcription factor binding site V$SP1_Q6_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++SP1_Q6///Genes having at least one occurence of the transcription factor binding site V$SP1_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++SRF_Q5_01///Genes having at least one occurence of the transcription factor binding site V$SRF_Q5_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++SRF_Q6///Genes having at least one occurence of the transcription factor binding site V$SRF_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++TCF4_Q5///Genes having at least one occurence of the transcription factor binding site V$TCF4_Q5 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++TEL2_Q6///Genes having at least one occurence of the transcription factor binding site V$TEL2_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++TFIII_Q6///Genes having at least one occurence of the transcription factor binding site V$TFIII_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++TGGAAA_NFAT_Q4_01///Genes having at least one occurence of the highly conserved motif M55 TGGAAA sites. The motif matches transcription factor binding site V$NFAT_Q4_01 (v7.4 TRANSFAC).+++TTANTCA_UNKNOWN///Genes having at least one occurence of the highly conserved motif M64 TTANTCA in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++ZF5_01///Genes having at least one occurence of the transcription factor binding site V$ZF5_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.	"ADNP_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9H2P0 (ADNP) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ATXN7L3_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q14CW9 (ATXN7L3) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++BCL6B_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8N143 (BCL6B) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++DNMT1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P26358 (DNMT1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++GCM2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O75603 (GCM2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HMGB1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P09429 (HMGB1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HOXC6_TARGET_GENES///Genes containing one or more binding sites for UniProt:P09630 (HOXC6) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++KDM5D_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9BY66 (KDM5D) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++KMT2D_TARGET_GENES///Genes containing one or more binding sites for UniProt:O14686 (KMT2D) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NAB2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q15742 (NAB2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++PAX3_TARGET_GENES///Genes containing one or more binding sites for UniProt:P23760 (PAX3) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++PAX7_TARGET_GENES///Genes containing one or more binding sites for UniProt:P23759 (PAX7) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SFMBT1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9UHJ3 (SFMBT1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SUPT16H_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9Y5B9 (SUPT16H) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++TFEB_TARGET_GENES///Genes containing one or more binding sites for UniProt:P19484 (TFEB) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZBTB24_TARGET_GENES///Genes containing one or more binding sites for UniProt:O43167 (ZBTB24) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF169_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q14929 (ZNF169) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF184_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q99676 (ZNF184) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF257_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9Y2Q1 (ZNF257) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF394_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q53GI3 (ZNF394) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF577_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9BSK1 (ZNF577) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF596_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8TC21 (ZNF596) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF664_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8N3J9 (ZNF664) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF92_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q03936 (ZNF92) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."		MODULE_321///Genes in the cancer module 321.		"FLETCHER_PBMC_BCG_10W_INFANT_BCG_STIMULATED_VS_UNSTIMULATED_10W_DN///Genes down-regulated in peripheral blood mononuclear cell stimulated vs unstimulated in infants (10w) after exposure to BCG (Danish strain BCG Statens Serum Institut, Denmark) , time point 10W. Comment: PBMCs drawn at 10 weeks following immunization at birth+++FLETCHER_PBMC_BCG_10W_INFANT_PPD_STIMULATED_VS_UNSTIMULATED_10W_DN///Genes down-regulated in peripheral blood mononuclear cell stimulated vs unstimulated in infants (10w) after exposure to BCG (Danish strain BCG Statens Serum Institut, Denmark) , time point 10W. Comment: PBMCs drawn at 10 weeks following immunization at birth+++GSE10325_CD4_TCELL_VS_MYELOID_DN///Genes down-regulated in comparison of healthy CD4 [GeneID=920] T cells versus healthy myeloid cells.+++GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_BCELL_DN///Genes down-regulated in comparison of systemic lupus erythematosus CD4 [GeneID=920] T cells versus systemic lupus erythematosus B cells.+++GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_MYELOID_DN///Genes down-regulated in comparison of systemic lupus erythematosus CD4 [GeneID=920] T cells versus systemic lupus erythematosus myeloid cells.+++GSE11057_CD4_EFF_MEM_VS_PBMC_DN///Genes down-regulated in comarison of effector memory T cells versus peripheral blood mononuclear cells (PBMC).+++GSE11864_CSF1_IFNG_VS_CSF1_PAM3CYS_IN_MAC_UP///Genes up-regulated in comparison of macrophages cultured with M-CSF [GeneID=1435] and IFNG [GeneID=3458] versus macrophages cultured with M-CSF [GeneID=1435] and Pam3Cyc.+++GSE11864_CSF1_VS_CSF1_PAM3CYS_IN_MAC_UP///Genes up-regulated in comparison of macrophages cultured with M-CSF [GeneID=1435] versus macrophages cultured with M-CSF [GeneID=1435] and Pam3Cyc.+++GSE12845_IGD_POS_VS_NEG_BLOOD_BCELL_DN///Genes down-regulated in comparison of IgD+ B cells versus IgD- B cells.+++GSE14000_TRANSLATED_RNA_VS_MRNA_DC_UP///Genes up-regulated in comparison of polysome bound (translated) mRNA versus total mRNA in dendritic cells.+++GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP///Genes up-regulated in comparison of CD4 [GeneID=920] thymocytes versus naive CD4 [GeneID=920] T cells from adult blood.+++GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_UP///Genes up-regulated in comparison of CD4 [GeneID=920] thymocytes versus naive CD4 [GeneID=920] T cells from cord blood.+++GSE15735_2H_VS_12H_HDAC_INHIBITOR_TREATED_CD4_TCELL_DN///Genes down-regulated in CD4 [GeneID=920] T cells treated with HDAC inhibitors: 2h versus 12h.+++GSE16385_UNTREATED_VS_12H_IFNG_TNF_TREATED_MACROPHAGE_DN///Genes down-regulated in macrophages (12h): control versus IFNG and TNF [GeneID=3458;7124].+++GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_DN///Genes down-regulated in transitional B lymphocytes: CR2 [GeneID=1380] low versus CR2 [GeneID=1380] high.+++GSE1925_3H_VS_24H_IFNG_STIM_MACROPHAGE_UP///Genes up-regulated in macrophages stimulated by IFNG [GeneID=3458]: 3h versus 24h.+++GSE20198_UNTREATED_VS_IFNA_TREATED_ACT_CD4_TCELL_DN///Genes down-regulated in the activated CD4 [GeneID=920] T cells (48h): control versus interferon alpha.+++GSE22103_UNSTIM_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_UP///Genes up-regulated in neutrophils: untreated versus stimulated by CSF2 and IFNG [GeneID=1437;3458].+++GSE22886_DAY0_VS_DAY7_MONOCYTE_IN_CULTURE_DN///Genes down-regulated in comparison of monocytes cultured for 0 days versus those cultured for 7 days.+++GSE22886_NAIVE_CD4_TCELL_VS_MONOCYTE_DN///Genes down-regulated in comparison of naive CD4 [GeneID=920] T cells versus day 0 monocytes.+++GSE22886_NAIVE_CD8_TCELL_VS_DC_DN///Genes down-regulated in comparison of naive CD8 T cells versus unstimulated dendritic cells (DC).+++GSE22886_NAIVE_CD8_TCELL_VS_MONOCYTE_DN///Genes down-regulated in comparison of naive CD8 T cells versus day 0 monocytes.+++GSE22886_NAIVE_TCELL_VS_DC_DN///Genes down-regulated in comparison of naive CD4 [GeneID=920] CD8 T cells versus unstimulated dendritic cells (DC).+++GSE22886_NAIVE_TCELL_VS_MONOCYTE_DN///Genes down-regulated in comparison of naive CD4 [GeneID=920] CD8 T cells versus monocytes cultured for 0 days.+++GSE22886_UNSTIM_VS_IL15_STIM_NKCELL_DN///Genes down-regulated in comparison of unstimulated NK cells versus those stimulated with IL2 [GeneID=3600] at 16 h.+++GSE24634_TEFF_VS_TCONV_DAY7_IN_CULTURE_DN///Genes down-regulated in comparison of untreated CD25+ T effector cells at day 7 versus untreated CD25- T cells at day 7.+++GSE26928_EFF_MEM_VS_CENTR_MEM_CD4_TCELL_UP///Genes up-regulated in comparison of CD4 [GeneID=920] effector memory T cells versus CD4 [GeneID=920] central memory T cells.+++GSE26928_NAIVE_VS_CXCR5_POS_CD4_TCELL_DN///Genes down-regulated in comparison of naive CD4 [GeneID=920] T cells versus CD4 [GeneID=920] CXCR5+ [GeneID=643] T cells.+++GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_UP///Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: IL-12 (48h) versus TGFB1 [GeneID=7040] and IL-12 (48h).+++GSE29618_BCELL_VS_PDC_DAY7_FLU_VACCINE_DN///Genes down-regulated in comparison of B cells from influenza vaccinee at day 7 post-vaccination versus plasmacytoid dendritic cells (pDC) at day 7 post-vaccination.+++GSE29618_BCELL_VS_PDC_DN///Genes down-regulated in comparison of B cells versus plasmacytoid dendritic cells (pDC) .+++GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_DN///Genes down-regulated in monocytes (6h): muramyl dipeptide [PubChem=11620162] versus M. tuberculosis 19 kDa lipopeptide.+++GSE34156_TLR1_TLR2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_UP///Genes up-regulated in monocytes (24h): M. tuberculosis 19 kDa lipopeptide versus M. tuberculosis 19 kDa lipopeptide and muramyl dipeptide [PubChem=11620162].+++GSE34156_TLR1_TLR2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_UP///Genes up-regulated in monocytes (6h): M. tuberculosis 19 kDa lipopeptide versus M. tuberculosis 19 kDa lipopeptide and muramyl dipeptide [PubChem=11620162].+++GSE34156_UNTREATED_VS_24H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP///Genes up-regulated in monocytes (24h): untreated versus muramyl dipeptide [PubChem=11620162] andM. tuberculosis 19 kDa lipopeptide.+++GSE34156_UNTREATED_VS_24H_NOD2_LIGAND_TREATED_MONOCYTE_DN///Genes down-regulated in monocytes (24h): untreated versus muramyl dipeptide [PubChem=11620162].+++GSE34156_UNTREATED_VS_24H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP///Genes up-regulated in monocytes (24h): untreated versus M. tuberculosis 19 kDa lipopeptide.+++GSE34156_UNTREATED_VS_6H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP///Genes up-regulated in monocytes (6h): untreated versus M. tuberculosis 19 kDa lipopeptide.+++GSE34515_CD16_NEG_MONOCYTE_VS_DC_DN///Genes down-regulated in CD16- monocytes versus dendritic cells.+++GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_OLD_DN///Genes down-regulated in comparison of untreated CD4 [GeneID=920] memory T cells from old donors versus those treated with TSST at 16 h.+++GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_OLD_DN///Genes down-regulated in comparison of untreated CD4 [GeneID=920] memory T cells from old donors versus those treated with TSST at 72 h.+++GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_YOUNG_DN///Genes down-regulated in comparison of untreated CD4 [GeneID=920] memory T cells from young donors versus those treated with TSST at 72 h.+++GSE3982_CTRL_VS_LPS_48H_DC_UP///Genes up-regulated in comparison of untreated dendritic cells (DC) versus DCs treated with LPS (TLR4 agonist) at 48 h.+++GSE3982_MAST_CELL_VS_CENT_MEMORY_CD4_TCELL_UP///Genes up-regulated in comparison of mast cells versus central memory CD4 [GeneID=920] T cells.+++GSE42724_MEMORY_BCELL_VS_PLASMABLAST_DN///Genes down-regulated in B lymphocytes: memory versus plasmablasts.+++GSE4984_LPS_VS_VEHICLE_CTRL_TREATED_DC_DN///Genes down-regulated in monocyte-derived dendritic cells: LPS versus vehicle.+++GSE5099_DAY3_VS_DAY7_MCSF_TREATED_MACROPHAGE_DN///Genes down-regulated upon CSF1 [GeneID=1435] treatment: monocytes (3 days) versus macrophages (7 days).+++GSE5142_HTERT_TRANSDUCED_VS_CTRL_CD8_TCELL_LATE_PASSAGE_CLONE_UP///Genes up-regulated in CD8 T cells: early passage clone over-expressing TERT [GeneID=7015] versus late passage control.+++GSE5542_IFNA_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN///Genes down-regulated in epithelial cells (6h): interferon alpha versus interferon alpha and IFNG [GeneID=3458].+++GSE5542_IFNG_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_UP///Genes up-regulated in epithelial cells (24h): IFNG [GeneID=3458] versus IFNG [GeneID=3458] and interferon alpha.+++GSE5542_IFNG_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN///Genes down-regulated in epithelial cells (6h): IFNG [GeneID=3458] versus IFNG [GeneID=3458] and interferon alpha.+++GSE5542_IFNG_VS_IFNA_TREATED_EPITHELIAL_CELLS_24H_UP///Genes up-regulated in epithelial cells (24h): IFNG [GeneID=3458] versus interferon alpha.+++GSE5542_IFNG_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_UP///Genes up-regulated in epithelial cells (6h): IFNG [GeneID=3458] versus interferon alpha.+++GSE5679_PPARG_LIGAND_ROSIGLITAZONE_VS_RARA_AGONIST_AM580_TREATED_DC_UP///Genes up-regulated in monocyte-derived dendritic cells: rosiglitazone [PubChem=77999] versus AM580 [PubChem=2126].+++GSE7568_CTRL_VS_3H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_DN///Genes down-regulated in macrophages differentiated in the presence of IL4 [GeneID=3565] and dexamethasone [PubChem=5743] for 5 days versus those subsequently treated with TGFB1 [GeneID=7040] for 3h.+++GSE8835_HEALTHY_VS_CLL_CD8_TCELL_UP///Genes up-regulated in CD8 T cells: healthy versus CLL (chronic lymphocytic leukemia).+++GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_24H_DN///Genes down-regulated in monocytes (24h): untreated versus M. tuberculosis 19 kDa lipopeptide.+++GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_1MONTH_POST_DX_UP///Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMCs from patients with type 1 diabetes at 1 month after the diagnosis.+++GSE9006_TYPE_1_DIABETES_AT_DX_VS_1MONTH_POST_DX_PBMC_UP///Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from patients with type 1 diabetes at the time of the diagnosis versus those at 1 month later.+++GSE9988_ANTI_TREM1_VS_LOW_LPS_MONOCYTE_UP///Genes up-regulated in comparison of monocytes treated with anti-TREM1 [GeneID=54210] versus monocytes treated with 1 ng/ml LPS (TLR4 agonist). +++GSE9988_ANTI_TREM1_VS_LPS_MONOCYTE_UP///Genes up-regulated in comparison of monocytes treated with anti-TREM1 [GeneID=54210] versus monocytes treated with 5000 ng/ml LPS (TLR4 agonist).+++GSE9988_ANTI_TREM1_VS_VEHICLE_TREATED_MONOCYTES_UP///Genes up-regulated in comparison of monocytes treated with anti-TREM1 [GeneID=54210] versus untreated monocytes.+++GSE9988_LOW_LPS_VS_ANTI_TREM1_AND_LPS_MONOCYTE_DN///Genes down-regulated in comparison of monocytes treated with 1 ng/ml LPS (TLR4 agonist) versus monocytes treated with anti-TREM1 [GeneID=54210] and 5000 ng/ml LPS (TLR4 agonist).+++GSE9988_LPS_VS_LPS_AND_ANTI_TREM1_MONOCYTE_DN///Genes down-regulated in comparison of monocytes treated with 5000 ng/ml LPS (TLR4 agonist) versus monocytes treated with anti-TREM1 [GeneID=54210].+++HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_POSITIVE///Genes positively correlated with memory B cell response at 28d in peripheral blood mononuclear cell in seniors (50-74) after exposure to Fluarix , time point 28D+++KANNAN_BLOOD_2012_2013_TIV_AGE_65PLS_REVACCINATED_IN_6_9_MO_VS_REVACCINATED_IN_12_13_MOS_DN///Genes down-regulated in blood cohort 1 (re-vaccinated in 6-9 months) vs cohort 2 (re-vaccinated in 12-13 months) in adults (65+) after exposure to 2012-2013 seasonal trivalent inactivated influenza vaccine (TIV) , time point N/A. Comment: Cohort 1 (re-vaccinated in 6-9 months) vs Cohort 2 (re-vaccinated in 12-13 months)+++NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_UP///Genes up-regulated in peripheral blood mononuclear cell 3d vs 0d in adults (18-50) after exposure to Fluarix/Fluvirin , time point 3D. Comment: Supplementary Table 1a: All the differentially expressed genes identified in PBMCs of TIV vaccinees.+++NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_UP///Genes up-regulated in peripheral blood mononuclear cell 3d vs 0d in adults (18-50) after exposure to FluMist , time point 3D. Comment: Supplementary Table 1b: All the differentially expressed genes identified in PBMCs of TIV vaccinees.+++THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_UP///Genes up-regulated in peripheral blood mononuclear cell 28d vs 0d in young adults (21-30) (responders) after exposure to Inactivated influenza vaccine , time point 28D"		XM_024448914	CORO1C				
Q9UJ68	sp|Q9UJ68|MSRA_HUMAN		MSRA		Mitochondrial peptide methionine sulfoxide reductase OS=Homo sapiens OX=9606 GN=MSRA PE=1 SV=1	4482	rna-NM_012331.5-2						MLSATRRACQLLLLHSLFPVPRMGNSASNIVSPQEALPGRKEQTPVAAKHHVNGNRTVEPFPEGTQMAVFGMGCFWGAERKFWVLKGVYSTQVGFAGGYTSNPTYKEVCSEKTGHAEVVRVVYQPEHMSFEELLKVFWENHDPTQGMRQGNDHGTQYRSAIYPTSAKQMEAALSSKENYQKVLSEHGFGPITTDIREGQTFYYAEDYHQQYLSKNPNGYCGLGGTGVSCPVGIKK	0.658757	-0.602181615	0.0413836	3.6819121			4.5546271	4.6734887	4.7640821	3.591464497	4.2472385	6.1654789	6.1885396	5.9745973	6.2675594	3.95144293	5.1120587	4.5048468	5.4119623		5.5618128		4.7396848	4.2395984	5.8496944	6.1071802	4.395549	4.26647323	3.88879473	4.3532695	7.506231	6.9672439	6.033903	5.8880893	4.318762	5.3534154	6.9410313	5.5985426	5.8940376	5.9406549	5.9011735	6.49982	4.972594	5.27704762	6.4065253	4.5784315	5.52377985																																	rna-NM_012331.5-2	MSRA				
Q9UHD8	sp|Q9UHD8|SEPT9_HUMAN		SEPTIN9		Septin-9 OS=Homo sapiens OX=9606 GN=SEPTIN9 PE=1 SV=2	10801	NM_001113491	NP_001106963	ENST00000427177	K16938			MKKSYSGGTRTSSGRLRRLGDSSGPALKRSFEVEEVETPNSTPPRRVQTPLLRATVASSTQKFQDLGVKNSEPSARHVDSLSQRSPKASLRRVELSGPKAAEPVSRRTELSIDISSKQVENAGAIGPSRFGLKRAEVLGHKTPEPAPRRTEITIVKPQESAHRRMEPPASKVPEVPTAPATDAAPKRVEIQMPKPAEAPTAPSPAQTLENSEPAPVSQLQSRLEPKPQPPVAEATPRSQEATEAAPSCVGDMADTPRDAGLKQAPASRNEKAPVDFGYVGIDSILEQMRRKAMKQGFEFNIMVVGQSGLGKSTLINTLFKSKISRKSVQPTSEERIPKTIEIKSITHDIEEKGVRMKLTVIDTPGFGDHINNENCWQPIMKFINDQYEKYLQEEVNINRKKRIPDTRVHCCLYFIPATGHSLRPLDIEFMKRLSKVVNIVPVIAKADTLTLEERVHFKQRITADLLSNGIDVYPQKEFDEDSEDRLVNEKFREMIPFAVVGSDHEYQVNGKRILGRKTKWGTIEVENTTHCEFAYLRDLLIRTHMQNIKDITSSIHFEAYRVKRLNEGSSAMANGMEEKEPEAPEM	0.584655	-0.77434256	0.00132233									6.1024987	7.3389755	6.492616	6.0983503			6.1820404	6.7481726		6.4059192			6.6834893	7.2183922	7.7193791					7.824603	7.1390534	7.712483	8.1317887			6.5513013	7.0384105		7.0005751	7.0397927	7.639906	7.6682031	7.28246806	7.7750761	5.8560694	8.02011911	05100///Bacterial invasion of epithelial cells+++05131///Shigellosis	H01131///Hereditary neuralgic amyotrophy+++H01282///Spermatogenic failure			GO:0001725///stress fiber+++GO:0005737///cytoplasm+++GO:0005856///cytoskeleton+++GO:0005874///microtubule+++GO:0005930///axoneme+++GO:0005940///septin ring+++GO:0015629///actin cytoskeleton+++GO:0015630///microtubule cytoskeleton+++GO:0031105///septin complex+++GO:0032153///cell division site+++GO:0048471///perinuclear region of cytoplasm+++GO:0097730///non-motile cilium	GO:0000166///nucleotide binding+++GO:0003924///GTPase activity+++GO:0005515///protein binding+++GO:0005525///GTP binding+++GO:0045296///cadherin binding+++GO:0060090///molecular adaptor activity	GO:0007049///cell cycle+++GO:0034613///cellular protein localization+++GO:0051301///cell division+++GO:0061640///cytoskeleton-dependent cytokinesis+++GO:1902857///positive regulation of non-motile cilium assembly			"Homo sapiens septin 9 (SEPTIN9), transcript variant 1, mRNA."		PF00735///Septin			KOG1547///GTP binding		IPR016491///Septin+++IPR027417///P-loop containing nucleoside triphosphate hydrolase+++IPR030379///Septin-type guanine nucleotide-binding (G) domain+++IPR030645///Septin 9	"[SEPT9_HUMAN|Reviewed]RecName: Full=Septin-9; AltName: Full=MLL septin-like fusion protein MSF-A; Short=MLL septin-like fusion protein; AltName: Full=Ovarian/Breast septin; Short=Ov/Br septin; AltName: Full=Septin D1;+++[A0A024R8Q0_HUMAN|Unreviewed]SubName: Full=Septin 9, isoform CRA_b {ECO:0000313|EMBL:EAW89466.1};+++[A0A024R8V0_HUMAN|Unreviewed]SubName: Full=Septin 9, isoform CRA_a {ECO:0000313|EMBL:EAW89465.1};+++[A0A0S2Z5W9_HUMAN|Unreviewed]SubName: Full=Septin 9 isoform 3 {ECO:0000313|EMBL:ALQ33996.1}; Flags: Fragment;+++[Q1WWK5_HUMAN|Unreviewed]SubName: Full=SEPT9 protein {ECO:0000313|EMBL:AAI14551.1}; Flags: Fragment;"	chr17q25///Ensembl 103 genes in cytogenetic band chr17q25					"GTGCCTT_MIR506///Genes having at least one occurence of the motif GTGCCTT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-506 (v7.1 miRBase).+++TTGCCAA_MIR182///Genes having at least one occurence of the motif TTGCCAA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-182 (v7.1 miRBase)."	"LET_7A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-let-7a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++LET_7B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-let-7b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++LET_7F_1_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-let-7f-1-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++LET_7F_2_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-let-7f-2-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1185_1_3P_MIR1185_2_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1185-1-3p, hsa-miR-1185-2-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1207_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1207-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR12133///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-12133 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR124_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-124-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1271_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1271-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR182_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-182-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR205_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-205-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR300///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-300 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3184_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3184-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR381_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-381-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR423_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-423-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4470///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4470 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4531///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4531 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4640_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4640-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4651///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4651 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4666A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4666a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4715_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4715-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4729///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4729 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4753_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4753-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4763_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4763-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4789_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4789-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR494_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-494-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR506_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-506-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR510_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-510-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR544A///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-544a in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR608///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-608 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR637///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-637 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6721_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6721-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6752_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6752-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6756_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6756-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6766_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6766-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6768_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6768-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6770_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6770-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6774_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6774-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6804_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6804-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6828_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6828-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6842_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6842-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6868_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6868-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7110_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7110-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR92A_2_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-92a-2-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR96_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-96-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR98_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-98-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets)."	AP1_01///Genes having at least one occurence of the transcription factor binding site V$AP1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++AP1_Q4_01///Genes having at least one occurence of the transcription factor binding site V$AP1_Q4_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++CATTGTYY_SOX9_B1///Genes having at least one occurence of the highly conserved motif M49 CATTGTYY sites. The motif matches transcription factor binding site V$SOX9_B1 (v7.4 TRANSFAC).+++CCCNNGGGAR_OLF1_01///Genes having at least one occurence of the highly conserved motif M130 CCCNNGGGAR sites. The motif matches transcription factor binding site V$OLF1_01 (v7.4 TRANSFAC).+++CEBP_01///Genes having at least one occurence of the transcription factor binding site V$CEBP_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++CEBP_Q3///Genes having at least one occurence of the transcription factor binding site V$CEBP_Q3 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++COREBINDINGFACTOR_Q6///Genes having at least one occurence of the transcription factor binding site V$COREBINDINGFACTOR_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++CTGRYYYNATT_UNKNOWN///Genes having at least one occurence of the highly conserved motif M153 CTGRYYYNATT in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++EVI1_02///Genes having at least one occurence of the transcription factor binding site V$EVI1_02 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++GATA4_Q3///Genes having at least one occurence of the transcription factor binding site V$GATA4_Q3 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++IRF7_01///Genes having at least one occurence of the transcription factor binding site V$IRF7_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++NCX_01///Genes having at least one occurence of the transcription factor binding site V$NCX_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++NFE2_01///Genes having at least one occurence of the transcription factor binding site V$NFE2_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++RYTTCCTG_ETS2_B///Genes having at least one occurence of the highly conserved motif M16 RYTTCCTG sites. The motif matches transcription factor binding site V$ETS2_B (v7.4 TRANSFAC).+++SCGGAAGY_ELK1_02///Genes having at least one occurence of the highly conserved motif M3 SCGGAAGY sites. The motif matches transcription factor binding site V$ELK1_02 (v7.4 TRANSFAC).+++STAT_01///Genes having at least one occurence of the transcription factor binding site V$STAT_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++STAT5A_01///Genes having at least one occurence of the transcription factor binding site V$STAT5A_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++STTTCRNTTT_IRF_Q6///Genes having at least one occurence of the highly conserved motif M85 STTTCRNTTT sites. The motif matches transcription factor binding site V$IRF_Q6 (v7.4 TRANSFAC).+++TGANNYRGCA_TCF11MAFG_01///Genes having at least one occurence of the highly conserved motif M67 TGANNYRGCA sites. The motif matches transcription factor binding site V$TCF11MAFG_01 (v7.4 TRANSFAC).+++TGANTCA_AP1_C///Genes having at least one occurence of the highly conserved motif M7 TGANTCA sites. The motif matches transcription factor binding site V$AP1_C (v7.4 TRANSFAC).+++TGGAAA_NFAT_Q4_01///Genes having at least one occurence of the highly conserved motif M55 TGGAAA sites. The motif matches transcription factor binding site V$NFAT_Q4_01 (v7.4 TRANSFAC).+++TITF1_Q3///Genes having at least one occurence of the transcription factor binding site V$TITF1_Q3 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++TST1_01///Genes having at least one occurence of the transcription factor binding site V$TST1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++TTCYNRGAA_STAT5B_01///Genes having at least one occurence of the highly conserved motif M40 TTCYNRGAA sites. The motif matches transcription factor binding site V$STAT5B_01 (v7.4 TRANSFAC).+++YATGNWAAT_OCT_C///Genes having at least one occurence of the highly conserved motif M44 YATGNWAAT sites. The motif matches transcription factor binding site V$OCT_C (v7.4 TRANSFAC).	"ADNP_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9H2P0 (ADNP) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ARID5B_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q14865 (ARID5B) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++BACH2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9BYV9 (BACH2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++BRCA2_TARGET_GENES///Genes containing one or more binding sites for UniProt:P51587 (BRCA2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++CBFA2T2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O43439 (CBFA2T2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++CBX5_TARGET_GENES///Genes containing one or more binding sites for UniProt:P45973 (CBX5) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++DLX6_TARGET_GENES///Genes containing one or more binding sites for UniProt:P56179 (DLX6) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++FEV_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q99581 (FEV) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++FOXN3_TARGET_GENES///Genes containing one or more binding sites for UniProt:O00409 (FOXN3) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++FOXP2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O15409 (FOXP2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++GCM2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O75603 (GCM2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++GREB1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q4ZG55 (GREB1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HAND1_TARGET_GENES///Genes containing one or more binding sites for UniProt:O96004 (HAND1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HDAC4_TARGET_GENES///Genes containing one or more binding sites for UniProt:P56524 (HDAC4) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HES2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9Y543 (HES2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HMG20B_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9P0W2 (HMG20B) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ID1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P41134 (ID1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++INSM2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96T92 (INSM2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++JDP2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8WYK2 (JDP2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++KAT2A_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q92830 (KAT2A) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++KMT2D_TARGET_GENES///Genes containing one or more binding sites for UniProt:O14686 (KMT2D) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++MAML1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q92585 (MAML1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NFE2L1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q14494 (NFE2L1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NFKBIA_TARGET_GENES///Genes containing one or more binding sites for UniProt:P25963 (NFKBIA) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NOTCH3_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9UM47 (NOTCH3) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++PAX7_TARGET_GENES///Genes containing one or more binding sites for UniProt:P23759 (PAX7) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++PHB2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q99623 (PHB2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++PRKDC_TARGET_GENES///Genes containing one or more binding sites for UniProt:P78527 (PRKDC) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SALL4_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9UJQ4 (SALL4) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SETX_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q7Z333 (SETX) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SFMBT1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9UHJ3 (SFMBT1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SIX1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q15475 (SIX1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SNAI1_TARGET_GENES///Genes containing one or more binding sites for UniProt:O95863 (SNAI1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SOX10_TARGET_GENES///Genes containing one or more binding sites for UniProt:P56693 (SOX10) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SOX3_TARGET_GENES///Genes containing one or more binding sites for UniProt:P41225 (SOX3) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SUPT16H_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9Y5B9 (SUPT16H) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++TAZ_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q16635 (TAZ) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++TCF7_TARGET_GENES///Genes containing one or more binding sites for UniProt:P36402 (TCF7) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++TEAD2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q15562 (TEAD2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++TFEB_TARGET_GENES///Genes containing one or more binding sites for UniProt:P19484 (TFEB) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++TP73_TARGET_GENES///Genes containing one or more binding sites for UniProt:O15350 (TP73) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++WRNIP1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96S55 (WRNIP1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZBTB18_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q99592 (ZBTB18) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZFP91_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96JP5 (ZFP91) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZIM3_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96PE6 (ZIM3) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF10_TARGET_GENES///Genes containing one or more binding sites for UniProt:P21506 (ZNF10) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF134_TARGET_GENES///Genes containing one or more binding sites for UniProt:P52741 (ZNF134) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF213_TARGET_GENES///Genes containing one or more binding sites for UniProt:O14771 (ZNF213) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF407_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9C0G0 (ZNF407) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF436_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9C0F3 (ZNF436) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF449_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6P9G9 (ZNF449) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF549_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6P9A3 (ZNF549) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF592_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q92610 (ZNF592) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF597_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96LX8 (ZNF597) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF610_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8N9Z0 (ZNF610) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF768_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9H5H4 (ZNF768) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF92_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q03936 (ZNF92) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZSCAN30_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q86W11 (ZSCAN30) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZSCAN4_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8NAM6 (ZSCAN4) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZSCAN5DP_TARGET_GENES///Genes containing one or more binding sites for UniProt:P0CG00 (ZSCAN5DP) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."				"GSE11864_CSF1_PAM3CYS_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP///Genes up-regulated in comparison of macrophages cultured with M-CSF [GeneID=1435] and Pam3Cyc versus macrophages cultured with M-CSF [GeneID=1435], IFNG [GeneID=3458] and Pam3Cyc.+++GSE13411_IGM_MEMORY_BCELL_VS_PLASMA_CELL_UP///Genes up-regulated in comparison of IgM-memory B cells versus plasma cells.+++GSE13411_PLASMA_CELL_VS_MEMORY_BCELL_DN///Genes down-regulated in comparison of plasma cells versus memory B cells.+++GSE13411_SWITCHED_MEMORY_BCELL_VS_PLASMA_CELL_UP///Genes up-regulated in comparison of Ig isotype switched memory B cells versus plasma cells.+++GSE13484_12H_VS_3H_YF17D_VACCINE_STIM_PBMC_UP///Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) cultured with YF17D vaccine for 12 h versus PBMC cultured for 3 h.+++GSE14000_4H_VS_16H_LPS_DC_UP///Genes up-regulated in comparison of dendritic cells (DC) at 4 h after LPS (TLR4 agonist) stimulation versus those at 16 h after the stimulation.+++GSE14000_UNSTIM_VS_16H_LPS_DC_UP///Genes up-regulated in comparison of dendritic cells (DC) before and 16 h after LPS (TLR4 agonist) stimulation.+++GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_DN///Genes down-regulated in comparison of CD4 [GeneID=920] CD8 thymocytes versus naive CD4 [GeneID=920] T cells from cord blood.+++GSE15735_CTRL_VS_HDAC_INHIBITOR_TREATED_CD4_TCELL_12H_DN///Genes down-regulated in CD4 [GeneID=920] T cells: control versus treated with HDAC inhibitors for 12h.+++GSE16385_MONOCYTE_VS_12H_IFNG_TNF_TREATED_MACROPHAGE_UP///Genes up-regulated in monocytes (12h) versus macrophages (12h) treated with IFNG and TNF [GeneID=3458;7124].+++GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_IL4_TREATED_MACROPHAGE_UP///Genes up-regulated in macrophages (12h): control versus rosiglitazone [PubChem=77999] and IL4 [GeneID=3565].+++GSE17186_BLOOD_VS_CORD_BLOOD_NAIVE_BCELL_DN///Genes down-regulated in nave B lymphocytes versus those from cord blood.+++GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_CORD_BLOOD_UP///Genes up-regulated in transitional B lymphocytes from cord blood: CR2 [GeneID=1380] low versus CR2 [GeneID=1380] high.+++GSE17186_NAIVE_VS_CD21LOW_TRANSITIONAL_BCELL_CORD_BLOOD_UP///Genes up-regulated in B lymphocytes from cord blood: nave versus transitional CR2 [GeneID=1380].+++GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_DN///Genes down-regulated in control macrophages: untreated versus primed by IFNG [GeneID=3458].+++GSE22589_SIV_VS_HIV_AND_SIV_INFECTED_DC_DN///Genes down-regulated in monocyte-derived dendritic cells infected by: SIV versus HIV and SIV.+++GSE22601_CD4_SINGLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_DN///Genes down-regulated in single positive thymocytes: CD4 [GeneID=920] versus CD8.+++GSE22886_IGG_IGA_MEMORY_BCELL_VS_BM_PLASMA_CELL_UP///Genes up-regulated in comparison of memory IgG IgA B cells versus plasma cells from bone marrow and blood.+++GSE22886_NAIVE_BCELL_VS_BM_PLASMA_CELL_UP///Genes up-regulated in comparison of naive B cells versus plasma cells from bone marrow and blood.+++GSE22886_NAIVE_CD8_TCELL_VS_MEMORY_TCELL_DN///Genes down-regulated in comparison of naive CD8 T cells versus naive CD4 [GeneID=920] CD8 T cells.+++GSE22886_NAIVE_VS_MEMORY_TCELL_DN///Genes down-regulated in comparison of naive CD4 [GeneID=920] CD8 T cells versus unstimulated memory CD4 [GeneID=920] CD8 T cells.+++GSE22886_UNSTIM_VS_STIM_MEMORY_TCELL_UP///Genes up-regulated in comparison of unstimulated memory CD4 [GeneID=920] CD8 T cells versus stimulated CD4 [GeneID=920] CD8 T cells.+++GSE22919_RESTING_VS_IL2_IL12_IL15_STIM_NK_CELL_DN///Genes down-regulated in NK cells: fresh versus stimulated with IL2 [GeneID=3558], IL-12 and IL15 [GeneID=3600].+++GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY10_UP///Genes up-regulated in comparison of CD25- T cells treated with IL4 [GeneID=3565] at day 10 versus untreated CD25- T cells at day 10.+++GSE26351_UNSTIM_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_UP///Genes up-regulated in CD34+ [GeneID=947] cells: control versus stimulated by BMP4 [GeneID=652].+++GSE27670_CTRL_VS_LMP1_TRANSDUCED_GC_BCELL_DN///Genes down-regulated in germinal center B lymphocytes: control versus over-expressing Epstein-Barr virus protein LMP1.+++GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_6H_UP///Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 [GeneID=7040] and IL-12 (6h) versus untreated (6h).+++GSE28726_NAIVE_VS_ACTIVATED_CD4_TCELL_UP///Genes up-regulated in CD4 [GeneID=920] T cells: nave versus activated.+++GSE33374_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_DN///Genes down-regulated in KLRB1 high [GeneID=3820] T cells: CD8A [GeneID=925] versus CD8A CD8B [GeneID=925;926].+++GSE33425_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_DN///Genes down-regulated in KLRB1 high [GeneID=3820] T cells: CD8A [GeneID=925] versus CD8A CD8B [GeneID=925;926].+++GSE34156_UNTREATED_VS_6H_NOD2_LIGAND_TREATED_MONOCYTE_UP///Genes up-regulated in monocytes (6h): untreated versus muramyl dipeptide [PubChem=11620162].+++GSE34515_CD16_NEG_VS_POS_MONOCYTE_UP///Genes up-regulated in monocytes: CD16- versus CD16+.+++GSE360_CTRL_VS_M_TUBERCULOSIS_DC_UP///Genes up-regulated in comparison of dendritic cells (DC) versus DCs exposed to M.tuberculosis.+++GSE360_DC_VS_MAC_M_TUBERCULOSIS_DN///Genes down-regulated in comparison of dendritic cells (DC) exposed to M. tuberculosis versus macrophages exposed to L. major.+++GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_UP///Genes up-regulated in comparison of dendritic cells (DC) exposed to 50 worms/well B. malayi versus DC exposed to M. tuberculosis+++GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_DC_DN///Genes down-regulated in comparison of dendritic cells (DC) exposed to L. donovani versus DCs exposed to 50 worm/well B. malayi.+++GSE3982_BASOPHIL_VS_NKCELL_DN///Genes down-regulated in comparison of basophils versus NK cells.+++GSE3982_BCELL_VS_CENT_MEMORY_CD4_TCELL_DN///Genes down-regulated in comparison of B cells versus central memory CD4 [GeneID=920] T cells.+++GSE3982_DC_VS_BASOPHIL_UP///Genes up-regulated in comparison of dendritic cells (DC) versus basophils.+++GSE3982_DC_VS_CENT_MEMORY_CD4_TCELL_DN///Genes down-regulated in comparison of dendritic cells (DC) versus central memory CD4 [GeneID=920] T cells.+++GSE3982_DC_VS_MAC_LPS_STIM_DN///Genes down-regulated in comparison of dendritic cells (DC) stimulatd with LPS (TLR4 agonist) at 48 h versus macrophages stimulated with LPS (TLR4 agonist) at 4 h.+++GSE3982_MAST_CELL_VS_BASOPHIL_UP///Genes up-regulated in comparison of mast cells versus basophils.+++GSE3982_MAST_CELL_VS_CENT_MEMORY_CD4_TCELL_DN///Genes down-regulated in comparison of mast cells versus central memory CD4 [GeneID=920] T cells.+++GSE3982_MAST_CELL_VS_EFF_MEMORY_CD4_TCELL_DN///Genes down-regulated in comparison of mast cells versus effector memory CD4 [GeneID=920] T cells.+++GSE3982_MEMORY_CD4_TCELL_VS_BCELL_UP///Genes up-regulated in comparison of memory CD4 [GeneID=920] T cells versus B cells.+++GSE3982_MEMORY_CD4_TCELL_VS_TH1_UP///Genes up-regulated in comparison of memory CD4 [GeneID=920] T cells versus Th1 cells.+++GSE42724_MEMORY_BCELL_VS_PLASMABLAST_DN///Genes down-regulated in B lymphocytes: memory versus plasmablasts.+++GSE42724_NAIVE_BCELL_VS_PLASMABLAST_DN///Genes down-regulated in B lymphocytes: nave versus plasmablasts.+++GSE5542_IFNA_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_UP///Genes up-regulated in epithelial cells (6h): interferon alpha versus interferon alpha and IFNG [GeneID=3458].+++GSE5679_PPARG_LIGAND_ROSIGLITAZONE_VS_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_UP///Genes up-regulated in monocyte-derived dendritic cells: rosiglitazone [PubChem=77999] versus rosiglitazone and AM580 [PubChem=77999;2126].+++GSE6269_E_COLI_VS_STAPH_AUREUS_INF_PBMC_UP///Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from patients with acute E. coli infection versus PBMC from patients with acute S. aureus infection.+++GSE6269_E_COLI_VS_STREP_PNEUMO_INF_PBMC_UP///Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from patients with acute E. coli infection versus PBMC from patients with acute S. pneumoniae infection.+++GSE8685_IL2_STARVED_VS_IL2_ACT_IL2_STARVED_CD4_TCELL_UP///Genes up-regulated in Sez-2 cells (T cell lymphoma): untreated versus IL2 [GeneID=3558].+++GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_1MONTH_POST_DX_DN///Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMCs from patients with type 1 diabetes at 1 month after the diagnosis.+++NAKAYA_B_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN///Genes down-regulated in B cell 7d vs 0d in young adults (18-50) after exposure to Fluarix/Fluvirin , time point 7D+++NAKAYA_PBMC_FLUMIST_AGE_18_50YO_7DY_UP///Genes up-regulated in peripheral blood mononuclear cell 7d vs 0d in adults (18-50) after exposure to FluMist , time point 7D. Comment: Supplementary Table 1b: All the differentially expressed genes identified in PBMCs of TIV vaccinees.+++NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN///Genes down-regulated in plasmacytoid dendritic cell 7d vs 0d in young adults (18-50) after exposure to Fluarix/Fluvirin , time point 7D+++THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN///Genes down-regulated in peripheral blood mononuclear cell 28d vs 0d in young adults (21-30) (responders) after exposure to Inactivated influenza vaccine , time point 28D+++THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_70PLS_NONRESPONDER_2DY_DN///Genes down-regulated in peripheral blood mononuclear cell 2d vs 0d in seniors (70+) (nonresponder) after exposure to Inactivated influenza vaccine , time point 2D"	HALLMARK_MITOTIC_SPINDLE///Genes important for mitotic spindle assembly.	NM_001113491	SEPTIN9				
Q9UHA4	sp|Q9UHA4|LTOR3_HUMAN		LAMTOR3		Ragulator complex protein LAMTOR3 OS=Homo sapiens OX=9606 GN=LAMTOR3 PE=1 SV=1	8649	URS0000EB6957						MADDLKRFLYKKLPSVEGLHAIVVSDRDGVPVIKVANDNAPEHALRPGFLSTFALATDQGSKLGLSKNKSIICYYNTYQVVQFNRLPLVVSFIASSSANTGLIVSLEKELAPLFEELRQVVEVS	0.5775136	-0.792073099	0.01306684				6.3082928	4.9408175				6.3777325	6.4892208	6.494668	6.0420378				6.8810864				5.6186283				5.4293989				8.041965	7.443368	7.221368	6.8195649		7.2164081	7.1375681	6.6041089	6.5816047				5.9213432		7.7049593		7.1119461																																	URS0000EB6957	LAMTOR3				
Q9UBQ0	sp|Q9UBQ0|VPS29_HUMAN		VPS29		Vacuolar protein sorting-associated protein 29 OS=Homo sapiens OX=9606 GN=VPS29 PE=1 SV=1	51699	URS0000E96F0F						MLVLVLGDLHIPHRCNSLPAKFKKLLVPGKIQHILCTGNLCTKESYDYLKTLAGDVHIVRGDFDENLNYPEQKVVTVGQFKIGLIHGHQVIPWGDMASLALLQRQFDVDILISGHTHKFEAFEHENKFYINPGSATGAYNALETNIIPSFVLMDIQASTVVTYVYQLIGDDVKVERIEYKKP	0.5239455	-0.932511443	0.02051018						3.0137028	2.012889925	2.8432848	2.7760776	2.6854452	2.722995	3.1347968		3.0240758	0.4920513	3.6692944		1.6606404			2.9097143	3.865893	2.1591968					5.802132	5.0964039	5.731427	4.7397847	2.349944	2.8594858	4.203696	2.1207418	3.986624	2.2510061	2.9491394	4.709538	3.4124509	2.84305355	4.0137001	1.9320255	3.82451072																																	URS0000E96F0F	VPS29				
Q9NZN3	sp|Q9NZN3|EHD3_HUMAN		EHD3		EH domain-containing protein 3 OS=Homo sapiens OX=9606 GN=EHD3 PE=1 SV=2	30845	NM_014600	NP_055415	ENST00000322054	K12476			MFSWLGTDDRRRKDPEVFQTVSEGLKKLYKSKLLPLEEHYRFHEFHSPALEDADFDNKPMVLLVGQYSTGKTTFIRYLLEQDFPGMRIGPEPTTDSFIAVMQGDMEGIIPGNALVVDPKKPFRKLNAFGNAFLNRFVCAQLPNPVLESISVIDTPGILSGEKQRISRGYDFAAVLEWFAERVDRIILLFDAHKLDISDEFSEVIKALKNHEDKMRVVLNKADQIETQQLMRVYGALMWSLGKIVNTPEVIRVYIGSFWSHPLLIPDNRKLFEAEEQDLFRDIQSLPRNAALRKLNDLIKRARLAKVHAYIISSLKKEMPSVFGKDNKKKELVNNLAEIYGRIEREHQISPGDFPNLKRMQDQLQAQDFSKFQPLKSKLLEVVDDMLAHDIAQLMVLVRQEESQRPIQMVKGGAFEGTLHGPFGHGYGEGAGEGIDDAEWVVARDKPMYDEIFYTLSPVDGKITGANAKKEMVRSKLPNSVLGKIWKLADIDKDGMLDDDEFALANHLIKVKLEGHELPNELPAHLLPPSKRKVAE	0.455699	-1.133847016	0.00666581				3.6923006	5.1948499	5.9355552		4.8904018	6.478413	6.5421126	5.8314091	6.7328946		5.0431322	4.1985828	5.7615327		3.490226			5.5184278	6.7869614	7.2067044	3.7465866	4.44486332			8.637366	7.9025144	8.173169	7.953465	5.235131	6.1380353	6.4926361	6.5379487	6.29754	7.1407441	6.1459544	7.395597	6.0965419	5.9683884	7.4826049	4.8497346	7.54112867	04144///Endocytosis				GO:0005634///nucleus+++GO:0005737///cytoplasm+++GO:0005768///endosome+++GO:0005769///early endosome+++GO:0005829///cytosol+++GO:0005886///plasma membrane+++GO:0005925///focal adhesion+++GO:0005929///cilium+++GO:0010008///endosome membrane+++GO:0016020///membrane+++GO:0020018///ciliary pocket membrane+++GO:0030139///endocytic vesicle+++GO:0042995///cell projection+++GO:0043231///intracellular membrane-bounded organelle+++GO:0048471///perinuclear region of cytoplasm+++GO:0055038///recycling endosome membrane+++GO:0060170///ciliary membrane	GO:0000166///nucleotide binding+++GO:0003676///nucleic acid binding+++GO:0005509///calcium ion binding+++GO:0005515///protein binding+++GO:0005524///ATP binding+++GO:0005525///GTP binding+++GO:0046872///metal ion binding	GO:0001881///receptor recycling+++GO:0006897///endocytosis+++GO:0007596///blood coagulation+++GO:0015031///protein transport+++GO:0016197///endosomal transport+++GO:0030030///cell projection organization+++GO:0032456///endocytic recycling+++GO:0034498///early endosome to Golgi transport+++GO:0051260///protein homooligomerization+++GO:0055117///regulation of cardiac muscle contraction+++GO:0060271///cilium assembly+++GO:0072659///protein localization to plasma membrane+++GO:0086036///regulation of cardiac muscle cell membrane potential+++GO:0090160///Golgi to lysosome transport+++GO:1901387///positive regulation of voltage-gated calcium channel activity+++GO:1903358///regulation of Golgi organization+++GO:1903779///regulation of cardiac conduction			"Homo sapiens EH domain containing 3 (EHD3), mRNA."		PF00350///Dynamin family+++PF12763///Cytoskeletal-regulatory complex EF hand+++PF16880///N-terminal EH-domain containing protein+++PF18150///Domain of unknown function (DUF5600)	R-HSA-109582///Hemostasis+++R-HSA-983231///Factors involved in megakaryocyte development and platelet production		KOG1954///endocytic recycling		"IPR000261///EH domain+++IPR002048///EF-hand domain+++IPR011992///EF-hand domain pair+++IPR018247///EF-Hand 1, calcium-binding site+++IPR027417///P-loop containing nucleoside triphosphate hydrolase+++IPR029951///EH domain-containing protein 1/3+++IPR030381///Dynamin-type guanine nucleotide-binding (G) domain+++IPR031692///EH domain-containing protein, N-terminal+++IPR040990///Domain of unknown function DUF5600+++IPR045063///Dynamin, N-terminal"	[EHD3_HUMAN|Reviewed]RecName: Full=EH domain-containing protein 3 {ECO:0000305}; AltName: Full=PAST homolog 3 {ECO:0000305};	chr2p23///Ensembl 103 genes in cytogenetic band chr2p23		KEGG_ENDOCYTOSIS///Endocytosis	REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION///Factors involved in megakaryocyte development and platelet production+++REACTOME_HEMOSTASIS///Hemostasis		"ACTGTGA_MIR27A_MIR27B///Genes having at least one occurence of the motif ACTGTGA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-27a and hsa-miR-27b (v7.1 miRBase).+++ATGTTAA_MIR302C///Genes having at least one occurence of the motif ATGTTAA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-302c* (v7.1 miRBase).+++CTACTGT_MIR199A///Genes having at least one occurence of the motif CTACTGT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-199a* (v7.1 miRBase).+++CTCCAAG_MIR432///Genes having at least one occurence of the motif CTCCAAG in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-432 (v7.1 miRBase).+++GCACTTT_MIR175P_MIR20A_MIR106A_MIR106B_MIR20B_MIR519D///Genes having at least one occurence of the motif GCACTTT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-17-5p, hsa-miR-20a, hsa-miR-106a, hsa-miR-106b, hsa-miR-20b and hsa-miR-519d (v7.1 miRBase).+++GGCACTT_MIR519E///Genes having at least one occurence of the motif GGCACTT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-519e (v7.1 miRBase)."	"MIR3183///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3183 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4667_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4667-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4700_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4700-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4723_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4723-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5193///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5193 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR520G_3P_MIR520H///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-520g-3p, hsa-miR-520h in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5689///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5689 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6769B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6769b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6867_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6867-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6884_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6884-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR8089///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-8089 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR934///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-934 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets)."	GGGNRMNNYCAT_UNKNOWN///Genes having at least one occurence of the highly conserved motif M119 GGGNRMNNYCAT in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).	"BACH2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9BYV9 (BACH2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++PAX7_TARGET_GENES///Genes containing one or more binding sites for UniProt:P23759 (PAX7) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++THAP1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9NVV9 (THAP1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF618_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q5T7W0 (ZNF618) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZSCAN30_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q86W11 (ZSCAN30) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZSCAN31_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96LW9 (ZSCAN31) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."	GNF2_DNM1///Neighborhood of DNM1+++GNF2_RAB3A///Neighborhood of RAB3A		LTE2_UP.V1_UP///Genes up-regulated in MCF-7 cells (breast cancer) positive for ESR1 [Gene ID=2099] MCF-7 cells (breast cancer) and long-term adapted for estrogen-independent growth.	"GSE10240_CTRL_VS_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN///Genes down-regulated in primary bronchial epithelial cells: control versus stimulated with IL22 [GeneID=50616].+++GSE10325_BCELL_VS_MYELOID_UP///Genes up-regulated in comparison of healthy B cells versus healthy myeloid cells.+++GSE10325_CD4_TCELL_VS_BCELL_DN///Genes down-regulated in comparison of healthy CD4 [GeneID=920] T cells versus healthy CD19 [GeneID=920] B cells. +++GSE10325_CD4_TCELL_VS_LUPUS_CD4_TCELL_UP///Genes up-regulated in comparison of healthy CD4 [GeneID=920] T cells versus systemic lupus erythematosus CD4 [GeneID=920] T cells.+++GSE10325_LUPUS_BCELL_VS_LUPUS_MYELOID_UP///Genes up-regulated in comparison of systemic lupus erythematosus B cells versus systemic lupus erythromatosus myeloid cells.+++GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_BCELL_DN///Genes down-regulated in comparison of systemic lupus erythematosus CD4 [GeneID=920] T cells versus systemic lupus erythematosus B cells.+++GSE12845_IGD_POS_VS_NEG_BLOOD_BCELL_DN///Genes down-regulated in comparison of IgD+ B cells versus IgD- B cells.+++GSE13411_NAIVE_VS_IGM_MEMORY_BCELL_DN///Genes down-regulated in comparison of naive B cells versus IgM-memory B cells.+++GSE13484_UNSTIM_VS_12H_YF17D_VACCINE_STIM_PBMC_UP///Genes up-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) cultured for 0 h versus PBMC cultured for 12 h with YF17D vaccine.+++GSE1460_CORD_VS_ADULT_BLOOD_NAIVE_CD4_TCELL_UP///Genes up-regulated in CD4 [GeneID=920] T cells from cord blood versus those from adult blood.+++GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_IFNG_TNF_TREATED_MACROPHAGE_DN///Genes down-regulated in monocytes (12h) versus macrophages (12h) treated with IFNG, TNF [GeneID=3458;7124] and rosiglitazone [PubChem=77999].+++GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_IL4_TREATED_MACROPHAGE_UP///Genes up-regulated in monocytes (12h) versus macrophages (12h) treated with IL4 [GeneID=3565] and rosiglitazone [PubChem=77999].+++GSE16385_MONOCYTE_VS_MACROPHAGE_UP///Genes up-regulated in monocytes versus macrophages.+++GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_IMMATURE_NEURON_CELL_LINE_UP///Genes up-regulated in the immature neuron cell line: control versus infected with western equine encephalitis viruss.+++GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_1H_ACT_CD4_TCELL_DN///Genes down-regulated in comparison of CD4 [GeneID=920] T cells treated with IL4 [GeneID=3565] and anti-IL12 at 1 h versus the untreated cells at 1 h.+++GSE19888_ADENOSINE_A3R_INH_VS_INH_PRETREAT_AND_ACT_WITH_TCELL_MEMBRANES_MAST_CELL_DN///Genes down-regulated in HMC-1 (mast leukemia) cells incubated with the peptide ALL1 versus those then stimulated by T cell membranes.+++GSE22601_CD4_SINGLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_DN///Genes down-regulated in single positive thymocytes: CD4 [GeneID=920] versus CD8.+++GSE22601_DOUBLE_NEGATIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_UP///Genes up-regulated in thymocytes: double negative versus CD4 [GeneID=920] single positive.+++GSE22601_DOUBLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_UP///Genes up-regulated in thymocytes: double positive versus CD8 single positive.+++GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_UP///Genes up-regulated in single positive cells: immature CD4 [GeneID=920] versus CD8 thymocytes.+++GSE22611_NOD2_VS_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_DN///Genes down-regulated in HEK293 cells expressing: wildtype NOD2 [GeneID=64127] versus mutant NOD2 [GeneID=64127].+++GSE22886_CD4_TCELL_VS_BCELL_NAIVE_DN///Genes down-regulated in comparison of naive CD4 [GeneID=920] T cells versus naive B cells.+++GSE22886_NAIVE_BCELL_VS_BLOOD_PLASMA_CELL_DN///Genes down-regulated in comparison of naive B cells versus blood plasma cells.+++GSE22886_NAIVE_BCELL_VS_DC_UP///Genes up-regulated in comparison of naive B cells versus unstimulated dendritic cells (DC).+++GSE22886_NAIVE_VS_IGG_IGA_MEMORY_BCELL_DN///Genes down-regulated in comparison of naive B cells versus memory IgG IgA B cells.+++GSE22886_NAIVE_VS_IGM_MEMORY_BCELL_DN///Genes down-regulated in comparison of naive B cells versus memory IgM B cells.+++GSE23321_CENTRAL_VS_EFFECTOR_MEMORY_CD8_TCELL_DN///Genes down-regulated in CD8 T cells: central memory versus effector memory.+++GSE2405_0H_VS_12H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP///Genes up-regulated in polymorphonuclear leukocytes (12h): control versus infection by A. phagocytophilum.+++GSE26890_CXCR1_NEG_VS_POS_EFFECTOR_CD8_TCELL_UP///Genes up-regulated in effector CD8 T cells: CXCR1+ [GeneID=3577] versus CXCR1- [GeneID=3577].+++GSE29618_PRE_VS_DAY7_FLU_VACCINE_MDC_UP///Genes up-regulated in comparison of plasmacytoid dendritic cells (DC) from influenza vaccinee at day 0 versus myeloid DCs at day 7 post-vaccination.+++GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MDC_UP///Genes up-regulated in comparison of myeloid dendritic cells (mDC) from LAIV influenza vaccinee pre-vaccination versus those at day 7 post-vaccination.+++GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MDC_UP///Genes up-regulated in comparison of myeloid dendritic cells (mDC) from TIV influenza vaccinee pre-vaccination versus those at day 7 post-vaccination.+++GSE32901_NAIVE_VS_TH17_ENRICHED_CD4_TCELL_UP///Genes up-regulated in CD4 [GeneID=920] nave versus Th17 enriched.+++GSE33424_CD161_INT_VS_NEG_CD8_TCELL_UP///Genes up-regulated in CD8 T cells: KLRB1 int [GeneID=3820] versus KLRB1- [GeneID=3820].+++GSE3720_UNSTIM_VS_PMA_STIM_VD2_GAMMADELTA_TCELL_UP///Genes up-regulated in Vd2 gamma delta T cells: untreated versus phorbol myristate acetate and ionomycin [PubChem=4792;3733].+++GSE3982_BCELL_VS_CENT_MEMORY_CD4_TCELL_UP///Genes up-regulated in comparison of B cells versus central memory CD4 [GeneID=920] T cells.+++GSE3982_BCELL_VS_NKCELL_UP///Genes up-regulated in comparison of B cells versus NK cells.+++GSE3982_EOSINOPHIL_VS_CENT_MEMORY_CD4_TCELL_DN///Genes down-regulated in comparison of eosinophils versus central memory CD4 [GeneID=920] T cells.+++GSE3982_EOSINOPHIL_VS_TH2_DN///Genes down-regulated in comparison of eosinophils versus Th2 cells.+++GSE3982_MAC_VS_BCELL_DN///Genes down-regulated in comparison of macrophages versus B cells.+++GSE5542_IFNG_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN///Genes down-regulated in epithelial cells (6h): IFNG [GeneID=3458] versus IFNG [GeneID=3458] and interferon alpha.+++GSE5542_IFNG_VS_IFNA_TREATED_EPITHELIAL_CELLS_24H_UP///Genes up-regulated in epithelial cells (24h): IFNG [GeneID=3458] versus interferon alpha.+++GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN///Genes down-regulated in epithelial cells (6h): untreated versus IFNG [GeneID=3458].+++GSE5679_PPARG_LIGAND_ROSIGLITAZONE_VS_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_UP///Genes up-regulated in monocyte-derived dendritic cells: rosiglitazone [PubChem=77999] versus rosiglitazone and AM580 [PubChem=77999;2126].+++GSE7400_CTRL_VS_CSF3_IN_VIVO_TREATED_PBMC_UP///Genes up-regulated in comparison of untreated peripheral blood mononuclear cells (PBMC) versus PBMCs treated with CSF3 [GeneID=1440].+++GSE7460_CTRL_VS_TGFB_TREATED_ACT_CD8_TCELL_UP///Genes up-regulated in comparsion of ActCD8 versus ActCD8TGF (see Fig. 1 in the paper for details).+++GSE7460_TCONV_VS_TREG_LN_UP///Genes up-regulated in comparison of TconvLN versus TregLN (see Fig. 1 in the paper for details).+++GSE7509_UNSTIM_VS_TNFA_IL1B_IL6_PGE_STIM_DC_UP///Genes up-regulated in dendritic cells: untreated versus inflammatory cytokine cocktail."		NM_014600	EHD3				
Q9NZB2	sp|Q9NZB2|F120A_HUMAN		FAM120A		Constitutive coactivator of PPAR-gamma-like protein 1 OS=Homo sapiens OX=9606 GN=FAM120A PE=1 SV=2	23196	NM_014612	NP_055427	ENST00000277165				MGVQGFQDYIEKHCPSAVVPVELQKLARGSLVGGGRQRPPQTPLRLLVDADNCLHRLYGGFYTDWVSGGQWNHMLGYLAALAKACFGGNIELFVFFNGALEKARLHEWVKRQGNERQTAQQIVSHVQNKGTPPPKVWFLPPVCMAHCIRLALIRFHVKVAQSIEDHHQEVIGFCRENGFHGLVAYDSDYALCNIPYYFSAHALKLSRNGKSLTTSQYLMHEVAKQLDLNPNRFPIFAALLGNHILPDEDLASFHWSLLGPEHPLASLKVRAHQLVLPPCDVVIKAVADYVRNIQDTSDLDAIAKDVFQHSQSRTDDKVIRFKRAIGYYSATSKPMSFHPPHYLAARPGPFGMPGMVPPHVPPQMLNIPQTSLQAKPVAPQVPSPGGAPGQGPYPYSLSEPAPLTLDTSGKNLTEQNSYSNIPHEGKHTPLYERSSPINPAQSGSPNHVDSAYFPGSSTSSSSDNDEGSGGATNHISGNKIGWEKTGSHSEPQARGDPGDQTKAEGSSTASSGSQLAEGKGSQMGTVQPIPCLLSMPTRNHMDITTPPLPPVAPEVLRVAEHRHKKGLMYPYIFHVLTKGEIKIAVSIEDEANKDLPPAALLYRPVRQYVYGVLFSLAESRKKTERLAFRKNRLPPEFSPVIIKEWAAYKGKSPQTPELVEALAFREWTCPNLKRLWLGKAVEDKNRRMRAFLACMRSDTPAMLNPANVPTHLMVLCCVLRYMVQWPGARILRRQELDAFLAQALSPKLYEPDQLQELKIENLDPRGIQLSALFMSGVDMALFANDACGQPIPWEHCCPWMYFDGKLFQSKLLKASREKTPLIDLCDGQADQAAKVEKMRQSVLEGLSFSRQSHTLPFPPPPALPFYPASAYPRHFGPVPPSQGRGRGFAGVCGFGGPYGETVATGPYRAFRVAAASGHCGAFSGSDSSRTSKSQGGVQPIPSQGGKLEIAGTVVGHWAGSRRGRGGRGPFPLQVVSVGGPARGRPRGVISTPVIRTFGRGGRYYGRGYKNQAAIQGRPPYAASAEEVAKELKSKSGESKSSAMSSDGSLAENGVMAEEKPAPQMNGSTGDARAPSHSESALNNDSKTCNTNPHLNALSTDSACRREAALEAAVLNKEE	0.5676665	-0.816884401	0.01192862					4.6984158	6.6300043		4.8565782	5.463667	6.301784	5.281525	6.1217824			6.1391128	5.8749093		4.9725887			6.1443023	5.9680146	7.6831469					8.24321	7.0018071	7.622047	7.4746766		5.3607555	6.4126217	6.2992715	6.6586047	6.0020588	5.6128995	6.836785	6.0211357	5.01926771	7.0910196	4.6236859	6.898678					GO:0005634///nucleus+++GO:0005737///cytoplasm+++GO:0005829///cytosol+++GO:0005886///plasma membrane+++GO:0016020///membrane	GO:0003723///RNA binding				"Homo sapiens family with sequence similarity 120A (FAM120A), transcript variant 1, mRNA."					ENOG502QQNQ///No_INFO		IPR026784///Constitutive coactivator of PPAR-gamma+++IPR029060///PIN-like domain superfamily	[F120A_HUMAN|Reviewed]RecName: Full=Constitutive coactivator of PPAR-gamma-like protein 1; AltName: Full=Oxidative stress-associated Src activator; AltName: Full=Protein FAM120A;	chr9q22///Ensembl 103 genes in cytogenetic band chr9q22					"AATGGAG_MIR136///Genes having at least one occurence of the motif AATGGAG in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-136 (v7.1 miRBase).+++ATCTTGC_MIR31///Genes having at least one occurence of the motif ATCTTGC in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-31 (v7.1 miRBase).+++ATGCTGG_MIR338///Genes having at least one occurence of the motif ATGCTGG in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-338 (v7.1 miRBase).+++ATGTACA_MIR493///Genes having at least one occurence of the motif ATGTACA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-493 (v7.1 miRBase).+++ATGTTAA_MIR302C///Genes having at least one occurence of the motif ATGTTAA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-302c* (v7.1 miRBase).+++GCATTTG_MIR105///Genes having at least one occurence of the motif GCATTTG in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-105 (v7.1 miRBase).+++GGTGAAG_MIR412///Genes having at least one occurence of the motif GGTGAAG in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-412 (v7.1 miRBase).+++TAATAAT_MIR126///Genes having at least one occurence of the motif TAATAAT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-126* (v7.1 miRBase).+++TACTTGA_MIR26A_MIR26B///Genes having at least one occurence of the motif TACTTGA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-26a and hsa-miR-26b (v7.1 miRBase)."	"MIR10394_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-10394-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1205///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1205 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR12130///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-12130 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR12132///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-12132 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1250_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1250-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1252_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1252-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1304_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1304-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR130A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-130a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR144_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-144-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1468_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1468-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR147B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-147b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR153_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-153-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR186_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-186-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR19A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-19a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR19B_1_5P_MIR19B_2_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-19b-1-5p, hsa-miR-19b-2-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR298///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-298 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR29A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-29a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR302C_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-302c-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3123///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3123 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3151_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3151-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3192_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3192-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3609///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3609 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3614_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3614-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3658///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3658 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3671///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3671 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR374C_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-374c-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3973///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3973 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR409_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-409-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4261///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4261 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4289///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4289 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4325///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4325 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4433A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4433a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4443///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4443 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4477A///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4477a in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4489///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4489 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4503///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4503 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR450B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-450b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4698///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4698 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4753_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4753-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4759///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4759 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4762_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4762-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4768_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4768-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR495_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-495-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR497_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-497-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5197_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5197-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AH_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548ah-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AO_5P_MIR548AX///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548ao-5p, hsa-miR-548ax in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AR_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548ar-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AV_5P_MIR548K///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548av-5p, hsa-miR-548k in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548L///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548l in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR550B_2_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-550b-2-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR551B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-551b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5582_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5582-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR562///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-562 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5689///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5689 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5700///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5700 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR582_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-582-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR603///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-603 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR605_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-605-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6126///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6126 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6507_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6507-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6733_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6733-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6739_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6739-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6809_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6809-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6832_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6832-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6833_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6833-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6853_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6853-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6865_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6865-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6882_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6882-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7109_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7109-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7161_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7161-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7856_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7856-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR8054///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-8054 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR8063///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-8063 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR8066///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-8066 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR8080///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-8080 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets)."	GATTGGY_NFY_Q6_01///Genes having at least one occurence of the highly conserved motif M5 GATTGGY sites. The motif matches transcription factor binding site V$NFY_Q6_01 (v7.4 TRANSFAC).+++GGGTGGRR_PAX4_03///Genes having at least one occurence of the highly conserved motif M56 GGGTGGRR sites. The motif matches transcription factor binding site V$PAX4_03 (v7.4 TRANSFAC).+++PR_Q2///Genes having at least one occurence of the transcription factor binding site V$PR_Q2 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++SCGGAAGY_ELK1_02///Genes having at least one occurence of the highly conserved motif M3 SCGGAAGY sites. The motif matches transcription factor binding site V$ELK1_02 (v7.4 TRANSFAC).+++YNGTTNNNATT_UNKNOWN///Genes having at least one occurence of the highly conserved motif M170 YNGTTNNNATT in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).	"ADA2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9NZK5 (ADA2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ARID3B_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8IVW6 (ARID3B) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HMGB1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P09429 (HMGB1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++KDM7A_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6ZMT4 (KDM7A) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NAB2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q15742 (NAB2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++TCF7_TARGET_GENES///Genes containing one or more binding sites for UniProt:P36402 (TCF7) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF213_TARGET_GENES///Genes containing one or more binding sites for UniProt:O14771 (ZNF213) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF711_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9Y462 (ZNF711) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."	GNF2_BNIP2///Neighborhood of BNIP2+++GNF2_PPP6C///Neighborhood of PPP6C+++GNF2_TYK2///Neighborhood of TYK2+++MORF_AP3D1///Neighborhood of AP3D1+++MORF_BAG5///Neighborhood of BAG5+++MORF_CSNK2B///Neighborhood of CSNK2B+++MORF_CTBP1///Neighborhood of CTBP1+++MORF_DAP3///Neighborhood of DAP3+++MORF_DAP///Neighborhood of DAP+++MORF_DEK///Neighborhood of DEK+++MORF_EI24///Neighborhood of EI24+++MORF_HAT1///Neighborhood of HAT1+++MORF_HDAC1///Neighborhood of HDAC1+++MORF_HDAC2///Neighborhood of HDAC2+++MORF_MAP2K2///Neighborhood of MAP2K2+++MORF_MBD4///Neighborhood of MBD4+++MORF_MTA1///Neighborhood of MTA1+++MORF_PAPSS1///Neighborhood of PAPSS1+++MORF_PPP1CA///Neighborhood of PPP1CA+++MORF_PRDX3///Neighborhood of PRDX3+++MORF_PRKAR1A///Neighborhood of PRKAR1A+++MORF_PSMC2///Neighborhood of PSMC2+++MORF_RAB6A///Neighborhood of RAB6A+++MORF_RAC1///Neighborhood of RAC1+++MORF_RAD21///Neighborhood of RAD21+++MORF_RAD23A///Neighborhood of RAD23A+++MORF_RAD23B///Neighborhood of RAD23B+++MORF_SOD1///Neighborhood of SOD1+++MORF_SP3///Neighborhood of SP3			"GSE12845_IGD_POS_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_DN///Genes down-regulated in comparison of IgD+ peripheral blood B cells versus dark zone germincal center B cells.+++GSE12845_IGD_POS_BLOOD_VS_NAIVE_TONSIL_BCELL_DN///Genes down-regulated in comparison of IgD+ peripheral blood B cells versus IgD- naive tonsil B cells.+++GSE12845_IGD_POS_BLOOD_VS_PRE_GC_TONSIL_BCELL_DN///Genes down-regulated in comparison of IgD+ B cells from peripheral blood versus CD19 pre-germinal center tonsil B cell+++GSE14000_4H_VS_16H_LPS_DC_UP///Genes up-regulated in comparison of dendritic cells (DC) at 4 h after LPS (TLR4 agonist) stimulation versus those at 16 h after the stimulation.+++GSE15215_CD2_POS_VS_NEG_PDC_UP///Genes up-regulated in comparison of CD2+ plasmacytoid dendritic cells (DC) versus CD2- cells.+++GSE17974_1.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_DN///Genes down-regulated in comparison of CD4 [GeneID=920] T cells treated with IL4 [GeneID=3565] and anti-IL12 at 1.5 h versus those at 72 h.+++GSE17974_1H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_DN///Genes down-regulated in comparison of untreated CD4 [GeneID=920] T cells at 1 h versus the untreated cells at 72 h.+++GSE22611_MUTANT_NOD2_TRANSDUCED_VS_CTRL_HEK293T_STIMULATED_WITH_MDP_6H_DN///Genes down-regulated in HEK293 cells at 6h after stimulation by muramyl dipeptide [PubChem=11620162]: over-expressing mutant NOD2 [GeneID=64127] versus control.+++GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_DN///Genes down-regulated in AGS cells (gastric adenocarcinoma): control versus H. pylori LPS.+++GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_6H_UP///Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: IL-12 (6h) versus IL4 [GeneID=3565] (6h).+++GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_2H_UP///Genes up-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 and then stimulated by IL-12 (2h).+++GSE34156_TLR1_TLR2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_DN///Genes down-regulated in monocytes (24h): M. tuberculosis 19 kDa lipopeptide versus M. tuberculosis 19 kDa lipopeptide and muramyl dipeptide [PubChem=11620162].+++GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_MAC_DN///Genes down-regulated in comparison of macrophages versus macrophages exposed to B. malayi (5 worms/well).+++GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_MAC_DN///Genes down-regulated in comparison of macrophages exposed to L. donovani versus macrophages exposed to 5 worms/well B. malayi.+++GSE3982_CTRL_VS_LPS_1H_NEUTROPHIL_UP///Genes up-regulated in comparison of untreated neutrophils versus neutrophils treated with LPS (TLR4 agonist) at 1 h.+++NAKAYA_MYELOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN///Genes down-regulated in myeloid dendritic cell 7d vs 0d in young adults (18-50) after exposure to FluMist , time point 7D+++OCONNOR_PBMC_MENVEO_ACWYVAX_AGE_30_70YO_7DY_AFTER_SECOND_DOSE_VS_7DY_AFTER_FIRST_DOSE_DN///Genes down-regulated in peripheral blood mononuclear cell 7d after second dose vs 7d after first dose in adult (30-70) after exposure to Menveo/ACWYVax , time point 7D. Comment: second dose at 28 days+++OSMAN_BLOOD_CHAD63_KH_AGE_18_50YO_HIGH_DOSE_SUBJECTS_24HR_UP///Genes up-regulated in blood 24hr vs 0hr in adults (18-50) (high dose subjects) after exposure to ChAd63-KH , time point 24H , administered Intramuscular injection. Comment: DE gene list for high dose subjects."	HALLMARK_MYC_TARGETS_V1///A subgroup of genes regulated by MYC - version 1 (v1).	NM_014612	FAM120A				
Q9NR12	sp|Q9NR12|PDLI7_HUMAN		PDLIM7		PDZ and LIM domain protein 7 OS=Homo sapiens OX=9606 GN=PDLIM7 PE=1 SV=1	9260	NM_005451	NP_005442	ENST00000355841				MDSFKVVLEGPAPWGFRLQGGKDFNVPLSISRLTPGGKAAQAGVAVGDWVLSIDGENAGSLTHIEAQNKIRACGERLSLGLSRAQPVQSKPQKASAPAADPPRYTFAPSVSLNKTARPFGAPPPADSAPQQNGQPLRPLVPDASKQRLMENTEDWRPRPGTGQSRSFRILAHLTGTEFMQDPDEEHLKKSSQVPRTEAPAPASSTPQEPWPGPTAPSPTSRPPWAVDPAFAERYAPDKTSTVLTRHSQPATPTPLQSRTSIVQAAAGGVPGGGSNNGKTPVCHQCHKVIRGRYLVALGHAYHPEEFVCSQCGKVLEEGGFFEEKGAIFCPPCYDVRYAPSCAKCKKKITGEIMHALKMTWHVHCFTCAACKTPIRNRAFYMEEGVPYCERDYEKMFGTKCHGCDFKIDAGDRFLEALGFSWHDTCFVCAICQINLEGKTFYSKKDRPLCKSHAFSHV	0.5268505	-0.924534359	0.01889564		5.8405488		5.9358373	7.0863058	7.4512411		6.3588782	5.9389959	7.5855417	7.1976336	7.8050887		5.9372376	6.9326888	7.5356385	4.8439651	7.2998973			7.5445136	7.7160715	8.1960338	5.4066961				11.103397	7.843327	7.605314	8.3048293	5.560427	5.0485058	7.2247397	7.1879721	7.1042925	8.0722677	7.872421	8.516572	8.1899279	7.99692329	8.9744585	7.8592752	8.94824613		H00292///Hypertrophic cardiomyopathy+++H00294///Dilated cardiomyopathy+++H00595///Myofibrillar myopathies+++H01216///Left ventricular noncompaction			GO:0001725///stress fiber+++GO:0001726///ruffle+++GO:0005654///nucleoplasm+++GO:0005737///cytoplasm+++GO:0005829///cytosol+++GO:0005856///cytoskeleton+++GO:0005912///adherens junction+++GO:0005925///focal adhesion+++GO:0015629///actin cytoskeleton+++GO:0030018///Z disc+++GO:0031941///filamentous actin	GO:0003779///actin binding+++GO:0005515///protein binding+++GO:0046872///metal ion binding+++GO:0051371///muscle alpha-actinin binding	GO:0001503///ossification+++GO:0006898///receptor-mediated endocytosis+++GO:0007411///axon guidance+++GO:0007507///heart development+++GO:0030036///actin cytoskeleton organization+++GO:0030154///cell differentiation+++GO:0045669///positive regulation of osteoblast differentiation+++GO:0061061///muscle structure development	tissueType=Fetal gonad;cancerType=Normal;cellName=Gonadal endothelial cell+++tissueType=Fetal gonad;cancerType=Normal;cellName=Migration phase fetal germ cell+++tissueType=Blood;cancerType=Normal;cellName=CD141+CLEC9A+ dendritic cell+++tissueType=Liver;cancerType=Normal;cellName=Mesenchymal cell+++tissueType=Liver;cancerType=Normal;cellName=Liver bud hepatic cell+++tissueType=Liver;cancerType=Hepatocellular Cancer;cellName=Exhausted CD8+ T cell		"Homo sapiens PDZ and LIM domain 7 (PDLIM7), transcript variant 1, mRNA."		PF00412///LIM domain+++PF00595///PDZ domain	R-HSA-1266738///Developmental Biology+++R-HSA-422475///Axon guidance+++R-HSA-8853659///RET signaling+++R-HSA-9675108///Nervous system development		KOG1703///actinin binding		"IPR001478///PDZ domain+++IPR001781///Zinc finger, LIM-type+++IPR036034///PDZ superfamily"	[PDLI7_HUMAN|Reviewed]RecName: Full=PDZ and LIM domain protein 7; AltName: Full=LIM mineralization protein; Short=LMP; AltName: Full=Protein enigma;	chr5q35///Ensembl 103 genes in cytogenetic band chr5q35			REACTOME_DEVELOPMENTAL_BIOLOGY///Developmental Biology+++REACTOME_NERVOUS_SYSTEM_DEVELOPMENT///Nervous system development+++REACTOME_RET_SIGNALING///RET signaling		"CAGCCTC_MIR4855P///Genes having at least one occurence of the motif CAGCCTC in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-485-5p (v7.1 miRBase).+++CTATGCA_MIR153///Genes having at least one occurence of the motif CTATGCA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-153 (v7.1 miRBase).+++GCAAGAC_MIR431///Genes having at least one occurence of the motif GCAAGAC in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-431 (v7.1 miRBase).+++GTGACTT_MIR224///Genes having at least one occurence of the motif GTGACTT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-224 (v7.1 miRBase).+++GTGCCAA_MIR96///Genes having at least one occurence of the motif GTGCCAA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-96 (v7.1 miRBase)."	MIR1912_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1912-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3689D///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3689d in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6851_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6851-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6880_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6880-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7106_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7106-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).	COUP_DR1_Q6///Genes having at least one occurence of the transcription factor binding site V$COUP_DR1_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++DR1_Q3///Genes having at least one occurence of the transcription factor binding site V$DR1_Q3 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++GGGYGTGNY_UNKNOWN///Genes having at least one occurence of the highly conserved motif M31 GGGYGTGNY in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++HNF4_01///Genes having at least one occurence of the transcription factor binding site V$HNF4_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++HNF4_DR1_Q3///Genes having at least one occurence of the transcription factor binding site V$HNF4_DR1_Q3 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++LFA1_Q6///Genes having at least one occurence of the transcription factor binding site V$LFA1_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++PITX2_Q2///Genes having at least one occurence of the transcription factor binding site V$PITX2_Q2 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++RACTNNRTTTNC_UNKNOWN///Genes having at least one occurence of the highly conserved motif M66 RACTNNRTTTNC in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++RCGCANGCGY_NRF1_Q6///Genes having at least one occurence of the highly conserved motif M1 RCGCANGCGY sites. The motif matches transcription factor binding site V$NRF1_Q6 (v7.4 TRANSFAC).+++SP1_01///Genes having at least one occurence of the transcription factor binding site V$SP1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++SRF_C///Genes having at least one occurence of the transcription factor binding site V$SRF_C (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++SRF_Q5_01///Genes having at least one occurence of the transcription factor binding site V$SRF_Q5_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++SRF_Q6///Genes having at least one occurence of the transcription factor binding site V$SRF_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++TATA_01///Genes having at least one occurence of the transcription factor binding site V$TATA_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++TGGNNNNNNKCCAR_UNKNOWN///Genes having at least one occurence of the highly conserved motif M27 TGGNNNNNNKCCAR in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++WWTAAGGC_UNKNOWN///Genes having at least one occurence of the highly conserved motif M127 WWTAAGGC in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).	"CC2D1A_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6P1N0 (CC2D1A) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++GTF2E2_TARGET_GENES///Genes containing one or more binding sites for UniProt:P29084 (GTF2E2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HES2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9Y543 (HES2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++IRF9_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q00978 (IRF9) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++KDM7A_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6ZMT4 (KDM7A) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NAB2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q15742 (NAB2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NCOA4_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q13772 (NCOA4) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++PRKDC_TARGET_GENES///Genes containing one or more binding sites for UniProt:P78527 (PRKDC) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++RYBP_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8N488 (RYBP) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SUPT16H_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9Y5B9 (SUPT16H) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++UBN1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9NPG3 (UBN1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF423_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q2M1K9 (ZNF423) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF768_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9H5H4 (ZNF768) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF92_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q03936 (ZNF92) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZSCAN5DP_TARGET_GENES///Genes containing one or more binding sites for UniProt:P0CG00 (ZSCAN5DP) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."		MODULE_1///Ovary genes.+++MODULE_3///Genes in the cancer module 3.+++MODULE_493///Genes in the cancer module 493.+++MODULE_94///Signaling.	EGFR_UP.V1_UP///Genes up-regulated in MCF-7 cells (breast cancer) positive for ESR1 [Gene ID=2099] and engineered to express ligand-activatable EGFR [Gene ID=1956].+++MEK_UP.V1_UP///Genes up-regulated in MCF-7 cells (breast cancer) positive for ESR1 [Gene ID=2099] MCF-7 cells (breast cancer) stably over-expressing constitutively active MAP2K1 [Gene ID=5604] gene.	"FLETCHER_PBMC_BCG_10W_INFANT_BCG_STIMULATED_VS_UNSTIMULATED_10W_DN///Genes down-regulated in peripheral blood mononuclear cell stimulated vs unstimulated in infants (10w) after exposure to BCG (Danish strain BCG Statens Serum Institut, Denmark) , time point 10W. Comment: PBMCs drawn at 10 weeks following immunization at birth+++GSE10240_IL17_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP///Genes up-regulated in primary bronchial epithelial cells stimulated with: IL17A [GeneID=50616] versus IL17A and IL22 [GeneID=3605;50616].+++GSE11864_CSF1_VS_CSF1_IFNG_IN_MAC_DN///Genes down-regulated in comparison of macrophages cultured with M-CSF [GeneID=1435] versus macrophages cultured with M-CSF [GeneID=1435] and IFNG [GeneID=3458].+++GSE17186_NAIVE_VS_CD21HIGH_TRANSITIONAL_BCELL_DN///Genes down-regulated in B lymphocytes: nave versus transitional CR2 [GeneID=1380] high.+++GSE19888_ADENOSINE_A3R_INH_VS_ACT_WITH_INHIBITOR_PRETREATMENT_IN_MAST_CELL_DN///Genes down-regulated in HMC-1 (mast leukemia) cells incubated the peptide ALL1 versus those followed by treatment with Cl-IB-MECA [PubChem=3035850].+++GSE22611_NOD2_TRANSDUCED_VS_CTRL_HEK293T_STIMULATED_WITH_MDP_2H_UP///Genes up-regulated in HEK293 cells at 2h after stimulation by muramyl dipeptide [PubChem=11620162]: over-expressing wildtype NOD2 [GeneID=64127] versus control.+++GSE26351_UNSTIM_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_UP///Genes up-regulated in CD34+ [GeneID=947] cells: control versus stimulated by BMP4 [GeneID=652].+++GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_48H_UP///Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: IL4 [GeneID=3565] (48h) versus untreated (48h).+++GSE29614_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_UP///Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from TIV influenza vaccinee pre-vaccination versus those from day 7 post-vaccination.+++GSE29614_CTRL_VS_TIV_FLU_VACCINE_PBMC_2007_UP///Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from TIV influenza vaccinee pre-vaccination versus that after the vaccination+++GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MONOCYTE_DN///Genes down-regulated in comparison of monocytes from LAIV influenza vaccinee at day 7 post-vaccination vesus those from TIV influenza vaccinee at day 7.+++GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_PDC_UP///Genes up-regulated in comparison of plasmacytoid dendritic cells (pDC) from TIV influenza vaccinee pre-vaccination versus those at day 7 post-vaccination.+++GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10POS_BONE_MARROW_UP///Genes up-regulated in the bone marrow CD34+ [GeneID=947] cells: CD38- [GeneID=952] versus MME+ [GeneID=4311].+++GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_MAC_UP///Genes up-regulated in comparison of macrophages versus macrophages exposed to B. malayi (5 worms/well).+++GSE360_DC_VS_MAC_B_MALAYI_LOW_DOSE_UP///Genes up-regulated in comparison of dendritic cells (DC) exposed to 5 worm/well B. malayi versus macrophages exposed to 5 worms/well B. malayi.+++GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_DC_DN///Genes down-regulated in comparison of dendritic cells (DC) exposed to L. donovani versus DCs exposed to 5 worm/well B. malayi.+++GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_DN///Genes down-regulated in comparison of untreated memory CD4 [GeneID=920] T cells from young donors versus those from old donors.+++GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_WITH_PMA_STIM_DN///Genes down-regulated in gamma delta T cells stimulated by phorbol myristate acetate and ionomycin [PubChem=4792;3733]: Vd1 versus Vd2.+++GSE37416_0H_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_DN///Genes down-regulated in comparison of control polymorphonuclear leukocytes (PMN) at 0 h versus PMN treated with F. tularensis vaccine at 6 h.+++GSE37416_12H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP///Genes up-regulated in comparison of control polymorphonuclear leukocytes (PMN) at 12 h versus PMN treated with F. tularensis vaccine at 24 h.+++GSE37416_12H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_UP///Genes up-regulated in comparison of control polymorphonuclear leukocytes (PMN) at 12 h versus PMN treated with F. tularensis vaccine at 48 h.+++GSE41087_WT_VS_FOXP3_MUT_ANTI_CD3_CD28_STIM_CD4_TCELL_UP///Genes up-regulated in activated CD4 [GeneID=920] T cells expressing: wildtype versus mutant form of FOXP3 [GeneID=50943].+++GSE4748_CYANOBACTERIUM_LPSLIKE_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_DN///Genes down-regulated in monocyte-derived dendritic cells: LPS like antigen from O. planktothrix (3h) versus LPS and LPS like antigen from O. planktothrix (3h).+++GSE4984_UNTREATED_VS_GALECTIN1_TREATED_DC_UP///Genes up-regulated in monocyte-derived dendritic cells: control versus treated with LGALS1 [GeneID=3956].+++GSE5542_IFNG_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_UP///Genes up-regulated in epithelial cells (6h): IFNG [GeneID=3458] versus IFNG [GeneID=3458] and interferon alpha.+++GSE5679_PPARG_LIGAND_ROSIGLITAZONE_VS_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_UP///Genes up-regulated in monocyte-derived dendritic cells: rosiglitazone [PubChem=77999] versus rosiglitazone and AM580 [PubChem=77999;2126].+++GSE6269_E_COLI_VS_STAPH_AUREUS_INF_PBMC_DN///Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from patients with acute E. coli infection versus PBMC from patients with acute S. aureus infection.+++GSE6269_E_COLI_VS_STREP_PNEUMO_INF_PBMC_DN///Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from patients with acute E. coli infection versus PBMC from patients with acute S. pneumoniae infection.+++GSE7460_WT_VS_FOXP3_HET_ACT_WITH_TGFB_TCONV_DN///Genes down-regulated in comparison of ActCD4TGF versus WTActCD4TGF (see Fig. 1 in the paper for details).+++GSE8685_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_DN///Genes down-regulated in Sez-2 cells (T cell lymphoma): untreated versus IL5 [GeneID=3567].+++GSE9960_HEALTHY_VS_SEPSIS_PBMC_UP///Genes up-regulated in peripheral blood monocytes (PMBC): healthy versus sepsis.+++HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_POSITIVE///Genes positively correlated with memory B cell response at 28d in peripheral blood mononuclear cell in seniors (50-74) after exposure to Fluarix , time point 28D+++QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_CONTRACTION_OF_VZV_SPECIFIC_T_CELLS_PEAK_TO_28DY_AT_1DYPOSITIVE///Genes positively correlated with contraction of VZV specific T cells (peak to 28d) in peripheral blood mononuclear cell in seniors (50-75) after exposure to Zostavax , time point 1D+++QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_EXPANSION_OF_VZV_SPECIFIC_T_CELLS_TO_PEAK_AT_1DY_POSITIVE///Genes positively correlated with expansion of VZV specific T cells (0d to peak) in peripheral blood mononuclear cell in seniors (50-75) after exposure to Zostavax , time point 1D"	HALLMARK_MYOGENESIS///Genes involved in development of skeletal muscle (myogenesis).	NM_005451	PDLIM7				
Q9NQC3	sp|Q9NQC3|RTN4_HUMAN		RTN4		Reticulon-4 OS=Homo sapiens OX=9606 GN=RTN4 PE=1 SV=2	57142	NM_020532	NP_065393	ENST00000337526	K20720			MEDLDQSPLVSSSDSPPRPQPAFKYQFVREPEDEEEEEEEEEEDEDEDLEELEVLERKPAAGLSAAPVPTAPAAGAPLMDFGNDFVPPAPRGPLPAAPPVAPERQPSWDPSPVSSTVPAPSPLSAAAVSPSKLPEDDEPPARPPPPPPASVSPQAEPVWTPPAPAPAAPPSTPAAPKRRGSSGSVDETLFALPAASEPVIRSSAENMDLKEQPGNTISAGQEDFPSVLLETAASLPSLSPLSAASFKEHEYLGNLSTVLPTEGTLQENVSEASKEVSEKAKTLLIDRDLTEFSELEYSEMGSSFSVSPKAESAVIVANPREEIIVKNKDEEEKLVSNNILHNQQELPTALTKLVKEDEVVSSEKAKDSFNEKRVAVEAPMREEYADFKPFERVWEVKDSKEDSDMLAAGGKIESNLESKVDKKCFADSLEQTNHEKDSESSNDDTSFPSTPEGIKDRSGAYITCAPFNPAATESIATNIFPLLGDPTSENKTDEKKIEEKKAQIVTEKNTSTKTSNPFLVAAQDSETDYVTTDNLTKVTEEVVANMPEGLTPDLVQEACESELNEVTGTKIAYETKMDLVQTSEVMQESLYPAAQLCPSFEESEATPSPVLPDIVMEAPLNSAVPSAGASVIQPSSSPLEASSVNYESIKHEPENPPPYEEAMSVSLKKVSGIKEEIKEPENINAALQETEAPYISIACDLIKETKLSAEPAPDFSDYSEMAKVEQPVPDHSELVEDSSPDSEPVDLFSDDSIPDVPQKQDETVMLVKESLTETSFESMIEYENKEKLSALPPEGGKPYLESFKLSLDNTKDTLLPDEVSTLSKKEKIPLQMEELSTAVYSNDDLFISKEAQIRETETFSDSSPIEIIDEFPTLISSKTDSFSKLAREYTDLEVSHKSEIANAPDGAGSLPCTELPHDLSLKNIQPKVEEKISFSDDFSKNGSATSKVLLLPPDVSALATQAEIESIVKPKVLVKEAEKKLPSDTEKEDRSPSAIFSAELSKTSVVDLLYWRDIKKTGVVFGASLFLLLSLTVFSIVSVTAYIALALLSVTISFRIYKGVIQAIQKSDEGHPFRAYLESEVAISEELVQKYSNSALGHVNCTIKELRRLFLVDDLVDSLKFAVLMWVFTYVGALFNGLTLLILALISLFSVPVIYERHQAQIDHYLGLANKNVKDAMAKIQAKIPGLKRKAE	0.5409803	-0.886351978	0.0261156		4.7444128		4.3441016	6.3740637	5.2076623		4.1562122	5.9380189	6.3526552	5.1507375	5.7055355				4.7187265	5.1138048	4.2858781			6.4436013	8.2884954	7.3499674	5.0446809	3.92022596		4.8369228	7.091629	7.8113414	6.857338	6.3112279		6.2984748	6.8013419	6.389852	5.3731433	5.9974892	5.5289888	6.370739	5.6309115	5.79296514	9.3090146	7.6591202	7.10010307	05010///Alzheimer disease				GO:0005635///nuclear envelope+++GO:0005783///endoplasmic reticulum+++GO:0005789///endoplasmic reticulum membrane+++GO:0005886///plasma membrane+++GO:0014069///postsynaptic density+++GO:0016020///membrane+++GO:0016021///integral component of membrane+++GO:0030054///cell junction+++GO:0030176///integral component of endoplasmic reticulum membrane+++GO:0042995///cell projection+++GO:0043025///neuronal cell body+++GO:0071782///endoplasmic reticulum tubular network+++GO:0098826///endoplasmic reticulum tubular network membrane	GO:0003723///RNA binding+++GO:0005515///protein binding+++GO:0031625///ubiquitin protein ligase binding+++GO:0042803///protein homodimerization activity+++GO:0045296///cadherin binding	GO:0001825///blastocyst formation+++GO:0002523///leukocyte migration involved in inflammatory response+++GO:0006915///apoptotic process+++GO:0007029///endoplasmic reticulum organization+++GO:0007399///nervous system development+++GO:0007413///axonal fasciculation+++GO:0010634///positive regulation of epithelial cell migration+++GO:0021801///cerebral cortex radial glia guided migration+++GO:0022009///central nervous system vasculogenesis+++GO:0030308///negative regulation of cell growth+++GO:0030334///regulation of cell migration+++GO:0030517///negative regulation of axon extension+++GO:0033601///positive regulation of mammary gland epithelial cell proliferation+++GO:0034165///positive regulation of toll-like receptor 9 signaling pathway+++GO:0035022///positive regulation of Rac protein signal transduction+++GO:0035441///cell migration involved in vasculogenesis+++GO:0042981///regulation of apoptotic process+++GO:0045766///positive regulation of angiogenesis+++GO:0050771///negative regulation of axonogenesis+++GO:0050821///protein stabilization+++GO:0051292///nuclear pore complex assembly+++GO:0051897///positive regulation of protein kinase B signaling+++GO:0051960///regulation of nervous system development+++GO:0060317///cardiac epithelial to mesenchymal transition+++GO:0060907///positive regulation of macrophage cytokine production+++GO:0061462///protein localization to lysosome+++GO:0071456///cellular response to hypoxia+++GO:0071786///endoplasmic reticulum tubular network organization+++GO:0071787///endoplasmic reticulum tubular network formation+++GO:0090156///cellular sphingolipid homeostasis+++GO:0120078///cell adhesion involved in sprouting angiogenesis+++GO:1902430///negative regulation of amyloid-beta formation+++GO:1902624///positive regulation of neutrophil migration+++GO:1905523///positive regulation of macrophage migration+++GO:1905552///positive regulation of protein localization to endoplasmic reticulum+++GO:1905580///positive regulation of ERBB3 signaling pathway+++GO:1905653///positive regulation of artery morphogenesis+++GO:1990809///endoplasmic reticulum tubular network membrane organization+++GO:2000172///regulation of branching morphogenesis of a nerve+++GO:2000347///positive regulation of hepatocyte proliferation+++GO:2001213///negative regulation of vasculogenesis	tissueType=Brain;cancerType=Normal;cellName=Oligodendrocyte+++tissueType=Fetal kidney;cancerType=Normal;cellName=Monocyte+++tissueType=Fetal gonad;cancerType=Normal;cellName=Meiotic prophase fetal germ cell		"Homo sapiens reticulon 4 (RTN4), transcript variant 1, mRNA."		PF02453///Reticulon	R-HSA-162582///Signal Transduction+++R-HSA-193634///Axonal growth inhibition (RHOA activation)+++R-HSA-193697///p75NTR regulates axonogenesis+++R-HSA-193704///p75 NTR receptor-mediated signalling+++R-HSA-73887///Death Receptor Signalling		KOG1792///endoplasmic reticulum tubular network organization		IPR003388///Reticulon	[RTN4_HUMAN|Reviewed]RecName: Full=Reticulon-4 {ECO:0000305}; AltName: Full=Foocen; AltName: Full=Neurite outgrowth inhibitor; Short=Nogo protein {ECO:0000303|PubMed:12488097}; AltName: Full=Neuroendocrine-specific protein; Short=NSP; AltName: Full=Neuroendocrine-specific protein C homolog; AltName: Full=RTN-x; AltName: Full=Reticulon-5;+++[D6W5C2_HUMAN|Unreviewed]RecName: Full=Reticulon {ECO:0000256|RuleBase:RU210713};+++[Q3LIF1_HUMAN|Unreviewed]SubName: Full=NOGO-A {ECO:0000313|EMBL:BAE45717.1}; Flags: Fragment;+++[Q3LIF4_HUMAN|Unreviewed]RecName: Full=Reticulon {ECO:0000256|RuleBase:RU210713}; Flags: Fragment;+++[Q53R94_HUMAN|Unreviewed]SubName: Full=Uncharacterized protein RTN4 {ECO:0000313|EMBL:AAY24029.1}; Flags: Fragment;+++[Q53RF4_HUMAN|Unreviewed]SubName: Full=Uncharacterized protein RTN4 {ECO:0000313|EMBL:AAX93116.1}; Flags: Fragment;+++[Q53SY1_HUMAN|Unreviewed]RecName: Full=Reticulon {ECO:0000256|RuleBase:RU210713}; Flags: Fragment;+++[Q6IPN0_HUMAN|Unreviewed]RecName: Full=Reticulon {ECO:0000256|RuleBase:RU210713};	chr2p16///Ensembl 103 genes in cytogenetic band chr2p16			REACTOME_DEATH_RECEPTOR_SIGNALLING///Death Receptor Signalling+++REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING///p75 NTR receptor-mediated signalling+++REACTOME_P75NTR_REGULATES_AXONOGENESIS///p75NTR regulates axonogenesis		"AAGCACA_MIR218///Genes having at least one occurence of the motif AAGCACA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-218 (v7.1 miRBase).+++TTGCCAA_MIR182///Genes having at least one occurence of the motif TTGCCAA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-182 (v7.1 miRBase)."	MIR100_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-100-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR146A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-146a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR148A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-148a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR148B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-148b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR152_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-152-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR153_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-153-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR15A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-15a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR15B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-15b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR16_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-16-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1825///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1825 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR182_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-182-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR195_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-195-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR212_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-212-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3127_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3127-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3156_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3156-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3692_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3692-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR410_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-410-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR448///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-448 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4504///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4504 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4524B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4524b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR455_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-455-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4772_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4772-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR497_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-497-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR503_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-503-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR570_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-570-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR582_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-582-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6079///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6079 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR644A///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-644a in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR646///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-646 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR670_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-670-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR671_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-671-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6756_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6756-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6828_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6828-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).	AHR_01///Genes having at least one occurence of the transcription factor binding site V$AHR_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++AHR_Q5///Genes having at least one occurence of the transcription factor binding site V$AHR_Q5 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++AP1FJ_Q2///Genes having at least one occurence of the transcription factor binding site V$AP1FJ_Q2 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++AP1_Q2_01///Genes having at least one occurence of the transcription factor binding site V$AP1_Q2_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++AP1_Q4///Genes having at least one occurence of the transcription factor binding site V$AP1_Q4 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++AP1_Q6///Genes having at least one occurence of the transcription factor binding site V$AP1_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++ARNT_01///Genes having at least one occurence of the transcription factor binding site V$ARNT_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++BACH1_01///Genes having at least one occurence of the transcription factor binding site V$BACH1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++BACH2_01///Genes having at least one occurence of the transcription factor binding site V$BACH2_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++CACGTG_MYC_Q2///Genes having at least one occurence of the highly conserved motif M2 CACGTG sites. The motif matches transcription factor binding site V$MYC_Q2 (v7.4 TRANSFAC).+++CMYB_01///Genes having at least one occurence of the transcription factor binding site V$CMYB_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++COUP_DR1_Q6///Genes having at least one occurence of the transcription factor binding site V$COUP_DR1_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++CTGCAGY_UNKNOWN///Genes having at least one occurence of the highly conserved motif M101 CTGCAGY in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++CTTTAAR_UNKNOWN///Genes having at least one occurence of the highly conserved motif M29 CTTTAAR in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++DR1_Q3///Genes having at least one occurence of the transcription factor binding site V$DR1_Q3 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++ER_Q6_01///Genes having at least one occurence of the transcription factor binding site V$ER_Q6_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++FOXM1_01///Genes having at least one occurence of the transcription factor binding site V$FOXM1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++GGGTGGRR_PAX4_03///Genes having at least one occurence of the highly conserved motif M56 GGGTGGRR sites. The motif matches transcription factor binding site V$PAX4_03 (v7.4 TRANSFAC).+++HNF4_01_B///Genes having at least one occurence of the transcription factor binding site V$HNF4_01_B (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++HNF4_01///Genes having at least one occurence of the transcription factor binding site V$HNF4_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++HNF4ALPHA_Q6///Genes having at least one occurence of the transcription factor binding site V$HNF4ALPHA_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++IRF_Q6///Genes having at least one occurence of the transcription factor binding site V$IRF_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++POU1F1_Q6///Genes having at least one occurence of the transcription factor binding site V$POU1F1_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++POU6F1_01///Genes having at least one occurence of the transcription factor binding site V$POU6F1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++PPARA_01///Genes having at least one occurence of the transcription factor binding site V$PPARA_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++PPARA_02///Genes having at least one occurence of the transcription factor binding site V$PPARA_02 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++PPAR_DR1_Q2///Genes having at least one occurence of the transcription factor binding site V$PPAR_DR1_Q2 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++RGTTAMWNATT_HNF1_01///Genes having at least one occurence of the highly conserved motif M84 RGTTAMWNATT sites. The motif matches transcription factor binding site V$HNF1_01 (v7.4 TRANSFAC).+++SOX9_B1///Genes having at least one occurence of the transcription factor binding site V$SOX9_B1 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++SP3_Q3///Genes having at least one occurence of the transcription factor binding site V$SP3_Q3 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++TCANNTGAY_SREBP1_01///Genes having at least one occurence of the highly conserved motif M18 TCANNTGAY sites. The motif matches transcription factor binding site V$SREBP1_01 (v7.4 TRANSFAC).+++TGANTCA_AP1_C///Genes having at least one occurence of the highly conserved motif M7 TGANTCA sites. The motif matches transcription factor binding site V$AP1_C (v7.4 TRANSFAC).	"ASH1L_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9NR48 (ASH1L) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ATF5_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9Y2D1 (ATF5) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ATXN7L3_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q14CW9 (ATXN7L3) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++BACH2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9BYV9 (BACH2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++BARX1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9HBU1 (BARX1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++BRCA2_TARGET_GENES///Genes containing one or more binding sites for UniProt:P51587 (BRCA2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++CEBPZ_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q03701 (CEBPZ) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++CREB3L4_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8TEY5 (CREB3L4) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++EMX1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q04741 (EMX1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++FOXD2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O60548 (FOXD2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++FOXG1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P55316 (FOXG1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++FOXH1_TARGET_GENES///Genes containing one or more binding sites for UniProt:O75593 (FOXH1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++GCM2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O75603 (GCM2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++GREB1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q4ZG55 (GREB1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HAND1_TARGET_GENES///Genes containing one or more binding sites for UniProt:O96004 (HAND1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HES4_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9HCC6 (HES4) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HMGA1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P17096 (HMGA1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HOXA2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O43364 (HOXA2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HOXB4_TARGET_GENES///Genes containing one or more binding sites for UniProt:P17483 (HOXB4) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ID2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q02363 (ID2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++IRF9_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q00978 (IRF9) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++JDP2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8WYK2 (JDP2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++KLF7_TARGET_GENES///Genes containing one or more binding sites for UniProt:O75840 (KLF7) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++LHX9_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9NQ69 (LHX9) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++MAFG_TARGET_GENES///Genes containing one or more binding sites for UniProt:O15525 (MAFG) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++MZF1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P28698 (MZF1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++PCGF2_TARGET_GENES///Genes containing one or more binding sites for UniProt:P35227 (PCGF2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++PRKDC_TARGET_GENES///Genes containing one or more binding sites for UniProt:P78527 (PRKDC) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SATB1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q01826 (SATB1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SUPT16H_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9Y5B9 (SUPT16H) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++TCF7_TARGET_GENES///Genes containing one or more binding sites for UniProt:P36402 (TCF7) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++TEAD2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q15562 (TEAD2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++UBN1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9NPG3 (UBN1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF146_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q15072 (ZNF146) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF322_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6U7Q0 (ZNF322) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF513_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8N8E2 (ZNF513) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF816_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q0VGE8 (ZNF816) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."	GCM_BCL2L1///Neighborhood of BCL2L1+++GCM_BMPR2///Neighborhood of BMPR2+++GCM_CALM1///Neighborhood of CALM1+++GCM_CRKL///Neighborhood of CRKL+++GCM_DLG1///Neighborhood of DLG1+++GCM_IL6ST///Neighborhood of IL6ST+++GCM_MAP4K4///Neighborhood of MAP4K4+++GCM_NF2///Neighborhood of NF2+++GCM_PTK2///Neighborhood of PTK2+++GCM_RAN///Neighborhood of RAN+++GCM_SIRT2///Neighborhood of SIRT2+++MORF_AP3D1///Neighborhood of AP3D1+++MORF_CUL1///Neighborhood of CUL1+++MORF_DEK///Neighborhood of DEK+++MORF_EI24///Neighborhood of EI24+++MORF_GNB1///Neighborhood of GNB1+++MORF_HAT1///Neighborhood of HAT1+++MORF_HDAC2///Neighborhood of HDAC2+++MORF_PAPSS1///Neighborhood of PAPSS1+++MORF_PPP2CA///Neighborhood of PPP2CA+++MORF_PRKAG1///Neighborhood of PRKAG1+++MORF_RAB1A///Neighborhood of RAB1A+++MORF_RAB6A///Neighborhood of RAB6A+++MORF_RAC1///Neighborhood of RAC1+++MORF_SOD1///Neighborhood of SOD1+++MORF_SP3///Neighborhood of SP3			"GSE10147_IL3_VS_IL3_AND_HIVP17_STIM_PDC_UP///Genes up-regulated in plasmacytoid dendritic cells: IL3 [GeneID=3562] versus IL3 [GeneID=3562] and the HIV matrix protein p17.+++GSE10325_LUPUS_BCELL_VS_LUPUS_MYELOID_DN///Genes down-regulated in comparison of systemic lupus erythematosus B cells versus systemic lupus erythromatosus myeloid cells.+++GSE13411_NAIVE_VS_MEMORY_BCELL_DN///Genes down-regulated in comparison of naive B cells versus memory B cells.+++GSE15659_CD45RA_NEG_CD4_TCELL_VS_ACTIVATED_TREG_DN///Genes down-regulated in comparison of PTPRC- [GeneID=5788] CD4 [GeneID=920] T cells versus activated regulatory T cell (Treg).+++GSE15659_CD45RA_NEG_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_DN///Genes down-regulated in comparison of PTPRC- [GeneID=5788] CD4 [GeneID=920] T cells versus non-suppressive T cells.+++GSE15659_NAIVE_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_DN///Genes down-regulated in comparison of naive CD4 [GeneID=920] T cells versus non-suppressive T cells.+++GSE15659_NONSUPPRESSIVE_TCELL_VS_ACTIVATED_TREG_DN///Genes down-regulated in comparison of non-suppressive T cells versus activated regulatory T cell (Treg).+++GSE15659_TREG_VS_TCONV_UP///Genes up-regulated in comparison of regulatory T cell (Treg) versus conventional T cells.+++GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_IFNG_TNF_TREATED_MACROPHAGE_DN///Genes down-regulated in monocytes (12h) versus macrophages (12h) treated with IFNG, TNF [GeneID=3458;7124] and rosiglitazone [PubChem=77999].+++GSE17186_MEMORY_VS_CD21LOW_TRANSITIONAL_BCELL_UP///Genes up-regulated in B lymphocytes: memory versus transitional CR2 [GeneID=1380] low.+++GSE17186_MEMORY_VS_NAIVE_BCELL_DN///Genes down-regulated in B lymphocytes: memory versus nave.+++GSE1925_CTRL_VS_24H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_UP///Genes up-regulated in macrophages primed by IFNG [GeneID=3458]: untreated versus stimulated by IFNG [GeneID=3458] for 24h.+++GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_AND_A3R_INH_PRETREAT_IN_MAST_CELL_DN///Genes down-regulated in HMC-1 (mast leukemia) cells: Cl-IB-MECA [PubChem=3035850] versus incubated with the peptide ALL1 followed by stimulation with T cell membranes.+++GSE19888_CTRL_VS_A3R_ACTIVATION_MAST_CELL_UP///Genes up-regulated in HMC-1 (mast leukemia) cells: untreated versus Cl-IB-MECA [PubChem=3035850].+++GSE22886_NAIVE_BCELL_VS_DC_DN///Genes down-regulated in comparison of naive B cells versus unstimulated dendritic cells (DC).+++GSE22886_NAIVE_BCELL_VS_MONOCYTE_DN///Genes down-regulated in comparison of naive B cells versus day 0 monocytes.+++GSE22886_TCELL_VS_BCELL_NAIVE_UP///Genes up-regulated in comparison of naive CD4 [GeneID=920] CD8 T cells versus naive B cells.+++GSE26928_NAIVE_VS_CXCR5_POS_CD4_TCELL_DN///Genes down-regulated in comparison of naive CD4 [GeneID=920] T cells versus CD4 [GeneID=920] CXCR5+ [GeneID=643] T cells.+++GSE26928_NAIVE_VS_EFF_MEMORY_CD4_TCELL_DN///Genes down-regulated in comparison of naive CD4 [GeneID=920] T cells versus CD4 [GeneID=920] effector memory T cells.+++GSE27670_CTRL_VS_BLIMP1_TRANSDUCED_GC_BCELL_UP///Genes up-regulated in germinal center B lymphocytes: control versus over-expressing PRDM1 [GeneID=639].+++GSE29618_BCELL_VS_MDC_DAY7_FLU_VACCINE_DN///Genes down-regulated in comparison of B cells from influenza vaccinee at day 7 post-vaccination versus myeloid dendritic cells (mDC) at day 7 post-vaccination.+++GSE29618_BCELL_VS_MDC_DN///Genes down-regulated in comparison of B cells versus myeloid dendritic cells (mDC).+++GSE29618_BCELL_VS_MONOCYTE_DN///Genes down-regulated in comparison of B cells versus monocytes.+++GSE32901_TH17_EMRICHED_VS_TH17_NEG_CD4_TCELL_DN///Genes down-regulated in CD4 [GeneID=920] Th17 T cells: enriched versus negative.+++GSE35685_CD34POS_CD10NEG_CD62LPOS_VS_CD34POS_CD10POS_BONE_MARROW_UP///Genes up-regulated in the bone marrow CD34+ [GeneID=947] cells: MME- SELL+[GeneID=4311;6402] versus MME+ [GeneID=4311].+++GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10NEG_CD62LPOS_BONE_MARROW_UP///Genes up-regulated in the bone marrow CD34+ [GeneID=947] cells: CD38- [GeneID=952] versus MME- SELL+ [GeneID=4311;6402].+++GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_MAC_DN///Genes down-regulated in comparison of macrophages versus macrophages exposed to B. malayi (5 worms/well).+++GSE360_CTRL_VS_M_TUBERCULOSIS_MAC_DN///Genes down-regulated in comparison of macrophages versus macrophages exposed to M. tuberculosis.+++GSE5099_CLASSICAL_M1_VS_ALTERNATIVE_M2_MACROPHAGE_DN///Genes down-regulated in macrophages: classical (M1) versus alternative (M2).+++GSE7568_CTRL_VS_3H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_DN///Genes down-regulated in macrophages differentiated in the presence of IL4 [GeneID=3565] and dexamethasone [PubChem=5743] for 5 days versus those subsequently treated with TGFB1 [GeneID=7040] for 3h.+++GSE8835_CD4_VS_CD8_TCELL_UP///Genes up-regulated in T cells: CD4 [GeneID=920] versus CD8.+++KANNAN_BLOOD_2012_2013_TIV_AGE_65PLS_REVACCINATED_IN_6_9_MO_VS_REVACCINATED_IN_12_13_MOS_DN///Genes down-regulated in blood cohort 1 (re-vaccinated in 6-9 months) vs cohort 2 (re-vaccinated in 12-13 months) in adults (65+) after exposure to 2012-2013 seasonal trivalent inactivated influenza vaccine (TIV) , time point N/A. Comment: Cohort 1 (re-vaccinated in 6-9 months) vs Cohort 2 (re-vaccinated in 12-13 months)+++NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN///Genes down-regulated in peripheral blood mononuclear cell 3d vs 0d in adults (18-50) after exposure to FluMist , time point 3D. Comment: Supplementary Table 1b: All the differentially expressed genes identified in PBMCs of TIV vaccinees.+++NAKAYA_PBMC_FLUMIST_AGE_18_50YO_7DY_UP///Genes up-regulated in peripheral blood mononuclear cell 7d vs 0d in adults (18-50) after exposure to FluMist , time point 7D. Comment: Supplementary Table 1b: All the differentially expressed genes identified in PBMCs of TIV vaccinees.+++OCONNOR_PBMC_MENVEO_ACWYVAX_AGE_30_70YO_7DY_AFTER_SECOND_DOSE_VS_7DY_AFTER_FIRST_DOSE_UP///Genes up-regulated in peripheral blood mononuclear cell 7d after second dose vs 7d after first dose in adult (30-70) after exposure to Menveo/ACWYVax , time point 7D. Comment: second dose at 28 days"		NM_020532	RTN4				
Q9H299	sp|Q9H299|SH3L3_HUMAN		SH3BGRL3		SH3 domain-binding glutamic acid-rich-like protein 3 OS=Homo sapiens OX=9606 GN=SH3BGRL3 PE=1 SV=1	83442	NM_031286	NP_112576	ENST00000270792				MSGLRVYSTSVTGSREIKSQQSEVTRILDGKRIQYQLVDISQDNALRDEMRALAGNPKATPPQIVNGDQYCGDYELFVEAVEQNTLQEFLKLA	0.3982057	-1.32841436	0.001508867	4.7843284	6.6173036	6.613901	6.3829999	6.9224219	9.1578124	6.277994739	7.1634543	9.2615429	9.3530286	8.1368669	8.6515754	5.71409383	6.5408769	7.5083902	8.5787657	7.4176671	7.402429	5.204302611	6.7853534	8.3794511	8.6368495	10.1436961	6.9616587	7.11359269	6.3229722	6.522367	11.078695	11.5313569	9.595653	10.127002	7.429175	7.5795091	8.6744531	7.5328794	8.1196495	8.913486	8.82033	9.731504	8.7686527	7.64705098	10.1824709	8.4709568	9.44941347					GO:0005634///nucleus+++GO:0005737///cytoplasm+++GO:0016604///nuclear body+++GO:0070062///extracellular exosome	GO:0005515///protein binding+++GO:0015035///protein disulfide oxidoreductase activity		tissueType=Fetal gonad;cancerType=Normal;cellName=Endothelial cell+++tissueType=Fetal kidney;cancerType=Normal;cellName=Monocyte+++tissueType=Fetal kidney;cancerType=Normal;cellName=Natural killer T (NKT) cell+++tissueType=Lung;cancerType=Normal;cellName=Basal cell		"Homo sapiens SH3 domain binding glutamate rich protein like 3 (SH3BGRL3), mRNA."		"PF04908///SH3-binding, glutamic acid-rich protein"			KOG4023///SH3 domain binding		"IPR006993///SH3-binding, glutamic acid-rich protein+++IPR036249///Thioredoxin-like superfamily"	"[SH3L3_HUMAN|Reviewed]RecName: Full=SH3 domain-binding glutamic acid-rich-like protein 3; AltName: Full=SH3 domain-binding protein 1; Short=SH3BP-1;+++[D3DPK5_HUMAN|Unreviewed]SubName: Full=SH3 domain binding glutamic acid-rich protein like 3, isoform CRA_a {ECO:0000313|EMBL:EAX07832.1}; Flags: Fragment;+++[Q86Z22_HUMAN|Unreviewed]SubName: Full=Epididymis secretory protein Li 297 {ECO:0000313|EMBL:ACI46035.1}; SubName: Full=Epididymis secretory sperm binding protein {ECO:0000313|EMBL:ADO22516.1};"	chr1p36///Ensembl 103 genes in cytogenetic band chr1p36					"AACATTC_MIR4093P///Genes having at least one occurence of the motif AACATTC in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-409-3p (v7.1 miRBase).+++ACATTCC_MIR1_MIR206///Genes having at least one occurence of the motif ACATTCC in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-1 and hsa-miR-206 (v7.1 miRBase)."	MIR3064_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3064-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3085_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3085-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4423_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4423-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4441///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4441 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4506///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4506 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4534///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4534 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6501_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6501-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6504_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6504-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR744_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-744-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR8082///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-8082 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).	AACTTT_UNKNOWN///Genes having at least one occurence of the highly conserved motif M17 AACTTT in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++CAGCTG_AP4_Q5///Genes having at least one occurence of the highly conserved motif M15 CAGCTG sites. The motif matches transcription factor binding site V$AP4_Q5 (v7.4 TRANSFAC).+++GCANCTGNY_MYOD_Q6///Genes having at least one occurence of the highly conserved motif M35 GCANCTGNY sites. The motif matches transcription factor binding site V$MYOD_Q6 (v7.4 TRANSFAC).+++HFH8_01///Genes having at least one occurence of the transcription factor binding site V$HFH8_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++LBP1_Q6///Genes having at least one occurence of the transcription factor binding site V$LBP1_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++MCAATNNNNNGCG_UNKNOWN///Genes having at least one occurence of the highly conserved motif M110 MCAATNNNNNGCG in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++MMEF2_Q6///Genes having at least one occurence of the transcription factor binding site V$MMEF2_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++MYOGENIN_Q6///Genes having at least one occurence of the transcription factor binding site V$MYOGENIN_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++NKX61_01///Genes having at least one occurence of the transcription factor binding site V$NKX61_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++PITX2_Q2///Genes having at least one occurence of the transcription factor binding site V$PITX2_Q2 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++TATAAA_TATA_01///Genes having at least one occurence of the highly conserved motif M51 TATAAA sites. The motif matches transcription factor binding site V$TATA_01 (v7.4 TRANSFAC).+++TBP_01///Genes having at least one occurence of the transcription factor binding site V$TBP_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++TEF1_Q6///Genes having at least one occurence of the transcription factor binding site V$TEF1_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++TGCCAAR_NF1_Q6///Genes having at least one occurence of the highly conserved motif M47 TGCCAAR sites. The motif matches transcription factor binding site V$NF1_Q6 (v7.4 TRANSFAC).+++WGGAATGY_TEF1_Q6///Genes having at least one occurence of the highly conserved motif M79 WGGAATGY sites. The motif matches transcription factor binding site V$TEF1_Q6 (v7.4 TRANSFAC).	"BRCA2_TARGET_GENES///Genes containing one or more binding sites for UniProt:P51587 (BRCA2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++CREB3L4_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8TEY5 (CREB3L4) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++E2F2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q14209 (E2F2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++FEV_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q99581 (FEV) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HOXC6_TARGET_GENES///Genes containing one or more binding sites for UniProt:P09630 (HOXC6) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++IRX2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9BZI1 (IRX2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NFE2L1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q14494 (NFE2L1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NFKBIA_TARGET_GENES///Genes containing one or more binding sites for UniProt:P25963 (NFKBIA) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SFMBT1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9UHJ3 (SFMBT1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++WRNIP1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96S55 (WRNIP1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF236_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9UL36 (ZNF236) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF561_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8N587 (ZNF561) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."	GNF2_CASP1///Neighborhood of CASP1+++GNF2_CASP4///Neighborhood of CASP4+++GNF2_FGR///Neighborhood of FGR+++GNF2_HCK///Neighborhood of HCK+++GNF2_ICAM3///Neighborhood of ICAM3+++GNF2_ITGB2///Neighborhood of ITGB2+++GNF2_MYD88///Neighborhood of MYD88+++GNF2_PECAM1///Neighborhood of PECAM1+++GNF2_S100A4///Neighborhood of S100A4+++GNF2_TNFRSF1B///Neighborhood of TNFRSF1B			"FLETCHER_PBMC_BCG_10W_INFANT_BCG_STIMULATED_VS_UNSTIMULATED_10W_DN///Genes down-regulated in peripheral blood mononuclear cell stimulated vs unstimulated in infants (10w) after exposure to BCG (Danish strain BCG Statens Serum Institut, Denmark) , time point 10W. Comment: PBMCs drawn at 10 weeks following immunization at birth+++GSE10147_IL3_VS_IL3_AND_HIVP17_STIM_PDC_DN///Genes down-regulated in plasmacytoid dendritic cells: IL3 [GeneID=3562] versus IL3 [GeneID=3562] and the HIV matrix protein p17.+++GSE11057_NAIVE_CD4_VS_PBMC_CD4_TCELL_DN///Genes down-regulated in comparison of naive T cells versus peripheral blood mononuclear cells (PBMC).+++GSE11057_NAIVE_VS_CENT_MEMORY_CD4_TCELL_DN///Genes down-regulated in comparison of naive T cells versus central memory T cells.+++GSE11057_NAIVE_VS_EFF_MEMORY_CD4_TCELL_DN///Genes down-regulated in comparison of naive T cells versus effector memory T cells.+++GSE11057_NAIVE_VS_MEMORY_CD4_TCELL_DN///Genes down-regulated in comparison of naive T cells versus memory T cells.+++GSE12845_IGD_POS_BLOOD_VS_PRE_GC_TONSIL_BCELL_UP///Genes up-regulated in comparison of IgD+ B cells from peripheral blood versus CD19 pre-germinal center tonsil B cell+++GSE12845_NAIVE_VS_PRE_GC_TONSIL_BCELL_UP///Genes up-regulated in comparison of naive B cell versus pre-germinal tonsil B cells.+++GSE13411_SWITCHED_MEMORY_BCELL_VS_PLASMA_CELL_UP///Genes up-regulated in comparison of Ig isotype switched memory B cells versus plasma cells.+++GSE16385_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_ROSIGLITAZONE_TREATED_DN///Genes down-regulated in macrophages (12h): IFNG, TNF [GeneID=3458;7124] and rosiglitazone [PubChem=77999] versus rosiglitazone [PubChem=77999] and IL4 [GeneID=3565].+++GSE17186_BLOOD_VS_CORD_BLOOD_CD21HIGH_TRANSITIONAL_BCELL_UP///Genes up-regulated in transitional CR2 [GeneID=1380] high B lymphocytes versus those from cord blood.+++GSE18893_CTRL_VS_TNF_TREATED_TCONV_2H_UP///Genes up-regulated in T conv cells (2h): medium versus TNF [GeneID=7124].+++GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_TCELL_MEMBRANES_ACT_MAST_CELL_DN///Genes down-regulated in HMC-1 (mast leukemia) cells: incubated with the peptide ALL1 and then treated with Cl-IB-MECA [PubChem=3035850] versus stimulation by T cell membranes.+++GSE23321_CD8_STEM_CELL_MEMORY_VS_CENTRAL_MEMORY_CD8_TCELL_DN///Genes down-regulated in CD8 T cells: stem cell memory versus central memory.+++GSE24026_PD1_LIGATION_VS_CTRL_IN_ACT_TCELL_LINE_UP///Genes up-regulated in comparison of Jurkat T cells stimulated in the presence of PD-1 versus controls.+++GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_PDC_DN///Genes down-regulated in comparison of plasmacytoid dendritic cells from LAIV influenza vaccinee at day 7 post-vaccination vesus those from TIV influenza vaccinee at day 7.+++GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_PDC_DN///Genes down-regulated in comparison of plasmacytoid dendritic cells (pDC) from TIV influenza vaccinee pre-vaccination versus those at day 7 post-vaccination.+++GSE3982_MAC_VS_CENT_MEMORY_CD4_TCELL_UP///Genes up-regulated in comparison of macrophages versus central memory CD4 [GeneID=920] T cells.+++GSE4748_LPS_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP///Genes up-regulated in monocyte-derived dendritic cells: LPS (3h) versus LPS and LPS like antigen from O. planktothrix (3h).+++GSE4984_UNTREATED_VS_GALECTIN1_TREATED_DC_UP///Genes up-regulated in monocyte-derived dendritic cells: control versus treated with LGALS1 [GeneID=3956].+++GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY7_DN///Genes down-regulated in unstimulated monocytes versus macrophages incubated with CSF1 [GeneID=435] at day 7.+++GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_UP///Genes up-regulated in epithelial cells (6h): untreated versus interferon alpha.+++GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_24H_UP///Genes up-regulated in epithelial cells (24h): untreated versus IFNG [GeneID=3458].+++GSE8835_HEALTHY_VS_CLL_CD8_TCELL_UP///Genes up-regulated in CD8 T cells: healthy versus CLL (chronic lymphocytic leukemia).+++GSE8921_3H_VS_24H_TLR1_2_STIM_MONOCYTE_DN///Genes down-regulated in monocytes in response to M. tuberculosis 19 kDa lipopeptide: 3h versus 24h.+++GSE9988_ANTI_TREM1_VS_LPS_MONOCYTE_UP///Genes up-regulated in comparison of monocytes treated with anti-TREM1 [GeneID=54210] versus monocytes treated with 5000 ng/ml LPS (TLR4 agonist).+++HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_DN///Genes down-regulated in peripheral blood mononuclear cell vaccinated vs unvaccinated in adolescent/young adults (11-22) after exposure to M-M-R II , time point 7Y"		NM_031286	SH3BGRL3				
Q9H0U4	sp|Q9H0U4|RAB1B_HUMAN		RAB1B		Ras-related protein Rab-1B OS=Homo sapiens OX=9606 GN=RAB1B PE=1 SV=1	81876	NM_030981	NP_112243	ENST00000311481	K07875			MNPEYDYLFKLLLIGDSGVGKSCLLLRFADDTYTESYISTIGVDFKIRTIELDGKTIKLQIWDTAGQERFRTITSSYYRGAHGIIVVYDVTDQESYANVKQWLQEIDRYASENVNKLLVGNKSDLTTKKVVDNTTAKEFADSLGIPFLETSAKNATNVEQAFMTMAAEIKKRMGPGAASGGERPNLKIDSTPVKPAGGGCC	0.5594953	-0.83780198	0.01594006					5.2866772	4.8924549			5.7181712	6.1533591	4.8748181	6.5388087					5.3536624			4.7832462		4.6800448	5.6461249					7.024937	7.0216243	7.820401	7.7544576	5.727628	5.2405413	5.9332023	6.0721972		6.6036045	5.1548859	7.219883	5.6856123	6.08168389	6.1719001	4.785608	5.49624402	05134///Legionellosis				GO:0000139///Golgi membrane+++GO:0005737///cytoplasm+++GO:0005789///endoplasmic reticulum membrane+++GO:0005794///Golgi apparatus+++GO:0005829///cytosol+++GO:0012505///endomembrane system+++GO:0016020///membrane+++GO:0030133///transport vesicle+++GO:0033116///endoplasmic reticulum-Golgi intermediate compartment membrane+++GO:0034045///phagophore assembly site membrane+++GO:0048471///perinuclear region of cytoplasm+++GO:0070062///extracellular exosome	GO:0000166///nucleotide binding+++GO:0003924///GTPase activity+++GO:0005515///protein binding+++GO:0005525///GTP binding+++GO:0016787///hydrolase activity	"GO:0000045///autophagosome assembly+++GO:0006886///intracellular protein transport+++GO:0006888///ER to Golgi vesicle-mediated transport+++GO:0006890///retrograde vesicle-mediated transport, Golgi to ER+++GO:0006914///autophagy+++GO:0015031///protein transport+++GO:0019068///virion assembly+++GO:0043687///post-translational protein modification+++GO:0048208///COPII vesicle coating+++GO:0090557///establishment of endothelial intestinal barrier+++GO:1903020///positive regulation of glycoprotein metabolic process+++GO:2000785///regulation of autophagosome assembly"	tissueType=Fetal kidney;cancerType=Normal;cellName=Natural killer T (NKT) cell+++tissueType=Fetal gonad;cancerType=Normal;cellName=Endothelial cell		"Homo sapiens RAB1B, member RAS oncogene family (RAB1B), mRNA."		PF00071///Ras family	"R-HSA-162658///Golgi Cisternae Pericentriolar Stack Reorganization+++R-HSA-1640170///Cell Cycle+++R-HSA-199977///ER to Golgi Anterograde Transport+++R-HSA-199991///Membrane Trafficking+++R-HSA-204005///COPII-mediated vesicle transport+++R-HSA-392499///Metabolism of proteins+++R-HSA-446203///Asparagine N-linked glycosylation+++R-HSA-5653656///Vesicle-mediated transport+++R-HSA-597592///Post-translational protein modification+++R-HSA-6807878///COPI-mediated anterograde transport+++R-HSA-6811434///COPI-dependent Golgi-to-ER retrograde traffic+++R-HSA-6811442///Intra-Golgi and retrograde Golgi-to-ER traffic+++R-HSA-68875///Mitotic Prophase+++R-HSA-68886///M Phase+++R-HSA-69278///Cell Cycle, Mitotic+++R-HSA-8856688///Golgi-to-ER retrograde transport+++R-HSA-8873719///RAB geranylgeranylation+++R-HSA-8876198///RAB GEFs exchange GTP for GDP on RABs+++R-HSA-9007101///Rab regulation of trafficking+++R-HSA-948021///Transport to the Golgi and subsequent modification"		KOG0084///GTPase activity		IPR001806///Small GTPase+++IPR005225///Small GTP-binding protein domain+++IPR027417///P-loop containing nucleoside triphosphate hydrolase	[RAB1B_HUMAN|Reviewed]RecName: Full=Ras-related protein Rab-1B; EC=3.6.5.2 {ECO:0000250|UniProtKB:P62820};+++[Q6FIG4_HUMAN|Unreviewed]SubName: Full=RAB1B protein {ECO:0000313|EMBL:CAG38493.1};	chr11q13///Ensembl 103 genes in cytogenetic band chr11q13			"REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION///Asparagine N-linked glycosylation+++REACTOME_CELL_CYCLE///Cell Cycle+++REACTOME_CELL_CYCLE_MITOTIC///Cell Cycle, Mitotic+++REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC///COPI-dependent Golgi-to-ER retrograde traffic+++REACTOME_COPII_MEDIATED_VESICLE_TRANSPORT///COPII-mediated vesicle transport+++REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT///COPI-mediated anterograde transport+++REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT///ER to Golgi Anterograde Transport+++REACTOME_GOLGI_CISTERNAE_PERICENTRIOLAR_STACK_REORGANIZATION///Golgi Cisternae Pericentriolar Stack Reorganization+++REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT///Golgi-to-ER retrograde transport+++REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC///Intra-Golgi and retrograde Golgi-to-ER traffic+++REACTOME_MEMBRANE_TRAFFICKING///Membrane Trafficking+++REACTOME_MITOTIC_PROPHASE///Mitotic Prophase+++REACTOME_M_PHASE///M Phase+++REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION///Post-translational protein modification+++REACTOME_RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS///RAB GEFs exchange GTP for GDP on RABs+++REACTOME_RAB_GERANYLGERANYLATION///RAB geranylgeranylation+++REACTOME_RAB_REGULATION_OF_TRAFFICKING///Rab regulation of trafficking+++REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION///Transport to the Golgi and subsequent modification+++REACTOME_VESICLE_MEDIATED_TRANSPORT///Vesicle-mediated transport"		"AAGCCAT_MIR135A_MIR135B///Genes having at least one occurence of the motif AAGCCAT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-135a and hsa-miR-135b (v7.1 miRBase).+++ATGCTGC_MIR103_MIR107///Genes having at least one occurence of the motif ATGCTGC in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-103 and hsa-miR-107 (v7.1 miRBase).+++CCAGGTT_MIR490///Genes having at least one occurence of the motif CCAGGTT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-490 (v7.1 miRBase).+++GCAAGGA_MIR502///Genes having at least one occurence of the motif GCAAGGA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-502 (v7.1 miRBase).+++GCACCTT_MIR18A_MIR18B///Genes having at least one occurence of the motif GCACCTT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-18a and hsa-miR-18b (v7.1 miRBase).+++GCATTTG_MIR105///Genes having at least one occurence of the motif GCATTTG in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-105 (v7.1 miRBase).+++GGGCATT_MIR365///Genes having at least one occurence of the motif GGGCATT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-365 (v7.1 miRBase).+++TCCAGAT_MIR5165P///Genes having at least one occurence of the motif TCCAGAT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-516-5p (v7.1 miRBase)."	"MIR103A_3P_MIR107///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-103a-3p, hsa-miR-107 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1207_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1207-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1343_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1343-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1909_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1909-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1915_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1915-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR2355_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-2355-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4436B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4436b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4485_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4485-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR452_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-452-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4632_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4632-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4640_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4640-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4692///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4692 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4726_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4726-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4763_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4763-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR502_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-502-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR541_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-541-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6132///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6132 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR654_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-654-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6721_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6721-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6722_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6722-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6735_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6735-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6764_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6764-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6836_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6836-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6841_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6841-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6842_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6842-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6879_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6879-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6895_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6895-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7110_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7110-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7843_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7843-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR939_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-939-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets)."	AAGWWRNYGGC_UNKNOWN///Genes having at least one occurence of the highly conserved motif M63 AAGWWRNYGGC in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++ACTAYRNNNCCCR_UNKNOWN///Genes having at least one occurence of the highly conserved motif M4 ACTAYRNNNCCCR in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++AR_03///Genes having at least one occurence of the transcription factor binding site V$AR_03 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++EVI1_05///Genes having at least one occurence of the transcription factor binding site V$EVI1_05 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++GGCNNMSMYNTTG_UNKNOWN///Genes having at least one occurence of the highly conserved motif M123 GGCNNMSMYNTTG in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++GR_01///Genes having at least one occurence of the transcription factor binding site V$GR_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++GR_Q6///Genes having at least one occurence of the transcription factor binding site V$GR_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++HEB_Q6///Genes having at least one occurence of the transcription factor binding site V$HEB_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++LFA1_Q6///Genes having at least one occurence of the transcription factor binding site V$LFA1_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++MAZR_01///Genes having at least one occurence of the transcription factor binding site V$MAZR_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++MGGAAGTG_GABP_B///Genes having at least one occurence of the highly conserved motif M11 MGGAAGTG sites. The motif matches transcription factor binding site V$GABP_B (v7.4 TRANSFAC).+++NRF2_01///Genes having at least one occurence of the transcription factor binding site V$NRF2_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++P53_02///Genes having at least one occurence of the transcription factor binding site V$P53_02 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++P53_DECAMER_Q2///Genes having at least one occurence of the transcription factor binding site V$P53_DECAMER_Q2 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++PEA3_Q6///Genes having at least one occurence of the transcription factor binding site V$PEA3_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++PR_01///Genes having at least one occurence of the transcription factor binding site V$PR_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++PR_02///Genes having at least one occurence of the transcription factor binding site V$PR_02 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++PR_Q2///Genes having at least one occurence of the transcription factor binding site V$PR_Q2 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++RCGCANGCGY_NRF1_Q6///Genes having at least one occurence of the highly conserved motif M1 RCGCANGCGY sites. The motif matches transcription factor binding site V$NRF1_Q6 (v7.4 TRANSFAC).+++SMAD4_Q6///Genes having at least one occurence of the transcription factor binding site V$SMAD4_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++SNACANNNYSYAGA_UNKNOWN///Genes having at least one occurence of the highly conserved motif M80 SNACANNNYSYAGA in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++STAT4_01///Genes having at least one occurence of the transcription factor binding site V$STAT4_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++STAT6_02///Genes having at least one occurence of the transcription factor binding site V$STAT6_02 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++TGCGCANK_UNKNOWN///Genes having at least one occurence of the highly conserved motif M22 TGCGCANK in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++WWTAAGGC_UNKNOWN///Genes having at least one occurence of the highly conserved motif M127 WWTAAGGC in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++YY1_01///Genes having at least one occurence of the transcription factor binding site V$YY1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++YY1_02///Genes having at least one occurence of the transcription factor binding site V$YY1_02 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++ZIC1_01///Genes having at least one occurence of the transcription factor binding site V$ZIC1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++ZIC2_01///Genes having at least one occurence of the transcription factor binding site V$ZIC2_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++ZIC3_01///Genes having at least one occurence of the transcription factor binding site V$ZIC3_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.	"BANP_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8N9N5 (BANP) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++DYRK1A_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q13627 (DYRK1A) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++EBNA1BP2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q99848 (EBNA1BP2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++GCM2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O75603 (GCM2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HOXA1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P49639 (HOXA1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++LHX2_TARGET_GENES///Genes containing one or more binding sites for UniProt:P50458 (LHX2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++PAX6_TARGET_GENES///Genes containing one or more binding sites for UniProt:P26367 (PAX6) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++PCGF1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9BSM1 (PCGF1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SETD7_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8WTS6 (SETD7) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SETX_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q7Z333 (SETX) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++UBN1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9NPG3 (UBN1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++WRNIP1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96S55 (WRNIP1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZBTB18_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q99592 (ZBTB18) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."				"GSE11864_UNTREATED_VS_CSF1_IN_MAC_UP///Genes up-regulated in comparison of untreated macrophages versus those cultured with M-CSF [GeneID=1435].+++GSE17301_CTRL_VS_48H_ACD3_ACD28_STIM_CD8_TCELL_DN///Genes down-regulated in CD8 T lymphocytes: control versus activated by anti-CD3 and anti-CD28.+++GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_2H_CD4_TCELL_DN///Genes down-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the cells treated with IL4 [GeneID=3565] and anti-IL12 at 2 h.+++GSE22282_HYPOXIA_VS_NORMOXIA_MYELOID_DC_UP///Genes up-regulated in myeloid dendritic cells: hypoxia versus normoxia.+++GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_6H_UP///Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 and IL4 [GeneID=7040;3565] (6h) versus IL4 [GeneID=3565] (6h).+++GSE34515_CD16_NEG_VS_POS_MONOCYTE_UP///Genes up-regulated in monocytes: CD16- versus CD16+.+++GSE37416_CTRL_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_DN///Genes down-regulated in comparison of control polymorphonuclear leukocytes (PMN) at 48 h versus PMN treated with F. tularensis vaccine at 48 h.+++GSE42724_NAIVE_VS_B1_BCELL_DN///Genes down-regulated in B lymphocytes: nave versus B1.+++GSE4748_LPS_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP///Genes up-regulated in monocyte-derived dendritic cells: LPS (3h) versus LPS and LPS like antigen from O. planktothrix (3h).+++GSE4984_UNTREATED_VS_GALECTIN1_TREATED_DC_UP///Genes up-regulated in monocyte-derived dendritic cells: control versus treated with LGALS1 [GeneID=3956].+++GSE7400_CTRL_VS_CSF3_IN_VIVO_TREATED_PBMC_DN///Genes down-regulated in comparison of untreated peripheral blood mononuclear cells (PBMC) versus PBMCs treated with CSF3 [GeneID=1440].+++GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_UP///Genes up-regulated in monocytes: untreated versus anti- FcgRIIB.+++GSE9006_TYPE_1_DIABETES_AT_DX_VS_1MONTH_POST_DX_PBMC_UP///Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from patients with type 1 diabetes at the time of the diagnosis versus those at 1 month later.+++GSE9006_TYPE_1_DIABETES_AT_DX_VS_4MONTH_POST_DX_PBMC_UP///Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from patients with type 1 diabetes at the time of the diagnosis versus those at 4 months later.+++GSE9006_TYPE_1_VS_TYPE_2_DIABETES_PBMC_AT_DX_UP///Genes up-regulated in peripheral blood mononuclear cells (PBMC) from patients with type 1 diabetes at the time of diagnosis versus those with type 2 diabetes at the time of diagnosis.+++GSE9601_UNTREATED_VS_PI3K_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_UP///Genes up-regulated in monocytes after HCMV infection: untreated versus Ly294002 [PubChem=3973].+++NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_UP///Genes up-regulated in peripheral blood mononuclear cell 3d vs 0d in adults (18-50) after exposure to Fluarix/Fluvirin , time point 3D. Comment: Supplementary Table 1a: All the differentially expressed genes identified in PBMCs of TIV vaccinees.+++NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_POSITIVE///Genes positively correlated with HAI response at 28d in peripheral blood mononuclear cell in adults (18-50) after exposure to Fluarix/Fluvirin , time point 3D. Comment: Supplementary Table 5: All genes whose expression (d3/d0 or d7/d0) correlates to the fold increase in HAI titers (d28/d0)."		NM_030981	RAB1B				
Q9GZP8	sp|Q9GZP8|IMUP_HUMAN		C19orf33		Immortalization up-regulated protein OS=Homo sapiens OX=9606 GN=IMUP PE=1 SV=1	64073	NM_033520	NP_277055	ENST00000301246				MEFDLGAALEPTSQKPGVGAGHGGDPKLSPHKVQGRSEAGAGPGPKQGHHSSSDSSSSSSDSDTDVKSHAAGSKQHESIPGKAKKPKVKKKEKGKKEKGKKKEAPH	0.6147951	-0.701822465	0.04381465		3.3096674			6.4256555	7.7830192		5.5440832	6.4862819	6.1414343	5.3869362	6.8854916		4.3594912	4.9002752	5.4158722		5.8296216			5.6048302	6.7258838	6.7338723		5.33943497			7.269483	7.2473964	7.535959	6.4727192		5.3666317	6.7487062	5.8823049	6.4973132	7.7840826	6.7470223	5.90352	6.2588591	6.40777086	8.1507529	4.8001066	5.37071055					GO:0005634///nucleus+++GO:0005654///nucleoplasm+++GO:0005829///cytosol+++GO:0005886///plasma membrane	GO:0003690///double-stranded DNA binding+++GO:0003697///single-stranded DNA binding	GO:0008150///biological_process	tissueType=Liver;cancerType=Normal;cellName=Liver bud hepatic cell		"Homo sapiens chromosome 19 open reading frame 33 (C19orf33), transcript variant 1, mRNA."		PF15761///Immortalisation up-regulated protein			ENOG502TD4H///No_INFO		IPR026621///Immortalization up-regulated protein	[IMUP_HUMAN|Reviewed]RecName: Full=Immortalization up-regulated protein; AltName: Full=Hepatocyte growth factor activator inhibitor type 2-related small protein; Short=H2RSP; Short=HAI-2-related small protein;	chr19q13///Ensembl 103 genes in cytogenetic band chr19q13						MIR4778_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4778-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).	AP1_01///Genes having at least one occurence of the transcription factor binding site V$AP1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++AP1_C///Genes having at least one occurence of the transcription factor binding site V$AP1_C (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++AP1_Q4_01///Genes having at least one occurence of the transcription factor binding site V$AP1_Q4_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++BACH1_01///Genes having at least one occurence of the transcription factor binding site V$BACH1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++PBX1_01///Genes having at least one occurence of the transcription factor binding site V$PBX1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++TGANTCA_AP1_C///Genes having at least one occurence of the highly conserved motif M7 TGANTCA sites. The motif matches transcription factor binding site V$AP1_C (v7.4 TRANSFAC).	"DLX6_TARGET_GENES///Genes containing one or more binding sites for UniProt:P56179 (DLX6) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++KDM5D_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9BY66 (KDM5D) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SETX_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q7Z333 (SETX) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++UBN1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9NPG3 (UBN1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."				GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_MATURE_NEURON_CELL_LINE_UP///Genes up-regulated in the mature neuron cell line: control versus infected with western equine encephalitis virus.+++GSE23321_CD8_STEM_CELL_MEMORY_VS_CENTRAL_MEMORY_CD8_TCELL_UP///Genes up-regulated in CD8 T cells: stem cell memory versus central memory.+++GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP///Genes up-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 and then stimulated by IL4 [GeneID=3565] (2h).+++GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_UP///Genes up-regulated in comparison of Ctrlrv versus Foxp3rv (see Fig. 1 in the paper for details).		NM_033520	C19orf33				
Q9BVJ7	sp|Q9BVJ7|DUS23_HUMAN				Dual specificity protein phosphatase 23 OS=Homo sapiens OX=9606 GN=DUSP23 PE=1 SV=1 >tr|A0A140VJI5|A0A140VJI5_HUMAN Dual specificity phosphatase 23 OS=Homo sapiens OX=9606 GN=DUSP23 PE=2 SV=1								MGVQPPNFSWVLPGRLAGLALPRLPAHYQFLLDLGVRHLVSLTERGPPHSDSCPGLTLHRLRIPDFCPPAPDQIDRFVQIVDEANARGEAVGVHCALGFGRTGTMLACYLVKERGLAAGDAIAEIRRLRPGSIETYEQEKAVFQFYQRTK	0.3986641	-1.326754373	0.006459138		3.6123811		4.8192909	3.7948973	5.0461248		5.0917358	5.0082485			4.9175629										4.396348	6.7209793		4.00786492			7.809244	7.5140003	6.578852	4.9703052			6.4230382	5.0952673	6.5350922	6.3626329		4.153699	5.3816738		6.6025593		4.6208842																																	C9606_85093					
Q9BRG1	sp|Q9BRG1|VPS25_HUMAN				Vacuolar protein-sorting-associated protein 25 OS=Homo sapiens OX=9606 GN=VPS25 PE=1 SV=1 >tr|A0A024R1X3|A0A024R1X3_HUMAN ESCRT-II complex subunit VPS25 OS=Homo sapiens OX=9606 GN=VPS25 PE=3 SV=1								MAMSFEWPWQYRFPPFFTLQPNVDTRQKQLAAWCSLVLSFCRLHKQSSMTVMEAQESPLFNNVKLQRKLPVESIQIVLEELRKKGNLEWLDKSKSSFLIMWRRPEEWGKLIYQWVSRSGQNNSVFTLYELTNGEDTEDEEFHGLDEATLLRALQALQQEHKAEIITVSDGRGVKFF	2.1439255	1.100254762	0.01915608																2.9262395		2.4226776	2.269824865	2.9656835		2.9268354											1.6019974																																												C9606_115307					
Q99816	sp|Q99816|TS101_HUMAN		TSG101		Tumor susceptibility gene 101 protein OS=Homo sapiens OX=9606 GN=TSG101 PE=1 SV=2	7251	NM_006292	NP_006283	ENST00000251968	K12183			MAVSESQLKKMVSKYKYRDLTVRETVNVITLYKDLKPVLDSYVFNDGSSRELMNLTGTIPVPYRGNTYNIPICLWLLDTYPYNPPICFVKPTSSMTIKTGKHVDANGKIYLPYLHEWKHPQSDLLGLIQVMIVVFGDEPPVFSRPISASYPPYQATGPPNTSYMPGMPGGISPYPSGYPPNPSGYPGCPYPPGGPYPATTSSQYPSQPPVTTVGPSRDGTISEDTIRASLISAVSDKLRWRMKEEMDRAQAELNALKRTEEDLKKGHQKLEEMVTRLDQEVAEVDKNIELLKKKDEELSSALEKMENQSENNDIDEVIIPTAPLYKQILNLYAEENAIEDTIFYLGEALRRGVIDLDVFLKHVRLLSRKQFQLRALMQKARKTAGLSDLY	0.6110144	-0.710721623	0.01996027					4.5565012	3.8813249		3.7125873	4.5558683	4.9634849	4.1060257	4.8364943			3.9841134	4.3452644		3.2508334				5.2824533	4.0636683					6.850846	5.0748777	5.955655	6.1188984	4.931384	3.5035131	4.7209131	4.9551051	4.0165325	5.1348277	4.5066848	5.992156	5.1873187	4.63111143	5.6693669	3.6042272	5.56218589	04144///Endocytosis				GO:0000813///ESCRT I complex+++GO:0005634///nucleus+++GO:0005730///nucleolus+++GO:0005737///cytoplasm+++GO:0005768///endosome+++GO:0005769///early endosome+++GO:0005770///late endosome+++GO:0005771///multivesicular body+++GO:0005815///microtubule organizing center+++GO:0005829///cytosol+++GO:0005856///cytoskeleton+++GO:0005886///plasma membrane+++GO:0010008///endosome membrane+++GO:0016020///membrane+++GO:0031901///early endosome membrane+++GO:0031902///late endosome membrane+++GO:0043657///host cell+++GO:0070062///extracellular exosome+++GO:0090543///Flemming body	GO:0003677///DNA binding+++GO:0003714///transcription corepressor activity+++GO:0005515///protein binding+++GO:0030374///nuclear receptor transcription coactivator activity+++GO:0031625///ubiquitin protein ligase binding+++GO:0042803///protein homodimerization activity+++GO:0043130///ubiquitin binding+++GO:0044877///protein-containing complex binding+++GO:0046790///virion binding+++GO:0048306///calcium-dependent protein binding	"GO:0000122///negative regulation of transcription by RNA polymerase II+++GO:0001558///regulation of cell growth+++GO:0006464///cellular protein modification process+++GO:0006513///protein monoubiquitination+++GO:0006858///extracellular transport+++GO:0007049///cell cycle+++GO:0007050///cell cycle arrest+++GO:0007175///negative regulation of epidermal growth factor-activated receptor activity+++GO:0008285///negative regulation of cell proliferation+++GO:0008333///endosome to lysosome transport+++GO:0015031///protein transport+++GO:0016197///endosomal transport+++GO:0016236///macroautophagy+++GO:0019058///viral life cycle+++GO:0019076///viral release from host cell+++GO:0030154///cell differentiation+++GO:0030216///keratinocyte differentiation+++GO:0036258///multivesicular body assembly+++GO:0039702///viral budding via host ESCRT complex+++GO:0040008///regulation of growth+++GO:0042059///negative regulation of epidermal growth factor receptor signaling pathway+++GO:0043162///ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway+++GO:0043405///regulation of MAP kinase activity+++GO:0045893///positive regulation of transcription, DNA-templated+++GO:0046755///viral budding+++GO:0051301///cell division+++GO:0051726///regulation of cell cycle+++GO:0075733///intracellular transport of virus+++GO:0097352///autophagosome maturation+++GO:1902188///positive regulation of viral release from host cell+++GO:1903543///positive regulation of exosomal secretion+++GO:1903551///regulation of extracellular exosome assembly+++GO:1903774///positive regulation of viral budding via host ESCRT complex+++GO:1990182///exosomal secretion+++GO:2000397///positive regulation of ubiquitin-dependent endocytosis"	tissueType=Fetal kidney;cancerType=Normal;cellName=Natural killer T (NKT) cell		"Homo sapiens tumor susceptibility 101 (TSG101), mRNA."		PF05743///UEV domain+++PF09454///Vps23 core domain	"R-HSA-162587///HIV Life Cycle+++R-HSA-162588///Budding and maturation of HIV virion+++R-HSA-162599///Late Phase of HIV Life Cycle+++R-HSA-162906///HIV Infection+++R-HSA-1643685///Disease+++R-HSA-174490///Membrane binding and targetting of GAG proteins+++R-HSA-174495///Synthesis And Processing Of GAG, GAGPOL Polyproteins+++R-HSA-175474///Assembly Of The HIV Virion+++R-HSA-199991///Membrane Trafficking+++R-HSA-5653656///Vesicle-mediated transport+++R-HSA-5663205///Infectious disease+++R-HSA-917729///Endosomal Sorting Complex Required For Transport (ESCRT)+++R-HSA-9609646///HCMV Infection+++R-HSA-9610379///HCMV Late Events+++R-HSA-9612973///Autophagy+++R-HSA-9615710///Late endosomal microautophagy"		KOG2391///Tumor susceptibility	Others///Others	"IPR008883///Ubiquitin E2 variant, N-terminal+++IPR016135///Ubiquitin-conjugating enzyme/RWD-like+++IPR017916///Steadiness box (SB) domain+++IPR037202///ESCRT assembly domain"	"[TS101_HUMAN|Reviewed]RecName: Full=Tumor susceptibility gene 101 protein; AltName: Full=ESCRT-I complex subunit TSG101;+++[D3DQY6_HUMAN|Unreviewed]SubName: Full=Tumor susceptibility gene 101, isoform CRA_a {ECO:0000313|EMBL:EAW68383.1};+++[L0L6B6_HUMAN|Unreviewed]SubName: Full=Tumor susceptibility protein 101 {ECO:0000313|EMBL:AGB57493.1}; Flags: Fragment;+++[Q86SI0_HUMAN|Unreviewed]SubName: Full=Tumor susceptibility protein isoform 3 {ECO:0000313|EMBL:AAO59169.1}; SubName: Full=Tumor susceptibility protein isoform 4 {ECO:0000313|EMBL:AAO59170.1};"		BIOCARTA_STATHMIN_PATHWAY///Stathmin and breast cancer resistance to antimicrotubule agents	KEGG_ENDOCYTOSIS///Endocytosis	REACTOME_ASSEMBLY_OF_THE_HIV_VIRION///Assembly Of The HIV Virion+++REACTOME_AUTOPHAGY///Autophagy+++REACTOME_BUDDING_AND_MATURATION_OF_HIV_VIRION///Budding and maturation of HIV virion+++REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT///Endosomal Sorting Complex Required For Transport (ESCRT)+++REACTOME_HCMV_INFECTION///HCMV Infection+++REACTOME_HCMV_LATE_EVENTS///HCMV Late Events+++REACTOME_HIV_INFECTION///HIV Infection+++REACTOME_HIV_LIFE_CYCLE///HIV Life Cycle+++REACTOME_INFECTIOUS_DISEASE///Infectious disease+++REACTOME_LATE_ENDOSOMAL_MICROAUTOPHAGY///Late endosomal microautophagy+++REACTOME_MEMBRANE_TRAFFICKING///Membrane Trafficking+++REACTOME_VESICLE_MEDIATED_TRANSPORT///Vesicle-mediated transport		"GCACTTT_MIR175P_MIR20A_MIR106A_MIR106B_MIR20B_MIR519D///Genes having at least one occurence of the motif GCACTTT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-17-5p, hsa-miR-20a, hsa-miR-106a, hsa-miR-106b, hsa-miR-20b and hsa-miR-519d (v7.1 miRBase).+++TGCACTT_MIR519C_MIR519B_MIR519A///Genes having at least one occurence of the motif TGCACTT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-519c, hsa-miR-519b and hsa-miR-519a (v7.1 miRBase)."	"MIR106A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-106a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR106B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-106b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR17_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-17-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR20A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-20a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR20B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-20b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4797_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4797-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR519A_3P_MIR519B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-519a-3p, hsa-miR-519b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR519C_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-519c-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR519D_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-519d-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR526B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-526b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AV_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548av-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR656_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-656-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR93_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-93-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets)."	CTTTGA_LEF1_Q2///Genes having at least one occurence of the highly conserved motif M73 CTTTGA sites. The motif matches transcription factor binding site V$LEF1_Q2 (v7.4 TRANSFAC).+++GTGACGY_E4F1_Q6///Genes having at least one occurence of the highly conserved motif M20 GTGACGY sites. The motif matches transcription factor binding site V$E4F1_Q6 (v7.4 TRANSFAC).+++LEF1_Q2///Genes having at least one occurence of the transcription factor binding site V$LEF1_Q2 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.	"BACH2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9BYV9 (BACH2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++BRCA2_TARGET_GENES///Genes containing one or more binding sites for UniProt:P51587 (BRCA2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++DMRT1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9Y5R6 (DMRT1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++E2F2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q14209 (E2F2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ELF2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q15723 (ELF2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++EWSR1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q01844 (EWSR1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++FOXP2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O15409 (FOXP2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HMG20B_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9P0W2 (HMG20B) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HOXA2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O43364 (HOXA2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++LHX2_TARGET_GENES///Genes containing one or more binding sites for UniProt:P50458 (LHX2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NKX2_2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O95096 (NKX2_2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NKX2_5_TARGET_GENES///Genes containing one or more binding sites for UniProt:P52952 (NKX2_5) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NR1H4_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96RI1 (NR1H4) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SATB1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q01826 (SATB1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SETX_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q7Z333 (SETX) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZBTB7B_TARGET_GENES///Genes containing one or more binding sites for UniProt:O15156 (ZBTB7B) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF282_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9UDV7 (ZNF282) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF549_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6P9A3 (ZNF549) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF84_TARGET_GENES///Genes containing one or more binding sites for UniProt:P51523 (ZNF84) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."		MODULE_72///Testis genes.+++MODULE_82///Genes in the cancer module 82.+++MODULE_8///Genes in the cancer module 8.		"GSE11864_UNTREATED_VS_CSF1_PAM3CYS_IN_MAC_DN///Genes down-regulated in comparison of untreated macrophages versus those cultured with M-CSF [GeneID=1435] and Pam3Cys (TLR2 agonist).+++GSE12845_IGD_POS_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_DN///Genes down-regulated in comparison of IgD+ peripheral blood B cells versus dark zone germincal center B cells.+++GSE13485_PRE_VS_POST_YF17D_VACCINATION_PBMC_UP///Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) before vs after YF17D vaccination.+++GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_UP///Genes up-regulated in comparison of CD4 [GeneID=920] CD8 thymocytes versus naive CD4 [GeneID=920] T cells from cord blood.+++GSE1740_MCSF_VS_MCSF_AND_IFNG_DAY2_DERIVED_MACROPHAGE_DN///Genes down-regulated in monocyte-derived macrophages: no priming versus primed by IFNG [GeneID=3458].+++GSE22886_IGG_IGA_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_DN///Genes down-regulated in comparison of memory IgG IgA B cells versus blood plasma cells.+++GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH2_DN///Genes down-regulated in comparison of naive CD4 [GeneID=920] T cells versus stimulated CD4 [GeneID=920] Th2 cells at 12 h.+++GSE22886_NAIVE_CD4_TCELL_VS_DC_DN///Genes down-regulated in comparison of naive CD4 [GeneID=920] T cells versus unstimulatd dendritic cells (DC).+++GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_2H_DN///Genes down-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: IL-12 (2h) versus untreated (2h).+++GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP///Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 [GeneID=7040] and IL-12 (2h) versus IL4 [GeneID=3565] (2h).+++GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_48H_UP///Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 and IL4 [GeneID=7040;3565] (48h) versus IL4 [GeneID=3565] (48h).+++GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_48H_DN///Genes down-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 and then stimulated by IL4 [GeneID=3565] (48h).+++GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_UP///Genes up-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 and then stimulated by TGFB1 [GeneID=7040] and IL-12 (6h).+++GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_BCELL_DN///Genes down-regulated in comparison of B cells from LAIV influenza vaccinee at day 7 post-vaccination versus those from TIV influenza vaccinee at day 7 post-vaccination.+++GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_BCELL_UP///Genes up-regulated in comparison of B cells from LAIV influenza vaccinee pre-vaccination versus those at day 7 post-vaccination.+++GSE34156_TLR1_TLR2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_DN///Genes down-regulated in monocytes (24h): M. tuberculosis 19 kDa lipopeptide versus M. tuberculosis 19 kDa lipopeptide and muramyl dipeptide [PubChem=11620162].+++GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10NEG_CD62LPOS_BONE_MARROW_UP///Genes up-regulated in the bone marrow CD34+ [GeneID=947] cells: CD38- [GeneID=952] versus MME- SELL+ [GeneID=4311;6402].+++GSE360_DC_VS_MAC_L_MAJOR_UP///Genes up-regulated in comparison of dendritic cells exposed to L. major versus macrophages exposed to L. major.+++GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_DC_UP///Genes up-regulated in comparison of dendritic cells (DC) exposed to L. donovani versus DCs exposed to 5 worm/well B. malayi.+++GSE3982_DC_VS_EFF_MEMORY_CD4_TCELL_UP///Genes up-regulated in comparison of dendritic cells (DC) versus effector memory CD4 [GeneID=920] T cells.+++GSE3982_DC_VS_TH1_UP///Genes up-regulated in comparison of dendritic cells (DC) versus Th1 cells.+++GSE3982_MAST_CELL_VS_DC_UP///Genes up-regulated in comparison of mast cells versus dendritic cells (DC).+++GSE3982_MAST_CELL_VS_EFF_MEMORY_CD4_TCELL_UP///Genes up-regulated in comparison of mast cells versus effector memory CD4 [GeneID=920] T cells.+++GSE3982_MAST_CELL_VS_NKCELL_UP///Genes up-regulated in comparison of mast cells versus NK cells.+++GSE3982_MAST_CELL_VS_TH1_UP///Genes up-regulated in comparison of mast cells versus Th1 cells.+++GSE3982_NEUTROPHIL_VS_EFF_MEMORY_CD4_TCELL_UP///Genes up-regulated in comparison of neutrophils versus effector memory CD4 [GeneID=920] T cells.+++GSE3982_NEUTROPHIL_VS_NKCELL_UP///Genes up-regulated in comparison of neutrophils versus NK cells.+++GSE3982_NEUTROPHIL_VS_TH1_UP///Genes up-regulated in comparison of neutrophils versus Th1 cells.+++GSE4984_GALECTIN1_VS_VEHICLE_CTRL_TREATED_DC_DN///Genes down-regulated in monocyte-derived dendritic cells: LGALS1 [GeneID=3956] versus vehicle.+++GSE7460_CD8_TCELL_VS_TREG_ACT_DN///Genes down-regulated in comparsion of ActCD8 versus ActTreg(see Fig. 1 in the paper for details).+++GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_12H_DN///Genes down-regulated in monocytes: untreated versus M. tuberculosis 19 kDa lipopeptide (12h).+++GSE9006_1MONTH_VS_4MONTH_POST_TYPE_1_DIABETES_DX_PBMC_DN///Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from patients with type 1 diabetes at 1 month after the diagnosis versus those at 4 months later.+++HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_POSITIVE///Genes positively correlated with memory B cell response at 28d in peripheral blood mononuclear cell in seniors (50-74) after exposure to Fluarix , time point 28D+++NAKAYA_B_CELL_FLUMIST_AGE_18_50YO_7DY_DN///Genes down-regulated in B cell 7d vs 0d in young adults (18-50) after exposure to FluMist , time point 7D"	HALLMARK_DNA_REPAIR///Genes involved in DNA repair.+++HALLMARK_PROTEIN_SECRETION///Genes involved in protein secretion pathway.	NM_006292	TSG101				
Q99719	sp|Q99719|SEPT5_HUMAN		SEPTIN5		Septin-5 OS=Homo sapiens OX=9606 GN=SEPTIN5 PE=1 SV=1 >tr|X5DNA9|X5DNA9_HUMAN Septin-5 (Fragment) OS=Homo sapiens OX=9606 GN=SEPT5 PE=2 SV=1	5413	NM_002688	NP_002679	ENST00000455784	K04557			MSTGLRYKSKLATPEDKQDIDKQYVGFATLPNQVHRKSVKKGFDFTLMVAGESGLGKSTLVHSLFLTDLYKDRKLLSAEERISQTVEILKHTVDIEEKGVKLKLTIVDTPGFGDAVNNTECWKPITDYVDQQFEQYFRDESGLNRKNIQDNRVHCCLYFISPFGHGLRPVDVGFMKALHEKVNIVPLIAKADCLVPSEIRKLKERIREEIDKFGIHVYQFPECDSDEDEDFKQQDRELKESAPFAVIGSNTVVEAKGQRVRGRLYPWGIVEVENQAHCDFVKLRNMLIRTHMHDLKDVTCDVHYENYRAHCIQQMTSKLTQDSRMESPIPILPLPTPDAETEKLIRMKDEELRRMQEMLQRMKQQMQDQ	0.5273864	-0.923067703	0.004330516					5.8798116	4.8436564		4.5635762	5.9155043	7.2281677	5.9118002	6.1718436				5.272095					5.1173481	5.3311894						7.893818	7.0654768	7.541086	7.9509781	5.769286	5.6936911	6.0488573	5.7355989	6.3185469	5.8876858	6.6671953	6.935798	6.2018336	5.954759	7.2571424	5.4496701	6.9202157	05012///Parkinson disease+++05022///Pathways of neurodegeneration - multiple diseases				GO:0005737///cytoplasm+++GO:0005856///cytoskeleton+++GO:0005886///plasma membrane+++GO:0005940///septin ring+++GO:0008021///synaptic vesicle+++GO:0015630///microtubule cytoskeleton+++GO:0031105///septin complex+++GO:0032153///cell division site	GO:0000166///nucleotide binding+++GO:0003924///GTPase activity+++GO:0005198///structural molecule activity+++GO:0005515///protein binding+++GO:0005525///GTP binding+++GO:0042802///identical protein binding+++GO:0060090///molecular adaptor activity	GO:0007049///cell cycle+++GO:0016080///synaptic vesicle targeting+++GO:0017157///regulation of exocytosis+++GO:0030534///adult behavior+++GO:0034613///cellular protein localization+++GO:0035176///social behavior+++GO:0051301///cell division+++GO:0061640///cytoskeleton-dependent cytokinesis+++GO:2000300///regulation of synaptic vesicle exocytosis			"Homo sapiens septin 5 (SEPTIN5), transcript variant 1, mRNA."		PF00735///Septin			KOG2655///GTP binding		IPR016491///Septin+++IPR027417///P-loop containing nucleoside triphosphate hydrolase+++IPR030379///Septin-type guanine nucleotide-binding (G) domain+++IPR030647///Septin 5	[SEPT5_HUMAN|Reviewed]RecName: Full=Septin-5; AltName: Full=Cell division control-related protein 1; Short=CDCrel-1; AltName: Full=Peanut-like protein 1;+++[X5DQL7_HUMAN|Unreviewed]SubName: Full=Septin 5 isoform B {ECO:0000313|EMBL:AHW56397.1}; Flags: Fragment;	chr22q11///Ensembl 103 genes in cytogenetic band chr22q11	BIOCARTA_PARKIN_PATHWAY///Role of Parkin in the Ubiquitin-Proteasomal Pathway	KEGG_PARKINSONS_DISEASE///Parkinson's disease			"ATGAAGG_MIR205///Genes having at least one occurence of the motif ATGAAGG in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-205 (v7.1 miRBase)."	MIR1184///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1184 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1976///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1976 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4667_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4667-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4700_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4700-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4733_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4733-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR637///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-637 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR8089///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-8089 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).	AP3_Q6///Genes having at least one occurence of the transcription factor binding site V$AP3_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.	"ATF6_TARGET_GENES///Genes containing one or more binding sites for UniProt:P18850 (ATF6) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++CDC5L_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q99459 (CDC5L) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++LMTK3_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96Q04 (LMTK3) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++MEF2D_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q14814 (MEF2D) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NUP153_TARGET_GENES///Genes containing one or more binding sites for UniProt:P49790 (NUP153) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++RBM34_TARGET_GENES///Genes containing one or more binding sites for UniProt:P42696 (RBM34) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++RYBP_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8N488 (RYBP) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SAFB2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q14151 (SAFB2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SKIL_TARGET_GENES///Genes containing one or more binding sites for UniProt:P12757 (SKIL) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SNRNP70_TARGET_GENES///Genes containing one or more binding sites for UniProt:P08621 (SNRNP70) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZC3H11A_TARGET_GENES///Genes containing one or more binding sites for UniProt:O75152 (ZC3H11A) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF184_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q99676 (ZNF184) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF592_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q92610 (ZNF592) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF92_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q03936 (ZNF92) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZSCAN30_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q86W11 (ZSCAN30) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZSCAN4_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8NAM6 (ZSCAN4) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."		MODULE_100///Genes in the cancer module 100.+++MODULE_137///CNS genes.+++MODULE_205///Genes in the cancer module 205.+++MODULE_438///Intermediate filaments and MT.+++MODULE_533///Genes in the cancer module 533.+++MODULE_66///Genes in the cancer module 66.+++MODULE_94///Signaling.		"ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_6HR_DN///Genes down-regulated in blood 6hr vs 0hr in adults (18-45) after exposure to CN54gp140 adjuvanted with GLA-AF , time point 6H , administered i.m.+++GSE6269_HEALTHY_VS_STAPH_AUREUS_INF_PBMC_DN///Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from patients with acute influenza infection versus PBMC from patients with acute S. aureus infection.+++HOEK_NEUTROPHIL_2011_2012_TIV_ADULT_1DY_DN///Genes down-regulated in neutrophil 1d vs 0d in adults after exposure to 2011-2012 trivalent inactivated vaccine (A/California/7/09 (H1N1), A/Perth /16/2009 (H3N2), B/Brisbane/60/2008) , time point 1D. Comment: Down-regulated DE RNA transcripts (down &gt;= 1.5x) shared between both TIV-vaccinated donors"		NM_002688	SEPTIN5				
Q99439	sp|Q99439|CNN2_HUMAN		CNN2		Calponin-2 OS=Homo sapiens OX=9606 GN=CNN2 PE=1 SV=4	1265	NM_004368	NP_004359	ENST00000263097				MSSTQFNKGPSYGLSAEVKNRLLSKYDPQKEAELRTWIEGLTGLSIGPDFQKGLKDGTILCTLMNKLQPGSVPKINRSMQNWHQLENLSNFIKAMVSYGMNPVDLFEANDLFESGNMTQVQVSLLALAGKAKTKGLQSGVDIGVKYSEKQERNFDDATMKAGQCVIGLQMGTNKCASQSGMTAYGTRRHLYDPKNHILPPMDHSTISLQMGTNKCASQVGMTAPGTRRHIYDTKLGTDKCDNSSMSLQMGYTQGANQSGQVFGLGRQIYDPKYCPQGTVADGAPSGTGDCPDPGEVPEYPPYYQEEAGY	0.3714575	-1.428730799	8.11E-04		7.0281499	7.0893808	6.9417301	6.0186467	9.159276	7.255116292	7.2909316	8.3879725	9.1191247	8.4731592	8.9832283	5.80997699	7.4658158	7.2871282	7.9364408	4.6553726	6.2380873			7.831664	8.5734076	9.9070269	6.3516532	6.23234332	7.32175198	6.3249747	11.740013	10.4639301	9.887038	10.1637445	8.517595	8.1710962	9.6492107	9.2847111	8.9442383	9.5779388	8.5839001	10.063991	9.3613845	8.79583711	9.801866	7.2267733	8.9548175					GO:0001725///stress fiber+++GO:0005576///extracellular region+++GO:0005856///cytoskeleton+++GO:0005911///cell-cell junction+++GO:0005925///focal adhesion+++GO:0016020///membrane+++GO:0035580///specific granule lumen+++GO:1904724///tertiary granule lumen	GO:0003779///actin binding+++GO:0005516///calmodulin binding+++GO:0045296///cadherin binding	GO:0007010///cytoskeleton organization+++GO:0010628///positive regulation of gene expression+++GO:0030097///hemopoiesis+++GO:0030336///negative regulation of cell migration+++GO:0031032///actomyosin structure organization+++GO:0032970///regulation of actin filament-based process+++GO:0035722///interleukin-12-mediated signaling pathway+++GO:0042060///wound healing+++GO:0042127///regulation of cell proliferation+++GO:0043312///neutrophil degranulation+++GO:0050765///negative regulation of phagocytosis+++GO:0071260///cellular response to mechanical stimulus	tissueType=Fetal gonad;cancerType=Normal;cellName=Mitotic fetal germ cell+++tissueType=Fetal gonad;cancerType=Normal;cellName=Gonadal endothelial cell+++tissueType=Embryo;cancerType=Normal;cellName=Trophectoderm cell+++tissueType=Fetal gonad;cancerType=Normal;cellName=Migration phase fetal germ cell+++tissueType=Fetal kidney;cancerType=Normal;cellName=Natural killer T (NKT) cell		"Homo sapiens calponin 2 (CNN2), transcript variant 1, mRNA."		PF00307///Calponin homology (CH) domain+++PF00402///Calponin family repeat	R-HSA-1280215///Cytokine Signaling in Immune system+++R-HSA-168249///Innate Immune System+++R-HSA-168256///Immune System+++R-HSA-447115///Interleukin-12 family signaling+++R-HSA-449147///Signaling by Interleukins+++R-HSA-6798695///Neutrophil degranulation+++R-HSA-8950505///Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation+++R-HSA-9020591///Interleukin-12 signaling		KOG2046///actin binding		IPR000557///Calponin repeat+++IPR001715///Calponin homology domain+++IPR001997///Calponin/LIMCH1+++IPR003096///Smooth muscle protein/calponin+++IPR029974///Calponin-2+++IPR036872///CH domain superfamily	"[CNN2_HUMAN|Reviewed]RecName: Full=Calponin-2; AltName: Full=Calponin H2, smooth muscle; AltName: Full=Neutral calponin;+++[B2RWM5_HUMAN|Unreviewed]RecName: Full=Calponin {ECO:0000256|RuleBase:RU361224}; Flags: Fragment;+++[Q6FHC3_HUMAN|Unreviewed]RecName: Full=Calponin {ECO:0000256|RuleBase:RU361224}; Flags: Fragment;+++[Q6FHE4_HUMAN|Unreviewed]RecName: Full=Calponin {ECO:0000256|RuleBase:RU361224};"	chr19p13///Ensembl 103 genes in cytogenetic band chr19p13			REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM///Cytokine Signaling in Immune system+++REACTOME_GENE_AND_PROTEIN_EXPRESSION_BY_JAK_STAT_SIGNALING_AFTER_INTERLEUKIN_12_STIMULATION///Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation+++REACTOME_INNATE_IMMUNE_SYSTEM///Innate Immune System+++REACTOME_INTERLEUKIN_12_FAMILY_SIGNALING///Interleukin-12 family signaling+++REACTOME_INTERLEUKIN_12_SIGNALING///Interleukin-12 signaling+++REACTOME_NEUTROPHIL_DEGRANULATION///Neutrophil degranulation+++REACTOME_SIGNALING_BY_INTERLEUKINS///Signaling by Interleukins			"MIR133A_3P_MIR133B///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-133a-3p, hsa-miR-133b in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR23A_3P_MIR23B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-23a-3p, hsa-miR-23b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR23C///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-23c in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR497_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-497-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AS_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548as-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR625_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-625-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets)."	EGR1_01///Genes having at least one occurence of the transcription factor binding site V$EGR1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++LFA1_Q6///Genes having at least one occurence of the transcription factor binding site V$LFA1_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++MCAATNNNNNGCG_UNKNOWN///Genes having at least one occurence of the highly conserved motif M110 MCAATNNNNNGCG in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++RYTTCCTG_ETS2_B///Genes having at least one occurence of the highly conserved motif M16 RYTTCCTG sites. The motif matches transcription factor binding site V$ETS2_B (v7.4 TRANSFAC).+++SRF_01///Genes having at least one occurence of the transcription factor binding site V$SRF_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++SRF_C///Genes having at least one occurence of the transcription factor binding site V$SRF_C (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++SRF_Q5_01///Genes having at least one occurence of the transcription factor binding site V$SRF_Q5_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++SRF_Q6///Genes having at least one occurence of the transcription factor binding site V$SRF_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++STAT6_02///Genes having at least one occurence of the transcription factor binding site V$STAT6_02 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++WWTAAGGC_UNKNOWN///Genes having at least one occurence of the highly conserved motif M127 WWTAAGGC in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).	"AHRR_TARGET_GENES///Genes containing one or more binding sites for UniProt:A9YTQ3 (AHRR) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++CBFA2T2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O43439 (CBFA2T2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++CDH4_TARGET_GENES///Genes containing one or more binding sites for UniProt:P55283 (CDH4) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++KAT5_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q92993 (KAT5) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SFMBT1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9UHJ3 (SFMBT1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SKIL_TARGET_GENES///Genes containing one or more binding sites for UniProt:P12757 (SKIL) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SUMO1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P63165 (SUMO1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++TCF7_TARGET_GENES///Genes containing one or more binding sites for UniProt:P36402 (TCF7) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZFP3_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96NJ6 (ZFP3) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF184_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q99676 (ZNF184) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF239_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q16600 (ZNF239) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF354A_TARGET_GENES///Genes containing one or more binding sites for UniProt:O60765 (ZNF354A) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF92_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q03936 (ZNF92) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZSCAN29_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8IWY8 (ZSCAN29) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."		MODULE_321///Genes in the cancer module 321.+++MODULE_419///Genes in the cancer module 419.+++MODULE_47///ECM and collagens.+++MODULE_524///Actin cytoskeleton binding.	LTE2_UP.V1_DN///Genes down-regulated in MCF-7 cells (breast cancer) positive for ESR1 [Gene ID=2099] MCF-7 cells (breast cancer) and long-term adapted for estrogen-independent growth.	"GSE1460_DP_THYMOCYTE_VS_THYMIC_STROMAL_CELL_DN///Genes down-regulated in comparison of CD4 [GeneID=920] CD8 thymocytes versus thymic stromal cells.+++GSE15735_CTRL_VS_HDAC_INHIBITOR_TREATED_CD4_TCELL_12H_DN///Genes down-regulated in CD4 [GeneID=920] T cells: control versus treated with HDAC inhibitors for 12h.+++GSE18893_TCONV_VS_TREG_24H_TNF_STIM_DN///Genes down-regulated in lymphocytes treated with TNF [GeneID=7124] for 24h: T conv versus T reg cells.+++GSE1925_CTRL_VS_3H_IFNG_STIM_MACROPHAGE_UP///Genes up-regulated in macrophages: untreated versus stimulated by IFNG [GeneID=3458] for 3h.+++GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_24H_IFNG_STIM_UP///Genes up-regulated in macrophages stimulated by IFNG [GeneID=3458] for 24h: control versus primed by IFNG [GeneID=3458].+++GSE20151_CTRL_VS_FUSOBACT_NUCLEATUM_NEUTROPHIL_DN///Genes down-regulated in comparison of contols neutrophils versus those infected with a bacterium (F. nucleatum).+++GSE22282_HYPOXIA_VS_NORMOXIA_MYELOID_DC_DN///Genes down-regulated in myeloid dendritic cells: hypoxia versus normoxia.+++GSE22601_DOUBLE_NEGATIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_UP///Genes up-regulated in thymocytes: double negative versus CD8 single positive.+++GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_UP///Genes up-regulated in CD4 [GeneID=920] single positive cells: immature versus thymocytes.+++GSE22886_NAIVE_CD4_TCELL_VS_NKCELL_UP///Genes up-regulated in comparison of naive CD4 [GeneID=920] T cells versus unstimulated NK cells.+++GSE22886_NAIVE_CD8_TCELL_VS_NKCELL_UP///Genes up-regulated in comparison of naive CD8 T cells versus unstimulated NK cells.+++GSE22886_NAIVE_TCELL_VS_NKCELL_UP///Genes up-regulated in comparison of naive CD4 [GeneID=920] CD8 T cells versus unstimulated NK cells.+++GSE22886_UNSTIM_VS_STIM_MEMORY_TCELL_UP///Genes up-regulated in comparison of unstimulated memory CD4 [GeneID=920] CD8 T cells versus stimulated CD4 [GeneID=920] CD8 T cells.+++GSE2405_0H_VS_12H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP///Genes up-regulated in polymorphonuclear leukocytes (12h): control versus infection by A. phagocytophilum.+++GSE2405_0H_VS_6H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN///Genes down-regulated in polymorphonuclear leukocytes (6h): control versus infection by A. phagocytophilum.+++GSE2405_HEAT_KILLED_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_24H_UP///Genes up-regulated in polymorphonuclear leukocytes (24h) infection by A. phagocytophilum: heat killed versus live bacteria.+++GSE2405_S_AUREUS_VS_A_PHAGOCYTOPHILUM_NEUTROPHIL_UP///Genes up-regulated in polymorphonuclear leukocytes 9h after infection by: S. aureus versus A. phagocytophilum.+++GSE27670_BLIMP1_VS_LMP1_TRANSDUCED_GC_BCELL_DN///Genes down-regulated in germinal center B lymphocytes over-expressing: PRDM1 [GeneID=639] versus Epstein-Barr virus protein LMP1.+++GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_DN///Genes down-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 and then stimulated by TGFB1 [GeneID=7040] and IL-12 (48h).+++GSE29618_BCELL_VS_PDC_DAY7_FLU_VACCINE_UP///Genes up-regulated in comparison of B cells from influenza vaccinee at day 7 post-vaccination versus plasmacytoid dendritic cells (pDC) at day 7 post-vaccination.+++GSE29618_MONOCYTE_VS_MDC_DAY7_FLU_VACCINE_DN///Genes down-regulated in comparison of monocytes from influenza vaccinee at day 7 post-vaccination versus myeloid dendritic cells at day 7 post-vaccination.+++GSE29618_MONOCYTE_VS_MDC_DN///Genes down-regulated in comparison of monocytes versus myeloid dendritic cells (mDC).+++GSE29618_PDC_VS_MDC_DAY7_FLU_VACCINE_DN///Genes down-regulated in comparison of plasmacytoid dendritic cells (DC) from influenza vaccinee at day 7 post-vaccination versus myeloid DCs at day 7 post-vaccination.+++GSE29618_PDC_VS_MDC_DN///Genes down-regulated in comparison of plasmacytoid dendritic cells (DC) versus myeloid DCs.+++GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_YOUNG_UP///Genes up-regulated in comparison of untreated CD4 [GeneID=920] memory T cells from young donors versus those treated with TSST at 16 h.+++GSE37416_0H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_UP///Genes up-regulated in comparison of control polymorphonuclear leukocytes (PMN) at 0 h versus PMN treated with F. tularensis vaccine at 48 h.+++GSE3982_EOSINOPHIL_VS_MAST_CELL_UP///Genes up-regulated in comparison of eosinophils versus mast cells.+++GSE3982_EOSINOPHIL_VS_NEUTROPHIL_DN///Genes down-regulated in comparison of eosinophils versus neutrophils.+++GSE3982_EOSINOPHIL_VS_TH2_UP///Genes up-regulated in comparison of eosinophils versus Th2 cells.+++GSE3982_MAC_VS_NEUTROPHIL_LPS_STIM_DN///Genes down-regulated in comparison of macrophages stimulated with LPS (TLR4 agonist) at 4 h versus neutrophils stimulated with LPS (TLR4 agonist) at 1 h.+++GSE3982_MAC_VS_TH1_DN///Genes down-regulated in comparison of macrophages versus Th1 cells.+++GSE3982_MAC_VS_TH2_DN///Genes down-regulated in comparison of macrophages versus Th2 cells.+++GSE3982_MAST_CELL_VS_MAC_UP///Genes up-regulated in comparison of mast cells versus macrophages.+++GSE42088_2H_VS_24H_LEISHMANIA_INF_DC_UP///Genes up-regulated in dendritic cells infected by Leishmania major: 2h versus 24h.+++GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_DN///Genes down-regulated in monocyte-derived dendritic cells: untreated versus rosiglitazone and AM580 [PubChem=77999;2126].+++GSE6092_UNSTIM_VS_IFNG_STIM_ENDOTHELIAL_CELL_DN///Genes down-regulated in endothelial cells: untreated versus IFNG [GeneID=3458].+++GSE7509_DC_VS_MONOCYTE_UP///Genes up-regulated in dendritic cells versus monocytes.+++GSE8921_3H_VS_24H_TLR1_2_STIM_MONOCYTE_UP///Genes up-regulated in monocytes in response to M. tuberculosis 19 kDa lipopeptide: 3h versus 24h.+++GSE9006_TYPE_1_VS_TYPE_2_DIABETES_PBMC_AT_DX_UP///Genes up-regulated in peripheral blood mononuclear cells (PBMC) from patients with type 1 diabetes at the time of diagnosis versus those with type 2 diabetes at the time of diagnosis.+++GSE9988_LOW_LPS_VS_ANTI_TREM1_AND_LPS_MONOCYTE_UP///Genes up-regulated in comparison of monocytes treated with 1 ng/ml LPS (TLR4 agonist) versus monocytes treated with anti-TREM1 [GeneID=54210] and 5000 ng/ml LPS (TLR4 agonist).+++HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_DN///Genes down-regulated in peripheral blood mononuclear cell vaccinated vs unvaccinated in adolescent/young adults (11-22) after exposure to M-M-R II , time point 7Y+++THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN///Genes down-regulated in peripheral blood mononuclear cell 28d vs 0d in young adults (21-30) (responders) after exposure to Inactivated influenza vaccine , time point 28D+++THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_DN///Genes down-regulated in peripheral blood mononuclear cell 7d vs 0d in young adults (21-30) (responders) after exposure to Inactivated influenza vaccine , time point 7D. Comment: most (70-80%) of cohort were white"	HALLMARK_APICAL_JUNCTION///Genes encoding components of apical junction complex.	NM_004368	CNN2				
Q96P48	sp|Q96P48|ARAP1_HUMAN		ARAP1		"Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 1 OS=Homo sapiens OX=9606 GN=ARAP1 PE=1 SV=3"	116985	NM_001040118	NP_001035207	ENST00000393609	K18439			MAEAGDAALSVAEWLRALHLEQYTGLFEQHGLVWATECQGLSDTRLMDMGMLLPGHRRRILAGLLRAHTSPAPAPRPTPRPVPMKRHIFRSPPVPATPPEPLPTTTEDEGLPAAPPIPPRRSCLPPTCFTTPSTAAPDPVLPPLPAKRHLAELSVPPVPPRTGPPRLLVSLPTKEEESLLPSLSSPPQPQSEEPLSTLPQGPPQPPSPPPCPPEIPPKPVRLFPEFDDSDYDEVPEEGPGAPARVMTKKEEPPPSRVPRAVRVASLLSEGEELSGDDQGDEEEDDHAYEGVPNGGWHTSSLSLSLPSTIAAPHPMDGPPGGSTPVTPVIKAGWLDKNPPQGSYIYQKRWVRLDTDHLRYFDSNKDAYSKRFISVACISHVAAIGDQKFEVITNNRTFAFRAESDVERKEWMQALQQAMAEQRARARLSSAYLLGVPGSEQPDRAGSLELRGFKNKLYVAVVGDKVQLYKNLEEYHLGIGITFIDMSVGNVKEVDRRSFDLTTPYRIFSFSADSELEKEQWLEAMQGAIAEALSTSEVAERIWAAAPNRFCADCGAPQPDWASINLCVVICKRCAGEHRGLGAGVSKVRSLKMDRKVWTETLIELFLQLGNGAGNRFWAANVPPSEALQPSSSPSTRRCHLEAKYREGKYRRYHPLFGNQEELDKALCAAVTTTDLAETQALLGCGAGINCFSGDPEAPTPLALAEQAGQTLQMEFLRNNRTTEVPRLDSMKPLEKHYSVVLPTVSHSGFLYKTASAGKLLQDRRAREEFSRRWCVLGDGVLSYFENERAVTPNGEIRASEIVCLAVPPPDTHGFEHTFEVYTEGERLYLFGLESAEQAHEWVKCIAKAFVPPLAEDLLARDFERLGRLPYKAGLSLQRAQEGWFSLSGSELRAVFPEGPCEEPLQLRKLQELSIQGDSENQVLVLVERRRTLYIQGERRLDFMGWLGAIQKAAASMGDTLSEQQLGDSDIPVIVYRCVDYITQCGLTSEGIYRKCGQTSKTQRLLESLRQDARSVHLKEGEQHVDDVSSALKRFLRDLPDGLFTRAQRLTWLEASEIEDEEEKVSRYRELLVRLPPVNRATVKALISHLYCVQCFSDTNQMNVHNLAIVFGPTLFQTDGQDYKAGRVVEDLINHYVVVFSVDEEELRKQREEITAIVKMRVAGTASGTQHAGDFICTVYLEEKKAETEQHIKVPASMTAEELTLEILDRRNVGIREKDYWTCFEVNEREEAERPLHFAEKVLPILHGLGTDSHLVVKKHQAMEAMLLYLASRVGDTKHGMMKFREDRSLLGLGLPSGGFHDRYFILNSSCLRLYKEVRSQRPWSGAPETSHRPEKEWPIKSLKVYLGVKKKLRPPTCWGFTVVHETEKHEKQQWYLCCDTQMELREWFATFLFVQHDGLVWPSEPSRVSRAVPEVRLGSVSLIPLRGSENEMRRSVAAFTADPLSLLRNV	0.4371046	-1.193949669	0.01475898					4.7041653	2.7680166		5.0497229	5.1021676	3.8150303	3.6154747	6.3886911		3.2449144		3.384449		4.3106115			4.8959067	5.3293194	4.4463865					7.065094	7.7023689	6.46532	6.8519833		4.6014722	6.3588316	3.4740391	2.7240021	6.5542975	5.1684154	6.811869	4.1904031	5.28002983	7.1171902	3.8501251	6.16398295	04144///Endocytosis				GO:0005654///nucleoplasm+++GO:0005737///cytoplasm+++GO:0005794///Golgi apparatus+++GO:0005802///trans-Golgi network+++GO:0005829///cytosol+++GO:0005886///plasma membrane+++GO:0016020///membrane+++GO:0031410///cytoplasmic vesicle+++GO:0032580///Golgi cisterna membrane+++GO:0043231///intracellular membrane-bounded organelle	"GO:0005096///GTPase activator activity+++GO:0005515///protein binding+++GO:0005547///phosphatidylinositol-3,4,5-trisphosphate binding+++GO:0031702///type 1 angiotensin receptor binding+++GO:0046872///metal ion binding"	GO:0001921///positive regulation of receptor recycling+++GO:0007165///signal transduction+++GO:0008360///regulation of cell shape+++GO:0030037///actin filament reorganization involved in cell cycle+++GO:0043547///positive regulation of GTPase activity+++GO:0045742///positive regulation of epidermal growth factor receptor signaling pathway+++GO:0050790///regulation of catalytic activity+++GO:0051056///regulation of small GTPase mediated signal transduction+++GO:0051270///regulation of cellular component movement+++GO:0051491///positive regulation of filopodium assembly+++GO:0051497///negative regulation of stress fiber assembly	tissueType=Blood;cancerType=Normal;cellName=CD1C-CD141- dendritic cell+++tissueType=Lung;cancerType=Normal;cellName=SLC16A7+ cell		"Homo sapiens ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 (ARAP1), transcript variant 3, mRNA."		PF00169///PH domain+++PF00536///SAM domain (Sterile alpha motif)+++PF00620///RhoGAP domain+++PF00788///Ras association (RalGDS/AF-6) domain+++PF01412///Putative GTPase activating protein for Arf	"R-HSA-162582///Signal Transduction+++R-HSA-194315///Signaling by Rho GTPases+++R-HSA-8848021///Signaling by PTK6+++R-HSA-8849469///PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1+++R-HSA-8980692///RHOA GTPase cycle+++R-HSA-9006927///Signaling by Non-Receptor Tyrosine Kinases+++R-HSA-9012999///RHO GTPase cycle+++R-HSA-9013148///CDC42 GTPase cycle+++R-HSA-9013149///RAC1 GTPase cycle+++R-HSA-9716542///Signaling by Rho GTPases, Miro GTPases and RHOBTB3"		"KOG1117///phosphatidylinositol-3,4,5-trisphosphate binding"		"IPR000159///Ras-associating (RA) domain+++IPR000198///Rho GTPase-activating protein domain+++IPR001164///Arf GTPase activating protein+++IPR001660///Sterile alpha motif domain+++IPR001849///Pleckstrin homology domain+++IPR008936///Rho GTPase activation protein+++IPR011993///PH-like domain superfamily+++IPR013761///Sterile alpha motif/pointed domain superfamily+++IPR037278///ARFGAP/RecO-like zinc finger+++IPR037858///ARAP, RhoGAP domain+++IPR038508///ArfGAP domain superfamily"	"[ARAP1_HUMAN|Reviewed]RecName: Full=Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 1; AltName: Full=Centaurin-delta-2; Short=Cnt-d2;+++[A0A2X0SFK3_HUMAN|Unreviewed]SubName: Full=ARAP1 {ECO:0000313|EMBL:SPT35674.1}; Flags: Fragment;+++[B7ZMI2_HUMAN|Unreviewed]SubName: Full=ARAP1 protein {ECO:0000313|EMBL:AAI44563.1};"	chr11q13///Ensembl 103 genes in cytogenetic band chr11q13	BIOCARTA_ARAP_PATHWAY///ADP-Ribosylation Factor	KEGG_ENDOCYTOSIS///Endocytosis	"REACTOME_CDC42_GTPASE_CYCLE///CDC42 GTPase cycle+++REACTOME_PTK6_REGULATES_RTKS_AND_THEIR_EFFECTORS_AKT1_AND_DOK1///PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1+++REACTOME_RAC1_GTPASE_CYCLE///RAC1 GTPase cycle+++REACTOME_RHOA_GTPASE_CYCLE///RHOA GTPase cycle+++REACTOME_RHO_GTPASE_CYCLE///RHO GTPase cycle+++REACTOME_SIGNALING_BY_PTK6///Signaling by PTK6+++REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3///Signaling by Rho GTPases, Miro GTPases and RHOBTB3"		"GGGGCCC_MIR296///Genes having at least one occurence of the motif GGGGCCC in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-296 (v7.1 miRBase)."	"LET_7F_2_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-let-7f-2-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1185_1_3P_MIR1185_2_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1185-1-3p, hsa-miR-1185-2-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6083///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6083 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR656_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-656-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets)."	AP2_Q6_01///Genes having at least one occurence of the transcription factor binding site V$AP2_Q6_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++CAGGTA_AREB6_01///Genes having at least one occurence of the highly conserved motif M76 CAGGTA sites. The motif matches transcription factor binding site V$AREB6_01 (v7.4 TRANSFAC).+++ETS2_B///Genes having at least one occurence of the transcription factor binding site V$ETS2_B (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++ETS_Q4///Genes having at least one occurence of the transcription factor binding site V$ETS_Q4 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++GATTGGY_NFY_Q6_01///Genes having at least one occurence of the highly conserved motif M5 GATTGGY sites. The motif matches transcription factor binding site V$NFY_Q6_01 (v7.4 TRANSFAC).+++IRF1_Q6///Genes having at least one occurence of the transcription factor binding site V$IRF1_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++MGGAAGTG_GABP_B///Genes having at least one occurence of the highly conserved motif M11 MGGAAGTG sites. The motif matches transcription factor binding site V$GABP_B (v7.4 TRANSFAC).+++NERF_Q2///Genes having at least one occurence of the transcription factor binding site V$NERF_Q2 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++P300_01///Genes having at least one occurence of the transcription factor binding site V$P300_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++PEA3_Q6///Genes having at least one occurence of the transcription factor binding site V$PEA3_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++RGAGGAARY_PU1_Q6///Genes having at least one occurence of the highly conserved motif M50 RGAGGAARY sites. The motif matches transcription factor binding site V$PU1_Q6 (v7.4 TRANSFAC).+++RYTTCCTG_ETS2_B///Genes having at least one occurence of the highly conserved motif M16 RYTTCCTG sites. The motif matches transcription factor binding site V$ETS2_B (v7.4 TRANSFAC).+++SP1_01///Genes having at least one occurence of the transcription factor binding site V$SP1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++TEL2_Q6///Genes having at least one occurence of the transcription factor binding site V$TEL2_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++TGTYNNNNNRGCARM_UNKNOWN///Genes having at least one occurence of the highly conserved motif M117 TGTYNNNNNRGCARM in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++WTTGKCTG_UNKNOWN///Genes having at least one occurence of the highly conserved motif M46 WTTGKCTG in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).	"BACH2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9BYV9 (BACH2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++BARHL1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9BZE3 (BARHL1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++BARX1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9HBU1 (BARX1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++BDP1_TARGET_GENES///Genes containing one or more binding sites for UniProt:A6H8Y1 (BDP1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++BRCA2_TARGET_GENES///Genes containing one or more binding sites for UniProt:P51587 (BRCA2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++CBFA2T2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O43439 (CBFA2T2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++CIITA_TARGET_GENES///Genes containing one or more binding sites for UniProt:P33076 (CIITA) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++CUX1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P39880 (CUX1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++DACH1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9UI36 (DACH1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++DIDO1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9BTC0 (DIDO1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++FOXD2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O60548 (FOXD2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HOXA1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P49639 (HOXA1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++INSM2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96T92 (INSM2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NCOA4_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q13772 (NCOA4) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NFE2L1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q14494 (NFE2L1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NFKBIA_TARGET_GENES///Genes containing one or more binding sites for UniProt:P25963 (NFKBIA) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NFRKB_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6P4R8 (NFRKB) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NKX2_5_TARGET_GENES///Genes containing one or more binding sites for UniProt:P52952 (NKX2_5) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++OVOL3_TARGET_GENES///Genes containing one or more binding sites for UniProt:O00110 (OVOL3) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++PGM3_TARGET_GENES///Genes containing one or more binding sites for UniProt:O95394 (PGM3) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++PITX1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P78337 (PITX1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++TAZ_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q16635 (TAZ) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++TBX1_TARGET_GENES///Genes containing one or more binding sites for UniProt:O43435 (TBX1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++TFEB_TARGET_GENES///Genes containing one or more binding sites for UniProt:P19484 (TFEB) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++TP73_TARGET_GENES///Genes containing one or more binding sites for UniProt:O15350 (TP73) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++UBP1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9NZI7 (UBP1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZBTB24_TARGET_GENES///Genes containing one or more binding sites for UniProt:O43167 (ZBTB24) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF175_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9Y473 (ZNF175) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF197_TARGET_GENES///Genes containing one or more binding sites for UniProt:O14709 (ZNF197) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF260_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q3ZCT1 (ZNF260) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9BSG1 (ZNF2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF410_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q86VK4 (ZNF410) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF577_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9BSK1 (ZNF577) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF579_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8NAF0 (ZNF579) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF740_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8NDX6 (ZNF740) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZSCAN31_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96LW9 (ZSCAN31) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZSCAN4_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8NAM6 (ZSCAN4) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."		MODULE_45///Whole blood genes.		"ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_1DY_DN///Genes down-regulated in blood 1d vs 0hr in adults (18-45) after exposure to CN54gp140 adjuvanted with GLA-AF , time point 1D , administered i.m.+++GSE11864_UNTREATED_VS_CSF1_IN_MAC_DN///Genes down-regulated in comparison of untreated macrophages versus those cultured with M-CSF [GeneID=1435].+++GSE12845_NAIVE_VS_PRE_GC_TONSIL_BCELL_UP///Genes up-regulated in comparison of naive B cell versus pre-germinal tonsil B cells.+++GSE17186_BLOOD_VS_CORD_BLOOD_CD21LOW_TRANSITIONAL_BCELL_DN///Genes down-regulated in transitional CR2 [GeneID=1380] low B lymphocytes versus those from cord blood.+++GSE17186_NAIVE_VS_CD21LOW_TRANSITIONAL_BCELL_CORD_BLOOD_UP///Genes up-regulated in B lymphocytes from cord blood: nave versus transitional CR2 [GeneID=1380].+++GSE17301_CTRL_VS_48H_IFNA2_STIM_CD8_TCELL_DN///Genes down-regulated in CD8 T cells: control versus stimulated by IFNA2 [GeneID=3440].+++GSE17301_IFNA2_VS_IFNA2_AND_ACD3_ACD28_STIM_CD8_TCELL_UP///Genes up-regulated in CD8 T cells stimulated by IFNA2 [GeneID=3440] versus those activated by anti-CD3 and anti-CD28.+++GSE18893_CTRL_VS_TNF_TREATED_TREG_2H_DN///Genes down-regulated in T reg cells (2h): medium versus TNF [GeneID=7124].+++GSE1925_CTRL_VS_3H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_UP///Genes up-regulated in macrophages primed by IFNG [GeneID=3458]: untreated versus stimulated by IFNG [GeneID=3458] for 3h.+++GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_A3R_INH_AND_TCELL_MEMBRANES_ACT_MAST_CELL_UP///Genes up-regulated in HMC-1 (mast leukemia) cells incubated with the peptide ALL1 followed by treatment with: Cl-IB-MECA [PubChem=3035850] versus T cell membranes.+++GSE19888_CTRL_VS_A3R_INHIBITOR_TREATED_MAST_CELL_DN///Genes down-regulated in HMC-1 (mast leukemia) cells: untreated versus incubated with the peptide ALL1.+++GSE20151_CTRL_VS_FUSOBACT_NUCLEATUM_NEUTROPHIL_UP///Genes up-regulated in comparison of contols neutrophils versus those infected with a bacterium (F. nucleatum).+++GSE22025_UNTREATED_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP///Genes up-regulated in CD4 [GeneID=920] T cells: untreated versus TGFB1 [GeneID=7040] and progesterone [PubChem=5994].+++GSE22886_NAIVE_BCELL_VS_DC_DN///Genes down-regulated in comparison of naive B cells versus unstimulated dendritic cells (DC).+++GSE22886_NAIVE_CD8_TCELL_VS_MONOCYTE_DN///Genes down-regulated in comparison of naive CD8 T cells versus day 0 monocytes.+++GSE22886_NAIVE_TCELL_VS_MONOCYTE_DN///Genes down-regulated in comparison of naive CD4 [GeneID=920] CD8 T cells versus monocytes cultured for 0 days.+++GSE24634_TREG_VS_TCONV_POST_DAY5_IL4_CONVERSION_DN///Genes down-regulated in comparison of CD25+ T cells treated with IL4 [GeneID=3565] versus CD25- T cells treated with IL4 [GeneID=3565] at day 5.+++GSE24634_TREG_VS_TCONV_POST_DAY7_IL4_CONVERSION_DN///Genes down-regulated in comparison of CD25+ regulatory T cell (Treg) treated with IL4 [GeneID=3565] at day 7 versus CD25- T cells treated with IL4 [GeneID=3565] at day 7.+++GSE26928_CENTR_MEMORY_VS_CXCR5_POS_CD4_TCELL_DN///Genes down-regulated in comparison of CD4 [GeneID=920] central memory T cells versus CD4 [GeneID=920] CXCR5+ [GeneID=643] T cells.+++GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_6H_UP///Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: IL-12 (6h) versus untreated (6h).+++GSE32901_TH17_EMRICHED_VS_TH17_NEG_CD4_TCELL_DN///Genes down-regulated in CD4 [GeneID=920] Th17 T cells: enriched versus negative.+++GSE34205_HEALTHY_VS_RSV_INF_INFANT_PBMC_UP///Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMCs from infanct with acute RSV infection.+++GSE360_DC_VS_MAC_B_MALAYI_HIGH_DOSE_DN///Genes down-regulated in comparison of dendritic cells (DC) exposed to 50 worm/well B. malayi versus macrophages exposed to 50 worms/well B. malayi.+++GSE3982_EFF_MEMORY_CD4_TCELL_VS_NKCELL_DN///Genes down-regulated in comparison of effective memory CD4 [GeneID=920] T cells versus NK cells.+++GSE3982_MAC_VS_TH1_UP///Genes up-regulated in comparison of macrophages versus Th1 cells.+++GSE3982_MAST_CELL_VS_NEUTROPHIL_DN///Genes down-regulated in comparison of mast cells versus neutrophils.+++GSE3982_MAST_CELL_VS_NKCELL_DN///Genes down-regulated in comparison of mast cells versus NK cells.+++GSE3982_NEUTROPHIL_VS_TH1_UP///Genes up-regulated in comparison of neutrophils versus Th1 cells.+++GSE3982_NKCELL_VS_TH1_UP///Genes up-regulated in comparison of NK cells versus Th1 cells.+++GSE4984_GALECTIN1_VS_LPS_STIM_DC_UP///Genes up-regulated in monocyte-derived dendritic cells: LGALS1 [GeneID=3956] versus LPS.+++GSE7509_DC_VS_MONOCYTE_WITH_FCGRIIB_STIM_UP///Genes up-regulated in response to anti-FcgRIIB: dendritic cells versus monocytes.+++GSE8685_IL2_ACT_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_UP///Genes up-regulated in Sez-2 cells (T cell lymphoma): untreated versus IL15 [GeneID=3600].+++GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_24H_DN///Genes down-regulated in monocytes: untreated versus M. tuberculosis 19 kDa lipopeptide (24h).+++GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_3H_DN///Genes down-regulated in monocytes (3h): untreated versus M. tuberculosis 19 kDa lipopeptide.+++GSE9960_HEALTHY_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_UP///Genes up-regulated in peripheral blood monocytes (PMBC): healthy versus mixed infection sepsis.+++GSE9988_LPS_VS_CTRL_TREATED_MONOCYTE_DN///Genes down-regulated in comparison of monocytes treated with 5000 ng/ml LPS (TLR4 agonist) versus monocytes treated with control IgG.+++GSE9988_LPS_VS_VEHICLE_TREATED_MONOCYTE_DN///Genes down-regulated in comparison of monocytes treated with 1 ng/ml LPS (TLR4 agonist) versus untreated monocytes.+++HOFT_CD4_POSITIVE_ALPHA_BETA_MEMORY_T_CELL_BCG_VACCINE_AGE_18_45YO_56D_TOP_100_DEG_AFTER_IN_VITRO_RE_STIMULATION_DN///Genes down-regulated in CD4-positive, alpha-beta memory T cell 56d vs 0d in adults (18-45) after exposure to BCG vaccine , time point 56D , administered PO (oral). Comment: top 100 most differentially expressed genes comparing Day 0 and Day 56 responses after in vitro re-stimulation with BCG-infected autologous dendritic cells+++HOFT_CD4_POSITIVE_ALPHA_BETA_MEMORY_T_CELL_BCG_VACCINE_AGE_18_45YO_ID_56D_TOP_100_DEG_AFTER_IN_VITRO_RE_STIMULATION_DN///Genes down-regulated in CD4-positive, alpha-beta memory T cell 56d vs 0d in adults (18-45) after exposure to BCG vaccine , time point 56D , administered ID (intradermal). Comment: top 100 most differentially expressed genes comparing Day 0 and Day 56 responses after in vitro re-stimulation with BCG-infected autologous dendritic cells+++NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_POSITIVE///Genes positively correlated with HAI response at 28d in peripheral blood mononuclear cell in adults (18-50) after exposure to Fluarix/Fluvirin , time point 3D. Comment: Supplementary Table 5: All genes whose expression (d3/d0 or d7/d0) correlates to the fold increase in HAI titers (d28/d0)."		NM_001040118	ARAP1				
Q96IU4	sp|Q96IU4|ABHEB_HUMAN				"Protein ABHD14B OS=Homo sapiens OX=9606 GN=ABHD14B PE=1 SV=1 >tr|V9HW87|V9HW87_HUMAN Abhydrolase domain containing 14B, isoform CRA_a OS=Homo sapiens OX=9606 GN=HEL-S-299 PE=2 SV=1"								MAASVEQREGTIQVQGQALFFREALPGSGQARFSVLLLHGIRFSSETWQNLGTLHRLAQAGYRAVAIDLPGLGHSKEAAAPAPIGELAPGSFLAAVVDALELGPPVVISPSLSGMYSLPFLTAPGSQLPGFVPVAPICTDKINAANYASVKTPALIVYGDQDPMGQTSFEHLKQLPNHRVLIMKGAGHPCYLDKPEEWHTGLLDFLQGLQ	0.4537644	-1.139984588	4.56E-04		4.4906514	4.2346669	5.6753081	5.7395962	7.105441	4.922795624	5.8095483	6.7347306	6.534893	6.7216682	7.1598338	4.23428733	4.0379932	5.0055212	6.1928989	4.7053958	6.4452515		6.201928	6.1896322	7.3179997	7.2715683		5.88200238		6.0379082	8.78291	6.6564224	7.186901	7.470024	5.988536	6.6803236	6.6119093	7.0219513	6.9326774	6.8946779	6.9350789	7.774513	7.7354694	6.6146509	8.2475725	4.3950457	7.13959025																																	C9606_80824					
Q96HC4	sp|Q96HC4|PDLI5_HUMAN		PDLIM5		PDZ and LIM domain protein 5 OS=Homo sapiens OX=9606 GN=PDLIM5 PE=1 SV=5	10611	NM_006457	NP_006448	ENST00000317968				MSNYSVSLVGPAPWGFRLQGGKDFNMPLTISSLKDGGKAAQANVRIGDVVLSIDGINAQGMTHLEAQNKIKGCTGSLNMTLQRASAAPKPEPVPVQKGEPKEVVKPVPITSPAVSKVTSTNNMAYNKAPRPFGSVSSPKVTSIPSPSSAFTPAHATTSSHASPSPVAAVTPPLFAASGLHANANLSADQSPSALSAGKTAVNVPRQPTVTSVCSETSQELAEGQRRGSQGDSKQQNGPPRKHIVERYTEFYHVPTHSDASKKRLIEDTEDWRPRTGTTQSRSFRILAQITGTEHLKESEADNTKKANNSQEPSPQLASSVASTRSMPESLDSPTSGRPGVTSLTAAAAFKPVGSTGVIKSPSWQRPNQGVPSTGRISNSATYSGSVAPANSALGQTQPSDQDTLVQRAEHIPAGKRTPMCAHCNQVIRGPFLVALGKSWHPEEFNCAHCKNTMAYIGFVEEKGALYCELCYEKFFAPECGRCQRKILGEVISALKQTWHVSCFVCVACGKPIRNNVFHLEDGEPYCETDYYALFGTICHGCEFPIEAGDMFLEALGYTWHDTCFVCSVCCESLEGQTFFSKKDKPLCKKHAHSVNF	0.47148	-1.08473149	0.006516291		6.3025848	4.5319891	5.2266691	6.0085232	7.2347654	5.831100447	7.2174973	7.4858234	7.7070793	6.9157958	7.8865224	3.7645437	6.0744926	5.862805	6.5214264		5.4935244			6.1050048	7.1793964	8.1542652	5.1611053	4.90757854	4.93944936	5.037841	9.854464	8.7366688	8.769859	8.4908512	7.314587	7.4016362	7.8681137	7.7617911	7.0243095	7.8100634	7.2400939	8.78517	7.9947964	6.58029017	8.3002362	6.3278756	7.94137792		H00292///Hypertrophic cardiomyopathy+++H00294///Dilated cardiomyopathy+++H00595///Myofibrillar myopathies+++H01216///Left ventricular noncompaction			GO:0001725///stress fiber+++GO:0005737///cytoplasm+++GO:0005829///cytosol+++GO:0005912///adherens junction+++GO:0014069///postsynaptic density+++GO:0015629///actin cytoskeleton+++GO:0016020///membrane+++GO:0030018///Z disc+++GO:0030054///cell junction+++GO:0031941///filamentous actin+++GO:0042995///cell projection+++GO:0045202///synapse+++GO:0098793///presynapse+++GO:0098794///postsynapse	GO:0003779///actin binding+++GO:0005080///protein kinase C binding+++GO:0005515///protein binding+++GO:0042805///actinin binding+++GO:0046872///metal ion binding+++GO:0047485///protein N-terminus binding+++GO:0051371///muscle alpha-actinin binding+++GO:0098641///cadherin binding involved in cell-cell adhesion	GO:0007507///heart development+++GO:0030036///actin cytoskeleton organization+++GO:0051963///regulation of synapse assembly+++GO:0061001///regulation of dendritic spine morphogenesis+++GO:0061049///cell growth involved in cardiac muscle cell development+++GO:0061061///muscle structure development+++GO:0098609///cell-cell adhesion	tissueType=Embryonic prefrontal cortex;cancerType=Normal;cellName=Astrocyte+++tissueType=Blood;cancerType=Normal;cellName=CD1C-CD141- dendritic cell+++tissueType=Fetal gonad;cancerType=Normal;cellName=Mitotic fetal germ cell+++tissueType=Brain;cancerType=Normal;cellName=Lake et al.Science.Ex8		"Homo sapiens PDZ and LIM domain 5 (PDLIM5), transcript variant 1, mRNA."			R-HSA-112316///Neuronal System+++R-HSA-6794361///Neurexins and neuroligins+++R-HSA-6794362///Protein-protein interactions at synapses					[PDLI5_HUMAN|Reviewed]RecName: Full=PDZ and LIM domain protein 5; AltName: Full=Enigma homolog; AltName: Full=Enigma-like PDZ and LIM domains protein;+++[Q4W5K9_HUMAN|Unreviewed]SubName: Full=Uncharacterized protein LIM {ECO:0000313|EMBL:AAY40898.1}; Flags: Fragment;	chr4q22///Ensembl 103 genes in cytogenetic band chr4q22			REACTOME_NEUREXINS_AND_NEUROLIGINS///Neurexins and neuroligins+++REACTOME_NEURONAL_SYSTEM///Neuronal System+++REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES///Protein-protein interactions at synapses		"ACATTCC_MIR1_MIR206///Genes having at least one occurence of the motif ACATTCC in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-1 and hsa-miR-206 (v7.1 miRBase).+++ACTGTGA_MIR27A_MIR27B///Genes having at least one occurence of the motif ACTGTGA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-27a and hsa-miR-27b (v7.1 miRBase).+++CTCCAAG_MIR432///Genes having at least one occurence of the motif CTCCAAG in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-432 (v7.1 miRBase).+++GCAAAAA_MIR129///Genes having at least one occurence of the motif GCAAAAA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-129 (v7.1 miRBase).+++TGAATGT_MIR181A_MIR181B_MIR181C_MIR181D///Genes having at least one occurence of the motif TGAATGT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-181a, hsa-miR-181b, hsa-miR-181c and hsa-miR-181d (v7.1 miRBase).+++TGCTGCT_MIR15A_MIR16_MIR15B_MIR195_MIR424_MIR497///Genes having at least one occurence of the motif TGCTGCT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-15a, hsa-miR-16, hsa-miR-15b, hsa-miR-195, hsa-miR-424 and hsa-miR-497 (v7.1 miRBase).+++TGCTTTG_MIR330///Genes having at least one occurence of the motif TGCTTTG in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-330 (v7.1 miRBase)."	"LET_7A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-let-7a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++LET_7B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-let-7b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++LET_7F_1_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-let-7f-1-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR10522_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-10522-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR106A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-106a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR106B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-106b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR12124///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-12124 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR12132///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-12132 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR12136///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-12136 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR124_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-124-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1252_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1252-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR126_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-126-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1321///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1321 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR155_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-155-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR16_2_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-16-2-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR17_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-17-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR195_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-195-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR205_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-205-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR20A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-20a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR20B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-20b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR214_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-214-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR300///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-300 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3127_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3127-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3185///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3185 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR323B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-323b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3609///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3609 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3619_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3619-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3646///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3646 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3671///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3671 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3714///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3714 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR374C_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-374c-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR376A_2_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-376a-2-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR381_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-381-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3910///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3910 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3920///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3920 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4271///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4271 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4311///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4311 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4531///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4531 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4637///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4637 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4643///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4643 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4652_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4652-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4666A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4666a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR466///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-466 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4698///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4698 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4699_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4699-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4725_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4725-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4729///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4729 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4735_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4735-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4739///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4739 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4753_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4753-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4756_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4756-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4786_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4786-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4787_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4787-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4789_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4789-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4795_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4795-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4799_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4799-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR495_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-495-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5003_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5003-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR506_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-506-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5089_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5089-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR519D_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-519d-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR526B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-526b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AG///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548ag in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AH_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548ah-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AI_MIR570_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548ai, hsa-miR-570-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548BA///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548ba in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548L///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548l in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548N///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548n in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5688///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5688 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5692B_MIR5692C///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5692b, hsa-miR-5692c in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR607///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-607 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR627_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-627-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR630///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-630 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR633///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-633 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6502_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6502-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6505_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6505-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6516_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6516-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6780B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6780b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6809_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6809-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6830_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6830-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6867_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6867-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6879_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6879-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7_1_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7-1-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7_2_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7-2-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR761///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-761 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7849_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7849-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR922///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-922 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR93_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-93-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR944///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-944 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR98_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-98-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets)."	CCAWWNAAGG_SRF_Q4///Genes having at least one occurence of the highly conserved motif M121 CCAWWNAAGG sites. The motif matches transcription factor binding site V$SRF_Q4 (v7.4 TRANSFAC).+++ELK1_01///Genes having at least one occurence of the transcription factor binding site V$ELK1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++GGGYGTGNY_UNKNOWN///Genes having at least one occurence of the highly conserved motif M31 GGGYGTGNY in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++HSF2_01///Genes having at least one occurence of the transcription factor binding site V$HSF2_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++IK2_01///Genes having at least one occurence of the transcription factor binding site V$IK2_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++IPF1_Q4///Genes having at least one occurence of the transcription factor binding site V$IPF1_Q4 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++MEF2_03///Genes having at least one occurence of the transcription factor binding site V$MEF2_03 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++POU1F1_Q6///Genes having at least one occurence of the transcription factor binding site V$POU1F1_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++RGTTAMWNATT_HNF1_01///Genes having at least one occurence of the highly conserved motif M84 RGTTAMWNATT sites. The motif matches transcription factor binding site V$HNF1_01 (v7.4 TRANSFAC).+++SCGGAAGY_ELK1_02///Genes having at least one occurence of the highly conserved motif M3 SCGGAAGY sites. The motif matches transcription factor binding site V$ELK1_02 (v7.4 TRANSFAC).+++SRF_C///Genes having at least one occurence of the transcription factor binding site V$SRF_C (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++SRF_Q4///Genes having at least one occurence of the transcription factor binding site V$SRF_Q4 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++SRF_Q5_01///Genes having at least one occurence of the transcription factor binding site V$SRF_Q5_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++SRF_Q6///Genes having at least one occurence of the transcription factor binding site V$SRF_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++TGGAAA_NFAT_Q4_01///Genes having at least one occurence of the highly conserved motif M55 TGGAAA sites. The motif matches transcription factor binding site V$NFAT_Q4_01 (v7.4 TRANSFAC).+++TTANTCA_UNKNOWN///Genes having at least one occurence of the highly conserved motif M64 TTANTCA in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++YTATTTTNR_MEF2_02///Genes having at least one occurence of the highly conserved motif M33 YTATTTTNR sites. The motif matches transcription factor binding site V$MEF2_02 (v7.4 TRANSFAC).	"DNMT3A_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9Y6K1 (DNMT3A) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++FOXP2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O15409 (FOXP2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HES2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9Y543 (HES2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HMGA1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P17096 (HMGA1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HOXA2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O43364 (HOXA2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HOXB6_TARGET_GENES///Genes containing one or more binding sites for UniProt:P17509 (HOXB6) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++JDP2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8WYK2 (JDP2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++MAFG_TARGET_GENES///Genes containing one or more binding sites for UniProt:O15525 (MAFG) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++MORC2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9Y6X9 (MORC2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++PAX3_TARGET_GENES///Genes containing one or more binding sites for UniProt:P23760 (PAX3) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SATB1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q01826 (SATB1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++UBN1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9NPG3 (UBN1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF449_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6P9G9 (ZNF449) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF92_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q03936 (ZNF92) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZSCAN31_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96LW9 (ZSCAN31) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."		MODULE_12///Spinal cord (neuro-development) genes.+++MODULE_1///Ovary genes.+++MODULE_3///Genes in the cancer module 3.+++MODULE_60///Heart genes.	"BMI1_DN_MEL18_DN.V1_DN///Genes down-regulated in DAOY cells (medulloblastoma) upon knockdown of BMI1 and PCGF2 [Gene ID=648, 7703] genes by RNAi.+++CSR_LATE_UP.V1_UP///Genes up-regulated in late serum response of CRL 2091 cells (foreskin fibroblasts).+++MEL18_DN.V1_DN///Genes down-regulated in DAOY cells (medulloblastoma) upon knockdown of PCGF2 [Gene ID=7703] gene by RNAi."	"GSE12198_NK_VS_NK_ACT_EXPANSION_SYSTEM_DERIVED_NK_CELL_DN///Genes down-regulated in NK cells: primary versus activated and expanded.+++GSE13738_TCR_VS_BYSTANDER_ACTIVATED_CD4_TCELL_DN///Genes down-regulated in comparison of directly activated CD4 [GeneID=920] T cells versus bystander activated CD4 [GeneID=920] T cells.+++GSE1460_CD4_THYMOCYTE_VS_THYMIC_STROMAL_CELL_DN///Genes down-regulated in comparison of CD4 [GeneID=920] thymocytes versus thymic stromal cells.+++GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_12H_IFNA_STIM_DN///Genes down-regulated in neuron cell line treated with interferon alpha for 12h: immature versus mature.+++GSE17186_BLOOD_VS_CORD_BLOOD_NAIVE_BCELL_UP///Genes up-regulated in nave B lymphocytes versus those from cord blood.+++GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA2_STIM_CD8_TCELL_DN///Genes down-regulated in CD8 T cells activated by anti-CD3 and anti-CD28 versus those stimulated by IFNA2 [GeneID=3440].+++GSE17301_CTRL_VS_48H_ACD3_ACD28_STIM_CD8_TCELL_DN///Genes down-regulated in CD8 T lymphocytes: control versus activated by anti-CD3 and anti-CD28.+++GSE20198_UNTREATED_VS_IFNA_TREATED_ACT_CD4_TCELL_DN///Genes down-regulated in the activated CD4 [GeneID=920] T cells (48h): control versus interferon alpha.+++GSE20198_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_UP///Genes up-regulated in the activated CD4 [GeneID=920] T cells (48h): control versus IL-12.+++GSE22886_NAIVE_CD4_TCELL_VS_MONOCYTE_DN///Genes down-regulated in comparison of naive CD4 [GeneID=920] T cells versus day 0 monocytes.+++GSE22886_NAIVE_TCELL_VS_MONOCYTE_DN///Genes down-regulated in comparison of naive CD4 [GeneID=920] CD8 T cells versus monocytes cultured for 0 days.+++GSE24634_TEFF_VS_TCONV_DAY10_IN_CULTURE_DN///Genes down-regulated in comparison of untreated CD25+ T effector cells at day 10 versus untreated CD25- T cells at day 10.+++GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_4H_UP///Genes up-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 and then stimulated by TGFB1 and IL4 [GeneID=7040;3565] (6h).+++GSE29618_PRE_VS_DAY7_FLU_VACCINE_MONOCYTE_DN///Genes down-regulated in comparison of monocytes from influenza vaccinee pre-vaccination versus those at day 7 post-vaccination.+++GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MONOCYTE_DN///Genes down-regulated in comparison of monocytes from LAIV influenza vaccinee pre-vaccination versus those at day 7 post-vaccination+++GSE32901_TH17_EMRICHED_VS_TH17_NEG_CD4_TCELL_DN///Genes down-regulated in CD4 [GeneID=920] Th17 T cells: enriched versus negative.+++GSE360_CTRL_VS_L_DONOVANI_MAC_DN///Genes down-regulated in comparison of macrophages versus macrophages exposed to L.donovani.+++GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_MAC_UP///Genes up-regulated in comparison of macrophages exposed to L. donovani versus macrophages exposed to 5 worms/well B. malayi.+++GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_16H_TSST_ACT_UP///Genes up-regulated in comparison of memory CD4 [GeneID=920] T cells from young donors treated with TSST at 16 h versus those from old donors treated with TSST at 16 h.+++GSE3982_BASOPHIL_VS_NKCELL_UP///Genes up-regulated in comparison of basophils versus NK cells.+++GSE3982_EOSINOPHIL_VS_TH2_DN///Genes down-regulated in comparison of eosinophils versus Th2 cells.+++GSE42724_MEMORY_BCELL_VS_PLASMABLAST_DN///Genes down-regulated in B lymphocytes: memory versus plasmablasts.+++GSE4590_SMALL_VS_VPREB_POS_LARGE_PRE_BCELL_DN///Genes down-regulated during B lymphocyte differentiation: small pre-B II versus VPREB1+ [GeneID=7441] large pre-B II.+++GSE5542_IFNG_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_DN///Genes down-regulated in epithelial cells (24h): IFNG [GeneID=3458] versus IFNG [GeneID=3458] and interferon alpha.+++GSE7460_FOXP3_MUT_VS_WT_ACT_TCONV_DN///Genes down-regulated in comparsion of sfActCD4 versus ActCD4 (see Fig. 1 in the paper for details).+++GSE7568_IL4_VS_IL4_AND_TGFB_TREATED_MACROPHAGE_24H_UP///Genes up-regulated in macrophages differentiated in the presence of IL4 [GeneID=3565] for 5 days versus those subsequently treated with TGFB1 [GeneID=7040] for 24h.+++GSE8685_IL15_ACT_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_DN///Genes down-regulated in Sez-2 cells (T cell lymphoma): IL15 [GeneID=3600] versus IL21 [GeneID=3600].+++GSE8835_CD4_VS_CD8_TCELL_UP///Genes up-regulated in T cells: CD4 [GeneID=920] versus CD8.+++GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_6H_DN///Genes down-regulated in monocytes: untreated versus M. tuberculosis 19 kDa lipopeptide (6h).+++GSE9946_MATURE_STIMULATORY_VS_LISTERIA_INF_MATURE_DC_UP///Genes up-regulated in mature dendritic cells: stimulatory versus inhibitory infected with L. monocytogenes.+++NAKAYA_MYELOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN///Genes down-regulated in myeloid dendritic cell 7d vs 0d in young adults (18-50) after exposure to Fluarix/Fluvirin , time point 7D+++NAKAYA_MYELOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP///Genes up-regulated in myeloid dendritic cell 7d vs 0d in young adults (18-50) after exposure to Fluarix/Fluvirin , time point 7D+++NAKAYA_MYELOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN///Genes down-regulated in myeloid dendritic cell 7d vs 0d in young adults (18-50) after exposure to FluMist , time point 7D+++NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_UP///Genes up-regulated in peripheral blood mononuclear cell 3d vs 0d in adults (18-50) after exposure to Fluarix/Fluvirin , time point 3D. Comment: Supplementary Table 1a: All the differentially expressed genes identified in PBMCs of TIV vaccinees.+++NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_UP///Genes up-regulated in peripheral blood mononuclear cell 3d vs 0d in adults (18-50) after exposure to FluMist , time point 3D. Comment: Supplementary Table 1b: All the differentially expressed genes identified in PBMCs of TIV vaccinees.+++NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN///Genes down-regulated in plasmacytoid dendritic cell 7d vs 0d in young adults (18-50) after exposure to FluMist , time point 7D+++OSMAN_BLOOD_CHAD63_KH_AGE_18_50YO_HIGH_DOSE_SUBJECTS_24HR_UP///Genes up-regulated in blood 24hr vs 0hr in adults (18-50) (high dose subjects) after exposure to ChAd63-KH , time point 24H , administered Intramuscular injection. Comment: DE gene list for high dose subjects.+++ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_UP///Genes up-regulated in peripheral blood mononuclear cell 1d vs 0d in adults (20-50) after exposure to MRKAd5 HIV-1 gag/pol/nef , time point 1D. Comment: Table includes specific cell types"	HALLMARK_ANDROGEN_RESPONSE///Genes defining response to androgens.+++HALLMARK_MITOTIC_SPINDLE///Genes important for mitotic spindle assembly.+++HALLMARK_TNFA_SIGNALING_VIA_NFKB///Genes regulated by NF-kB in response to TNF [GeneID=7124].+++HALLMARK_UV_RESPONSE_DN///Genes down-regulated in response to ultraviolet (UV) radiation.+++HALLMARK_XENOBIOTIC_METABOLISM///Genes encoding proteins involved in processing of drugs and other xenobiotics.	NM_006457	PDLIM5				
Q96C24	sp|Q96C24|SYTL4_HUMAN		SYTL4		"Synaptotagmin-like protein 4 OS=Homo sapiens OX=9606 GN=SYTL4 PE=1 SV=2 >tr|A0A024RCF8|A0A024RCF8_HUMAN Synaptotagmin-like 4 (Granuphilin-a), isoform CRA_a OS=Homo sapiens OX=9606 GN=SYTL4 PE=4 SV=1"	94121	NM_001370168	NP_001357097					MSELLDLSFLSEEEKDLILSVLQRDEEVRKADEKRIRRLKNELLEIKRKGAKRGSQHYSDRTCARCQESLGRLSPKTNTCRGCNHLVCRDCRIQESNGTWRCKVCAKEIELKKATGDWFYDQKVNRFAYRTGSEIIRMSLRHKPAVSKRETVGQSLLHQTQMGDIWPGRKIIQERQKEPSVLFEVPKLKSGKSALEAESESLDSFTADSDSTSRRDSLDKSGLFPEWKKMSAPKSQVEKETQPGGQNVVFVDEGEMIFKKNTRKILRPSEYTKSVIDLRPEDVVHESGSLGDRSKSVPGLNVDMEEEEEEEDIDHLVKLHRQKLARSSMQSGSSMSTIGSMMSIYSEAGDFGNIFVTGRIAFSLKYEQQTQSLVVHVKECHQLAYADEAKKRSNPYVKTYLLPDKSRQGKRKTSIKRDTINPLYDETLRYEIPESLLAQRTLQFSVWHHGRFGRNTFLGEAEIQMDSWKLDKKLDHCLPLHGKISAESPTGLPSHKGELVVSLKYIPASKTPVGGDRKKSKGGEGGELQVWIKEAKNLTAAKAGGTSDSFVKGYLLPMRNKASKRKTPVMKKTLNPHYNHTFVYNGVRLEDLQHMCLELTVWDREPLASNDFLGGVRLGVGTGISNGEVVDWMDSTGEEVSLWQKMRQYPGSWAEGTLQLRSSMAKQKLGL	0.3930017	-1.347392606	0.001150172		6.1173427	5.3044774			6.3326313		6.0476306	6.0933224	6.9312652	7.2256859	6.6543517		5.0797858		7.4915044		5.899625			6.1569272	7.1730449	8.7097652	4.9003182		5.10051224		7.974268	8.5579623	8.352641	8.5738088	6.087549	5.902627	6.4788621	8.23132	7.9133965	8.5232804	7.6138751	8.723984	7.7164832	7.42210653	9.9281292	8.0201146	9.15160885					GO:0005768///endosome+++GO:0005886///plasma membrane+++GO:0016020///membrane+++GO:0019898///extrinsic component of membrane+++GO:0030141///secretory granule+++GO:0030658///transport vesicle membrane+++GO:0031092///platelet alpha granule membrane+++GO:0031410///cytoplasmic vesicle+++GO:0070382///exocytic vesicle	GO:0005515///protein binding+++GO:0005543///phospholipid binding+++GO:0031267///small GTPase binding+++GO:0042043///neurexin family protein binding+++GO:0046872///metal ion binding	GO:0001778///plasma membrane repair+++GO:0006886///intracellular protein transport+++GO:0006887///exocytosis+++GO:0032418///lysosome localization+++GO:0045921///positive regulation of exocytosis+++GO:0046676///negative regulation of insulin secretion+++GO:0050714///positive regulation of protein secretion+++GO:0071985///multivesicular body sorting pathway+++GO:1905684///regulation of plasma membrane repair	tissueType=Fetal gonad;cancerType=Normal;cellName=Mitotic fetal germ cell		"Homo sapiens synaptotagmin like 4 (SYTL4), transcript variant 12, mRNA."			"R-HSA-109582///Hemostasis+++R-HSA-114608///Platelet degranulation +++R-HSA-76002///Platelet activation, signaling and aggregation+++R-HSA-76005///Response to elevated platelet cytosolic Ca2+"						chrXq22///Ensembl 103 genes in cytogenetic band chrXq22			"REACTOME_HEMOSTASIS///Hemostasis+++REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION///Platelet activation, signaling and aggregation+++REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2///Response to elevated platelet cytosolic Ca2+"		"AATGGAG_MIR136///Genes having at least one occurence of the motif AATGGAG in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-136 (v7.1 miRBase)."	"MIR106A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-106a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR106B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-106b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1298_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1298-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR136_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-136-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR147B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-147b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR17_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-17-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1911_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1911-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR20A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-20a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR20B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-20b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR217_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-217-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR302A_3P_MIR302B_3P_MIR302C_3P_MIR302D_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-302a-3p, hsa-miR-302b-3p, hsa-miR-302c-3p, hsa-miR-302d-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR302E///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-302e in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR340_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-340-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3617_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3617-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR372_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-372-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR373_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-373-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3941///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3941 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4261///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4261 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4297///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4297 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4496///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4496 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR451B///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-451b in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4522///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4522 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4789_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4789-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR519D_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-519d-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR520A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-520a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR520B_3P_MIR520C_3P_MIR520E_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-520b-3p, hsa-miR-520c-3p, hsa-miR-520e-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR520D_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-520d-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR520F_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-520f-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR526B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-526b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AH_3P_MIR548AM_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548ah-3p, hsa-miR-548am-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548E_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548e-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR603///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-603 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR641///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-641 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6858_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6858-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR708_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-708-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7844_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7844-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR8485///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-8485 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR885_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-885-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR93_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-93-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets)."	CAGNYGKNAAA_UNKNOWN///Genes having at least one occurence of the highly conserved motif M160 CAGNYGKNAAA in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++IPF1_Q4///Genes having at least one occurence of the transcription factor binding site V$IPF1_Q4 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++TGGAAA_NFAT_Q4_01///Genes having at least one occurence of the highly conserved motif M55 TGGAAA sites. The motif matches transcription factor binding site V$NFAT_Q4_01 (v7.4 TRANSFAC).+++YCATTAA_UNKNOWN///Genes having at least one occurence of the highly conserved motif M58 YCATTAA in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).	"H1_6_TARGET_GENES///Genes containing one or more binding sites for UniProt:P22492 (H1_6) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++RYBP_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8N488 (RYBP) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZFP91_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96JP5 (ZFP91) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF618_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q5T7W0 (ZNF618) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."				GSE16385_MONOCYTE_VS_MACROPHAGE_DN///Genes down-regulated in monocytes versus macrophages.+++GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_2H_CD4_TCELL_UP///Genes up-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the cells treated with IL4 [GeneID=3565] and anti-IL12 at 2 h.+++GSE21774_CD56_BRIGHT_VS_DIM_CD62L_POSITIVE_NK_CELL_UP///Genes up-regulated in NCAM+ [GeneID=4684] NK cells: SELL bright [GeneID=6402] versus SELL dim [GeneID=6402].+++GSE27291_0H_VS_6H_STIM_GAMMADELTA_TCELL_UP///Genes up-regulated in gamma delta T cells activated by phophoantigen BrHPP and IL2 [GeneID=3558]: 0h versus 6h.+++GSE27670_CTRL_VS_BLIMP1_TRANSDUCED_GC_BCELL_UP///Genes up-regulated in germinal center B lymphocytes: control versus over-expressing PRDM1 [GeneID=639].+++GSE33424_CD161_INT_VS_NEG_CD8_TCELL_DN///Genes down-regulated in CD8 T cells: KLRB1 int [GeneID=3820] versus KLRB1- [GeneID=3820].+++GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_UP///Genes up-regulated in gamma delta T cells: Vd1 versus Vd2.+++GSE4748_CYANOBACTERIUM_LPSLIKE_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_DN///Genes down-regulated in monocyte-derived dendritic cells: LPS like antigen from O. planktothrix (3h) versus LPS and LPS like antigen from O. planktothrix (3h).+++GSE7568_CTRL_VS_3H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_UP///Genes up-regulated in macrophages differentiated in the presence of IL4 [GeneID=3565] and dexamethasone [PubChem=5743] for 5 days versus those subsequently treated with TGFB1 [GeneID=7040] for 3h.+++GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_3H_UP///Genes up-regulated in monocytes (3h): untreated versus M. tuberculosis 19 kDa lipopeptide.		NM_001370168	SYTL4				
Q96A00	sp|Q96A00|PP14A_HUMAN		PPP1R14A		Protein phosphatase 1 regulatory subunit 14A OS=Homo sapiens OX=9606 GN=PPP1R14A PE=1 SV=1	94274	NM_033256	NP_150281	ENST00000301242	K12328			MAAQRLGKRVLSKLQSPSRARGPGGSPGGLQKRHARVTVKYDRRELQRRLDVEKWIDGRLEELYRGMEADMPDEINIDELLELESEEERSRKIQGLLKSCGKPVEDFIQELLAKLQGLHRQPGLRQPSPSHDGSLSPLQDRARTAHP	0.4864643	-1.039594118	0.02675017					0.2681297	2.6740617		2.4887027	4.378857	3.4545007		3.1125925										2.8456291	2.4341074					5.455743	5.0395474	4.532276	4.8845774	2.766151	3.0708686	3.5062913	3.2310737	2.2991709	3.931944	3.4593041	3.831983	4.0895333		4.2523549			04270///Vascular smooth muscle contraction				GO:0005737///cytoplasm+++GO:0005829///cytosol	GO:0004864///protein phosphatase inhibitor activity+++GO:0004865///protein serine/threonine phosphatase inhibitor activity	GO:0042325///regulation of phosphorylation+++GO:0043086///negative regulation of catalytic activity	tissueType=Brain;cancerType=Normal;cellName=Oligodendrocyte+++tissueType=Blood;cancerType=Normal;cellName=AXL+SIGLEC6+ dendritic cell+++tissueType=Stomach;cancerType=Normal;cellName=Pit progenitor cell		"Homo sapiens protein phosphatase 1 regulatory inhibitor subunit 14A (PPP1R14A), transcript variant 1, mRNA."		PF05361///PKC-activated protein phosphatase-1 inhibitor	"R-HSA-162582///Signal Transduction+++R-HSA-194315///Signaling by Rho GTPases+++R-HSA-195258///RHO GTPase Effectors+++R-HSA-5625740///RHO GTPases activate PKNs+++R-HSA-9716542///Signaling by Rho GTPases, Miro GTPases and RHOBTB3"		ENOG502S2I4///No_INFO		IPR008025///CPI-17+++IPR036658///CPI-17 superfamily	[PP14A_HUMAN|Reviewed]RecName: Full=Protein phosphatase 1 regulatory subunit 14A; AltName: Full=17 kDa PKC-potentiated inhibitory protein of PP1; AltName: Full=Protein kinase C-potentiated inhibitor protein of 17 kDa; Short=CPI-17;	chr19q13///Ensembl 103 genes in cytogenetic band chr19q13		KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION///Vascular smooth muscle contraction	"REACTOME_RHO_GTPASE_EFFECTORS///RHO GTPase Effectors+++REACTOME_RHO_GTPASES_ACTIVATE_PKNS///RHO GTPases activate PKNs+++REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3///Signaling by Rho GTPases, Miro GTPases and RHOBTB3"					"POU2AF1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q16633 (POU2AF1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++RBM34_TARGET_GENES///Genes containing one or more binding sites for UniProt:P42696 (RBM34) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZFP91_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96JP5 (ZFP91) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF282_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9UDV7 (ZNF282) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF410_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q86VK4 (ZNF410) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."				"GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_0.5H_CD4_TCELL_UP///Genes up-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the cells treated with IL4 [GeneID=3565] and anti-IL12 at 0.5 h.+++GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_12H_ACT_CD4_TCELL_UP///Genes up-regulated in comparison of CD4 [GeneID=920] T cells treated with IL4 [GeneID=3565] and anti-IL12 at 12 h versus the untreated cells at 12 h.+++GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_1H_ACT_CD4_TCELL_UP///Genes up-regulated in comparison of CD4 [GeneID=920] T cells treated with IL4 [GeneID=3565] and anti-IL12 at 1 h versus the untreated cells at 1 h.+++GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_24H_ACT_CD4_TCELL_UP///Genes up-regulated in comparison of CD4 [GeneID=920] T cells treated with IL4 [GeneID=3565] and anti-IL12 at 24 h versus the untreated cells at 24 h.+++GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_48H_ACT_CD4_TCELL_UP///Genes up-regulated in comparison of CD4 [GeneID=920] T cells treated with IL4 [GeneID=3565] and anti-IL12 at 48 h versus the untreated cells at 48 h.+++GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_72H_ACT_CD4_TCELL_UP///Genes up-regulated in comparison of CD4 [GeneID=920] T cells treated with IL4 [GeneID=3565] and anti-IL12 at 72 h versus the untreated cells at 72 h.+++GSE26928_CENTR_MEMORY_VS_CXCR5_POS_CD4_TCELL_UP///Genes up-regulated in comparison of CD4 [GeneID=920] central memory T cells versus CD4 [GeneID=920] CXCR5+ [GeneID=643] T cells.+++GSE34156_TLR1_TLR2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_DN///Genes down-regulated in monocytes (24h): M. tuberculosis 19 kDa lipopeptide versus M. tuberculosis 19 kDa lipopeptide and muramyl dipeptide [PubChem=11620162].+++GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_24H_UP///Genes up-regulated in monocytes (24h): untreated versus M. tuberculosis 19 kDa lipopeptide.+++THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_NONRESPONDER_28DY_UP///Genes up-regulated in peripheral blood mononuclear cell 28d vs 0d in young adults (21-30) (nonresponder) after exposure to Inactivated influenza vaccine , time point 28D+++THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_UP///Genes up-regulated in peripheral blood mononuclear cell 28d vs 0d in young adults (21-30) (responders) after exposure to Inactivated influenza vaccine , time point 28D"		NM_033256	PPP1R14A				
Q93052	sp|Q93052|LPP_HUMAN		LPP		Lipoma-preferred partner OS=Homo sapiens OX=9606 GN=LPP PE=1 SV=1	4026	NM_001167671	NP_001161143		K16676			MSHPSWLPPKSTGEPLGHVPARMETTHSFGNPSISVSTQQPPKKFAPVVAPKPKYNPYKQPGGEGDFLPPPPPPLDDSSALPSISGNFPPPPPLDEEAFKVQGNPGGKTLEERRSSLDAEIDSLTSILADLECSSPYKPRPPQSSTGSTASPPVSTPVTGHKRMVIPNQPPLTATKKSTLKPQPAPQAGPIPVAPIGTLKPQPQPVPASYTTASTSSRPTFNVQVKSAQPSPHYMAAPSSGQIYGSGPQGYNTQPVPVSGQCPPPSTRGGMDYAYIPPPGLQPEPGYGYAPNQGRYYEGYYAAGPGYGGRNDSDPTYGQQGHPNTWKREPGYTPPGAGNQNPPGMYPVTGPKKTYITDPVSAPCAPPLQPKGGHSGQLGPSSVAPSFRPEDELEHLTKKMLYDMENPPADEYFGRCARCGENVVGEGTGCTAMDQVFHVDCFTCIICNNKLRGQPFYAVEKKAYCEPCYINTLEQCNVCSKPIMERILRATGKAYHPHCFTCVMCHRSLDGIPFTVDAGGLIHCIEDFHKKFAPRCSVCKEPIMPAPGQEETVRIVALDRDFHVHCYRCEDCGGLLSEGDNQGCYPLDGHILCKTCNSARIRVLTAKASTDL	0.4762591	-1.070181583	0.005892898					4.8483469	5.8034713						4.7579989										5.1779571	6.7511169					6.278161	6.5752376	5.906571	7.283163			5.2211923		5.2953212	6.0000784		5.087035	6.536467		6.7856574		6.88550096	04391///Hippo signaling pathway - fly	H00003///Acute myeloid leukemia			GO:0001725///stress fiber+++GO:0005634///nucleus+++GO:0005737///cytoplasm+++GO:0005829///cytosol+++GO:0005886///plasma membrane+++GO:0005925///focal adhesion+++GO:0016020///membrane+++GO:0030054///cell junction	GO:0005515///protein binding+++GO:0046872///metal ion binding	GO:0007155///cell adhesion+++GO:0008150///biological_process+++GO:0098609///cell-cell adhesion	tissueType=Lung;cancerType=Normal;cellName=SLC16A7+ cell		"Homo sapiens LIM domain containing preferred translocation partner in lipoma (LPP), transcript variant 2, mRNA."		PF00412///LIM domain			KOG1701///negative regulation of hippo signaling		"IPR001781///Zinc finger, LIM-type+++IPR028771///Lipoma-preferred partner"	[LPP_HUMAN|Reviewed]RecName: Full=Lipoma-preferred partner; AltName: Full=LIM domain-containing preferred translocation partner in lipoma;	chr3q27///Ensembl 103 genes in cytogenetic band chr3q27					"AAAGACA_MIR511///Genes having at least one occurence of the motif AAAGACA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-511 (v7.1 miRBase).+++AATGTGA_MIR23A_MIR23B///Genes having at least one occurence of the motif AATGTGA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-23a and hsa-miR-23b (v7.1 miRBase).+++ACCAAAG_MIR9///Genes having at least one occurence of the motif ACCAAAG in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-9 (v7.1 miRBase).+++CAGTGTT_MIR141_MIR200A///Genes having at least one occurence of the motif CAGTGTT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-141 and hsa-miR-200a (v7.1 miRBase).+++CATTTCA_MIR203///Genes having at least one occurence of the motif CATTTCA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-203 (v7.1 miRBase).+++GACAATC_MIR219///Genes having at least one occurence of the motif GACAATC in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-219 (v7.1 miRBase).+++GGCAGCT_MIR22///Genes having at least one occurence of the motif GGCAGCT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-22 (v7.1 miRBase).+++GTGCCTT_MIR506///Genes having at least one occurence of the motif GTGCCTT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-506 (v7.1 miRBase).+++TAATAAT_MIR126///Genes having at least one occurence of the motif TAATAAT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-126* (v7.1 miRBase).+++TAATGTG_MIR323///Genes having at least one occurence of the motif TAATGTG in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-323 (v7.1 miRBase).+++TGAATGT_MIR181A_MIR181B_MIR181C_MIR181D///Genes having at least one occurence of the motif TGAATGT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-181a, hsa-miR-181b, hsa-miR-181c and hsa-miR-181d (v7.1 miRBase).+++TGCCTTA_MIR124A///Genes having at least one occurence of the motif TGCCTTA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-124a (v7.1 miRBase).+++TGTTTAC_MIR30A5P_MIR30C_MIR30D_MIR30B_MIR30E5P///Genes having at least one occurence of the motif TGTTTAC in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-30a-5p, hsa-miR-30c, hsa-miR-30d, hsa-miR-30b and hsa-miR-30e-5p (v7.1 miRBase).+++TTTGCAC_MIR19A_MIR19B///Genes having at least one occurence of the motif TTTGCAC in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-19a and hsa-miR-19b (v7.1 miRBase).+++TTTGTAG_MIR520D///Genes having at least one occurence of the motif TTTGTAG in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-520d* (v7.1 miRBase)."	"MIR10393_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-10393-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR10522_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-10522-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1200///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1200 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR12133///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-12133 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR12135///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-12135 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1233_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1233-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR124_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-124-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1245B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1245b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1252_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1252-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1253///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1253 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR126_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-126-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1271_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1271-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR129_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-129-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR130A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-130a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR130B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-130b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1323///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1323 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1324///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1324 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR141_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-141-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR142_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-142-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR182_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-182-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1843///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1843 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR186_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-186-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR186_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-186-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR190B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-190b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1976///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1976 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR200A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-200a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR204_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-204-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR211_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-211-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR219A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-219a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR223_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-223-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR2355_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-2355-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR2392///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-2392 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR23A_3P_MIR23B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-23a-3p, hsa-miR-23b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR23C///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-23c in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR298///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-298 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR29A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-29a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR302A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-302a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR30A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-30a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR30B_5P_MIR30C_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-30b-5p, hsa-miR-30c-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR30D_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-30d-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR30E_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-30e-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3121_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3121-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3123///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3123 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3144_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3144-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3159///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3159 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3167///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3167 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3185///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3185 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3190_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3190-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3202///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3202 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR33A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-33a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR340_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-340-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3667_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3667-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3688_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3688-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3714///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3714 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR371B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-371b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR380_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-380-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3924///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3924 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4263///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4263 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4311///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4311 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4446_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4446-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4451///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4451 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4463///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4463 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4516///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4516 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4517///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4517 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4528///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4528 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4533///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4533 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4648///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4648 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4652_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4652-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4722_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4722-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4728_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4728-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4742_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4742-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4753_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4753-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4755_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4755-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4768_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4768-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4782_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4782-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4794///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4794 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4795_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4795-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4799_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4799-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR499B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-499b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5001_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5001-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5002_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5002-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5003_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5003-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5006_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5006-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR506_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-506-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR511_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-511-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR511_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-511-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR539_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-539-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR541_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-541-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR542_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-542-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR543///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-543 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR544B///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-544b in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AB///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548ab in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AD_5P_MIR548AE_5P_MIR548AY_5P_MIR548B_5P_MIR548D_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548ad-5p, hsa-miR-548ae-5p, hsa-miR-548ay-5p, hsa-miR-548b-5p, hsa-miR-548d-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AE_3P_MIR548AQ_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548ae-3p, hsa-miR-548aq-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AG///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548ag in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AH_3P_MIR548AM_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548ah-3p, hsa-miR-548am-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AI_MIR570_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548ai, hsa-miR-570-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AJ_3P_MIR548X_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548aj-3p, hsa-miR-548x-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AK_MIR548AM_5P_MIR548C_5P_MIR548H_5P_MIR548O_5P_MIR548AU_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548ak, hsa-miR-548am-5p, hsa-miR-548c-5p, hsa-miR-548h-5p, hsa-miR-548o-5p, hsa-miR-548au-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AN///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548an in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AP_5P_MIR548J_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548ap-5p, hsa-miR-548j-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AQ_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548aq-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AR_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548ar-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AR_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548ar-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AS_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548as-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AT_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548at-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AZ_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548az-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548BA///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548ba in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548BB_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548bb-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548BC///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548bc in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548E_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548e-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548F_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548f-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548I///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548i in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548J_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548j-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548M///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548m in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548N///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548n in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548O_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548o-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548O_5P_MIR548W///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548o-5p, hsa-miR-548w in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548Y///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548y in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR551B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-551b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5580_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5580-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5582_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5582-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR558///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-558 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5590_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5590-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR559///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-559 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5680///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5680 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5700///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5700 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5702///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5702 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR576_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-576-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR578///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-578 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR587///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-587 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6073///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6073 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6074///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6074 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6079///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6079 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6126///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6126 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR627_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-627-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6507_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6507-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6508_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6508-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR651_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-651-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR651_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-651-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR656_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-656-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR664A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-664a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR664A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-664a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6740_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6740-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6766_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6766-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6778_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6778-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6778_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6778-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6809_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6809-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6809_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6809-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6814_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6814-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6817_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6817-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6827_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6827-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6828_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6828-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6832_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6832-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6833_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6833-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6833_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6833-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6845_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6845-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6861_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6861-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6867_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6867-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6873_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6873-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6895_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6895-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR708_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-708-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7110_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7110-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7114_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7114-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7162_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7162-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR760///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-760 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7844_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7844-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7855_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7855-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR8066///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-8066 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR8067///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-8067 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR8076///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-8076 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR876_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-876-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR876_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-876-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR892C_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-892c-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR937_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-937-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR942_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-942-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR95_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-95-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR96_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-96-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR9983_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-9983-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets)."	AP1_C///Genes having at least one occurence of the transcription factor binding site V$AP1_C (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++AP1FJ_Q2///Genes having at least one occurence of the transcription factor binding site V$AP1FJ_Q2 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++AP1_Q2_01///Genes having at least one occurence of the transcription factor binding site V$AP1_Q2_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++AP1_Q2///Genes having at least one occurence of the transcription factor binding site V$AP1_Q2 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++AP1_Q4///Genes having at least one occurence of the transcription factor binding site V$AP1_Q4 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++AP1_Q6_01///Genes having at least one occurence of the transcription factor binding site V$AP1_Q6_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++AP1_Q6///Genes having at least one occurence of the transcription factor binding site V$AP1_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++ATF4_Q2///Genes having at least one occurence of the transcription factor binding site V$ATF4_Q2 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++BACH1_01///Genes having at least one occurence of the transcription factor binding site V$BACH1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++BACH2_01///Genes having at least one occurence of the transcription factor binding site V$BACH2_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++CCCNNGGGAR_OLF1_01///Genes having at least one occurence of the highly conserved motif M130 CCCNNGGGAR sites. The motif matches transcription factor binding site V$OLF1_01 (v7.4 TRANSFAC).+++HNF1_C///Genes having at least one occurence of the transcription factor binding site V$HNF1_C (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++HNF1_Q6///Genes having at least one occurence of the transcription factor binding site V$HNF1_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++HNF3B_01///Genes having at least one occurence of the transcription factor binding site V$HNF3B_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++OCT1_05///Genes having at least one occurence of the transcription factor binding site V$OCT1_05 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++P53_02///Genes having at least one occurence of the transcription factor binding site V$P53_02 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++RTAAACA_FREAC2_01///Genes having at least one occurence of the highly conserved motif M36 RTAAACA sites. The motif matches transcription factor binding site V$FREAC2_01 (v7.4 TRANSFAC).+++SRF_C///Genes having at least one occurence of the transcription factor binding site V$SRF_C (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++SRF_Q4///Genes having at least one occurence of the transcription factor binding site V$SRF_Q4 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++SRF_Q5_01///Genes having at least one occurence of the transcription factor binding site V$SRF_Q5_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++SRF_Q6///Genes having at least one occurence of the transcription factor binding site V$SRF_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++TGACATY_UNKNOWN///Genes having at least one occurence of the highly conserved motif M42 TGACATY in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++TGANTCA_AP1_C///Genes having at least one occurence of the highly conserved motif M7 TGANTCA sites. The motif matches transcription factor binding site V$AP1_C (v7.4 TRANSFAC).+++WGTTNNNNNAAA_UNKNOWN///Genes having at least one occurence of the highly conserved motif M155 WGTTNNNNNAAA in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).	"AHRR_TARGET_GENES///Genes containing one or more binding sites for UniProt:A9YTQ3 (AHRR) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++BACH2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9BYV9 (BACH2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++BARX2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9UMQ3 (BARX2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++BPTF_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q12830 (BPTF) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++CUX1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P39880 (CUX1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++GREB1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q4ZG55 (GREB1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++IRF9_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q00978 (IRF9) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++KDM1B_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8NB78 (KDM1B) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++KMT2D_TARGET_GENES///Genes containing one or more binding sites for UniProt:O14686 (KMT2D) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++PAX3_TARGET_GENES///Genes containing one or more binding sites for UniProt:P23760 (PAX3) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++PAX7_TARGET_GENES///Genes containing one or more binding sites for UniProt:P23759 (PAX7) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SATB1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q01826 (SATB1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF22_TARGET_GENES///Genes containing one or more binding sites for UniProt:P17026 (ZNF22) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF513_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8N8E2 (ZNF513) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF84_TARGET_GENES///Genes containing one or more binding sites for UniProt:P51523 (ZNF84) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF92_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q03936 (ZNF92) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."		MODULE_261///Genes in the cancer module 262.+++MODULE_358///B lymphoma expression clusters.	EGFR_UP.V1_UP///Genes up-regulated in MCF-7 cells (breast cancer) positive for ESR1 [Gene ID=2099] and engineered to express ligand-activatable EGFR [Gene ID=1956].	"GSE11057_NAIVE_VS_CENT_MEMORY_CD4_TCELL_DN///Genes down-regulated in comparison of naive T cells versus central memory T cells.+++GSE11057_NAIVE_VS_MEMORY_CD4_TCELL_DN///Genes down-regulated in comparison of naive T cells versus memory T cells.+++GSE12198_NK_VS_NK_ACT_EXPANSION_SYSTEM_DERIVED_NK_CELL_UP///Genes up-regulated in NK cells: primary versus activated and expanded.+++GSE12845_IGD_NEG_BLOOD_VS_PRE_GC_TONSIL_BCELL_DN///Genes down-regulated in comparison of IgD- peripheral blood B cells versus pre-germinal center B cells.+++GSE12845_IGD_POS_BLOOD_VS_NAIVE_TONSIL_BCELL_DN///Genes down-regulated in comparison of IgD+ peripheral blood B cells versus IgD- naive tonsil B cells.+++GSE13484_12H_VS_3H_YF17D_VACCINE_STIM_PBMC_UP///Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) cultured with YF17D vaccine for 12 h versus PBMC cultured for 3 h.+++GSE13485_CTRL_VS_DAY21_YF17D_VACCINE_PBMC_UP///Genes up-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) versus PBMC 21 days after stimulation with YF17D vaccine.+++GSE13485_DAY3_VS_DAY21_YF17D_VACCINE_PBMC_UP///Genes up-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) 3 days after stimulation with YF17D vaccine versus PBMC 21 days after the stimulation.+++GSE13485_DAY7_VS_DAY21_YF17D_VACCINE_PBMC_UP///Genes up-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) 7 days after stimulation with YF17D vaccine versus PBMC 21 days after the stimulation.+++GSE13738_RESTING_VS_BYSTANDER_ACTIVATED_CD4_TCELL_DN///Genes down-regulated in comparison of resting CD4 [GeneID=920] T cells versus bystander activated CD4 [GeneID=920] T cells.+++GSE13738_RESTING_VS_TCR_ACTIVATED_CD4_TCELL_DN///Genes down-regulated in comparison of resting CD4 [GeneID=920] T cells versus directly activated CD4 [GeneID=920] T cells.+++GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_UP///Genes up-regulated in immature neuron cell line: control versus interferon alpha (12h).+++GSE16451_IMMATURE_VS_MATURE_NEURON_CELL_LINE_WEST_EQUINE_ENC_VIRUS_DN///Genes down-regulated in neuron cell line infected with western equine encephalitis virus: immature versus mature cells.+++GSE1740_MCSF_VS_MCSF_AND_IFNG_DAY2_DERIVED_MACROPHAGE_DN///Genes down-regulated in monocyte-derived macrophages: no priming versus primed by IFNG [GeneID=3458].+++GSE17974_0H_VS_4H_IN_VITRO_ACT_CD4_TCELL_UP///Genes up-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the untreated cells at 4 h.+++GSE17974_0H_VS_6H_IN_VITRO_ACT_CD4_TCELL_UP///Genes up-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the untreated cells at 6 h.+++GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_12H_CD4_TCELL_UP///Genes up-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the cells treated with IL4 [GeneID=3565] and anti-IL12 at 12 h.+++GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_4H_CD4_TCELL_UP///Genes up-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the cells treated with IL4 [GeneID=3565] and anti-IL12 at 4 h.+++GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_6H_CD4_TCELL_UP///Genes up-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the cells treated with IL4 [GeneID=3565] and anti-IL12 at 6 h.+++GSE18893_CTRL_VS_TNF_TREATED_TREG_2H_UP///Genes up-regulated in T reg cells (2h): medium versus TNF [GeneID=7124].+++GSE18893_TCONV_VS_TREG_2H_CULTURE_DN///Genes down-regulated in lymphocytes treated with medium for 2h: T conv versus T reg cells.+++GSE19772_CTRL_VS_HCMV_INF_MONOCYTES_AND_PI3K_INHIBITION_UP///Genes up-regulated in monocytes pre-treated with Ly294002 [PubChem=3973]: control versus HCMV infection.+++GSE21774_CD62L_POS_CD56_DIM_VS_CD62L_NEG_CD56_DIM_NK_CELL_UP///Genes up-regulated in SELL dim [GeneID=6402] NK cells: NCAM1+ [GeneID=4684] versus NCAM1- [GeneID=4684].+++GSE22886_DC_VS_MONOCYTE_UP///Genes up-regulated in comparison of dendritic cells (DC) versus monocytes.+++GSE26495_NAIVE_VS_PD1HIGH_CD8_TCELL_DN///Genes down-regulated in comparison of naive CD8 T cells versus PD-1 high CD8 T cells.+++GSE26495_NAIVE_VS_PD1LOW_CD8_TCELL_DN///Genes down-regulated in comparison of naive CD8 T cells versus PD-1 low CD8 T cells.+++GSE26495_PD1HIGH_VS_PD1LOW_CD8_TCELL_DN///Genes down-regulated in comparison of PD-1 high CD8 T cells versus PD-1 low CD8 T cells.+++GSE27670_CTRL_VS_BLIMP1_TRANSDUCED_GC_BCELL_DN///Genes down-regulated in germinal center B lymphocytes: control versus over-expressing PRDM1 [GeneID=639].+++GSE27670_CTRL_VS_LMP1_TRANSDUCED_GC_BCELL_DN///Genes down-regulated in germinal center B lymphocytes: control versus over-expressing Epstein-Barr virus protein LMP1.+++GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_2H_DN///Genes down-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: IL4 [GeneID=3565] (2h) versus untreated (2h).+++GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_48H_DN///Genes down-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 and IL4 [GeneID=7040;3565] (48h) versus IL-12 (48h).+++GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_PDC_DN///Genes down-regulated in comparison of plasmacytoid dendritic cells (pDC) from TIV influenza vaccinee pre-vaccination versus those at day 7 post-vaccination.+++GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10NEG_CD62LPOS_BONE_MARROW_DN///Genes down-regulated in the bone marrow CD34+ [GeneID=947] cells: CD38- [GeneID=952] versus MME- SELL+ [GeneID=4311;6402].+++GSE360_DC_VS_MAC_UP///Genes up-regulated in comparison of dendritic cells (DC) versus untreated macrophages.+++GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_MAC_UP///Genes up-regulated in comparison of macrophages exposed to L. donovani versus macrophages exposed to 5 worms/well B. malayi.+++GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_DN///Genes down-regulated in gamma delta T cells: Vd1 versus Vd2.+++GSE38697_LIGHT_ZONE_VS_DARK_ZONE_BCELL_UP///Genes up-regulated in B lymphocytes: light zone versus dark zone.+++GSE3920_IFNA_VS_IFNB_TREATED_ENDOTHELIAL_CELL_UP///Genes up-regulated in endothelial cells: interferon alpha versus interferon beta.+++GSE3920_UNTREATED_VS_IFNA_TREATED_FIBROBLAST_DN///Genes down-regulated fibroblasts: untreated versus interferon alpha.+++GSE3982_BASOPHIL_VS_NKCELL_DN///Genes down-regulated in comparison of basophils versus NK cells.+++GSE3982_BCELL_VS_NKCELL_DN///Genes down-regulated in comparison of B cells versus NK cells.+++GSE3982_CTRL_VS_IGE_STIM_MAST_CELL_DN///Genes down-regulated in comparison of untreated mast cells versus mast cells treated with IgE at 2 h.+++GSE3982_DC_VS_BASOPHIL_UP///Genes up-regulated in comparison of dendritic cells (DC) versus basophils.+++GSE3982_MAC_VS_BCELL_UP///Genes up-regulated in comparison of macrophages versus B cells.+++GSE3982_NEUTROPHIL_VS_BASOPHIL_UP///Genes up-regulated in comparison of neutrophils versus basophils.+++GSE3982_NKCELL_VS_TH1_UP///Genes up-regulated in comparison of NK cells versus Th1 cells.+++GSE42088_UNINF_VS_LEISHMANIA_INF_DC_4H_UP///Genes up-regulated in dendritic cells: untreated versus 4h after infection of Leishmania major.+++GSE4984_GALECTIN1_VS_LPS_STIM_DC_DN///Genes down-regulated in monocyte-derived dendritic cells: LGALS1 [GeneID=3956] versus LPS.+++GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_UP///Genes up-regulated in monocyte-derived dendritic cells: untreated versus rosiglitazone and AM580 [PubChem=77999;2126].+++GSE5679_RARA_AGONIST_AM580_VS_AM580_AND_ROSIGLITAZONE_TREATED_DC_UP///Genes up-regulated in monocyte-derived dendritic cells: AM580 [PubChem=2126] versus rosiglitazone and AM580 [PubChem=77999;2126].+++GSE7460_TREG_VS_TCONV_ACT_WITH_TGFB_DN///Genes down-regulated in comparsion of ActTregTGF versus ActCD4TGF (see Fig. 1 in the paper for details).+++GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_24H_DN///Genes down-regulated in monocytes: untreated versus M. tuberculosis 19 kDa lipopeptide (24h).+++GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_AT_DX_UP///Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMCs from patients with type 1 diabetes at the time of diagnosis.+++GSE9006_TYPE_1_DIABETES_AT_DX_VS_1MONTH_POST_DX_PBMC_DN///Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from patients with type 1 diabetes at the time of the diagnosis versus those at 1 month later.+++GSE9006_TYPE_1_DIABETES_AT_DX_VS_4MONTH_POST_DX_PBMC_DN///Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from patients with type 1 diabetes at the time of the diagnosis versus those at 4 months later.+++GSE9006_TYPE_1_VS_TYPE_2_DIABETES_PBMC_AT_DX_DN///Genes down-regulated in peripheral blood mononuclear cells (PBMC) from patients with type 1 diabetes at the time of diagnosis versus those with type 2 diabetes at the time of diagnosis.+++NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE///Genes negatively correlated with HAI response at 28d in peripheral blood mononuclear cell in adults (18-50) after exposure to Fluarix/Fluvirin , time point 7D. Comment: Supplementary Table 5: All genes whose expression (d3/d0 or d7/d0) correlates to the fold increase in HAI titers (d28/d0).+++NAKAYA_PBMC_FLUMIST_AGE_18_50YO_7DY_UP///Genes up-regulated in peripheral blood mononuclear cell 7d vs 0d in adults (18-50) after exposure to FluMist , time point 7D. Comment: Supplementary Table 1b: All the differentially expressed genes identified in PBMCs of TIV vaccinees.+++OSMAN_BLOOD_CHAD63_KH_AGE_18_50YO_HIGH_DOSE_SUBJECTS_24HR_UP///Genes up-regulated in blood 24hr vs 0hr in adults (18-50) (high dose subjects) after exposure to ChAd63-KH , time point 24H , administered Intramuscular injection. Comment: DE gene list for high dose subjects."		NM_001167671	LPP				
Q92619	sp|Q92619|HMHA1_HUMAN		ARHGAP45		Rho GTPase-activating protein 45 OS=Homo sapiens OX=9606 GN=ARHGAP45 PE=1 SV=2	23526	NM_012292	NP_036424	ENST00000313093				MFSRKKRELMKTPSISKKNRAGSPSPQPSGELPRKDGADAVFPGPSLEPPAGSSGVKATGTLKRPTSLSRHASAAGFPLSGAASWTLGRSHRSPLTAASPGELPTEGAGPDVVEDISHLLADVARFAEGLEKLKECVLRDDLLEARRPRAHECLGEALRVMHQIISKYPLLNTVETLTAAGTLIAKVKAFHYESNNDLEKQEFEKALETIAVAFSSTVSEFLMGEVDSSTLLAVPPGDSSQSMESLYGPGSEGTPPSLEDCDAGCLPAEEVDVLLQRCEGGVDAALLYAKNMAKYMKDLISYLEKRTTLEMEFAKGLQKIAHNCRQSVMQEPHMPLLSIYSLALEQDLEFGHSMVQAVGTLQTQTFMQPLTLRRLEHEKRRKEIKEAWHRAQRKLQEAESNLRKAKQGYVQRCEDHDKARFLVAKAEEEQAGSAPGAGSTATKTLDKRRRLEEEAKNKAEEAMATYRTCVADAKTQKQELEDTKVTALRQIQEVIRQSDQTIKSATISYYQMMHMQTAPLPVHFQMLCESSKLYDPGQQYASHVRQLQRDQEPDVHYDFEPHVSANAWSPVMRARKSSFNVSDVARPEAAGSPPEEGGCTEGTPAKDHRAGRGHQVHKSWPLSISDSDSGLDPGPGAGDFKKFERTSSSGTMSSTEELVDPDGGAGASAFEQADLNGMTPELPVAVPSGPFRHEGLSKAARTHRLRKLRTPAKCRECNSYVYFQGAECEECCLACHKKCLETLAIQCGHKKLQGRLQLFGQDFSHAARSAPDGVPFIVKKCVCEIERRALRTKGIYRVNGVKTRVEKLCQAFENGKELVELSQASPHDISNVLKLYLRQLPEPLISFRLYHELVGLAKDSLKAEAEAKAASRGRQDGSESEAVAVALAGRLRELLRDLPPENRASLQYLLRHLRRIVEVEQDNKMTPGNLGIVFGPTLLRPRPTEATVSLSSLVDYPHQARVIETLIVHYGLVFEEEPEETPGGQDESSNQRAEVVVQVPYLEAGEAVVYPLQEAAADGCRESRVVSNDSDSDLEEASELLSSSEASALGHLSFLEQQQSEASLEVASGSHSGSEEQLEATAREDGDGDEDGPAQQLSGFNTNQSNNVLQAPLPPMRLRGGRMTLGSCRERQPEFV	0.414159	-1.27174321	1.53E-04		3.2690638	2.2711635		3.7169696	5.837448		4.2311722	4.8897328	5.4999477	4.4423268	5.7069898		3.6189926		4.2210332		4.2467062			5.1232267	4.9526036	5.8848446					6.988099	6.1759844	6.005395	6.4677544	5.263769	4.2481633	5.9097413	5.8049832	5.1275876	5.9241174	4.768167	5.98501	5.9818678	5.08937766	6.5739825	4.265037	6.176982					GO:0005576///extracellular region+++GO:0005737///cytoplasm+++GO:0005829///cytosol+++GO:0005886///plasma membrane+++GO:0016020///membrane+++GO:0032587///ruffle membrane+++GO:0034774///secretory granule lumen+++GO:0035578///azurophil granule lumen+++GO:0042995///cell projection	GO:0005096///GTPase activator activity+++GO:0005515///protein binding+++GO:0046872///metal ion binding	GO:0007165///signal transduction+++GO:0035556///intracellular signal transduction+++GO:0043312///neutrophil degranulation+++GO:0050790///regulation of catalytic activity+++GO:0051056///regulation of small GTPase mediated signal transduction+++GO:0090630///activation of GTPase activity	tissueType=Peripheral blood;cancerType=Normal;cellName=Naive CD8+ T cell		"Homo sapiens Rho GTPase activating protein 45 (ARHGAP45), transcript variant 1, mRNA."		PF00620///RhoGAP domain	"R-HSA-162582///Signal Transduction+++R-HSA-168249///Innate Immune System+++R-HSA-168256///Immune System+++R-HSA-194315///Signaling by Rho GTPases+++R-HSA-6798695///Neutrophil degranulation+++R-HSA-8980692///RHOA GTPase cycle+++R-HSA-9012999///RHO GTPase cycle+++R-HSA-9013148///CDC42 GTPase cycle+++R-HSA-9013149///RAC1 GTPase cycle+++R-HSA-9716542///Signaling by Rho GTPases, Miro GTPases and RHOBTB3"		KOG1453///GTPase activator activity		"IPR000198///Rho GTPase-activating protein domain+++IPR001060///FCH domain+++IPR002219///Protein kinase C-like, phorbol ester/diacylglycerol-binding domain+++IPR008936///Rho GTPase activation protein+++IPR027267///AH/BAR domain superfamily+++IPR031160///F-BAR domain"	[HMHA1_HUMAN|Reviewed]RecName: Full=Rho GTPase-activating protein 45 {ECO:0000312|HGNC:HGNC:17102}; Contains: RecName: Full=Minor histocompatibility antigen HA-1; Short=mHag HA-1;+++[A0A2X0U2E5_HUMAN|Unreviewed]SubName: Full=ARHGAP45 {ECO:0000313|EMBL:SPT35711.1}; Flags: Fragment;	chr19p13///Ensembl 103 genes in cytogenetic band chr19p13			"REACTOME_CDC42_GTPASE_CYCLE///CDC42 GTPase cycle+++REACTOME_INNATE_IMMUNE_SYSTEM///Innate Immune System+++REACTOME_NEUTROPHIL_DEGRANULATION///Neutrophil degranulation+++REACTOME_RAC1_GTPASE_CYCLE///RAC1 GTPase cycle+++REACTOME_RHOA_GTPASE_CYCLE///RHOA GTPase cycle+++REACTOME_RHO_GTPASE_CYCLE///RHO GTPase cycle+++REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3///Signaling by Rho GTPases, Miro GTPases and RHOBTB3"			"MIR1299///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1299 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4477A///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4477a in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AJ_3P_MIR548X_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548aj-3p, hsa-miR-548x-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6867_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6867-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets)."	AML_Q6///Genes having at least one occurence of the transcription factor binding site V$AML_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++AP4_Q5///Genes having at least one occurence of the transcription factor binding site V$AP4_Q5 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++CACGTG_MYC_Q2///Genes having at least one occurence of the highly conserved motif M2 CACGTG sites. The motif matches transcription factor binding site V$MYC_Q2 (v7.4 TRANSFAC).+++CAGCTG_AP4_Q5///Genes having at least one occurence of the highly conserved motif M15 CAGCTG sites. The motif matches transcription factor binding site V$AP4_Q5 (v7.4 TRANSFAC).+++CMYB_01///Genes having at least one occurence of the transcription factor binding site V$CMYB_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++COREBINDINGFACTOR_Q6///Genes having at least one occurence of the transcription factor binding site V$COREBINDINGFACTOR_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++CP2_01///Genes having at least one occurence of the transcription factor binding site V$CP2_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++ETS1_B///Genes having at least one occurence of the transcription factor binding site V$ETS1_B (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++ETS_Q4///Genes having at least one occurence of the transcription factor binding site V$ETS_Q4 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++GGGTGGRR_PAX4_03///Genes having at least one occurence of the highly conserved motif M56 GGGTGGRR sites. The motif matches transcription factor binding site V$PAX4_03 (v7.4 TRANSFAC).+++MGGAAGTG_GABP_B///Genes having at least one occurence of the highly conserved motif M11 MGGAAGTG sites. The motif matches transcription factor binding site V$GABP_B (v7.4 TRANSFAC).+++MYCMAX_03///Genes having at least one occurence of the transcription factor binding site V$MYCMAX_03 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++MZF1_01///Genes having at least one occurence of the transcription factor binding site V$MZF1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++PAX4_04///Genes having at least one occurence of the transcription factor binding site V$PAX4_04 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++RACCACAR_AML_Q6///Genes having at least one occurence of the highly conserved motif M111 RACCACAR sites. The motif matches transcription factor binding site V$AML_Q6 (v7.4 TRANSFAC).+++RREB1_01///Genes having at least one occurence of the transcription factor binding site V$RREB1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++RYTTCCTG_ETS2_B///Genes having at least one occurence of the highly conserved motif M16 RYTTCCTG sites. The motif matches transcription factor binding site V$ETS2_B (v7.4 TRANSFAC).+++SP3_Q3///Genes having at least one occurence of the transcription factor binding site V$SP3_Q3 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++TEL2_Q6///Genes having at least one occurence of the transcription factor binding site V$TEL2_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++TGACAGNY_MEIS1_01///Genes having at least one occurence of the highly conserved motif M41 TGACAGNY sites. The motif matches transcription factor binding site V$MEIS1_01 (v7.4 TRANSFAC).+++TGTTTGY_HNF3_Q6///Genes having at least one occurence of the highly conserved motif M83 TGTTTGY sites. The motif matches transcription factor binding site V$HNF3_Q6 (v7.4 TRANSFAC).+++USF_Q6_01///Genes having at least one occurence of the transcription factor binding site V$USF_Q6_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++USF_Q6///Genes having at least one occurence of the transcription factor binding site V$USF_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++ZIC1_01///Genes having at least one occurence of the transcription factor binding site V$ZIC1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.	"ARID5B_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q14865 (ARID5B) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++CBFA2T2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O43439 (CBFA2T2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++CDC73_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6P1J9 (CDC73) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++FXR1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P51114 (FXR1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++GLI4_TARGET_GENES///Genes containing one or more binding sites for UniProt:P10075 (GLI4) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HBZ_TARGET_GENES///Genes containing one or more binding sites for UniProt:P02008 (HBZ) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HDGF_TARGET_GENES///Genes containing one or more binding sites for UniProt:P51858 (HDGF) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HMGB1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P09429 (HMGB1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++JDP2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8WYK2 (JDP2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++KDM5D_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9BY66 (KDM5D) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++KLF7_TARGET_GENES///Genes containing one or more binding sites for UniProt:O75840 (KLF7) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++LMTK3_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96Q04 (LMTK3) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++MAML1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q92585 (MAML1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NPM1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P06748 (NPM1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SKIL_TARGET_GENES///Genes containing one or more binding sites for UniProt:P12757 (SKIL) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZBTB18_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q99592 (ZBTB18) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZFP3_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96NJ6 (ZFP3) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF146_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q15072 (ZNF146) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF16_TARGET_GENES///Genes containing one or more binding sites for UniProt:P17020 (ZNF16) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF22_TARGET_GENES///Genes containing one or more binding sites for UniProt:P17026 (ZNF22) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF257_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9Y2Q1 (ZNF257) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF362_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q5T0B9 (ZNF362) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF436_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9C0F3 (ZNF436) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF563_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8TA94 (ZNF563) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF592_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q92610 (ZNF592) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF597_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96LX8 (ZNF597) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF768_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9H5H4 (ZNF768) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF92_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q03936 (ZNF92) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZSCAN30_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q86W11 (ZSCAN30) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZSCAN31_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96LW9 (ZSCAN31) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."	GCM_CBFB///Neighborhood of CBFB+++GNF2_ATM///Neighborhood of ATM+++GNF2_CASP8///Neighborhood of CASP8+++GNF2_DDX5///Neighborhood of DDX5+++GNF2_HLA_C///Neighborhood of HLA-C+++GNF2_ITGAL///Neighborhood of ITGAL+++GNF2_PTPRC///Neighborhood of PTPRC	MODULE_136///Genes in the cancer module 136.+++MODULE_163///Genes in the cancer module 163.+++MODULE_179///Blood cells and cancer expression cancer.+++MODULE_255///Genes in the cancer module 255.+++MODULE_317///Genes in the cancer module 317.+++MODULE_378///Genes in the cancer module 378.+++MODULE_37///Genes in the cancer module 37.+++MODULE_44///Thymus genes.+++MODULE_459///Genes in the cancer module 459.+++MODULE_48///Genes in the cancer module 48.+++MODULE_532///Blood cells and cancer expression clusters.+++MODULE_69///Genes in the cancer module 69.+++MODULE_95///Genes in the cancer module 95.+++MODULE_9///Genes in the cancer module 9.		"GSE11864_CSF1_PAM3CYS_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN///Genes down-regulated in comparison of macrophages cultured with M-CSF [GeneID=1435] and Pam3Cyc versus macrophages cultured with M-CSF [GeneID=1435], IFNG [GeneID=3458] and Pam3Cyc.+++GSE12366_PLASMA_CELL_VS_NAIVE_BCELL_DN///Genes down-regulated in plasma cells versus naive B cells.+++GSE14000_4H_VS_16H_LPS_DC_TRANSLATED_RNA_DN///Genes down-regulated in comparison of polysome bound (translated) mRNA in dendritic cells (DC) at 4 h after LPS (TLR4 agonist) stimulation versus those at 16 h after the stimulation.+++GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_DN///Genes down-regulated in comparison of CD4 [GeneID=920] CD8 thymocytes versus naive CD4 [GeneID=920] T cells from adult blood.+++GSE1460_DP_VS_CD4_THYMOCYTE_DN///Genes down-regulated in comparison of CD4 [GeneID=920] CD8 thymocytes versus T cells from cord blood.+++GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_UP///Genes up-regulated in the neuron cell line: immature versus mature.+++GSE17186_BLOOD_VS_CORD_BLOOD_CD21HIGH_TRANSITIONAL_BCELL_DN///Genes down-regulated in transitional CR2 [GeneID=1380] high B lymphocytes versus those from cord blood.+++GSE17186_NAIVE_VS_CD21HIGH_TRANSITIONAL_BCELL_CORD_BLOOD_DN///Genes down-regulated in B lymphocytes from cord blood: nave versus transitional CR2 [GeneID=1380] high.+++GSE17186_NAIVE_VS_CD21LOW_TRANSITIONAL_BCELL_CORD_BLOOD_UP///Genes up-regulated in B lymphocytes from cord blood: nave versus transitional CR2 [GeneID=1380].+++GSE22589_HEALTHY_VS_SIV_INFECTED_DC_UP///Genes up-regulated in monocyte-derived dendritic cells: control versus SIV infection.+++GSE22589_HIV_VS_HIV_AND_SIV_INFECTED_DC_DN///Genes down-regulated in monocyte-derived dendritic cells infected by: HIV versus HIV and SIV.+++GSE22886_DAY0_VS_DAY7_MONOCYTE_IN_CULTURE_UP///Genes up-regulated in comparison of monocytes cultured for 0 days versus those cultured for 7 days.+++GSE22886_DAY1_VS_DAY7_MONOCYTE_IN_CULTURE_UP///Genes up-regulated in comparison of monocytes cultured for 1 day versus those cultured for 7 days.+++GSE22886_IGG_IGA_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_UP///Genes up-regulated in comparison of memory IgG IgA B cells versus blood plasma cells.+++GSE22886_IGG_IGA_MEMORY_BCELL_VS_BM_PLASMA_CELL_UP///Genes up-regulated in comparison of memory IgG IgA B cells versus plasma cells from bone marrow and blood.+++GSE22886_IGM_MEMORY_BCELL_VS_BM_PLASMA_CELL_UP///Genes up-regulated in comparison of memory IgM B cells versus plasma cells from bone marrow and blood.+++GSE22886_NAIVE_BCELL_VS_BM_PLASMA_CELL_UP///Genes up-regulated in comparison of naive B cells versus plasma cells from bone marrow and blood.+++GSE22919_RESTING_VS_IL2_IL12_IL15_STIM_NK_CELL_DN///Genes down-regulated in NK cells: fresh versus stimulated with IL2 [GeneID=3558], IL-12 and IL15 [GeneID=3600].+++GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_UP///Genes up-regulated in AGS cells (gastric adenocarcinoma): control versus H. pylori LPS.+++GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_6H_UP///Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 and IL4 [GeneID=7040;3565] (6h) versus IL-12 (6h).+++GSE28726_ACT_CD4_TCELL_VS_ACT_NKTCELL_DN///Genes down-regulated in activated T cells: CD4 [GeneID=920] versus NKT.+++GSE28726_ACT_CD4_TCELL_VS_ACT_VA24NEG_NKTCELL_DN///Genes down-regulated in activated T cells: CD4 [GeneID=920] versus Va24- NKT.+++GSE28726_NAIVE_CD4_TCELL_VS_NAIVE_NKTCELL_DN///Genes down-regulated in nave T cells: CD4 [GeneID=920] versus NK.+++GSE28726_NAIVE_CD4_TCELL_VS_NAIVE_VA24NEG_NKTCELL_DN///Genes down-regulated in nave T cells: CD4 [GeneID=920] versus Va24- NKT.+++GSE28726_NAIVE_VS_ACTIVATED_CD4_TCELL_UP///Genes up-regulated in CD4 [GeneID=920] T cells: nave versus activated.+++GSE29618_PDC_VS_MDC_DAY7_FLU_VACCINE_DN///Genes down-regulated in comparison of plasmacytoid dendritic cells (DC) from influenza vaccinee at day 7 post-vaccination versus myeloid DCs at day 7 post-vaccination.+++GSE33425_CD161_HIGH_VS_NEG_CD8_TCELL_UP///Genes up-regulated in CD8 T cells: KLRB1 high [GeneID=3820] versus KLRB1- [GeneID=3820].+++GSE34515_CD16_NEG_MONOCYTE_VS_DC_DN///Genes down-regulated in CD16- monocytes versus dendritic cells.+++GSE360_CTRL_VS_L_MAJOR_MAC_UP///Genes up-regulated in comparison of macrophages versus macrophages exposed to L. major.+++GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_MAC_DN///Genes down-regulated in comparison of macrophages exposed to L. major versus macrophages exposed to 5 worms/well B. malayi.+++GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_MAC_DN///Genes down-regulated in comparison of macrophages exposed to T. gondii versus macrophages exposed to 5 worms/well B. malayi.+++GSE3982_CENT_MEMORY_CD4_TCELL_VS_NKCELL_UP///Genes up-regulated in comparison of central memory CD4 [GeneID=920] T cells versus NK cells.+++GSE3982_DC_VS_EFF_MEMORY_CD4_TCELL_DN///Genes down-regulated in comparison of dendritic cells (DC) versus effector memory CD4 [GeneID=920] T cells.+++GSE3982_DC_VS_MAC_LPS_STIM_UP///Genes up-regulated in comparison of dendritic cells (DC) stimulatd with LPS (TLR4 agonist) at 48 h versus macrophages stimulated with LPS (TLR4 agonist) at 4 h.+++GSE3982_DC_VS_MAC_UP///Genes up-regulated in comparison of dendritic cells (DC) versus macrophages.+++GSE3982_DC_VS_NEUTROPHIL_DN///Genes down-regulated in comparison of dendritic cells (DC) versus neutrophils.+++GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH1_UP///Genes up-regulated in comparison of effective memory CD4 [GeneID=920] T cells versus Th1 cells.+++GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH2_UP///Genes up-regulated in comparison of effective memory CD4 [GeneID=920] T cells versus Th2 cells.+++GSE3982_MEMORY_CD4_TCELL_VS_TH1_UP///Genes up-regulated in comparison of memory CD4 [GeneID=920] T cells versus Th1 cells.+++GSE3982_MEMORY_CD4_TCELL_VS_TH2_UP///Genes up-regulated in comparison of memory CD4 [GeneID=920] T cells versus Th2 cells.+++GSE3982_NEUTROPHIL_VS_TH1_UP///Genes up-regulated in comparison of neutrophils versus Th1 cells.+++GSE3982_NEUTROPHIL_VS_TH2_UP///Genes up-regulated in comparison of neutrophils versus Th2 cells.+++GSE42088_UNINF_VS_LEISHMANIA_INF_DC_24H_UP///Genes up-regulated in dendritic cells: untreated versus 24h after infection of Leishmania major.+++GSE5099_CLASSICAL_M1_VS_ALTERNATIVE_M2_MACROPHAGE_UP///Genes up-regulated in macrophages: classical (M1) versus alternative (M2).+++GSE5099_MONOCYTE_VS_ALTERNATIVE_M2_MACROPHAGE_DN///Genes down-regulated in monocytes versus alternatively activated (M2) macrophages.+++GSE5542_UNTREATED_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_DN///Genes down-regulated in epithelial cells (24h): untreated versus interferon alpha and IFNG [GeneID=3458].+++GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_24H_DN///Genes down-regulated in epithelial cells (24h): untreated versus IFNG [GeneID=3458].+++GSE5679_CTRL_VS_RARA_AGONIST_AM580_TREATED_DC_DN///Genes down-regulated in monocyte-derived dendritic cells: untreated versus AM580 [PubChem=2126].+++GSE6269_FLU_VS_STAPH_AUREUS_INF_PBMC_UP///Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMC from patients with acute S. aureus infection.+++GSE6269_HEALTHY_VS_E_COLI_INF_PBMC_UP///Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMC from patients with acute E. coli infection.+++GSE6269_HEALTHY_VS_STAPH_PNEUMO_INF_PBMC_UP///Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMC from patients with acute S. pneumoniae infection.+++GSE7509_DC_VS_MONOCYTE_WITH_FCGRIIB_STIM_UP///Genes up-regulated in response to anti-FcgRIIB: dendritic cells versus monocytes.+++GSE8685_IL2_ACT_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_UP///Genes up-regulated in Sez-2 cells (T cell lymphoma): untreated versus IL15 [GeneID=3600].+++GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_24H_DN///Genes down-regulated in monocytes: untreated versus M. tuberculosis 19 kDa lipopeptide (24h).+++GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_3H_DN///Genes down-regulated in monocytes (3h): untreated versus M. tuberculosis 19 kDa lipopeptide.+++GSE9239_CTRL_VS_TNF_INHIBITOR_TREATED_DC_UP///Genes up-regulated in monocyte-derived dendritic cells: control versus TNF [GeneID=7124] inhibitor etanercept.+++GSE9601_UNTREATED_VS_PI3K_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_UP///Genes up-regulated in monocytes after HCMV infection: untreated versus Ly294002 [PubChem=3973].+++GSE9988_ANTI_TREM1_VS_VEHICLE_TREATED_MONOCYTES_DN///Genes down-regulated in comparison of monocytes treated with anti-TREM1 [GeneID=54210] versus untreated monocytes.+++GSE9988_LPS_VS_VEHICLE_TREATED_MONOCYTE_DN///Genes down-regulated in comparison of monocytes treated with 1 ng/ml LPS (TLR4 agonist) versus untreated monocytes."		NM_012292	ARHGAP45				
Q8TC07	sp|Q8TC07|TBC15_HUMAN		TBC1D15		TBC1 domain family member 15 OS=Homo sapiens OX=9606 GN=TBC1D15 PE=1 SV=2	64786	NM_022771	NP_073608	ENST00000550746	K20168			MAAAGVVSGKIIYEQEGVYIHSSCGKTNDQDGLISGILRVLEKDAEVIVDWRPLDDALDSSSILYARKDSSSVVEWTQAPKERGHRGSEHLNSYEAEWDMVNTVSFKRKPHTNGDAPSHRNGKSKWSFLFSLTDLKSIKQNKEGMGWSYLVFCLKDDVVLPALHFHQGDSKLLIESLEKYVVLCESPQDKRTLLVNCQNKSLSQSFENLLDEPAYGLIQAGLLDRRKLLWAIHHWKKIKKDPYTATMIGFSKVTNYIFDSLRGSDPSTHQRPPSEMADFLSDAIPGLKINQQEEPGFEVITRIDLGERPVVQRREPVSLEEWTKNIDSEGRILNVDNMKQMIFRGGLSHALRKQAWKFLLGYFPWDSTKEERTQLQKQKTDEYFRMKLQWKSISQEQEKRNSRLRDYRSLIEKDVNRTDRTNKFYEGQDNPGLILLHDILMTYCMYDFDLGYVQGMSDLLSPLLYVMENEVDAFWCFASYMDQMHQNFEEQMQGMKTQLIQLSTLLRLLDSGFCSYLESQDSGYLYFCFRWLLIRFKREFSFLDILRLWEVMWTELPCTNFHLLLCCAILESEKQQIMEKHYGFNEILKHINELSMKIDVEDILCKAEAISLQMVKCKELPQAVCEILGLQGSEVTTPDSDVGEDENVVMTPCPTSAFQSNALPTLSASGARNDSPTQIPVSSDVCRLTPA	0.3428297	-1.544435959	0.03921414																						4.7755242						6.83115		6.126139	6.6184341								5.628021			6.3960572			04137///Mitophagy - animal				GO:0005576///extracellular region+++GO:0005737///cytoplasm	GO:0005096///GTPase activator activity+++GO:0005515///protein binding	GO:0006886///intracellular protein transport+++GO:0043087///regulation of GTPase activity+++GO:0090630///activation of GTPase activity+++GO:1902017///regulation of cilium assembly	tissueType=Stomach;cancerType=Normal;cellName=Multipotent progenitor cell+++tissueType=Fetal gonad;cancerType=Normal;cellName=Meiotic prophase fetal germ cell		"Homo sapiens TBC1 domain family member 15 (TBC1D15), transcript variant 1, mRNA."		PF00566///Rab-GTPase-TBC domain+++PF12068///Rab-binding domain (RBD)	R-HSA-199991///Membrane Trafficking+++R-HSA-5653656///Vesicle-mediated transport+++R-HSA-8854214///TBC/RABGAPs+++R-HSA-9007101///Rab regulation of trafficking		KOG2197///regulation of vesicle fusion		"IPR000195///Rab-GTPase-TBC domain+++IPR021935///Small G protein signalling modulator 1/2, Rab-binding domain+++IPR035969///Rab-GTPase-TBC domain superfamily"	[TBC15_HUMAN|Reviewed]RecName: Full=TBC1 domain family member 15; AltName: Full=GTPase-activating protein RAB7; Short=GAP for RAB7; Short=Rab7-GAP;	chr12q21///Ensembl 103 genes in cytogenetic band chr12q21			REACTOME_MEMBRANE_TRAFFICKING///Membrane Trafficking+++REACTOME_RAB_REGULATION_OF_TRAFFICKING///Rab regulation of trafficking+++REACTOME_TBC_RABGAPS///TBC/RABGAPs+++REACTOME_VESICLE_MEDIATED_TRANSPORT///Vesicle-mediated transport		"AACATTC_MIR4093P///Genes having at least one occurence of the motif AACATTC in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-409-3p (v7.1 miRBase).+++AATGTGA_MIR23A_MIR23B///Genes having at least one occurence of the motif AATGTGA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-23a and hsa-miR-23b (v7.1 miRBase).+++ACATTCC_MIR1_MIR206///Genes having at least one occurence of the motif ACATTCC in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-1 and hsa-miR-206 (v7.1 miRBase).+++ATGCAGT_MIR217///Genes having at least one occurence of the motif ATGCAGT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-217 (v7.1 miRBase).+++ATGCTGG_MIR338///Genes having at least one occurence of the motif ATGCTGG in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-338 (v7.1 miRBase).+++CTTGTAT_MIR381///Genes having at least one occurence of the motif CTTGTAT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-381 (v7.1 miRBase).+++GCAAAAA_MIR129///Genes having at least one occurence of the motif GCAAAAA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-129 (v7.1 miRBase).+++TAATAAT_MIR126///Genes having at least one occurence of the motif TAATAAT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-126* (v7.1 miRBase).+++TGTTTAC_MIR30A5P_MIR30C_MIR30D_MIR30B_MIR30E5P///Genes having at least one occurence of the motif TGTTTAC in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-30a-5p, hsa-miR-30c, hsa-miR-30d, hsa-miR-30b and hsa-miR-30e-5p (v7.1 miRBase).+++TTTGTAG_MIR520D///Genes having at least one occurence of the motif TTTGTAG in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-520d* (v7.1 miRBase)."	"MIR126_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-126-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1275///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1275 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1283///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1283 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1297///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1297 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1305///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1305 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR145_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-145-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR2054///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-2054 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR206///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-206 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR23A_3P_MIR23B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-23a-3p, hsa-miR-23b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR23C///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-23c in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR26A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-26a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR26B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-26b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR300///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-300 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR30A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-30a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR30B_5P_MIR30C_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-30b-5p, hsa-miR-30c-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR30D_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-30d-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR30E_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-30e-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3146///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3146 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR320A_3P_MIR320B_MIR320C_MIR320D///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-320a-3p, hsa-miR-320b, hsa-miR-320c, hsa-miR-320d in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR338_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-338-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR340_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-340-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3658///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3658 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR381_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-381-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3915///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3915 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4429///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4429 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4436B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4436b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4465///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4465 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4659A_3P_MIR4659B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4659a-3p, hsa-miR-4659b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5002_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5002-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR506_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-506-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5195_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5195-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR520G_3P_MIR520H///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-520g-3p, hsa-miR-520h in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR551B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-551b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR569///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-569 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR587///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-587 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR606///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-606 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR613///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-613 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6787_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6787-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR8063///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-8063 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR892C_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-892c-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR935///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-935 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR9_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-9-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets)."	ARNT_01///Genes having at least one occurence of the transcription factor binding site V$ARNT_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++CACGTG_MYC_Q2///Genes having at least one occurence of the highly conserved motif M2 CACGTG sites. The motif matches transcription factor binding site V$MYC_Q2 (v7.4 TRANSFAC).+++CREB_Q3///Genes having at least one occurence of the transcription factor binding site V$CREB_Q3 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++ER_Q6_01///Genes having at least one occurence of the transcription factor binding site V$ER_Q6_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++ERR1_Q2///Genes having at least one occurence of the transcription factor binding site V$ERR1_Q2 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++MYCMAX_03///Genes having at least one occurence of the transcription factor binding site V$MYCMAX_03 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++RCGCANGCGY_NRF1_Q6///Genes having at least one occurence of the highly conserved motif M1 RCGCANGCGY sites. The motif matches transcription factor binding site V$NRF1_Q6 (v7.4 TRANSFAC).+++SF1_Q6///Genes having at least one occurence of the transcription factor binding site V$SF1_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++TGACCTTG_SF1_Q6///Genes having at least one occurence of the highly conserved motif M38 TGACCTTG sites. The motif matches transcription factor binding site V$SF1_Q6 (v7.4 TRANSFAC).+++TGACCTY_ERR1_Q2///Genes having at least one occurence of the highly conserved motif M25 TGACCTY sites. The motif matches transcription factor binding site V$ERR1_Q2 (v7.4 TRANSFAC).	"AHRR_TARGET_GENES///Genes containing one or more binding sites for UniProt:A9YTQ3 (AHRR) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++BACH2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9BYV9 (BACH2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++DLX4_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q92988 (DLX4) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++E2F2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q14209 (E2F2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++FOXP2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O15409 (FOXP2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HOXA2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O43364 (HOXA2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++KDM5D_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9BY66 (KDM5D) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++KLF7_TARGET_GENES///Genes containing one or more binding sites for UniProt:O75840 (KLF7) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++MAFG_TARGET_GENES///Genes containing one or more binding sites for UniProt:O15525 (MAFG) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NFRKB_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6P4R8 (NFRKB) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NKX2_2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O95096 (NKX2_2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SALL4_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9UJQ4 (SALL4) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++TFEB_TARGET_GENES///Genes containing one or more binding sites for UniProt:P19484 (TFEB) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZBED4_TARGET_GENES///Genes containing one or more binding sites for UniProt:O75132 (ZBED4) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZBTB7B_TARGET_GENES///Genes containing one or more binding sites for UniProt:O15156 (ZBTB7B) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZIM3_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96PE6 (ZIM3) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF84_TARGET_GENES///Genes containing one or more binding sites for UniProt:P51523 (ZNF84) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."	GCM_CSNK1A1///Neighborhood of CSNK1A1+++GCM_CSNK1D///Neighborhood of CSNK1D+++GCM_ERBB2IP///Neighborhood of ERBB2IP+++GCM_NF2///Neighborhood of NF2	MODULE_26///Genes in the cancer module 26.	CAMP_UP.V1_UP///Genes up-regulated in primary thyrocyte cultures in response to cAMP signaling pathway activation by thyrotropin (TSH).	"GSE15271_CXCR4_POS_VS_NEG_GC_BCELL_DN///Genes down-regulated in centroblasts versus centrocytes.+++GSE16385_UNTREATED_VS_12H_IL4_TREATED_MACROPHAGE_DN///Genes down-regulated in macrophages (12h): control versus IL4 [GeneID=3565].+++GSE17301_IFNA2_VS_IFNA5_STIM_ACD3_ACD28_ACT_CD8_TCELL_UP///Genes up-regulated in CD8 T cells stimulated by IFNA2 [GeneID=3440] versus CD8 T cells stimulated by IFNA5 [GeneID=3442] and activated by anti-CD3 and anti-CD28.+++GSE2770_UNTREATED_VS_ACT_CD4_TCELL_6H_UP///Genes up-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 (6h).+++GSE29615_CTRL_VS_DAY3_LAIV_IFLU_VACCINE_PBMC_UP///Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from LAIV influenza vaccinee pre-vaccination versus those at day 3 post-vaccination.+++GSE29615_DAY3_VS_DAY7_LAIV_FLU_VACCINE_PBMC_DN///Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from LAIV influenza vaccinee at day 3 post-vaccination versus those at day 7 post-vaccination.+++GSE37416_CTRL_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_DN///Genes down-regulated in comparison of control polymorphonuclear leukocytes (PMN) at 24 h versus PMN treated with F. tularensis vaccine at 24 h.+++GSE3982_CTRL_VS_PMA_STIM_EOSINOPHIL_DN///Genes down-regulated in comparison of untreated eosinophils versus eosinophils treated with PMA [PubChem=4792] at 2 h.+++GSE3982_MAST_CELL_VS_NEUTROPHIL_DN///Genes down-regulated in comparison of mast cells versus neutrophils.+++GSE4748_CTRL_VS_LPS_STIM_DC_3H_DN///Genes down-regulated in monocyte-derived dendritic cells: untreated versus LPS (3h).+++NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_NEGATIVE///Genes negatively correlated with HAI response at 28d in peripheral blood mononuclear cell in adults (18-50) after exposure to Fluarix/Fluvirin , time point 3D. Comment: Supplementary Table 5: All genes whose expression (d3/d0 or d7/d0) correlates to the fold increase in HAI titers (d28/d0).+++NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN///Genes down-regulated in peripheral blood mononuclear cell 3d vs 0d in adults (18-50) after exposure to FluMist , time point 3D. Comment: Supplementary Table 1b: All the differentially expressed genes identified in PBMCs of TIV vaccinees.+++THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_UP///Genes up-regulated in peripheral blood mononuclear cell 28d vs 0d in young adults (21-30) (responders) after exposure to Inactivated influenza vaccine , time point 28D"		NM_022771	TBC1D15				
Q8IZP0	sp|Q8IZP0|ABI1_HUMAN		ABI1		Abl interactor 1 OS=Homo sapiens OX=9606 GN=ABI1 PE=1 SV=4	10006	NM_005470	NP_005461	ENST00000376142	K23649			MAELQMLLEEEIPSGKRALIESYQNLTRVADYCENNYIQATDKRKALEETKAYTTQSLASVAYQINALANNVLQLLDIQASQLRRMESSINHISQTVDIHKEKVARREIGILTTNKNTSRTHKIIAPANMERPVRYIRKPIDYTVLDDVGHGVKWLKAKHGNNQPARTGTLSRTNPPTQKPPSPPMSGRGTLGRNTPYKTLEPVKPPTVPNDYMTSPARLGSQHSPGRTASLNQRPRTHSGSSGGSGSRENSGSSSIGIPIAVPTPSPPTIGPENISVPPPSGAPPAPPLAPLLPVSTVIAAPGSAPGSQYGTMTRQISRHNSTTSSTSSGGYRRTPSVTAQFSAQPHVNGGPLYSQNSISIAPPPPPMPQLTPQIPLTGFVARVQENIADSPTPPPPPPPDDIPMFDDSPPPPPPPPVDYEDEEAAVVQYNDPYADGDPAWAPKNYIEKVVAIYDYTKDKDDELSFMEGAIIYVIKKNDDGWYEGVCNRVTGLFPGNYVESIMHYTD	0.5357347	-0.900409294	0.01061868		4.0617461	3.0205085	3.1299061	4.6351145	5.7369557	4.634668939	4.5415965	6.8402877	5.3324951	5.2491703	6.5865841		4.5283643	5.0224305	5.0931287		4.1539557			4.8863297	5.2882292	6.1263573		4.35945626		2.8066438	6.249598	6.6150877	6.878605	7.5046573	3.796169	6.4284282	6.0763714	5.2956566	5.4583417	6.5034363	5.4733989	6.413104	6.5281238	5.98834011	5.8774291	5.0092312	5.96265694	05130///Pathogenic Escherichia coli infection+++05132///Salmonella infection				GO:0005622///intracellular+++GO:0005634///nucleus+++GO:0005737///cytoplasm+++GO:0005783///endoplasmic reticulum+++GO:0005829///cytosol+++GO:0005856///cytoskeleton+++GO:0014069///postsynaptic density+++GO:0030027///lamellipodium+++GO:0030054///cell junction+++GO:0030175///filopodium+++GO:0030426///growth cone+++GO:0031209///SCAR complex+++GO:0031252///cell leading edge+++GO:0032433///filopodium tip+++GO:0042995///cell projection+++GO:0043005///neuron projection+++GO:0045202///synapse+++GO:0070062///extracellular exosome	GO:0005515///protein binding+++GO:0008092///cytoskeletal protein binding+++GO:0017124///SH3 domain binding+++GO:0030296///protein tyrosine kinase activator activity+++GO:0035591///signaling adaptor activity+++GO:0045296///cadherin binding	GO:0001756///somitogenesis+++GO:0007169///transmembrane receptor protein tyrosine kinase signaling pathway+++GO:0008154///actin polymerization or depolymerization+++GO:0008285///negative regulation of cell proliferation+++GO:0016032///viral process+++GO:0018108///peptidyl-tyrosine phosphorylation+++GO:0035855///megakaryocyte development+++GO:0038096///Fc-gamma receptor signaling pathway involved in phagocytosis+++GO:0048010///vascular endothelial growth factor receptor signaling pathway+++GO:0048813///dendrite morphogenesis+++GO:0061098///positive regulation of protein tyrosine kinase activity+++GO:0072673///lamellipodium morphogenesis	tissueType=Fetal kidney;cancerType=Normal;cellName=Natural killer T (NKT) cell		"Homo sapiens abl interactor 1 (ABI1), transcript variant 1, mRNA."		PF00018///SH3 domain+++PF07815///Abl-interactor HHR	"R-HSA-162582///Signal Transduction+++R-HSA-1643685///Disease+++R-HSA-168249///Innate Immune System+++R-HSA-168256///Immune System+++R-HSA-194138///Signaling by VEGF+++R-HSA-194315///Signaling by Rho GTPases+++R-HSA-195258///RHO GTPase Effectors+++R-HSA-2029480///Fcgamma receptor (FCGR) dependent phagocytosis+++R-HSA-2029482///Regulation of actin dynamics for phagocytic cup formation+++R-HSA-4420097///VEGFA-VEGFR2 Pathway+++R-HSA-5663205///Infectious disease+++R-HSA-5663213///RHO GTPases Activate WASPs and WAVEs+++R-HSA-9006934///Signaling by Receptor Tyrosine Kinases+++R-HSA-9012999///RHO GTPase cycle+++R-HSA-9013149///RAC1 GTPase cycle+++R-HSA-9013404///RAC2 GTPase cycle+++R-HSA-9013423///RAC3 GTPase cycle+++R-HSA-9658195///Leishmania infection+++R-HSA-9664407///Parasite infection+++R-HSA-9664417///Leishmania phagocytosis+++R-HSA-9664422///FCGR3A-mediated phagocytosis+++R-HSA-9716542///Signaling by Rho GTPases, Miro GTPases and RHOBTB3"		KOG2546///actin polymerization or depolymerization		"IPR000727///Target SNARE coiled-coil homology domain+++IPR001452///SH3 domain+++IPR012849///Abl-interactor, homeo-domain homologous domain+++IPR028456///Abl interactor 1+++IPR028457///ABI family+++IPR035725///Abl Interactor 1, SH3 domain+++IPR036028///SH3-like domain superfamily"	[ABI1_HUMAN|Reviewed]RecName: Full=Abl interactor 1; AltName: Full=Abelson interactor 1; Short=Abi-1; AltName: Full=Abl-binding protein 4; Short=AblBP4; AltName: Full=Eps8 SH3 domain-binding protein; Short=Eps8-binding protein; AltName: Full=Nap1-binding protein; Short=Nap1BP; AltName: Full=Spectrin SH3 domain-binding protein 1; AltName: Full=e3B1;+++[L8EC66_HUMAN|Unreviewed]SubName: Full=Alternative protein ABI1 {ECO:0000313|EMBL:CCQ43032.1};	chr10p12///Ensembl 103 genes in cytogenetic band chr10p12			"REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS///Fcgamma receptor (FCGR) dependent phagocytosis+++REACTOME_INFECTIOUS_DISEASE///Infectious disease+++REACTOME_INNATE_IMMUNE_SYSTEM///Innate Immune System+++REACTOME_LEISHMANIA_INFECTION///Leishmania infection+++REACTOME_PARASITE_INFECTION///Parasite infection+++REACTOME_RAC1_GTPASE_CYCLE///RAC1 GTPase cycle+++REACTOME_RAC2_GTPASE_CYCLE///RAC2 GTPase cycle+++REACTOME_RAC3_GTPASE_CYCLE///RAC3 GTPase cycle+++REACTOME_RHO_GTPASE_CYCLE///RHO GTPase cycle+++REACTOME_RHO_GTPASE_EFFECTORS///RHO GTPase Effectors+++REACTOME_RHO_GTPASES_ACTIVATE_WASPS_AND_WAVES///RHO GTPases Activate WASPs and WAVEs+++REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES///Signaling by Receptor Tyrosine Kinases+++REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3///Signaling by Rho GTPases, Miro GTPases and RHOBTB3+++REACTOME_SIGNALING_BY_VEGF///Signaling by VEGF"			"LET_7A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-let-7a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++LET_7B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-let-7b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++LET_7F_1_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-let-7f-1-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR10399_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-10399-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR10527_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-10527-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR106A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-106a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR106B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-106b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1252_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1252-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR138_1_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-138-1-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR144_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-144-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR15B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-15b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR17_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-17-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR181B_2_3P_MIR181B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-181b-2-3p, hsa-miR-181b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR183_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-183-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR20A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-20a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR20B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-20b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR300///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-300 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3136_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3136-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3606_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3606-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR361_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-361-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3688_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3688-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR380_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-380-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR381_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-381-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3924///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3924 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3929///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3929 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3941///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3941 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3942_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3942-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4420///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4420 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4439///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4439 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4452///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4452 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4478///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4478 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4666A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4666a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR466///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-466 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4672///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4672 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4703_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4703-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4719///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4719 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4731_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4731-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4790_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4790-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4795_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4795-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4801///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4801 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR491_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-491-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR513A_3P_MIR513C_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-513a-3p, hsa-miR-513c-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5187_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5187-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR519D_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-519d-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR520G_3P_MIR520H///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-520g-3p, hsa-miR-520h in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR526B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-526b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR544A///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-544a in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AE_3P_MIR548AQ_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548ae-3p, hsa-miR-548aq-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AH_3P_MIR548AM_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548ah-3p, hsa-miR-548am-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AJ_3P_MIR548X_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548aj-3p, hsa-miR-548x-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AJ_5P_MIR548G_5P_MIR548X_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548aj-5p, hsa-miR-548g-5p, hsa-miR-548x-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AT_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548at-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548F_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548f-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548J_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548j-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5571_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5571-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5582_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5582-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5588_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5588-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5700///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5700 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR580_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-580-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6131///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6131 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6504_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6504-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6857_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6857-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR8069///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-8069 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR889_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-889-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR93_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-93-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR98_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-98-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets)."	CTGYNNCTYTAA_UNKNOWN///Genes having at least one occurence of the highly conserved motif M82 CTGYNNCTYTAA in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++GGGTGGRR_PAX4_03///Genes having at least one occurence of the highly conserved motif M56 GGGTGGRR sites. The motif matches transcription factor binding site V$PAX4_03 (v7.4 TRANSFAC).+++GGGYGTGNY_UNKNOWN///Genes having at least one occurence of the highly conserved motif M31 GGGYGTGNY in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++HNF3ALPHA_Q6///Genes having at least one occurence of the transcription factor binding site V$HNF3ALPHA_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++HNF3_Q6///Genes having at least one occurence of the transcription factor binding site V$HNF3_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++HNF6_Q6///Genes having at least one occurence of the transcription factor binding site V$HNF6_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++MCAATNNNNNGCG_UNKNOWN///Genes having at least one occurence of the highly conserved motif M110 MCAATNNNNNGCG in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++PU1_Q6///Genes having at least one occurence of the transcription factor binding site V$PU1_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++RCGCANGCGY_NRF1_Q6///Genes having at least one occurence of the highly conserved motif M1 RCGCANGCGY sites. The motif matches transcription factor binding site V$NRF1_Q6 (v7.4 TRANSFAC).+++RGAGGAARY_PU1_Q6///Genes having at least one occurence of the highly conserved motif M50 RGAGGAARY sites. The motif matches transcription factor binding site V$PU1_Q6 (v7.4 TRANSFAC).+++SYATTGTG_UNKNOWN///Genes having at least one occurence of the highly conserved motif M71 SYATTGTG in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).	"AHRR_TARGET_GENES///Genes containing one or more binding sites for UniProt:A9YTQ3 (AHRR) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++BANP_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8N9N5 (BANP) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++CREB3L4_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8TEY5 (CREB3L4) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++DYRK1A_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q13627 (DYRK1A) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++IRF5_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q13568 (IRF5) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++JDP2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8WYK2 (JDP2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++MZF1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P28698 (MZF1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NFRKB_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6P4R8 (NFRKB) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++RAG1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P15918 (RAG1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SALL4_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9UJQ4 (SALL4) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++TERF1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P54274 (TERF1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++TET1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8NFU7 (TET1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++UBP1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9NZI7 (UBP1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZFP91_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96JP5 (ZFP91) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZIM3_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96PE6 (ZIM3) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF331_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9NQX6 (ZNF331) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF362_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q5T0B9 (ZNF362) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF581_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9P0T4 (ZNF581) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."		MODULE_491///Genes in the cancer module 491.+++MODULE_568///Genes in the cancer module 568.		"GSE13484_12H_VS_3H_YF17D_VACCINE_STIM_PBMC_UP///Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) cultured with YF17D vaccine for 12 h versus PBMC cultured for 3 h.+++GSE16385_UNTREATED_VS_12H_IFNG_TNF_TREATED_MACROPHAGE_DN///Genes down-regulated in macrophages (12h): control versus IFNG and TNF [GeneID=3458;7124].+++GSE18893_CTRL_VS_TNF_TREATED_TCONV_24H_DN///Genes down-regulated in T conv cells (24h): medium versus TNF [GeneID=7124].+++GSE19888_CTRL_VS_T_CELL_MEMBRANES_ACT_MAST_CELL_UP///Genes up-regulated in HMC-1 (mast leukemia) cells: untreated versus stimulated with T cell membranes.+++GSE20198_IL12_VS_IL12_IL18_TREATED_ACT_CD4_TCELL_DN///Genes down-regulated in the activated CD4 [GeneID=920] T cells (48h): IL-12 versus IL-12 and IL18 [GeneID=3606].+++GSE27670_BLIMP1_VS_LMP1_TRANSDUCED_GC_BCELL_DN///Genes down-regulated in germinal center B lymphocytes over-expressing: PRDM1 [GeneID=639] versus Epstein-Barr virus protein LMP1.+++GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_6H_UP///Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: IL-12 (6h) versus IL4 [GeneID=3565] (6h).+++GSE2770_UNTREATED_VS_ACT_CD4_TCELL_6H_UP///Genes up-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 (6h).+++GSE32901_NAIVE_VS_TH17_ENRICHED_CD4_TCELL_DN///Genes down-regulated in CD4 [GeneID=920] nave versus Th17 enriched.+++GSE32901_TH17_EMRICHED_VS_TH17_NEG_CD4_TCELL_DN///Genes down-regulated in CD4 [GeneID=920] Th17 T cells: enriched versus negative.+++GSE32901_TH1_VS_TH17_ENRICHED_CD4_TCELL_UP///Genes up-regulated in CD4 [GeneID=920] T cells: Th1 versus Th17 enriched.+++GSE34156_UNTREATED_VS_6H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN///Genes down-regulated in monocytes (6h): untreated versus muramyl dipeptide [PubChem=11620162] andM. tuberculosis 19 kDa lipopeptide.+++GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_DN///Genes down-regulated in comparison of dendritic cells (DC) exposed to 50 worms/well B. malayi versus DC exposed to M. tuberculosis+++GSE360_L_DONOVANI_VS_L_MAJOR_MAC_DN///Genes down-regulated in comparison of macrophages exposed to L. donovani versus macrophages exposed to L. major.+++GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_DC_DN///Genes down-regulated in comparison of dendritic cells (DC) exposed to L. donovani versus DCs exposed to M. tuberculosis.+++GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_MAC_UP///Genes up-regulated in comparison of macrophages exposed to L. major versus macrophages exposed to 50 worms/well B. malayi.+++GSE3982_CTRL_VS_LPS_1H_NEUTROPHIL_UP///Genes up-regulated in comparison of untreated neutrophils versus neutrophils treated with LPS (TLR4 agonist) at 1 h.+++GSE43700_UNTREATED_VS_IL10_TREATED_PBMC_DN///Genes down-regulated in peripheral blood monocytes (PBMC): control versus IL10 [GeneID=3586].+++GSE4590_PRE_BCELL_VS_LARGE_PRE_BCELL_UP///Genes up-regulated during B lymphocyte differentiation: pre-B I versus large pre-B II.+++GSE5542_IFNG_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_DN///Genes down-regulated in epithelial cells (24h): IFNG [GeneID=3458] versus IFNG [GeneID=3458] and interferon alpha.+++GSE6092_B_BURGDOFERI_VS_B_BURGDORFERI_AND_IFNG_STIM_ENDOTHELIAL_CELL_DN///Genes down-regulated in endothelial cells: B. burgdoferi versus IFNG [GeneID=3459] and B. burgdoferi .+++GSE8685_IL15_ACT_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_UP///Genes up-regulated in Sez-2 cells (T cell lymphoma): IL15 [GeneID=3600] versus IL21 [GeneID=3600].+++OSMAN_BLOOD_CHAD63_KH_AGE_18_50YO_HIGH_DOSE_SUBJECTS_24HR_UP///Genes up-regulated in blood 24hr vs 0hr in adults (18-50) (high dose subjects) after exposure to ChAd63-KH , time point 24H , administered Intramuscular injection. Comment: DE gene list for high dose subjects.+++THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_NONRESPONDER_28DY_UP///Genes up-regulated in peripheral blood mononuclear cell 28d vs 0d in young adults (21-30) (nonresponder) after exposure to Inactivated influenza vaccine , time point 28D+++THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_UP///Genes up-regulated in peripheral blood mononuclear cell 7d vs 0d in young adults (21-30) (responders) after exposure to Inactivated influenza vaccine , time point 7D"	HALLMARK_ALLOGRAFT_REJECTION///Genes up-regulated during transplant rejection.+++HALLMARK_INFLAMMATORY_RESPONSE///Genes defining inflammatory response.+++HALLMARK_MITOTIC_SPINDLE///Genes important for mitotic spindle assembly.	NM_005470	ABI1				
Q8IVB4	sp|Q8IVB4|SL9A9_HUMAN		SLC9A9		Sodium/hydrogen exchanger 9 OS=Homo sapiens OX=9606 GN=SLC9A9 PE=1 SV=1	285195	NM_173653	NP_775924	ENST00000316549				MERQSRVMSEKDEYQFQHQGAVELLVFNFLLILTILTIWLFKNHRFRFLHETGGAMVYGLIMGLILRYATAPTDIESGTVYDCVKLTFSPSTLLVNITDQVYEYKYKREISQHNINPHQGNAILEKMTFDPEIFFNVLLPPIIFHAGYSLKKRHFFQNLGSILTYAFLGTAISCIVIGLIMYGFVKAMIHAGQLKNGDFHFTDCLFFGSLMSATDPVTVLAIFHELHVDPDLYTLLFGESVLNDAVAIVLTYSISIYSPKENPNAFDAAAFFQSVGNFLGIFAGSFAMGSAYAIITALLTKFTKLCEFPMLETGLFFLLSWSAFLSAEAAGLTGIVAVLFCGVTQAHYTYNNLSSDSKIRTKQLFEFMNFLAENVIFCYMGLALFTFQNHIFNALFILGAFLAIFVARACNIYPLSFLLNLGRKQKIPWNFQHMMMFSGLRGAIAFALAIRNTESQPKQMMFTTTLLLVFFTVWVFGGGTTPMLTWLQIRVGVDLDENLKEDPSSQHQEANNLDKNMTKAESARLFRMWYSFDHKYLKPILTHSGPPLTTTLPEWCGPISRLLTSPQAYGEQLKEDDVECIVNQDELAINYQEQASSPCSPPARLGLDQKASPQTPGKENIYEGDLGLGGYELKLEQTLGQSQLN	0.5621388	-0.831001715	0.01381701						5.3026642				6.5233897		7.4253062			6.0864766							7.1608731	7.6383449					7.672878	6.9003272	7.313991	8.215995		6.8662964	7.241976	7.1225521		7.4139405	7.0365413	7.668078			7.6883266	6.1866534	7.66451107		H02111///Autism			GO:0005768///endosome+++GO:0005886///plasma membrane+++GO:0016020///membrane+++GO:0016021///integral component of membrane+++GO:0031902///late endosome membrane+++GO:0055037///recycling endosome	GO:0005515///protein binding+++GO:0015297///antiporter activity+++GO:0015299///solute:proton antiporter activity+++GO:0015385///sodium:proton antiporter activity+++GO:0015386///potassium:proton antiporter activity	GO:0006811///ion transport+++GO:0006812///cation transport+++GO:0006814///sodium ion transport+++GO:0006885///regulation of pH+++GO:0035725///sodium ion transmembrane transport+++GO:0051453///regulation of intracellular pH+++GO:0055085///transmembrane transport+++GO:0071805///potassium ion transmembrane transport+++GO:0098656///anion transmembrane transport+++GO:0098719///sodium ion import across plasma membrane+++GO:1902600///proton transmembrane transport	tissueType=Blood;cancerType=Normal;cellName=CD141+CLEC9A+ dendritic cell+++tissueType=Liver;cancerType=Normal;cellName=Exhausted CD4+ T cell+++tissueType=Large intestine;cancerType=Normal;cellName=Paneth cell+++tissueType=Embryonic prefrontal cortex;cancerType=Normal;cellName=Microglial cell		"Homo sapiens solute carrier family 9 member A9 (SLC9A9), mRNA."		PF00999///Sodium/hydrogen exchanger family	R-HSA-1643685///Disease+++R-HSA-382551///Transport of small molecules+++R-HSA-425393///Transport of inorganic cations/anions and amino acids/oligopeptides+++R-HSA-425407///SLC-mediated transmembrane transport+++R-HSA-425986///Sodium/Proton exchangers+++R-HSA-5619052///Defective SLC9A9 causes autism 16 (AUTS16)+++R-HSA-5619102///SLC transporter disorders+++R-HSA-5619115///Disorders of transmembrane transporters		KOG1965///potassium:proton antiporter activity		"IPR002090///Na+/H+ exchanger, isoform 6/7/9+++IPR004709///Na+/H+ exchanger+++IPR006153///Cation/H+ exchanger+++IPR018416///Na+/H+ exchanger 9+++IPR018422///Cation/H+ exchanger, CPA1 family"	[SL9A9_HUMAN|Reviewed]RecName: Full=Sodium/hydrogen exchanger 9; AltName: Full=Na(+)/H(+) exchanger 9; Short=NHE-9; AltName: Full=Solute carrier family 9 member 9;+++[L8EBG2_HUMAN|Unreviewed]SubName: Full=Alternative protein SLC9A9 {ECO:0000313|EMBL:CCQ43898.1};				REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS///Disorders of transmembrane transporters+++REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT///SLC-mediated transmembrane transport+++REACTOME_SLC_TRANSPORTER_DISORDERS///SLC transporter disorders+++REACTOME_SODIUM_PROTON_EXCHANGERS///Sodium/Proton exchangers+++REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES///Transport of inorganic cations/anions and amino acids/oligopeptides+++REACTOME_TRANSPORT_OF_SMALL_MOLECULES///Transport of small molecules		"AAGCCAT_MIR135A_MIR135B///Genes having at least one occurence of the motif AAGCCAT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-135a and hsa-miR-135b (v7.1 miRBase).+++ATACCTC_MIR202///Genes having at least one occurence of the motif ATACCTC in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-202 (v7.1 miRBase).+++ATGCTGG_MIR338///Genes having at least one occurence of the motif ATGCTGG in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-338 (v7.1 miRBase).+++GTGCCTT_MIR506///Genes having at least one occurence of the motif GTGCCTT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-506 (v7.1 miRBase).+++TAGCTTT_MIR9///Genes having at least one occurence of the motif TAGCTTT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-9* (v7.1 miRBase)."	MIR100_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-100-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR10527_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-10527-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR124_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-124-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1249_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1249-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR135A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-135a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR135B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-135b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR153_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-153-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR202_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-202-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3159///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3159 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3167///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3167 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3680_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3680-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR374C_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-374c-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3978///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3978 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR448///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-448 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4668_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4668-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR506_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-506-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6797_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6797-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6845_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6845-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR876_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-876-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).	AP1_Q2///Genes having at least one occurence of the transcription factor binding site V$AP1_Q2 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++AR_Q6///Genes having at least one occurence of the transcription factor binding site V$AR_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++CTTTAAR_UNKNOWN///Genes having at least one occurence of the highly conserved motif M29 CTTTAAR in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++ELF1_Q6///Genes having at least one occurence of the transcription factor binding site V$ELF1_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++ETS1_B///Genes having at least one occurence of the transcription factor binding site V$ETS1_B (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++ETS_Q4///Genes having at least one occurence of the transcription factor binding site V$ETS_Q4 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++EVI1_02///Genes having at least one occurence of the transcription factor binding site V$EVI1_02 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++EVI1_06///Genes having at least one occurence of the transcription factor binding site V$EVI1_06 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++GCANCTGNY_MYOD_Q6///Genes having at least one occurence of the highly conserved motif M35 GCANCTGNY sites. The motif matches transcription factor binding site V$MYOD_Q6 (v7.4 TRANSFAC).+++GR_Q6///Genes having at least one occurence of the transcription factor binding site V$GR_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++IPF1_Q4///Genes having at least one occurence of the transcription factor binding site V$IPF1_Q4 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++RRAGTTGT_UNKNOWN///Genes having at least one occurence of the highly conserved motif M129 RRAGTTGT in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++RYTTCCTG_ETS2_B///Genes having at least one occurence of the highly conserved motif M16 RYTTCCTG sites. The motif matches transcription factor binding site V$ETS2_B (v7.4 TRANSFAC).+++TAL1BETAITF2_01///Genes having at least one occurence of the transcription factor binding site V$TAL1BETAITF2_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++TFIIA_Q6///Genes having at least one occurence of the transcription factor binding site V$TFIIA_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++TGACAGNY_MEIS1_01///Genes having at least one occurence of the highly conserved motif M41 TGACAGNY sites. The motif matches transcription factor binding site V$MEIS1_01 (v7.4 TRANSFAC).+++TGCCAAR_NF1_Q6///Genes having at least one occurence of the highly conserved motif M47 TGCCAAR sites. The motif matches transcription factor binding site V$NF1_Q6 (v7.4 TRANSFAC).+++TGCTGAY_UNKNOWN///Genes having at least one occurence of the highly conserved motif M92 TGCTGAY in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++TTANTCA_UNKNOWN///Genes having at least one occurence of the highly conserved motif M64 TTANTCA in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).	"HBZ_TARGET_GENES///Genes containing one or more binding sites for UniProt:P02008 (HBZ) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++TERF2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q15554 (TERF2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZFP91_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96JP5 (ZFP91) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."				"GSE10463_CD40L_AND_VA347_VS_CD40L_IN_DC_UP///Genes up-regulated in comparison of dendritic cells activated in the absense of VAF347 [PubChem=10172275] versus those activated in the presence of VAF347 [PubChem=10172275].+++GSE11057_NAIVE_VS_CENT_MEMORY_CD4_TCELL_DN///Genes down-regulated in comparison of naive T cells versus central memory T cells.+++GSE11057_NAIVE_VS_MEMORY_CD4_TCELL_DN///Genes down-regulated in comparison of naive T cells versus memory T cells.+++GSE11864_CSF1_IFNG_VS_CSF1_PAM3CYS_IN_MAC_UP///Genes up-regulated in comparison of macrophages cultured with M-CSF [GeneID=1435] and IFNG [GeneID=3458] versus macrophages cultured with M-CSF [GeneID=1435] and Pam3Cyc.+++GSE13485_DAY7_VS_DAY21_YF17D_VACCINE_PBMC_UP///Genes up-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) 7 days after stimulation with YF17D vaccine versus PBMC 21 days after the stimulation.+++GSE15735_2H_VS_12H_HDAC_INHIBITOR_TREATED_CD4_TCELL_DN///Genes down-regulated in CD4 [GeneID=920] T cells treated with HDAC inhibitors: 2h versus 12h.+++GSE15735_CTRL_VS_HDAC_INHIBITOR_TREATED_CD4_TCELL_12H_DN///Genes down-regulated in CD4 [GeneID=920] T cells: control versus treated with HDAC inhibitors for 12h.+++GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_IFNG_TNF_TREATED_MACROPHAGE_DN///Genes down-regulated in monocytes (12h) versus macrophages (12h) treated with IFNG, TNF [GeneID=3458;7124] and rosiglitazone [PubChem=77999].+++GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_IL4_TREATED_MACROPHAGE_DN///Genes down-regulated in monocytes (12h) versus macrophages (12h) treated with IL4 [GeneID=3565] and rosiglitazone [PubChem=77999].+++GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_IL4_TREATED_MACROPHAGE_UP///Genes up-regulated in macrophages (12h): control versus rosiglitazone [PubChem=77999] and IL4 [GeneID=3565].+++GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_UP///Genes up-regulated in immature neuron cell line: control versus interferon alpha (12h).+++GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_12H_IFNA_STIM_UP///Genes up-regulated in neuron cell line treated with interferon alpha for 12h: immature versus mature.+++GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_UP///Genes up-regulated in the neuron cell line: immature versus mature.+++GSE17186_NAIVE_VS_CD21HIGH_TRANSITIONAL_BCELL_DN///Genes down-regulated in B lymphocytes: nave versus transitional CR2 [GeneID=1380] high.+++GSE17974_0H_VS_24H_IN_VITRO_ACT_CD4_TCELL_UP///Genes up-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the untreated cells at 24 h.+++GSE17974_0H_VS_4H_IN_VITRO_ACT_CD4_TCELL_UP///Genes up-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the untreated cells at 4 h.+++GSE17974_0H_VS_6H_IN_VITRO_ACT_CD4_TCELL_UP///Genes up-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the untreated cells at 6 h.+++GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_12H_CD4_TCELL_UP///Genes up-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the cells treated with IL4 [GeneID=3565] and anti-IL12 at 12 h.+++GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_4H_CD4_TCELL_UP///Genes up-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the cells treated with IL4 [GeneID=3565] and anti-IL12 at 4 h.+++GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_24H_ACT_CD4_TCELL_UP///Genes up-regulated in comparison of CD4 [GeneID=920] T cells treated with IL4 [GeneID=3565] and anti-IL12 at 24 h versus the untreated cells at 24 h.+++GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_48H_ACT_CD4_TCELL_UP///Genes up-regulated in comparison of CD4 [GeneID=920] T cells treated with IL4 [GeneID=3565] and anti-IL12 at 48 h versus the untreated cells at 48 h.+++GSE18893_CTRL_VS_TNF_TREATED_TREG_24H_DN///Genes down-regulated in T reg cells: 2h versus 24h medium treatment.+++GSE18893_CTRL_VS_TNF_TREATED_TREG_2H_UP///Genes up-regulated in T reg cells (2h): medium versus TNF [GeneID=7124].+++GSE20198_UNTREATED_VS_IL12_IL18_TREATED_ACT_CD4_TCELL_DN///Genes down-regulated in the activated CD4 [GeneID=920] T cells (48h): control versus IL-12 and IL18 [GeneID=3606].+++GSE22601_CD4_SINGLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_DN///Genes down-regulated in single positive thymocytes: CD4 [GeneID=920] versus CD8.+++GSE22601_DOUBLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_UP///Genes up-regulated in thymocytes: double positive versus CD8 single positive.+++GSE23984_CTRL_VS_HYPOCALEMIC_VITAMIND_ANALOG_TCELL_DN///Genes down-regulated in T cells: control versus TX527 (hypocalemic analog of 25-hydroxyvitamin D3 [PubChem=1593]).+++GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_2H_DN///Genes down-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 [GeneID=7040] and IL-12 (2h) versus untreated (2h).+++GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_6H_UP///Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: IL4 [GeneID=3565] (6h) versus untreated (6h).+++GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_DN///Genes down-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 and IL4 [GeneID=7040;3565] (48h) versus TGFB1 [GeneID-7040] and IL-12 (48h).+++GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_UP///Genes up-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 and then stimulated by TGFB1 [GeneID=7040] and IL-12 (6h).+++GSE34156_UNTREATED_VS_6H_NOD2_LIGAND_TREATED_MONOCYTE_DN///Genes down-regulated in monocytes (6h): untreated versus muramyl dipeptide [PubChem=11620162].+++GSE4984_LPS_VS_VEHICLE_CTRL_TREATED_DC_DN///Genes down-regulated in monocyte-derived dendritic cells: LPS versus vehicle.+++GSE6092_UNSTIM_VS_IFNG_STIM_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_UP///Genes up-regulated in endothelial cells: untreated versus IFNG [GeneID=3459] and B. burgdoferi.+++GSE7460_CD8_TCELL_VS_CD4_TCELL_ACT_UP///Genes up-regulated in comparsion of ActCD8 versus ActCD4 (see Fig. 1 in the paper for details).+++GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_12H_UP///Genes up-regulated in monocytes (12h): untreated versus M. tuberculosis 19 kDa lipopeptide.+++PATEL_SKIN_OF_BODY_ZOSTAVAX_AGE_70_93YO_VZV_CHALLENGE_6HR_DN///Genes down-regulated in skin of body 6hr vs 0hr in adults (70-93) (VZV challenge) after exposure to Zostavax , time point 6H+++SCHERER_PBMC_APSV_WETVAX_AGE_18_32YO_5_TO_7DY_UP///Genes up-regulated in peripheral blood mononuclear cell (5 to 7)d vs 0d in adults (18-32) after exposure to APSV Wetvax , time point 5 to 7D+++ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_UP///Genes up-regulated in peripheral blood mononuclear cell 1d vs 0d in adults (20-50) after exposure to MRKAd5 HIV-1 gag/pol/nef , time point 1D. Comment: Table includes specific cell types"		NM_173653	SLC9A9				
Q86YW5	sp|Q86YW5|TRML1_HUMAN		TREML1		Trem-like transcript 1 protein OS=Homo sapiens OX=9606 GN=TREML1 PE=1 SV=2	340205	NM_178174	NP_835468	ENST00000426005				MGLTLLLLLLLGLEGQGIVGSLPEVLQAPVGSSILVQCHYRLQDVKAQKVWCRFLPEGCQPLVSSAVDRRAPAGRRTFLTDLGGGLLQVEMVTLQEEDAGEYGCMVDGARGPQILHRVSLNILPPEEEEETHKIGSLAENAFSDPAGSANPLEPSQDEKSIPLIWGAVLLVGLLVAAVVLFAVMAKRKQGNRLGVCGRFLSSRVSGMNPSSVVHHVSDSGPAAELPLDVPHIRLDSPPSFDNTTYTSLPLDSPSGKPSLPAPSSLPPLPPKVLVCSKPVTYATVIFPGGNKGGGTSCGPAQNPPNNQTPSS	0.3899342	-1.358697568	0.002222516	2.6194752	3.7566085	4.7825034	2.8446637	2.9583453	3.8228462	2.120725301	3.3937128	5.9233939	5.7499439	5.6162951	6.523878	3.5285553	3.4020328	3.5818021	4.1875119	2.9648676	4.1364636	1.133914392		4.5755637	5.4766448	4.2009829	1.2376262	3.98413402			5.760829	5.2140198	6.415629	7.4123432	5.839372	6.4605474	5.2174569	4.2858124	4.8334225	5.7776234	3.7751267	8.125679	5.9242459	5.5815071	6.4178953	4.8051476	5.04716871					GO:0005737///cytoplasm+++GO:0005794///Golgi apparatus+++GO:0005829///cytosol+++GO:0005886///plasma membrane+++GO:0009986///cell surface+++GO:0016020///membrane+++GO:0016021///integral component of membrane+++GO:0016607///nuclear speck+++GO:0031091///platelet alpha granule	GO:0004888///transmembrane signaling receptor activity+++GO:0005515///protein binding	GO:0019722///calcium-mediated signaling+++GO:0030168///platelet activation+++GO:0045087///innate immune response+++GO:0050776///regulation of immune response	tissueType=Umbilical cord blood;cancerType=Normal;cellName=Lymphoid-primed multipotent progenitor cell		"Homo sapiens triggering receptor expressed on myeloid cells like 1 (TREML1), transcript variant 1, mRNA."			R-HSA-1280218///Adaptive Immune System+++R-HSA-168256///Immune System+++R-HSA-198933///Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell		ENOG502SRZV///No_INFO		IPR013783///Immunoglobulin-like fold+++IPR036179///Immunoglobulin-like domain superfamily	[TRML1_HUMAN|Reviewed]RecName: Full=Trem-like transcript 1 protein; Short=TLT-1; AltName: Full=Triggering receptor expressed on myeloid cells-like protein 1; Flags: Precursor;	chr6p21///Ensembl 103 genes in cytogenetic band chr6p21			REACTOME_ADAPTIVE_IMMUNE_SYSTEM///Adaptive Immune System+++REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL///Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell			MIR12114///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-12114 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR12122///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-12122 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3157_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3157-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4264///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4264 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4266///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4266 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4500///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4500 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4723_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4723-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR513A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-513a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5698///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5698 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6802_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6802-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6870_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6870-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7111_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7111-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7161_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7161-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).	AAAYRNCTG_UNKNOWN///Genes having at least one occurence of the highly conserved motif M77 AAAYRNCTG in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++ETS2_B///Genes having at least one occurence of the transcription factor binding site V$ETS2_B (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++RYTTCCTG_ETS2_B///Genes having at least one occurence of the highly conserved motif M16 RYTTCCTG sites. The motif matches transcription factor binding site V$ETS2_B (v7.4 TRANSFAC).	"IRF9_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q00978 (IRF9) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."			SRC_UP.V1_DN///Genes down-regulated in primary epithelial breast cancer cell culture over-expressing SRC [Gene ID=6714] gene.	"GSE15659_TREG_VS_TCONV_UP///Genes up-regulated in comparison of regulatory T cell (Treg) versus conventional T cells.+++GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_0.5H_ACT_CD4_TCELL_DN///Genes down-regulated in comparison of CD4 [GeneID=920] T cells treated with IL4 [GeneID=3565] and anti-IL12 at 0.5 h versus the untreated cells at 0.5 h.+++GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_UP///Genes up-regulated in comparison of control conventional dendritic cells (cDC) at 6 h versus cDCs infected with Newcastle disease virus (NDV) at 6 h.+++GSE19888_ADENOSINE_A3R_INH_VS_INH_PRETREAT_AND_ACT_WITH_TCELL_MEMBRANES_MAST_CELL_DN///Genes down-regulated in HMC-1 (mast leukemia) cells incubated with the peptide ALL1 versus those then stimulated by T cell membranes.+++GSE22589_HIV_VS_HIV_AND_SIV_INFECTED_DC_UP///Genes up-regulated in monocyte-derived dendritic cells infected by: HIV versus HIV and SIV.+++GSE26928_EFF_MEMORY_VS_CXCR5_POS_CD4_TCELL_UP///Genes up-regulated in comparison of CD4 [GeneID=920] effector memory T cells versus CD4 [GeneID=920] CXCR5+ [GeneID=643] T cells.+++GSE2706_2H_VS_8H_R848_STIM_DC_UP///Genes up-regulated in comparison of dendritic cells (DC) stimulated with R848 at 2 h versus DCs stimulatd with R848 for 8 h.+++GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_48H_UP///Genes up-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 and then stimulated by IL-12 (48h).+++GSE3720_UNSTIM_VS_LPS_STIM_VD2_GAMMADELTA_TCELL_DN///Genes down-regulated in Vd2 gamma delta T cells: untreated versus LPS.+++GSE42724_NAIVE_VS_B1_BCELL_DN///Genes down-regulated in B lymphocytes: nave versus B1.+++GSE7400_CTRL_VS_CSF3_IN_VIVO_TREATED_PBMC_UP///Genes up-regulated in comparison of untreated peripheral blood mononuclear cells (PBMC) versus PBMCs treated with CSF3 [GeneID=1440].+++THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_UP///Genes up-regulated in peripheral blood mononuclear cell 28d vs 0d in young adults (21-30) (responders) after exposure to Inactivated influenza vaccine , time point 28D"		NM_178174	TREML1				
Q86UX7	sp|Q86UX7|URP2_HUMAN		FERMT3		Fermitin family homolog 3 OS=Homo sapiens OX=9606 GN=FERMT3 PE=1 SV=1	83706	NM_178443	NP_848537	ENST00000279227	K17084			MAGMKTASGDYIDSSWELRVFVGEEDPEAESVTLRVTGESHIGGVLLKIVEQINRKQDWSDHAIWWEQKRQWLLQTHWTLDKYGILADARLFFGPQHRPVILRLPNRRALRLRASFSQPLFQAVAAICRLLSIRHPEELSLLRAPEKKEKKKKEKEPEEELYDLSKVVLAGGVAPALFRGMPAHFSDSAQTEACYHMLSRPQPPPDPLLLQRLPRPSSLSDKTQLHSRWLDSSRCLMQQGIKAGDALWLRFKYYSFFDLDPKTDPVRLTQLYEQARWDLLLEEIDCTEEEMMVFAALQYHINKLSQSGEVGEPAGTDPGLDDLDVALSNLEVKLEGSAPTDVLDSLTTIPELKDHLRIFRIPRRPRKLTLKGYRQHWVVFKETTLSYYKSQDEAPGDPIQQLNLKGCEVVPDVNVSGQKFCIKLLVPSPEGMSEIYLRCQDEQQYARWMAGCRLASKGRTMADSSYTSEVQAILAFLSLQRTGSGGPGNHPHGPDASAEGLNPYGLVAPRFQRKFKAKQLTPRILEAHQNVAQLSLAEAQLRFIQAWQSLPDFGISYVMVRFKGSRKDEILGIANNRLIRIDLAVGDVVKTWRFSNMRQWNVNWDIRQVAIEFDEHINVAFSCVSASCRIVHEYIGGYIFLSTRERARGEELDEDLFLQLTGGHEAF	0.33961	-1.558049093	4.16E-04	6.1040976	6.6159864	5.9634652	6.9304276	7.7488188	6.8370593	4.761980225	7.0559463	8.9781731	8.9183881	8.4200842	9.2985819		8.2684916	7.950164	9.0062387	5.136548	5.8752663			5.8700366	8.69148	9.4699926		5.06524289			10.269195	10.2395097	9.479095	10.70882	8.281332	8.8601279	9.082859	8.2998179	8.6107707	9.2972997	8.474231	9.551604	8.4382687	7.96932195	9.4225067	7.4697768	9.04439439	04611///Platelet activation	H00099///Leukocyte adhesion deficiency			GO:0002102///podosome+++GO:0005576///extracellular region+++GO:0016020///membrane+++GO:0030054///cell junction+++GO:0030055///cell-substrate junction+++GO:0031093///platelet alpha granule lumen+++GO:0042995///cell projection+++GO:0070062///extracellular exosome	GO:0005178///integrin binding+++GO:0005515///protein binding	GO:0002576///platelet degranulation+++GO:0007155///cell adhesion+++GO:0007159///leukocyte cell-cell adhesion+++GO:0007160///cell-matrix adhesion+++GO:0007229///integrin-mediated signaling pathway+++GO:0030335///positive regulation of cell migration+++GO:0033622///integrin activation+++GO:0033632///regulation of cell-cell adhesion mediated by integrin+++GO:0034446///substrate adhesion-dependent cell spreading+++GO:0070527///platelet aggregation	tissueType=Fetal kidney;cancerType=Normal;cellName=Natural killer T (NKT) cell+++tissueType=Large intestine;cancerType=Normal;cellName=Paneth cell		"Homo sapiens FERM domain containing kindlin 3 (FERMT3), transcript variant URP2LF, mRNA."		PF00169///PH domain+++PF00373///FERM central domain+++PF18124///Kindlin-2 N-terminal domain	"R-HSA-109582///Hemostasis+++R-HSA-114608///Platelet degranulation +++R-HSA-76002///Platelet activation, signaling and aggregation+++R-HSA-76005///Response to elevated platelet cytosolic Ca2+"		KOG3727///integrin-mediated signaling pathway		"IPR001849///Pleckstrin homology domain+++IPR011993///PH-like domain superfamily+++IPR019748///FERM central domain+++IPR019749///Band 4.1 domain+++IPR035963///FERM superfamily, second domain+++IPR037837///Kindlin/fermitin, PH domain+++IPR037843///Kindlin/fermitin+++IPR040790///Kindlin-2, N-terminal"	[URP2_HUMAN|Reviewed]RecName: Full=Fermitin family homolog 3; AltName: Full=Kindlin-3; AltName: Full=MIG2-like protein; AltName: Full=Unc-112-related protein 2;	chr11q13///Ensembl 103 genes in cytogenetic band chr11q13			"REACTOME_HEMOSTASIS///Hemostasis+++REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION///Platelet activation, signaling and aggregation+++REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2///Response to elevated platelet cytosolic Ca2+"			MIR95_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-95-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).	AP1_C///Genes having at least one occurence of the transcription factor binding site V$AP1_C (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++AP1_Q4///Genes having at least one occurence of the transcription factor binding site V$AP1_Q4 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++AP1_Q6_01///Genes having at least one occurence of the transcription factor binding site V$AP1_Q6_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++AP1_Q6///Genes having at least one occurence of the transcription factor binding site V$AP1_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++CCCNNGGGAR_OLF1_01///Genes having at least one occurence of the highly conserved motif M130 CCCNNGGGAR sites. The motif matches transcription factor binding site V$OLF1_01 (v7.4 TRANSFAC).+++CTGCAGY_UNKNOWN///Genes having at least one occurence of the highly conserved motif M101 CTGCAGY in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++ELK1_02///Genes having at least one occurence of the transcription factor binding site V$ELK1_02 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++GATAAGR_GATA_C///Genes having at least one occurence of the highly conserved motif M131 GATAAGR sites. The motif matches transcription factor binding site V$GATA_C (v7.4 TRANSFAC).+++PEA3_Q6///Genes having at least one occurence of the transcription factor binding site V$PEA3_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++RYTTCCTG_ETS2_B///Genes having at least one occurence of the highly conserved motif M16 RYTTCCTG sites. The motif matches transcription factor binding site V$ETS2_B (v7.4 TRANSFAC).+++TGANTCA_AP1_C///Genes having at least one occurence of the highly conserved motif M7 TGANTCA sites. The motif matches transcription factor binding site V$AP1_C (v7.4 TRANSFAC).	"BACH2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9BYV9 (BACH2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++EWSR1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q01844 (EWSR1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++GTF2E2_TARGET_GENES///Genes containing one or more binding sites for UniProt:P29084 (GTF2E2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++MAFG_TARGET_GENES///Genes containing one or more binding sites for UniProt:O15525 (MAFG) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++MEF2C_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q06413 (MEF2C) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++MYOCD_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8IZQ8 (MYOCD) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NUP153_TARGET_GENES///Genes containing one or more binding sites for UniProt:P49790 (NUP153) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++PAX3_TARGET_GENES///Genes containing one or more binding sites for UniProt:P23760 (PAX3) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SNRNP70_TARGET_GENES///Genes containing one or more binding sites for UniProt:P08621 (SNRNP70) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF282_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9UDV7 (ZNF282) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF436_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9C0F3 (ZNF436) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF92_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q03936 (ZNF92) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."		MODULE_84///Immune (humoral) and inflammatory response.		"GSE10463_CD40L_AND_VA347_VS_CD40L_IN_DC_UP///Genes up-regulated in comparison of dendritic cells activated in the absense of VAF347 [PubChem=10172275] versus those activated in the presence of VAF347 [PubChem=10172275].+++GSE12366_GC_BCELL_VS_PLASMA_CELL_UP///Genes up-regulated in comparison of germinal center B cells versus plasma cells.+++GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_IN_MAST_CELL_UP///Genes up-regulated in HMC-1 (mast leukemia) cells: Cl-IB-MECA [PubChem=3035850] versus T cell membranes.+++GSE22589_HEALTHY_VS_SIV_INFECTED_DC_UP///Genes up-regulated in monocyte-derived dendritic cells: control versus SIV infection.+++GSE2405_0H_VS_24H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP///Genes up-regulated in polymorphonuclear leukocytes (24h): control versus infection by A. phagocytophilum.+++GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_DN///Genes down-regulated in polymorphonuclear leukocytes (9h): treated by heat killed HC60 cell (promyelocytic leukemia) lysate versus A. phagocytophilum infection.+++GSE2405_HEAT_KILLED_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_UP///Genes up-regulated in polymorphonuclear leukocytes (9h) infection by A. phagocytophilum: heat killed versus live bacteria.+++GSE26351_UNSTIM_VS_WNT_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_UP///Genes up-regulated in CD34+ [GeneID=947] cells: control versus treated with GSK-3 Inhibitor IX (BIO) [PubChem=5287844].+++GSE26928_NAIVE_VS_CENT_MEMORY_CD4_TCELL_DN///Genes down-regulated in comparison of naive CD4 [GeneID=920] T cells versus CD4 [GeneID=920] central memory T cells.+++GSE26928_NAIVE_VS_CXCR5_POS_CD4_TCELL_DN///Genes down-regulated in comparison of naive CD4 [GeneID=920] T cells versus CD4 [GeneID=920] CXCR5+ [GeneID=643] T cells.+++GSE27670_BLIMP1_VS_LMP1_TRANSDUCED_GC_BCELL_DN///Genes down-regulated in germinal center B lymphocytes over-expressing: PRDM1 [GeneID=639] versus Epstein-Barr virus protein LMP1.+++GSE29617_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_UP///Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from TIV influenza vaccinee at day 3 post-vaccination versus those at day 7 post-vaccination.+++GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_DN///Genes down-regulated in monocytes (6h): muramyl dipeptide [PubChem=11620162] versus M. tuberculosis 19 kDa lipopeptide.+++GSE34156_TLR1_TLR2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_UP///Genes up-regulated in monocytes (24h): M. tuberculosis 19 kDa lipopeptide versus M. tuberculosis 19 kDa lipopeptide and muramyl dipeptide [PubChem=11620162].+++GSE34205_HEALTHY_VS_FLU_INF_INFANT_PBMC_DN///Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMCs from infanct with acute influenza infection.+++GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY3_DN///Genes down-regulated in monocytes: untreated versus CSF1 [GeneID=1435] knockout at day 3.+++GSE7460_CTRL_VS_TGFB_TREATED_ACT_TREG_UP///Genes up-regulated in comparsion of ActTreg versus ActTregTGF (see Fig. 1 in the paper for details).+++GSE7460_TREG_VS_TCONV_ACT_WITH_TGFB_DN///Genes down-regulated in comparsion of ActTregTGF versus ActCD4TGF (see Fig. 1 in the paper for details).+++QUEREC_MODEL_PBMC_YF_17D_VACCINE_AGE_18_45YO_3DY_PREDICTIVE///Genes that are components of a model predictive of response in peripheral blood mononuclear cell 3d vs 0d in adults (18-45) after exposure to YF-17D vaccine , time point 3D. Comment: Suppl Table 4: genes validated by ClaNC as being predictive of CD8+ T cell responses from Fig. 4.+++SCHERER_PBMC_YF_VAX_AGE_18_40YO_4_TO_7DY_UP///Genes up-regulated in peripheral blood mononuclear cell (4 to 7)d vs 0d in adults (18-40) after exposure to YF-Vax , time point 4 to 7D+++ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_UP///Genes up-regulated in peripheral blood mononuclear cell 1d vs 0d in adults (20-50) after exposure to MRKAd5 HIV-1 gag/pol/nef , time point 1D. Comment: Table includes specific cell types"		NM_178443	FERMT3				
Q6ZVM7	sp|Q6ZVM7|TM1L2_HUMAN		TOM1L2		TOM1-like protein 2 OS=Homo sapiens OX=9606 GN=TOM1L2 PE=1 SV=1	146691	NM_001082968	NP_001076437	ENST00000379504				MEFLLGNPFSTPVGQCLEKATDGSLQSEDWTLNMEICDIINETEEGPKDAIRALKKRLNGNRNYREVMLALTVLETCVKNCGHRFHILVANRDFIDSVLVKIISPKNNPPTIVQDKVLALIQAWADAFRSSPDLTGVVHIYEELKRKGVEFPMADLDALSPIHTPQRSVPEVDPAATMPRSQSQQRTSAGSYSSPPPAPYSAPQAPALSVTGPITANSEQIARLRSELDVVRGNTKVMSEMLTEMVPGQEDSSDLELLQELNRTCRAMQQRIVELISRVSNEEVTEELLHVNDDLNNVFLRYERFERYRSGRSVQNASNGVLNEVTEDNLIDLGPGSPAVVSPMVGNTAPPSSLSSQLAGLDLGTESVSGTLSSLQQCNPRDGFDMFAQTRGNSLAEQRKTVTYEDPQAVGGLASALDNRKQSSEGIPVAQPSVMDDIEVWLRTDLKGDDLEEGVTSEEFDKFLEERAKAAEMVPDLPSPPMEAPAPASNPSGRKKPERSEDALFAL	0.5520871	-0.857032117	0.03882458						5.2533206		4.2014358		6.0986207	5.0653091	5.6529388	5.49899489			5.158618						6.0052084	5.4771908					7.915381	6.0312727	8.211435	5.9926143	4.394584		6.0090231	5.7110244		5.7512882	5.019216	7.35947	5.1823054	6.45668743	7.2171756		6.62890116					GO:0005768///endosome+++GO:0016020///membrane+++GO:0070062///extracellular exosome	GO:0005515///protein binding+++GO:0019901///protein kinase binding+++GO:0030276///clathrin binding+++GO:0035091///phosphatidylinositol binding+++GO:0043130///ubiquitin binding	GO:0006886///intracellular protein transport+++GO:0007165///signal transduction+++GO:0015031///protein transport+++GO:0045839///negative regulation of mitotic nuclear division	tissueType=Fetal gonad;cancerType=Normal;cellName=Mitotic arrest phase fetal germ cell		"Homo sapiens target of myb1 like 2 membrane trafficking protein (TOM1L2), transcript variant 3, mRNA."		PF00790///VHS domain+++PF03127///GAT domain			KOG1087///intracellular protein transport		IPR002014///VHS domain+++IPR004152///GAT domain+++IPR008942///ENTH/VHS+++IPR014645///Target of Myb protein 1+++IPR027429///Target of Myb1-like 2+++IPR038425///GAT domain superfamily	[TM1L2_HUMAN|Reviewed]RecName: Full=TOM1-like protein 2; AltName: Full=Target of Myb-like protein 2;	chr17p11///Ensembl 103 genes in cytogenetic band chr17p11					"GTCAGGA_MIR378///Genes having at least one occurence of the motif GTCAGGA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-378 (v7.1 miRBase)."	MIR122B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-122b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1236_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1236-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1249_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1249-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR185_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-185-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR330_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-330-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR378A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-378a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3926///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3926 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3943///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3943 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4261///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4261 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4270///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4270 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4441///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4441 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4473///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4473 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4492///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4492 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4534///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4534 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4641///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4641 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4651///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4651 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4679///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4679 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4731_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4731-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4755_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4755-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4779///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4779 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR520F_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-520f-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6081///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6081 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR608///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-608 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR661///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-661 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6731_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6731-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6754_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6754-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6758_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6758-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6797_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6797-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6808_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6808-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6856_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6856-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6893_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6893-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7106_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7106-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7977///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7977 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR8082///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-8082 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR8085///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-8085 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR92A_2_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-92a-2-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR940///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-940 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).	AACTTT_UNKNOWN///Genes having at least one occurence of the highly conserved motif M17 AACTTT in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++AR_Q6///Genes having at least one occurence of the transcription factor binding site V$AR_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++CACGTG_MYC_Q2///Genes having at least one occurence of the highly conserved motif M2 CACGTG sites. The motif matches transcription factor binding site V$MYC_Q2 (v7.4 TRANSFAC).+++COUP_DR1_Q6///Genes having at least one occurence of the transcription factor binding site V$COUP_DR1_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++CYTAGCAAY_UNKNOWN///Genes having at least one occurence of the highly conserved motif M34 CYTAGCAAY in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++DR1_Q3///Genes having at least one occurence of the transcription factor binding site V$DR1_Q3 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++HFH4_01///Genes having at least one occurence of the transcription factor binding site V$HFH4_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++HNF4_DR1_Q3///Genes having at least one occurence of the transcription factor binding site V$HNF4_DR1_Q3 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++PPAR_DR1_Q2///Genes having at least one occurence of the transcription factor binding site V$PPAR_DR1_Q2 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++SF1_Q6///Genes having at least one occurence of the transcription factor binding site V$SF1_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++SPZ1_01///Genes having at least one occurence of the transcription factor binding site V$SPZ1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++TGCCAAR_NF1_Q6///Genes having at least one occurence of the highly conserved motif M47 TGCCAAR sites. The motif matches transcription factor binding site V$NF1_Q6 (v7.4 TRANSFAC).+++USF_01///Genes having at least one occurence of the transcription factor binding site V$USF_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++USF_02///Genes having at least one occurence of the transcription factor binding site V$USF_02 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++USF_Q6///Genes having at least one occurence of the transcription factor binding site V$USF_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.	"AEBP2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6ZN18 (AEBP2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ARID5B_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q14865 (ARID5B) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ASH1L_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9NR48 (ASH1L) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++BARHL1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9BZE3 (BARHL1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++BARX1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9HBU1 (BARX1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++BARX2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9UMQ3 (BARX2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++CBFA2T2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O43439 (CBFA2T2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++CEBPZ_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q03701 (CEBPZ) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++CIITA_TARGET_GENES///Genes containing one or more binding sites for UniProt:P33076 (CIITA) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++CREB3L4_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8TEY5 (CREB3L4) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++FOXJ2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9P0K8 (FOXJ2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++FOXN3_TARGET_GENES///Genes containing one or more binding sites for UniProt:O00409 (FOXN3) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++GCM2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O75603 (GCM2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++GREB1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q4ZG55 (GREB1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HES4_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9HCC6 (HES4) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HOXA1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P49639 (HOXA1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++LHX2_TARGET_GENES///Genes containing one or more binding sites for UniProt:P50458 (LHX2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++MSX1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P28360 (MSX1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++MZF1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P28698 (MZF1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++PRKDC_TARGET_GENES///Genes containing one or more binding sites for UniProt:P78527 (PRKDC) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SALL4_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9UJQ4 (SALL4) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SETD1A_TARGET_GENES///Genes containing one or more binding sites for UniProt:O15047 (SETD1A) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SKIL_TARGET_GENES///Genes containing one or more binding sites for UniProt:P12757 (SKIL) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SUPT16H_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9Y5B9 (SUPT16H) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SUPT20H_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8NEM7 (SUPT20H) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++TOX4_TARGET_GENES///Genes containing one or more binding sites for UniProt:O94842 (TOX4) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++UBN1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9NPG3 (UBN1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZFHX3_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q15911 (ZFHX3) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZFP91_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96JP5 (ZFP91) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZIM3_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96PE6 (ZIM3) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF140_TARGET_GENES///Genes containing one or more binding sites for UniProt:P52738 (ZNF140) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF250_TARGET_GENES///Genes containing one or more binding sites for UniProt:P15622 (ZNF250) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF30_TARGET_GENES///Genes containing one or more binding sites for UniProt:P17039 (ZNF30) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF407_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9C0G0 (ZNF407) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF423_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q2M1K9 (ZNF423) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF449_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6P9G9 (ZNF449) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF507_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8TCN5 (ZNF507) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF528_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q3MIS6 (ZNF528) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF592_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q92610 (ZNF592) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF84_TARGET_GENES///Genes containing one or more binding sites for UniProt:P51523 (ZNF84) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZSCAN30_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q86W11 (ZSCAN30) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."			PRC2_SUZ12_UP.V1_UP///Genes up-regulated in TIG3 cells (fibroblasts) upon knockdown of SUZ12 [Gene ID=23512] gene.	"GSE11057_NAIVE_VS_CENT_MEMORY_CD4_TCELL_UP///Genes up-regulated in comparison of naive T cells versus central memory T cells.+++GSE11057_NAIVE_VS_EFF_MEMORY_CD4_TCELL_UP///Genes up-regulated in comparison of naive T cells versus effector memory T cells.+++GSE11057_NAIVE_VS_MEMORY_CD4_TCELL_UP///Genes up-regulated in comparison of naive T cells versus memory T cells.+++GSE12366_PLASMA_CELL_VS_NAIVE_BCELL_UP///Genes up-regulated in plasma cells versus naive B cells.+++GSE20198_UNTREATED_VS_IL12_IL18_TREATED_ACT_CD4_TCELL_UP///Genes up-regulated in the activated CD4 [GeneID=920] T cells (48h): control versus IL-12 and IL18 [GeneID=3606].+++GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_48H_UP///Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 [GeneID=7040] and IL-12 (48h) versus IL4 [GeneID=3565] (48h).+++GSE2770_UNTREATED_VS_ACT_CD4_TCELL_2H_UP///Genes up-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 (2h).+++GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_48H_UP///Genes up-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 and then stimulated by IL4 [GeneID=3565] (48h).+++GSE3982_BASOPHIL_VS_NKCELL_DN///Genes down-regulated in comparison of basophils versus NK cells.+++GSE3982_NEUTROPHIL_VS_NKCELL_DN///Genes down-regulated in comparison of neutrophils versus NK cells.+++GSE3982_NKCELL_VS_TH1_UP///Genes up-regulated in comparison of NK cells versus Th1 cells.+++GSE4748_CTRL_VS_CYANOBACTERIUM_LPSLIKE_STIM_DC_1H_DN///Genes down-regulated in monocyte-derived dendritic cells: untreated versus LPS like antigen from O. planktothrix (1h).+++GSE4748_LPS_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_DN///Genes down-regulated in monocyte-derived dendritic cells: LPS (3h) versus LPS and LPS like antigen from O. planktothrix (3h).+++GSE4984_UNTREATED_VS_LPS_TREATED_DC_UP///Genes up-regulated in monocyte-derived dendritic cells: control versus LPS.+++GSE4984_UNTREATED_VS_VEHICLE_CTRL_TREATED_DC_UP///Genes up-regulated in monocyte-derived dendritic cells: untreated versus vehicle.+++GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_DN///Genes down-regulated in epithelial cells (6h): untreated versus interferon alpha.+++GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_24H_DN///Genes down-regulated in epithelial cells (24h): untreated versus IFNG [GeneID=3458].+++GSE7509_UNSTIM_VS_FCGRIIB_STIM_DC_UP///Genes up-regulated in dendritic cells: untreated versus anti-FcgRIIB.+++GSE7509_UNSTIM_VS_IFNA_STIM_IMMATURE_DC_UP///Genes up-regulated in immature dendritic cells: untreated versus interferon alpha.+++NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN///Genes down-regulated in plasmacytoid dendritic cell 7d vs 0d in young adults (18-50) after exposure to FluMist , time point 7D+++OSMAN_BLOOD_CHAD63_KH_AGE_18_50YO_HIGH_DOSE_SUBJECTS_24HR_DN///Genes down-regulated in blood 24hr vs 0hr in adults (18-50) (high dose subjects) after exposure to ChAd63-KH , time point 24H , administered Intramuscular injection. Comment: DE gene list for high dose subjects."		NM_001082968	TOM1L2				
Q5SQ64	sp|Q5SQ64|LY66F_HUMAN		LY6G6F		Lymphocyte antigen 6 complex locus protein G6f OS=Homo sapiens OX=9606 GN=LY6G6F PE=1 SV=2 >tr|A0A1L6Z9Z3|A0A1L6Z9Z3_HUMAN LY6G6F OS=Homo sapiens OX=9606 GN=LY6G6 PE=2 SV=1	259215	rna-NM_001003693.3-5						MAVLFLLLFLCGTPQAADNMQAIYVALGEAVELPCPSPPTLHGDEHLSWFCSPAAGSFTTLVAQVQVGRPAPDPGKPGRESRLRLLGNYSLWLEGSKEEDAGRYWCAVLGQHHNYQNWRVYDVLVLKGSQLSARAADGSPCNVLLCSVVPSRRMDSVTWQEGKGPVRGRVQSFWGSEAALLLVCPGEGLSEPRSRRPRIIRCLMTHNKGVSFSLAASIDASPALCAPSTGWDMPWILMLLLTMGQGVVILALSIVLWRQRVRGAPGRDASIPQFKPEIQVYENIHLARLGPPAHKPR	0.5096764	-0.972346522	0.003952912						5.0095291		4.1395637			3.9506789	4.4739881									3.0205803	3.486323	4.6530096					6.299221	4.95163	5.239854	5.2797019		4.2863068	4.9877269			4.3928754		4.896286		4.12854926	5.7285336																																			rna-NM_001003693.3-5	LY6G6F				
Q5JSH3	sp|Q5JSH3|WDR44_HUMAN		WDR44		WD repeat-containing protein 44 OS=Homo sapiens OX=9606 GN=WDR44 PE=1 SV=1	54521	NM_019045	NP_061918	ENST00000254029				MASESDTEEFYDAPEDVHLGGGYPVGSPGKVGLSTFKETENTAYKVGNESPVQELKQDVSKKIIESIIEESQKVLQLEDDSLDSKGKELSDQATASPIVARTDLSNIPGLLAIDQVLPEESQKAESQNTFEETELELKKCFPSDETCEKPVDETTKLTQTSSTEQLNVLETETEVLNKEAVEVKGGGDVLEPVSSDSLSTKDFAAVEEVAPAKPPRHLTPEPDIVASTKKPVPARPPPPTNFPPPRPPPPSRPAPPPRKRKSELEFETLKTPDIDVPKENITSDSLLTASMASESTVKDSQPSLDLASATSGDKIVTAQENGKAPDGQTVAGEVMGPQRPRSNSGRELTDEEILASVMIKNLDTGEEIPLSLAEEKLPTGINPLTLHIMRRTKEYVSNDAAQSDDEEKLQSQPTDTDGGRLKQKTTQLKKFLGKSVKRAKHLAEEYGERAINKVKSVRDEVFHTDQDDPSSSDDEGMPYTRPVKFKAAHGFKGPYDFDQIKVVQDLSGEHMGAVWTMKFSHCGRLLASAGQDNVVRIWALKNAFDYFNNMRMKYNTEGRVSPSPSQESLSSSKSDTDTGVCSGTDEDPDDKNAPFRQRPFCKYKGHTADLLDLSWSKNYFLLSSSMDKTVRLWHISRRECLCCFQHIDFVTAIAFHPRDDRYFLSGSLDGKLRLWNIPDKKVALWNEVDGQTKLITAANFCQNGKYAVIGTYDGRCIFYDTEHLKYHTQIHVRSTRGRNKVGRKITGIEPLPGENKILVTSNDSRIRLYDLRDLSLSMKYKGYVNSSSQIKASFSHDFTYLVSGSEDKYVYIWSTYHDLSKFTSVRRDRNDFWEGIKAHNAVVTSAIFAPNPSLMLSLDVQSEKSEGNEKSEDAEVLDATPSGIMKTDNTEVLLSADFTGAIKVFVNKRKNVS	0.3999358	-1.322159765	0.006261321		5.3049488	5.0425438	4.0996566	4.5950648	7.3233598	4.811400596	5.7503688	6.5362957	7.5319356	6.8396705	7.4164839	3.4896249	4.5952283	6.1965401	6.7340852	1.3683507	5.6481832			6.5505879	7.0730622	8.7723602	3.7838115	4.90788275	4.29180379	4.1612131	7.22939	8.5392578	8.066321	8.6566822	6.471351	5.5929736	8.3738877	6.6122308	7.7074334	7.5045951	6.7508835	8.212297	7.5792255	7.68520899	7.7491674	6.0401853	8.18685828					GO:0005737///cytoplasm+++GO:0005768///endosome+++GO:0005794///Golgi apparatus+++GO:0005829///cytosol+++GO:0010008///endosome membrane+++GO:0016020///membrane+++GO:0048471///perinuclear region of cytoplasm	GO:0005515///protein binding				"Homo sapiens WD repeat domain 44 (WDR44), transcript variant 1, mRNA."		"PF00400///WD domain, G-beta repeat"			KOG0283///Rab GTPase binding		IPR001680///WD40 repeat+++IPR015943///WD40/YVTN repeat-like-containing domain superfamily+++IPR020472///G-protein beta WD-40 repeat+++IPR036322///WD40-repeat-containing domain superfamily+++IPR040324///WD repeat-containing protein WDR44/Dgr2	[WDR44_HUMAN|Reviewed]RecName: Full=WD repeat-containing protein 44; AltName: Full=Rabphilin-11;	chrXq24///Ensembl 103 genes in cytogenetic band chrXq24					"ACACTGG_MIR199A_MIR199B///Genes having at least one occurence of the motif ACACTGG in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-199a and hsa-miR-199b (v7.1 miRBase).+++ACATATC_MIR190///Genes having at least one occurence of the motif ACATATC in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-190 (v7.1 miRBase).+++AGGAGTG_MIR483///Genes having at least one occurence of the motif AGGAGTG in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-483 (v7.1 miRBase).+++ATGTTTC_MIR494///Genes having at least one occurence of the motif ATGTTTC in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-494 (v7.1 miRBase).+++CAGTGTT_MIR141_MIR200A///Genes having at least one occurence of the motif CAGTGTT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-141 and hsa-miR-200a (v7.1 miRBase).+++CTTTGTA_MIR524///Genes having at least one occurence of the motif CTTTGTA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-524* (v7.1 miRBase).+++GGCAGTG_MIR3243P///Genes having at least one occurence of the motif GGCAGTG in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-324-3p (v7.1 miRBase).+++GTGCCTT_MIR506///Genes having at least one occurence of the motif GTGCCTT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-506 (v7.1 miRBase).+++TAGGTCA_MIR192_MIR215///Genes having at least one occurence of the motif TAGGTCA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-192 and hsa-miR-215 (v7.1 miRBase).+++TGTTTAC_MIR30A5P_MIR30C_MIR30D_MIR30B_MIR30E5P///Genes having at least one occurence of the motif TGTTTAC in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-30a-5p, hsa-miR-30c, hsa-miR-30d, hsa-miR-30b and hsa-miR-30e-5p (v7.1 miRBase).+++TTTGCAC_MIR19A_MIR19B///Genes having at least one occurence of the motif TTTGCAC in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-19a and hsa-miR-19b (v7.1 miRBase).+++TTTTGAG_MIR373///Genes having at least one occurence of the motif TTTTGAG in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-373* (v7.1 miRBase)."	"MIR124_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-124-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1255B_2_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1255b-2-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1261///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1261 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1277_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1277-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1287_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1287-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1468_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1468-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR150_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-150-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR186_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-186-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR190A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-190a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR190B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-190b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1912_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1912-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR192_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-192-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR196A_1_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-196a-1-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR19A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-19a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR19B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-19b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR2113///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-2113 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR215_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-215-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR218_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-218-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR2681_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-2681-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3065_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3065-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR30A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-30a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR30A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-30a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR30B_5P_MIR30C_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-30b-5p, hsa-miR-30c-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR30D_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-30d-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR30D_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-30d-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR30E_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-30e-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR30E_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-30e-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR323A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-323a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR340_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-340-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3688_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3688-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR371B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-371b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR373_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-373-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR384///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-384 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3907///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3907 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3942_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3942-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4264///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4264 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4666B///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4666b in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR483_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-483-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR490_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-490-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5010_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5010-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR506_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-506-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR539_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-539-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AC///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548ac in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AE_3P_MIR548AQ_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548ae-3p, hsa-miR-548aq-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AH_3P_MIR548AM_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548ah-3p, hsa-miR-548am-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AJ_3P_MIR548X_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548aj-3p, hsa-miR-548x-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AJ_5P_MIR548G_5P_MIR548X_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548aj-5p, hsa-miR-548g-5p, hsa-miR-548x-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AW///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548aw in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548BB_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548bb-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548D_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548d-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548F_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548f-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548H_3P_MIR548Z///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548h-3p, hsa-miR-548z in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548J_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548j-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5580_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5580-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5582_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5582-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR616_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-616-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR644A///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-644a in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR656_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-656-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7159_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7159-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR8070///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-8070 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR889_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-889-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR95_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-95-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets)."	CEBP_Q2///Genes having at least one occurence of the transcription factor binding site V$CEBP_Q2 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++EGR1_01///Genes having at least one occurence of the transcription factor binding site V$EGR1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++EGR2_01///Genes having at least one occurence of the transcription factor binding site V$EGR2_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++EGR3_01///Genes having at least one occurence of the transcription factor binding site V$EGR3_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++EGR_Q6///Genes having at least one occurence of the transcription factor binding site V$EGR_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++GGGYGTGNY_UNKNOWN///Genes having at least one occurence of the highly conserved motif M31 GGGYGTGNY in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++HFH3_01///Genes having at least one occurence of the transcription factor binding site V$HFH3_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++NGFIC_01///Genes having at least one occurence of the transcription factor binding site V$NGFIC_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++RCGCANGCGY_NRF1_Q6///Genes having at least one occurence of the highly conserved motif M1 RCGCANGCGY sites. The motif matches transcription factor binding site V$NRF1_Q6 (v7.4 TRANSFAC).+++RNGTGGGC_UNKNOWN///Genes having at least one occurence of the highly conserved motif M140 RNGTGGGC in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++TCF11MAFG_01///Genes having at least one occurence of the transcription factor binding site V$TCF11MAFG_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++TGCGCANK_UNKNOWN///Genes having at least one occurence of the highly conserved motif M22 TGCGCANK in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++TGGAAA_NFAT_Q4_01///Genes having at least one occurence of the highly conserved motif M55 TGGAAA sites. The motif matches transcription factor binding site V$NFAT_Q4_01 (v7.4 TRANSFAC).+++TGGNNNNNNKCCAR_UNKNOWN///Genes having at least one occurence of the highly conserved motif M27 TGGNNNNNNKCCAR in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++TGTTTGY_HNF3_Q6///Genes having at least one occurence of the highly conserved motif M83 TGTTTGY sites. The motif matches transcription factor binding site V$HNF3_Q6 (v7.4 TRANSFAC).+++TMTCGCGANR_UNKNOWN///Genes having at least one occurence of the highly conserved motif M8 TMTCGCGANR in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++TTANTCA_UNKNOWN///Genes having at least one occurence of the highly conserved motif M64 TTANTCA in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).	"BANP_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8N9N5 (BANP) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++BARX2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9UMQ3 (BARX2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++BRCA2_TARGET_GENES///Genes containing one or more binding sites for UniProt:P51587 (BRCA2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++DYRK1A_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q13627 (DYRK1A) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NAB2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q15742 (NAB2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."				"FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_UP///Genes up-regulated in blood responders vs poor responders in adults (25-83) (responders) after exposure to Twinrix , time point 0D+++GSE10240_IL17_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP///Genes up-regulated in primary bronchial epithelial cells stimulated with: IL17A [GeneID=50616] versus IL17A and IL22 [GeneID=3605;50616].+++GSE16385_IFNG_TNF_VS_UNSTIM_MACROPHAGE_ROSIGLITAZONE_TREATED_DN///Genes down-regulated in macrophages (12h): IFNG, TNF [GeneID=3458;7124] and rosiglitazone [PubChem=77999] versus rosiglitazone [PubChem=77999].+++GSE16385_ROSIGLITAZONE_IL4_VS_IL4_ALONE_STIM_MACROPHAGE_12H_UP///Genes up-regulated in macrophages (12h): rosiglitazone [PubChem=77999] and IL4 [GeneID=3565] versus IL4 [GeneID=3565].+++GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_12H_ACT_CD4_TCELL_UP///Genes up-regulated in comparison of CD4 [GeneID=920] T cells treated with IL4 [GeneID=3565] and anti-IL12 at 12 h versus the untreated cells at 12 h.+++GSE21774_CD56_BRIGHT_VS_DIM_CD62L_POSITIVE_NK_CELL_UP///Genes up-regulated in NCAM+ [GeneID=4684] NK cells: SELL bright [GeneID=6402] versus SELL dim [GeneID=6402].+++GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_DN///Genes down-regulated in single positive cells: immature CD4 [GeneID=920] versus CD8 thymocytes.+++GSE27291_0H_VS_7D_STIM_GAMMADELTA_TCELL_DN///Genes down-regulated in gamma delta T cells activated by phophoantigen BrHPP and IL2 [GeneID=3558]: 0h versus 7 days.+++GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_DN///Genes down-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: IL-12 (2h) versus TGFB1 [GeneID=7040] and IL-12 (2h).+++GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_48H_UP///Genes up-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 and then stimulated by TGFB1 and IL4 [GeneID=7040;3565] (48h).+++GSE34156_NOD2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_UP///Genes up-regulated in monocytes (6h): muramyl dipeptide [PubChem=11620162] versus muramyl dipeptide [PubChem=11620162] and M. tuberculosis 19 kDa lipopeptide.+++GSE34156_TLR1_TLR2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_DN///Genes down-regulated in monocytes (24h): M. tuberculosis 19 kDa lipopeptide versus M. tuberculosis 19 kDa lipopeptide and muramyl dipeptide [PubChem=11620162].+++GSE3982_NEUTROPHIL_VS_CENT_MEMORY_CD4_TCELL_DN///Genes down-regulated in comparison of neutrophils versus central memory CD4 [GeneID=920] T cells.+++GSE5542_UNTREATED_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_UP///Genes up-regulated in epithelial cells (24h): untreated versus interferon alpha and IFNG [GeneID=3458].+++GSE6092_UNSTIM_VS_IFNG_STIM_ENDOTHELIAL_CELL_DN///Genes down-regulated in endothelial cells: untreated versus IFNG [GeneID=3458].+++GSE9988_ANTI_TREM1_VS_VEHICLE_TREATED_MONOCYTES_DN///Genes down-regulated in comparison of monocytes treated with anti-TREM1 [GeneID=54210] versus untreated monocytes.+++GSE9988_LOW_LPS_VS_VEHICLE_TREATED_MONOCYTE_DN///Genes down-regulated in comparison of monocytes treated with 1 ng/ml LPS (TLR4 agonist) versus untreated monocytes.+++GSE9988_LPS_VS_VEHICLE_TREATED_MONOCYTE_DN///Genes down-regulated in comparison of monocytes treated with 1 ng/ml LPS (TLR4 agonist) versus untreated monocytes."		NM_019045	WDR44				
Q53FT3	sp|Q53FT3|HIKES_HUMAN		HIKESHI		Protein Hikeshi OS=Homo sapiens OX=9606 GN=HIKESHI PE=1 SV=2	51501	NM_016401	NP_057485	ENST00000278483				MFGCLVAGRLVQTAAQQVAEDKFVFDLPDYESINHVVVFMLGTIPFPEGMGGSVYFSYPDSNGMPVWQLLGFVTNGKPSAIFKISGLKSGEGSQHPFGAMNIVRTPSVAQIGISVELLDSMAQQTPVGNAAVSSVDSFTQFTQKMLDNFYNFASSFAVSQAQMTPSPSEMFIPANVVLKWYENFQRRLAQNPLFWKT	0.6250249	-0.678014393	0.01327127					4.947232					6.1529802	6.1901532	6.4168946			5.6105201		5.3033849					6.4407884						7.69585	7.3662732	6.874407	6.3718992			5.670343	6.3506073	6.1112066	6.2143829	5.6482308	6.737679	6.780412	5.90843936	6.8691757		7.01720239		H00679///Hypomyelinating leukodystrophy			GO:0005634///nucleus+++GO:0005654///nucleoplasm+++GO:0005737///cytoplasm+++GO:0005829///cytosol+++GO:0016604///nuclear body+++GO:0016607///nuclear speck	GO:0005515///protein binding+++GO:0030544///Hsp70 protein binding+++GO:0061608///nuclear import signal receptor activity	GO:0006606///protein import into nucleus+++GO:0007030///Golgi organization+++GO:0015031///protein transport+++GO:0030324///lung development+++GO:0034605///cellular response to heat+++GO:1900034///regulation of cellular response to heat			"Homo sapiens heat shock protein nuclear import factor hikeshi (HIKESHI), transcript variant 1, mRNA."		PF05603///Protein of unknown function (DUF775)	R-HSA-2262752///Cellular responses to stress+++R-HSA-3371453///Regulation of HSF1-mediated heat shock response+++R-HSA-3371556///Cellular response to heat stress+++R-HSA-8953897///Cellular responses to stimuli		KOG4067///Hsp70 protein binding		IPR008493///Domain of unknown function DUF775+++IPR031318///OPI10 family	[HIKES_HUMAN|Reviewed]RecName: Full=Protein Hikeshi {ECO:0000305};	chr11q14///Ensembl 103 genes in cytogenetic band chr11q14			REACTOME_CELLULAR_RESPONSES_TO_EXTERNAL_STIMULI///Cellular responses to external stimuli+++REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS///Cellular response to heat stress+++REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE///Regulation of HSF1-mediated heat shock response			MIR103B///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-103b in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR329_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-329-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4790_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4790-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).	ACTAYRNNNCCCR_UNKNOWN///Genes having at least one occurence of the highly conserved motif M4 ACTAYRNNNCCCR in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++HNF4_01_B///Genes having at least one occurence of the transcription factor binding site V$HNF4_01_B (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++HNF4_01///Genes having at least one occurence of the transcription factor binding site V$HNF4_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++HSF1_01///Genes having at least one occurence of the transcription factor binding site V$HSF1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++HSF2_01///Genes having at least one occurence of the transcription factor binding site V$HSF2_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++RGAANNTTC_HSF1_01///Genes having at least one occurence of the highly conserved motif M68 RGAANNTTC sites. The motif matches transcription factor binding site V$HSF1_01 (v7.4 TRANSFAC).+++SCGGAAGY_ELK1_02///Genes having at least one occurence of the highly conserved motif M3 SCGGAAGY sites. The motif matches transcription factor binding site V$ELK1_02 (v7.4 TRANSFAC).+++TTCNRGNNNNTTC_HSF_Q6///Genes having at least one occurence of the highly conserved motif M141 TTCNRGNNNNTTC sites. The motif matches transcription factor binding site V$HSF_Q6 (v7.4 TRANSFAC).+++TTCYRGAA_UNKNOWN///Genes having at least one occurence of the highly conserved motif M72 TTCYRGAA in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).	"AHRR_TARGET_GENES///Genes containing one or more binding sites for UniProt:A9YTQ3 (AHRR) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ALX4_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9H161 (ALX4) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ARID5B_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q14865 (ARID5B) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ASH1L_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9NR48 (ASH1L) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++DNMT1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P26358 (DNMT1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++E2F5_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q15329 (E2F5) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ELF2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q15723 (ELF2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ELF5_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9UKW6 (ELF5) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++EWSR1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q01844 (EWSR1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++FOXG1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P55316 (FOXG1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++GLI3_TARGET_GENES///Genes containing one or more binding sites for UniProt:P10071 (GLI3) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HOXA2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O43364 (HOXA2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HOXA7_TARGET_GENES///Genes containing one or more binding sites for UniProt:P31268 (HOXA7) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++LHX2_TARGET_GENES///Genes containing one or more binding sites for UniProt:P50458 (LHX2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++LMX1B_TARGET_GENES///Genes containing one or more binding sites for UniProt:O60663 (LMX1B) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NFKBIA_TARGET_GENES///Genes containing one or more binding sites for UniProt:P25963 (NFKBIA) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NFRKB_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6P4R8 (NFRKB) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++PPARGC1A_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9UBK2 (PPARGC1A) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SUPT20H_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8NEM7 (SUPT20H) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++TEAD2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q15562 (TEAD2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZBTB7B_TARGET_GENES///Genes containing one or more binding sites for UniProt:O15156 (ZBTB7B) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF175_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9Y473 (ZNF175) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF197_TARGET_GENES///Genes containing one or more binding sites for UniProt:O14709 (ZNF197) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF592_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q92610 (ZNF592) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF766_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q5HY98 (ZNF766) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF816_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q0VGE8 (ZNF816) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF8_TARGET_GENES///Genes containing one or more binding sites for UniProt:P17098 (ZNF8) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."		MODULE_238///Genes in the cancer module 238.+++MODULE_301///Genes in the cancer module 301.+++MODULE_361///B lymphoma expression clusters.		"GSE12845_IGD_NEG_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_DN///Genes down-regulated in comparison of IgD- peripheral blood B cells versus dark zone germinal center B cells.+++GSE12845_IGD_NEG_BLOOD_VS_NAIVE_TONSIL_BCELL_UP///Genes up-regulated in comparison of IgD- peripheral blood B cells versus dark zone germinal center B cells.+++GSE12845_NAIVE_VS_DARKZONE_GC_TONSIL_BCELL_DN///Genes down-regulated in comparison of naive B cell versus dark zone germinal center B cells.+++GSE12845_PRE_GC_VS_DARKZONE_GC_TONSIL_BCELL_DN///Genes down-regulated in comparison of pre-germinal center B cells versus dark zone germinal center B cells.+++GSE13485_DAY1_VS_DAY21_YF17D_VACCINE_PBMC_DN///Genes down-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) 1 day after stimulation with YF17D vaccine versus PBMC 21 days after the stimulation.+++GSE14000_TRANSLATED_RNA_VS_MRNA_16H_LPS_DC_DN///Genes down-regulated in comparison of polysome bound (translated) mRNA versus total mRNA 16 h after LPS (TLR4 agonist) stimulation.+++GSE14000_TRANSLATED_RNA_VS_MRNA_DC_DN///Genes down-regulated in comparison of polysome bound (translated) mRNA versus total mRNA in dendritic cells.+++GSE15139_GMCSF_TREATED_VS_UNTREATED_NEUTROPHILS_UP///Genes up-regulated in neutrophils treated with CSF2 [GeneID=1437] versus control.+++GSE18893_TCONV_VS_TREG_24H_TNF_STIM_UP///Genes up-regulated in lymphocytes treated with TNF [GeneID=7124] for 24h: T conv versus T reg cells.+++GSE22611_MUTANT_NOD2_VS_CTRL_TRANSDUCED_HEK293T_CELL_UP///Genes up-regulated in HEK293 cells: expressing mutant NOD2 [GeneID=64127] versus control.+++GSE22611_NOD2_VS_CTRL_TRANSDUCED_HEK293T_CELL_UP///Genes up-regulated in HEK293 cells: over-expressing wildtype NOD2 [GeneID=64127] versus control.+++GSE22611_UNSTIM_VS_2H_MDP_STIM_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_UP///Genes up-regulated in HEK293 cells expressing mutant NOD2 [GeneID=64127]: untreated versus muramyl dipeptide [PubChem=11620162] for 2h.+++GSE2405_0H_VS_1.5H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN///Genes down-regulated in polymorphonuclear leukocytes (1.5h): control versus infection by A. phagocytophilum.+++GSE25087_TREG_VS_TCONV_FETUS_UP///Genes up-regulated in comparison of fetal regulatory T cell (Treg) versus fetal conventional T cells.+++GSE29617_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_2008_DN///Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from TIV influenza vaccinee pre-vaccination versus those at day 3 post-vaccination.+++GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_TREATED_DC_UP///Genes up-regulated in monocyte-derived dendritic cells: untreated versus rosiglitazone [PubChem=77999].+++GSE5679_PPARG_LIGAND_ROSIGLITAZONE_VS_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_UP///Genes up-regulated in monocyte-derived dendritic cells: rosiglitazone [PubChem=77999] versus rosiglitazone and AM580 [PubChem=77999;2126].+++GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_6H_UP///Genes up-regulated in monocytes: untreated versus M. tuberculosis 19 kDa lipopeptide (6h).+++GSE9601_NFKB_INHIBITOR_VS_PI3K_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_UP///Genes up-regulated in monocytes after HCMV infection: BAY 11-7082 [PubChem=5353431] versus Ly294002 [PubChem=3973].+++HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_0DY_POSITIVE///Genes positively correlated with memory B cell response at 28d in peripheral blood mononuclear cell in seniors(50-74) after exposure to Fluarix , time point 0D+++HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_3DY_NEGATIVE///Genes negatively correlated with memory B cell response at 28d in peripheral blood mononuclear cell in seniors (50-74) after exposure to Fluarix , time point 3D+++NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_UP///Genes up-regulated in peripheral blood mononuclear cell 3d vs 0d in adults (18-50) after exposure to Fluarix/Fluvirin , time point 3D. Comment: Supplementary Table 1a: All the differentially expressed genes identified in PBMCs of TIV vaccinees.+++NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP///Genes up-regulated in peripheral blood mononuclear cell 7d vs 0d in adults (18-50) after exposure to Fluarix/Fluvirin , time point 7D. Comment: Supplementary Table 1b: All the differentially expressed genes identified in PBMCs of TIV vaccinees.+++NAKAYA_PBMC_FLUMIST_AGE_18_50YO_7DY_UP///Genes up-regulated in peripheral blood mononuclear cell 7d vs 0d in adults (18-50) after exposure to FluMist , time point 7D. Comment: Supplementary Table 1b: All the differentially expressed genes identified in PBMCs of TIV vaccinees.+++THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_UP///Genes up-regulated in peripheral blood mononuclear cell 7d vs 0d in young adults (21-30) (responders) after exposure to Inactivated influenza vaccine , time point 7D"		NM_016401	HIKESHI				
Q4G148	sp|Q4G148|GXLT1_HUMAN		GXYLT1		Glucoside xylosyltransferase 1 OS=Homo sapiens OX=9606 GN=GXYLT1 PE=1 SV=2	283464	NM_173601	NP_775872	ENST00000398675	K13676			MRRYLRVVVLCVACGFCSLLYAFSQLAVSLEEGTGGGGGKPQAAVASWLAGGGRGAVRGAGVAGPAAHPGVSDRCKDFSLCYWNPYWMLPSDVCGMNCFWEAAFRYSLKIQPVEKMHLAVVACGERLEETMTMLKSAIIFSIKPLQFHIFAEDQLHHSFKGRLDNWSFLQTFNYTLYPITFPSENAAEWKKLFKPCASQRLFLPLILKEVDSLLYVDTDILFLRPVDDIWSLLKKFNSTQIAAMAPEHEEPRIGWYNRFARHPYYGKTGVNSGVMLMNMTRMRRKYFKNDMTTVRLQWGDILMPLLKKYKLNITWGDQDLLNIVFFHNPESLFVFPCQWNYRPDHCIYGSNCQEAEEGGIFILHGNRGVYHDDKQPAFRAVYEALRNCSFEDDNIRSLLKPLELELQKTVHTYCGKIYKIFIKQLAKSVRDRYARSPKEK	0.6521154	-0.616800758	0.01140275		4.1644133	3.1825144				2.468268349	2.4933625	4.2450309	2.1575816	3.0960611	2.1685765	3.09228732	3.5888049		2.3033386	3.1792963		2.297059101		3.5948467	1.5626807		3.4304183	3.49158017			3.403353	3.8712893	3.789789	4.3053433	3.923039	2.9219855	3.1003993	3.4349727		3.6283137		4.022685		2.50980339	3.2113088		3.80185325	00514///Other types of O-glycan biosynthesis			R09290///UDP-alpha-D-xylose:[protein with EGF-like domain]-3-O-(beta-D-glucosyl)-L-serine 3-alpha-D-xylosyltransferase (configuration-retaining)   UDP-D-xylose + G13051 <=> UDP + G03532	GO:0016020///membrane+++GO:0016021///integral component of membrane	"GO:0016740///transferase activity+++GO:0016757///transferase activity, transferring glycosyl groups+++GO:0035252///UDP-xylosyltransferase activity"	GO:0016266///O-glycan processing	tissueType=Fetal kidney;cancerType=Normal;cellName=Natural killer T (NKT) cell		"Homo sapiens glucoside xylosyltransferase 1 (GXYLT1), transcript variant 1, mRNA."		PF01501///Glycosyl transferase family 8			KOG3765///protein O-linked glycosylation		"IPR002495///Glycosyl transferase, family 8+++IPR029044///Nucleotide-diphospho-sugar transferases"	[GXLT1_HUMAN|Reviewed]RecName: Full=Glucoside xylosyltransferase 1; EC=2.4.2.42 {ECO:0000269|PubMed:19940119}; AltName: Full=Glycosyltransferase 8 domain-containing protein 3;	chr12q12///Ensembl 103 genes in cytogenetic band chr12q12						"LET_7A_5P_LET_7C_5P_LET_7E_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-let-7a-5p, hsa-let-7c-5p, hsa-let-7e-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++LET_7B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-let-7b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++LET_7D_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-let-7d-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++LET_7F_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-let-7f-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++LET_7G_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-let-7g-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++LET_7I_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-let-7i-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR103A_1_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-103a-1-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR103A_2_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-103a-2-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR106A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-106a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR106B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-106b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR12119///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-12119 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR12133///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-12133 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR124_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-124-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1250_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1250-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1271_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1271-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1276///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1276 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR128_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-128-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1294///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1294 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1299///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1299 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1301_3P_MIR5047///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1301-3p, hsa-miR-5047 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR137_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-137-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR138_1_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-138-1-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR143_3P_MIR4770///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-143-3p, hsa-miR-4770 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR144_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-144-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1468_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1468-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR17_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-17-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR182_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-182-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR200B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-200b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR200C_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-200c-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR202_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-202-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR203A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-203a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR205_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-205-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR20A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-20a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR20B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-20b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR2115_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-2115-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR216A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-216a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR216B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-216b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR217_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-217-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR219A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-219a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR23A_3P_MIR23B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-23a-3p, hsa-miR-23b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR23C///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-23c in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR27A_3P_MIR27B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-27a-3p, hsa-miR-27b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3125///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3125 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR31_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-31-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR320A_3P_MIR320B_MIR320C_MIR320D///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-320a-3p, hsa-miR-320b, hsa-miR-320c, hsa-miR-320d in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR335_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-335-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR342_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-342-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR345_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-345-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3609///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3609 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3646///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3646 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3658///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3658 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3662///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3662 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3681_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3681-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3714///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3714 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR371A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-371a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR371B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-371b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR372_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-372-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR373_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-373-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR374C_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-374c-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR376C_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-376c-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3910///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3910 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3915///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3915 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3927_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3927-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4270///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4270 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR429///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-429 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR433_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-433-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4429///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4429 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4441///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4441 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4445_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4445-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4458///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4458 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4500///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4500 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4650_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4650-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4659A_3P_MIR4659B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4659a-3p, hsa-miR-4659b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4660///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4660 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4684_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4684-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4696///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4696 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4698///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4698 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4729///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4729 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4753_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4753-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4756_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4756-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4778_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4778-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4782_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4782-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4782_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4782-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4796_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4796-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR499A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-499a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR499B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-499b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5008_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5008-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR506_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-506-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR508_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-508-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR512_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-512-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR513A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-513a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR513C_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-513c-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR514B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-514b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR516A_3P_MIR516B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-516a-3p, hsa-miR-516b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR516B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-516b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR519D_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-519d-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR520F_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-520f-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR526B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-526b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AH_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548ah-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AT_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548at-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AV_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548av-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AW///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548aw in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5680///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5680 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5692B_MIR5692C///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5692b, hsa-miR-5692c in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5696///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5696 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5706///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5706 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR577///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-577 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR579_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-579-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR597_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-597-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6074///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6074 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6088///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6088 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR616_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-616-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR627_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-627-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6515_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6515-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR655_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-655-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR664B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-664b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR670_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-670-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6738_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6738-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6754_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6754-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6766_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6766-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6807_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6807-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6809_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6809-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6828_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6828-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6831_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6831-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6868_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6868-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6885_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6885-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7110_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7110-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7111_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7111-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7162_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7162-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7854_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7854-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7856_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7856-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR8062///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-8062 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR888_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-888-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR93_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-93-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR944///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-944 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR96_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-96-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR98_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-98-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR9985///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-9985 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR9986///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-9986 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets)."		"DBP_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q10586 (DBP) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HOXA2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O43364 (HOXA2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++KDM5D_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9BY66 (KDM5D) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++MORC2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9Y6X9 (MORC2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NAB2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q15742 (NAB2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SAFB2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q14151 (SAFB2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++TCF7_TARGET_GENES///Genes containing one or more binding sites for UniProt:P36402 (TCF7) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++THRA_TARGET_GENES///Genes containing one or more binding sites for UniProt:P10827 (THRA) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF274_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96GC6 (ZNF274) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF282_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9UDV7 (ZNF282) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZSCAN31_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96LW9 (ZSCAN31) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."				GSE10240_IL17_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP///Genes up-regulated in primary bronchial epithelial cells stimulated with: IL17A [GeneID=50616] versus IL17A and IL22 [GeneID=3605;50616].+++GSE14000_UNSTIM_VS_16H_LPS_DC_TRANSLATED_RNA_UP///Genes up-regulated in comparison of polysome bound (translated) mRNA before and 16 h after LPS (TLR4 agonist) stimulation.+++GSE14000_UNSTIM_VS_4H_LPS_DC_TRANSLATED_RNA_UP///Genes up-regulated in comparison of polysome bound (translated) mRNA before and 4 h after LPS (TLR4 agonist) stimulation.+++GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_10H_UP///Genes up-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 10 h.+++GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_2H_UP///Genes up-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 2 h.+++GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_4H_UP///Genes up-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 4 h.+++GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_6H_UP///Genes up-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 6 h.+++GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_8H_UP///Genes up-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 8 h.+++GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_10H_UP///Genes up-regulated in comparison of control conventional dendritic cells (cDC) at 10 h versus cDCs infected with Newcastle disease virus (NDV) at 10 h.+++GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_2H_DN///Genes down-regulated in comparison of control conventional dendritic cells (cDC) at 2 h versus cDCs infected with Newcastle disease virus (NDV) at 2 h.+++GSE22589_HEALTHY_VS_HIV_AND_SIV_INFECTED_DC_DN///Genes down-regulated in monocyte-derived dendritic cells: control versus HIV and SIV infection.+++GSE22589_HIV_VS_HIV_AND_SIV_INFECTED_DC_DN///Genes down-regulated in monocyte-derived dendritic cells infected by: HIV versus HIV and SIV.+++GSE26928_NAIVE_VS_CXCR5_POS_CD4_TCELL_UP///Genes up-regulated in comparison of naive CD4 [GeneID=920] T cells versus CD4 [GeneID=920] CXCR5+ [GeneID=643] T cells.+++GSE26928_NAIVE_VS_EFF_MEMORY_CD4_TCELL_UP///Genes up-regulated in comparison of naive CD4 [GeneID=920] T cells versus CD4 [GeneID=920] effector memory T cells.+++GSE34156_NOD2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_DN///Genes down-regulated in monocytes (24h): muramyl dipeptide [PubChem=11620162] versus muramyl dipeptide [PubChem=11620162] and M. tuberculosis 19 kDa lipopeptide.+++GSE34156_UNTREATED_VS_24H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN///Genes down-regulated in monocytes (24h): untreated versus M. tuberculosis 19 kDa lipopeptide.+++GSE37416_CTRL_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_UP///Genes up-regulated in comparison of control polymorphonuclear leukocytes (PMN) at 3 h versus PMN treated with F. tularensis vaccine at 3 h.+++GSE3920_UNTREATED_VS_IFNB_TREATED_ENDOTHELIAL_CELL_UP///Genes up-regulated in endothelial cells: untreated versus interferon beta.+++GSE5542_UNTREATED_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_UP///Genes up-regulated in epithelial cells (24h): untreated versus interferon alpha and IFNG [GeneID=3458].+++GSE7460_CTRL_VS_TGFB_TREATED_ACT_FOXP3_MUT_TCONV_UP///Genes up-regulated in comparsion of sfActCD4 versus sfActCD4TGF (see Fig. 1 in the paper for details).		NM_173601	GXYLT1				
Q3ZCW2	sp|Q3ZCW2|LEGL_HUMAN		LGALSL		Galectin-related protein OS=Homo sapiens OX=9606 GN=LGALSL PE=1 SV=2	29094	NM_014181	NP_054900	ENST00000238875				MAGSVADSDAVVKLDDGHLNNSLSSPVQADVYFPRLIVPFCGHIKGGMRPGKKVLVMGIVDLNPESFAISLTCGDSEDPPADVAIELKAVFTDRQLLRNSCISGERGEEQSAIPYFPFIPDQPFRVEILCEHPRFRVFVDGHQLFDFYHRIQTLSAIDTIKINGDLQITKLG	0.3544275	-1.496437602	0.00657803	0.3501453	2.5388818	1.8060693	2.4644779	4.3683316	5.3768189	1.914679027	3.6985357	4.752012	5.2120817	4.9652702	6.0134073	0.6306857	3.4008822	2.6661931	4.0453976	1.5376563	2.0181555			3.3372892	4.1281213	3.8835174	0.9895225	1.32803243	2.04343754	1.6227938	7.825538	5.7114807	6.859586	6.8004035	5.641009	4.6989057	5.7527565	5.5302547	3.9713596	6.1829925	4.7667828	6.200153	5.2709607	5.01516531	6.5738234	3.3809055	4.619848						GO:0005515///protein binding+++GO:0030246///carbohydrate binding				"Homo sapiens galectin like (LGALSL), mRNA."		PF00337///Galactoside-binding lectin			KOG3587///carbohydrate binding		"IPR001079///Galectin, carbohydrate recognition domain+++IPR013320///Concanavalin A-like lectin/glucanase domain superfamily+++IPR030651///Galectin-related protein+++IPR044156///Galectin-like"	[LEGL_HUMAN|Reviewed]RecName: Full=Galectin-related protein; AltName: Full=Galectin-like protein; AltName: Full=Lectin galactoside-binding-like protein;+++[L0R6H9_HUMAN|Unreviewed]SubName: Full=Alternative protein HSPC159 {ECO:0000313|EMBL:CCO13745.1};	chr2p14///Ensembl 103 genes in cytogenetic band chr2p14				"NABA_ECM_AFFILIATED///Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins+++NABA_MATRISOME_ASSOCIATED///Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors+++NABA_MATRISOME///Ensemble of genes encoding extracellular matrix and extracellular matrix-associated proteins "		"LET_7A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-let-7a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++LET_7B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-let-7b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++LET_7F_1_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-let-7f-1-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR10A_5P_MIR10B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-10a-5p, hsa-miR-10b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1183///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1183 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1229_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1229-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1250_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1250-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR130A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-130a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR130B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-130b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR181A_5P_MIR181B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-181a-5p, hsa-miR-181b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR181C_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-181c-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR181D_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-181d-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR196A_1_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-196a-1-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR19A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-19a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR19B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-19b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR219A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-219a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR301A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-301a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR301B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-301b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3119///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3119 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3121_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3121-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3143///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3143 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR338_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-338-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3666///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3666 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3667_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3667-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3674///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3674 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR374C_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-374c-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3908///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3908 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4262///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4262 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4291///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4291 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4293///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4293 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4295///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4295 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4427///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4427 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4445_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4445-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4495///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4495 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4519///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4519 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4520_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4520-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4530///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4530 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR454_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-454-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4659A_3P_MIR4659B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4659a-3p, hsa-miR-4659b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4671_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4671-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4680_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4680-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4698///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4698 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4719///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4719 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4732_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4732-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4782_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4782-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4786_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4786-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR510_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-510-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5190///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5190 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR545_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-545-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR556_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-556-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5586_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5586-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6071///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6071 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR610///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-610 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR655_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-655-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6766_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6766-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6844///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6844 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7856_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7856-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR891A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-891a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR93_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-93-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR98_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-98-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets)."	CTAWWWATA_RSRFC4_Q2///Genes having at least one occurence of the highly conserved motif M28 CTAWWWATA sites. The motif matches transcription factor binding site V$RSRFC4_Q2 (v7.4 TRANSFAC).+++CTTTGA_LEF1_Q2///Genes having at least one occurence of the highly conserved motif M73 CTTTGA sites. The motif matches transcription factor binding site V$LEF1_Q2 (v7.4 TRANSFAC).+++E4BP4_01///Genes having at least one occurence of the transcription factor binding site V$E4BP4_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++GATTGGY_NFY_Q6_01///Genes having at least one occurence of the highly conserved motif M5 GATTGGY sites. The motif matches transcription factor binding site V$NFY_Q6_01 (v7.4 TRANSFAC).+++HLF_01///Genes having at least one occurence of the transcription factor binding site V$HLF_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++MEF2_Q6_01///Genes having at least one occurence of the transcription factor binding site V$MEF2_Q6_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++RTAAACA_FREAC2_01///Genes having at least one occurence of the highly conserved motif M36 RTAAACA sites. The motif matches transcription factor binding site V$FREAC2_01 (v7.4 TRANSFAC).+++SMTTTTGT_UNKNOWN///Genes having at least one occurence of the highly conserved motif M62 SMTTTTGT in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++TAAWWATAG_RSRFC4_Q2///Genes having at least one occurence of the highly conserved motif M54 TAAWWATAG sites. The motif matches transcription factor binding site V$RSRFC4_Q2 (v7.4 TRANSFAC).+++TATAAA_TATA_01///Genes having at least one occurence of the highly conserved motif M51 TATAAA sites. The motif matches transcription factor binding site V$TATA_01 (v7.4 TRANSFAC).+++TBP_01///Genes having at least one occurence of the transcription factor binding site V$TBP_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++TGANTCA_AP1_C///Genes having at least one occurence of the highly conserved motif M7 TGANTCA sites. The motif matches transcription factor binding site V$AP1_C (v7.4 TRANSFAC).+++TGCCAAR_NF1_Q6///Genes having at least one occurence of the highly conserved motif M47 TGCCAAR sites. The motif matches transcription factor binding site V$NF1_Q6 (v7.4 TRANSFAC).+++TGGAAA_NFAT_Q4_01///Genes having at least one occurence of the highly conserved motif M55 TGGAAA sites. The motif matches transcription factor binding site V$NFAT_Q4_01 (v7.4 TRANSFAC).+++TTAYRTAA_E4BP4_01///Genes having at least one occurence of the highly conserved motif M26 TTAYRTAA sites. The motif matches transcription factor binding site V$E4BP4_01 (v7.4 TRANSFAC).	"DLX4_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q92988 (DLX4) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++E2F5_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q15329 (E2F5) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HES2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9Y543 (HES2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HMGB1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P09429 (HMGB1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HOXA1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P49639 (HOXA1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++JDP2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8WYK2 (JDP2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++KDM7A_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6ZMT4 (KDM7A) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++LHX9_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9NQ69 (LHX9) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++PAX3_TARGET_GENES///Genes containing one or more binding sites for UniProt:P23760 (PAX3) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZSCAN30_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q86W11 (ZSCAN30) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."			IL15_UP.V1_UP///Genes up-regulated in Sez-4 cells (T lymphocyte) that were first starved of IL2 [Gene ID=3558] and then stimulated with IL15 [Gene ID=3600].+++IL2_UP.V1_UP///Genes up-regulated in Sez-4 cells (T lymphocyte) that were first starved of IL2 [Gene ID=3558] and then stimulated with IL2 [Gene ID=3558].+++MEK_UP.V1_UP///Genes up-regulated in MCF-7 cells (breast cancer) positive for ESR1 [Gene ID=2099] MCF-7 cells (breast cancer) stably over-expressing constitutively active MAP2K1 [Gene ID=5604] gene.+++STK33_DN///Genes down-regulated in NOMO-1 and SKM-1 cells (AML) after knockdown of STK33 [Gene ID=65975] by RNAi.	"GSE11057_PBMC_VS_MEM_CD4_TCELL_UP///Genes up-regulated in comparison of peripheral mononuclear blood cells (PBMC) versus memory T cells.+++GSE12366_GC_BCELL_VS_PLASMA_CELL_DN///Genes down-regulated in comparison of germinal center B cells versus plasma cells.+++GSE13411_NAIVE_VS_SWITCHED_MEMORY_BCELL_UP///Genes up-regulated in comparison of naive B cells versus Ig isotype switched memory B cells.+++GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_ATOPIC_PATIENT_UP///Genes up-regulated in CD4 [GeneID=920] T cells from atopic patients: resting versus stimulated with allergen (house dust mite).+++GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_72H_ACT_CD4_TCELL_DN///Genes down-regulated in comparison of CD4 [GeneID=920] T cells treated with IL4 [GeneID=3565] and anti-IL12 at 72 h versus the untreated cells at 72 h.+++GSE18893_TCONV_VS_TREG_2H_TNF_STIM_UP///Genes up-regulated in lymphocytes treated with TNF [GeneID=7124] for 2h: T conv versus T reg cells.+++GSE1925_3H_VS_24H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_UP///Genes up-regulated in macrophages primed and then stimulated by IFNG [GeneID=3458]: 3h versus 24h.+++GSE22886_UNSTIM_VS_IL15_STIM_NKCELL_UP///Genes up-regulated in comparison of unstimulated NK cells versus those stimulated with IL15 [GeneID=3600] at 16 h.+++GSE26890_CXCR1_NEG_VS_POS_EFFECTOR_CD8_TCELL_DN///Genes down-regulated in effector CD8 T cells: CXCR1+ [GeneID=3577] versus CXCR1- [GeneID=3577].+++GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_DN///Genes down-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: IL-12 (6h) versus TGFB1 [GeneID=7040] and IL-12 (6h).+++GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_48H_UP///Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: IL4 [GeneID=3565] (48h) versus untreated (48h).+++GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_BCELL_DN///Genes down-regulated in comparison of B cells from LAIV influenza vaccinee at day 7 post-vaccination versus those from TIV influenza vaccinee at day 7 post-vaccination.+++GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_BCELL_UP///Genes up-regulated in comparison of B cells from LAIV influenza vaccinee pre-vaccination versus those at day 7 post-vaccination.+++GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_BCELL_DN///Genes down-regulated in comparison of B cells from TIV influenza vaccinee pre-vaccination versus those at day 7 post-vaccination.+++GSE33424_CD161_INT_VS_NEG_CD8_TCELL_DN///Genes down-regulated in CD8 T cells: KLRB1 int [GeneID=3820] versus KLRB1- [GeneID=3820].+++GSE37416_12H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP///Genes up-regulated in comparison of control polymorphonuclear leukocytes (PMN) at 12 h versus PMN treated with F. tularensis vaccine at 24 h.+++GSE37416_12H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_UP///Genes up-regulated in comparison of control polymorphonuclear leukocytes (PMN) at 12 h versus PMN treated with F. tularensis vaccine at 48 h.+++GSE3982_EOSINOPHIL_VS_BCELL_UP///Genes up-regulated in comparison of eosinophils versus B cells.+++GSE41087_WT_VS_FOXP3_MUT_ANTI_CD3_CD28_STIM_CD4_TCELL_UP///Genes up-regulated in activated CD4 [GeneID=920] T cells expressing: wildtype versus mutant form of FOXP3 [GeneID=50943].+++GSE6092_UNSTIM_VS_IFNG_STIM_ENDOTHELIAL_CELL_UP///Genes up-regulated in endothelial cells: untreated versus IFNG [GeneID=3458].+++GSE6269_STAPH_AUREUS_VS_STREP_PNEUMO_INF_PBMC_DN///Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from patients with acute infection: S. aureus versus S. pneumoniae.+++GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_24H_DN///Genes down-regulated in monocytes: untreated versus M. tuberculosis 19 kDa lipopeptide (24h).+++OSMAN_BLOOD_CHAD63_KH_AGE_18_50YO_HIGH_DOSE_SUBJECTS_24HR_UP///Genes up-regulated in blood 24hr vs 0hr in adults (18-50) (high dose subjects) after exposure to ChAd63-KH , time point 24H , administered Intramuscular injection. Comment: DE gene list for high dose subjects."		NM_014181	LGALSL				
Q27J81	sp|Q27J81|INF2_HUMAN		INF2		Inverted formin-2 OS=Homo sapiens OX=9606 GN=INF2 PE=1 SV=2	64423	NM_022489	NP_071934	ENST00000392634				MSVKEGAQRKWAALKEKLGPQDSDPTEANLESADPELCIRLLQMPSVVNYSGLRKRLEGSDGGWMVQFLEQSGLDLLLEALARLSGRGVARISDALLQLTCVSCVRAVMNSRQGIEYILSNQGYVRQLSQALDTSNVMVKKQVFELLAALCIYSPEGHVLTLDALDHYKTVCSQQYRFSIVMNELSGSDNVPYVVTLLSVINAVILGPEDLRARTQLRNEFIGLQLLDVLARLRDLEDADLLIQLEAFEEAKAEDEEELLRVSGGVDMSSHQEVFASLFHKVSCSPVSAQLLSVLQGLLHLEPTLRSSQLLWEALESLVNRAVLLASDAQECTLEEVVERLLSVKGRPRPSPLVKAHKSVQANLDQSQRGSSPQNTTTPKPSVEGQQPAAAAACEPVDHAQSESILKVSQPRALEQQASTPPPPPPPPLLPGSSAEPPPPPPPPPLPSVGAKALPTAPPPPPLPGLGAMAPPAPPLPPPLPGSCEFLPPPPPPLPGLGCPPPPPPLLPGMGWGPPPPPPPLLPCTCSPPVAGGMEEVIVAQVDHGLGSAWVPSHRRVNPPTLRMKKLNWQKLPSNVAREHNSMWASLSSPDAEAVEPDFSSIERLFSFPAAKPKEPTMVAPRARKEPKEITFLDAKKSLNLNIFLKQFKCSNEEVAAMIRAGDTTKFDVEVLKQLLKLLPEKHEIENLRAFTEERAKLASADHFYLLLLAIPCYQLRIECMLLCEGAAAVLDMVRPKAQLVLAACESLLTSRQLPIFCQLILRIGNFLNYGSHTGDADGFKISTLLKLTETKSQQNRVTLLHHVLEEAEKSHPDLLQLPRDLEQPSQAAGINLEIIRSEASSNLKKLLETERKVSASVAEVQEQYTERLQASISAFRALDELFEAIEQKQRELADYLCEDAQQLSLEDTFSTMKAFRDLFLRALKENKDRKEQAAKAERRKQQLAEEEARRPRGEDGKPVRKGPGKQEEVCVIDALLADIRKGFQLRKTARGRGDTDGGSKAASMDPPRATEPVATSNPAGDPVGSTRCPASEPGLDATTASESRGWDLVDAVTPGPQPTLEQLEEGGPRPLERRSSWYVDASDVLTTEDPQCPQPLEGAWPVTLGDAQALKPLKFSSNQPPAAGSSRQDAKDPTSLLGVLQAEADSTSEGLEDAVHSRGARPPAAGPGGDEDEDEEDTAPESALDTSLDKSFSEDAVTDSSGSGTLPRARGRASKGTGKRRKKRPSRSQEEVPPDSDDNKTKKLCVIQ	0.415969	-1.265452012	0.004443095									3.7210456	4.5078387		4.4568777						3.4071119			3.8176039		6.3198201					6.315755	4.8778616	6.167031	4.9816855			4.1760962					4.081302		4.93160504	5.573016		5.05130362		H00264///Charcot-Marie-Tooth disease+++H00626///Focal segmental glomerulosclerosis			GO:0005737///cytoplasm+++GO:0048471///perinuclear region of cytoplasm	GO:0003779///actin binding+++GO:0031267///small GTPase binding	GO:0016043///cellular component organization+++GO:0030036///actin cytoskeleton organization+++GO:0090140///regulation of mitochondrial fission	tissueType=Blood;cancerType=Normal;cellName=CD141+CLEC9A+ dendritic cell+++tissueType=Fetal gonad;cancerType=Normal;cellName=Gonadal endothelial cell		"Homo sapiens inverted formin 2 (INF2), transcript variant 1, mRNA."		PF02181///Formin Homology 2 Domain+++PF02205///WH2 motif+++PF06367///Diaphanous FH3 Domain+++PF06371///Diaphanous GTPase-binding Domain			KOG1922///actin binding		"IPR003124///WH2 domain+++IPR010472///Formin, FH3 domain+++IPR010473///Formin, GTPase-binding domain+++IPR011989///Armadillo-like helical+++IPR014768///Rho GTPase-binding/formin homology 3 (GBD/FH3) domain+++IPR015425///Formin, FH2 domain+++IPR016024///Armadillo-type fold+++IPR027649///Inverted formin-2+++IPR042201///Formin, FH2 domain superfamily"	[INF2_HUMAN|Reviewed]RecName: Full=Inverted formin-2; AltName: Full=HBEBP2-binding protein C;+++[Q8WYS3_HUMAN|Unreviewed]SubName: Full=Uncharacterized protein pp9484 {ECO:0000313|EMBL:AAL55886.1};	chr14q32///Ensembl 103 genes in cytogenetic band chr14q32						MIR2861///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-2861 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4787_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4787-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6827_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6827-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).	AACTTT_UNKNOWN///Genes having at least one occurence of the highly conserved motif M17 AACTTT in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++CAGCTG_AP4_Q5///Genes having at least one occurence of the highly conserved motif M15 CAGCTG sites. The motif matches transcription factor binding site V$AP4_Q5 (v7.4 TRANSFAC).+++HEB_Q6///Genes having at least one occurence of the transcription factor binding site V$HEB_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++HEN1_01///Genes having at least one occurence of the transcription factor binding site V$HEN1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.	"CBX5_TARGET_GENES///Genes containing one or more binding sites for UniProt:P45973 (CBX5) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ID1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P41134 (ID1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NAB2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q15742 (NAB2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SUPT16H_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9Y5B9 (SUPT16H) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF592_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q92610 (ZNF592) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF740_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8NDX6 (ZNF740) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF92_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q03936 (ZNF92) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZSCAN30_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q86W11 (ZSCAN30) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."		MODULE_26///Genes in the cancer module 26.		"FLETCHER_PBMC_BCG_10W_INFANT_BCG_STIMULATED_VS_UNSTIMULATED_10W_DN///Genes down-regulated in peripheral blood mononuclear cell stimulated vs unstimulated in infants (10w) after exposure to BCG (Danish strain BCG Statens Serum Institut, Denmark) , time point 10W. Comment: PBMCs drawn at 10 weeks following immunization at birth+++FLETCHER_PBMC_BCG_10W_INFANT_PPD_STIMULATED_VS_UNSTIMULATED_10W_DN///Genes down-regulated in peripheral blood mononuclear cell stimulated vs unstimulated in infants (10w) after exposure to BCG (Danish strain BCG Statens Serum Institut, Denmark) , time point 10W. Comment: PBMCs drawn at 10 weeks following immunization at birth+++FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_DN///Genes down-regulated in blood responders vs poor responders in adults (25-83) (responders) after exposure to Twinrix , time point 0D+++GSE12845_NAIVE_VS_PRE_GC_TONSIL_BCELL_UP///Genes up-regulated in comparison of naive B cell versus pre-germinal tonsil B cells.+++GSE13485_DAY1_VS_DAY21_YF17D_VACCINE_PBMC_UP///Genes up-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) 1 day after stimulation with YF17D vaccine versus PBMC 21 days after the stimulation.+++GSE1460_DP_THYMOCYTE_VS_THYMIC_STROMAL_CELL_UP///Genes up-regulated in comparison of CD4 [GeneID=920] CD8 thymocytes versus thymic stromal cells.+++GSE1460_NAIVE_CD4_TCELL_CORD_BLOOD_VS_THYMIC_STROMAL_CELL_UP///Genes up-regulated in naive CD4 [GeneID=920] T cells from cord blood versus thymic stromal cells.+++GSE19888_ADENOSINE_A3R_INH_VS_TCELL_MEMBRANES_ACT_MAST_CELL_DN///Genes down-regulated in HMC-1 (mast leukemia) cells: incubated with the peptide ALL1 versus stimulated with T cell membranes.+++GSE22589_HEALTHY_VS_SIV_INFECTED_DC_UP///Genes up-regulated in monocyte-derived dendritic cells: control versus SIV infection.+++GSE22886_NAIVE_CD4_TCELL_VS_NKCELL_UP///Genes up-regulated in comparison of naive CD4 [GeneID=920] T cells versus unstimulated NK cells.+++GSE23695_CD57_POS_VS_NEG_NK_CELL_UP///Genes up-regulated in NK cells: B3GAT1+ [GeneID=27087] versus B3GAT1- [GeneID=27087].+++GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_24H_UP///Genes up-regulated in polymorphonuclear leukocytes (24h): treated by heat killed HC60 cell (promyelocytic leukemia) lysate versus A. phagocytophilum infection.+++GSE2405_S_AUREUS_VS_A_PHAGOCYTOPHILUM_NEUTROPHIL_UP///Genes up-regulated in polymorphonuclear leukocytes 9h after infection by: S. aureus versus A. phagocytophilum.+++GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_48H_UP///Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 [GeneID=7040] and IL-12 (48h) versus untreated (48h).+++GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_PDC_UP///Genes up-regulated in comparison of plasmacytoid dendritic cells (pDC) from TIV influenza vaccinee pre-vaccination versus those at day 7 post-vaccination.+++GSE34156_UNTREATED_VS_24H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN///Genes down-regulated in monocytes (24h): untreated versus muramyl dipeptide [PubChem=11620162] andM. tuberculosis 19 kDa lipopeptide.+++GSE3920_IFNA_VS_IFNB_TREATED_ENDOTHELIAL_CELL_UP///Genes up-regulated in endothelial cells: interferon alpha versus interferon beta.+++GSE3982_MAST_CELL_VS_DC_DN///Genes down-regulated in comparison of mast cells versus dendritic cells (DC).+++GSE3982_MAST_CELL_VS_MAC_DN///Genes down-regulated in comparison of mast cells versus macrophages.+++GSE40184_HEALTHY_VS_HCV_INFECTED_DONOR_PBMC_DN///Genes down-regulated in peripheral blood monocytes (PBMC): healthy donors versus patients with HCV infection.+++GSE5142_CTRL_VS_HTERT_TRANSDUCED_CD8_TCELL_EARLY_PASSAGE_CLONE_UP///Genes up-regulated in CD8 T cells: control versus over-expressing TERT [GeneID=7015].+++GSE6092_B_BURGDOFERI_VS_B_BURGDORFERI_AND_IFNG_STIM_ENDOTHELIAL_CELL_UP///Genes up-regulated in endothelial cells: B. burgdoferi versus IFNG [GeneID=3459] and B. burgdoferi .+++GSE6092_UNSTIM_VS_IFNG_STIM_ENDOTHELIAL_CELL_DN///Genes down-regulated in endothelial cells: untreated versus IFNG [GeneID=3458].+++GSE9946_LISTERIA_INF_MATURE_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_UP///Genes up-regulated in mature inhibitory dendritic cells: L. monocytogenes infection versus prostaglandin E2 [PubChem=5280360]."		NM_022489	INF2				
Q16799	sp|Q16799|RTN1_HUMAN		RTN1		Reticulon-1 OS=Homo sapiens OX=9606 GN=RTN1 PE=1 SV=1	6252	NM_021136	NP_066959	ENST00000267484				MAAPGDPQDELLPLAGPGSQWLRHRGEGENEAVTPKGATPAPQAGEPSPGLGARAREAASREAGSGPARQSPVAMETASTGVAGVSSAMDHTFSTTSKDGEGSCYTSLISDICYPPQEDSTYFTGILQKENGHVTISESPEELGTPGPSLPDVPGIESRGLFSSDSGIEMTPAESTEVNKILADPLDQMKAEAYKYIDITRPEEVKHQEQHHPELEDKDLDFKNKDTDISIKPEGVREPDKPAPVEGKIIKDHLLEESTFAPYIDDLSEEQRRAPQITTPVKITLTEIEPSVETTTQEKTPEKQDICLKPSPDTVPTVTVSEPEDDSPGSITPPSSGTEPSAAESQGKGSISEDELITAIKEAKGLSYETAENPRPVGQLADRPEVKARSGPPTIPSPLDHEASSAESGDSEIELVSEDPMAAEDALPSGYVSFGHVGGPPPSPASPSIQYSILREEREAELDSELIIESCDASSASEESPKREQDSPPMKPSALDAIREETGVRAEERAPSRRGLAEPGSFLDYPSTEPQPGPELPPGDGALEPETPMLPRKPEEDSSSNQSPAATKGPGPLGPGAPPPLLFLNKQKAIDLLYWRDIKQTGIVFGSFLLLLFSLTQFSVVSVVAYLALAALSATISFRIYKSVLQAVQKTDEGHPFKAYLELEITLSQEQIQKYTDCLQFYVNSTLKELRRLFLVQDLVDSLKFAVLMWLLTYVGALFNGLTLLLMAVVSMFTLPVVYVKHQAQIDQYLGLVRTHINAVVAKIQAKIPGAKRHAE	0.4864954	-1.039501911	0.01004425						5.7928606		4.030329	5.9583347	6.8064349	5.6281527					5.1287797		5.4283785		3.2841622	4.9400492	6.2091782	6.6824453					7.838026	7.3725457	6.604042	7.2966821	4.727446	5.7965867	5.9694197	6.8662743		5.2914698	4.9579294	6.360542	6.9341542	6.39862673	6.9682208	4.4327206	7.62572275					GO:0000139///Golgi membrane+++GO:0005783///endoplasmic reticulum+++GO:0005789///endoplasmic reticulum membrane+++GO:0005794///Golgi apparatus+++GO:0016020///membrane+++GO:0016021///integral component of membrane+++GO:0030176///integral component of endoplasmic reticulum membrane	GO:0005515///protein binding	GO:0030182///neuron differentiation+++GO:1902430///negative regulation of amyloid-beta formation	tissueType=Embryonic prefrontal cortex;cancerType=Normal;cellName=Oligodendrocyte progenitor cell+++tissueType=Embryonic prefrontal cortex;cancerType=Normal;cellName=Astrocyte+++tissueType=Embryonic prefrontal cortex;cancerType=Normal;cellName=Microglial cell+++tissueType=Embryonic prefrontal cortex;cancerType=Normal;cellName=Neural progenitor cell		"Homo sapiens reticulon 1 (RTN1), transcript variant 1, mRNA."		PF02453///Reticulon			KOG1792///endoplasmic reticulum tubular network organization		IPR003388///Reticulon	[RTN1_HUMAN|Reviewed]RecName: Full=Reticulon-1; AltName: Full=Neuroendocrine-specific protein;+++[Q2L7A7_HUMAN|Unreviewed]SubName: Full=Reticulon 1 isoform A {ECO:0000313|EMBL:ABC71342.1}; Flags: Fragment;+++[Q6IAX4_HUMAN|Unreviewed]RecName: Full=Reticulon {ECO:0000256|RuleBase:RU210713};	chr14q23///Ensembl 103 genes in cytogenetic band chr14q23					"ACTTTAT_MIR1425P///Genes having at least one occurence of the motif ACTTTAT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-142-5p (v7.1 miRBase).+++TACTTGA_MIR26A_MIR26B///Genes having at least one occurence of the motif TACTTGA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-26a and hsa-miR-26b (v7.1 miRBase).+++TGCACTT_MIR519C_MIR519B_MIR519A///Genes having at least one occurence of the motif TGCACTT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-519c, hsa-miR-519b and hsa-miR-519a (v7.1 miRBase).+++TTGCACT_MIR130A_MIR301_MIR130B///Genes having at least one occurence of the motif TTGCACT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-130a, hsa-miR-301 and hsa-miR-130b (v7.1 miRBase).+++TTTGCAC_MIR19A_MIR19B///Genes having at least one occurence of the motif TTTGCAC in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-19a and hsa-miR-19b (v7.1 miRBase)."	"LET_7A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-let-7a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++LET_7B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-let-7b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++LET_7F_1_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-let-7f-1-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR12123///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-12123 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1278///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1278 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR130A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-130a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR130B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-130b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR133A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-133a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR19A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-19a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR19B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-19b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR2054///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-2054 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR300///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-300 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR301A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-301a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR301B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-301b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR302A_3P_MIR302B_3P_MIR302C_3P_MIR302D_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-302a-3p, hsa-miR-302b-3p, hsa-miR-302c-3p, hsa-miR-302d-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR302E///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-302e in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3143///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3143 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3618///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3618 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3666///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3666 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3678_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3678-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR372_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-372-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR373_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-373-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR374C_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-374c-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR380_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-380-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR381_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-381-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3914///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3914 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4295///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4295 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4325///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4325 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR454_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-454-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4666A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4666a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4729///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4729 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4797_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4797-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR497_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-497-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR519A_3P_MIR519B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-519a-3p, hsa-miR-519b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR519C_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-519c-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR520A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-520a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR520B_3P_MIR520C_3P_MIR520E_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-520b-3p, hsa-miR-520c-3p, hsa-miR-520e-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR520D_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-520d-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548V///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548v in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR563///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-563 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5696///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5696 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5697///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5697 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6516_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6516-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR655_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-655-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR664A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-664a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6814_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6814-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6818_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6818-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6867_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6867-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR802///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-802 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR8068///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-8068 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR944///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-944 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR98_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-98-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets)."	AAAYRNCTG_UNKNOWN///Genes having at least one occurence of the highly conserved motif M77 AAAYRNCTG in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++AMEF2_Q6///Genes having at least one occurence of the transcription factor binding site V$AMEF2_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++AREB6_01///Genes having at least one occurence of the transcription factor binding site V$AREB6_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++AREB6_02///Genes having at least one occurence of the transcription factor binding site V$AREB6_02 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++CP2_01///Genes having at least one occurence of the transcription factor binding site V$CP2_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++CP2_02///Genes having at least one occurence of the transcription factor binding site V$CP2_02 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++CTTTGA_LEF1_Q2///Genes having at least one occurence of the highly conserved motif M73 CTTTGA sites. The motif matches transcription factor binding site V$LEF1_Q2 (v7.4 TRANSFAC).+++EVI1_05///Genes having at least one occurence of the transcription factor binding site V$EVI1_05 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++GGGYGTGNY_UNKNOWN///Genes having at least one occurence of the highly conserved motif M31 GGGYGTGNY in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++HSF1_01///Genes having at least one occurence of the transcription factor binding site V$HSF1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++HSF_Q6///Genes having at least one occurence of the transcription factor binding site V$HSF_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++IK3_01///Genes having at least one occurence of the transcription factor binding site V$IK3_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++MMEF2_Q6///Genes having at least one occurence of the transcription factor binding site V$MMEF2_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++PAX2_02///Genes having at least one occurence of the transcription factor binding site V$PAX2_02 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++RGAANNTTC_HSF1_01///Genes having at least one occurence of the highly conserved motif M68 RGAANNTTC sites. The motif matches transcription factor binding site V$HSF1_01 (v7.4 TRANSFAC).+++STAT_Q6///Genes having at least one occurence of the transcription factor binding site V$STAT_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++SYATTGTG_UNKNOWN///Genes having at least one occurence of the highly conserved motif M71 SYATTGTG in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++TATA_C///Genes having at least one occurence of the transcription factor binding site V$TATA_C (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++TGANTCA_AP1_C///Genes having at least one occurence of the highly conserved motif M7 TGANTCA sites. The motif matches transcription factor binding site V$AP1_C (v7.4 TRANSFAC).+++TGGNNNNNNKCCAR_UNKNOWN///Genes having at least one occurence of the highly conserved motif M27 TGGNNNNNNKCCAR in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++TGTTTGY_HNF3_Q6///Genes having at least one occurence of the highly conserved motif M83 TGTTTGY sites. The motif matches transcription factor binding site V$HNF3_Q6 (v7.4 TRANSFAC).+++TST1_01///Genes having at least one occurence of the transcription factor binding site V$TST1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++TTANTCA_UNKNOWN///Genes having at least one occurence of the highly conserved motif M64 TTANTCA in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++TTCNRGNNNNTTC_HSF_Q6///Genes having at least one occurence of the highly conserved motif M141 TTCNRGNNNNTTC sites. The motif matches transcription factor binding site V$HSF_Q6 (v7.4 TRANSFAC).+++TTCYRGAA_UNKNOWN///Genes having at least one occurence of the highly conserved motif M72 TTCYRGAA in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++YCATTAA_UNKNOWN///Genes having at least one occurence of the highly conserved motif M58 YCATTAA in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).	"FOXP2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O15409 (FOXP2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++KDM5D_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9BY66 (KDM5D) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++PCGF2_TARGET_GENES///Genes containing one or more binding sites for UniProt:P35227 (PCGF2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF224_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9NZL3 (ZNF224) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF274_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96GC6 (ZNF274) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF394_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q53GI3 (ZNF394) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF513_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8N8E2 (ZNF513) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF610_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8N9Z0 (ZNF610) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."	GNF2_AF1Q///Neighborhood of AF1Q+++GNF2_MAPT///Neighborhood of MAPT+++GNF2_RTN1///Neighborhood of RTN1	MODULE_100///Genes in the cancer module 100.+++MODULE_117///Signaling.+++MODULE_11///Genes in the cancer module 11.+++MODULE_12///Spinal cord (neuro-development) genes.+++MODULE_137///CNS genes.+++MODULE_220///Developmental processes.+++MODULE_2///DRG (dorsal root ganglia) genes.+++MODULE_66///Genes in the cancer module 66.	KRAS.300_UP.V1_UP///Genes up-regulated in four lineages of epithelial cell lines over-expressing an oncogenic form of KRAS [Gene ID=3845] gene.+++KRAS.600_UP.V1_UP///Genes up-regulated in four lineages of epithelial cell lines over-expressing an oncogenic form of KRAS [Gene ID=3845] gene.+++KRAS.KIDNEY_UP.V1_UP///Genes up-regulated in epithelial kidney cancer cell lines over-expressing an oncogenic form of KRAS [Gene ID=3845] gene.+++PTEN_DN.V2_UP///Genes up-regulated in HCT116 cells (colon carcinoma) upon knockdown of PTEN [Gene ID=5728] by RNAi.+++STK33_SKM_UP///Genes up-regulated in SKM-1 cells (AML) after knockdown of STK33 [Gene ID=65975] by RNAi.+++STK33_UP///Genes up-regulated in NOMO-1 and SKM-1 cells (AML) after knockdown of STK33 [Gene ID=65975] by RNAi.	"GSE11057_CD4_CENT_MEM_VS_PBMC_DN///Genes down-regulated in comparison of central memory T cells versus peripheral blood mononuclear cells (PBMC).+++GSE11057_CD4_EFF_MEM_VS_PBMC_DN///Genes down-regulated in comarison of effector memory T cells versus peripheral blood mononuclear cells (PBMC).+++GSE11057_NAIVE_CD4_VS_PBMC_CD4_TCELL_DN///Genes down-regulated in comparison of naive T cells versus peripheral blood mononuclear cells (PBMC).+++GSE11057_PBMC_VS_MEM_CD4_TCELL_UP///Genes up-regulated in comparison of peripheral mononuclear blood cells (PBMC) versus memory T cells.+++GSE13411_NAIVE_VS_SWITCHED_MEMORY_BCELL_UP///Genes up-regulated in comparison of naive B cells versus Ig isotype switched memory B cells.+++GSE13411_SWITCHED_MEMORY_BCELL_VS_PLASMA_CELL_DN///Genes down-regulated in comparison of Ig isotype switched memory B cells versus plasma cells.+++GSE16385_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_UP///Genes up-regulated in macrophages (12h): IFNG and TNF [GeneID=3458;7124] versus IL4 [GeneID=3565].+++GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_6H_IFNA_STIM_UP///Genes up-regulated in neuron cell line treated with interferon alpha for 6h: immature versus mature.+++GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_24H_ACT_CD4_TCELL_UP///Genes up-regulated in comparison of CD4 [GeneID=920] T cells treated with IL4 [GeneID=3565] and anti-IL12 at 24 h versus the untreated cells at 24 h.+++GSE22886_NAIVE_CD8_TCELL_VS_MONOCYTE_DN///Genes down-regulated in comparison of naive CD8 T cells versus day 0 monocytes.+++GSE22886_NAIVE_TCELL_VS_MONOCYTE_DN///Genes down-regulated in comparison of naive CD4 [GeneID=920] CD8 T cells versus monocytes cultured for 0 days.+++GSE22886_TH1_VS_TH2_48H_ACT_UP///Genes up-regulated in comparison of stimulated CD4 [GeneID=920] Th1 cells at 48 h versus stimulated CD4 [GeneID=920] Th2 cells at 48 h.+++GSE24081_CONTROLLER_VS_PROGRESSOR_HIV_SPECIFIC_CD8_TCELL_UP///Genes up-regulated in comparison of CD8 T cells with progressing HIV infection versus those with controlled HIV infection.+++GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY10_DN///Genes down-regulated in comparison of CD25- T cells treated with IL4 [GeneID=3565] at day 10 versus untreated CD25- T cells at day 10.+++GSE24634_TEFF_VS_TCONV_DAY10_IN_CULTURE_DN///Genes down-regulated in comparison of untreated CD25+ T effector cells at day 10 versus untreated CD25- T cells at day 10.+++GSE24634_TREG_VS_TCONV_POST_DAY10_IL4_CONVERSION_DN///Genes down-regulated in comparison of CD25+ regulatory T cell (Treg) treated with IL4 [GeneID=3565] at day 10 versus CD25- T cells treated with IL4 [GeneID=3565] at 10 h.+++GSE24634_TREG_VS_TCONV_POST_DAY5_IL4_CONVERSION_DN///Genes down-regulated in comparison of CD25+ T cells treated with IL4 [GeneID=3565] versus CD25- T cells treated with IL4 [GeneID=3565] at day 5.+++GSE24634_TREG_VS_TCONV_POST_DAY7_IL4_CONVERSION_DN///Genes down-regulated in comparison of CD25+ regulatory T cell (Treg) treated with IL4 [GeneID=3565] at day 7 versus CD25- T cells treated with IL4 [GeneID=3565] at day 7.+++GSE26351_WNT_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_UP///Genes up-regulated in CD34+ [GeneID=947] cells treated with GSK-3 Inhibitor IX (BIO) [PubChem=5287844] versus those stimulated by BMP4 [GeneID=652].+++GSE27670_CTRL_VS_LMP1_TRANSDUCED_GC_BCELL_UP///Genes up-regulated in germinal center B lymphocytes: control versus over-expressing Epstein-Barr virus protein LMP1.+++GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_2H_DN///Genes down-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 [GeneID=7040] and IL-12 (2h) versus IL4 [GeneID=3565] (2h).+++GSE29618_BCELL_VS_MDC_DAY7_FLU_VACCINE_DN///Genes down-regulated in comparison of B cells from influenza vaccinee at day 7 post-vaccination versus myeloid dendritic cells (mDC) at day 7 post-vaccination.+++GSE29618_BCELL_VS_MDC_DN///Genes down-regulated in comparison of B cells versus myeloid dendritic cells (mDC).+++GSE29618_BCELL_VS_MONOCYTE_DAY7_FLU_VACCINE_DN///Genes down-regulated in comparison of B cells from influenza vaccinee at day 7 versus monocytes from influenza vaccinee at day 7.+++GSE29618_BCELL_VS_MONOCYTE_DN///Genes down-regulated in comparison of B cells versus monocytes.+++GSE29618_MONOCYTE_VS_PDC_DAY7_FLU_VACCINE_UP///Genes up-regulated in comparison of monocytes from influenza vaccinee at day 7 post-vaccination versus plasmacytoid dendritic cells (mDC) at day 7 post-vaccination.+++GSE29618_PDC_VS_MDC_DAY7_FLU_VACCINE_DN///Genes down-regulated in comparison of plasmacytoid dendritic cells (DC) from influenza vaccinee at day 7 post-vaccination versus myeloid DCs at day 7 post-vaccination.+++GSE29618_PDC_VS_MDC_DN///Genes down-regulated in comparison of plasmacytoid dendritic cells (DC) versus myeloid DCs.+++GSE34156_UNTREATED_VS_6H_NOD2_LIGAND_TREATED_MONOCYTE_DN///Genes down-regulated in monocytes (6h): untreated versus muramyl dipeptide [PubChem=11620162].+++GSE34205_HEALTHY_VS_FLU_INF_INFANT_PBMC_UP///Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMCs from infanct with acute influenza infection.+++GSE34205_HEALTHY_VS_RSV_INF_INFANT_PBMC_UP///Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMCs from infanct with acute RSV infection.+++GSE360_DC_VS_MAC_B_MALAYI_HIGH_DOSE_DN///Genes down-regulated in comparison of dendritic cells (DC) exposed to 50 worm/well B. malayi versus macrophages exposed to 50 worms/well B. malayi.+++GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_DN///Genes down-regulated in comparison of dendritic cells (DC) exposed to 50 worms/well B. malayi versus DC exposed to M. tuberculosis+++GSE3982_CTRL_VS_PMA_STIM_EOSINOPHIL_DN///Genes down-regulated in comparison of untreated eosinophils versus eosinophils treated with PMA [PubChem=4792] at 2 h.+++GSE3982_MAC_VS_BASOPHIL_UP///Genes up-regulated in comparison of macrophages versus basophils.+++GSE3982_MAC_VS_CENT_MEMORY_CD4_TCELL_UP///Genes up-regulated in comparison of macrophages versus central memory CD4 [GeneID=920] T cells.+++GSE3982_MAC_VS_TH1_UP///Genes up-regulated in comparison of macrophages versus Th1 cells.+++GSE3982_NKCELL_VS_TH1_UP///Genes up-regulated in comparison of NK cells versus Th1 cells.+++GSE42724_NAIVE_BCELL_VS_PLASMABLAST_UP///Genes up-regulated in B lymphocytes: nave versus plasmablasts.+++GSE8685_IL2_STARVED_VS_IL2_ACT_IL2_STARVED_CD4_TCELL_UP///Genes up-regulated in Sez-2 cells (T cell lymphoma): untreated versus IL2 [GeneID=3558].+++HOEK_NK_CELL_2011_2012_TIV_3D_VS_0DY_ADULT_3D_DN///Genes down-regulated in natural killer cell 3d vs 0d in adults after exposure to 2011-2012 trivalent inactivated vaccine (A/California/7/09 (H1N1), A/Perth /16/2009 (H3N2), B/Brisbane/60/2008) , time point 3D. Comment: Down-regulated DE RNA transcripts (down &gt;= 1.5x) shared between both TIV-vaccinated donors+++LI_PBMC_MENACTRA_AGE_18_45YO_CORRELATED_WITH_ANTI_DT_ANTIBODY_3DY_POSITIVE///Genes positively correlated with antibody response in peripheral blood mononuclear cell in adults (18-45) (anti-DT antibody-correlation profile) after exposure to Menactra , time point 3D+++LI_PBMC_MENACTRA_AGE_18_45YO_CORRELATED_WITH_ANTI_POLYSACCHARIDE_ANTIBODY_3DY_POSITIVE///Genes positively correlated with antibody response in peripheral blood mononuclear cell in adults (18-45) (anti-polysaccharide antibody-correlation profile) after exposure to Menactra , time point 3D+++NAKAYA_MONOCYTE_FLUMIST_AGE_18_50YO_7DY_UP///Genes up-regulated in monocyte 7d vs 0d in young adults (18-50) after exposure to FluMist , time point 7D+++NAKAYA_MYELOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP///Genes up-regulated in myeloid dendritic cell 7d vs 0d in young adults (18-50) after exposure to FluMist , time point 7D+++NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_POSITIVE///Genes positively correlated with HAI response at 28d in peripheral blood mononuclear cell in adults (18-50) after exposure to Fluarix/Fluvirin , time point 3D. Comment: Supplementary Table 5: All genes whose expression (d3/d0 or d7/d0) correlates to the fold increase in HAI titers (d28/d0).+++NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_UP///Genes up-regulated in peripheral blood mononuclear cell 3d vs 0d in adults (18-50) after exposure to FluMist , time point 3D. Comment: Supplementary Table 1b: All the differentially expressed genes identified in PBMCs of TIV vaccinees.+++NAKAYA_PBMC_FLUMIST_AGE_18_50YO_7DY_UP///Genes up-regulated in peripheral blood mononuclear cell 7d vs 0d in adults (18-50) after exposure to FluMist , time point 7D. Comment: Supplementary Table 1b: All the differentially expressed genes identified in PBMCs of TIV vaccinees.+++NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN///Genes down-regulated in plasmacytoid dendritic cell 7d vs 0d in young adults (18-50) after exposure to FluMist , time point 7D+++OSMAN_BLOOD_CHAD63_KH_AGE_18_50YO_HIGH_DOSE_SUBJECTS_24HR_UP///Genes up-regulated in blood 24hr vs 0hr in adults (18-50) (high dose subjects) after exposure to ChAd63-KH , time point 24H , administered Intramuscular injection. Comment: DE gene list for high dose subjects."	HALLMARK_HEDGEHOG_SIGNALING///Genes up-regulated by activation of hedgehog signaling.	NM_021136	RTN1				
Q16643	sp|Q16643|DREB_HUMAN		DBN1		Drebrin OS=Homo sapiens OX=9606 GN=DBN1 PE=1 SV=4	1627	NM_004395	NP_004386	ENST00000309007				MAGVSFSGHRLELLAAYEEVIREESAADWALYTYEDGSDDLKLAASGEGGLQELSGHFENQKVMYGFCSVKDSQAALPKYVLINWVGEDVPDARKCACASHVAKVAEFFQGVDVIVNASSVEDIDAGAIGQRLSNGLARLSSPVLHRLRLREDENAEPVGTTYQKTDAAVEMKRINREQFWEQAKKEEELRKEEERKKALDERLRFEQERMEQERQEQEERERRYREREQQIEEHRRKQQTLEAEEAKRRLKEQSIFGDHRDEEEETHMKKSESEVEEAAAIIAQRPDNPREFFKQQERVASASAGSCDVPSPFNHRPGSHLDSHRRMAPTPIPTRSPSDSSTASTPVAEQIERALDEVTSSQPPPLPPPPPPAQETQEPSPILDSEETRAAAPQAWAGPMEEPPQAQAPPRGPGSPAEDLMFMESAEQAVLAAPVEPATADATEIHDAADTIETDTATADTTVANNVPPAATSLIDLWPGNGEGASTLQGEPRAPTPPSGTEVTLAEVPLLDEVAPEPLLPAGEGCATLLNFDELPEPPATFCDPEEVEGESLAAPQTPTLPSALEELEQEQEPEPHLLTNGETTQKEGTQASEGYFSQSQEEEFAQSEELCAKAPPPVFYNKPPEIDITCWDADPVPEEEEGFEGGD	0.5243269	-0.931461497	0.01277861					4.7269111						5.8990662	6.8503317			6.0392704							6.006899	6.270173					6.37086	7.7558857	6.579441	7.1704824			6.4249772			6.037447		7.666607	6.8449706	7.33823057	7.4601648		6.1122475					GO:0005737///cytoplasm+++GO:0005829///cytosol+++GO:0005856///cytoskeleton+++GO:0005884///actin filament+++GO:0005886///plasma membrane+++GO:0005911///cell-cell junction+++GO:0005921///gap junction+++GO:0005938///cell cortex+++GO:0014069///postsynaptic density+++GO:0015629///actin cytoskeleton+++GO:0016020///membrane+++GO:0030027///lamellipodium+++GO:0030054///cell junction+++GO:0030425///dendrite+++GO:0030426///growth cone+++GO:0030427///site of polarized growth+++GO:0030863///cortical cytoskeleton+++GO:0030864///cortical actin cytoskeleton+++GO:0042641///actomyosin+++GO:0042995///cell projection+++GO:0045211///postsynaptic membrane+++GO:0098978///glutamatergic synapse+++GO:0099524///postsynaptic cytosol	GO:0003779///actin binding+++GO:0005515///protein binding+++GO:0005522///profilin binding+++GO:0045296///cadherin binding+++GO:0051015///actin filament binding	GO:0001701///in utero embryonic development+++GO:0007015///actin filament organization+++GO:0007399///nervous system development+++GO:0010643///cell communication by chemical coupling+++GO:0010644///cell communication by electrical coupling+++GO:0030154///cell differentiation+++GO:0030833///regulation of actin filament polymerization+++GO:0031915///positive regulation of synaptic plasticity+++GO:0032507///maintenance of protein location in cell+++GO:0045773///positive regulation of axon extension+++GO:0048168///regulation of neuronal synaptic plasticity+++GO:0048699///generation of neurons+++GO:0048812///neuron projection morphogenesis+++GO:0050773///regulation of dendrite development+++GO:0051220///cytoplasmic sequestering of protein+++GO:0061003///positive regulation of dendritic spine morphogenesis+++GO:0061351///neural precursor cell proliferation+++GO:0098974///postsynaptic actin cytoskeleton organization+++GO:1902685///positive regulation of receptor localization to synapse	tissueType=Embryonic prefrontal cortex;cancerType=Normal;cellName=Microglial cell		"Homo sapiens drebrin 1 (DBN1), transcript variant 1, mRNA."			"R-HSA-162582///Signal Transduction+++R-HSA-194315///Signaling by Rho GTPases+++R-HSA-9012999///RHO GTPase cycle+++R-HSA-9013405///RHOD GTPase cycle+++R-HSA-9013407///RHOH GTPase cycle+++R-HSA-9013418///RHOBTB2 GTPase cycle+++R-HSA-9013422///RHOBTB1 GTPase cycle+++R-HSA-9706574///RHOBTB GTPase Cycle+++R-HSA-9716542///Signaling by Rho GTPases, Miro GTPases and RHOBTB3"					"[DREB_HUMAN|Reviewed]RecName: Full=Drebrin; AltName: Full=Developmentally-regulated brain protein;+++[A0A2Z6ATB6_HUMAN|Unreviewed]SubName: Full=Drebrin A {ECO:0000313|EMBL:BBD06306.1};+++[B3KSQ7_HUMAN|Unreviewed]SubName: Full=Drebrin 1, isoform CRA_d {ECO:0000313|EMBL:EAW84992.1}; SubName: Full=cDNA FLJ36806 fis, clone ASTRO1000165, highly similar to Drebrin {ECO:0000313|EMBL:BAG52819.1};"	chr5q35///Ensembl 103 genes in cytogenetic band chr5q35			"REACTOME_RHOBTB1_GTPASE_CYCLE///RHOBTB1 GTPase cycle+++REACTOME_RHOBTB2_GTPASE_CYCLE///RHOBTB2 GTPase cycle+++REACTOME_RHOBTB_GTPASE_CYCLE///RHOBTB GTPase Cycle+++REACTOME_RHOD_GTPASE_CYCLE///RHOD GTPase cycle+++REACTOME_RHO_GTPASE_CYCLE///RHO GTPase cycle+++REACTOME_RHOH_GTPASE_CYCLE///RHOH GTPase cycle+++REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3///Signaling by Rho GTPases, Miro GTPases and RHOBTB3"		"AAGCACA_MIR218///Genes having at least one occurence of the motif AAGCACA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-218 (v7.1 miRBase).+++ATGTTTC_MIR494///Genes having at least one occurence of the motif ATGTTTC in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-494 (v7.1 miRBase).+++CACTTTG_MIR520G_MIR520H///Genes having at least one occurence of the motif CACTTTG in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-520g and hsa-miR-520h (v7.1 miRBase).+++CAGCTTT_MIR320///Genes having at least one occurence of the motif CAGCTTT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-320 (v7.1 miRBase).+++CAGGTCC_MIR492///Genes having at least one occurence of the motif CAGGTCC in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-492 (v7.1 miRBase).+++CTTTGTA_MIR524///Genes having at least one occurence of the motif CTTTGTA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-524* (v7.1 miRBase).+++GGGGCCC_MIR296///Genes having at least one occurence of the motif GGGGCCC in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-296 (v7.1 miRBase).+++TCCAGAT_MIR5165P///Genes having at least one occurence of the motif TCCAGAT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-516-5p (v7.1 miRBase).+++TGCACGA_MIR517A_MIR517C///Genes having at least one occurence of the motif TGCACGA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-517a and hsa-miR-517c (v7.1 miRBase).+++TTTGCAC_MIR19A_MIR19B///Genes having at least one occurence of the motif TTTGCAC in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-19a and hsa-miR-19b (v7.1 miRBase)."	"MIR1468_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1468-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1537_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1537-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR19A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-19a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR19B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-19b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR218_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-218-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3167///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3167 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3927_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3927-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4536_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4536-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4640_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4640-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4659A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4659a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4659B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4659b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4726_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4726-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR517A_3P_MIR517B_3P_MIR517C_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-517a-3p, hsa-miR-517b-3p, hsa-miR-517c-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AW///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548aw in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6124///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6124 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6839_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6839-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6882_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6882-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7844_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7844-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR874_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-874-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR876_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-876-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets)."	AP2_Q6_01///Genes having at least one occurence of the transcription factor binding site V$AP2_Q6_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++TGGAAA_NFAT_Q4_01///Genes having at least one occurence of the highly conserved motif M55 TGGAAA sites. The motif matches transcription factor binding site V$NFAT_Q4_01 (v7.4 TRANSFAC).+++TTANTCA_UNKNOWN///Genes having at least one occurence of the highly conserved motif M64 TTANTCA in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).	"ADA2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9NZK5 (ADA2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++KDM7A_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6ZMT4 (KDM7A) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NFKBIA_TARGET_GENES///Genes containing one or more binding sites for UniProt:P25963 (NFKBIA) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NFXL1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6ZNB6 (NFXL1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SUPT16H_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9Y5B9 (SUPT16H) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF184_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q99676 (ZNF184) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."		MODULE_100///Genes in the cancer module 100.+++MODULE_118///cell line expressed genes.+++MODULE_11///Genes in the cancer module 11.+++MODULE_129///Signaling.+++MODULE_12///Spinal cord (neuro-development) genes.+++MODULE_137///CNS genes.+++MODULE_13///Genes in the cancer module 12.+++MODULE_165///Genes in the cancer module 165.+++MODULE_1///Ovary genes.+++MODULE_3///Genes in the cancer module 3.+++MODULE_52///Cell line expressed genes.+++MODULE_53///Cell line expressed genes.+++MODULE_66///Genes in the cancer module 66.+++MODULE_70///Genes in the cancer module 70.+++MODULE_8///Genes in the cancer module 8.	"LEF1_UP.V1_UP///Genes up-regulated in DLD1 cells (colon carcinoma) over-expressing LEF1 [Gene ID=51176].+++MTOR_UP.N4.V1_UP///Genes up-regulated in CEM-C1 cells (T-CLL) in comparison of control vs rapamycin (sirolimus) [PubChem=6610346], an mTOR pathway inhibitor."	"GSE13738_TCR_VS_BYSTANDER_ACTIVATED_CD4_TCELL_UP///Genes up-regulated in comparison of directly activated CD4 [GeneID=920] T cells versus bystander activated CD4 [GeneID=920] T cells.+++GSE13762_CTRL_VS_125_VITAMIND_DAY5_DC_DN///Genes down-regulated in dendritic cells (5 days): control versus 25-hydroxyvitamin D3 [PubChem=1593].+++GSE16385_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_UP///Genes up-regulated in macrophages (12h): IFNG and TNF [GeneID=3458;7124] versus IL4 [GeneID=3565].+++GSE1925_CTRL_VS_24H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_UP///Genes up-regulated in macrophages primed by IFNG [GeneID=3458]: untreated versus stimulated by IFNG [GeneID=3458] for 24h.+++GSE22886_TH1_VS_TH2_12H_ACT_UP///Genes up-regulated in comparison of stimulated CD4 [GeneID=920] Th1 cells at 12 h versus stimulated CD4 [GeneID=920] Th2 cells at 12 h.+++GSE23321_CD8_STEM_CELL_MEMORY_VS_EFFECTOR_MEMORY_CD8_TCELL_UP///Genes up-regulated in CD8 T cells: stem cell memory versus effector memory.+++GSE26351_UNSTIM_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_UP///Genes up-regulated in CD34+ [GeneID=947] cells: control versus stimulated by BMP4 [GeneID=652].+++GSE26928_CENTR_MEMORY_VS_CXCR5_POS_CD4_TCELL_UP///Genes up-regulated in comparison of CD4 [GeneID=920] central memory T cells versus CD4 [GeneID=920] CXCR5+ [GeneID=643] T cells.+++GSE26928_EFF_MEMORY_VS_CXCR5_POS_CD4_TCELL_UP///Genes up-regulated in comparison of CD4 [GeneID=920] effector memory T cells versus CD4 [GeneID=920] CXCR5+ [GeneID=643] T cells.+++GSE2770_UNTREATED_VS_ACT_CD4_TCELL_2H_DN///Genes down-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 (2h).+++GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP///Genes up-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 and then stimulated by IL4 [GeneID=3565] (2h).+++GSE360_DC_VS_MAC_L_MAJOR_UP///Genes up-regulated in comparison of dendritic cells exposed to L. major versus macrophages exposed to L. major.+++GSE37416_12H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP///Genes up-regulated in comparison of control polymorphonuclear leukocytes (PMN) at 12 h versus PMN treated with F. tularensis vaccine at 24 h.+++GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH1_DN///Genes down-regulated in comparison of central memory CD4 [GeneID=920] T cells versus Th1 cells.+++GSE3982_NEUTROPHIL_VS_CENT_MEMORY_CD4_TCELL_UP///Genes up-regulated in comparison of neutrophils versus central memory CD4 [GeneID=920] T cells.+++GSE3982_NEUTROPHIL_VS_EFF_MEMORY_CD4_TCELL_UP///Genes up-regulated in comparison of neutrophils versus effector memory CD4 [GeneID=920] T cells.+++GSE3982_NEUTROPHIL_VS_NKCELL_UP///Genes up-regulated in comparison of neutrophils versus NK cells.+++GSE3982_NKCELL_VS_TH1_DN///Genes down-regulated in comparison of NK cells versus Th1 cells.+++GSE42088_2H_VS_24H_LEISHMANIA_INF_DC_DN///Genes down-regulated in dendritic cells infected by Leishmania major: 2h versus 24h.+++GSE5099_CLASSICAL_M1_VS_ALTERNATIVE_M2_MACROPHAGE_DN///Genes down-regulated in macrophages: classical (M1) versus alternative (M2).+++GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_24H_UP///Genes up-regulated in monocytes: untreated versus M. tuberculosis 19 kDa lipopeptide (24h).+++NAKAYA_MYELOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN///Genes down-regulated in myeloid dendritic cell 7d vs 0d in young adults (18-50) after exposure to Fluarix/Fluvirin , time point 7D"		NM_004395	DBN1				
Q15942	sp|Q15942|ZYX_HUMAN		ZYX		Zyxin OS=Homo sapiens OX=9606 GN=ZYX PE=1 SV=1	7791	rna-NM_003461.5-2						MAAPRPSPAISVSVSAPAFYAPQKKFGPVVAPKPKVNPFRPGDSEPPPAPGAQRAQMGRVGEIPPPPPEDFPLPPPPLAGDGDDAEGALGGAFPPPPPPIEESFPPAPLEEEIFPSPPPPPEEEGGPEAPIPPPPQPREKVSSIDLEIDSLSSLLDDMTKNDPFKARVSSGYVPPPVATPFSSKSSTKPAAGGTAPLPPWKSPSSSQPLPQVPAPAQSQTQFHVQPQPQPKPQVQLHVQSQTQPVSLANTQPRGPPASSPAPAPKFSPVTPKFTPVASKFSPGAPGGSGSQPNQKLGHPEALSAGTGSPQPPSFTYAQQREKPRVQEKQHPVPPPAQNQNQVRSPGAPGPLTLKEVEELEQLTQQLMQDMEHPQRQNVAVNELCGRCHQPLARAQPAVRALGQLFHIACFTCHQCAQQLQGQQFYSLEGAPYCEGCYTDTLEKCNTCGEPITDRMLRATGKAYHPHCFTCVVCARPLEGTSFIVDQANRPHCVPDYHKQYAPRCSVCSEPIMPEPGRDETVRVVALDKNFHMKCYKCEDCGKPLSIEADDNGCFPLDGHVLCRKCHTARAQT	0.3348943	-1.57822241	0.003497463	6.8645921	10.7098147	9.630919	9.6112871	11.0762891	12.0131746	9.95148219	11.2163478	12.3015119	13.0243687	13.0013337	12.9124597	9.1300975	10.7146522	11.4855763	12.0481698	8.8107784	11.2257402	6.11213143	5.9671588	11.7941368	11.7374123	13.1207116	9.7202799	9.57759349	9.7715419	9.4821337	11.880383	13.4016144	13.150698	13.0973139	10.328876	10.8417527	12.6063828	12.1069216	13.2071608	13.4425329	12.93903	13.096435	13.2413779	12.81179617	13.6046853	11.4751599	13.15594626																																	rna-NM_003461.5-2	ZYX				
Q15819	sp|Q15819|UB2V2_HUMAN				Ubiquitin-conjugating enzyme E2 variant 2 OS=Homo sapiens OX=9606 GN=UBE2V2 PE=1 SV=4 >tr|A0M8W4|A0M8W4_HUMAN Ubiquitin-conjugating enzyme E2 variant 2 OS=Homo sapiens OX=9606 GN=UBE2V2 PE=2 SV=1								MAVSTGVKVPRNFRLLEELEEGQKGVGDGTVSWGLEDDEDMTLTRWTGMIIGPPRTNYENRIYSLKVECGPKYPEAPPSVRFVTKINMNGINNSSGMVDARSIPVLAKWQNSYSIKVVLQELRRLMMSKENMKLPQPPEGQTYNN	0.5382447	-0.893665885	0.002629716	5.4087097	4.7232394	4.1208133	4.7391823	5.6572576	6.596332	5.290534705	5.5255372	6.6787451	6.1282005	6.4176661	7.0667704	4.56892339	5.6769375	5.4469145	6.5058457	4.6440824	6.2649982	3.247675695	6.2333758	6.2940304	6.1709865	6.8384089	4.7482083	5.70806262	5.40725137	5.2727358	8.395824	7.9982748	7.629163	8.1346554	5.814566	6.3200349	6.5826262	6.3677198	5.9323258	7.1652964	6.835424	7.545554	5.131713	5.86893819	6.6857814	5.8811487	6.80369612																																	C9606_78101					
Q15555	sp|Q15555|MARE2_HUMAN		MAPRE2		Microtubule-associated protein RP/EB family member 2 OS=Homo sapiens OX=9606 GN=MAPRE2 PE=1 SV=1 >tr|A0A024RC33|A0A024RC33_HUMAN Microtubule-associated protein RP/EB family member 2 OS=Homo sapiens OX=9606 GN=MAPRE2 PE=3 SV=1	10982	NM_014268	NP_055083	ENST00000300249				MPGPTQTLSPNGENNNDIIQDNNGTIIPFRKHTVRGERSYSWGMAVNVYSTSITQETMSRHDIIAWVNDIVSLNYTKVEQLCSGAAYCQFMDMLFPGCISLKKVKFQAKLEHEYIHNFKLLQASFKRMNVDKVIPVEKLVKGRFQDNLDFIQWFKKFYDANYDGKEYDPVEARQGQDAIPPPDPGEQIFNLPKKSHHANSPTAGAAKSSPAAKPGSTPSRPSSAKRASSSGSASKSDKDLETQVIQLNEQVHSLKLALEGVEKERDFYFGKLREIELLCQEHGQENDDLVQRLMDILYASEEHEGHTEEPEAEEQAHEQQPPQQEEY	0.4212182	-1.247360455	0.009187175		6.7377521	5.8601264	6.0897185	6.120146	8.5096998	5.840916613	7.4206787	7.936635	8.3666777	8.1211155	9.0126641	4.70389826	7.6159703	7.5263007	8.719938	5.1960175	7.0343978			7.7106412	8.120682	8.1151529	4.6960621	4.47171425	5.43730711	6.030909	10.509134	9.9498974	10.149265	10.1748348	8.344146	7.6059438	9.0576655	9.2126264	9.1798553	9.3482556	9.4069744	9.540122	9.2443803	8.51347071	9.1325914	7.7520605	9.78890271		H01579///Congenital symmetric circumferential skin creases			GO:0001750///photoreceptor outer segment+++GO:0001917///photoreceptor inner segment+++GO:0005737///cytoplasm+++GO:0005815///microtubule organizing center+++GO:0005856///cytoskeleton+++GO:0005874///microtubule+++GO:0005875///microtubule associated complex+++GO:0005881///cytoplasmic microtubule+++GO:0005925///focal adhesion+++GO:0005929///cilium+++GO:0005930///axoneme+++GO:0015630///microtubule cytoskeleton+++GO:0032391///photoreceptor connecting cilium+++GO:0035371///microtubule plus-end+++GO:0042995///cell projection+++GO:0051233///spindle midzone+++GO:0097542///ciliary tip+++GO:0097733///photoreceptor cell cilium	GO:0005515///protein binding+++GO:0008017///microtubule binding+++GO:0019901///protein kinase binding+++GO:0042802///identical protein binding+++GO:0051010///microtubule plus-end binding	"GO:0007049///cell cycle+++GO:0007601///visual perception+++GO:0007603///phototransduction, visible light+++GO:0030030///cell projection organization+++GO:0031110///regulation of microtubule polymerization or depolymerization+++GO:0032014///positive regulation of ARF protein signal transduction+++GO:0035082///axoneme assembly+++GO:0035556///intracellular signal transduction+++GO:0035845///photoreceptor cell outer segment organization+++GO:0042461///photoreceptor cell development+++GO:0043547///positive regulation of GTPase activity+++GO:0045494///photoreceptor cell maintenance+++GO:0046548///retinal rod cell development+++GO:0046549///retinal cone cell development+++GO:0050896///response to stimulus+++GO:0051225///spindle assembly+++GO:0051301///cell division+++GO:0051549///positive regulation of keratinocyte migration+++GO:0060041///retina development in camera-type eye+++GO:0060042///retina morphogenesis in camera-type eye+++GO:0071482///cellular response to light stimulus+++GO:0120183///positive regulation of focal adhesion disassembly+++GO:1902857///positive regulation of non-motile cilium assembly+++GO:1904825///protein localization to microtubule plus-end"	tissueType=Fetal kidney;cancerType=Normal;cellName=Natural killer T (NKT) cell+++tissueType=Liver;cancerType=Hepatocellular Cancer;cellName=Exhausted CD8+ T cell		"Homo sapiens microtubule associated protein RP/EB family member 2 (MAPRE2), transcript variant 1, mRNA."		PF00307///Calponin homology (CH) domain+++PF03271///EB1-like C-terminal motif			KOG3000///microtubule binding		"IPR001715///Calponin homology domain+++IPR004953///EB1, C-terminal+++IPR027328///Microtubule-associated protein RP/EB+++IPR027735///EB2, vertebrate+++IPR036133///EB1, C-terminal domain superfamily+++IPR036872///CH domain superfamily"	[MARE2_HUMAN|Reviewed]RecName: Full=Microtubule-associated protein RP/EB family member 2; AltName: Full=APC-binding protein EB2; AltName: Full=End-binding protein 2; Short=EB2;+++[A0FDN2_HUMAN|Unreviewed]SubName: Full=Retinitis pigmentosa 1 {ECO:0000313|EMBL:ABJ97137.1}; Flags: Fragment;+++[Q6DKV0_HUMAN|Unreviewed]SubName: Full=Retinitis pigmentosa 1 {ECO:0000313|EMBL:AAT75005.1}; Flags: Fragment;	chr18q12///Ensembl 103 genes in cytogenetic band chr18q12						"MIR1227_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1227-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR125A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-125a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR125B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-125b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1273C///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1273c in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1299///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1299 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR135A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-135a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR135B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-135b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR204_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-204-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR211_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-211-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR212_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-212-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR29A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-29a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR29B_3P_MIR29C_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-29b-3p, hsa-miR-29c-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3059_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3059-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3119///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3119 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3615///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3615 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3646///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3646 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3662///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3662 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4319///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4319 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4446_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4446-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4495///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4495 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4725_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4725-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4733_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4733-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4755_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4755-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4760_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4760-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR498_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-498-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5006_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5006-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR504_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-504-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AJ_5P_MIR548G_5P_MIR548X_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548aj-5p, hsa-miR-548g-5p, hsa-miR-548x-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548F_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548f-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5680///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5680 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6733_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6733-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6739_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6739-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6769A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6769a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6769B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6769b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6808_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6808-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7973///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7973 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR942_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-942-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets)."		"BACH2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9BYV9 (BACH2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++BPTF_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q12830 (BPTF) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++CBFA2T2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O43439 (CBFA2T2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++CIITA_TARGET_GENES///Genes containing one or more binding sites for UniProt:P33076 (CIITA) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++DIDO1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9BTC0 (DIDO1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++GCM2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O75603 (GCM2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HAND1_TARGET_GENES///Genes containing one or more binding sites for UniProt:O96004 (HAND1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ISL1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P61371 (ISL1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++JDP2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8WYK2 (JDP2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++MAFG_TARGET_GENES///Genes containing one or more binding sites for UniProt:O15525 (MAFG) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++MAML1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q92585 (MAML1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++PHF2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O75151 (PHF2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SATB1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q01826 (SATB1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SNAI1_TARGET_GENES///Genes containing one or more binding sites for UniProt:O95863 (SNAI1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SOX10_TARGET_GENES///Genes containing one or more binding sites for UniProt:P56693 (SOX10) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++TBX3_TARGET_GENES///Genes containing one or more binding sites for UniProt:O15119 (TBX3) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++TFEB_TARGET_GENES///Genes containing one or more binding sites for UniProt:P19484 (TFEB) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++THAP1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9NVV9 (THAP1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++UBP1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9NZI7 (UBP1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZBTB7B_TARGET_GENES///Genes containing one or more binding sites for UniProt:O15156 (ZBTB7B) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZFP91_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96JP5 (ZFP91) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF592_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q92610 (ZNF592) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."		MODULE_100///Genes in the cancer module 100.+++MODULE_11///Genes in the cancer module 11.+++MODULE_121///Genes in the cancer module 121.+++MODULE_12///Spinal cord (neuro-development) genes.+++MODULE_137///CNS genes.+++MODULE_19///Adrenal gland - metabolic genes.+++MODULE_1///Ovary genes.+++MODULE_2///DRG (dorsal root ganglia) genes.+++MODULE_60///Heart genes.+++MODULE_66///Genes in the cancer module 66.	RAF_UP.V1_UP///Genes up-regulated in MCF-7 cells (breast cancer) positive for ESR1 [Gene ID=2099] MCF-7 cells (breast cancer) stably over-expressing constitutively active RAF1 [Gene ID=5894] gene.	"GSE11864_UNTREATED_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP///Genes up-regulated in comparison of untreated macrophages versus those cultured with M-CSF [GeneID=1435], IFNG [GeneID=3458] and Pam3Cys (TLR2 agonist).+++GSE12198_LOW_IL2_STIM_NK_CELL_VS_HIGH_IL2_STIM_NK_CELL_UP///Genes up-regulated in NK cells: low dose versus high dose of IL2 [GeneID=3558].+++GSE12366_PLASMA_CELL_VS_MEMORY_BCELL_DN///Genes down-regulated in plasma cells versus memory B cells.+++GSE12845_IGD_POS_BLOOD_VS_NAIVE_TONSIL_BCELL_DN///Genes down-regulated in comparison of IgD+ peripheral blood B cells versus IgD- naive tonsil B cells.+++GSE12845_NAIVE_VS_DARKZONE_GC_TONSIL_BCELL_UP///Genes up-regulated in comparison of naive B cell versus dark zone germinal center B cells.+++GSE13484_12H_VS_3H_YF17D_VACCINE_STIM_PBMC_DN///Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) cultured with YF17D vaccine for 12 h versus PBMC cultured for 3 h.+++GSE13738_TCR_VS_BYSTANDER_ACTIVATED_CD4_TCELL_UP///Genes up-regulated in comparison of directly activated CD4 [GeneID=920] T cells versus bystander activated CD4 [GeneID=920] T cells.+++GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_IFNG_TNF_TREATED_MACROPHAGE_DN///Genes down-regulated in monocytes (12h) versus macrophages (12h) treated with IFNG, TNF [GeneID=3458;7124] and rosiglitazone [PubChem=77999].+++GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA5_STIM_CD8_TCELL_UP///Genes up-regulated in CD8 T cells: control versus stimulated by IFNA5 [GeneID=3442] and activated by anti-CD3 and anti-CD28.+++GSE17974_2.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP///Genes up-regulated in comparison of CD4 [GeneID=920] T cells treated with IL4 [GeneID=3565] and anti-IL12 at 2 h versus those at 72 h.+++GSE1925_3H_VS_24H_IFNG_STIM_MACROPHAGE_DN///Genes down-regulated in macrophages stimulated by IFNG [GeneID=3458]: 3h versus 24h.+++GSE19772_HCMV_INFL_VS_HCMV_INF_MONOCYTES_AND_PI3K_INHIBITION_DN///Genes down-regulated in monocytes after HCMV infection: untreated versus pre-treated with Ly294002 [PubChem=3973].+++GSE22589_HEALTHY_VS_HIV_AND_SIV_INFECTED_DC_DN///Genes down-regulated in monocyte-derived dendritic cells: control versus HIV and SIV infection.+++GSE22589_SIV_VS_HIV_AND_SIV_INFECTED_DC_UP///Genes up-regulated in monocyte-derived dendritic cells infected by: SIV versus HIV and SIV.+++GSE22601_CD4_SINGLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_UP///Genes up-regulated in single positive thymocytes: CD4 [GeneID=920] versus CD8.+++GSE22611_UNSTIM_VS_2H_MDP_STIM_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_DN///Genes down-regulated in HEK293 cells expressing mutant NOD2 [GeneID=64127]: untreated versus muramyl dipeptide [PubChem=11620162] for 2h.+++GSE22886_IGG_IGA_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_UP///Genes up-regulated in comparison of memory IgG IgA B cells versus blood plasma cells.+++GSE22886_IGG_IGA_MEMORY_BCELL_VS_BM_PLASMA_CELL_UP///Genes up-regulated in comparison of memory IgG IgA B cells versus plasma cells from bone marrow and blood.+++GSE22886_IGM_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_UP///Genes up-regulated in comparison of memory IgM B cells versus blood plasma cells.+++GSE22886_IGM_MEMORY_BCELL_VS_BM_PLASMA_CELL_UP///Genes up-regulated in comparison of memory IgM B cells versus plasma cells from bone marrow and blood.+++GSE22886_NAIVE_CD8_TCELL_VS_DC_UP///Genes up-regulated in comparison of naive CD8 T cells versus unstimulated dendritic cells (DC).+++GSE22886_NAIVE_CD8_TCELL_VS_NEUTROPHIL_UP///Genes up-regulated in comparison of naive CD8 T cells versus unstimulated neutrophils.+++GSE22886_NAIVE_TCELL_VS_DC_UP///Genes up-regulated in comparison of naive CD4 [GeneID=920] CD8 T cells versus unstimulated dendritic cells (DC).+++GSE22886_NAIVE_TCELL_VS_NEUTROPHIL_UP///Genes up-regulated in comparison of naive CD4 [GeneID=920] CD8 T cells versus unstimulated neutrophils.+++GSE22886_NAIVE_VS_MEMORY_TCELL_UP///Genes up-regulated in comparison of naive CD4 [GeneID=920] CD8 T cells versus unstimulated memory CD4 [GeneID=920] CD8 T cells.+++GSE23984_CTRL_VS_HYPOCALEMIC_VITAMIND_ANALOG_TCELL_DN///Genes down-regulated in T cells: control versus TX527 (hypocalemic analog of 25-hydroxyvitamin D3 [PubChem=1593]).+++GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_24H_DN///Genes down-regulated in polymorphonuclear leukocytes (24h): treated by heat killed HC60 cell (promyelocytic leukemia) lysate versus A. phagocytophilum infection.+++GSE26351_WNT_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_DN///Genes down-regulated in CD34+ [GeneID=947] cells treated with GSK-3 Inhibitor IX (BIO) [PubChem=5287844] versus those stimulated by BMP4 [GeneID=652].+++GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_2H_DN///Genes down-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 [GeneID=7040] and IL-12 (2h) versus untreated (2h).+++GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_2H_UP///Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: IL4 [GeneID=3565] (2h) versus untreated (2h).+++GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_6H_UP///Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: IL4 [GeneID=3565] (6h) versus untreated (6h).+++GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_48H_UP///Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 and IL4 [GeneID=7040;3565] (48h) versus IL-12 (48h).+++GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_48H_DN///Genes down-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 and IL4 [GeneID=7040;3565] (48h) versus IL4 [GeneID=3565] (48h).+++GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_DN///Genes down-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 and IL4 [GeneID=7040;3565] (48h) versus TGFB1 [GeneID-7040] and IL-12 (48h).+++GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_2H_DN///Genes down-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 and then stimulated by IL4 [GeneID=3565] (2h).+++GSE28726_ACT_CD4_TCELL_VS_ACT_NKTCELL_UP///Genes up-regulated in activated T cells: CD4 [GeneID=920] versus NKT.+++GSE28726_ACT_CD4_TCELL_VS_ACT_VA24NEG_NKTCELL_UP///Genes up-regulated in activated T cells: CD4 [GeneID=920] versus Va24- NKT.+++GSE28726_NAIVE_CD4_TCELL_VS_NAIVE_NKTCELL_UP///Genes up-regulated in nave T cells: CD4 [GeneID=920] versus NK.+++GSE29618_MONOCYTE_VS_PDC_DAY7_FLU_VACCINE_DN///Genes down-regulated in comparison of monocytes from influenza vaccinee at day 7 post-vaccination versus plasmacytoid dendritic cells (mDC) at day 7 post-vaccination.+++GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_UP///Genes up-regulated in comparison of macrophages exposed to 50 worms/well B. malayi versus macrophages exposed to M. tuberculosis.+++GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_UP///Genes up-regulated in comparison of macrophages exposed to 5 worms/well B. malayi versus macrophages exposed to M. tuberculosis.+++GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_OLD_UP///Genes up-regulated in comparison of untreated CD4 [GeneID=920] memory T cells from old donors versus those treated with TSST at 16 h.+++GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_YOUNG_UP///Genes up-regulated in comparison of untreated CD4 [GeneID=920] memory T cells from young donors versus those treated with TSST at 16 h.+++GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_YOUNG_UP///Genes up-regulated in comparison of untreated CD4 [GeneID=920] memory T cells from young donors versus those treated with TSST at 40 h.+++GSE3982_CENT_MEMORY_CD4_TCELL_VS_NKCELL_DN///Genes down-regulated in comparison of central memory CD4 [GeneID=920] T cells versus NK cells.+++GSE3982_CTRL_VS_IGE_STIM_MAST_CELL_DN///Genes down-regulated in comparison of untreated mast cells versus mast cells treated with IgE at 2 h.+++GSE3982_DC_VS_NKCELL_DN///Genes down-regulated in comparison of dendritic cells (DC) versus NK cells.+++GSE3982_MAC_VS_NKCELL_DN///Genes down-regulated in comparison of macrophages versus NK cells.+++GSE3982_NEUTROPHIL_VS_BASOPHIL_DN///Genes down-regulated in comparison of neutrophils versus basophils.+++GSE3982_NEUTROPHIL_VS_CENT_MEMORY_CD4_TCELL_DN///Genes down-regulated in comparison of neutrophils versus central memory CD4 [GeneID=920] T cells.+++GSE3982_NEUTROPHIL_VS_EFF_MEMORY_CD4_TCELL_DN///Genes down-regulated in comparison of neutrophils versus effector memory CD4 [GeneID=920] T cells.+++GSE42088_2H_VS_24H_LEISHMANIA_INF_DC_UP///Genes up-regulated in dendritic cells infected by Leishmania major: 2h versus 24h.+++GSE42088_UNINF_VS_LEISHMANIA_INF_DC_2H_DN///Genes down-regulated in dendritic cells: untreated versus 2h after infection of Leishmania major.+++GSE5679_PPARG_LIGAND_ROSIGLITAZONE_VS_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_UP///Genes up-regulated in monocyte-derived dendritic cells: rosiglitazone [PubChem=77999] versus rosiglitazone and AM580 [PubChem=77999;2126].+++GSE5679_RARA_AGONIST_AM580_VS_AM580_AND_ROSIGLITAZONE_TREATED_DC_UP///Genes up-regulated in monocyte-derived dendritic cells: AM580 [PubChem=2126] versus rosiglitazone and AM580 [PubChem=77999;2126].+++GSE6269_E_COLI_VS_STAPH_AUREUS_INF_PBMC_UP///Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from patients with acute E. coli infection versus PBMC from patients with acute S. aureus infection.+++GSE6269_FLU_VS_STAPH_AUREUS_INF_PBMC_UP///Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMC from patients with acute S. aureus infection.+++GSE6269_HEALTHY_VS_STAPH_AUREUS_INF_PBMC_UP///Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from patients with acute influenza infection versus PBMC from patients with acute S. aureus infection.+++GSE7460_TCONV_VS_TREG_THYMUS_DN///Genes down-regulated in comparison of TconvThy versus TregThy (see Fig. 1 in the paper for details).+++GSE8685_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_DN///Genes down-regulated in Sez-2 cells (T cell lymphoma): untreated versus IL21 [GeneID=59067].+++GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_6H_DN///Genes down-regulated in monocytes (6h): untreated versus M. tuberculosis 19 kDa lipopeptide.+++NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN///Genes down-regulated in plasmacytoid dendritic cell 7d vs 0d in young adults (18-50) after exposure to Fluarix/Fluvirin , time point 7D"		NM_014268	MAPRE2				
Q15365	sp|Q15365|PCBP1_HUMAN		PCBP1		Poly(rC)-binding protein 1 OS=Homo sapiens OX=9606 GN=PCBP1 PE=1 SV=2 >tr|Q53SS8|Q53SS8_HUMAN Epididymis secretory protein Li 85 OS=Homo sapiens OX=9606 GN=PCBP1 PE=2 SV=1	5093	NM_006196	NP_006187	ENST00000303577	K12889			MDAGVTESGLNVTLTIRLLMHGKEVGSIIGKKGESVKRIREESGARINISEGNCPERIITLTGPTNAIFKAFAMIIDKLEEDINSSMTNSTAASRPPVTLRLVVPATQCGSLIGKGGCKIKEIRESTGAQVQVAGDMLPNSTERAITIAGVPQSVTECVKQICLVMLETLSQSPQGRVMTIPYQPMPASSPVICAGGQDRCSDAAGYPHATHDLEGPPLDAYSIQGQHTISPLDLAKLNQVARQQSHFAMMHGGTGFAGIDSSSPEVKGYWASLDASTQTTHELTIPNNLIGCIIGRQGANINEIRQMSGAQIKIANPVEGSSGRQVTITGSAASISLAQYLINARLSSEKGMGCS	0.4807388	-1.056674953	0.001766749				6.5125917	6.1365236	6.3788804	6.482882786	5.8301666	7.302701	7.0612048	7.9784292	8.1038807	6.23262402			5.8810174		5.7735419			5.8116496	5.7741905	6.5989282					8.903301	8.6775973	8.335971	8.3782628	6.274773	8.5591669	7.0053657	7.5928347	6.4252852	7.724922	7.0175668	9.42684	7.4722346	6.33316923	8.6785695	6.3326329	6.61738038	03040///Spliceosome+++04216///Ferroptosis				GO:0005634///nucleus+++GO:0005654///nucleoplasm+++GO:0005737///cytoplasm+++GO:0005829///cytosol+++GO:0016020///membrane+++GO:0016607///nuclear speck+++GO:0036464///cytoplasmic ribonucleoprotein granule+++GO:0070062///extracellular exosome	"GO:0000981///DNA-binding transcription factor activity, RNA polymerase II-specific+++GO:0003676///nucleic acid binding+++GO:0003677///DNA binding+++GO:0003697///single-stranded DNA binding+++GO:0003723///RNA binding+++GO:0003729///mRNA binding+++GO:0005515///protein binding+++GO:0045296///cadherin binding+++GO:0098847///sequence-specific single stranded DNA binding"	"GO:0000398///mRNA splicing, via spliceosome+++GO:0010468///regulation of gene expression+++GO:0016070///RNA metabolic process+++GO:0039694///viral RNA genome replication+++GO:0045944///positive regulation of transcription by RNA polymerase II+++GO:0051252///regulation of RNA metabolic process"	tissueType=Fetal kidney;cancerType=Normal;cellName=Natural killer T (NKT) cell+++tissueType=Fetal kidney;cancerType=Normal;cellName=Monocyte		"Homo sapiens poly(rC) binding protein 1 (PCBP1), mRNA."		PF00013///KH domain	R-HSA-72163///mRNA Splicing - Major Pathway+++R-HSA-72172///mRNA Splicing+++R-HSA-72203///Processing of Capped Intron-Containing Pre-mRNA+++R-HSA-8953854///Metabolism of RNA		KOG2190///C-rich single-stranded DNA binding		"IPR004087///K Homology domain+++IPR004088///K Homology domain, type 1+++IPR036612///K Homology domain, type 1 superfamily"	[PCBP1_HUMAN|Reviewed]RecName: Full=Poly(rC)-binding protein 1; AltName: Full=Alpha-CP1; AltName: Full=Heterogeneous nuclear ribonucleoprotein E1; Short=hnRNP E1; AltName: Full=Nucleic acid-binding protein SUB2.3;	chr2p13///Ensembl 103 genes in cytogenetic band chr2p13		KEGG_SPLICEOSOME///Spliceosome	REACTOME_METABOLISM_OF_RNA///Metabolism of RNA+++REACTOME_MRNA_SPLICING///mRNA Splicing+++REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA///Processing of Capped Intron-Containing Pre-mRNA		"ACTTTAT_MIR1425P///Genes having at least one occurence of the motif ACTTTAT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-142-5p (v7.1 miRBase).+++ATAAGCT_MIR21///Genes having at least one occurence of the motif ATAAGCT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-21 (v7.1 miRBase).+++ATGTTAA_MIR302C///Genes having at least one occurence of the motif ATGTTAA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-302c* (v7.1 miRBase).+++CCAGGTT_MIR490///Genes having at least one occurence of the motif CCAGGTT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-490 (v7.1 miRBase)."	MIR10A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-10a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR335_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-335-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3941///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3941 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR466///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-466 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4672///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4672 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR490_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-490-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AR_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548ar-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AS_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548as-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AZ_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548az-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548BC///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548bc in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548E_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548e-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548F_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548f-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5582_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5582-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR607///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-607 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR619_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-619-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6777_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6777-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6807_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6807-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7977///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7977 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR8070///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-8070 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR922///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-922 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).	AFP1_Q6///Genes having at least one occurence of the transcription factor binding site V$AFP1_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++CEBPDELTA_Q6///Genes having at least one occurence of the transcription factor binding site V$CEBPDELTA_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++GABP_B///Genes having at least one occurence of the transcription factor binding site V$GABP_B (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++GATTGGY_NFY_Q6_01///Genes having at least one occurence of the highly conserved motif M5 GATTGGY sites. The motif matches transcription factor binding site V$NFY_Q6_01 (v7.4 TRANSFAC).+++HNF1_01///Genes having at least one occurence of the transcription factor binding site V$HNF1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++HNF1_Q6///Genes having at least one occurence of the transcription factor binding site V$HNF1_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++HNF4ALPHA_Q6///Genes having at least one occurence of the transcription factor binding site V$HNF4ALPHA_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++IRF7_01///Genes having at least one occurence of the transcription factor binding site V$IRF7_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++LEF1_Q6///Genes having at least one occurence of the transcription factor binding site V$LEF1_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++SCGGAAGY_ELK1_02///Genes having at least one occurence of the highly conserved motif M3 SCGGAAGY sites. The motif matches transcription factor binding site V$ELK1_02 (v7.4 TRANSFAC).+++TATAAA_TATA_01///Genes having at least one occurence of the highly conserved motif M51 TATAAA sites. The motif matches transcription factor binding site V$TATA_01 (v7.4 TRANSFAC).+++TEF_Q6///Genes having at least one occurence of the transcription factor binding site V$TEF_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++TGACATY_UNKNOWN///Genes having at least one occurence of the highly conserved motif M42 TGACATY in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++TGTTTGY_HNF3_Q6///Genes having at least one occurence of the highly conserved motif M83 TGTTTGY sites. The motif matches transcription factor binding site V$HNF3_Q6 (v7.4 TRANSFAC).+++WGGAATGY_TEF1_Q6///Genes having at least one occurence of the highly conserved motif M79 WGGAATGY sites. The motif matches transcription factor binding site V$TEF1_Q6 (v7.4 TRANSFAC).+++YGACNNYACAR_UNKNOWN///Genes having at least one occurence of the highly conserved motif M149 YGACNNYACAR in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++YTAAYNGCT_UNKNOWN///Genes having at least one occurence of the highly conserved motif M168 YTAAYNGCT in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).	"AEBP2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6ZN18 (AEBP2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ATF6_TARGET_GENES///Genes containing one or more binding sites for UniProt:P18850 (ATF6) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++BARHL1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9BZE3 (BARHL1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++BARX1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9HBU1 (BARX1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++BARX2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9UMQ3 (BARX2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++CIC_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96RK0 (CIC) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++DLX6_TARGET_GENES///Genes containing one or more binding sites for UniProt:P56179 (DLX6) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ELF2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q15723 (ELF2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++FEV_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q99581 (FEV) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++FOXG1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P55316 (FOXG1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++FOXR2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6PJQ5 (FOXR2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++GLI3_TARGET_GENES///Genes containing one or more binding sites for UniProt:P10071 (GLI3) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HES2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9Y543 (HES2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HMGB2_TARGET_GENES///Genes containing one or more binding sites for UniProt:P26583 (HMGB2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HOXA1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P49639 (HOXA1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++IRF5_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q13568 (IRF5) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++KAT5_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q92993 (KAT5) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++LHX2_TARGET_GENES///Genes containing one or more binding sites for UniProt:P50458 (LHX2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NCOA2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q15596 (NCOA2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NFE2L1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q14494 (NFE2L1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++RFX7_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q2KHR2 (RFX7) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++RUVBL2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9Y230 (RUVBL2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++RYBP_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8N488 (RYBP) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SETD1A_TARGET_GENES///Genes containing one or more binding sites for UniProt:O15047 (SETD1A) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SNIP1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8TAD8 (SNIP1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++TEAD2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q15562 (TEAD2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF362_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q5T0B9 (ZNF362) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF579_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8NAF0 (ZNF579) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZSCAN2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q7Z7L9 (ZSCAN2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."	GCM_ACTG1///Neighborhood of ACTG1+++GCM_APEX1///Neighborhood of APEX1+++GCM_CBFB///Neighborhood of CBFB+++GCM_CSNK2B///Neighborhood of CSNK2B+++GCM_DDX5///Neighborhood of DDX5+++GCM_MSN///Neighborhood of MSN+++GCM_PSME1///Neighborhood of PSME1+++GCM_RAD21///Neighborhood of RAD21+++GCM_RAF1///Neighborhood of RAF1+++GCM_SMARCC1///Neighborhood of SMARCC1+++GCM_TPR///Neighborhood of TPR	MODULE_114///Protein biosynthesis and ribosomes.+++MODULE_151///Genes in the cancer module 151.+++MODULE_183///RNA splicing.+++MODULE_32///Genes in the cancer module 32.+++MODULE_83///Genes in the cancer module 83.+++MODULE_98///Genes in the cancer module 98.		"GSE12484_HEALTHY_VS_PERIDONTITIS_NEUTROPHILS_DN///Genes down-regulated in neutrophils isolated from: healthy versus patients with peridontitis.+++GSE1460_CORD_VS_ADULT_BLOOD_NAIVE_CD4_TCELL_DN///Genes down-regulated in CD4 [GeneID=920] T cells from cord blood versus those from adult blood.+++GSE14908_ATOPIC_VS_NONATOPIC_PATIENT_HDM_STIM_CD4_TCELL_UP///Genes up-regulated in CD4 [GeneID=920] T cells stimulated with allergen (house dust mite): atopy versus healthy.+++GSE16385_IFNG_TNF_VS_UNSTIM_MACROPHAGE_ROSIGLITAZONE_TREATED_UP///Genes up-regulated in macrophages (12h): IFNG, TNF [GeneID=3458;7124] and rosiglitazone [PubChem=77999] versus rosiglitazone [PubChem=77999].+++GSE19772_HCMV_INFL_VS_HCMV_INF_MONOCYTES_AND_PI3K_INHIBITION_DN///Genes down-regulated in monocytes after HCMV infection: untreated versus pre-treated with Ly294002 [PubChem=3973].+++GSE22611_NOD2_TRANSDUCED_VS_CTRL_HEK293T_STIMULATED_WITH_MDP_2H_DN///Genes down-regulated in HEK293 cells at 2h after stimulation by muramyl dipeptide [PubChem=11620162]: over-expressing wildtype NOD2 [GeneID=64127] versus control.+++GSE23321_CD8_STEM_CELL_MEMORY_VS_CENTRAL_MEMORY_CD8_TCELL_DN///Genes down-regulated in CD8 T cells: stem cell memory versus central memory.+++GSE24634_TREG_VS_TCONV_POST_DAY10_IL4_CONVERSION_UP///Genes up-regulated in comparison of CD25+ regulatory T cell (Treg) treated with IL4 [GeneID=3565] at day 10 versus CD25- T cells treated with IL4 [GeneID=3565] at 10 h.+++GSE2770_UNTREATED_VS_ACT_CD4_TCELL_2H_DN///Genes down-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 (2h).+++GSE32164_ALTERNATIVELY_ACT_M2_VS_CMYC_INHIBITED_MACROPHAGE_DN///Genes down-regulated in macrophages: alternatively activated M2 versus MYC [GeneID=4609] inhibited.+++GSE33425_CD161_INT_VS_NEG_CD8_TCELL_UP///Genes up-regulated in CD8 T cells: KLRB1 int [GeneID=3820] versus KLRB1- [GeneID=3820].+++GSE360_L_MAJOR_VS_M_TUBERCULOSIS_DC_UP///Genes up-regulated in comparison of dendritic cells (DC) exposed to L. major versus DCs exposed to M. tuberculosis.+++GSE3720_UNSTIM_VS_PMA_STIM_VD2_GAMMADELTA_TCELL_UP///Genes up-regulated in Vd2 gamma delta T cells: untreated versus phorbol myristate acetate and ionomycin [PubChem=4792;3733].+++GSE37416_CTRL_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_DN///Genes down-regulated in comparison of control polymorphonuclear leukocytes (PMN) at 24 h versus PMN treated with F. tularensis vaccine at 24 h.+++GSE3982_DC_VS_MAC_DN///Genes down-regulated in comparison of dendritic cells (DC) versus macrophages.+++GSE7460_CTRL_VS_TGFB_TREATED_ACT_CD8_TCELL_UP///Genes up-regulated in comparsion of ActCD8 versus ActCD8TGF (see Fig. 1 in the paper for details).+++GSE7568_IL4_VS_IL4_AND_DEXAMETHASONE_TREATED_MACROPHAGE_UP///Genes up-regulated in macrophages differentiated for 5 days in the presence of: IL4 [GeneID=3565] versus IL4 [GeneID=3565] and dexamethasone [PubChem=5743].+++GSE8835_HEALTHY_VS_CLL_CD8_TCELL_UP///Genes up-regulated in CD8 T cells: healthy versus CLL (chronic lymphocytic leukemia).+++GSE9006_HEALTHY_VS_TYPE_2_DIABETES_PBMC_AT_DX_UP///Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMCs from patients with type 2 diabetes at the time of diagnosis.+++GSE9988_ANTI_TREM1_AND_LPS_VS_VEHICLE_TREATED_MONOCYTES_DN///Genes down-regulated in comparison of monocytes treated with anti-TREM1 [GeneID=54210] and 5000 ng/ml LPS (TLR4 agonist) versus untreated monocytes.+++GSE9988_ANTI_TREM1_VS_ANTI_TREM1_AND_LPS_MONOCYTE_UP///Genes up-regulated in comparison of monocytes treated with anti-TREM1 [GeneID=54210] versus monocytes treated with anti-TREM1 [GeneID=54210] and 5000 ng/ml LPS (TLR4 agonist).+++GSE9988_LOW_LPS_VS_CTRL_TREATED_MONOCYTE_DN///Genes down-regulated in comparison of monocytes treated with 1 ng/ml LPS (TLR4 agonist) versus monocytes treated with control IgG.+++GSE9988_LOW_LPS_VS_VEHICLE_TREATED_MONOCYTE_DN///Genes down-regulated in comparison of monocytes treated with 1 ng/ml LPS (TLR4 agonist) versus untreated monocytes.+++GSE9988_LPS_VS_CTRL_TREATED_MONOCYTE_DN///Genes down-regulated in comparison of monocytes treated with 5000 ng/ml LPS (TLR4 agonist) versus monocytes treated with control IgG.+++GSE9988_LPS_VS_VEHICLE_TREATED_MONOCYTE_DN///Genes down-regulated in comparison of monocytes treated with 1 ng/ml LPS (TLR4 agonist) versus untreated monocytes.+++QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_CONTRACTION_OF_VZV_SPECIFIC_T_CELLS_PEAK_TO_28DY_AT_1DYPOSITIVE///Genes positively correlated with contraction of VZV specific T cells (peak to 28d) in peripheral blood mononuclear cell in seniors (50-75) after exposure to Zostavax , time point 1D+++QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_EXPANSION_OF_VZV_SPECIFIC_T_CELLS_TO_PEAK_AT_1DY_POSITIVE///Genes positively correlated with expansion of VZV specific T cells (0d to peak) in peripheral blood mononuclear cell in seniors (50-75) after exposure to Zostavax , time point 1D+++THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_DN///Genes down-regulated in peripheral blood mononuclear cell 7d vs 0d in young adults (21-30) (responders) after exposure to Inactivated influenza vaccine , time point 7D. Comment: most (70-80%) of cohort were white"	HALLMARK_MYC_TARGETS_V1///A subgroup of genes regulated by MYC - version 1 (v1).	NM_006196	PCBP1				
Q15113	sp|Q15113|PCOC1_HUMAN				Procollagen C-endopeptidase enhancer 1 OS=Homo sapiens OX=9606 GN=PCOLCE PE=1 SV=2								MLPAATASLLGPLLTACALLPFAQGQTPNYTRPVFLCGGDVKGESGYVASEGFPNLYPPNKECIWTITVPEGQTVSLSFRVFDLELHPACRYDALEVFAGSGTSGQRLGRFCGTFRPAPLVAPGNQVTLRMTTDEGTGGRGFLLWYSGRATSGTEHQFCGGRLEKAQGTLTTPNWPESDYPPGISCSWHIIAPPDQVIALTFEKFDLEPDTYCRYDSVSVFNGAVSDDSRRLGKFCGDAVPGSISSEGNELLVQFVSDLSVTADGFSASYKTLPRGTAKEGQGPGPKRGTEPKVKLPPKSQPPEKTEESPSAPDAPTCPKQCRRTGTLQSNFCASSLVVTATVKSMVREPGEGLAVTVSLIGAYKTGGLDLPSPPTGASLKFYVPCKQCPPMKKGVSYLLMGQVEENRGPVLPPESFVVLHRPNQDQILTNLSKRKCPSQPVRAAASQD	0.5919368	-0.756484862	0.02102858	5.8979171					6.2667812			5.2534735	5.3165373	4.627717	4.8441133	5.11280177	5.7199166		5.0750816	4.7270016			4.0398632		4.8582147		5.5371682	6.82043364			4.856893	5.5944954	6.612347	6.9547564	5.98917	6.3087852		4.8946837				7.162778	4.8453231	6.46672974	4.6751105																																			C9606_26329					
Q14767	sp|Q14767|LTBP2_HUMAN		LTBP2		Latent-transforming growth factor beta-binding protein 2 OS=Homo sapiens OX=9606 GN=LTBP2 PE=1 SV=3	4053	NM_000428	NP_000419	ENST00000261978				MRPRTKARSPGRALRNPWRGFLPLTLALFVGAGHAQRDPVGRYEPAGGDANRLRRPGGSYPAAAAAKVYSLFREQDAPVAGLQPVERAQPGWGSPRRPTEAEARRPSRAQQSRRVQPPAQTRRSTPLGQQQPAPRTRAAPALPRLGTPQRSGAAPPTPPRGRLTGRNVCGGQCCPGWTTANSTNHCIKPVCEPPCQNRGSCSRPQLCVCRSGFRGARCEEVIPDEEFDPQNSRLAPRRWAERSPNLRRSSAAGEGTLARAQPPAPQSPPAPQSPPAGTLSGLSQTHPSQQHVGLSRTVRLHPTATASSQLSSNALPPGPGLEQRDGTQQAVPLEHPSSPWGLNLTEKIKKIKIVFTPTICKQTCARGHCANSCERGDTTTLYSQGGHGHDPKSGFRIYFCQIPCLNGGRCIGRDECWCPANSTGKFCHLPIPQPDREPPGRGSRPRALLEAPLKQSTFTLPLSNQLASVNPSLVKVHIHHPPEASVQIHQVAQVRGGVEEALVENSVETRPPPWLPASPGHSLWDSNNIPARSGEPPRPLPPAAPRPRGLLGRCYLNTVNGQCANPLLELTTQEDCCGSVGAFWGVTLCAPCPPRPASPVIENGQLECPQGYKRLNLTHCQDINECLTLGLCKDAECVNTRGSYLCTCRPGLMLDPSRSRCVSDKAISMLQGLCYRSLGPGTCTLPLAQRITKQICCCSRVGKAWGSECEKCPLPGTEAFREICPAGHGYTYASSDIRLSMRKAEEEELARPPREQGQRSSGALPGPAERQPLRVVTDTWLEAGTIPDKGDSQAGQVTTSVTHAPAWVTGNATTPPMPEQGIAEIQEEQVTPSTDVLVTLSTPGIDRCAAGATNVCGPGTCVNLPDGYRCVCSPGYQLHPSQAYCTDDNECLRDPCKGKGRCINRVGSYSCFCYPGYTLATSGATQECQDINECEQPGVCSGGQCTNTEGSYHCECDQGYIMVRKGHCQDINECRHPGTCPDGRCVNSPGSYTCLACEEGYRGQSGSCVDVNECLTPGVCAHGKCTNLEGSFRCSCEQGYEVTSDEKGCQDVDECASRASCPTGLCLNTEGSFACSACENGYWVNEDGTACEDLDECAFPGVCPSGVCTNTAGSFSCKDCDGGYRPSPLGDSCEDVDECEDPQSSCLGGECKNTVGSYQCLCPQGFQLANGTVCEDVNECMGEEHCAPHGECLNSHGSFFCLCAPGFVSAEGGTSCQDVDECATTDPCVGGHCVNTEGSFNCLCETGFQPSPESGECVDIDECEDYGDPVCGTWKCENSPGSYRCVLGCQPGFHMAPNGDCIDIDECANDTMCGSHGFCDNTDGSFRCLCDQGFEISPSGWDCVDVNECELMLAVCGAALCENVEGSFLCLCASDLEEYDAQEGHCRPRGAGGQSMSEAPTGDHAPAPTRMDCYSGQKGHAPCSSVLGRNTTQAECCCTQGASWGDACDLCPSEDSAEFSEICPSGKGYIPVEGAWTFGQTMYTDADECVIFGPGLCPNGRCLNTVPGYVCLCNPGFHYDASHKKCEDHDECQDLACENGECVNTEGSFHCFCSPPLTLDLSQQRCMNSTSSTEDLPDHDIHMDICWKKVTNDVCSEPLRGHRTTYTECCCQDGEAWSQQCALCPPRSSEVYAQLCNVARIEAEREAGVHFRPGYEYGPGPDDLHYSIYGPDGAPFYNYLGPEDTVPEPAFPNTAGHSADRTPILESPLQPSELQPHYVASHPEPPAGFEGLQAEECGILNGCENGRCVRVREGYTCDCFEGFQLDAAHMACVDVNECDDLNGPAVLCVHGYCENTEGSYRCHCSPGYVAEAGPPHCTAKE	0.5221437	-0.93748124	0.002100012	6.6439085			7.1527072				7.1853379	6.117556	6.0931775		6.5846082				6.8233505	6.8192097	7.4776377	6.486983846			8.0604207		8.4753188	7.77991772	8.12451267	8.2617949							6.8007033				7.966568				7.1639427				"H00557///Cutis laxa+++H00625///Tooth agenesis+++H00673///Weill-Marchesani syndrome+++H00904///Cutis laxa with severe pulmonary, gastrointestinal, and urinary abnormalities+++H01203///Primary congenital glaucoma"			GO:0005576///extracellular region+++GO:0005615///extracellular space+++GO:0031012///extracellular matrix+++GO:0062023///collagen-containing extracellular matrix+++GO:0070062///extracellular exosome	GO:0005201///extracellular matrix structural constituent+++GO:0005509///calcium ion binding+++GO:0005515///protein binding+++GO:0008201///heparin binding+++GO:0019838///growth factor binding+++GO:0050436///microfibril binding	GO:0006605///protein targeting+++GO:0007179///transforming growth factor beta receptor signaling pathway+++GO:0009306///protein secretion+++GO:0097435///supramolecular fiber organization	tissueType=Lung;cancerType=Normal;cellName=Ionocyte cell		"Homo sapiens latent transforming growth factor beta binding protein 2 (LTBP2), mRNA."		PF00008///EGF-like domain+++PF00683///TB domain+++PF07645///Calcium-binding EGF domain	R-HSA-1474244///Extracellular matrix organization+++R-HSA-1566948///Elastic fibre formation+++R-HSA-2129379///Molecules associated with elastic fibres		KOG1217///calcium ion binding		"IPR000152///EGF-type aspartate/asparagine hydroxylation site+++IPR000742///EGF-like domain+++IPR001881///EGF-like calcium-binding domain+++IPR009030///Growth factor receptor cysteine-rich domain superfamily+++IPR017878///TB domain+++IPR018097///EGF-like calcium-binding, conserved site+++IPR036773///TGF-beta binding (TB) domain superfamily"	[LTBP2_HUMAN|Reviewed]RecName: Full=Latent-transforming growth factor beta-binding protein 2; Short=LTBP-2; Flags: Precursor;	chr14q24///Ensembl 103 genes in cytogenetic band chr14q24			REACTOME_ELASTIC_FIBRE_FORMATION///Elastic fibre formation+++REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION///Extracellular matrix organization+++REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES///Molecules associated with elastic fibres	"NABA_CORE_MATRISOME///Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans+++NABA_ECM_GLYCOPROTEINS///Genes encoding structural ECM glycoproteins+++NABA_MATRISOME///Ensemble of genes encoding extracellular matrix and extracellular matrix-associated proteins "		MIR152_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-152-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR182_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-182-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3646///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3646 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3688_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3688-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4261///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4261 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4288///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4288 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5579_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5579-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR597_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-597-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6731_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6731-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6809_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6809-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7150///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7150 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7854_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7854-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7977///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7977 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR8066///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-8066 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR8085///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-8085 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR877_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-877-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).	IRF1_01///Genes having at least one occurence of the transcription factor binding site V$IRF1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++OCT1_03///Genes having at least one occurence of the transcription factor binding site V$OCT1_03 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++RNGTGGGC_UNKNOWN///Genes having at least one occurence of the highly conserved motif M140 RNGTGGGC in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++TGCCAAR_NF1_Q6///Genes having at least one occurence of the highly conserved motif M47 TGCCAAR sites. The motif matches transcription factor binding site V$NF1_Q6 (v7.4 TRANSFAC).+++TGGAAA_NFAT_Q4_01///Genes having at least one occurence of the highly conserved motif M55 TGGAAA sites. The motif matches transcription factor binding site V$NFAT_Q4_01 (v7.4 TRANSFAC).+++TTANTCA_UNKNOWN///Genes having at least one occurence of the highly conserved motif M64 TTANTCA in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).	"CBX5_TARGET_GENES///Genes containing one or more binding sites for UniProt:P45973 (CBX5) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++KDM5D_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9BY66 (KDM5D) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++KDM7A_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6ZMT4 (KDM7A) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++MEF2C_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q06413 (MEF2C) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++PHF2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O75151 (PHF2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++RBM34_TARGET_GENES///Genes containing one or more binding sites for UniProt:P42696 (RBM34) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SMN1_SMN2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q16637 (SMN1_SMN2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++TAZ_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q16635 (TAZ) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF184_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q99676 (ZNF184) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF560_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96MR9 (ZNF560) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."		MODULE_186///Genes in the cancer module 186.+++MODULE_1///Ovary genes.+++MODULE_2///DRG (dorsal root ganglia) genes.+++MODULE_324///Metal / Ca ion binding.+++MODULE_350///Genes in the cancer module 350.+++MODULE_38///Placenta genes.+++MODULE_3///Genes in the cancer module 3.+++MODULE_47///ECM and collagens.+++MODULE_5///Lung genes.+++MODULE_71///Genes in the cancer module 71.+++MODULE_92///Secreted signaling molecules.	CSR_LATE_UP.V1_UP///Genes up-regulated in late serum response of CRL 2091 cells (foreskin fibroblasts).+++LEF1_UP.V1_UP///Genes up-regulated in DLD1 cells (colon carcinoma) over-expressing LEF1 [Gene ID=51176].+++TGFB_UP.V1_UP///Genes up-regulated in a panel of epithelial cell lines by TGFB1 [Gene ID=7040].	"GSE1432_1H_VS_24H_IFNG_MICROGLIA_UP///Genes up-regulated in comparison of microglia cells 1 h after stimulation with IFNG [GeneID=3458] versus microglia cells 24 h after the stimulation.+++GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_UP///Genes up-regulated in comparison of control microglia cells versus those 24 h after stimulation with IFNG [GeneID=3458].+++GSE17186_MEMORY_VS_NAIVE_BCELL_DN///Genes down-regulated in B lymphocytes: memory versus nave.+++GSE1925_CTRL_VS_24H_IFNG_STIM_MACROPHAGE_DN///Genes down-regulated in macrophages: untreated versus stimulated by IFNG [GeneID=3458] for 24h.+++GSE22886_TH1_VS_TH2_48H_ACT_UP///Genes up-regulated in comparison of stimulated CD4 [GeneID=920] Th1 cells at 48 h versus stimulated CD4 [GeneID=920] Th2 cells at 48 h.+++GSE2405_0H_VS_24H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN///Genes down-regulated in polymorphonuclear leukocytes (24h): control versus infection by A. phagocytophilum.+++GSE2405_0H_VS_3H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP///Genes up-regulated in polymorphonuclear leukocytes (3h): control versus infection by A. phagocytophilum.+++GSE24634_NAIVE_CD4_TCELL_VS_DAY10_IL4_CONV_TREG_UP///Genes up-regulated in comparison of naive T cells at day 0 versus CD25+ regulatory T cell (Treg) treated with IL4 [GeneID=3565] at day 10.+++GSE24634_TEFF_VS_TCONV_DAY3_IN_CULTURE_DN///Genes down-regulated in comparison of CD25+ T effector cells treated with IL4 [GeneID=3565] at day 3 versus untreated CD25- T cells at day 3.+++GSE360_DC_VS_MAC_B_MALAYI_LOW_DOSE_UP///Genes up-regulated in comparison of dendritic cells (DC) exposed to 5 worm/well B. malayi versus macrophages exposed to 5 worms/well B. malayi.+++GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_DC_DN///Genes down-regulated in comparison of dendritic cells (DC) exposed to 50 worms/well B. malayi versus those exposed to 5 worms/well B. malayi.+++GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_DC_UP///Genes up-regulated in comparison of dendritic cells (DC) exposed to T. gondii versus DCs exposed to 50 worms/well B. malayi.+++GSE3982_BASOPHIL_VS_TH2_DN///Genes down-regulated in comparison of basophils versus Th2 cells.+++GSE3982_NEUTROPHIL_VS_TH1_UP///Genes up-regulated in comparison of neutrophils versus Th1 cells.+++GSE3982_NEUTROPHIL_VS_TH2_UP///Genes up-regulated in comparison of neutrophils versus Th2 cells.+++GSE3982_NKCELL_VS_TH1_UP///Genes up-regulated in comparison of NK cells versus Th1 cells.+++GSE3982_NKCELL_VS_TH2_UP///Genes up-regulated in comparison of NK cells versus Th2 cells.+++GSE42088_UNINF_VS_LEISHMANIA_INF_DC_8H_UP///Genes up-regulated in dendritic cells: untreated versus 8h after infection of Leishmania major.+++GSE46143_CTRL_VS_LMP2A_TRANSDUCED_CD10_POS_GC_BCELL_DN///Genes down-regulated in MME+ [GeneID=4311] germinal center B lymphocytes: control versus over-expressing viral (EBV) gene LMP2A.+++GSE9988_ANTI_TREM1_VS_VEHICLE_TREATED_MONOCYTES_DN///Genes down-regulated in comparison of monocytes treated with anti-TREM1 [GeneID=54210] versus untreated monocytes.+++HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_DN///Genes down-regulated in peripheral blood mononuclear cell vaccinated vs unvaccinated in adolescent/young adults (11-22) after exposure to M-M-R II , time point 7Y"	HALLMARK_TGF_BETA_SIGNALING///Genes up-regulated in response to TGFB1 [GeneID=7040].	NM_000428	LTBP2				
Q14314	sp|Q14314|FGL2_HUMAN		FGL2		Fibroleukin OS=Homo sapiens OX=9606 GN=FGL2 PE=1 SV=1 >tr|A4D1B8|A4D1B8_HUMAN Fibrinogen-like 2 OS=Homo sapiens OX=9606 GN=FGL2 PE=2 SV=1	10875	NM_006682	NP_006673	ENST00000248598				MKLANWYWLSSAVLATYGFLVVANNETEEIKDERAKDVCPVRLESRGKCEEAGECPYQVSLPPLTIQLPKQFSRIEEVFKEVQNLKEIVNSLKKSCQDCKLQADDNGDPGRNGLLLPSTGAPGEVGDNRVRELESEVNKLSSELKNAKEEINVLHGRLEKLNLVNMNNIENYVDSKVANLTFVVNSLDGKCSKCPSQEQIQSRPVQHLIYKDCSDYYAIGKRSSETYRVTPDPKNSSFEVYCDMETMGGGWTVLQARLDGSTNFTRTWQDYKAGFGNLRREFWLGNDKIHLLTKSKEMILRIDLEDFNGVELYALYDQFYVANEFLKYRLHVGNYNGTAGDALRFNKHYNHDLKFFTTPDKDNDRYPSGNCGLYYSSGWWFDACLSANLNGKYYHQKYRGVRNGIFWGTWPGVSEAHPGGYKSSFKEAKMMIRPKHFKP	0.6395272	-0.644922379	0.0471155	4.2294986	5.1015881	4.4455413	5.3711813	6.7998425	2.9715493	3.387066645	4.5035209	6.6298071	4.0161425	4.3855403	5.3348665	4.79205303	4.8387413	3.2446141	4.0047139	5.9428202	3.3338704	1.970913395	2.9804036	3.9614473	4.709583	4.0755805	5.12649	4.10413183	5.52607328	4.283066	6.454054	6.4490544	5.665007	6.4332268	5.375445	5.7472358	4.435691	4.8994449	5.7130751	5.6913482	3.2754171	5.562492	3.8782929	5.5472676	5.6782644	4.2791541	2.94378573					GO:0005576///extracellular region+++GO:0005577///fibrinogen complex+++GO:0005615///extracellular space+++GO:0062023///collagen-containing extracellular matrix+++GO:0070062///extracellular exosome+++GO:1904813///ficolin-1-rich granule lumen	GO:0005102///signaling receptor binding+++GO:0005201///extracellular matrix structural constituent+++GO:0008233///peptidase activity	GO:0002291///T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell+++GO:0002605///negative regulation of dendritic cell antigen processing and presentation+++GO:0002617///negative regulation of macrophage antigen processing and presentation+++GO:0006508///proteolysis+++GO:0043312///neutrophil degranulation+++GO:0043381///negative regulation of memory T cell differentiation+++GO:0050687///negative regulation of defense response to virus	tissueType=Fetal kidney;cancerType=Normal;cellName=Monocyte+++tissueType=Large intestine;cancerType=Normal;cellName=Paneth cell		"Homo sapiens fibrinogen like 2 (FGL2), mRNA."		"PF00147///Fibrinogen beta and gamma chains, C-terminal globular domain"	R-HSA-168249///Innate Immune System+++R-HSA-168256///Immune System+++R-HSA-6798695///Neutrophil degranulation		KOG2579///signaling receptor binding		"IPR002181///Fibrinogen, alpha/beta/gamma chain, C-terminal globular domain+++IPR014716///Fibrinogen, alpha/beta/gamma chain, C-terminal globular, subdomain 1+++IPR020837///Fibrinogen, conserved site+++IPR033083///Fibroleukin+++IPR036056///Fibrinogen-like, C-terminal"	[FGL2_HUMAN|Reviewed]RecName: Full=Fibroleukin; AltName: Full=Fibrinogen-like protein 2; AltName: Full=pT49; Flags: Precursor;	chr7q11///Ensembl 103 genes in cytogenetic band chr7q11			REACTOME_INNATE_IMMUNE_SYSTEM///Innate Immune System+++REACTOME_NEUTROPHIL_DEGRANULATION///Neutrophil degranulation	"NABA_CORE_MATRISOME///Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans+++NABA_ECM_GLYCOPROTEINS///Genes encoding structural ECM glycoproteins+++NABA_MATRISOME///Ensemble of genes encoding extracellular matrix and extracellular matrix-associated proteins "		"MIR10522_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-10522-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR106B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-106b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR12136///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-12136 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1252_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1252-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1305///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1305 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR137_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-137-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR153_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-153-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR16_2_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-16-2-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR195_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-195-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR205_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-205-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR20A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-20a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3157_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3157-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR338_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-338-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR340_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-340-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3646///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3646 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR367_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-367-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3692_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3692-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4255///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4255 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4293///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4293 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4698///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4698 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4802_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4802-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR512_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-512-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR545_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-545-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AB///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548ab in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AD_5P_MIR548AE_5P_MIR548AY_5P_MIR548B_5P_MIR548D_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548ad-5p, hsa-miR-548ae-5p, hsa-miR-548ay-5p, hsa-miR-548b-5p, hsa-miR-548d-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AK_MIR548AM_5P_MIR548C_5P_MIR548H_5P_MIR548O_5P_MIR548AU_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548ak, hsa-miR-548am-5p, hsa-miR-548c-5p, hsa-miR-548h-5p, hsa-miR-548o-5p, hsa-miR-548au-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AP_5P_MIR548J_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548ap-5p, hsa-miR-548j-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AQ_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548aq-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AR_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548ar-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AS_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548as-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548BB_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548bb-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548I///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548i in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548O_5P_MIR548W///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548o-5p, hsa-miR-548w in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548Y///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548y in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR559///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-559 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR568///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-568 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR576_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-576-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR607///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-607 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR656_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-656-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6817_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6817-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7_1_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7-1-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7_2_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7-2-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR935///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-935 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR944///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-944 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets)."	RTAAACA_FREAC2_01///Genes having at least one occurence of the highly conserved motif M36 RTAAACA sites. The motif matches transcription factor binding site V$FREAC2_01 (v7.4 TRANSFAC).	"BACH2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9BYV9 (BACH2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF257_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9Y2Q1 (ZNF257) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."	GNF2_CARD15///Neighborhood of CARD15+++GNF2_CASP1///Neighborhood of CASP1+++GNF2_CD14///Neighborhood of CD14+++GNF2_CD1D///Neighborhood of CD1D+++GNF2_CD33///Neighborhood of CD33+++GNF2_FGR///Neighborhood of FGR+++GNF2_FOS///Neighborhood of FOS+++GNF2_HCK///Neighborhood of HCK+++GNF2_PECAM1///Neighborhood of PECAM1+++GNF2_S100A4///Neighborhood of S100A4+++GNF2_TNFRSF1B///Neighborhood of TNFRSF1B	MODULE_44///Thymus genes.+++MODULE_45///Whole blood genes.+++MODULE_84///Immune (humoral) and inflammatory response.	ALK_DN.V1_DN///Genes down-regulated in DAOY cells (medulloblastoma) upon knockdown of ALK [Gene ID=238] gene by RNAi.+++HOXA9_DN.V1_UP///Genes up-regulated in MOLM-14 cells (AML) with knockdown of HOXA9 [Gene ID=3205] gene by RNAi vs controls.+++KRAS.AMP.LUNG_UP.V1_DN///Genes down-regulated in epithelial lung cancer cell lines over-expressing KRAS [Gene ID=3845] gene.+++STK33_SKM_UP///Genes up-regulated in SKM-1 cells (AML) after knockdown of STK33 [Gene ID=65975] by RNAi.+++STK33_UP///Genes up-regulated in NOMO-1 and SKM-1 cells (AML) after knockdown of STK33 [Gene ID=65975] by RNAi.	"FLETCHER_PBMC_BCG_10W_INFANT_BCG_STIMULATED_VS_UNSTIMULATED_10W_DN///Genes down-regulated in peripheral blood mononuclear cell stimulated vs unstimulated in infants (10w) after exposure to BCG (Danish strain BCG Statens Serum Institut, Denmark) , time point 10W. Comment: PBMCs drawn at 10 weeks following immunization at birth+++FLETCHER_PBMC_BCG_10W_INFANT_PPD_STIMULATED_VS_UNSTIMULATED_10W_DN///Genes down-regulated in peripheral blood mononuclear cell stimulated vs unstimulated in infants (10w) after exposure to BCG (Danish strain BCG Statens Serum Institut, Denmark) , time point 10W. Comment: PBMCs drawn at 10 weeks following immunization at birth+++FRANCO_BLOOD_SANOFI_PASTEUR_SA_INACTIVATED_INFLUENZA_VACCINE_CORRELATED_WITH_ANTIBODY_RESPONSE_AGE_18_40YO_1DY_POSITIVE///Genes positively correlated with antibody response in blood in adults (18-40) after exposure to Sanofi Pasteur, SA, Inactivated influenza vaccine , time point 1D+++GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_STIMULATED_VS_UNSTIMULATED_0DY_VACCINATION_INDEPENDENT_UP///Genes up-regulated in peripheral blood mononuclear cell stimulated vs unstimulated in young adults (18-25) after exposure to HPV-16 L1 VLP , time point 0D. Comment: List of Genes induced by VLP directly, independently of vaccination (p&lt;0.05 and FC&gt;1.30)+++GSE10325_BCELL_VS_MYELOID_DN///Genes down-regulated in comparison of healthy B cells versus healthy myeloid cells.+++GSE10325_CD4_TCELL_VS_MYELOID_DN///Genes down-regulated in comparison of healthy CD4 [GeneID=920] T cells versus healthy myeloid cells.+++GSE10325_LUPUS_BCELL_VS_LUPUS_MYELOID_DN///Genes down-regulated in comparison of systemic lupus erythematosus B cells versus systemic lupus erythromatosus myeloid cells.+++GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_MYELOID_DN///Genes down-regulated in comparison of systemic lupus erythematosus CD4 [GeneID=920] T cells versus systemic lupus erythematosus myeloid cells.+++GSE13411_NAIVE_VS_IGM_MEMORY_BCELL_DN///Genes down-regulated in comparison of naive B cells versus IgM-memory B cells.+++GSE13485_PRE_VS_POST_YF17D_VACCINATION_PBMC_DN///Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) before vs after YF17D vaccination.+++GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_DN///Genes down-regulated in comparison of control microglia cells versus those 24 h after stimulation with IFNG [GeneID=3458].+++GSE14386_UNTREATED_VS_IFNA_TREATED_ACT_PBMC_MS_PATIENT_DN///Genes down-regulated in peripheral blood mononclear cells (PBMC) from multiple sclerosis (MS) patient: untreated versus IFNB1 [GeneID=3456].+++GSE19772_CTRL_VS_HCMV_INF_MONOCYTES_UP///Genes up-regulated in monocytes: control versus HCMV infection.+++GSE19772_HCMV_INFL_VS_HCMV_INF_MONOCYTES_AND_PI3K_INHIBITION_DN///Genes down-regulated in monocytes after HCMV infection: untreated versus pre-treated with Ly294002 [PubChem=3973].+++GSE19888_ADENOSINE_A3R_INH_VS_ACT_IN_MAST_CELL_DN///Genes down-regulated in HMC-1 (mast leukemia) cells incubated with: the peptide ALL1 versus Cl-IB-MECA [PubChem=3035850].+++GSE19888_ADENOSINE_A3R_INH_VS_ACT_WITH_INHIBITOR_PRETREATMENT_IN_MAST_CELL_UP///Genes up-regulated in HMC-1 (mast leukemia) cells incubated the peptide ALL1 versus those followed by treatment with Cl-IB-MECA [PubChem=3035850].+++GSE20484_MCSG_VS_CXCL4_MONOCYTE_DERIVED_MACROPHAGE_DN///Genes down-regulated in monocyte derived macrophages: CSF1 [GeneID=1435] versus PF4 [GeneID=5196].+++GSE21774_CD62L_POS_CD56_DIM_VS_CD62L_NEG_CD56_DIM_NK_CELL_DN///Genes down-regulated in SELL dim [GeneID=6402] NK cells: NCAM1+ [GeneID=4684] versus NCAM1- [GeneID=4684].+++GSE22501_PERIPHERAL_BLOOD_VS_CORD_BLOOD_TREG_DN///Genes down-regulated in T reg from: peripheral blood versus cord blood.+++GSE22886_DAY0_VS_DAY1_MONOCYTE_IN_CULTURE_UP///Genes up-regulated in comparison of monocytes cultured for 0 days versus those cultured for 1 day.+++GSE22886_IGA_VS_IGM_MEMORY_BCELL_DN///Genes down-regulated in comparison of memory IgG IgA B cells versus memory IgM B cells.+++GSE22886_NAIVE_BCELL_VS_NEUTROPHIL_DN///Genes down-regulated in comparison of naive B cells versus unstimulated neutrophils.+++GSE22886_NAIVE_CD4_TCELL_VS_DC_DN///Genes down-regulated in comparison of naive CD4 [GeneID=920] T cells versus unstimulatd dendritic cells (DC).+++GSE22886_NAIVE_CD4_TCELL_VS_MONOCYTE_DN///Genes down-regulated in comparison of naive CD4 [GeneID=920] T cells versus day 0 monocytes.+++GSE22886_NAIVE_CD4_TCELL_VS_NEUTROPHIL_DN///Genes down-regulated in comparison of naive CD4 [GeneID=920] T cells versus unstimulated neutrophils.+++GSE22886_NAIVE_CD8_TCELL_VS_MONOCYTE_DN///Genes down-regulated in comparison of naive CD8 T cells versus day 0 monocytes.+++GSE22886_NAIVE_CD8_TCELL_VS_NEUTROPHIL_DN///Genes down-regulated in comparison of naive CD8 T cells versus unstimulated neutrophils.+++GSE22886_NAIVE_TCELL_VS_MONOCYTE_DN///Genes down-regulated in comparison of naive CD4 [GeneID=920] CD8 T cells versus monocytes cultured for 0 days.+++GSE24634_TEFF_VS_TCONV_DAY10_IN_CULTURE_DN///Genes down-regulated in comparison of untreated CD25+ T effector cells at day 10 versus untreated CD25- T cells at day 10.+++GSE24634_TEFF_VS_TCONV_DAY3_IN_CULTURE_DN///Genes down-regulated in comparison of CD25+ T effector cells treated with IL4 [GeneID=3565] at day 3 versus untreated CD25- T cells at day 3.+++GSE24634_TREG_VS_TCONV_POST_DAY10_IL4_CONVERSION_DN///Genes down-regulated in comparison of CD25+ regulatory T cell (Treg) treated with IL4 [GeneID=3565] at day 10 versus CD25- T cells treated with IL4 [GeneID=3565] at 10 h.+++GSE24634_TREG_VS_TCONV_POST_DAY7_IL4_CONVERSION_DN///Genes down-regulated in comparison of CD25+ regulatory T cell (Treg) treated with IL4 [GeneID=3565] at day 7 versus CD25- T cells treated with IL4 [GeneID=3565] at day 7.+++GSE25087_TREG_VS_TCONV_ADULT_UP///Genes up-regulated in comparison of adult regulatory T cell (Treg) versus adult conventional T cells.+++GSE2706_R848_VS_R848_AND_LPS_8H_STIM_DC_UP///Genes up-regulated in comparison of dendritic cells (DC) stimulated with R848 at 8 h versus DCs stimulated with LPS (TLR4 agonist) and R848 for 8 h.+++GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_6H_UP///Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: IL4 [GeneID=3565] (6h) versus untreated (6h).+++GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_48H_DN///Genes down-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 and IL4 [GeneID=7040;3565] (48h) versus untreated (48h).+++GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_2H_UP///Genes up-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 and then stimulated by IL-12 (2h).+++GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_4H_UP///Genes up-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 and then stimulated by TGFB1 and IL4 [GeneID=7040;3565] (6h).+++GSE29615_DAY3_VS_DAY7_LAIV_FLU_VACCINE_PBMC_UP///Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from LAIV influenza vaccinee at day 3 post-vaccination versus those at day 7 post-vaccination.+++GSE29618_MONOCYTE_VS_PDC_DAY7_FLU_VACCINE_UP///Genes up-regulated in comparison of monocytes from influenza vaccinee at day 7 post-vaccination versus plasmacytoid dendritic cells (mDC) at day 7 post-vaccination.+++GSE29618_MONOCYTE_VS_PDC_UP///Genes up-regulated in comparison of monocytes versus plasmacytoid dendritic cells (pDC).+++GSE29618_PDC_VS_MDC_DAY7_FLU_VACCINE_DN///Genes down-regulated in comparison of plasmacytoid dendritic cells (DC) from influenza vaccinee at day 7 post-vaccination versus myeloid DCs at day 7 post-vaccination.+++GSE29618_PDC_VS_MDC_DN///Genes down-regulated in comparison of plasmacytoid dendritic cells (DC) versus myeloid DCs.+++GSE32164_RESTING_DIFFERENTIATED_VS_ALTERNATIVELY_ACT_M2_MACROPHAGE_DN///Genes down-regulated in macrophages: resting differentiated versus alternatively activated M2.+++GSE33425_CD161_HIGH_VS_NEG_CD8_TCELL_DN///Genes down-regulated in CD8 T cells: KLRB1 high [GeneID=3820] versus KLRB1- [GeneID=3820].+++GSE33425_CD161_INT_VS_NEG_CD8_TCELL_UP///Genes up-regulated in CD8 T cells: KLRB1 int [GeneID=3820] versus KLRB1- [GeneID=3820].+++GSE34156_UNTREATED_VS_6H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN///Genes down-regulated in monocytes (6h): untreated versus muramyl dipeptide [PubChem=11620162] andM. tuberculosis 19 kDa lipopeptide.+++GSE34515_CD16_POS_MONOCYTE_VS_DC_UP///Genes up-regulated in CD16+ monocytes versus dendritic cells.+++GSE35685_CD34POS_CD10NEG_CD62LPOS_VS_CD34POS_CD10POS_BONE_MARROW_DN///Genes down-regulated in the bone marrow CD34+ [GeneID=947] cells: MME- SELL+[GeneID=4311;6402] versus MME+ [GeneID=4311].+++GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10NEG_CD62LPOS_BONE_MARROW_DN///Genes down-regulated in the bone marrow CD34+ [GeneID=947] cells: CD38- [GeneID=952] versus MME- SELL+ [GeneID=4311;6402].+++GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10POS_BONE_MARROW_DN///Genes down-regulated in the bone marrow CD34+ [GeneID=947] cells: CD38- [GeneID=952] versus MME+ [GeneID=4311].+++GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_DC_DN///Genes down-regulated in comparison of dendritic cells (DC) exposed to L. donovani versus DCs exposed to 50 worm/well B. malayi.+++GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_DC_DN///Genes down-regulated in comparison of dendritic cells (DC) exposed to L. donovani versus DCs exposed to 5 worm/well B. malayi.+++GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_DC_DN///Genes down-regulated in comparison of dendritic cells (DC) exposed to T. gondii versus DCs exposed to 5 worms/well B. malayi.+++GSE3720_LPS_VS_PMA_STIM_VD1_GAMMADELTA_TCELL_UP///Genes up-regulated in Vd1 gamma delta T cells: LPS versus phorbol myristate acetate and ionomycin [PubChem=4792;3733].+++GSE37416_CTRL_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP///Genes up-regulated in comparison of control polymorphonuclear leukocytes (PMN) at 24 h versus PMN treated with F. tularensis vaccine at 24 h.+++GSE3920_IFNA_VS_IFNG_TREATED_ENDOTHELIAL_CELL_DN///Genes down-regulated in endothelial cells: interferon alpha versus IFNG [GeneID=3458].+++GSE3920_IFNB_VS_IFNG_TREATED_ENDOTHELIAL_CELL_DN///Genes down-regulated in endothelial cells: interferon beta versus IFNG [GeneID=3458].+++GSE3920_UNTREATED_VS_IFNA_TREATED_ENDOTHELIAL_CELL_UP///Genes up-regulated in ndothelial cells: untreated versus interferon alpha.+++GSE3920_UNTREATED_VS_IFNB_TREATED_ENDOTHELIAL_CELL_DN///Genes down-regulated in endothelial cells: untreated versus interferon beta.+++GSE3982_EFF_MEMORY_CD4_TCELL_VS_NKCELL_DN///Genes down-regulated in comparison of effective memory CD4 [GeneID=920] T cells versus NK cells.+++GSE3982_NEUTROPHIL_VS_CENT_MEMORY_CD4_TCELL_UP///Genes up-regulated in comparison of neutrophils versus central memory CD4 [GeneID=920] T cells.+++GSE44732_UNSTIM_VS_IL27_STIM_IMATURE_DC_UP///Genes up-regulated in immature dendritic cells: untreated versus IL27 [GeneID=246778].+++GSE6092_IFNG_VS_IFNG_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_DN///Genes down-regulated in endothelial cells: IFNG [GeneID=3459] versus IFNG [GeneID=3459] and B. burgdoferi.+++GSE7460_CD8_TCELL_VS_CD4_TCELL_ACT_UP///Genes up-regulated in comparsion of ActCD8 versus ActCD4 (see Fig. 1 in the paper for details).+++GSE7460_CTRL_VS_TGFB_TREATED_ACT_CD8_TCELL_UP///Genes up-regulated in comparsion of ActCD8 versus ActCD8TGF (see Fig. 1 in the paper for details).+++GSE7460_CTRL_VS_TGFB_TREATED_ACT_TCONV_DN///Genes down-regulated in comparsion of ActCD4 versus ActCD4TGF (see Fig. 1 in the paper for details).+++GSE7460_TCONV_VS_TREG_LN_DN///Genes down-regulated in comparison of TconvLN versus TregLN (see Fig. 1 in the paper for details).+++GSE7460_TCONV_VS_TREG_THYMUS_DN///Genes down-regulated in comparison of TconvThy versus TregThy (see Fig. 1 in the paper for details).+++GSE7509_UNSTIM_VS_FCGRIIB_STIM_DC_DN///Genes down-regulated in dendritic cells: untreated versus anti-FcgRIIB.+++GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_24H_DN///Genes down-regulated in monocytes: untreated versus M. tuberculosis 19 kDa lipopeptide (24h).+++GSE9601_NFKB_INHIBITOR_VS_PI3K_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_DN///Genes down-regulated in monocytes after HCMV infection: BAY 11-7082 [PubChem=5353431] versus Ly294002 [PubChem=3973].+++GSE9960_GRAM_POS_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_UP///Genes up-regulated in peripheral blood monocytes (PMBC): Gram positive sepsis versus mixed infection sepsis.+++HOWARD_PBMC_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_19_39YO_AS03_ADJUVANT_VS_BUFFER_1DY_UP///Genes up-regulated in peripheral blood mononuclear cell vaccinated with AS03 adjuvant vs phosphate-bufferred saline in adults (19-39) after exposure to inactivated monovalent influenza A/Indonesia/05/2005 H5N1 split-virus vaccine , time point 1D , administered i.m.+++NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_POSITIVE///Genes positively correlated with HAI response at 28d in peripheral blood mononuclear cell in adults (18-50) after exposure to Fluarix/Fluvirin , time point 3D. Comment: Supplementary Table 5: All genes whose expression (d3/d0 or d7/d0) correlates to the fold increase in HAI titers (d28/d0).+++NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_UP///Genes up-regulated in peripheral blood mononuclear cell 3d vs 0d in adults (18-50) after exposure to FluMist , time point 3D. Comment: Supplementary Table 1b: All the differentially expressed genes identified in PBMCs of TIV vaccinees.+++OSMAN_BLOOD_CHAD63_KH_AGE_18_50YO_HIGH_DOSE_SUBJECTS_24HR_UP///Genes up-regulated in blood 24hr vs 0hr in adults (18-50) (high dose subjects) after exposure to ChAd63-KH , time point 24H , administered Intramuscular injection. Comment: DE gene list for high dose subjects.+++PATEL_SKIN_OF_BODY_ZOSTAVAX_AGE_70_93YO_VZV_CHALLENGE_6HR_UP///Genes up-regulated in skin of body 6hr vs 0hr in adults (70-93) (VZV challenge) after exposure to Zostavax , time point 6H+++SCHERER_PBMC_APSV_WETVAX_AGE_18_32YO_2_TO_4DY_UP///Genes up-regulated in peripheral blood mononuclear cell (2 to 4)d vs 0d in adults (18-32) after exposure to APSV Wetvax , time point 2 to 4D+++SCHERER_PBMC_APSV_WETVAX_AGE_18_32YO_50_TO_60DY_DN///Genes down-regulated in peripheral blood mononuclear cell (50 to 60)d vs 0d in adults (18-32) after exposure to APSV Wetvax , time point 50 to 60D+++SCHERER_PBMC_APSV_WETVAX_AGE_18_32YO_5_TO_7DY_UP///Genes up-regulated in peripheral blood mononuclear cell (5 to 7)d vs 0d in adults (18-32) after exposure to APSV Wetvax , time point 5 to 7D+++VAN_DEN_BIGGELAAR_PBMC_PREVNAR_9MO_INFANT_STIMULATED_VS_UNSTIMULATED_8MO_UP///Genes up-regulated in peripheral blood mononuclear cell stimulated vs unstimulated in infants (9m) (neonatal) after exposure to Prevnar (USA) , time point 8M+++VAN_DEN_BIGGELAAR_PBMC_PREVNAR_9MO_INFANT_STIMULATED_VS_UNSTIMULATED_9MO_UP///Genes up-regulated in peripheral blood mononuclear cell stimulated vs unstimulated in infants (9m) (infant) after exposure to Prevnar (USA) , time point 9M+++ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_UP///Genes up-regulated in peripheral blood mononuclear cell 1d vs 0d in adults (20-50) after exposure to MRKAd5 HIV-1 gag/pol/nef , time point 1D. Comment: Table includes specific cell types"	HALLMARK_IL2_STAT5_SIGNALING///Genes up-regulated by STAT5 in response to IL2 stimulation.+++HALLMARK_INTERFERON_GAMMA_RESPONSE///Genes up-regulated in response to IFNG [GeneID=3458].+++HALLMARK_MTORC1_SIGNALING///Genes up-regulated through activation of mTORC1 complex.	NM_006682	FGL2				
Q13586	sp|Q13586|STIM1_HUMAN		STIM1		Stromal interaction molecule 1 OS=Homo sapiens OX=9606 GN=STIM1 PE=1 SV=3	6786	NM_003156	NP_003147	ENST00000300737	K16059			MDVCVRLALWLLWGLLLHQGQSLSHSHSEKATGTSSGANSEESTAAEFCRIDKPLCHSEDEKLSFEAVRNIHKLMDDDANGDVDVEESDEFLREDLNYHDPTVKHSTFHGEDKLISVEDLWKAWKSSEVYNWTVDEVVQWLITYVELPQYEETFRKLQLSGHAMPRLAVTNTTMTGTVLKMTDRSHRQKLQLKALDTVLFGPPLLTRHNHLKDFMLVVSIVIGVGGCWFAYIQNRYSKEHMKKMMKDLEGLHRAEQSLHDLQERLHKAQEEHRTVEVEKVHLEKKLRDEINLAKQEAQRLKELREGTENERSRQKYAEEELEQVREALRKAEKELESHSSWYAPEALQKWLQLTHEVEVQYYNIKKQNAEKQLLVAKEGAEKIKKKRNTLFGTFHVAHSSSLDDVDHKILTAKQALSEVTAALRERLHRWQQIEILCGFQIVNNPGIHSLVAALNIDPSWMGSTRPNPAHFIMTDDVDDMDEEIVSPLSMQSPSLQSSVRQRLTEPQHGLGSQRDLTHSDSESSLHMSDRQRVAPKPPQMSRAADEALNAMTSNGSHRLIEGVHPGSLVEKLPDSPALAKKALLALNHGLDKAHSLMELSPSAPPGGSPHLDSSRSHSPSSPDPDTPSPVGDSRALQASRNTRIPHLAGKKAVAEEDNGSIGEETDSSPGRKKFPLKIFKKPLKK	0.5171835	-0.951251835	0.003940256		5.5202081				7.8565314		5.4441611	6.5937276	7.233337	5.5591137	6.9528286		4.8797402	6.3572925	7.0239581		5.7525762			6.4011024	7.3278251	8.3927822	4.6387822				8.368645	8.6456008	7.778518	7.6260805	6.330788	6.6870902	7.5322749	7.5210514	6.9999856	7.0080208	6.9671617	7.575102	7.8876516	6.60614957	7.8499877	6.662912	8.16025041	04020///Calcium signaling pathway+++04611///Platelet activation	H00093///Combined immunodeficiency+++H02258///Tubular aggregate myopathy+++H02259///Stormorken syndrome			GO:0005737///cytoplasm+++GO:0005783///endoplasmic reticulum+++GO:0005789///endoplasmic reticulum membrane+++GO:0005856///cytoskeleton+++GO:0005874///microtubule+++GO:0005886///plasma membrane+++GO:0005887///integral component of plasma membrane+++GO:0016020///membrane+++GO:0016021///integral component of membrane+++GO:0016529///sarcoplasmic reticulum+++GO:0030176///integral component of endoplasmic reticulum membrane+++GO:0030426///growth cone+++GO:0032541///cortical endoplasmic reticulum+++GO:0033017///sarcoplasmic reticulum membrane+++GO:0044853///plasma membrane raft	GO:0002020///protease binding+++GO:0005246///calcium channel regulator activity+++GO:0005509///calcium ion binding+++GO:0005515///protein binding+++GO:0015279///store-operated calcium channel activity+++GO:0042802///identical protein binding+++GO:0046872///metal ion binding+++GO:0051010///microtubule plus-end binding	GO:0002115///store-operated calcium entry+++GO:0005513///detection of calcium ion+++GO:0006811///ion transport+++GO:0006816///calcium ion transport+++GO:0006874///cellular calcium ion homeostasis+++GO:0032237///activation of store-operated calcium channel activity+++GO:0045762///positive regulation of adenylate cyclase activity+++GO:0045766///positive regulation of angiogenesis+++GO:0051924///regulation of calcium ion transport+++GO:0070166///enamel mineralization+++GO:0070588///calcium ion transmembrane transport+++GO:1903779///regulation of cardiac conduction+++GO:2001256///regulation of store-operated calcium entry	tissueType=Fetal kidney;cancerType=Normal;cellName=Natural killer T (NKT) cell		"Homo sapiens stromal interaction molecule 1 (STIM1), transcript variant 2, mRNA."		PF07647///SAM domain (Sterile alpha motif)+++PF16533///STIM1 Orai1-activating region	R-HSA-109582///Hemostasis+++R-HSA-1280218///Adaptive Immune System+++R-HSA-139853///Elevation of cytosolic Ca2+ levels+++R-HSA-168256///Immune System+++R-HSA-397014///Muscle contraction+++R-HSA-418346///Platelet homeostasis+++R-HSA-418360///Platelet calcium homeostasis+++R-HSA-5576891///Cardiac conduction+++R-HSA-5578775///Ion homeostasis+++R-HSA-983695///Antigen activates B Cell Receptor (BCR) leading to generation of second messengers+++R-HSA-983705///Signaling by the B Cell Receptor (BCR)		KOG4403///positive regulation of store-operated calcium channel activity		"IPR001660///Sterile alpha motif domain+++IPR013761///Sterile alpha motif/pointed domain superfamily+++IPR030463///Stromal interaction molecule 1+++IPR032393///Stromal interaction molecule, Orai1-activating region+++IPR037608///Stromal interaction molecule+++IPR037609///Stromal interaction molecule 1, SAM domain"	[STIM1_HUMAN|Reviewed]RecName: Full=Stromal interaction molecule 1; Flags: Precursor;+++[V5J3L2_HUMAN|Unreviewed]SubName: Full=STIM1 {ECO:0000313|EMBL:AFZ76986.1};				REACTOME_ADAPTIVE_IMMUNE_SYSTEM///Adaptive Immune System+++REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS///Antigen activates B Cell Receptor (BCR) leading to generation of second messengers+++REACTOME_CARDIAC_CONDUCTION///Cardiac conduction+++REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS///Elevation of cytosolic Ca2+ levels+++REACTOME_HEMOSTASIS///Hemostasis+++REACTOME_ION_HOMEOSTASIS///Ion homeostasis+++REACTOME_MUSCLE_CONTRACTION///Muscle contraction+++REACTOME_PLATELET_CALCIUM_HOMEOSTASIS///Platelet calcium homeostasis+++REACTOME_PLATELET_HOMEOSTASIS///Platelet homeostasis+++REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR///Signaling by the B Cell Receptor (BCR)		"AACTGAC_MIR223///Genes having at least one occurence of the motif AACTGAC in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-223 (v7.1 miRBase).+++AAGTCCA_MIR422B_MIR422A///Genes having at least one occurence of the motif AAGTCCA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-422b and hsa-miR-422a (v7.1 miRBase).+++ACTGCCT_MIR34B///Genes having at least one occurence of the motif ACTGCCT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-34b (v7.1 miRBase)."	MIR10401_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-10401-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1207_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1207-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1275///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1275 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1343_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1343-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR149_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-149-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR218_1_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-218-1-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3150A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3150a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3151_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3151-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3202///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3202 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR323A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-323a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4524A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4524a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4649_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4649-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4661_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4661-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4723_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4723-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4728_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4728-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4736///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4736 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4747_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4747-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4763_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4763-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4795_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4795-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5009_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5009-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5193///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5193 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5196_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5196-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5698///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5698 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR625_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-625-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR659_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-659-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6734_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6734-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6756_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6756-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6763_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6763-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6766_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6766-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6785_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6785-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6808_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6808-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6840_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6840-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6870_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6870-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6883_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6883-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6893_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6893-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7111_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7111-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7113_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7113-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR8058///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-8058 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR939_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-939-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR940///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-940 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).	AACTTT_UNKNOWN///Genes having at least one occurence of the highly conserved motif M17 AACTTT in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++AP4_Q5///Genes having at least one occurence of the transcription factor binding site V$AP4_Q5 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++AP4_Q6_01///Genes having at least one occurence of the transcription factor binding site V$AP4_Q6_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++AR_01///Genes having at least one occurence of the transcription factor binding site V$AR_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++ATF4_Q2///Genes having at least one occurence of the transcription factor binding site V$ATF4_Q2 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++CAGCTG_AP4_Q5///Genes having at least one occurence of the highly conserved motif M15 CAGCTG sites. The motif matches transcription factor binding site V$AP4_Q5 (v7.4 TRANSFAC).+++CIZ_01///Genes having at least one occurence of the transcription factor binding site V$CIZ_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++DR3_Q4///Genes having at least one occurence of the transcription factor binding site V$DR3_Q4 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++ELF1_Q6///Genes having at least one occurence of the transcription factor binding site V$ELF1_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++GATTGGY_NFY_Q6_01///Genes having at least one occurence of the highly conserved motif M5 GATTGGY sites. The motif matches transcription factor binding site V$NFY_Q6_01 (v7.4 TRANSFAC).+++GCANCTGNY_MYOD_Q6///Genes having at least one occurence of the highly conserved motif M35 GCANCTGNY sites. The motif matches transcription factor binding site V$MYOD_Q6 (v7.4 TRANSFAC).+++LBP1_Q6///Genes having at least one occurence of the transcription factor binding site V$LBP1_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++MYOD_01///Genes having at least one occurence of the transcription factor binding site V$MYOD_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++MYOGENIN_Q6///Genes having at least one occurence of the transcription factor binding site V$MYOGENIN_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++PR_Q2///Genes having at least one occurence of the transcription factor binding site V$PR_Q2 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++RYTTCCTG_ETS2_B///Genes having at least one occurence of the highly conserved motif M16 RYTTCCTG sites. The motif matches transcription factor binding site V$ETS2_B (v7.4 TRANSFAC).+++SCGGAAGY_ELK1_02///Genes having at least one occurence of the highly conserved motif M3 SCGGAAGY sites. The motif matches transcription factor binding site V$ELK1_02 (v7.4 TRANSFAC).+++T3R_Q6///Genes having at least one occurence of the transcription factor binding site V$T3R_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++TATAAA_TATA_01///Genes having at least one occurence of the highly conserved motif M51 TATAAA sites. The motif matches transcription factor binding site V$TATA_01 (v7.4 TRANSFAC).+++TGACCTY_ERR1_Q2///Genes having at least one occurence of the highly conserved motif M25 TGACCTY sites. The motif matches transcription factor binding site V$ERR1_Q2 (v7.4 TRANSFAC).+++TGCCAAR_NF1_Q6///Genes having at least one occurence of the highly conserved motif M47 TGCCAAR sites. The motif matches transcription factor binding site V$NF1_Q6 (v7.4 TRANSFAC).+++TGCTGAY_UNKNOWN///Genes having at least one occurence of the highly conserved motif M92 TGCTGAY in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++YGTCCTTGR_UNKNOWN///Genes having at least one occurence of the highly conserved motif M109 YGTCCTTGR in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++ZF5_B///Genes having at least one occurence of the transcription factor binding site V$ZF5_B (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.	"ARID5B_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q14865 (ARID5B) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++AUTS2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8WXX7 (AUTS2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++BACH2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9BYV9 (BACH2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++CBFA2T2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O43439 (CBFA2T2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++EBNA1BP2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q99848 (EBNA1BP2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++FOXP2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O15409 (FOXP2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++GCM2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O75603 (GCM2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HEY2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9UBP5 (HEY2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NKX2_5_TARGET_GENES///Genes containing one or more binding sites for UniProt:P52952 (NKX2_5) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++PHF2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O75151 (PHF2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SATB1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q01826 (SATB1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SNRNP70_TARGET_GENES///Genes containing one or more binding sites for UniProt:P08621 (SNRNP70) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SUPT16H_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9Y5B9 (SUPT16H) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZBTB12_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9Y330 (ZBTB12) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF274_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96GC6 (ZNF274) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF282_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9UDV7 (ZNF282) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF563_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8TA94 (ZNF563) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF768_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9H5H4 (ZNF768) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZSCAN29_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8IWY8 (ZSCAN29) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."	GCM_RING1///Neighborhood of RING1	MODULE_20///Genes in the cancer module 20.+++MODULE_521///T-cell proliferation genes.		"GSE12198_LOW_IL2_STIM_NK_CELL_VS_HIGH_IL2_STIM_NK_CELL_DN///Genes down-regulated in NK cells: low dose versus high dose of IL2 [GeneID=3558].+++GSE13762_CTRL_VS_125_VITAMIND_DAY5_DC_DN///Genes down-regulated in dendritic cells (5 days): control versus 25-hydroxyvitamin D3 [PubChem=1593].+++GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_DN///Genes down-regulated in comparison of CD4 [GeneID=920] thymocytes versus naive CD4 [GeneID=920] T cells from cord blood.+++GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_CORD_BLOOD_DN///Genes down-regulated in comparison of intrathymic T progenitor cells (ITTP) versus naive CD4 [GeneID=920] T cells from cord blood.+++GSE1460_INTRATHYMIC_T_PROGENITOR_VS_THYMIC_STROMAL_CELL_UP///Genes up-regulated in comparison of intrathymic T progenitor cells (ITTP) versus thymic stromal cells.+++GSE16385_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_ROSIGLITAZONE_TREATED_DN///Genes down-regulated in macrophages (12h): IFNG, TNF [GeneID=3458;7124] and rosiglitazone [PubChem=77999] versus rosiglitazone [PubChem=77999] and IL4 [GeneID=3565].+++GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_6H_IFNA_STIM_UP///Genes up-regulated in neuron cell line treated with interferon alpha for 6h: immature versus mature.+++GSE17974_2H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_DN///Genes down-regulated in comparison of untreated CD4 [GeneID=920] T cells at 2 h versus the untreated cells at 72 h.+++GSE22229_RENAL_TRANSPLANT_VS_HEALTHY_PBMC_DN///Genes down-regulated in periperal blood monocytes (PBMC): tolerant kidney transplants versus healthy controls.+++GSE22342_CD11C_HIGH_VS_LOW_DECIDUAL_MACROPHAGES_UP///Genes up-regulated in decidual macrophages with ITGAX [GeneID=3687] high versus low.+++GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH1_UP///Genes up-regulated in comparison of naive CD4 [GeneID=920] T cells versus stimulated CD4 [GeneID=920] Th1 cells at 12 h.+++GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH2_UP///Genes up-regulated in comparison of naive CD4 [GeneID=920] T cells versus stimulated CD4 [GeneID=920] Th2 cells at 12 h.+++GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_2H_DN///Genes down-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: IL-12 (2h) versus IL4 [GeneID=3565] (2h).+++GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_6H_UP///Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 and IL4 [GeneID=7040;3565] (6h) versus untreated (6h).+++GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_2H_UP///Genes up-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 and then stimulated by IL-12 (2h).+++GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_UP///Genes up-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 and then stimulated by TGFB1 [GeneID=7040] and IL-12 (2h).+++GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MONOCYTE_UP///Genes up-regulated in comparison of monocytes from LAIV influenza vaccinee pre-vaccination versus those at day 7 post-vaccination+++GSE32164_RESTING_DIFFERENTIATED_VS_CMYC_INHIBITED_MACROPHAGE_DN///Genes down-regulated in macrophages: resting differentiated versus MYC [GeneID=4609] inhibited.+++GSE33374_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_DN///Genes down-regulated in KLRB1 high [GeneID=3820] T cells: CD8A [GeneID=925] versus CD8A CD8B [GeneID=925;926].+++GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_DC_UP///Genes up-regulated in comparison of dendritic cells (DC) versus DCs exposed to B. malayi (50 worms/well).+++GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_DC_UP///Genes up-regulated in comparison of dendritic cells (DC) versus DCs exposed to B. malayi (5 worms/well).+++GSE360_CTRL_VS_L_DONOVANI_MAC_UP///Genes up-regulated in comparison of macrophages versus macrophages exposed to L.donovani.+++GSE360_L_DONOVANI_VS_L_MAJOR_MAC_UP///Genes up-regulated in comparison of macrophages exposed to L. donovani versus macrophages exposed to L. major.+++GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_MAC_UP///Genes up-regulated in comparison of macrophages exposed to L. donovani versus macrophages exposed to M. tuberculosis.+++GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_DC_DN///Genes down-regulated in comparison of dendritic cells (DC) exposed to L. major versus DCs exposed to 50 worms/well B. malayi.+++GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_DC_DN///Genes down-regulated in comparison of dendritic cells (DC) exposed to L. major versus DCs exposed to 5 worms/well B. malayi.+++NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP///Genes up-regulated in plasmacytoid dendritic cell 7d vs 0d in young adults (18-50) after exposure to FluMist , time point 7D+++SCHERER_PBMC_APSV_WETVAX_AGE_18_32YO_50_TO_60DY_UP///Genes up-regulated in peripheral blood mononuclear cell (50 to 60)d vs 0d in adults (18-32) after exposure to APSV Wetvax , time point 50 to 60D"		NM_003156	STIM1				
Q13561	sp|Q13561|DCTN2_HUMAN		DCTN2		"Dynactin subunit 2 OS=Homo sapiens OX=9606 GN=DCTN2 PE=1 SV=4 >tr|A0A384MDU9|A0A384MDU9_HUMAN Dynactin 2 (P50), isoform CRA_c OS=Homo sapiens OX=9606 GN=DCTN2 PE=2 SV=1"	10540	NM_001261413	NP_001248342	ENST00000548249	K10424			MADPKYADLPGIARNEPDVYETSDLPEDDQAEFDAEELTSTSVEHIIVNPNAAYDKFKDKRVGTKGLDFSDRIGKTKRTGYESGEYEMLGEGLGVKETPQQKYQRLLHEVQELTTEVEKIKTTVKESATEEKLTPVLLAKQLAALKQQLVASHLEKLLGPDAAINLTDPDGALAKRLLLQLEATKNSKGGSGGKTTGTPPDSSLVTYELHSRPEQDKFSQAAKVAELEKRLTELETAVRCDQDAQNPLSAGLQGACLMETVELLQAKVSALDLAVLDQVEARLQSVLGKVNEIAKHKASVEDADTQSKVHQLYETIQRWSPIASTLPELVQRLVTIKQLHEQAMQFGQLLTHLDTTQQMIANSLKDNTTLLTQVQTTMRENLATVEGNFASIDERMKKLGK	0.5813022	-0.782639814	0.03766063						5.0888042		3.2769303	5.2110257	5.8527674	5.4188962	5.1620412			3.7022012	4.6066218						4.5906065						6.182987	6.0664053	6.319557	6.684048	4.509033	3.9565327	5.1267989	4.8099814	5.5842369	5.7164123	4.8947096	6.49895	6.2943286	5.65966713	6.6253838	3.3022791	6.12558905	04962///Vasopressin-regulated water reabsorption+++05014///Amyotrophic lateral sclerosis+++05016///Huntington disease+++05022///Pathways of neurodegeneration - multiple diseases+++05132///Salmonella infection				GO:0000776///kinetochore+++GO:0005737///cytoplasm+++GO:0005813///centrosome+++GO:0005815///microtubule organizing center+++GO:0005829///cytosol+++GO:0005856///cytoskeleton+++GO:0005869///dynactin complex+++GO:0005874///microtubule+++GO:0016020///membrane+++GO:0030286///dynein complex+++GO:0030426///growth cone+++GO:0031982///vesicle+++GO:0070062///extracellular exosome	GO:0005515///protein binding+++GO:0019901///protein kinase binding+++GO:0030507///spectrin binding+++GO:0042802///identical protein binding	GO:0000086///G2/M transition of mitotic cell cycle+++GO:0006888///ER to Golgi vesicle-mediated transport+++GO:0007017///microtubule-based process+++GO:0007052///mitotic spindle organization+++GO:0007080///mitotic metaphase plate congression+++GO:0010389///regulation of G2/M transition of mitotic cell cycle+++GO:0019886///antigen processing and presentation of exogenous peptide antigen via MHC class II+++GO:0032402///melanosome transport+++GO:0071539///protein localization to centrosome+++GO:0097711///ciliary basal body-plasma membrane docking	tissueType=Fetal kidney;cancerType=Normal;cellName=Natural killer T (NKT) cell		"Homo sapiens dynactin subunit 2 (DCTN2), transcript variant 3, mRNA."		PF04912///Dynamitin 	"R-HSA-1280218///Adaptive Immune System+++R-HSA-1640170///Cell Cycle+++R-HSA-168256///Immune System+++R-HSA-1852241///Organelle biogenesis and maintenance+++R-HSA-199977///ER to Golgi Anterograde Transport+++R-HSA-199991///Membrane Trafficking+++R-HSA-2132295///MHC class II antigen presentation+++R-HSA-2262752///Cellular responses to stress+++R-HSA-2565942///Regulation of PLK1 Activity at G2/M Transition+++R-HSA-3371497///HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand+++R-HSA-380259///Loss of Nlp from mitotic centrosomes+++R-HSA-380270///Recruitment of mitotic centrosome proteins and complexes+++R-HSA-380284///Loss of proteins required for interphase microtubule organization from the centrosome+++R-HSA-380287///Centrosome maturation+++R-HSA-380320///Recruitment of NuMA to mitotic centrosomes+++R-HSA-392499///Metabolism of proteins+++R-HSA-446203///Asparagine N-linked glycosylation+++R-HSA-453274///Mitotic G2-G2/M phases+++R-HSA-5617833///Cilium Assembly+++R-HSA-5620912///Anchoring of the basal body to the plasma membrane+++R-HSA-5653656///Vesicle-mediated transport+++R-HSA-597592///Post-translational protein modification+++R-HSA-6807878///COPI-mediated anterograde transport+++R-HSA-6811436///COPI-independent Golgi-to-ER retrograde traffic+++R-HSA-6811442///Intra-Golgi and retrograde Golgi-to-ER traffic+++R-HSA-68877///Mitotic Prometaphase+++R-HSA-68886///M Phase+++R-HSA-69275///G2/M Transition+++R-HSA-69278///Cell Cycle, Mitotic+++R-HSA-8854518///AURKA Activation by TPX2+++R-HSA-8856688///Golgi-to-ER retrograde transport+++R-HSA-8953897///Cellular responses to stimuli+++R-HSA-948021///Transport to the Golgi and subsequent modification"		KOG3958///motor activity		IPR028133///Dynamitin	[DCTN2_HUMAN|Reviewed]RecName: Full=Dynactin subunit 2; AltName: Full=50 kDa dynein-associated polypeptide; AltName: Full=Dynactin complex 50 kDa subunit; Short=DCTN-50; AltName: Full=p50 dynamitin;	chr12q13///Ensembl 103 genes in cytogenetic band chr12q13		KEGG_HUNTINGTONS_DISEASE///Huntington's disease+++KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION///Vasopressin-regulated water reabsorption	"REACTOME_ADAPTIVE_IMMUNE_SYSTEM///Adaptive Immune System+++REACTOME_ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE///Anchoring of the basal body to the plasma membrane+++REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION///Asparagine N-linked glycosylation+++REACTOME_AURKA_ACTIVATION_BY_TPX2///AURKA Activation by TPX2+++REACTOME_CELL_CYCLE///Cell Cycle+++REACTOME_CELL_CYCLE_MITOTIC///Cell Cycle, Mitotic+++REACTOME_CELLULAR_RESPONSES_TO_EXTERNAL_STIMULI///Cellular responses to external stimuli+++REACTOME_CILIUM_ASSEMBLY///Cilium Assembly+++REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC///COPI-independent Golgi-to-ER retrograde traffic+++REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT///COPI-mediated anterograde transport+++REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT///ER to Golgi Anterograde Transport+++REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT///Golgi-to-ER retrograde transport+++REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR///HSP90 chaperone cycle for steroid hormone receptors (SHR)+++REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC///Intra-Golgi and retrograde Golgi-to-ER traffic+++REACTOME_MEMBRANE_TRAFFICKING///Membrane Trafficking+++REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION///MHC class II antigen presentation+++REACTOME_MITOTIC_G2_G2_M_PHASES///Mitotic G2-G2/M phases+++REACTOME_MITOTIC_PROMETAPHASE///Mitotic Prometaphase+++REACTOME_M_PHASE///M Phase+++REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE///Organelle biogenesis and maintenance+++REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION///Post-translational protein modification+++REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES///Recruitment of mitotic centrosome proteins and complexes+++REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES///Recruitment of NuMA to mitotic centrosomes+++REACTOME_REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION///Regulation of PLK1 Activity at G2/M Transition+++REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION///Transport to the Golgi and subsequent modification+++REACTOME_VESICLE_MEDIATED_TRANSPORT///Vesicle-mediated transport"			LET_7A_2_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-let-7a-2-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++LET_7C_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-let-7c-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++LET_7G_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-let-7g-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR10393_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-10393-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR493_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-493-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6514_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6514-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6771_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6771-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6801_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6801-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).	ACTAYRNNNCCCR_UNKNOWN///Genes having at least one occurence of the highly conserved motif M4 ACTAYRNNNCCCR in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++AP1_01///Genes having at least one occurence of the transcription factor binding site V$AP1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++AP1_Q2///Genes having at least one occurence of the transcription factor binding site V$AP1_Q2 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++AP1_Q4///Genes having at least one occurence of the transcription factor binding site V$AP1_Q4 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++AP1_Q6_01///Genes having at least one occurence of the transcription factor binding site V$AP1_Q6_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++AP1_Q6///Genes having at least one occurence of the transcription factor binding site V$AP1_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++BACH1_01///Genes having at least one occurence of the transcription factor binding site V$BACH1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++CACBINDINGPROTEIN_Q6///Genes having at least one occurence of the transcription factor binding site V$CACBINDINGPROTEIN_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++CEBPDELTA_Q6///Genes having at least one occurence of the transcription factor binding site V$CEBPDELTA_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++COUP_DR1_Q6///Genes having at least one occurence of the transcription factor binding site V$COUP_DR1_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++DR1_Q3///Genes having at least one occurence of the transcription factor binding site V$DR1_Q3 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++ER_Q6_02///Genes having at least one occurence of the transcription factor binding site V$ER_Q6_02 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++GCGNNANTTCC_UNKNOWN///Genes having at least one occurence of the highly conserved motif M48 GCGNNANTTCC in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++GGGYGTGNY_UNKNOWN///Genes having at least one occurence of the highly conserved motif M31 GGGYGTGNY in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++HNF4_01_B///Genes having at least one occurence of the transcription factor binding site V$HNF4_01_B (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++HNF4_DR1_Q3///Genes having at least one occurence of the transcription factor binding site V$HNF4_DR1_Q3 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++MCAATNNNNNGCG_UNKNOWN///Genes having at least one occurence of the highly conserved motif M110 MCAATNNNNNGCG in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++MYAATNNNNNNNGGC_UNKNOWN///Genes having at least one occurence of the highly conserved motif M138 MYAATNNNNNNNGGC in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++NFE2_01///Genes having at least one occurence of the transcription factor binding site V$NFE2_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++NRF2_Q4///Genes having at least one occurence of the transcription factor binding site V$NRF2_Q4 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++PPAR_DR1_Q2///Genes having at least one occurence of the transcription factor binding site V$PPAR_DR1_Q2 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++RYTTCCTG_ETS2_B///Genes having at least one occurence of the highly conserved motif M16 RYTTCCTG sites. The motif matches transcription factor binding site V$ETS2_B (v7.4 TRANSFAC).+++SMAD3_Q6///Genes having at least one occurence of the transcription factor binding site V$SMAD3_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++STAT5A_03///Genes having at least one occurence of the transcription factor binding site V$STAT5A_03 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++STAT6_02///Genes having at least one occurence of the transcription factor binding site V$STAT6_02 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++TGACCTY_ERR1_Q2///Genes having at least one occurence of the highly conserved motif M25 TGACCTY sites. The motif matches transcription factor binding site V$ERR1_Q2 (v7.4 TRANSFAC).+++TGANTCA_AP1_C///Genes having at least one occurence of the highly conserved motif M7 TGANTCA sites. The motif matches transcription factor binding site V$AP1_C (v7.4 TRANSFAC).+++TMTCGCGANR_UNKNOWN///Genes having at least one occurence of the highly conserved motif M8 TMTCGCGANR in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).	"BANP_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8N9N5 (BANP) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++BARX2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9UMQ3 (BARX2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++DYRK1A_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q13627 (DYRK1A) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++FOXD2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O60548 (FOXD2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HMBOX1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6NT76 (HMBOX1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HOXA2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O43364 (HOXA2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HOXB4_TARGET_GENES///Genes containing one or more binding sites for UniProt:P17483 (HOXB4) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++IRF5_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q13568 (IRF5) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++MSX1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P28360 (MSX1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NKX2_2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O95096 (NKX2_2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SOX3_TARGET_GENES///Genes containing one or more binding sites for UniProt:P41225 (SOX3) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SUPT16H_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9Y5B9 (SUPT16H) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF175_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9Y473 (ZNF175) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF184_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q99676 (ZNF184) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF282_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9UDV7 (ZNF282) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF610_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8N9Z0 (ZNF610) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF766_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q5HY98 (ZNF766) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZSCAN31_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96LW9 (ZSCAN31) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."	MORF_AP2M1///Neighborhood of AP2M1+++MORF_AP3D1///Neighborhood of AP3D1+++MORF_ATOX1///Neighborhood of ATOX1+++MORF_CSNK2B///Neighborhood of CSNK2B+++MORF_DAP///Neighborhood of DAP+++MORF_MAP2K2///Neighborhood of MAP2K2+++MORF_MTA1///Neighborhood of MTA1+++MORF_PPP1CA///Neighborhood of PPP1CA+++MORF_PRKAR1A///Neighborhood of PRKAR1A+++MORF_PSMC1///Neighborhood of PSMC1+++MORF_RAB1A///Neighborhood of RAB1A+++MORF_RAB6A///Neighborhood of RAB6A+++MORF_RAC1///Neighborhood of RAC1+++MORF_RAD21///Neighborhood of RAD21+++MORF_RAD23B///Neighborhood of RAD23B+++MORF_RAN///Neighborhood of RAN+++MORF_SKP1A///Neighborhood of SKP1A+++MORF_SOD1///Neighborhood of SOD1	MODULE_124///Transcription.+++MODULE_196///Genes in the cancer module 196.+++MODULE_253///Intracellular transport (MT cytoskeleton and motors).		"FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_18HR_UP///Genes up-regulated in peripheral blood mononuclear cell 18hr vs 0hr in adults (22-54) after exposure to F. tularensis vaccine LVS , time point 18H+++FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_192HR_UP///Genes up-regulated in peripheral blood mononuclear cell 192h vs 0h in adults (22-54) after exposure to F. tularensis vaccine LVS , time point 192H+++FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_336HR_UP///Genes up-regulated in peripheral blood mononuclear cell 336h vs 0h in adults (22-54) after exposure to F. tularensis vaccine LVS , time point 336H+++FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_48HR_UP///Genes up-regulated in peripheral blood mononuclear cell 48h vs 0h in adults (22-54) after exposure to F. tularensis vaccine LVS , time point 48H+++GSE12198_NK_VS_NK_ACT_EXPANSION_SYSTEM_DERIVED_NK_CELL_DN///Genes down-regulated in NK cells: primary versus activated and expanded.+++GSE1432_6H_VS_24H_IFNG_MICROGLIA_UP///Genes up-regulated in comparison of microglia cells 6 h after stimulation with IFNG [GeneID=3458] versus microglia cells 24 h after the stimulation.+++GSE17974_0.5H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_DN///Genes down-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0.5 h versus the untreated cells at 72 h.+++GSE17974_0H_VS_1H_IN_VITRO_ACT_CD4_TCELL_UP///Genes up-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the untreated cells at 1 h.+++GSE24634_NAIVE_CD4_TCELL_VS_DAY10_IL4_CONV_TREG_DN///Genes down-regulated in comparison of naive T cells at day 0 versus CD25+ regulatory T cell (Treg) treated with IL4 [GeneID=3565] at day 10.+++GSE24634_NAIVE_CD4_TCELL_VS_DAY7_IL4_CONV_TREG_DN///Genes down-regulated in comparison of naive T cells at day 0 versus CD25+ regulatory T cell (Treg) treated with IL4 [GeneID=3565] at day 7.+++GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_6H_UP///Genes up-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 and then stimulated by IL4 [GeneID=3565] (6h).+++GSE29618_PRE_VS_DAY7_FLU_VACCINE_MONOCYTE_DN///Genes down-regulated in comparison of monocytes from influenza vaccinee pre-vaccination versus those at day 7 post-vaccination.+++GSE34156_UNTREATED_VS_6H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN///Genes down-regulated in monocytes (6h): untreated versus M. tuberculosis 19 kDa lipopeptide.+++GSE360_CTRL_VS_M_TUBERCULOSIS_DC_UP///Genes up-regulated in comparison of dendritic cells (DC) versus DCs exposed to M.tuberculosis.+++GSE360_DC_VS_MAC_B_MALAYI_LOW_DOSE_DN///Genes down-regulated in comparison of dendritic cells (DC) exposed to 5 worm/well B. malayi versus macrophages exposed to 5 worms/well B. malayi.+++GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_DC_UP///Genes up-regulated in comparison of dendritic cells (DC) exposed to 50 worms/well B. malayi versus those exposed to 5 worms/well B. malayi.+++GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_DC_UP///Genes up-regulated in comparison of dendritic cells (DC) exposed to L. donovani versus DCs exposed to M. tuberculosis.+++GSE42724_NAIVE_VS_B1_BCELL_DN///Genes down-regulated in B lymphocytes: nave versus B1.+++GSE4984_GALECTIN1_VS_VEHICLE_CTRL_TREATED_DC_DN///Genes down-regulated in monocyte-derived dendritic cells: LGALS1 [GeneID=3956] versus vehicle.+++GSE4984_UNTREATED_VS_LPS_TREATED_DC_DN///Genes down-regulated in monocyte-derived dendritic cells: control versus LPS.+++GSE7400_CTRL_VS_CSF3_IN_VIVO_TREATED_PBMC_DN///Genes down-regulated in comparison of untreated peripheral blood mononuclear cells (PBMC) versus PBMCs treated with CSF3 [GeneID=1440].+++GSE8921_3H_VS_24H_TLR1_2_STIM_MONOCYTE_DN///Genes down-regulated in monocytes in response to M. tuberculosis 19 kDa lipopeptide: 3h versus 24h.+++GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_24H_DN///Genes down-regulated in monocytes (24h): untreated versus M. tuberculosis 19 kDa lipopeptide.+++GSE9006_TYPE_1_DIABETES_AT_DX_VS_1MONTH_POST_DX_PBMC_DN///Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from patients with type 1 diabetes at the time of the diagnosis versus those at 1 month later.+++NAKAYA_B_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP///Genes up-regulated in B cell 7d vs 0d in young adults (18-50) after exposure to Fluarix/Fluvirin , time point 7D+++NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_UP///Genes up-regulated in peripheral blood mononuclear cell 3d vs 0d in adults (18-50) after exposure to FluMist , time point 3D. Comment: Supplementary Table 1b: All the differentially expressed genes identified in PBMCs of TIV vaccinees."		NM_001261413	DCTN2				
Q13526	sp|Q13526|PIN1_HUMAN		PIN1		Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 OS=Homo sapiens OX=9606 GN=PIN1 PE=1 SV=1	5300	NM_006221	NP_006212	ENST00000247970	K09578			MADEEKLPPGWEKRMSRSSGRVYYFNHITNASQWERPSGNSSSGGKNGQGEPARVRCSHLLVKHSQSRRPSSWRQEKITRTKEEALELINGYIQKIKSGEEDFESLASQFSDCSSAKARGDLGAFSRGQMQKPFEDASFALRTGEMSGPVFTDSGIHIILRTE	0.6079212	-0.718043874	0.01615185						3.5994895	3.01592051		4.5261954	4.6918996		3.7311206				3.328692		3.8741752			2.9924844				3.42854166			5.963915	5.0126337	5.292775	4.9268688		4.0201767	3.9342196	3.5661601	3.6710666	4.1755102	4.2735115	4.684599	4.6903065	3.79820829	4.9311738		4.63899003	04622///RIG-I-like receptor signaling pathway				GO:0005634///nucleus+++GO:0005654///nucleoplasm+++GO:0005737///cytoplasm+++GO:0005739///mitochondrion+++GO:0005829///cytosol+++GO:0016607///nuclear speck+++GO:0030496///midbody+++GO:0036064///ciliary basal body+++GO:0043005///neuron projection+++GO:0098978///glutamatergic synapse+++GO:0099524///postsynaptic cytosol	GO:0003755///peptidyl-prolyl cis-trans isomerase activity+++GO:0003774///motor activity+++GO:0005515///protein binding+++GO:0008013///beta-catenin binding+++GO:0016859///cis-trans isomerase activity+++GO:0031434///mitogen-activated protein kinase kinase binding+++GO:0032794///GTPase activating protein binding+++GO:0048156///tau protein binding+++GO:0050815///phosphoserine residue binding+++GO:0050816///phosphothreonine residue binding+++GO:0051219///phosphoprotein binding	GO:0000413///protein peptidyl-prolyl isomerization+++GO:0001666///response to hypoxia+++GO:0001932///regulation of protein phosphorylation+++GO:0001934///positive regulation of protein phosphorylation+++GO:0007049///cell cycle+++GO:0007088///regulation of mitotic nuclear division+++GO:0010468///regulation of gene expression+++GO:0030182///neuron differentiation+++GO:0030512///negative regulation of transforming growth factor beta receptor signaling pathway+++GO:0031647///regulation of protein stability+++GO:0032091///negative regulation of protein binding+++GO:0032092///positive regulation of protein binding+++GO:0032465///regulation of cytokinesis+++GO:0032480///negative regulation of type I interferon production+++GO:0035307///positive regulation of protein dephosphorylation+++GO:0042177///negative regulation of protein catabolic process+++GO:0043524///negative regulation of neuron apoptotic process+++GO:0043525///positive regulation of neuron apoptotic process+++GO:0043547///positive regulation of GTPase activity+++GO:0045944///positive regulation of transcription by RNA polymerase II+++GO:0046785///microtubule polymerization+++GO:0050808///synapse organization+++GO:0050821///protein stabilization+++GO:0051443///positive regulation of ubiquitin-protein transferase activity+++GO:0060393///regulation of pathway-restricted SMAD protein phosphorylation+++GO:0061051///positive regulation of cell growth involved in cardiac muscle cell development+++GO:0070373///negative regulation of ERK1 and ERK2 cascade+++GO:0090263///positive regulation of canonical Wnt signaling pathway+++GO:1900180///regulation of protein localization to nucleus+++GO:1901796///regulation of signal transduction by p53 class mediator+++GO:1902430///negative regulation of amyloid-beta formation+++GO:2000146///negative regulation of cell motility	tissueType=Fetal kidney;cancerType=Normal;cellName=Natural killer T (NKT) cell		"Homo sapiens peptidylprolyl cis/trans isomerase, NIMA-interacting 1 (PIN1), transcript variant 1, mRNA."		PF00397///WW domain+++PF00639///PPIC-type PPIASE domain	"R-HSA-1169408///ISG15 antiviral mechanism+++R-HSA-1169410///Antiviral mechanism by IFN-stimulated genes+++R-HSA-1280215///Cytokine Signaling in Immune system+++R-HSA-162582///Signal Transduction+++R-HSA-168249///Innate Immune System+++R-HSA-168256///Immune System+++R-HSA-168928///DDX58/IFIH1-mediated induction of interferon-alpha/beta+++R-HSA-194315///Signaling by Rho GTPases+++R-HSA-195258///RHO GTPase Effectors+++R-HSA-212436///Generic Transcription Pathway+++R-HSA-3700989///Transcriptional Regulation by TP53+++R-HSA-5633007///Regulation of TP53 Activity+++R-HSA-5668599///RHO GTPases Activate NADPH Oxidases+++R-HSA-6804756///Regulation of TP53 Activity through Phosphorylation+++R-HSA-6804758///Regulation of TP53 Activity through Acetylation+++R-HSA-6811555///PI5P Regulates TP53 Acetylation+++R-HSA-73857///RNA Polymerase II Transcription+++R-HSA-74160///Gene expression (Transcription)+++R-HSA-913531///Interferon Signaling+++R-HSA-936440///Negative regulators of DDX58/IFIH1 signaling+++R-HSA-9716542///Signaling by Rho GTPases, Miro GTPases and RHOBTB3"		KOG3259///positive regulation of chromatin silencing at rDNA	Others///Others	"IPR000297///Peptidyl-prolyl cis-trans isomerase, PpiC-type+++IPR001202///WW domain+++IPR023058///Peptidyl-prolyl cis-trans isomerase, PpiC-type, conserved site+++IPR036020///WW domain superfamily"	"[PIN1_HUMAN|Reviewed]RecName: Full=Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1; EC=5.2.1.8 {ECO:0000269|PubMed:21497122, ECO:0000269|PubMed:23623683, ECO:0000269|PubMed:29686383}; AltName: Full=Peptidyl-prolyl cis-trans isomerase Pin1; Short=PPIase Pin1; AltName: Full=Rotamase Pin1;"	chr19p13///Ensembl 103 genes in cytogenetic band chr19p13	BIOCARTA_MPR_PATHWAY///How Progesterone Initiates the Oocyte Maturation	KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY///RIG-I-like receptor signaling pathway	"REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES///Antiviral mechanism by IFN-stimulated genes+++REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM///Cytokine Signaling in Immune system+++REACTOME_DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA///DDX58/IFIH1-mediated induction of interferon-alpha/beta+++REACTOME_INNATE_IMMUNE_SYSTEM///Innate Immune System+++REACTOME_INTERFERON_SIGNALING///Interferon Signaling+++REACTOME_NEGATIVE_REGULATORS_OF_DDX58_IFIH1_SIGNALING///Negative regulators of DDX58/IFIH1 signaling+++REACTOME_PI5P_REGULATES_TP53_ACETYLATION///PI5P Regulates TP53 Acetylation+++REACTOME_REGULATION_OF_TP53_ACTIVITY///Regulation of TP53 Activity+++REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ACETYLATION///Regulation of TP53 Activity through Acetylation+++REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION///Regulation of TP53 Activity through Phosphorylation+++REACTOME_RHO_GTPASE_EFFECTORS///RHO GTPase Effectors+++REACTOME_RHO_GTPASES_ACTIVATE_NADPH_OXIDASES///RHO GTPases Activate NADPH Oxidases+++REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION///RNA Polymerase II Transcription+++REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3///Signaling by Rho GTPases, Miro GTPases and RHOBTB3+++REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53///Transcriptional Regulation by TP53"		"CAGTATT_MIR200B_MIR200C_MIR429///Genes having at least one occurence of the motif CAGTATT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-200b, hsa-miR-200c and hsa-miR-429 (v7.1 miRBase)."	MIR629_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-629-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6752_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6752-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6842_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6842-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7110_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7110-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR95_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-95-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).	RFX1_02///Genes having at least one occurence of the transcription factor binding site V$RFX1_02 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++RYTGCNWTGGNR_UNKNOWN///Genes having at least one occurence of the highly conserved motif M87 RYTGCNWTGGNR in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).	"ASH1L_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9NR48 (ASH1L) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++CDC73_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6P1J9 (CDC73) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++CEBPZ_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q03701 (CEBPZ) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NFRKB_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6P4R8 (NFRKB) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++RBM34_TARGET_GENES///Genes containing one or more binding sites for UniProt:P42696 (RBM34) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++THAP1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9NVV9 (THAP1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++TOP2B_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q02880 (TOP2B) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."	MORF_AATF///Neighborhood of AATF+++MORF_AP3D1///Neighborhood of AP3D1+++MORF_CDC10///Neighborhood of CDC10+++MORF_CTBP1///Neighborhood of CTBP1+++MORF_DAP3///Neighborhood of DAP3+++MORF_DDB1///Neighborhood of DDB1+++MORF_DEK///Neighborhood of DEK+++MORF_EIF3S2///Neighborhood of EIF3S2+++MORF_GNB1///Neighborhood of GNB1+++MORF_PPP2CA///Neighborhood of PPP2CA+++MORF_PRKDC///Neighborhood of PRKDC+++MORF_XRCC5///Neighborhood of XRCC5	MODULE_212///Catalytic activities / metabolism.+++MODULE_98///Genes in the cancer module 98.	ATF2_UP.V1_UP///Genes up-regulated in myometrial cells over-expressing ATF2 [Gene ID=1386] gene.+++DCA_UP.V1_DN///Genes down-regulated in A549 lung carcinoma and M059K glioblastoma cells treated with dichloroacetate [PubChem=6597].+++E2F3_UP.V1_UP///Genes up-regulated in primary epithelial breast cancer cell culture over-expressing E2F3 [Gene ID=1871] gene.+++SRC_UP.V1_UP///Genes up-regulated in primary epithelial breast cancer cell culture over-expressing SRC [Gene ID=6714] gene.	"GSE12845_NAIVE_VS_DARKZONE_GC_TONSIL_BCELL_DN///Genes down-regulated in comparison of naive B cell versus dark zone germinal center B cells.+++GSE13411_NAIVE_VS_IGM_MEMORY_BCELL_DN///Genes down-regulated in comparison of naive B cells versus IgM-memory B cells.+++GSE22025_UNTREATED_VS_TGFB1_TREATED_CD4_TCELL_UP///Genes up-regulated in CD4 [GeneID=920] T cells: untreated versus TGFB1 [GeneID=7040].+++GSE22886_TH1_VS_TH2_12H_ACT_UP///Genes up-regulated in comparison of stimulated CD4 [GeneID=920] Th1 cells at 12 h versus stimulated CD4 [GeneID=920] Th2 cells at 12 h.+++GSE22919_RESTING_VS_IL2_IL12_IL15_STIM_NK_CELL_UP///Genes up-regulated in NK cells: fresh versus stimulated with IL2 [GeneID=3558], IL-12 and IL15 [GeneID=3600].+++GSE2405_HEAT_KILLED_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_UP///Genes up-regulated in polymorphonuclear leukocytes (9h) infection by A. phagocytophilum: heat killed versus live bacteria.+++GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_UP///Genes up-regulated in monocytes (24h): muramyl dipeptide [PubChem=11620162] versus M. tuberculosis 19 kDa lipopeptide.+++GSE360_DC_VS_MAC_L_MAJOR_UP///Genes up-regulated in comparison of dendritic cells exposed to L. major versus macrophages exposed to L. major.+++GSE360_L_MAJOR_VS_T_GONDII_MAC_DN///Genes down-regulated in comparison of macrophages exposed to L. major versus macrophages exposed to T. gondii.+++GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_MAC_DN///Genes down-regulated in comparison of macrophages exposed to T. gondii versus macrophages exposed to 5 worms/well B. malayi.+++GSE9006_TYPE_1_VS_TYPE_2_DIABETES_PBMC_AT_DX_UP///Genes up-regulated in peripheral blood mononuclear cells (PBMC) from patients with type 1 diabetes at the time of diagnosis versus those with type 2 diabetes at the time of diagnosis.+++NAKAYA_B_CELL_FLUMIST_AGE_18_50YO_7DY_DN///Genes down-regulated in B cell 7d vs 0d in young adults (18-50) after exposure to FluMist , time point 7D"	HALLMARK_PI3K_AKT_MTOR_SIGNALING///Genes up-regulated by activation of the PI3K/AKT/mTOR pathway.	NM_006221	PIN1				
Q13418	sp|Q13418|ILK_HUMAN				Integrin-linked protein kinase OS=Homo sapiens OX=9606 GN=ILK PE=1 SV=2 >tr|V9HWF0|V9HWF0_HUMAN 59 kDa serine/threonine-protein kinase OS=Homo sapiens OX=9606 GN=HEL-S-28 PE=2 SV=1								MDDIFTQCREGNAVAVRLWLDNTENDLNQGDDHGFSPLHWACREGRSAVVEMLIMRGARINVMNRGDDTPLHLAASHGHRDIVQKLLQYKADINAVNEHGNVPLHYACFWGQDQVAEDLVANGALVSICNKYGEMPVDKAKAPLRELLRERAEKMGQNLNRIPYKDTFWKGTTRTRPRNGTLNKHSGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQCPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVCKLMKICMNEDPAKRPKFDMIVPILEKMQDK	0.505991	-0.982816259	0.02677686	5.7342739	7.3157576	6.5700893	8.6499315	5.8062469	7.796955	5.064335621	8.525512	9.2299382	9.3504722	7.9966606	9.661158	5.87102651	9.8658052	8.9387815	9.0130772	4.5594281	7.0484199	4.798756518		5.4708431	7.2671841	8.6990805	6.8430982	5.30840613	6.90120981	6.7620344	9.946655	9.7925478	9.892713	9.4581013	6.672582	8.4055845	8.6345092	8.8263124	8.1182441	8.6371178	8.6759142	10.072435	7.9060908	7.83188972	8.8845435	8.269799	8.97653414																																	C9606_132278					
Q13094	sp|Q13094|LCP2_HUMAN		LCP2		Lymphocyte cytosolic protein 2 OS=Homo sapiens OX=9606 GN=LCP2 PE=1 SV=1	3937	NM_005565	NP_005556	ENST00000046794	K07361			MALRNVPFRSEVLGWDPDSLADYFKKLNYKDCEKAVKKYHIDGARFLNLTENDIQKFPKLRVPILSKLSQEINKNEERRSIFTRKPQVPRFPEETESHEEDNGGWSSFEEDDYESPNDDQDGEDDGDYESPNEEEEAPVEDDADYEPPPSNDEEALQNSILPAKPFPNSNSMYIDRPPSGKTPQQPPVPPQRPMAALPPPPAGRNHSPLPPPQTNHEEPSRSRNHKTAKLPAPSIDRSTKPPLDRSLAPFDREPFTLGKKPPFSDKPSIPAGRSLGEHLPKIQKPPLPPTTERHERSSPLPGKKPPVPKHGWGPDRRENDEDDVHQRPLPQPALLPMSSNTFPSRSTKPSPMNPLPSSHMPGAFSESNSSFPQSASLPPYFSQGPSNRPPIRAEGRNFPLPLPNKPRPPSPAEEENSLNEEWYVSYITRPEAEAALRKINQDGTFLVRDSSKKTTTNPYVLMVLYKDKVYNIQIRYQKESQVYLLGTGLRGKEDFLSVSDIIDYFRKMPLLLIDGKNRGSRYQCTLTHAAGYP	0.5728186	-0.803849719	0.03162649						6.9129082		5.9635931	7.2029944	7.6109461	6.9827239	6.3608841			5.3611352	6.4898428		6.1433842			6.0764748	7.6331107	7.6445801					8.167109	6.8116761	8.943189	9.1344328	6.150719			6.6802406		6.1511923	5.6637304	8.293846	7.5224708		8.094782	6.6956797	7.87588224	04015///Rap1 signaling pathway+++04380///Osteoclast differentiation+++04611///Platelet activation+++04650///Natural killer cell mediated cytotoxicity+++04660///T cell receptor signaling pathway+++04664///Fc epsilon RI signaling pathway+++05135///Yersinia infection	H02526///Disorders of adaptive immunity			GO:0005737///cytoplasm+++GO:0005829///cytosol+++GO:0005911///cell-cell junction+++GO:0036398///TCR signalosome+++GO:0044853///plasma membrane raft	GO:0005515///protein binding	GO:0006955///immune response+++GO:0007169///transmembrane receptor protein tyrosine kinase signaling pathway+++GO:0030168///platelet activation+++GO:0035556///intracellular signal transduction+++GO:0038095///Fc-epsilon receptor signaling pathway+++GO:0045576///mast cell activation+++GO:0045860///positive regulation of protein kinase activity+++GO:0050852///T cell receptor signaling pathway	tissueType=Blood;cancerType=Normal;cellName=CD1C-CD141- dendritic cell+++tissueType=Large intestine;cancerType=Normal;cellName=Paneth cell		"Homo sapiens lymphocyte cytosolic protein 2 (LCP2), mRNA."		PF00017///SH2 domain+++PF07647///SAM domain (Sterile alpha motif)	"R-HSA-109582///Hemostasis+++R-HSA-114604///GPVI-mediated activation cascade+++R-HSA-1280218///Adaptive Immune System+++R-HSA-168249///Innate Immune System+++R-HSA-168256///Immune System+++R-HSA-202403///TCR signaling+++R-HSA-202433///Generation of second messenger molecules+++R-HSA-2172127///DAP12 interactions+++R-HSA-2424491///DAP12 signaling+++R-HSA-2454202///Fc epsilon receptor (FCERI) signaling+++R-HSA-2871796///FCERI mediated MAPK activation+++R-HSA-2871809///FCERI mediated Ca+2 mobilization+++R-HSA-76002///Platelet activation, signaling and aggregation"		ENOG502QV3T///No_INFO		IPR000980///SH2 domain+++IPR001660///Sterile alpha motif domain+++IPR013761///Sterile alpha motif/pointed domain superfamily+++IPR036860///SH2 domain superfamily	[LCP2_HUMAN|Reviewed]RecName: Full=Lymphocyte cytosolic protein 2; AltName: Full=SH2 domain-containing leukocyte protein of 76 kDa; AltName: Full=SLP-76 tyrosine phosphoprotein; Short=SLP76;+++[C7C5T4_HUMAN|Unreviewed]SubName: Full=Lymphocyte cytosolic protein 2 {ECO:0000313|EMBL:CBA11531.1};+++[Q14759_HUMAN|Unreviewed]SubName: Full=Lymphocyte cytosolic protein 2 {ECO:0000313|EMBL:AAA93308.1}; Flags: Fragment;+++[Q14760_HUMAN|Unreviewed]SubName: Full=Lymphocyte cytosolic protein 2 {ECO:0000313|EMBL:AAA93309.1}; Flags: Fragment;	chr5q35///Ensembl 103 genes in cytogenetic band chr5q35		KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY///Fc epsilon RI signaling pathway+++KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY///Natural killer cell mediated cytotoxicity+++KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY///T cell receptor signaling pathway	"REACTOME_ADAPTIVE_IMMUNE_SYSTEM///Adaptive Immune System+++REACTOME_DAP12_INTERACTIONS///DAP12 interactions+++REACTOME_DAP12_SIGNALING///DAP12 signaling+++REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING///Fc epsilon receptor (FCERI) signaling+++REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION///FCERI mediated Ca+2 mobilization+++REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION///FCERI mediated MAPK activation+++REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES///Generation of second messenger molecules+++REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE///GPVI-mediated activation cascade+++REACTOME_HEMOSTASIS///Hemostasis+++REACTOME_INNATE_IMMUNE_SYSTEM///Innate Immune System+++REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION///Platelet activation, signaling and aggregation+++REACTOME_TCR_SIGNALING///TCR signaling"		"ACTGAAA_MIR30A3P_MIR30E3P///Genes having at least one occurence of the motif ACTGAAA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-30a-3p and hsa-miR-30e-3p (v7.1 miRBase)."	MIR10522_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-10522-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR137_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-137-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1910_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1910-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3185///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3185 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4328///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4328 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4513///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4513 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR452_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-452-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4666A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4666a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AR_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548ar-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AS_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548as-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5582_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5582-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5586_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5586-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5699_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5699-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR579_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-579-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR664B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-664b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6855_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6855-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).	ETS1_B///Genes having at least one occurence of the transcription factor binding site V$ETS1_B (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++ETS_Q4///Genes having at least one occurence of the transcription factor binding site V$ETS_Q4 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++FOXJ2_01///Genes having at least one occurence of the transcription factor binding site V$FOXJ2_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++FOXO1_01///Genes having at least one occurence of the transcription factor binding site V$FOXO1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++FOXO3_01///Genes having at least one occurence of the transcription factor binding site V$FOXO3_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++FOXO4_02///Genes having at least one occurence of the transcription factor binding site V$FOXO4_02 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++FREAC3_01///Genes having at least one occurence of the transcription factor binding site V$FREAC3_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++FREAC7_01///Genes having at least one occurence of the transcription factor binding site V$FREAC7_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++HAND1E47_01///Genes having at least one occurence of the transcription factor binding site V$HAND1E47_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++HFH1_01///Genes having at least one occurence of the transcription factor binding site V$HFH1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++HFH8_01///Genes having at least one occurence of the transcription factor binding site V$HFH8_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++HNF3ALPHA_Q6///Genes having at least one occurence of the transcription factor binding site V$HNF3ALPHA_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++HNF3B_01///Genes having at least one occurence of the transcription factor binding site V$HNF3B_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++HNF3_Q6///Genes having at least one occurence of the transcription factor binding site V$HNF3_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++MGGAAGTG_GABP_B///Genes having at least one occurence of the highly conserved motif M11 MGGAAGTG sites. The motif matches transcription factor binding site V$GABP_B (v7.4 TRANSFAC).+++NKX3A_01///Genes having at least one occurence of the transcription factor binding site V$NKX3A_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++PU1_Q6///Genes having at least one occurence of the transcription factor binding site V$PU1_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++RGAGGAARY_PU1_Q6///Genes having at least one occurence of the highly conserved motif M50 RGAGGAARY sites. The motif matches transcription factor binding site V$PU1_Q6 (v7.4 TRANSFAC).+++RTAAACA_FREAC2_01///Genes having at least one occurence of the highly conserved motif M36 RTAAACA sites. The motif matches transcription factor binding site V$FREAC2_01 (v7.4 TRANSFAC).+++STAT5B_01///Genes having at least one occurence of the transcription factor binding site V$STAT5B_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++TTCYNRGAA_STAT5B_01///Genes having at least one occurence of the highly conserved motif M40 TTCYNRGAA sites. The motif matches transcription factor binding site V$STAT5B_01 (v7.4 TRANSFAC).+++YY1_01///Genes having at least one occurence of the transcription factor binding site V$YY1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.	"ADNP_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9H2P0 (ADNP) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++CDC73_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6P1J9 (CDC73) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HMBOX1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6NT76 (HMBOX1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++IRF9_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q00978 (IRF9) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++PAX3_TARGET_GENES///Genes containing one or more binding sites for UniProt:P23760 (PAX3) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++PAX7_TARGET_GENES///Genes containing one or more binding sites for UniProt:P23759 (PAX7) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF513_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8N8E2 (ZNF513) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF664_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8N3J9 (ZNF664) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF92_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q03936 (ZNF92) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZSCAN30_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q86W11 (ZSCAN30) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."	GNF2_CASP8///Neighborhood of CASP8+++GNF2_ITGAL///Neighborhood of ITGAL+++GNF2_PTPRC///Neighborhood of PTPRC+++GNF2_SNRK///Neighborhood of SNRK	MODULE_117///Signaling.+++MODULE_15///Genes in the cancer module 14.+++MODULE_165///Genes in the cancer module 165.+++MODULE_16///Genes in the cancer module 15.+++MODULE_44///Thymus genes.+++MODULE_45///Whole blood genes.+++MODULE_46///Genes in the cancer module 46.+++MODULE_51///Genes in the cancer module 51.+++MODULE_5///Lung genes.+++MODULE_75///Immune response.+++MODULE_84///Immune (humoral) and inflammatory response.		"GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_BCELL_UP///Genes up-regulated in comparison of systemic lupus erythematosus CD4 [GeneID=920] T cells versus systemic lupus erythematosus B cells.+++GSE12198_LOW_IL2_STIM_NK_CELL_VS_HIGH_IL2_STIM_NK_CELL_DN///Genes down-regulated in NK cells: low dose versus high dose of IL2 [GeneID=3558].+++GSE12845_IGD_NEG_BLOOD_VS_NAIVE_TONSIL_BCELL_UP///Genes up-regulated in comparison of IgD- peripheral blood B cells versus dark zone germinal center B cells.+++GSE12845_IGD_NEG_BLOOD_VS_PRE_GC_TONSIL_BCELL_UP///Genes up-regulated in comparison of IgD- peripheral blood B cells versus pre-germinal center B cells.+++GSE13485_CTRL_VS_DAY3_YF17D_VACCINE_PBMC_DN///Genes down-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) versus PBMC 3 days after stimulation with YF17D vaccine.+++GSE13485_CTRL_VS_DAY7_YF17D_VACCINE_PBMC_DN///Genes down-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) versus PBMC 7 days after stimulation with YF17D vaccine.+++GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_DN///Genes down-regulated in comparison of control microglia cells versus those 1 h after stimulation with IFNG [GeneID=3458].+++GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_DN///Genes down-regulated in comparison of control microglia cells versus those 6 h after stimulation with IFNG [GeneID=3458].+++GSE1460_INTRATHYMIC_T_PROGENITOR_VS_CD4_THYMOCYTE_DN///Genes down-regulated in comparison of intrathymic T progenitor cells (ITTP) versus CD4 [GeneID=920] thymocytes.+++GSE1460_INTRATHYMIC_T_PROGENITOR_VS_DP_THYMOCYTE_DN///Genes down-regulated in comparison of intrathymic T progenitor cells (ITTP) versus CD4 [GeneID=920] CD8 thymocytes. +++GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_DN///Genes down-regulated in comparison of intrathymic T progenitor cells (ITTP) versus naive CD4 [GeneID=920] T cells from adult blood.+++GSE16385_IFNG_TNF_VS_UNSTIM_MACROPHAGE_ROSIGLITAZONE_TREATED_DN///Genes down-regulated in macrophages (12h): IFNG, TNF [GeneID=3458;7124] and rosiglitazone [PubChem=77999] versus rosiglitazone [PubChem=77999].+++GSE16385_ROSIGLITAZONE_IL4_VS_IFNG_TNF_STIM_MACROPHAGE_DN///Genes down-regulated in macrophages (12h): rosiglitazone [PubChem=77999] and IL4 [GeneID=3565] versus IFNG and TNF [GeneID=3458;7124].+++GSE17186_BLOOD_VS_CORD_BLOOD_CD21LOW_TRANSITIONAL_BCELL_UP///Genes up-regulated in transitional CR2 [GeneID=1380] low B lymphocytes versus those from cord blood.+++GSE17301_CTRL_VS_48H_ACD3_ACD28_STIM_CD8_TCELL_DN///Genes down-regulated in CD8 T lymphocytes: control versus activated by anti-CD3 and anti-CD28.+++GSE17974_0H_VS_6H_IN_VITRO_ACT_CD4_TCELL_DN///Genes down-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the untreated cells at 6 h.+++GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_4H_CD4_TCELL_DN///Genes down-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the cells treated with IL4 [GeneID=3565] and anti-IL12 at 4 h.+++GSE18893_TCONV_VS_TREG_24H_CULTURE_UP///Genes up-regulated in lymphocytes treated with medium for 24h: T conv versus T reg cells.+++GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_TCELL_MEMBRANES_ACT_MAST_CELL_UP///Genes up-regulated in HMC-1 (mast leukemia) cells: incubated with the peptide ALL1 and then treated with Cl-IB-MECA [PubChem=3035850] versus stimulation by T cell membranes.+++GSE22025_PROGESTERONE_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_DN///Genes down-regulated in CD4 [GeneID=920] T cells: progesterone [PubChem=5994] versus TGFB1 [GeneID=7040] and progesterone [PubChem=5994].+++GSE22025_PROGESTERONE_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP///Genes up-regulated in CD4 [GeneID=920] T cells: progesterone [PubChem=5994] versus TGFB1 [GeneID=7040] and progesterone [PubChem=5994].+++GSE22501_PERIPHERAL_BLOOD_VS_CORD_BLOOD_TREG_DN///Genes down-regulated in T reg from: peripheral blood versus cord blood.+++GSE22589_HEALTHY_VS_HIV_INFECTED_DC_DN///Genes down-regulated in monocyte-derived dendritic cells: control versus HIV infection.+++GSE22589_SIV_VS_HIV_AND_SIV_INFECTED_DC_UP///Genes up-regulated in monocyte-derived dendritic cells infected by: SIV versus HIV and SIV.+++GSE22611_MUTANT_NOD2_VS_CTRL_TRANSDUCED_HEK293T_CELL_UP///Genes up-regulated in HEK293 cells: expressing mutant NOD2 [GeneID=64127] versus control.+++GSE22886_DAY1_VS_DAY7_MONOCYTE_IN_CULTURE_UP///Genes up-regulated in comparison of monocytes cultured for 1 day versus those cultured for 7 days.+++GSE22886_UNSTIM_VS_STIM_MEMORY_TCELL_UP///Genes up-regulated in comparison of unstimulated memory CD4 [GeneID=920] CD8 T cells versus stimulated CD4 [GeneID=920] CD8 T cells.+++GSE23321_CD8_STEM_CELL_MEMORY_VS_CENTRAL_MEMORY_CD8_TCELL_DN///Genes down-regulated in CD8 T cells: stem cell memory versus central memory.+++GSE24026_PD1_LIGATION_VS_CTRL_IN_ACT_TCELL_LINE_UP///Genes up-regulated in comparison of Jurkat T cells stimulated in the presence of PD-1 versus controls.+++GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY10_UP///Genes up-regulated in comparison of CD25- T cells treated with IL4 [GeneID=3565] at day 10 versus untreated CD25- T cells at day 10.+++GSE24634_TEFF_VS_TCONV_DAY10_IN_CULTURE_UP///Genes up-regulated in comparison of untreated CD25+ T effector cells at day 10 versus untreated CD25- T cells at day 10.+++GSE25085_FETAL_BM_VS_ADULT_BM_SP4_THYMIC_IMPLANT_UP///Genes up-regulated in thymic implants from fetal versus those from adult bone marrow.+++GSE25085_FETAL_LIVER_VS_FETAL_BM_SP4_THYMIC_IMPLANT_UP///Genes up-regulated in thymic implants from fetal liver versus those from fetal bone marrow.+++GSE26156_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN///Genes down-regulated in thymocytes: double positive versus CD4 [GeneID=920] single positive.+++GSE2706_2H_VS_8H_LPS_STIM_DC_UP///Genes up-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 2 h versus DCs stimulated with LPS (TLR4 agonist) at 8 h.+++GSE2706_2H_VS_8H_R848_AND_LPS_STIM_DC_UP///Genes up-regulated in comparison of dendritic cells (DC) stimulated with R848 at 2 h versus DCs stimulated with LPS (TLR4 agonist) at 8 h.+++GSE2706_R848_VS_LPS_2H_STIM_DC_DN///Genes down-regulated in comparison of dendritic cells (DC) stimulated with R848 at 2 h versus DCs stimulated with LPS (TLR4 agonist) for 2 h.+++GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_UP///Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: IL-12 (6h) versus TGFB1 [GeneID=7040] and IL-12 (6h).+++GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_2H_DN///Genes down-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: IL4 [GeneID=3565] (2h) versus untreated (2h).+++GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_6H_UP///Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 and IL4 [GeneID=7040;3565] (6h) versus IL-12 (6h).+++GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_6H_UP///Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 and IL4 [GeneID=7040;3565] (6h) versus IL4 [GeneID=3565] (6h).+++GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_DN///Genes down-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 and then stimulated by TGFB1 [GeneID=7040] and IL-12 (48h).+++GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_48H_DN///Genes down-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 and then stimulated by TGFB1 and IL4 [GeneID=7040;3565] (48h).+++GSE28726_ACT_CD4_TCELL_VS_ACT_VA24NEG_NKTCELL_UP///Genes up-regulated in activated T cells: CD4 [GeneID=920] versus Va24- NKT.+++GSE28726_NAIVE_CD4_TCELL_VS_NAIVE_NKTCELL_UP///Genes up-regulated in nave T cells: CD4 [GeneID=920] versus NK.+++GSE28726_NAIVE_VS_ACTIVATED_NKTCELL_DN///Genes down-regulated in NKT cells: nave versus activated.+++GSE28726_NAIVE_VS_ACTIVATED_VA24NEG_NKTCELL_UP///Genes up-regulated in Va24- NKT cells: nave versus activated.+++GSE33425_CD161_HIGH_VS_INT_CD8_TCELL_DN///Genes down-regulated in CD8 T cells: KLRB1 high [GeneID=3820] versus KLRB1 int [GeneID=3820].+++GSE33425_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_DN///Genes down-regulated in KLRB1 high [GeneID=3820] T cells: CD8A [GeneID=925] versus CD8A CD8B [GeneID=925;926].+++GSE34156_UNTREATED_VS_6H_NOD2_LIGAND_TREATED_MONOCYTE_UP///Genes up-regulated in monocytes (6h): untreated versus muramyl dipeptide [PubChem=11620162].+++GSE35685_CD34POS_CD10NEG_CD62LPOS_VS_CD34POS_CD10POS_BONE_MARROW_DN///Genes down-regulated in the bone marrow CD34+ [GeneID=947] cells: MME- SELL+[GeneID=4311;6402] versus MME+ [GeneID=4311].+++GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10POS_BONE_MARROW_DN///Genes down-regulated in the bone marrow CD34+ [GeneID=947] cells: CD38- [GeneID=952] versus MME+ [GeneID=4311].+++GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_DC_DN///Genes down-regulated in comparison of dendritic cells (DC) versus DCs exposed to B. malayi (5 worms/well).+++GSE360_CTRL_VS_M_TUBERCULOSIS_DC_DN///Genes down-regulated in comparison of dendritic cells (DC) versus DCs exposed to M.tuberculosis.+++GSE360_DC_VS_MAC_L_MAJOR_DN///Genes down-regulated in comparison of dendritic cells exposed to L. major versus macrophages exposed to L. major.+++GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_DC_DN///Genes down-regulated in comparison of dendritic cells (DC) exposed to L. donovani versus DCs exposed to M. tuberculosis.+++GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_MAC_UP///Genes up-regulated in comparison of macrophages exposed to L. major versus macrophages exposed to 50 worms/well B. malayi.+++GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_MAC_UP///Genes up-regulated in comparison of macrophages exposed to L. major versus macrophages exposed to 5 worms/well B. malayi.+++GSE360_L_MAJOR_VS_T_GONDII_MAC_UP///Genes up-regulated in comparison of macrophages exposed to L. major versus macrophages exposed to T. gondii.+++GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_DN///Genes down-regulated in comparison of dendritic cells (DC) exposed to 5 worms/well B. malayi versus DC exposed to M. tuberculosis+++GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_DN///Genes down-regulated in gamma delta T cells: Vd1 versus Vd2.+++GSE3982_MAC_VS_NEUTROPHIL_LPS_STIM_DN///Genes down-regulated in comparison of macrophages stimulated with LPS (TLR4 agonist) at 4 h versus neutrophils stimulated with LPS (TLR4 agonist) at 1 h.+++GSE3982_MEMORY_CD4_TCELL_VS_BCELL_UP///Genes up-regulated in comparison of memory CD4 [GeneID=920] T cells versus B cells.+++GSE4590_PRE_BCELL_VS_LARGE_PRE_BCELL_UP///Genes up-regulated during B lymphocyte differentiation: pre-B I versus large pre-B II.+++GSE5542_UNTREATED_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_DN///Genes down-regulated in epithelial cells (24h): untreated versus interferon alpha and IFNG [GeneID=3458].+++GSE5542_UNTREATED_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN///Genes down-regulated in epithelial cells (6h): untreated versus interferon alpha and IFNG [GeneID=3458].+++GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN///Genes down-regulated in epithelial cells (6h): untreated versus IFNG [GeneID=3458].+++GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_UP///Genes up-regulated in monocyte-derived dendritic cells: untreated versus rosiglitazone and AM580 [PubChem=77999;2126].+++GSE6092_IFNG_VS_IFNG_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_DN///Genes down-regulated in endothelial cells: IFNG [GeneID=3459] versus IFNG [GeneID=3459] and B. burgdoferi.+++GSE6092_UNSTIM_VS_IFNG_STIM_ENDOTHELIAL_CELL_DN///Genes down-regulated in endothelial cells: untreated versus IFNG [GeneID=3458].+++GSE7509_DC_VS_MONOCYTE_WITH_FCGRIIB_STIM_DN///Genes down-regulated in response to anti-FcgRIIB: dendritic cells versus monocytes.+++GSE8515_CTRL_VS_IL1_4H_STIM_MAC_DN///Genes down-regulated in comparison of untreated macrophages versus those treated with IL1.+++NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP///Genes up-regulated in plasmacytoid dendritic cell 7d vs 0d in young adults (18-50) after exposure to FluMist , time point 7D+++OSMAN_BLOOD_CHAD63_KH_AGE_18_50YO_HIGH_DOSE_SUBJECTS_24HR_UP///Genes up-regulated in blood 24hr vs 0hr in adults (18-50) (high dose subjects) after exposure to ChAd63-KH , time point 24H , administered Intramuscular injection. Comment: DE gene list for high dose subjects.+++ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_ADDNL_EXON_LVL_UP///Genes up-regulated in peripheral blood mononuclear cell 1d vs 0d in adults (20-50) after exposure to MRKAd5 HIV-1 gag/pol/nef , time point 1D. Comment: Additional genes induced by MRKAd5 in vivo and in vitro, identified by exon-level analysis"	"HALLMARK_ALLOGRAFT_REJECTION///Genes up-regulated during transplant rejection.+++HALLMARK_COMPLEMENT///Genes encoding components of the complement system, which is part of the innate immune system.+++HALLMARK_INFLAMMATORY_RESPONSE///Genes defining inflammatory response.+++HALLMARK_INTERFERON_GAMMA_RESPONSE///Genes up-regulated in response to IFNG [GeneID=3458]."	NM_005565	LCP2				
Q12912	sp|Q12912|IRAG2_HUMAN		IRAG2		"Inositol 1,4,5-triphosphate receptor associated 2 OS=Homo sapiens OX=9606 GN=IRAG2 PE=1 SV=3"	4033	NM_001394803	NP_001381732					MESTPFSGVANQIHTLCERPTYGEVKDGALDVKRQHKCPGPTSGPSPGTNLSGCIRMNDDPSMEENGVERVCPESLLQSREYSSLPLPRHTSSTDGTITSSDPGLEILNMASCDLDRNSLCKKEEDTRSASPTIEAQGTSPAHDNIAFQDSTSKDKTILNLEAKEEPETIEEHKKEHASGDSVVSPLPVTTVKSVNLRQSENTSANEKEVEAEFLRLSLGFKCDWFTLEKRVKLEERSRDLAEENLKKEITNCLKLLESLTPLCEDDNQAQEIIKKLEKSIKFLSQCAARVASRAEMLGAINQESRVSKAVEVMIQHVENLKRMYAKEHAELEELKQVLLQNERSFNPLEDDDDCQIKKRSASLNSKPSSLRRVTIASLPRNIGNAGMVAGMENNDRFSRRSSSWRILGSKQSEHRPSLPRFISTYSWADAEEEKCELKTKDDSEPSGEETVERTRKPSLSEKKNNPSKWDVSSVYDTIASWATNLKSSIRKANKALWLSIAFIVLFAALMSFLTGQLFQKSVDAAPTQQEDSWTSLEHILWPFTRLRHNGPPPV	3.3501475	1.74422462	0.02244758				5.9393006	8.1898168	7.0945385	5.946701477	5.0675641		7.580135									6.862883731	9.8994845				4.9010181	6.67488372		5.6034582			6.268389			5.9083068	5.4049346			2.2193012	6.0905128					4.8841519						GO:0000922///spindle pole+++GO:0005634///nucleus+++GO:0005635///nuclear envelope+++GO:0005694///chromosome+++GO:0005737///cytoplasm+++GO:0005783///endoplasmic reticulum+++GO:0005789///endoplasmic reticulum membrane+++GO:0005815///microtubule organizing center+++GO:0005856///cytoskeleton+++GO:0005886///plasma membrane+++GO:0005887///integral component of plasma membrane+++GO:0016020///membrane+++GO:0016021///integral component of membrane+++GO:0035577///azurophil granule membrane	GO:0008017///microtubule binding	GO:0002376///immune system process+++GO:0006903///vesicle targeting+++GO:0006906///vesicle fusion+++GO:0006997///nucleus organization+++GO:0007338///single fertilization	tissueType=Kidney;cancerType=Normal;cellName=B cell+++tissueType=Embryo;cancerType=Normal;cellName=Oocyte+++tissueType=Lung;cancerType=Normal;cellName=Brush cell (Tuft cell)+++tissueType=Lung;cancerType=Normal;cellName=Neuroendocrine cell+++tissueType=Fetal kidney;cancerType=Normal;cellName=Natural killer T (NKT) cell+++tissueType=Embryonic prefrontal cortex;cancerType=Normal;cellName=Microglial cell		"Homo sapiens inositol 1,4,5-triphosphate receptor associated 2 (IRAG2), transcript variant 18, mRNA."			R-HSA-168249///Innate Immune System+++R-HSA-168256///Immune System+++R-HSA-6798695///Neutrophil degranulation					"[A0A024RAY9_HUMAN|Unreviewed]SubName: Full=Lymphoid-restricted membrane protein, isoform CRA_a {ECO:0000313|EMBL:EAW96504.1};"	chr12p12///Ensembl 103 genes in cytogenetic band chr12p12			REACTOME_INNATE_IMMUNE_SYSTEM///Innate Immune System+++REACTOME_NEUTROPHIL_DEGRANULATION///Neutrophil degranulation			MIR3150A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3150a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3175///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3175 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR495_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-495-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AN///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548an in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5688///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5688 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR583///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-583 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6763_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6763-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6875_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6875-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7977///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7977 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR95_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-95-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).	CIZ_01///Genes having at least one occurence of the transcription factor binding site V$CIZ_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++CTTTAAR_UNKNOWN///Genes having at least one occurence of the highly conserved motif M29 CTTTAAR in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++ETS2_B///Genes having at least one occurence of the transcription factor binding site V$ETS2_B (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++GATA6_01///Genes having at least one occurence of the transcription factor binding site V$GATA6_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++ICSBP_Q6///Genes having at least one occurence of the transcription factor binding site V$ICSBP_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++IRF1_01///Genes having at least one occurence of the transcription factor binding site V$IRF1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++PEA3_Q6///Genes having at least one occurence of the transcription factor binding site V$PEA3_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++RGAGGAARY_PU1_Q6///Genes having at least one occurence of the highly conserved motif M50 RGAGGAARY sites. The motif matches transcription factor binding site V$PU1_Q6 (v7.4 TRANSFAC).+++STTTCRNTTT_IRF_Q6///Genes having at least one occurence of the highly conserved motif M85 STTTCRNTTT sites. The motif matches transcription factor binding site V$IRF_Q6 (v7.4 TRANSFAC).+++TGACATY_UNKNOWN///Genes having at least one occurence of the highly conserved motif M42 TGACATY in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++TGTTTGY_HNF3_Q6///Genes having at least one occurence of the highly conserved motif M83 TGTTTGY sites. The motif matches transcription factor binding site V$HNF3_Q6 (v7.4 TRANSFAC).	"BACH2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9BYV9 (BACH2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++EBNA1BP2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q99848 (EBNA1BP2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HDAC4_TARGET_GENES///Genes containing one or more binding sites for UniProt:P56524 (HDAC4) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HOXA2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O43364 (HOXA2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++IRF5_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q13568 (IRF5) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++MAML1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q92585 (MAML1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NUP153_TARGET_GENES///Genes containing one or more binding sites for UniProt:P49790 (NUP153) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++PCGF2_TARGET_GENES///Genes containing one or more binding sites for UniProt:P35227 (PCGF2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++POU2AF1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q16633 (POU2AF1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++RAG1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P15918 (RAG1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SKIL_TARGET_GENES///Genes containing one or more binding sites for UniProt:P12757 (SKIL) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SRCAP_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6ZRS2 (SRCAP) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SRSF9_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q13242 (SRSF9) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF597_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96LX8 (ZNF597) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF768_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9H5H4 (ZNF768) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF816_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q0VGE8 (ZNF816) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZSCAN4_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8NAM6 (ZSCAN4) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."		MODULE_117///Signaling.+++MODULE_118///cell line expressed genes.+++MODULE_119///Genes in the cancer module 119.+++MODULE_165///Genes in the cancer module 165.+++MODULE_220///Developmental processes.+++MODULE_45///Whole blood genes.+++MODULE_53///Cell line expressed genes.+++MODULE_64///Membranal receptors.+++MODULE_84///Immune (humoral) and inflammatory response.	BRCA1_DN.V1_UP///Genes up-regulated in MCF10A cells (breast cancer) upon knockdown of BRCA1 [Gene ID=672] gene by RNAi.+++CYCLIN_D1_KE_.V1_DN///Genes down-regulated in MCF-7 cells (breast cancer) over-expressing a mutant K112E form of CCND1 [Gene ID=595] gene.+++IL15_UP.V1_DN///Genes down-regulated in Sez-4 cells (T lymphocyte) that were first starved of IL2 [Gene ID=3558] and then stimulated with IL15 [Gene ID=3600].	"GSE10325_CD4_TCELL_VS_BCELL_DN///Genes down-regulated in comparison of healthy CD4 [GeneID=920] T cells versus healthy CD19 [GeneID=920] B cells. +++GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_BCELL_DN///Genes down-regulated in comparison of systemic lupus erythematosus CD4 [GeneID=920] T cells versus systemic lupus erythematosus B cells.+++GSE11057_CD4_EFF_MEM_VS_PBMC_DN///Genes down-regulated in comarison of effector memory T cells versus peripheral blood mononuclear cells (PBMC).+++GSE11864_UNTREATED_VS_CSF1_IN_MAC_UP///Genes up-regulated in comparison of untreated macrophages versus those cultured with M-CSF [GeneID=1435].+++GSE12366_GC_VS_MEMORY_BCELL_UP///Genes up-regulated in comparison of germinal center B cells versus memory B cells.+++GSE12845_IGD_NEG_BLOOD_VS_PRE_GC_TONSIL_BCELL_DN///Genes down-regulated in comparison of IgD- peripheral blood B cells versus pre-germinal center B cells.+++GSE12845_NAIVE_VS_PRE_GC_TONSIL_BCELL_DN///Genes down-regulated in comparison of naive B cell versus pre-germinal tonsil B cells.+++GSE13738_RESTING_VS_BYSTANDER_ACTIVATED_CD4_TCELL_UP///Genes up-regulated in comparison of resting CD4 [GeneID=920] T cells versus bystander activated CD4 [GeneID=920] T cells.+++GSE14000_UNSTIM_VS_16H_LPS_DC_TRANSLATED_RNA_UP///Genes up-regulated in comparison of polysome bound (translated) mRNA before and 16 h after LPS (TLR4 agonist) stimulation.+++GSE14000_UNSTIM_VS_16H_LPS_DC_UP///Genes up-regulated in comparison of dendritic cells (DC) before and 16 h after LPS (TLR4 agonist) stimulation.+++GSE14000_UNSTIM_VS_4H_LPS_DC_UP///Genes up-regulated in comparison of dendritic cells (DC) before and 4 h after LPS (TLR4 agonist) stimulation.+++GSE1460_NAIVE_CD4_TCELL_ADULT_BLOOD_VS_THYMIC_STROMAL_CELL_UP///Genes up-regulated in naive CD4 [GeneID=920] T cells from adult blood versus thymic stromal cells.+++GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_CELL_LINE_DN///Genes down-regulated in immature neuron cell line: control versus interferon alpha (6h).+++GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_UP///Genes up-regulated in the neuron cell line: immature versus mature.+++GSE17186_MEMORY_VS_CD21HIGH_TRANSITIONAL_BCELL_DN///Genes down-regulated in B lymphocytes: memory versus transitional CR2 [GeneID=1380] high.+++GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_10H_UP///Genes up-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 10 h.+++GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_4H_UP///Genes up-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 4 h.+++GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_6H_UP///Genes up-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 6 h.+++GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_UP///Genes up-regulated in comparison of control conventional dendritic cells (cDC) at 6 h versus cDCs infected with Newcastle disease virus (NDV) at 6 h.+++GSE18893_TCONV_VS_TREG_24H_CULTURE_DN///Genes down-regulated in lymphocytes treated with medium for 24h: T conv versus T reg cells.+++GSE19772_HCMV_INFL_VS_HCMV_INF_MONOCYTES_AND_PI3K_INHIBITION_DN///Genes down-regulated in monocytes after HCMV infection: untreated versus pre-treated with Ly294002 [PubChem=3973].+++GSE20198_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_UP///Genes up-regulated in the activated CD4 [GeneID=920] T cells (48h): control versus IL-12.+++GSE22611_NOD2_VS_CTRL_TRANSDUCED_HEK293T_CELL_DN///Genes down-regulated in HEK293 cells: over-expressing wildtype NOD2 [GeneID=64127] versus control.+++GSE22886_DAY0_VS_DAY1_MONOCYTE_IN_CULTURE_UP///Genes up-regulated in comparison of monocytes cultured for 0 days versus those cultured for 1 day.+++GSE22886_NAIVE_CD4_TCELL_VS_MEMORY_TCELL_UP///Genes up-regulated in comparison of naive CD4 [GeneID=920] T cells versus unstimulated memory CD4 [GeneID=920] CD8 T cells.+++GSE22886_NAIVE_VS_MEMORY_TCELL_UP///Genes up-regulated in comparison of naive CD4 [GeneID=920] CD8 T cells versus unstimulated memory CD4 [GeneID=920] CD8 T cells.+++GSE23321_CD8_STEM_CELL_MEMORY_VS_CENTRAL_MEMORY_CD8_TCELL_DN///Genes down-regulated in CD8 T cells: stem cell memory versus central memory.+++GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_UP///Genes up-regulated in AGS cells (gastric adenocarcinoma): control versus H. pylori LPS.+++GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_2H_DN///Genes down-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 and then stimulated by TGFB1 and IL4 [GeneID=7040;3565] (2h).+++GSE32901_NAIVE_VS_TH1_CD4_TCELL_DN///Genes down-regulated in CD4 [GeneID=920] T cells: nave versus Th1.+++GSE32901_TH1_VS_TH17_NEG_CD4_TCELL_DN///Genes down-regulated in CD4 [GeneID=920] T cells: Th1 versus Th17 negative.+++GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10NEG_CD62LPOS_BONE_MARROW_UP///Genes up-regulated in the bone marrow CD34+ [GeneID=947] cells: CD38- [GeneID=952] versus MME- SELL+ [GeneID=4311;6402].+++GSE360_DC_VS_MAC_B_MALAYI_HIGH_DOSE_UP///Genes up-regulated in comparison of dendritic cells (DC) exposed to 50 worm/well B. malayi versus macrophages exposed to 50 worms/well B. malayi.+++GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_DC_DN///Genes down-regulated in comparison of dendritic cells (DC) exposed to 50 worms/well B. malayi versus those exposed to 5 worms/well B. malayi.+++GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_DC_DN///Genes down-regulated in comparison of dendritic cells (DC) exposed to L. donovani versus DCs exposed to 5 worm/well B. malayi.+++GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_DC_DN///Genes down-regulated in comparison of dendritic cells (DC) exposed to L. major versus DCs exposed to 5 worms/well B. malayi.+++GSE42088_UNINF_VS_LEISHMANIA_INF_DC_2H_DN///Genes down-regulated in dendritic cells: untreated versus 2h after infection of Leishmania major.+++GSE42724_NAIVE_BCELL_VS_PLASMABLAST_DN///Genes down-regulated in B lymphocytes: nave versus plasmablasts.+++GSE4984_GALECTIN1_VS_LPS_STIM_DC_DN///Genes down-regulated in monocyte-derived dendritic cells: LGALS1 [GeneID=3956] versus LPS.+++GSE5679_PPARG_LIGAND_ROSIGLITAZONE_VS_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_UP///Genes up-regulated in monocyte-derived dendritic cells: rosiglitazone [PubChem=77999] versus rosiglitazone and AM580 [PubChem=77999;2126].+++GSE6092_IFNG_VS_IFNG_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_UP///Genes up-regulated in endothelial cells: IFNG [GeneID=3459] versus IFNG [GeneID=3459] and B. burgdoferi.+++GSE7460_CD8_TCELL_VS_TREG_ACT_UP///Genes up-regulated in comparsion of ActCD8 versus ActTreg (see Fig. 1 in the paper for details).+++GSE7460_CTRL_VS_TGFB_TREATED_ACT_CD8_TCELL_UP///Genes up-regulated in comparsion of ActCD8 versus ActCD8TGF (see Fig. 1 in the paper for details).+++GSE7460_TREG_VS_TCONV_ACT_DN///Genes down-regulated in comparsion of ActTreg versus ActCD4 (see Fig. 1 in the paper for details).+++GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_6H_UP///Genes up-regulated in monocytes: untreated versus M. tuberculosis 19 kDa lipopeptide (6h).+++HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_POSITIVE///Genes positively correlated with memory B cell response at 28d in peripheral blood mononuclear cell in seniors (50-74) after exposure to Fluarix , time point 28D+++NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN///Genes down-regulated in peripheral blood mononuclear cell 3d vs 0d in adults (18-50) after exposure to FluMist , time point 3D. Comment: Supplementary Table 1b: All the differentially expressed genes identified in PBMCs of TIV vaccinees."	HALLMARK_P53_PATHWAY///Genes involved in p53 pathways and networks.	NM_001394803	IRAG2				
Q0ZGT2	sp|Q0ZGT2|NEXN_HUMAN		NEXN		Nexilin OS=Homo sapiens OX=9606 GN=NEXN PE=1 SV=1	91624	NM_144573	NP_653174	ENST00000334785				MNDISQKAEILLSSSKPVPKTYVPKLGKGDVKDKFEAMQRAREERNQRRSRDEKQRRKEQYIREREWNRRKQEIKEMLASDDEEDVSSKVEKAYVPKLTGTVKGRFAEMEKQRQEEQRKRTEEERKRRIEQDMLEKRKIQRELAKRAEQIEDINNTGTESASEEGDDSLLITVVPVKSYKTSGKMKKNFEDLEKEREEKERIKYEEDKRIRYEEQRPSLKEAKCLSLVMDDEIESEAKKESLSPGKLKLTFEELERQRQENRKKQAEEEARKRLEEEKRAFEEARRQMVNEDEENQDTAKIFKGYRPGKLKLSFEEMERQRREDEKRKAEEEARRRIEEEKKAFAEARRNMVVDDDSPEMYKTISQEFLTPGKLEINFEELLKQKMEEEKRRTEEERKHKLEMEKQEFEQLRQEMGEEEEENETFGLSREYEELIKLKRSGSIQAKNLKSKFEKIGQLSEKEIQKKIEEERARRRAIDLEIKEREAENFHEEDDVDVRPARKSEAPFTHKVNMKARFEQMAKAREEEEQRRIEEQKLLRMQFEQREIDAALQKKREEEEEEEGSIMNGSTAEDEEQTRSGAPWFKKPLKNTSVVDSEPVRFTVKVTGEPKPEITWWFEGEILQDGEDYQYIERGETYCLYLPETFPEDGGEYMCKAVNNKGSAASTCILTIESKN	0.5935983	-0.752441124	0.01226078									6.9774521	6.95645	6.2018835	7.0852806			5.5542683	6.7998908		5.6367001			5.1309626	7.1213319	6.6256805					7.608797	7.9273066		8.8262591	6.181774	6.8652285	7.0712222	6.1549644	6.8816508	6.9087029	7.0015121	7.743812	6.870554	6.60662545	7.9798455	6.2567617	7.82432886		H00292///Hypertrophic cardiomyopathy+++H00294///Dilated cardiomyopathy			GO:0005737///cytoplasm+++GO:0005856///cytoskeleton+++GO:0005886///plasma membrane+++GO:0005912///adherens junction+++GO:0005925///focal adhesion+++GO:0015629///actin cytoskeleton+++GO:0030018///Z disc+++GO:0030054///cell junction+++GO:0030424///axon	GO:0003779///actin binding+++GO:0005515///protein binding+++GO:0008307///structural constituent of muscle+++GO:0051015///actin filament binding+++GO:0098632///cell-cell adhesion mediator activity	GO:0007155///cell adhesion+++GO:0007156///homophilic cell adhesion via plasma membrane adhesion molecules+++GO:0007411///axon guidance+++GO:0030334///regulation of cell migration+++GO:0051493///regulation of cytoskeleton organization+++GO:0070593///dendrite self-avoidance	tissueType=Fetal gonad;cancerType=Normal;cellName=Retinoid acid signaling-responsive fetal germ cell		"Homo sapiens nexilin F-actin binding protein (NEXN), transcript variant 1, mRNA."		PF07679///Immunoglobulin I-set domain			ENOG502QU7W///No_INFO		IPR003599///Immunoglobulin subtype+++IPR007110///Immunoglobulin-like domain+++IPR013098///Immunoglobulin I-set+++IPR013783///Immunoglobulin-like fold+++IPR036179///Immunoglobulin-like domain superfamily+++IPR043204///Basigin-like	[NEXN_HUMAN|Reviewed]RecName: Full=Nexilin; AltName: Full=F-actin-binding protein; AltName: Full=Nelin;+++[A0A7R6M6R6_HUMAN|Unreviewed]SubName: Full=Nexilin f-actin binding protein {ECO:0000313|EMBL:AXU40256.1}; Flags: Fragment;+++[A0A7R6RQ55_HUMAN|Unreviewed]SubName: Full=Nexilin f-actin binding protein {ECO:0000313|EMBL:AXU40257.1}; Flags: Fragment;	chr1p31///Ensembl 103 genes in cytogenetic band chr1p31					"CTACTAG_MIR325///Genes having at least one occurence of the motif CTACTAG in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-325 (v7.1 miRBase)."	MIR1277_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1277-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1468_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1468-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR152_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-152-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR217_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-217-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3185///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3185 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4311///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4311 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4426///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4426 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4477B///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4477b in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5003_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5003-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AW///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548aw in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548U///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548u in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5690///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5690 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR633///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-633 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR651_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-651-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6780A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6780a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7161_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7161-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7856_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7856-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR9902///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-9902 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).	CTTTGA_LEF1_Q2///Genes having at least one occurence of the highly conserved motif M73 CTTTGA sites. The motif matches transcription factor binding site V$LEF1_Q2 (v7.4 TRANSFAC).+++GATA4_Q3///Genes having at least one occurence of the transcription factor binding site V$GATA4_Q3 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++GFI1_01///Genes having at least one occurence of the transcription factor binding site V$GFI1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++GR_01///Genes having at least one occurence of the transcription factor binding site V$GR_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++LEF1_Q2///Genes having at least one occurence of the transcription factor binding site V$LEF1_Q2 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++PR_Q2///Genes having at least one occurence of the transcription factor binding site V$PR_Q2 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++STAT4_01///Genes having at least one occurence of the transcription factor binding site V$STAT4_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++STAT5A_04///Genes having at least one occurence of the transcription factor binding site V$STAT5A_04 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++TATAAA_TATA_01///Genes having at least one occurence of the highly conserved motif M51 TATAAA sites. The motif matches transcription factor binding site V$TATA_01 (v7.4 TRANSFAC).+++TCF4_Q5///Genes having at least one occurence of the transcription factor binding site V$TCF4_Q5 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++TGCTGAY_UNKNOWN///Genes having at least one occurence of the highly conserved motif M92 TGCTGAY in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++WCAANNNYCAG_UNKNOWN///Genes having at least one occurence of the highly conserved motif M152 WCAANNNYCAG in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).	"FOXH1_TARGET_GENES///Genes containing one or more binding sites for UniProt:O75593 (FOXH1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++GCM2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O75603 (GCM2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++IRF9_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q00978 (IRF9) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++KDM5D_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9BY66 (KDM5D) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++PAX3_TARGET_GENES///Genes containing one or more binding sites for UniProt:P23760 (PAX3) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SRSF9_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q13242 (SRSF9) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++TET1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8NFU7 (TET1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF512_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96ME7 (ZNF512) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF513_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8N8E2 (ZNF513) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF528_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q3MIS6 (ZNF528) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF740_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8NDX6 (ZNF740) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."				"ERWIN_COHEN_BLOOD_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_2DY_UP///Genes up-regulated in blood vaccinated vs control in adults (23-48) after exposure to Live attenuated vaccine TC-83 , time point 2D+++ERWIN_COHEN_BLOOD_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_7DY_UP///Genes up-regulated in blood vaccinated vs control in adults (23-48) after exposure to Live attenuated vaccine TC-83 , time point 7D+++ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_NAIVE_NOT_PREVIOUSLY_IMMUNIZED_24HR_DEG_CANONICAL_PATHWAY_MEMBERS_UP///Genes up-regulated in peripheral blood mononuclear cell 24h vs 0h in adults (18-45) (naive (not previously immunized)) after exposure to Live attenuated vaccine TC-83 , time point 24H. Comment: significant genes chosen for membership in canonical pathways+++ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_NON_RESPONDERS_PREVIOUSLY_IMMUNIZED_24HR_DEG_CANONICAL_PATHWAY_MEMBERS_UP///Genes up-regulated in peripheral blood mononuclear cell 24h vs 0h in adults (18-45) (non-responders (previously immunized)) after exposure to Live attenuated vaccine TC-83 , time point 24H. Comment: initial exposure 2-10 months before PBMCs drawn. significant genes chosen for membership in canonical pathways+++ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_RESPONDERS_PREVIOUSLY_IMMUNIZED_24HR_DEG_CANONICAL_PATHWAY_MEMBERS_UP///Genes up-regulated in peripheral blood mononuclear cell 24h vs 0h in adults (18-45) (responders (previously immunized)) after exposure to Live attenuated vaccine TC-83 , time point 24H. Comment: initial exposure 2-10 months before PBMCs drawn. significant genes chosen for membership in canonical pathways+++FRANCO_BLOOD_SANOFI_PASTEUR_SA_INACTIVATED_INFLUENZA_VACCINE_CORRELATED_WITH_ANTIBODY_RESPONSE_AGE_18_40YO_14DY_NEGATIVE///Genes negatively correlated with antibody response in blood in adults (18-40) after exposure to Sanofi Pasteur, SA, Inactivated influenza vaccine , time point 14D+++GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_10DY_UP///Genes up-regulated in peripheral blood mononuclear cell 10d vs 0d in unknown after exposure to YF-Vax/Stamaril , time point 10D+++GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_7DY_UP///Genes up-regulated in peripheral blood mononuclear cell 7d vs 0d in unknown after exposure to YF-Vax/Stamaril , time point 7D+++GSE11057_CD4_CENT_MEM_VS_PBMC_DN///Genes down-regulated in comparison of central memory T cells versus peripheral blood mononuclear cells (PBMC).+++GSE11057_CD4_EFF_MEM_VS_PBMC_DN///Genes down-regulated in comarison of effector memory T cells versus peripheral blood mononuclear cells (PBMC).+++GSE11057_PBMC_VS_MEM_CD4_TCELL_UP///Genes up-regulated in comparison of peripheral mononuclear blood cells (PBMC) versus memory T cells.+++GSE13485_CTRL_VS_DAY7_YF17D_VACCINE_PBMC_DN///Genes down-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) versus PBMC 7 days after stimulation with YF17D vaccine.+++GSE13485_DAY1_VS_DAY7_YF17D_VACCINE_PBMC_DN///Genes down-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) 1 day after stimulation with YF17D vaccine versus PBMC 7 days after the stimulation.+++GSE13485_DAY3_VS_DAY7_YF17D_VACCINE_PBMC_DN///Genes down-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) 3 days after stimulation with YF17D vaccine versus PBMC 7 days after the stimulation.+++GSE13485_DAY7_VS_DAY21_YF17D_VACCINE_PBMC_UP///Genes up-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) 7 days after stimulation with YF17D vaccine versus PBMC 21 days after the stimulation.+++GSE13887_RESTING_VS_ACT_CD4_TCELL_DN///Genes down-regulated in CD4 [GeneID=920] T cells from healthy donors: resting versus activated by anti-CD3 and anti-CD28.+++GSE14000_UNSTIM_VS_16H_LPS_DC_TRANSLATED_RNA_DN///Genes down-regulated in comparison of polysome bound (translated) mRNA before and 16 h after LPS (TLR4 agonist) stimulation.+++GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_72H_ACT_CD4_TCELL_DN///Genes down-regulated in comparison of CD4 [GeneID=920] T cells treated with IL4 [GeneID=3565] and anti-IL12 at 72 h versus the untreated cells at 72 h.+++GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_10H_DN///Genes down-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 10 h.+++GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_12H_DN///Genes down-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 12 h.+++GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_14H_DN///Genes down-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 14 h.+++GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_16H_DN///Genes down-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 16 h.+++GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_18H_DN///Genes down-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 18 h.+++GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_6H_DN///Genes down-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 6 h.+++GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_8H_DN///Genes down-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 8 h.+++GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_10H_DN///Genes down-regulated in comparison of control conventional dendritic cells (cDC) at 10 h versus cDCs infected with Newcastle disease virus (NDV) at 10 h.+++GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_DN///Genes down-regulated in comparison of control conventional dendritic cells (cDC) at 6 h versus cDCs infected with Newcastle disease virus (NDV) at 6 h.+++GSE20484_MCSG_VS_CXCL4_MONOCYTE_DERIVED_MACROPHAGE_UP///Genes up-regulated in monocyte derived macrophages: CSF1 [GeneID=1435] versus PF4 [GeneID=5196].+++GSE22103_UNSTIM_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_DN///Genes down-regulated in neutrophils: untreated versus stimulated by CSF2 and IFNG [GeneID=1437;3458].+++GSE22229_RENAL_TRANSPLANT_VS_HEALTHY_PBMC_DN///Genes down-regulated in periperal blood monocytes (PBMC): tolerant kidney transplants versus healthy controls.+++GSE22229_UNTREATED_VS_IMMUNOSUPP_THERAPY_RENAL_TRANSPLANT_PATIENT_PBMC_DN///Genes down-regulated in periperal blood monocytes (PBMC) from kidney transplant recipients: tolerant versus immunosuppressive therapy.+++GSE26928_NAIVE_VS_CENT_MEMORY_CD4_TCELL_UP///Genes up-regulated in comparison of naive CD4 [GeneID=920] T cells versus CD4 [GeneID=920] central memory T cells.+++GSE26928_NAIVE_VS_EFF_MEMORY_CD4_TCELL_UP///Genes up-regulated in comparison of naive CD4 [GeneID=920] T cells versus CD4 [GeneID=920] effector memory T cells.+++GSE34205_HEALTHY_VS_FLU_INF_INFANT_PBMC_DN///Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMCs from infanct with acute influenza infection.+++GSE42724_NAIVE_BCELL_VS_PLASMABLAST_UP///Genes up-regulated in B lymphocytes: nave versus plasmablasts.+++HARALAMBIEVA_PBMC_DRYVAX_AGE_18_40YO_STIMULATED_VS_UNSTIMULATED_9_TO_34MO_UP///Genes up-regulated in peripheral blood mononuclear cell stimulated vs unstimulated in adults (18-40) after exposure to Dryvax , time point 9 to 34M. Comment: Original exposure within previous 4 years+++HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_UP///Genes up-regulated in peripheral blood mononuclear cell vaccinated vs unvaccinated in adolescent/young adults (11-22) after exposure to M-M-R II , time point 7Y+++HOWARD_DENDRITIC_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP///Genes up-regulated in dendritic cell 1d vs 0d in adults (18-49) after exposure to inactivated monovalent influenza A/Indonesia/05/2005 H5N1 split-virus vaccine , time point 1D , administered i.m.+++HOWARD_MONOCYTE_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP///Genes up-regulated in monocyte 1d vs 0d in adults (18-49) after exposure to inactivated monovalent influenza A/Indonesia/05/2005 H5N1 split-virus vaccine , time point 1D , administered i.m.+++HOWARD_PBMC_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_19_39YO_AS03_ADJUVANT_VS_BUFFER_1DY_UP///Genes up-regulated in peripheral blood mononuclear cell vaccinated with AS03 adjuvant vs phosphate-bufferred saline in adults (19-39) after exposure to inactivated monovalent influenza A/Indonesia/05/2005 H5N1 split-virus vaccine , time point 1D , administered i.m.+++OSMAN_BLOOD_CHAD63_KH_AGE_18_50YO_HIGH_DOSE_SUBJECTS_24HR_UP///Genes up-regulated in blood 24hr vs 0hr in adults (18-50) (high dose subjects) after exposure to ChAd63-KH , time point 24H , administered Intramuscular injection. Comment: DE gene list for high dose subjects.+++QUEREC_PBMC_YF_17D_VACCINE_AGE_18_45YO_3DY_UP///Genes up-regulated in peripheral blood mononuclear cell 3d vs 0d in adults (18-45) after exposure to YF-17D vaccine , time point 3D+++QUEREC_PBMC_YF_17D_VACCINE_AGE_18_45YO_7DY_UP///Genes up-regulated in peripheral blood mononuclear cell 7d vs 0d in adults (18-45) after exposure to YF-17D vaccine , time point 7D+++ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_UP///Genes up-regulated in peripheral blood mononuclear cell 1d vs 0d in adults (20-50) after exposure to MRKAd5 HIV-1 gag/pol/nef , time point 1D. Comment: Table includes specific cell types"	HALLMARK_APICAL_JUNCTION///Genes encoding components of apical junction complex.	NM_144573	NEXN				
Q05682	sp|Q05682|CALD1_HUMAN		CALD1		Caldesmon OS=Homo sapiens OX=9606 GN=CALD1 PE=1 SV=3	800	NM_033138	NP_149129	ENST00000361675	K12327			MDDFERRRELRRQKREEMRLEAERIAYQRNDDDEEEAARERRRRARQERLRQKQEEESLGQVTDQVEVNAQNSVPDEEAKTTTTNTQVEGDDEAAFLERLARREERRQKRLQEALERQKEFDPTITDASLSLPSRRMQNDTAENETTEKEEKSESRQERYEIEETETVTKSYQKNDWRDAEENKKEDKEKEEEEEEKPKRGSIGENQVEVMVEEKTTESQEETVVMSLKNGQISSEEPKQEEEREQGSDEISHHEKMEEEDKERAEAERARLEAEERERIKAEQDKKIADERARIEAEEKAAAQERERREAEERERMREEEKRAAEERQRIKEEEKRAAEERQRIKEEEKRAAEERQRIKEEEKRAAEERQRARAEEEEKAKVEEQKRNKQLEEKKHAMQETKIKGEKVEQKIEGKWVNEKKAQEDKLQTAVLKKQGEEKGTKVQAKREKLQEDKPTFKKEEIKDEKIKKDKEPKEEVKSFMDRKKGFTEVKSQNGEFMTHKLKHTENTFSRPGGRASVDTKEAEGAPQVEAGKRLEELRRRRGETESEEFEKLKQKQQEAALELEELKKKREERRKVLEEEEQRRKQEEADRKLREEEEKRRLKEEIERRRAEAAEKRQKMPEDGLSDDKKPFKCFTPKGSSLKIEERAEFLNKSVQKSSGVKSTHQAAIVSKIDSRLEQYTSAIEGTKSAKPTKPAASDLPVPAEGVRNIKSMWEKGNVFSSPTAAGTPNKETAGLKVGVSSRINEWLTKTPDGNKSPAPKPSDLRPGDVSSKRNLWEKQSVDKVTSPTKV	0.3734146	-1.42114964	0.00784874	3.6073346	7.8318424	6.8291745	7.2651252	6.9995126	9.6892357	6.982525602	9.0083928	10.0190356	10.0847295	10.1334495	9.7154697	5.832846	7.2063356	8.9458786	9.7314544	6.1336268	8.8914954		3.5464239	9.2529525	10.1865655	11.0945817	6.8265251	7.26709155	6.84093801	6.8146559	11.158334	9.6000921	9.860338	11.5812881	8.332306	9.3899701	8.0197335	10.1503967	9.8696543	9.2922335	10.2337722	10.905526	9.4047313	9.19363583	10.5668225	9.7060033	11.04499281	04270///Vascular smooth muscle contraction				GO:0005737///cytoplasm+++GO:0005829///cytosol+++GO:0005856///cytoskeleton+++GO:0005886///plasma membrane+++GO:0015629///actin cytoskeleton+++GO:0016020///membrane+++GO:0030016///myofibril+++GO:0030478///actin cap	GO:0003779///actin binding+++GO:0005515///protein binding+++GO:0005516///calmodulin binding+++GO:0005523///tropomyosin binding+++GO:0017022///myosin binding+++GO:0045296///cadherin binding	GO:0001525///angiogenesis+++GO:0006936///muscle contraction+++GO:0051017///actin filament bundle assembly	tissueType=Fetal gonad;cancerType=Normal;cellName=Mitotic fetal germ cell+++tissueType=Fetal gonad;cancerType=Normal;cellName=Leydig precursor cell+++tissueType=Heart;cancerType=Normal;cellName=Smooth muscle cell		"Homo sapiens caldesmon 1 (CALD1), transcript variant 1, mRNA."		PF02029///Caldesmon	R-HSA-397014///Muscle contraction+++R-HSA-445355///Smooth Muscle Contraction		ENOG502QSYB///No_INFO		IPR006017///Caldesmon+++IPR006018///Caldesmon/lymphocyte specific protein	"[CALD1_HUMAN|Reviewed]RecName: Full=Caldesmon; Short=CDM;+++[Q05DR4_HUMAN|Unreviewed]SubName: Full=CALD1 protein {ECO:0000313|EMBL:AAH05006.1}; Flags: Fragment;+++[Q6P707_HUMAN|Unreviewed]SubName: Full=CALD1 protein {ECO:0000313|EMBL:AAH61926.1}; Flags: Fragment;+++[Q6PJM5_HUMAN|Unreviewed]SubName: Full=CALD1 protein {ECO:0000313|EMBL:AAH14035.1}; Flags: Fragment;+++[Q9NYG1_HUMAN|Unreviewed]SubName: Full=Caldesmon 1, isoform CRA_b {ECO:0000313|EMBL:EAW83827.1}; SubName: Full=NAG22 protein {ECO:0000313|EMBL:AAF69498.3};"	chr7q33///Ensembl 103 genes in cytogenetic band chr7q33		KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION///Vascular smooth muscle contraction	REACTOME_MUSCLE_CONTRACTION///Muscle contraction+++REACTOME_SMOOTH_MUSCLE_CONTRACTION///Smooth Muscle Contraction		"ATACCTC_MIR202///Genes having at least one occurence of the motif ATACCTC in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-202 (v7.1 miRBase).+++CAGCTTT_MIR320///Genes having at least one occurence of the motif CAGCTTT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-320 (v7.1 miRBase).+++CTTTGCA_MIR527///Genes having at least one occurence of the motif CTTTGCA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-527 (v7.1 miRBase).+++GCACTTT_MIR175P_MIR20A_MIR106A_MIR106B_MIR20B_MIR519D///Genes having at least one occurence of the motif GCACTTT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-17-5p, hsa-miR-20a, hsa-miR-106a, hsa-miR-106b, hsa-miR-20b and hsa-miR-519d (v7.1 miRBase).+++TAGCTTT_MIR9///Genes having at least one occurence of the motif TAGCTTT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-9* (v7.1 miRBase).+++TGCACTT_MIR519C_MIR519B_MIR519A///Genes having at least one occurence of the motif TGCACTT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-519c, hsa-miR-519b and hsa-miR-519a (v7.1 miRBase)."	"MIR106A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-106a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR106B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-106b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR12113///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-12113 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1250_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1250-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR153_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-153-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR17_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-17-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1914_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1914-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR20A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-20a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR20B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-20b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR222_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-222-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR24_1_5P_MIR24_2_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-24-1-5p, hsa-miR-24-2-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR27A_3P_MIR27B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-27a-3p, hsa-miR-27b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3182///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3182 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR32_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-32-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR380_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-380-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4418///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4418 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4679///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4679 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4742_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4742-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4772_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4772-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4803///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4803 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR493_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-493-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5003_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5003-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR509_3_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-509-3-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5094///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5094 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR509_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-509-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR513A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-513a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR519D_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-519d-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR526B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-526b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR619_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-619-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6505_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6505-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6505_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6505-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6506_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6506-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6508_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6508-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6513_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6513-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6839_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6839-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6867_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6867-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6875_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6875-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR8067///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-8067 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR93_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-93-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR936///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-936 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR9985///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-9985 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets)."	AAAYWAACM_HFH4_01///Genes having at least one occurence of the highly conserved motif M139 AAAYWAACM sites. The motif matches transcription factor binding site V$HFH4_01 (v7.4 TRANSFAC).+++AACTTT_UNKNOWN///Genes having at least one occurence of the highly conserved motif M17 AACTTT in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++AFP1_Q6///Genes having at least one occurence of the transcription factor binding site V$AFP1_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++ALPHACP1_01///Genes having at least one occurence of the transcription factor binding site V$ALPHACP1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++AP2REP_01///Genes having at least one occurence of the transcription factor binding site V$AP2REP_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++AP3_Q6///Genes having at least one occurence of the transcription factor binding site V$AP3_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++ATF_01///Genes having at least one occurence of the transcription factor binding site V$ATF_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++ATF1_Q6///Genes having at least one occurence of the transcription factor binding site V$ATF1_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++CART1_01///Genes having at least one occurence of the transcription factor binding site V$CART1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++CATTGTYY_SOX9_B1///Genes having at least one occurence of the highly conserved motif M49 CATTGTYY sites. The motif matches transcription factor binding site V$SOX9_B1 (v7.4 TRANSFAC).+++CCAWWNAAGG_SRF_Q4///Genes having at least one occurence of the highly conserved motif M121 CCAWWNAAGG sites. The motif matches transcription factor binding site V$SRF_Q4 (v7.4 TRANSFAC).+++CDC5_01///Genes having at least one occurence of the transcription factor binding site V$CDC5_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++CEBP_Q2_01///Genes having at least one occurence of the transcription factor binding site V$CEBP_Q2_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++CEBP_Q3///Genes having at least one occurence of the transcription factor binding site V$CEBP_Q3 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++COMP1_01///Genes having at least one occurence of the transcription factor binding site V$COMP1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++CP2_01///Genes having at least one occurence of the transcription factor binding site V$CP2_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++CP2_02///Genes having at least one occurence of the transcription factor binding site V$CP2_02 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++CREB_Q2_01///Genes having at least one occurence of the transcription factor binding site V$CREB_Q2_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++DBP_Q6///Genes having at least one occurence of the transcription factor binding site V$DBP_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++E4F1_Q6///Genes having at least one occurence of the transcription factor binding site V$E4F1_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++ER_Q6_01///Genes having at least one occurence of the transcription factor binding site V$ER_Q6_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++FOXD3_01///Genes having at least one occurence of the transcription factor binding site V$FOXD3_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++FREAC2_01///Genes having at least one occurence of the transcription factor binding site V$FREAC2_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++FREAC3_01///Genes having at least one occurence of the transcription factor binding site V$FREAC3_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++FREAC4_01///Genes having at least one occurence of the transcription factor binding site V$FREAC4_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++GATA1_04///Genes having at least one occurence of the transcription factor binding site V$GATA1_04 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++GCTNWTTGK_UNKNOWN///Genes having at least one occurence of the highly conserved motif M78 GCTNWTTGK in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++GR_Q6_01///Genes having at least one occurence of the transcription factor binding site V$GR_Q6_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++HAND1E47_01///Genes having at least one occurence of the transcription factor binding site V$HAND1E47_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++HNF1_01///Genes having at least one occurence of the transcription factor binding site V$HNF1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++HNF3ALPHA_Q6///Genes having at least one occurence of the transcription factor binding site V$HNF3ALPHA_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++HNF3B_01///Genes having at least one occurence of the transcription factor binding site V$HNF3B_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++HNF3_Q6///Genes having at least one occurence of the transcription factor binding site V$HNF3_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++HOX13_01///Genes having at least one occurence of the transcription factor binding site V$HOX13_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++IRF1_Q6///Genes having at least one occurence of the transcription factor binding site V$IRF1_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++IRF7_01///Genes having at least one occurence of the transcription factor binding site V$IRF7_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++LYF1_01///Genes having at least one occurence of the transcription factor binding site V$LYF1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++NKX62_Q2///Genes having at least one occurence of the transcription factor binding site V$NKX62_Q2 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++P53_02///Genes having at least one occurence of the transcription factor binding site V$P53_02 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++PAX4_04///Genes having at least one occurence of the transcription factor binding site V$PAX4_04 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++PAX5_01///Genes having at least one occurence of the transcription factor binding site V$PAX5_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++PAX8_B///Genes having at least one occurence of the transcription factor binding site V$PAX8_B (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++PBX1_01///Genes having at least one occurence of the transcription factor binding site V$PBX1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++PTF1BETA_Q6///Genes having at least one occurence of the transcription factor binding site V$PTF1BETA_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++RNCTGNYNRNCTGNY_UNKNOWN///Genes having at least one occurence of the highly conserved motif M154 RNCTGNYNRNCTGNY in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++RNGTGGGC_UNKNOWN///Genes having at least one occurence of the highly conserved motif M140 RNGTGGGC in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++RTAAACA_FREAC2_01///Genes having at least one occurence of the highly conserved motif M36 RTAAACA sites. The motif matches transcription factor binding site V$FREAC2_01 (v7.4 TRANSFAC).+++RTTTNNNYTGGM_UNKNOWN///Genes having at least one occurence of the highly conserved motif M107 RTTTNNNYTGGM in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++RYAAAKNNNNNNTTGW_UNKNOWN///Genes having at least one occurence of the highly conserved motif M151 RYAAAKNNNNNNTTGW in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++RYTTCCTG_ETS2_B///Genes having at least one occurence of the highly conserved motif M16 RYTTCCTG sites. The motif matches transcription factor binding site V$ETS2_B (v7.4 TRANSFAC).+++S8_01///Genes having at least one occurence of the transcription factor binding site V$S8_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++SMAD4_Q6///Genes having at least one occurence of the transcription factor binding site V$SMAD4_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++SMAD_Q6///Genes having at least one occurence of the transcription factor binding site V$SMAD_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++SMTTTTGT_UNKNOWN///Genes having at least one occurence of the highly conserved motif M62 SMTTTTGT in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++SRF_01///Genes having at least one occurence of the transcription factor binding site V$SRF_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++SRF_C///Genes having at least one occurence of the transcription factor binding site V$SRF_C (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++SRF_Q4///Genes having at least one occurence of the transcription factor binding site V$SRF_Q4 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++SRF_Q5_01///Genes having at least one occurence of the transcription factor binding site V$SRF_Q5_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++SRF_Q6///Genes having at least one occurence of the transcription factor binding site V$SRF_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++STAT_Q6///Genes having at least one occurence of the transcription factor binding site V$STAT_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++TAATTA_CHX10_01///Genes having at least one occurence of the highly conserved motif M23 TAATTA sites. The motif matches transcription factor binding site V$CHX10_01 (v7.4 TRANSFAC).+++TATAAA_TATA_01///Genes having at least one occurence of the highly conserved motif M51 TATAAA sites. The motif matches transcription factor binding site V$TATA_01 (v7.4 TRANSFAC).+++TCCATTKW_UNKNOWN///Genes having at least one occurence of the highly conserved motif M132 TCCATTKW in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++TGACAGNY_MEIS1_01///Genes having at least one occurence of the highly conserved motif M41 TGACAGNY sites. The motif matches transcription factor binding site V$MEIS1_01 (v7.4 TRANSFAC).+++TGACATY_UNKNOWN///Genes having at least one occurence of the highly conserved motif M42 TGACATY in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++TGCCAAR_NF1_Q6///Genes having at least one occurence of the highly conserved motif M47 TGCCAAR sites. The motif matches transcription factor binding site V$NF1_Q6 (v7.4 TRANSFAC).+++TGGAAA_NFAT_Q4_01///Genes having at least one occurence of the highly conserved motif M55 TGGAAA sites. The motif matches transcription factor binding site V$NFAT_Q4_01 (v7.4 TRANSFAC).+++TGTTTGY_HNF3_Q6///Genes having at least one occurence of the highly conserved motif M83 TGTTTGY sites. The motif matches transcription factor binding site V$HNF3_Q6 (v7.4 TRANSFAC).+++WGTTNNNNNAAA_UNKNOWN///Genes having at least one occurence of the highly conserved motif M155 WGTTNNNNNAAA in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++WTTGKCTG_UNKNOWN///Genes having at least one occurence of the highly conserved motif M46 WTTGKCTG in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++YAATNANRNNNCAG_UNKNOWN///Genes having at least one occurence of the highly conserved motif M147 YAATNANRNNNCAG in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++YATTNATC_UNKNOWN///Genes having at least one occurence of the highly conserved motif M97 YATTNATC in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++YNGTTNNNATT_UNKNOWN///Genes having at least one occurence of the highly conserved motif M170 YNGTTNNNATT in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++YY1_01///Genes having at least one occurence of the transcription factor binding site V$YY1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.	"BRCA2_TARGET_GENES///Genes containing one or more binding sites for UniProt:P51587 (BRCA2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++FOXH1_TARGET_GENES///Genes containing one or more binding sites for UniProt:O75593 (FOXH1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HES2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9Y543 (HES2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HMGB2_TARGET_GENES///Genes containing one or more binding sites for UniProt:P26583 (HMGB2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SALL4_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9UJQ4 (SALL4) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SUPT16H_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9Y5B9 (SUPT16H) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++TFEB_TARGET_GENES///Genes containing one or more binding sites for UniProt:P19484 (TFEB) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++UBN1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9NPG3 (UBN1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZBTB24_TARGET_GENES///Genes containing one or more binding sites for UniProt:O43167 (ZBTB24) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZFHX3_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q15911 (ZFHX3) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF22_TARGET_GENES///Genes containing one or more binding sites for UniProt:P17026 (ZNF22) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF274_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96GC6 (ZNF274) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF362_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q5T0B9 (ZNF362) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF92_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q03936 (ZNF92) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."		MODULE_118///cell line expressed genes.+++MODULE_1///Ovary genes.+++MODULE_201///Genes in the cancer module 201.+++MODULE_220///Developmental processes.+++MODULE_257///Genes in the cancer module 257.+++MODULE_329///Genes in the cancer module 329.+++MODULE_330///Genes in the cancer module 330.+++MODULE_33///Immune / stress response genes.+++MODULE_387///Genes in the cancer module 387.+++MODULE_3///Genes in the cancer module 3.+++MODULE_419///Genes in the cancer module 419.+++MODULE_47///ECM and collagens.+++MODULE_512///Muscle genes.+++MODULE_524///Actin cytoskeleton binding.+++MODULE_52///Cell line expressed genes.+++MODULE_5///Lung genes.	STK33_SKM_DN///Genes down-regulated in SKM-1 cells (AML) after knockdown of STK33 [Gene ID=65975] by RNAi.	"GSE13887_HEALTHY_VS_LUPUS_RESTING_CD4_TCELL_DN///Genes down-regulated in resting CD4 [GeneID=920] T cells: healthy versus systemic lupus erythrematosus (SLE).+++GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_48H_ACT_CD4_TCELL_UP///Genes up-regulated in comparison of CD4 [GeneID=920] T cells treated with IL4 [GeneID=3565] and anti-IL12 at 48 h versus the untreated cells at 48 h.+++GSE360_CTRL_VS_M_TUBERCULOSIS_MAC_UP///Genes up-regulated in comparison of macrophages versus macrophages exposed to M. tuberculosis.+++GSE3982_MAC_VS_NEUTROPHIL_LPS_STIM_DN///Genes down-regulated in comparison of macrophages stimulated with LPS (TLR4 agonist) at 4 h versus neutrophils stimulated with LPS (TLR4 agonist) at 1 h.+++GSE5542_UNTREATED_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_UP///Genes up-regulated in epithelial cells (6h): untreated versus interferon alpha and IFNG [GeneID=3458].+++GSE6269_FLU_VS_E_COLI_INF_PBMC_DN///Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from patients with acute influenza infection versus PBMC from patients with acute E. coli infection.+++GSE6269_HEALTHY_VS_STAPH_AUREUS_INF_PBMC_DN///Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from patients with acute influenza infection versus PBMC from patients with acute S. aureus infection.+++HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_UP///Genes up-regulated in peripheral blood mononuclear cell vaccinated vs unvaccinated in adolescent/young adults (11-22) after exposure to M-M-R II , time point 7Y+++THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_UP///Genes up-regulated in peripheral blood mononuclear cell 28d vs 0d in young adults (21-30) (responders) after exposure to Inactivated influenza vaccine , time point 28D"	"HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION///Genes defining epithelial-mesenchymal transition, as in wound healing, fibrosis and metastasis."	NM_033138	CALD1				
Q05655	sp|Q05655|KPCD_HUMAN		PRKCD		Protein kinase C delta type OS=Homo sapiens OX=9606 GN=PRKCD PE=1 SV=2 >tr|A0A024R328|A0A024R328_HUMAN Protein kinase C delta type OS=Homo sapiens OX=9606 GN=PRKCD PE=3 SV=1	5580	NM_001354678	NP_001341607		K06068			MAPFLRIAFNSYELGSLQAEDEANQPFCAVKMKEALSTERGKTLVQKKPTMYPEWKSTFDAHIYEGRVIQIVLMRAAEEPVSEVTVGVSVLAERCKKNNGKAEFWLDLQPQAKVLMSVQYFLEDVDCKQSMRSEDEAKFPTMNRRGAIKQAKIHYIKNHEFIATFFGQPTFCSVCKDFVWGLNKQGYKCRQCNAAIHKKCIDKIIGRCTGTAANSRDTIFQKERFNIDMPHRFKVHNYMSPTFCDHCGSLLWGLVKQGLKCEDCGMNVHHKCREKVANLCGINQKLLAEALNQVTQRASRRSDSASSEPVGIYQGFEKKTGVAGEDMQDNSGTYGKIWEGSSKCNINNFIFHKVLGKGSFGKVLLGELKGRGEYFAIKALKKDVVLIDDDVECTMVEKRVLTLAAENPFLTHLICTFQTKDHLFFVMEFLNGGDLMYHIQDKGRFELYRATFYAAEIMCGLQFLHSKGIIYRDLKLDNVLLDRDGHIKIADFGMCKENIFGESRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFEREPTKRLGVTGNIKIHPFFKTINWTLLEKRRLEPPFRPKVKSPRDYSNFDQEFLNEKARLSYSDKNLIDSMDQSAFAGFSFVNPKFEHLLED	2.4625058	1.300127133	0.02433222		10.017196							6.6694673							8.4922667						6.7935843	6.8995517					7.507004	6.3897665	6.71907	7.0817333		6.7865518		6.9484769		5.2986801		6.841159			6.4580209			04062///Chemokine signaling pathway+++04140///Autophagy - animal+++04270///Vascular smooth muscle contraction+++04361///Axon regeneration+++04621///NOD-like receptor signaling pathway+++04625///C-type lectin receptor signaling pathway+++04666///Fc gamma R-mediated phagocytosis+++04722///Neurotrophin signaling pathway+++04750///Inflammatory mediator regulation of TRP channels+++04912///GnRH signaling pathway+++04915///Estrogen signaling pathway+++04930///Type II diabetes mellitus+++04931///Insulin resistance+++04933///AGE-RAGE signaling pathway in diabetic complications+++05020///Prion disease+++05131///Shigellosis+++05208///Chemical carcinogenesis - reactive oxygen species+++05415///Diabetic cardiomyopathy	H00108///Autoimmune lymphoproliferative syndromes			GO:0005576///extracellular region+++GO:0005634///nucleus+++GO:0005654///nucleoplasm+++GO:0005737///cytoplasm+++GO:0005739///mitochondrion+++GO:0005783///endoplasmic reticulum+++GO:0005829///cytosol+++GO:0005886///plasma membrane+++GO:0005911///cell-cell junction+++GO:0012505///endomembrane system+++GO:0016020///membrane+++GO:0016363///nuclear matrix+++GO:0035578///azurophil granule lumen+++GO:0036019///endolysosome+++GO:0048471///perinuclear region of cytoplasm+++GO:0070062///extracellular exosome	GO:0000166///nucleotide binding+++GO:0004672///protein kinase activity+++GO:0004674///protein serine/threonine kinase activity+++GO:0004697///protein kinase C activity+++GO:0004698///calcium-dependent protein kinase C activity+++GO:0004699///calcium-independent protein kinase C activity+++GO:0004714///transmembrane receptor protein tyrosine kinase activity+++GO:0004715///non-membrane spanning protein tyrosine kinase activity+++GO:0005515///protein binding+++GO:0005524///ATP binding+++GO:0008047///enzyme activator activity+++GO:0016301///kinase activity+++GO:0016740///transferase activity+++GO:0019899///enzyme binding+++GO:0019900///kinase binding+++GO:0019901///protein kinase binding+++GO:0043560///insulin receptor substrate binding+++GO:0046872///metal ion binding	GO:0006468///protein phosphorylation+++GO:0006915///apoptotic process+++GO:0007049///cell cycle+++GO:0007165///signal transduction+++GO:0008631///intrinsic apoptotic signaling pathway in response to oxidative stress+++GO:0010469///regulation of signaling receptor activity+++GO:0016064///immunoglobulin mediated immune response+++GO:0016310///phosphorylation+++GO:0016572///histone phosphorylation+++GO:0018105///peptidyl-serine phosphorylation+++GO:0018107///peptidyl-threonine phosphorylation+++GO:0018108///peptidyl-tyrosine phosphorylation+++GO:0023021///termination of signal transduction+++GO:0030837///negative regulation of actin filament polymerization+++GO:0032079///positive regulation of endodeoxyribonuclease activity+++GO:0032091///negative regulation of protein binding+++GO:0032147///activation of protein kinase activity+++GO:0032930///positive regulation of superoxide anion generation+++GO:0032956///regulation of actin cytoskeleton organization+++GO:0034351///negative regulation of glial cell apoptotic process+++GO:0034644///cellular response to UV+++GO:0035307///positive regulation of protein dephosphorylation+++GO:0035556///intracellular signal transduction+++GO:0038096///Fc-gamma receptor signaling pathway involved in phagocytosis+++GO:0042100///B cell proliferation+++GO:0042119///neutrophil activation+++GO:0042307///positive regulation of protein import into nucleus+++GO:0042742///defense response to bacterium+++GO:0043407///negative regulation of MAP kinase activity+++GO:0043488///regulation of mRNA stability+++GO:0046627///negative regulation of insulin receptor signaling pathway+++GO:0050728///negative regulation of inflammatory response+++GO:0050732///negative regulation of peptidyl-tyrosine phosphorylation+++GO:0050821///protein stabilization+++GO:0051490///negative regulation of filopodium assembly+++GO:0060326///cell chemotaxis+++GO:0070301///cellular response to hydrogen peroxide+++GO:0071447///cellular response to hydroperoxide+++GO:0090331///negative regulation of platelet aggregation+++GO:0090398///cellular senescence+++GO:1900163///positive regulation of phospholipid scramblase activity+++GO:1904385///cellular response to angiotensin+++GO:2000303///regulation of ceramide biosynthetic process+++GO:2000304///positive regulation of ceramide biosynthetic process+++GO:2000753///positive regulation of glucosylceramide catabolic process+++GO:2000755///positive regulation of sphingomyelin catabolic process+++GO:2001022///positive regulation of response to DNA damage stimulus+++GO:2001235///positive regulation of apoptotic signaling pathway	tissueType=Fetal gonad;cancerType=Normal;cellName=Leydig cell		"Homo sapiens protein kinase C delta (PRKCD), transcript variant 5, mRNA."			"R-HSA-109581///Apoptosis+++R-HSA-109582///Hemostasis+++R-HSA-111465///Apoptotic cleavage of cellular proteins+++R-HSA-111885///Opioid Signalling+++R-HSA-111933///Calmodulin induced events+++R-HSA-111996///Ca-dependent events+++R-HSA-111997///CaM pathway+++R-HSA-112040///G-protein mediated events+++R-HSA-112043///PLC beta mediated events+++R-HSA-114508///Effects of PIP2 hydrolysis+++R-HSA-1227986///Signaling by ERBB2+++R-HSA-1250196///SHC1 events in ERBB2 signaling+++R-HSA-1280215///Cytokine Signaling in Immune system+++R-HSA-1489509///DAG and IP3 signaling+++R-HSA-162582///Signal Transduction+++R-HSA-168249///Innate Immune System+++R-HSA-168256///Immune System+++R-HSA-194138///Signaling by VEGF+++R-HSA-194315///Signaling by Rho GTPases+++R-HSA-195258///RHO GTPase Effectors+++R-HSA-2029480///Fcgamma receptor (FCGR) dependent phagocytosis+++R-HSA-2029485///Role of phospholipids in phagocytosis+++R-HSA-2262752///Cellular responses to stress+++R-HSA-372790///Signaling by GPCR+++R-HSA-388396///GPCR downstream signalling+++R-HSA-416476///G alpha (q) signalling events+++R-HSA-418594///G alpha (i) signalling events+++R-HSA-418597///G alpha (z) signalling events+++R-HSA-4420097///VEGFA-VEGFR2 Pathway+++R-HSA-450520///HuR (ELAVL1) binds and stabilizes mRNA+++R-HSA-450531///Regulation of mRNA stability by proteins that bind AU-rich elements+++R-HSA-5218921///VEGFR2 mediated cell proliferation+++R-HSA-5357801///Programmed Cell Death+++R-HSA-5607764///CLEC7A (Dectin-1) signaling+++R-HSA-5621481///C-type lectin receptors (CLRs)+++R-HSA-5668599///RHO GTPases Activate NADPH Oxidases+++R-HSA-6798695///Neutrophil degranulation+++R-HSA-75153///Apoptotic execution phase+++R-HSA-76002///Platelet activation, signaling and aggregation+++R-HSA-877300///Interferon gamma signaling+++R-HSA-8932339///ROS sensing by NFE2L2+++R-HSA-8953854///Metabolism of RNA+++R-HSA-8953897///Cellular responses to stimuli+++R-HSA-9006925///Intracellular signaling by second messengers+++R-HSA-9006934///Signaling by Receptor Tyrosine Kinases+++R-HSA-913531///Interferon Signaling+++R-HSA-9707564///Cytoprotection by HMOX1+++R-HSA-9707587///Regulation of HMOX1 expression and activity+++R-HSA-9711123///Cellular response to chemical stress+++R-HSA-9716542///Signaling by Rho GTPases, Miro GTPases and RHOBTB3"						chr3p21///Ensembl 103 genes in cytogenetic band chr3p21	BIOCARTA_HIVNEF_PATHWAY///HIV-I Nef: negative effector of Fas and TNF+++BIOCARTA_KERATINOCYTE_PATHWAY///Keratinocyte Differentiation	KEGG_CHEMOKINE_SIGNALING_PATHWAY///Chemokine signaling pathway+++KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY///Fc epsilon RI signaling pathway+++KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS///Fc gamma R-mediated phagocytosis+++KEGG_GNRH_SIGNALING_PATHWAY///GnRH signaling pathway+++KEGG_NEUROTROPHIN_SIGNALING_PATHWAY///Neurotrophin signaling pathway+++KEGG_TIGHT_JUNCTION///Tight junction+++KEGG_TYPE_II_DIABETES_MELLITUS///Type II diabetes mellitus+++KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION///Vascular smooth muscle contraction	"REACTOME_APOPTOSIS///Apoptosis+++REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS///Apoptotic cleavage of cellular proteins+++REACTOME_APOPTOTIC_EXECUTION_PHASE///Apoptotic execution phase+++REACTOME_CA_DEPENDENT_EVENTS///Ca-dependent events+++REACTOME_CELLULAR_RESPONSES_TO_EXTERNAL_STIMULI///Cellular responses to external stimuli+++REACTOME_CELLULAR_RESPONSE_TO_CHEMICAL_STRESS///Cellular response to chemical stress+++REACTOME_CLEC7A_DECTIN_1_SIGNALING///CLEC7A (Dectin-1) signaling+++REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS///C-type lectin receptors (CLRs)+++REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM///Cytokine Signaling in Immune system+++REACTOME_CYTOPROTECTION_BY_HMOX1///Cytoprotection by HMOX1+++REACTOME_DAG_AND_IP3_SIGNALING///DAG and IP3 signaling+++REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS///Effects of PIP2 hydrolysis+++REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS///Fcgamma receptor (FCGR) dependent phagocytosis+++REACTOME_G_ALPHA_I_SIGNALLING_EVENTS///G alpha (i) signalling events+++REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS///G alpha (q) signalling events+++REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS///G alpha (z) signalling events+++REACTOME_G_PROTEIN_MEDIATED_EVENTS///G-protein mediated events+++REACTOME_HEMOSTASIS///Hemostasis+++REACTOME_HUR_ELAVL1_BINDS_AND_STABILIZES_MRNA///HuR (ELAVL1) binds and stabilizes mRNA+++REACTOME_INNATE_IMMUNE_SYSTEM///Innate Immune System+++REACTOME_INTERFERON_GAMMA_SIGNALING///Interferon gamma signaling+++REACTOME_INTERFERON_SIGNALING///Interferon Signaling+++REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS///Intracellular signaling by second messengers+++REACTOME_METABOLISM_OF_RNA///Metabolism of RNA+++REACTOME_NEUTROPHIL_DEGRANULATION///Neutrophil degranulation+++REACTOME_OPIOID_SIGNALLING///Opioid Signalling+++REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION///Platelet activation, signaling and aggregation+++REACTOME_PROGRAMMED_CELL_DEATH///Programmed Cell Death+++REACTOME_REGULATION_OF_HMOX1_EXPRESSION_AND_ACTIVITY///Regulation of HMOX1 expression and activity+++REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS///Regulation of mRNA stability by proteins that bind AU-rich elements+++REACTOME_RHO_GTPASE_EFFECTORS///RHO GTPase Effectors+++REACTOME_RHO_GTPASES_ACTIVATE_NADPH_OXIDASES///RHO GTPases Activate NADPH Oxidases+++REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS///Role of phospholipids in phagocytosis+++REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING///SHC1 events in ERBB2 signaling+++REACTOME_SIGNALING_BY_ERBB2///Signaling by ERBB2+++REACTOME_SIGNALING_BY_GPCR///Signaling by GPCR+++REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES///Signaling by Receptor Tyrosine Kinases+++REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3///Signaling by Rho GTPases, Miro GTPases and RHOBTB3+++REACTOME_SIGNALING_BY_VEGF///Signaling by VEGF+++REACTOME_VEGFR2_MEDIATED_CELL_PROLIFERATION///VEGFR2 mediated cell proliferation"		"TACTTGA_MIR26A_MIR26B///Genes having at least one occurence of the motif TACTTGA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-26a and hsa-miR-26b (v7.1 miRBase).+++TATTATA_MIR374///Genes having at least one occurence of the motif TATTATA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-374 (v7.1 miRBase).+++TGAATGT_MIR181A_MIR181B_MIR181C_MIR181D///Genes having at least one occurence of the motif TGAATGT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-181a, hsa-miR-181b, hsa-miR-181c and hsa-miR-181d (v7.1 miRBase)."	"MIR1277_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1277-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1297///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1297 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR181A_5P_MIR181B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-181a-5p, hsa-miR-181b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR181C_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-181c-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR181D_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-181d-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR26A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-26a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR26B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-26b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3924///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3924 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3942_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3942-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4262///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4262 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4465///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4465 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4703_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4703-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5692B_MIR5692C///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5692b, hsa-miR-5692c in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR606///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-606 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR642A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-642a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6768_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6768-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets)."	COUP_01///Genes having at least one occurence of the transcription factor binding site V$COUP_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++COUP_DR1_Q6///Genes having at least one occurence of the transcription factor binding site V$COUP_DR1_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++HNF4_01_B///Genes having at least one occurence of the transcription factor binding site V$HNF4_01_B (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++HNF4_01///Genes having at least one occurence of the transcription factor binding site V$HNF4_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++HNF4_DR1_Q3///Genes having at least one occurence of the transcription factor binding site V$HNF4_DR1_Q3 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++NFKB_C///Genes having at least one occurence of the transcription factor binding site V$NFKB_C (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++NFKB_Q6_01///Genes having at least one occurence of the transcription factor binding site V$NFKB_Q6_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++NFKB_Q6///Genes having at least one occurence of the transcription factor binding site V$NFKB_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.	"AHRR_TARGET_GENES///Genes containing one or more binding sites for UniProt:A9YTQ3 (AHRR) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++FOXN3_TARGET_GENES///Genes containing one or more binding sites for UniProt:O00409 (FOXN3) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++FOXP2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O15409 (FOXP2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++GREB1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q4ZG55 (GREB1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HMGB1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P09429 (HMGB1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++KMT2D_TARGET_GENES///Genes containing one or more binding sites for UniProt:O14686 (KMT2D) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++LMTK3_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96Q04 (LMTK3) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NFKBIA_TARGET_GENES///Genes containing one or more binding sites for UniProt:P25963 (NFKBIA) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SFMBT1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9UHJ3 (SFMBT1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++WDHD1_TARGET_GENES///Genes containing one or more binding sites for UniProt:O75717 (WDHD1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF597_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96LX8 (ZNF597) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF92_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q03936 (ZNF92) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZSCAN29_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8IWY8 (ZSCAN29) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."	GNF2_CASP1///Neighborhood of CASP1+++GNF2_MCL1///Neighborhood of MCL1+++GNF2_MYD88///Neighborhood of MYD88	MODULE_16///Genes in the cancer module 15.+++MODULE_244///Response to DNA damage.+++MODULE_45///Whole blood genes.	ATF2_S_UP.V1_UP///Genes up-regulated in myometrial cells over-expressing a shortened splice form of ATF2 [Gene ID=1386] gene.+++ATF2_UP.V1_UP///Genes up-regulated in myometrial cells over-expressing ATF2 [Gene ID=1386] gene.+++IL2_UP.V1_UP///Genes up-regulated in Sez-4 cells (T lymphocyte) that were first starved of IL2 [Gene ID=3558] and then stimulated with IL2 [Gene ID=3558].	"GSE10325_BCELL_VS_MYELOID_DN///Genes down-regulated in comparison of healthy B cells versus healthy myeloid cells.+++GSE10325_CD4_TCELL_VS_MYELOID_DN///Genes down-regulated in comparison of healthy CD4 [GeneID=920] T cells versus healthy myeloid cells.+++GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_BCELL_DN///Genes down-regulated in comparison of systemic lupus erythematosus CD4 [GeneID=920] T cells versus systemic lupus erythematosus B cells.+++GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_MYELOID_DN///Genes down-regulated in comparison of systemic lupus erythematosus CD4 [GeneID=920] T cells versus systemic lupus erythematosus myeloid cells.+++GSE11057_CD4_CENT_MEM_VS_PBMC_DN///Genes down-regulated in comparison of central memory T cells versus peripheral blood mononuclear cells (PBMC).+++GSE11057_CD4_EFF_MEM_VS_PBMC_DN///Genes down-regulated in comarison of effector memory T cells versus peripheral blood mononuclear cells (PBMC).+++GSE11057_NAIVE_VS_CENT_MEMORY_CD4_TCELL_DN///Genes down-regulated in comparison of naive T cells versus central memory T cells.+++GSE11057_NAIVE_VS_MEMORY_CD4_TCELL_DN///Genes down-regulated in comparison of naive T cells versus memory T cells.+++GSE11057_PBMC_VS_MEM_CD4_TCELL_UP///Genes up-regulated in comparison of peripheral mononuclear blood cells (PBMC) versus memory T cells.+++GSE11864_CSF1_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN///Genes down-regulated in comparison of macrophages cultured with M-CSF [GeneID=1435] versus macrophages cultured with M-CSF [GeneID=1435], IFNG [GeneID=3458] and Pam3Cyc.+++GSE12845_IGD_NEG_BLOOD_VS_NAIVE_TONSIL_BCELL_UP///Genes up-regulated in comparison of IgD- peripheral blood B cells versus dark zone germinal center B cells.+++GSE12845_IGD_POS_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_DN///Genes down-regulated in comparison of IgD+ peripheral blood B cells versus dark zone germincal center B cells.+++GSE12845_IGD_POS_VS_NEG_BLOOD_BCELL_DN///Genes down-regulated in comparison of IgD+ B cells versus IgD- B cells.+++GSE12845_NAIVE_VS_DARKZONE_GC_TONSIL_BCELL_DN///Genes down-regulated in comparison of naive B cell versus dark zone germinal center B cells.+++GSE13411_NAIVE_VS_MEMORY_BCELL_DN///Genes down-regulated in comparison of naive B cells versus memory B cells.+++GSE15215_CD2_POS_VS_NEG_PDC_DN///Genes down-regulated in comparison of CD2+ plasmacytoid dendritic cells (DC) versus CD2- cells.+++GSE15735_CTRL_VS_HDAC_INHIBITOR_TREATED_CD4_TCELL_2H_UP///Genes up-regulated in CD4 [GeneID=920] T cells: control versus treated with HDAC inhibitors for 2h.+++GSE16385_ROSIGLITAZONE_IL4_VS_IL4_ALONE_STIM_MACROPHAGE_12H_UP///Genes up-regulated in macrophages (12h): rosiglitazone [PubChem=77999] and IL4 [GeneID=3565] versus IL4 [GeneID=3565].+++GSE17186_MEMORY_VS_CD21HIGH_TRANSITIONAL_BCELL_DN///Genes down-regulated in B lymphocytes: memory versus transitional CR2 [GeneID=1380] high.+++GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA5_STIM_CD8_TCELL_DN///Genes down-regulated in CD8 T cells activated by anti-CD3 and anti-CD28 versus those stimulated by IFNA5 [GeneID=3442].+++GSE18893_CTRL_VS_TNF_TREATED_TREG_24H_DN///Genes down-regulated in T reg cells: 2h versus 24h medium treatment.+++GSE20198_IL12_IL18_VS_IFNA_TREATED_ACT_CD4_TCELL_UP///Genes up-regulated in the activated CD4 [GeneID=920] T cells (48h): IL-12 and IL18 [GeneID=3606] versus interferon alpha.+++GSE20198_UNTREATED_VS_IFNA_TREATED_ACT_CD4_TCELL_UP///Genes up-regulated in the activated CD4 [GeneID=920] T cells (48h): control versus interferon alpha.+++GSE22601_DOUBLE_NEGATIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_DN///Genes down-regulated in thymocytes: double negative versus CD8 single positive.+++GSE22601_DOUBLE_NEGATIVE_VS_IMMATURE_CD4_SP_THYMOCYTE_UP///Genes up-regulated in double negative thymocyte versus immature CD4 [GeneID=920] single positive cells.+++GSE22601_DOUBLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_DN///Genes down-regulated in thymocytes: double positive versus CD8 single positive.+++GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN///Genes down-regulated in CD4 [GeneID=920] single positive cells: immature versus thymocytes.+++GSE22886_NAIVE_BCELL_VS_MONOCYTE_DN///Genes down-regulated in comparison of naive B cells versus day 0 monocytes.+++GSE22886_NAIVE_CD4_TCELL_VS_DC_DN///Genes down-regulated in comparison of naive CD4 [GeneID=920] T cells versus unstimulatd dendritic cells (DC).+++GSE22886_NAIVE_CD4_TCELL_VS_MONOCYTE_DN///Genes down-regulated in comparison of naive CD4 [GeneID=920] T cells versus day 0 monocytes.+++GSE22886_NAIVE_CD8_TCELL_VS_MONOCYTE_DN///Genes down-regulated in comparison of naive CD8 T cells versus day 0 monocytes.+++GSE22886_NAIVE_TCELL_VS_MONOCYTE_DN///Genes down-regulated in comparison of naive CD4 [GeneID=920] CD8 T cells versus monocytes cultured for 0 days.+++GSE2405_0H_VS_6H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP///Genes up-regulated in polymorphonuclear leukocytes (6h): control versus infection by A. phagocytophilum.+++GSE2405_0H_VS_9H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP///Genes up-regulated in polymorphonuclear leukocytes (9h): control versus infection by A. phagocytophilum.+++GSE24634_TEFF_VS_TCONV_DAY7_IN_CULTURE_DN///Genes down-regulated in comparison of untreated CD25+ T effector cells at day 7 versus untreated CD25- T cells at day 7.+++GSE27670_BLIMP1_VS_LMP1_TRANSDUCED_GC_BCELL_DN///Genes down-regulated in germinal center B lymphocytes over-expressing: PRDM1 [GeneID=639] versus Epstein-Barr virus protein LMP1.+++GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_PDC_DN///Genes down-regulated in comparison of plasmacytoid dendritic cells (pDC) from influenza vaccinee pre-vaccination versus those at day 7 post-vaccination.+++GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_BCELL_DN///Genes down-regulated in comparison of B cells from TIV influenza vaccinee pre-vaccination versus those at day 7 post-vaccination.+++GSE32164_RESTING_DIFFERENTIATED_VS_ALTERNATIVELY_ACT_M2_MACROPHAGE_DN///Genes down-regulated in macrophages: resting differentiated versus alternatively activated M2.+++GSE32164_RESTING_DIFFERENTIATED_VS_CMYC_INHIBITED_MACROPHAGE_UP///Genes up-regulated in macrophages: resting differentiated versus MYC [GeneID=4609] inhibited.+++GSE33424_CD161_HIGH_VS_INT_CD8_TCELL_UP///Genes up-regulated in CD8 T cells: KLRB1 high [GeneID=3820] versus KLRB1 int [GeneID=3820].+++GSE33424_CD161_HIGH_VS_NEG_CD8_TCELL_UP///Genes up-regulated in CD8 T cells: KLRB1 high [GeneID=3820] versus KLRB1- [GeneID=3820].+++GSE33425_CD161_HIGH_VS_INT_CD8_TCELL_UP///Genes up-regulated in CD8 T cells: KLRB1 high [GeneID=3820] versus KLRB1 int [GeneID=3820].+++GSE33425_CD161_INT_VS_NEG_CD8_TCELL_DN///Genes down-regulated in CD8 T cells: KLRB1 int [GeneID=3820] versus KLRB1- [GeneID=3820].+++GSE33425_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_UP///Genes up-regulated in KLRB1 high [GeneID=3820] T cells: CD8A [GeneID=925] versus CD8A CD8B [GeneID=925;926].+++GSE34515_CD16_NEG_VS_POS_MONOCYTE_UP///Genes up-regulated in monocytes: CD16- versus CD16+.+++GSE35685_CD34POS_CD10NEG_CD62LPOS_VS_CD34POS_CD10POS_BONE_MARROW_UP///Genes up-regulated in the bone marrow CD34+ [GeneID=947] cells: MME- SELL+[GeneID=4311;6402] versus MME+ [GeneID=4311].+++GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10POS_BONE_MARROW_UP///Genes up-regulated in the bone marrow CD34+ [GeneID=947] cells: CD38- [GeneID=952] versus MME+ [GeneID=4311].+++GSE360_CTRL_VS_T_GONDII_MAC_UP///Genes up-regulated in comparison of macrophages versus macrophages exposed to T. gondii.+++GSE360_DC_VS_MAC_L_DONOVANI_UP///Genes up-regulated in comparison of dendritic cells (DC) exposed to L. donovani versus macrophages exposed to L. donovani.+++GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_MAC_DN///Genes down-regulated in comparison of macrophages exposed to L. donovani versus macrophages exposed to 50 worms/well B. malayi.+++GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_MAC_DN///Genes down-regulated in comparison of macrophages exposed to T. gondii versus macrophages exposed to 50 worms/well B. malayi.+++GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_MAC_DN///Genes down-regulated in comparison of macrophages exposed to T. gondii versus macrophages exposed to 5 worms/well B. malayi.+++GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_40H_TSST_ACT_DN///Genes down-regulated in comparison of memory CD4 [GeneID=920] T cells from young donors treated with TSST at 40 h versus those from old donors treated with TSST at 40 h.+++GSE3982_CTRL_VS_LPS_1H_NEUTROPHIL_DN///Genes down-regulated in comparison of untreated neutrophils versus neutrophils treated with LPS (TLR4 agonist) at 1 h.+++GSE3982_EOSINOPHIL_VS_NEUTROPHIL_DN///Genes down-regulated in comparison of eosinophils versus neutrophils.+++GSE4984_LPS_VS_VEHICLE_CTRL_TREATED_DC_DN///Genes down-regulated in monocyte-derived dendritic cells: LPS versus vehicle.+++GSE6092_B_BURGDOFERI_VS_B_BURGDORFERI_AND_IFNG_STIM_ENDOTHELIAL_CELL_DN///Genes down-regulated in endothelial cells: B. burgdoferi versus IFNG [GeneID=3459] and B. burgdoferi .+++GSE6092_IFNG_VS_IFNG_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_DN///Genes down-regulated in endothelial cells: IFNG [GeneID=3459] versus IFNG [GeneID=3459] and B. burgdoferi.+++GSE6269_E_COLI_VS_STAPH_AUREUS_INF_PBMC_DN///Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from patients with acute E. coli infection versus PBMC from patients with acute S. aureus infection.+++GSE7568_IL4_TGFB_DEXAMETHASONE_VS_IL4_TGFB_TREATED_MACROPHAGE_DN///Genes down-regulated in macrophages: 5 days with IL4 [GeneID=3565] and dexamethasone [PubChem=5743] followed by TGFB1 [GeneID=7040] for 24h versus 5 days with IL4 [GeneID=3565] followed by TGFB1 [GeneID=7040] for 24h.+++GSE8515_CTRL_VS_IL1_4H_STIM_MAC_DN///Genes down-regulated in comparison of untreated macrophages versus those treated with IL1.+++GSE8515_IL1_VS_IL6_4H_STIM_MAC_UP///Genes up-regulated in comparison of untreated macrophages versus those treated with IL1 and IL6 [GeneID=3569].+++GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_12H_DN///Genes down-regulated in monocytes (12h): untreated versus M. tuberculosis 19 kDa lipopeptide.+++LI_PBMC_MENACTRA_AGE_18_45YO_CORRELATED_WITH_ANTI_DT_ANTIBODY_3DY_POSITIVE///Genes positively correlated with antibody response in peripheral blood mononuclear cell in adults (18-45) (anti-DT antibody-correlation profile) after exposure to Menactra , time point 3D+++LI_PBMC_MENACTRA_AGE_18_45YO_CORRELATED_WITH_ANTI_POLYSACCHARIDE_ANTIBODY_3DY_POSITIVE///Genes positively correlated with antibody response in peripheral blood mononuclear cell in adults (18-45) (anti-polysaccharide antibody-correlation profile) after exposure to Menactra , time point 3D+++LI_PBMC_MENOMUNE_A_C_Y_W_135_AGE_18_45YO_CORRELATED_WITH_ANTIBODY_RESPONSE_3DY_NEGATIVE///Genes negatively correlated with antibody response in peripheral blood mononuclear cell in adults (18-45) after exposure to Menomune A/C/Y/W-135 , time point 3D+++NAKAYA_B_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP///Genes up-regulated in B cell 7d vs 0d in young adults (18-50) after exposure to Fluarix/Fluvirin , time point 7D+++NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_POSITIVE///Genes positively correlated with HAI response at 28d in peripheral blood mononuclear cell in adults (18-50) after exposure to Fluarix/Fluvirin , time point 3D. Comment: Supplementary Table 5: All genes whose expression (d3/d0 or d7/d0) correlates to the fold increase in HAI titers (d28/d0).+++NAKAYA_PBMC_FLUMIST_AGE_18_50YO_7DY_UP///Genes up-regulated in peripheral blood mononuclear cell 7d vs 0d in adults (18-50) after exposure to FluMist , time point 7D. Comment: Supplementary Table 1b: All the differentially expressed genes identified in PBMCs of TIV vaccinees.+++NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP///Genes up-regulated in plasmacytoid dendritic cell 7d vs 0d in young adults (18-50) after exposure to FluMist , time point 7D+++OSMAN_BLOOD_CHAD63_KH_AGE_18_50YO_HIGH_DOSE_SUBJECTS_24HR_UP///Genes up-regulated in blood 24hr vs 0hr in adults (18-50) (high dose subjects) after exposure to ChAd63-KH , time point 24H , administered Intramuscular injection. Comment: DE gene list for high dose subjects.+++QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_CONTRACTION_OF_VZV_SPECIFIC_T_CELLS_PEAK_TO_28DY_AT_1DYPOSITIVE///Genes positively correlated with contraction of VZV specific T cells (peak to 28d) in peripheral blood mononuclear cell in seniors (50-75) after exposure to Zostavax , time point 1D+++THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN///Genes down-regulated in peripheral blood mononuclear cell 28d vs 0d in young adults (21-30) (responders) after exposure to Inactivated influenza vaccine , time point 28D+++THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_DN///Genes down-regulated in peripheral blood mononuclear cell 7d vs 0d in young adults (21-30) (responders) after exposure to Inactivated influenza vaccine , time point 7D. Comment: most (70-80%) of cohort were white+++ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_UP///Genes up-regulated in peripheral blood mononuclear cell 1d vs 0d in adults (20-50) after exposure to MRKAd5 HIV-1 gag/pol/nef , time point 1D. Comment: Table includes specific cell types"	"HALLMARK_COMPLEMENT///Genes encoding components of the complement system, which is part of the innate immune system.+++HALLMARK_UV_RESPONSE_UP///Genes up-regulated in response to ultraviolet (UV) radiation."	NM_001354678	PRKCD				
Q04756	sp|Q04756|HGFA_HUMAN		HGFAC		Hepatocyte growth factor activator OS=Homo sapiens OX=9606 GN=HGFAC PE=1 SV=1	3083	NM_001528	NP_001519	ENST00000382774				MGRWAWVPSPWPPPGLGPFLLLLLLLLLLPRGFQPQPGGNRTESPEPNATATPAIPTILVTSVTSETPATSAPEAEGPQSGGLPPPPRAVPSSSSPQAQALTEDGRPCRFPFRYGGRMLHACTSEGSAHRKWCATTHNYDRDRAWGYCVEATPPPGGPAALDPCASGPCLNGGSCSNTQDPQSYHCSCPRAFTGKDCGTEKCFDETRYEYLEGGDRWARVRQGHVEQCECFGGRTWCEGTRHTACLSSPCLNGGTCHLIVATGTTVCACPPGFAGRLCNIEPDERCFLGNGTGYRGVASTSASGLSCLAWNSDLLYQELHVDSVGAAALLGLGPHAYCRNPDNDERPWCYVVKDSALSWEYCRLEACESLTRVQLSPDLLATLPEPASPGRQACGRRHKKRTFLRPRIIGGSSSLPGSHPWLAAIYIGDSFCAGSLVHTCWVVSAAHCFSHSPPRDSVSVVLGQHFFNRTTDVTQTFGIEKYIPYTLYSVFNPSDHDLVLIRLKKKGDRCATRSQFVQPICLPEPGSTFPAGHKCQIAGWGHLDENVSGYSSSLREALVPLVADHKCSSPEVYGADISPNMLCAGYFDCKSDACQGDSGGPLACEKNGVAYLYGIISWGDGCGRLHKPGVYTRVANYVDWINDRIRPPRRLVAPS	0.5464989	-0.871709552	0.04213999	12.0959184	10.6351316	11.9164549	9.0362128	7.0496667	8.8873148	8.579236564	9.0880079	11.539107	10.0303829	8.674805	11.4094636	10.95181094	9.2506061	8.0223291	7.034067	8.353033	8.5991453	9.450169146	9.15284	9.994206	6.1454072	11.7386904	9.634204	11.57481661	9.27375753	8.2694224	10.448948	9.8264756	11.348213	11.2857981	10.677236	10.9784778	8.3936557	9.8821022	8.2889104	11.0558191	7.2875212	11.798282	11.4959086	11.09652189	11.1113288	10.4604294	9.14640842					GO:0005576///extracellular region+++GO:0005615///extracellular space+++GO:0005737///cytoplasm+++GO:0005791///rough endoplasmic reticulum+++GO:0005829///cytosol	GO:0004252///serine-type endopeptidase activity+++GO:0005515///protein binding+++GO:0008233///peptidase activity+++GO:0008236///serine-type peptidase activity+++GO:0016787///hydrolase activity	GO:0006508///proteolysis+++GO:0007596///blood coagulation+++GO:0031638///zymogen activation			"Homo sapiens HGF activator (HGFAC), transcript variant 2, mRNA."		PF00008///EGF-like domain+++PF00039///Fibronectin type I domain+++PF00040///Fibronectin type II domain+++PF00051///Kringle domain+++PF00089///Trypsin	R-HSA-162582///Signal Transduction+++R-HSA-6806834///Signaling by MET+++R-HSA-6806942///MET Receptor Activation+++R-HSA-9006934///Signaling by Receptor Tyrosine Kinases		KOG1217///calcium ion binding+++KOG3627///serine-type endopeptidase activity		"IPR000001///Kringle+++IPR000083///Fibronectin, type I+++IPR000562///Fibronectin type II domain+++IPR000742///EGF-like domain+++IPR001254///Serine proteases, trypsin domain+++IPR001314///Peptidase S1A, chymotrypsin family+++IPR009003///Peptidase S1, PA clan+++IPR013806///Kringle-like fold+++IPR014394///Coagulation factor XII/hepatocyte growth factor activator+++IPR018056///Kringle, conserved site+++IPR018114///Serine proteases, trypsin family, histidine active site+++IPR033116///Serine proteases, trypsin family, serine active site+++IPR036943///Fibronectin type II domain superfamily+++IPR038178///Kringle superfamily+++IPR043504///Peptidase S1, PA clan, chymotrypsin-like fold"	[HGFA_HUMAN|Reviewed]RecName: Full=Hepatocyte growth factor activator; Short=HGF activator; Short=HGFA; EC=3.4.21.-; Contains: RecName: Full=Hepatocyte growth factor activator short chain; Contains: RecName: Full=Hepatocyte growth factor activator long chain; Flags: Precursor;	chr4p16///Ensembl 103 genes in cytogenetic band chr4p16			REACTOME_MET_RECEPTOR_ACTIVATION///MET Receptor Activation+++REACTOME_SIGNALING_BY_MET///Signaling by MET+++REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES///Signaling by Receptor Tyrosine Kinases	"NABA_MATRISOME_ASSOCIATED///Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors+++NABA_MATRISOME///Ensemble of genes encoding extracellular matrix and extracellular matrix-associated proteins +++NABA_SECRETED_FACTORS///Genes encoding secreted soluble factors"			HNF1_01///Genes having at least one occurence of the transcription factor binding site V$HNF1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++HNF1_Q6///Genes having at least one occurence of the transcription factor binding site V$HNF1_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++RGTTAMWNATT_HNF1_01///Genes having at least one occurence of the highly conserved motif M84 RGTTAMWNATT sites. The motif matches transcription factor binding site V$HNF1_01 (v7.4 TRANSFAC).+++STAT6_02///Genes having at least one occurence of the transcription factor binding site V$STAT6_02 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++TTANTCA_UNKNOWN///Genes having at least one occurence of the highly conserved motif M64 TTANTCA in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).	"ADNP_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9H2P0 (ADNP) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++IGLV5_37_TARGET_GENES///Genes containing one or more binding sites for UniProt:A0A075B6J1 (IGLV5_37) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SUPT16H_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9Y5B9 (SUPT16H) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF436_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9C0F3 (ZNF436) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF528_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q3MIS6 (ZNF528) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF92_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q03936 (ZNF92) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."	CAR_HPX///Neighborhood of HPX+++CAR_IGFBP1///Neighborhood of IGFBP1+++GNF2_CEBPA///Neighborhood of CEBPA+++GNF2_CYP2B6///Neighborhood of CYP2B6+++GNF2_GSTM1///Neighborhood of GSTM1+++GNF2_HPN///Neighborhood of HPN+++GNF2_HPX///Neighborhood of HPX+++GNF2_IGF1///Neighborhood of IGF1+++GNF2_LCAT///Neighborhood of LCAT+++GNF2_TST///Neighborhood of TST		CYCLIN_D1_KE_.V1_UP///Genes up-regulated in MCF-7 cells (breast cancer) over-expressing a mutant K112E form of CCND1 [Gene ID=595] gene.+++KRAS.AMP.LUNG_UP.V1_UP///Genes up-regulated in epithelial lung cancer cell lines over-expressing KRAS [Gene ID=3845] gene.	"GSE12198_CTRL_VS_LOW_IL2_STIM_NK_CELL_DN///Genes down-regulated in NK cells: primary versus stimulated by low dose of IL2 [GeneID=3558].+++GSE12198_LOW_IL2_STIM_NK_CELL_VS_HIGH_IL2_STIM_NK_CELL_DN///Genes down-regulated in NK cells: low dose versus high dose of IL2 [GeneID=3558].+++GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_CORD_BLOOD_UP///Genes up-regulated in transitional B lymphocytes from cord blood: CR2 [GeneID=1380] low versus CR2 [GeneID=1380] high.+++GSE17186_MEMORY_VS_NAIVE_BCELL_DN///Genes down-regulated in B lymphocytes: memory versus nave.+++GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_1H_UP///Genes up-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 1 h.+++GSE20151_CTRL_VS_FUSOBACT_NUCLEATUM_NEUTROPHIL_UP///Genes up-regulated in comparison of contols neutrophils versus those infected with a bacterium (F. nucleatum).+++GSE22025_PROGESTERONE_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_DN///Genes down-regulated in CD4 [GeneID=920] T cells: progesterone [PubChem=5994] versus TGFB1 [GeneID=7040] and progesterone [PubChem=5994].+++GSE22025_UNTREATED_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_DN///Genes down-regulated in CD4 [GeneID=920] T cells: untreated versus TGFB1 [GeneID=7040] and progesterone [PubChem=5994].+++GSE22025_UNTREATED_VS_TGFB1_TREATED_CD4_TCELL_UP///Genes up-regulated in CD4 [GeneID=920] T cells: untreated versus TGFB1 [GeneID=7040].+++GSE22589_HEALTHY_VS_SIV_INFECTED_DC_UP///Genes up-regulated in monocyte-derived dendritic cells: control versus SIV infection.+++GSE2706_LPS_VS_R848_AND_LPS_2H_STIM_DC_DN///Genes down-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 2 h versus DCs stimulated with LPS (TLR4 agonist) and R848 for 2 h.+++GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_2H_UP///Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 and IL4 [GeneID=7040;3565] (2h) versus IL-12 (2h).+++GSE28726_NAIVE_CD4_TCELL_VS_NAIVE_NKTCELL_DN///Genes down-regulated in nave T cells: CD4 [GeneID=920] versus NK.+++GSE28726_NAIVE_VS_ACTIVATED_CD4_TCELL_UP///Genes up-regulated in CD4 [GeneID=920] T cells: nave versus activated.+++GSE28726_NAIVE_VS_ACTIVATED_NKTCELL_UP///Genes up-regulated in NKT cells: nave versus activated.+++GSE29614_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_UP///Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from TIV influenza vaccinee at day 3 post-vaccination versus those at day 7 post-vaccination.+++GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MDC_DN///Genes down-regulated in comparison of myeloid dendritic cells from LAIV influenza vaccinee at day 7 post-vaccination vesus those from TIV influenza vaccinee at day 7.+++GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MONOCYTE_DN///Genes down-regulated in comparison of monocytes from LAIV influenza vaccinee pre-vaccination versus those at day 7 post-vaccination+++GSE34156_NOD2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_DN///Genes down-regulated in monocytes (6h): muramyl dipeptide [PubChem=11620162] versus muramyl dipeptide [PubChem=11620162] and M. tuberculosis 19 kDa lipopeptide.+++GSE360_CTRL_VS_L_MAJOR_DC_DN///Genes down-regulated in untreated dendritic cells (DC) versus DCs exposed to parasite L. major.+++GSE360_L_DONOVANI_VS_L_MAJOR_DC_DN///Genes down-regulated in comparison of dendritic cells (DC) exposed to L. donovani versus DCs exposed to L. major.+++GSE7568_CTRL_VS_24H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_UP///Genes up-regulated in macrophages differentiated in the presence of IL4 [GeneID=3565] and dexamethasone [PubChem=5743] for 5 days versus those subsequently treated with TGFB1 [GeneID=7040] for 24h.+++GSE8835_CD4_VS_CD8_TCELL_CLL_PATIENT_UP///Genes up-regulated in T cells from CLL (chronic lymphocytic leukemia) patients: CD4 [GeneID=920] versus CD8.+++NAKAYA_B_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN///Genes down-regulated in B cell 7d vs 0d in young adults (18-50) after exposure to Fluarix/Fluvirin , time point 7D"	HALLMARK_XENOBIOTIC_METABOLISM///Genes encoding proteins involved in processing of drugs and other xenobiotics.	NM_001528	HGFAC				
Q00688	sp|Q00688|FKBP3_HUMAN		FKBP3		Peptidyl-prolyl cis-trans isomerase FKBP3 OS=Homo sapiens OX=9606 GN=FKBP3 PE=1 SV=1	2287	NM_002013	NP_002004	ENST00000396062				MAAAVPQRAWTVEQLRSEQLPKKDIIKFLQEHGSDSFLAEHKLLGNIKNVAKTANKDHLVTAYNHLFETKRFKGTESISKVSEQVKNVKLNEDKPKETKSEETLDEGPPKYTKSVLKKGDKTNFPKKGDVVHCWYTGTLQDGTVFDTNIQTSAKKKKNAKPLSFKVGVGKVIRGWDEALLTMSKGEKARLEIEPEWAYGKKGQPDAKIPPNAKLTFEVELVDID	0.483462	-1.04852556	0.001013534		4.9295763	3.507533		3.35802	5.6321798	4.202647855	4.8491765	5.3719928	5.8384357	6.0885746	6.2571025			4.9103507	5.2380426		4.1299964			6.2522382	5.4310801	7.1118713		4.87690364			7.541219	6.6807367	6.764662	6.7579149	5.225002	4.548525	5.443436	5.1922861	6.1293487	5.6869658	6.4255254	7.043397	6.7436113	5.28375523	6.9329076	5.2661433	6.53057367					GO:0005634///nucleus	GO:0003723///RNA binding+++GO:0003755///peptidyl-prolyl cis-trans isomerase activity+++GO:0005515///protein binding+++GO:0005528///FK506 binding+++GO:0016853///isomerase activity+++GO:0038023///signaling receptor activity	GO:0000413///protein peptidyl-prolyl isomerization	tissueType=Fetal kidney;cancerType=Normal;cellName=Natural killer T (NKT) cell		"Homo sapiens FKBP prolyl isomerase 3 (FKBP3), mRNA."		PF00254///FKBP-type peptidyl-prolyl cis-trans isomerase+++PF18410///Basic tilted helix bundle domain			KOG0544///Peptidyl-prolyl cis-trans isomerase		"IPR001179///FKBP-type peptidyl-prolyl cis-trans isomerase domain+++IPR041200///FKBP3, basic tilted helix bundle domain+++IPR043368///Peptidyl-prolyl cis-trans isomerase FKBP3"	[FKBP3_HUMAN|Reviewed]RecName: Full=Peptidyl-prolyl cis-trans isomerase FKBP3; Short=PPIase FKBP3; EC=5.2.1.8; AltName: Full=25 kDa FK506-binding protein; Short=25 kDa FKBP; Short=FKBP-25; AltName: Full=FK506-binding protein 3; Short=FKBP-3; AltName: Full=Immunophilin FKBP25; AltName: Full=Rapamycin-selective 25 kDa immunophilin; AltName: Full=Rotamase;	chr14q21///Ensembl 103 genes in cytogenetic band chr14q21					"AACTGGA_MIR145///Genes having at least one occurence of the motif AACTGGA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-145 (v7.1 miRBase).+++TGTTTAC_MIR30A5P_MIR30C_MIR30D_MIR30B_MIR30E5P///Genes having at least one occurence of the motif TGTTTAC in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-30a-5p, hsa-miR-30c, hsa-miR-30d, hsa-miR-30b and hsa-miR-30e-5p (v7.1 miRBase)."	"MIR11399///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-11399 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR145_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-145-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR30A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-30a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR30B_5P_MIR30C_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-30b-5p, hsa-miR-30c-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR30D_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-30d-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR30E_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-30e-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3922_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3922-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4764_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4764-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5195_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5195-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR589_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-589-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7109_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7109-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR8065///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-8065 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets)."	ACAWNRNSRCGG_UNKNOWN///Genes having at least one occurence of the highly conserved motif M103 ACAWNRNSRCGG in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++AP4_01///Genes having at least one occurence of the transcription factor binding site V$AP4_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++CAGGTA_AREB6_01///Genes having at least one occurence of the highly conserved motif M76 CAGGTA sites. The motif matches transcription factor binding site V$AREB6_01 (v7.4 TRANSFAC).+++CEBP_C///Genes having at least one occurence of the transcription factor binding site V$CEBP_C (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++CTTTAAR_UNKNOWN///Genes having at least one occurence of the highly conserved motif M29 CTTTAAR in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++GATTGGY_NFY_Q6_01///Genes having at least one occurence of the highly conserved motif M5 GATTGGY sites. The motif matches transcription factor binding site V$NFY_Q6_01 (v7.4 TRANSFAC).+++HIF1_Q3///Genes having at least one occurence of the transcription factor binding site V$HIF1_Q3 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++HIF1_Q5///Genes having at least one occurence of the transcription factor binding site V$HIF1_Q5 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++MEIS1_01///Genes having at least one occurence of the transcription factor binding site V$MEIS1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++TGACAGNY_MEIS1_01///Genes having at least one occurence of the highly conserved motif M41 TGACAGNY sites. The motif matches transcription factor binding site V$MEIS1_01 (v7.4 TRANSFAC).+++TGIF_01///Genes having at least one occurence of the transcription factor binding site V$TGIF_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.	"ADA2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9NZK5 (ADA2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++BARX2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9UMQ3 (BARX2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++DLX4_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q92988 (DLX4) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HOXA2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O43364 (HOXA2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HSD17B8_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q92506 (HSD17B8) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++LHX9_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9NQ69 (LHX9) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NKX2_2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O95096 (NKX2_2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++PRKDC_TARGET_GENES///Genes containing one or more binding sites for UniProt:P78527 (PRKDC) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++RORA_TARGET_GENES///Genes containing one or more binding sites for UniProt:P35398 (RORA) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SALL4_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9UJQ4 (SALL4) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SUMO1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P63165 (SUMO1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++UBN1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9NPG3 (UBN1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZBTB12_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9Y330 (ZBTB12) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZFHX3_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q15911 (ZFHX3) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF350_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9GZX5 (ZNF350) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF563_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8TA94 (ZNF563) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZSCAN29_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8IWY8 (ZSCAN29) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."		MODULE_453///Genes in the cancer module 453.	CYCLIN_D1_KE_.V1_DN///Genes down-regulated in MCF-7 cells (breast cancer) over-expressing a mutant K112E form of CCND1 [Gene ID=595] gene.	"ERWIN_COHEN_BLOOD_LIVE_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_14DY_UP///Genes up-regulated in blood vaccinated vs control in adults (23-48) after exposure to Live attenuated vaccine TC-83 , time point 14D+++GSE14000_TRANSLATED_RNA_VS_MRNA_4H_LPS_DC_UP///Genes up-regulated in comparison of polysome bound (translated) mRNA versus total mRNA 4 h after LPS (TLR4 agonist) stimulation.+++GSE1432_6H_VS_24H_IFNG_MICROGLIA_DN///Genes down-regulated in comparison of microglia cells 6 h after stimulation with IFNG [GeneID=3458] versus microglia cells 24 h after the stimulation.+++GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_CORD_BLOOD_UP///Genes up-regulated in comparison of intrathymic T progenitor cells (ITTP) versus naive CD4 [GeneID=920] T cells from cord blood.+++GSE1460_NAIVE_CD4_TCELL_CORD_BLOOD_VS_THYMIC_STROMAL_CELL_DN///Genes down-regulated in naive CD4 [GeneID=920] T cells from cord blood versus thymic stromal cells.+++GSE24634_TREG_VS_TCONV_POST_DAY10_IL4_CONVERSION_UP///Genes up-regulated in comparison of CD25+ regulatory T cell (Treg) treated with IL4 [GeneID=3565] at day 10 versus CD25- T cells treated with IL4 [GeneID=3565] at 10 h.+++GSE29614_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_DN///Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from TIV influenza vaccinee at day 3 post-vaccination versus those at day 7 post-vaccination.+++GSE29618_PRE_VS_DAY7_FLU_VACCINE_MDC_DN///Genes down-regulated in comparison of plasmacytoid dendritic cells (DC) from influenza vaccinee at day 0 versus myeloid DCs at day 7 post-vaccination.+++GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MDC_DN///Genes down-regulated in comparison of myeloid dendritic cells (mDC) from TIV influenza vaccinee pre-vaccination versus those at day 7 post-vaccination.+++GSE3982_EOSINOPHIL_VS_BASOPHIL_DN///Genes down-regulated in comparison of eosinophils versus basophils.+++GSE3982_MAC_VS_NEUTROPHIL_UP///Genes up-regulated in comparison of macrophages versus neutrophils.+++GSE3982_MAST_CELL_VS_NEUTROPHIL_UP///Genes up-regulated in comparison of mast cells versus neutrophils.+++HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_3DY_NEGATIVE///Genes negatively correlated with memory B cell response at 28d in peripheral blood mononuclear cell in seniors (50-74) after exposure to Fluarix , time point 3D+++THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_UP///Genes up-regulated in peripheral blood mononuclear cell 28d vs 0d in young adults (21-30) (responders) after exposure to Inactivated influenza vaccine , time point 28D"		NM_002013	FKBP3				
P68431	sp|P68431|H31_HUMAN		H3C10		Histone H3.1 OS=Homo sapiens OX=9606 GN=H3C1 PE=1 SV=2	8357	NM_003536	NP_003527	ENST00000369163	K11253			MARTKQTARKSTGGKAPRKQLATKAARKSAPATGGVKKPHRYRPGTVALREIRRYQKSTELLIRKLPFQRLVREIAQDFKTDLRFQSSAVMALQEACEAYLVGLFEDTNLCAIHAKRVTIMPKDIQLARRIRGERA	0.5096618	-0.972387917	0.03288797	7.7991557	8.9483797	6.3455547	10.771422	10.131618	11.4318238	9.926864018	9.3224079	11.2605249	11.5147498	12.0603211	12.0431255	9.73102578	8.5601707	12.6113006	11.8194035	9.4520507	7.6432517	6.251285669	7.7255714	8.8638318	9.0260358	11.9740316	10.5065728	10.35336263	10.17301178	11.9883873	11.036959	10.7017918	9.695741	9.5017322	7.826036	9.3442828	12.2118557	11.9159174	11.2773617	10.8720574	11.7432796	11.330485	11.4144659	9.96440526	10.0620688	8.7717714	11.9668315	04613///Neutrophil extracellular trap formation+++05034///Alcoholism+++05131///Shigellosis+++05202///Transcriptional misregulation in cancer+++05322///Systemic lupus erythematosus	H01470///Giant cell tumor of bone			GO:0000228///nuclear chromosome+++GO:0000786///nucleosome+++GO:0005576///extracellular region+++GO:0005634///nucleus+++GO:0005654///nucleoplasm+++GO:0016020///membrane+++GO:0032991///protein-containing complex+++GO:0070062///extracellular exosome	GO:0003677///DNA binding+++GO:0005515///protein binding+++GO:0045296///cadherin binding+++GO:0046982///protein heterodimerization activity	"GO:0000183///chromatin silencing at rDNA+++GO:0006325///chromatin organization+++GO:0006334///nucleosome assembly+++GO:0006335///DNA replication-dependent nucleosome assembly+++GO:0007596///blood coagulation+++GO:0032200///telomere organization+++GO:0038111///interleukin-7-mediated signaling pathway+++GO:0045652///regulation of megakaryocyte differentiation+++GO:0045814///negative regulation of gene expression, epigenetic+++GO:0060765///regulation of androgen receptor signaling pathway+++GO:0060964///regulation of gene silencing by miRNA+++GO:0060968///regulation of gene silencing+++GO:1990000///amyloid fibril formation"			"Homo sapiens H3 clustered histone 10 (H3C10), mRNA."		PF00125///Core histone H2A/H2B/H3/H4	"R-HSA-109582///Hemostasis+++R-HSA-1266695///Interleukin-7 signaling+++R-HSA-1266738///Developmental Biology+++R-HSA-1280215///Cytokine Signaling in Immune system+++R-HSA-1474165///Reproduction+++R-HSA-1500620///Meiosis+++R-HSA-157118///Signaling by NOTCH+++R-HSA-162582///Signal Transduction+++R-HSA-1640170///Cell Cycle+++R-HSA-1643685///Disease+++R-HSA-168256///Immune System+++R-HSA-1912408///Pre-NOTCH Transcription and Translation+++R-HSA-1912422///Pre-NOTCH Expression and Processing+++R-HSA-194315///Signaling by Rho GTPases+++R-HSA-195258///RHO GTPase Effectors+++R-HSA-195721///Signaling by WNT+++R-HSA-201681///TCF dependent signaling in response to WNT+++R-HSA-201722///Formation of the beta-catenin:TCF transactivating complex+++R-HSA-211000///Gene Silencing by RNA+++R-HSA-212165///Epigenetic regulation of gene expression+++R-HSA-212300///PRC2 methylates histones and DNA+++R-HSA-212436///Generic Transcription Pathway+++R-HSA-2262752///Cellular responses to stress+++R-HSA-2299718///Condensation of Prophase Chromosomes+++R-HSA-2559580///Oxidative Stress Induced Senescence+++R-HSA-2559582///Senescence-Associated Secretory Phenotype (SASP)+++R-HSA-2559583///Cellular Senescence+++R-HSA-3214815///HDACs deacetylate histones+++R-HSA-3214841///PKMTs methylate histone lysines+++R-HSA-3214842///HDMs demethylate histones+++R-HSA-3214847///HATs acetylate histones+++R-HSA-3214858///RMTs methylate histone arginines+++R-HSA-3247509///Chromatin modifying enzymes+++R-HSA-392499///Metabolism of proteins+++R-HSA-427359///SIRT1 negatively regulates rRNA expression+++R-HSA-427389///ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression+++R-HSA-427413///NoRC negatively regulates rRNA expression+++R-HSA-449147///Signaling by Interleukins+++R-HSA-4839726///Chromatin organization+++R-HSA-5250913///Positive epigenetic regulation of rRNA expression+++R-HSA-5250924///B-WICH complex positively regulates rRNA expression+++R-HSA-5250941///Negative epigenetic regulation of rRNA expression+++R-HSA-5334118///DNA methylation+++R-HSA-5578749///Transcriptional regulation by small RNAs+++R-HSA-5617472///Activation of anterior HOX genes in hindbrain development during early embryogenesis+++R-HSA-5619507///Activation of HOX genes during differentiation+++R-HSA-5625740///RHO GTPases activate PKNs+++R-HSA-5625886///Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3+++R-HSA-5663205///Infectious disease+++R-HSA-68616///Assembly of the ORC complex at the origin of replication+++R-HSA-68867///Assembly of the pre-replicative complex+++R-HSA-68875///Mitotic Prophase+++R-HSA-68886///M Phase+++R-HSA-69002///DNA Replication Pre-Initiation+++R-HSA-69278///Cell Cycle, Mitotic+++R-HSA-69306///DNA Replication+++R-HSA-73728///RNA Polymerase I Promoter Opening+++R-HSA-73772///RNA Polymerase I Promoter Escape+++R-HSA-73854///RNA Polymerase I Promoter Clearance+++R-HSA-73857///RNA Polymerase II Transcription+++R-HSA-73864///RNA Polymerase I Transcription+++R-HSA-74160///Gene expression (Transcription)+++R-HSA-8878171///Transcriptional regulation by RUNX1+++R-HSA-8936459///RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function+++R-HSA-8939211///ESR-mediated signaling+++R-HSA-8939236///RUNX1 regulates transcription of genes involved in differentiation of HSCs+++R-HSA-8953897///Cellular responses to stimuli+++R-HSA-9006931///Signaling by Nuclear Receptors+++R-HSA-9018519///Estrogen-dependent gene expression+++R-HSA-912446///Meiotic recombination+++R-HSA-9609646///HCMV Infection+++R-HSA-9609690///HCMV Early Events+++R-HSA-9610379///HCMV Late Events+++R-HSA-9616222///Transcriptional regulation of granulopoiesis+++R-HSA-9645723///Diseases of programmed cell death+++R-HSA-9710421///Defective pyroptosis+++R-HSA-9716542///Signaling by Rho GTPases, Miro GTPases and RHOBTB3+++R-HSA-977225///Amyloid fiber formation+++R-HSA-983231///Factors involved in megakaryocyte development and platelet production"		KOG1745///protein heterodimerization activity		IPR000164///Histone H3/CENP-A+++IPR007125///Histone H2A/H2B/H3+++IPR009072///Histone-fold	[H31_HUMAN|Reviewed]RecName: Full=Histone H3.1; AltName: Full=Histone H3/a; AltName: Full=Histone H3/b; AltName: Full=Histone H3/c; AltName: Full=Histone H3/d; AltName: Full=Histone H3/f; AltName: Full=Histone H3/h; AltName: Full=Histone H3/i; AltName: Full=Histone H3/j; AltName: Full=Histone H3/k; AltName: Full=Histone H3/l;	chr6p22///Ensembl 103 genes in cytogenetic band chr6p22		KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS///Systemic lupus erythematosus	"REACTOME_ACTIVATED_PKN1_STIMULATES_TRANSCRIPTION_OF_AR_ANDROGEN_RECEPTOR_REGULATED_GENES_KLK2_AND_KLK3///Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3+++REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS///Activation of anterior HOX genes in hindbrain development during early embryogenesis+++REACTOME_AMYLOID_FIBER_FORMATION///Amyloid fiber formation+++REACTOME_B_WICH_COMPLEX_POSITIVELY_REGULATES_RRNA_EXPRESSION///B-WICH complex positively regulates rRNA expression+++REACTOME_CELL_CYCLE///Cell Cycle+++REACTOME_CELL_CYCLE_MITOTIC///Cell Cycle, Mitotic+++REACTOME_CELLULAR_RESPONSES_TO_EXTERNAL_STIMULI///Cellular responses to external stimuli+++REACTOME_CELLULAR_SENESCENCE///Cellular Senescence+++REACTOME_CHROMATIN_MODIFYING_ENZYMES///Chromatin modifying enzymes+++REACTOME_CONDENSATION_OF_PROPHASE_CHROMOSOMES///Condensation of Prophase Chromosomes+++REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM///Cytokine Signaling in Immune system+++REACTOME_DEVELOPMENTAL_BIOLOGY///Developmental Biology+++REACTOME_DISEASES_OF_PROGRAMMED_CELL_DEATH///Diseases of programmed cell death+++REACTOME_DNA_METHYLATION///DNA methylation+++REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION///Epigenetic regulation of gene expression+++REACTOME_ERCC6_CSB_AND_EHMT2_G9A_POSITIVELY_REGULATE_RRNA_EXPRESSION///ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression+++REACTOME_ESR_MEDIATED_SIGNALING///ESR-mediated signaling+++REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION///Estrogen-dependent gene expression+++REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION///Factors involved in megakaryocyte development and platelet production+++REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX///Formation of the beta-catenin:TCF transactivating complex+++REACTOME_GENE_SILENCING_BY_RNA///Gene Silencing by RNA+++REACTOME_HATS_ACETYLATE_HISTONES///HATs acetylate histones+++REACTOME_HCMV_EARLY_EVENTS///HCMV Early Events+++REACTOME_HCMV_INFECTION///HCMV Infection+++REACTOME_HCMV_LATE_EVENTS///HCMV Late Events+++REACTOME_HDACS_DEACETYLATE_HISTONES///HDACs deacetylate histones+++REACTOME_HDMS_DEMETHYLATE_HISTONES///HDMs demethylate histones+++REACTOME_HEMOSTASIS///Hemostasis+++REACTOME_INFECTIOUS_DISEASE///Infectious disease+++REACTOME_INTERLEUKIN_7_SIGNALING///Interleukin-7 signaling+++REACTOME_MEIOSIS///Meiosis+++REACTOME_MEIOTIC_RECOMBINATION///Meiotic recombination+++REACTOME_MITOTIC_PROPHASE///Mitotic Prophase+++REACTOME_M_PHASE///M Phase+++REACTOME_NEGATIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION///Negative epigenetic regulation of rRNA expression+++REACTOME_OXIDATIVE_STRESS_INDUCED_SENESCENCE///Oxidative Stress Induced Senescence+++REACTOME_PKMTS_METHYLATE_HISTONE_LYSINES///PKMTs methylate histone lysines+++REACTOME_POSITIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION///Positive epigenetic regulation of rRNA expression+++REACTOME_PRC2_METHYLATES_HISTONES_AND_DNA///PRC2 methylates histones and DNA+++REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING///Pre-NOTCH Expression and Processing+++REACTOME_REPRODUCTION///Reproduction+++REACTOME_RHO_GTPASE_EFFECTORS///RHO GTPase Effectors+++REACTOME_RHO_GTPASES_ACTIVATE_PKNS///RHO GTPases activate PKNs+++REACTOME_RMTS_METHYLATE_HISTONE_ARGININES///RMTs methylate histone arginines+++REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION///RNA Polymerase II Transcription+++REACTOME_RNA_POLYMERASE_I_PROMOTER_ESCAPE///RNA Polymerase I Promoter Escape+++REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION///RNA Polymerase I Transcription+++REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION///RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function+++REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_HSCS///RUNX1 regulates transcription of genes involved in differentiation of HSCs+++REACTOME_SENESCENCE_ASSOCIATED_SECRETORY_PHENOTYPE_SASP///Senescence-Associated Secretory Phenotype (SASP)+++REACTOME_SIGNALING_BY_INTERLEUKINS///Signaling by Interleukins+++REACTOME_SIGNALING_BY_NOTCH///Signaling by NOTCH+++REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS///Signaling by Nuclear Receptors+++REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3///Signaling by Rho GTPases, Miro GTPases and RHOBTB3+++REACTOME_SIGNALING_BY_WNT///Signaling by WNT+++REACTOME_SIRT1_NEGATIVELY_REGULATES_RRNA_EXPRESSION///SIRT1 negatively regulates rRNA expression+++REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT///TCF dependent signaling in response to WNT+++REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1///Transcriptional regulation by RUNX1+++REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS///Transcriptional regulation by small RNAs+++REACTOME_TRANSCRIPTIONAL_REGULATION_OF_GRANULOPOIESIS///Transcriptional regulation of granulopoiesis"				KRCTCNNNNMANAGC_UNKNOWN///Genes having at least one occurence of the highly conserved motif M120 KRCTCNNNNMANAGC in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++TATAAA_TATA_01///Genes having at least one occurence of the highly conserved motif M51 TATAAA sites. The motif matches transcription factor binding site V$TATA_01 (v7.4 TRANSFAC).+++TTTNNANAGCYR_UNKNOWN///Genes having at least one occurence of the highly conserved motif M169 TTTNNANAGCYR in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).	"ATF5_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9Y2D1 (ATF5) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++BARX2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9UMQ3 (BARX2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++CREB3L4_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8TEY5 (CREB3L4) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++FOXE1_TARGET_GENES///Genes containing one or more binding sites for UniProt:O00358 (FOXE1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++GTF2E2_TARGET_GENES///Genes containing one or more binding sites for UniProt:P29084 (GTF2E2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++KAT5_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q92993 (KAT5) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++LHX9_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9NQ69 (LHX9) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NKX2_2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O95096 (NKX2_2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NPAT_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q14207 (NPAT) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++PAX6_TARGET_GENES///Genes containing one or more binding sites for UniProt:P26367 (PAX6) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++PIAS4_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8N2W9 (PIAS4) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++PSMB5_TARGET_GENES///Genes containing one or more binding sites for UniProt:P28074 (PSMB5) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SETD7_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8WTS6 (SETD7) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++THAP1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9NVV9 (THAP1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZSCAN5DP_TARGET_GENES///Genes containing one or more binding sites for UniProt:P0CG00 (ZSCAN5DP) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."		MODULE_117///Signaling.+++MODULE_340///Genes in the cancer module 340.+++MODULE_99///Genes in the cancer module 99.	"EGFR_UP.V1_DN///Genes down-regulated in MCF-7 cells (breast cancer) positive for ESR1 [Gene ID=2099] and engineered to express ligand-activatable EGFR [Gene ID=1956].+++LTE2_UP.V1_DN///Genes down-regulated in MCF-7 cells (breast cancer) positive for ESR1 [Gene ID=2099] MCF-7 cells (breast cancer) and long-term adapted for estrogen-independent growth.+++MEK_UP.V1_DN///Genes down-regulated in MCF-7 cells (breast cancer) positive for ESR1 [Gene ID=2099] MCF-7 cells (breast cancer) stably over-expressing constitutively active MAP2K1 [Gene ID=5604] gene.+++MTOR_UP.N4.V1_DN///Genes down-regulated in CEM-C1 cells (T-CLL) in comparison of control vs rapamycin (sirolimus) [PubChem=6610346], an mTOR pathway inhibitor.+++STK33_SKM_UP///Genes up-regulated in SKM-1 cells (AML) after knockdown of STK33 [Gene ID=65975] by RNAi."	"GSE13485_DAY3_VS_DAY7_YF17D_VACCINE_PBMC_DN///Genes down-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) 3 days after stimulation with YF17D vaccine versus PBMC 7 days after the stimulation.+++GSE14000_4H_VS_16H_LPS_DC_DN///Genes down-regulated in comparison of dendritic cells (DC) at 4 h after LPS (TLR4 agonist) stimulation versus those at 16 h after the stimulation.+++GSE14000_UNSTIM_VS_16H_LPS_DC_DN///Genes down-regulated in comparison of dendritic cells (DC) before and 16 h after LPS (TLR4 agonist) stimulation.+++GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP///Genes up-regulated in comparison of CD4 [GeneID=920] thymocytes versus naive CD4 [GeneID=920] T cells from adult blood.+++GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP///Genes up-regulated in comparison of CD4 [GeneID=920] CD8 thymocytes versus naive CD4 [GeneID=920] T cells from adult blood.+++GSE1460_DP_VS_CD4_THYMOCYTE_UP///Genes up-regulated in comparison of CD4 [GeneID=920] CD8 thymocytes versus T cells from cord blood.+++GSE22886_NAIVE_CD4_TCELL_VS_NEUTROPHIL_DN///Genes down-regulated in comparison of naive CD4 [GeneID=920] T cells versus unstimulated neutrophils.+++GSE22886_NEUTROPHIL_VS_MONOCYTE_UP///Genes up-regulated in comparison of neuthrophils versus monocytes.+++GSE2706_R848_VS_R848_AND_LPS_8H_STIM_DC_UP///Genes up-regulated in comparison of dendritic cells (DC) stimulated with R848 at 8 h versus DCs stimulated with LPS (TLR4 agonist) and R848 for 8 h.+++GSE28726_NAIVE_VS_ACTIVATED_CD4_TCELL_UP///Genes up-regulated in CD4 [GeneID=920] T cells: nave versus activated.+++GSE360_L_MAJOR_VS_T_GONDII_DC_UP///Genes up-regulated in comparison of dendritic cells (DC) exposed to L. major versus DCs exposed to T. gondii.+++GSE3982_BCELL_VS_BASOPHIL_DN///Genes down-regulated in comparison of B cells versus basophils.+++GSE3982_EFF_MEMORY_VS_CENT_MEMORY_CD4_TCELL_DN///Genes down-regulated in comparison of effective memory CD4 [GeneID=920] T cells versus central memory CD4 [GeneID=920] T cells.+++NAKAYA_PBMC_FLUMIST_AGE_18_50YO_7DY_DN///Genes down-regulated in peripheral blood mononuclear cell 7d vs 0d in adults (18-50) after exposure to FluMist , time point 7D. Comment: Supplementary Table 1a: All the differentially expressed genes identified in PBMCs of TIV vaccinees.+++THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_UP///Genes up-regulated in peripheral blood mononuclear cell 28d vs 0d in young adults (21-30) (responders) after exposure to Inactivated influenza vaccine , time point 28D+++VAN_DEN_BIGGELAAR_PBMC_PREVNAR_9MO_INFANT_STIMULATED_VS_UNSTIMULATED_9MO_UP///Genes up-regulated in peripheral blood mononuclear cell stimulated vs unstimulated in infants (9m) (infant) after exposure to Prevnar (USA) , time point 9M"		NM_003536	H3C10				
P68402	sp|P68402|PA1B2_HUMAN				Platelet-activating factor acetylhydrolase IB subunit alpha2 OS=Homo sapiens OX=9606 GN=PAFAH1B2 PE=1 SV=1 >tr|V9HW44|V9HW44_HUMAN Epididymis secretory protein Li 303 OS=Homo sapiens OX=9606 GN=HEL-S-303 PE=2 SV=1								MSQGDSNPAAIPHAAEDIQGDDRWMSQHNRFVLDCKDKEPDVLFVGDSMVQLMQQYEIWRELFSPLHALNFGIGGDTTRHVLWRLKNGELENIKPKVIVVWVGTNNHENTAEEVAGGIEAIVQLINTRQPQAKIIVLGLLPRGEKPNPLRQKNAKVNQLLKVSLPKLANVQLLDTDGGFVHSDGAISCHDMFDFLHLTGGGYAKICKPLHELIMQLLEETPEEKQTTIA	0.5445518	-0.876858809	0.01377025			2.5536386		3.3512495		2.974495474	2.9481533	4.1341844	4.0777172	2.5745807	4.0175398	2.13634232	4.8989513	3.0177977	3.3820901						3.6413022	2.7834235	3.4302038	4.41840825	2.33614103	3.6901229	6.370914	5.5258883	4.271394	6.060117			4.1663152	3.7265974	3.7238304	4.4552863	3.677654	5.750419	3.9628488	4.06334195	5.6675663	2.9225785	3.77726803																																	C9606_137904					
P68366	sp|P68366|TBA4A_HUMAN		TUBA4A		Tubulin alpha-4A chain OS=Homo sapiens OX=9606 GN=TUBA4A PE=1 SV=1	7277	NM_006000	NP_005991	ENST00000248437	K07374			MRECISVHVGQAGVQMGNACWELYCLEHGIQPDGQMPSDKTIGGGDDSFTTFFCETGAGKHVPRAVFVDLEPTVIDEIRNGPYRQLFHPEQLITGKEDAANNYARGHYTIGKEIIDPVLDRIRKLSDQCTGLQGFLVFHSFGGGTGSGFTSLLMERLSVDYGKKSKLEFSIYPAPQVSTAVVEPYNSILTTHTTLEHSDCAFMVDNEAIYDICRRNLDIERPTYTNLNRLISQIVSSITASLRFDGALNVDLTEFQTNLVPYPRIHFPLATYAPVISAEKAYHEQLSVAEITNACFEPANQMVKCDPRHGKYMACCLLYRGDVVPKDVNAAIAAIKTKRSIQFVDWCPTGFKVGINYQPPTVVPGGDLAKVQRAVCMLSNTTAIAEAWARLDHKFDLMYAKRAFVHWYVGEGMEEGEFSEAREDMAALEKDYEEVGIDSYEDEDEGEE	0.4439744	-1.171451694	0.007201674	0.612411	3.4044409		3.7135582	5.0597391	3.2075118		3.9504731	5.0851957	5.2729661	4.3917295	5.6236582	0.09438702	6.151118	4.5931842	5.544523	3.6243986	4.5365569			2.9551905	4.8430693	3.0720621					5.634678	5.7573701	6.255777	6.1908556	3.623754	5.264617	5.5827497	4.4592329	6.0290965	5.5525952	4.7932415	6.659961	4.9816684	4.70869342	5.5488949	5.0871544	4.54783946	04145///Phagosome+++04210///Apoptosis+++04530///Tight junction+++04540///Gap junction+++05010///Alzheimer disease+++05012///Parkinson disease+++05014///Amyotrophic lateral sclerosis+++05016///Huntington disease+++05020///Prion disease+++05022///Pathways of neurodegeneration - multiple diseases+++05130///Pathogenic Escherichia coli infection+++05132///Salmonella infection	H00058///Amyotrophic lateral sclerosis (ALS)+++H00268///Lissencephaly+++H00789///Keratoconus+++H01881///Complex cortical dysplasia with other brain malformations			GO:0005576///extracellular region+++GO:0005737///cytoplasm+++GO:0005829///cytosol+++GO:0005856///cytoskeleton+++GO:0005874///microtubule+++GO:0015630///microtubule cytoskeleton+++GO:0070062///extracellular exosome	GO:0000166///nucleotide binding+++GO:0003924///GTPase activity+++GO:0005200///structural constituent of cytoskeleton+++GO:0005515///protein binding+++GO:0005525///GTP binding+++GO:0019901///protein kinase binding	GO:0000086///G2/M transition of mitotic cell cycle+++GO:0000226///microtubule cytoskeleton organization+++GO:0000278///mitotic cell cycle+++GO:0002576///platelet degranulation+++GO:0007010///cytoskeleton organization+++GO:0007017///microtubule-based process+++GO:0010389///regulation of G2/M transition of mitotic cell cycle+++GO:0097711///ciliary basal body-plasma membrane docking	tissueType=Liver;cancerType=Normal;cellName=Liver bud hepatic cell+++tissueType=Fetal kidney;cancerType=Normal;cellName=Natural killer T (NKT) cell+++tissueType=Fetal gonad;cancerType=Normal;cellName=Oogenesis phase fetal germ cell		"Homo sapiens tubulin alpha 4a (TUBA4A), transcript variant 1, mRNA."		"PF00091///Tubulin/FtsZ family, GTPase domain+++PF03953///Tubulin C-terminal domain"	"R-HSA-109582///Hemostasis+++R-HSA-112314///Neurotransmitter receptors and postsynaptic signal transmission+++R-HSA-112315///Transmission across Chemical Synapses+++R-HSA-112316///Neuronal System+++R-HSA-114608///Platelet degranulation +++R-HSA-1266738///Developmental Biology+++R-HSA-1280218///Adaptive Immune System+++R-HSA-1445148///Translocation of SLC2A4 (GLUT4) to the plasma membrane+++R-HSA-157858///Gap junction trafficking and regulation+++R-HSA-162582///Signal Transduction+++R-HSA-1632852///Macroautophagy+++R-HSA-1640170///Cell Cycle+++R-HSA-1643685///Disease+++R-HSA-168256///Immune System+++R-HSA-1852241///Organelle biogenesis and maintenance+++R-HSA-190828///Gap junction trafficking+++R-HSA-190840///Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane+++R-HSA-190861///Gap junction assembly+++R-HSA-190872///Transport of connexons to the plasma membrane+++R-HSA-194315///Signaling by Rho GTPases+++R-HSA-195258///RHO GTPase Effectors+++R-HSA-199977///ER to Golgi Anterograde Transport+++R-HSA-199991///Membrane Trafficking+++R-HSA-2132295///MHC class II antigen presentation+++R-HSA-2262752///Cellular responses to stress+++R-HSA-2467813///Separation of Sister Chromatids+++R-HSA-2500257///Resolution of Sister Chromatid Cohesion+++R-HSA-2555396///Mitotic Metaphase and Anaphase+++R-HSA-2565942///Regulation of PLK1 Activity at G2/M Transition+++R-HSA-2995410///Nuclear Envelope (NE) Reassembly+++R-HSA-3371497///HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand+++R-HSA-373760///L1CAM interactions+++R-HSA-380259///Loss of Nlp from mitotic centrosomes+++R-HSA-380270///Recruitment of mitotic centrosome proteins and complexes+++R-HSA-380284///Loss of proteins required for interphase microtubule organization from the centrosome+++R-HSA-380287///Centrosome maturation+++R-HSA-380320///Recruitment of NuMA to mitotic centrosomes+++R-HSA-389957///Prefoldin mediated transfer of substrate  to CCT/TriC+++R-HSA-389958///Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding+++R-HSA-389960///Formation of tubulin folding intermediates by CCT/TriC+++R-HSA-389977///Post-chaperonin tubulin folding pathway+++R-HSA-390466///Chaperonin-mediated protein folding+++R-HSA-391251///Protein folding+++R-HSA-392499///Metabolism of proteins+++R-HSA-422475///Axon guidance+++R-HSA-437239///Recycling pathway of L1+++R-HSA-438064///Post NMDA receptor activation events+++R-HSA-442755///Activation of NMDA receptors and postsynaptic events+++R-HSA-446203///Asparagine N-linked glycosylation+++R-HSA-453274///Mitotic G2-G2/M phases+++R-HSA-5358351///Signaling by Hedgehog+++R-HSA-5610787///Hedgehog 'off' state+++R-HSA-5617833///Cilium Assembly+++R-HSA-5620912///Anchoring of the basal body to the plasma membrane+++R-HSA-5620924///Intraflagellar transport+++R-HSA-5626467///RHO GTPases activate IQGAPs+++R-HSA-5653656///Vesicle-mediated transport+++R-HSA-5663205///Infectious disease+++R-HSA-5663220///RHO GTPases Activate Formins+++R-HSA-597592///Post-translational protein modification+++R-HSA-6807878///COPI-mediated anterograde transport+++R-HSA-6811434///COPI-dependent Golgi-to-ER retrograde traffic+++R-HSA-6811436///COPI-independent Golgi-to-ER retrograde traffic+++R-HSA-6811442///Intra-Golgi and retrograde Golgi-to-ER traffic+++R-HSA-68877///Mitotic Prometaphase+++R-HSA-68882///Mitotic Anaphase+++R-HSA-68886///M Phase+++R-HSA-69275///G2/M Transition+++R-HSA-69278///Cell Cycle, Mitotic+++R-HSA-76002///Platelet activation, signaling and aggregation+++R-HSA-76005///Response to elevated platelet cytosolic Ca2++++R-HSA-8852276///The role of GTSE1 in G2/M progression after G2 checkpoint+++R-HSA-8854518///AURKA Activation by TPX2+++R-HSA-8856688///Golgi-to-ER retrograde transport+++R-HSA-8953897///Cellular responses to stimuli+++R-HSA-8955332///Carboxyterminal post-translational modifications of tubulin+++R-HSA-948021///Transport to the Golgi and subsequent modification+++R-HSA-9609646///HCMV Infection+++R-HSA-9609690///HCMV Early Events+++R-HSA-9609736///Assembly and cell surface presentation of NMDA receptors+++R-HSA-9612973///Autophagy+++R-HSA-9619483///Activation of AMPK downstream of NMDARs+++R-HSA-9646399///Aggrephagy+++R-HSA-9648025///EML4 and NUDC in mitotic spindle formation+++R-HSA-9663891///Selective autophagy+++R-HSA-9668328///Sealing of the nuclear envelope (NE) by ESCRT-III+++R-HSA-9675108///Nervous system development+++R-HSA-9716542///Signaling by Rho GTPases, Miro GTPases and RHOBTB3+++R-HSA-983189///Kinesins+++R-HSA-983231///Factors involved in megakaryocyte development and platelet production"		KOG1376///structural constituent of cytoskeleton		"IPR000217///Tubulin+++IPR002452///Alpha tubulin+++IPR003008///Tubulin/FtsZ, GTPase domain+++IPR008280///Tubulin/FtsZ, C-terminal+++IPR017975///Tubulin, conserved site+++IPR018316///Tubulin/FtsZ, 2-layer sandwich domain+++IPR023123///Tubulin, C-terminal+++IPR036525///Tubulin/FtsZ, GTPase domain superfamily+++IPR037103///Tubulin/FtsZ-like, C-terminal domain"	[TBA4A_HUMAN|Reviewed]RecName: Full=Tubulin alpha-4A chain; AltName: Full=Alpha-tubulin 1; AltName: Full=Testis-specific alpha-tubulin; AltName: Full=Tubulin H2-alpha; AltName: Full=Tubulin alpha-1 chain;+++[Q6QMJ5_HUMAN|Unreviewed]RecName: Full=Tubulin alpha chain {ECO:0000256|RuleBase:RU000352}; Flags: Fragment;	chr2q35///Ensembl 103 genes in cytogenetic band chr2q35	BIOCARTA_MTA3_PATHWAY///Downregulated of MTA-3 in ER-negative Breast Tumors	KEGG_GAP_JUNCTION///Gap junction+++KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION///Pathogenic Escherichia coli infection	"REACTOME_ACTIVATION_OF_AMPK_DOWNSTREAM_OF_NMDARS///Activation of AMPK downstream of NMDARs+++REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS///Activation of NMDA receptors and postsynaptic events+++REACTOME_ADAPTIVE_IMMUNE_SYSTEM///Adaptive Immune System+++REACTOME_AGGREPHAGY///Aggrephagy+++REACTOME_ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE///Anchoring of the basal body to the plasma membrane+++REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION///Asparagine N-linked glycosylation+++REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS///Assembly and cell surface presentation of NMDA receptors+++REACTOME_AURKA_ACTIVATION_BY_TPX2///AURKA Activation by TPX2+++REACTOME_AUTOPHAGY///Autophagy+++REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN///Carboxyterminal post-translational modifications of tubulin+++REACTOME_CELL_CYCLE///Cell Cycle+++REACTOME_CELL_CYCLE_MITOTIC///Cell Cycle, Mitotic+++REACTOME_CELLULAR_RESPONSES_TO_EXTERNAL_STIMULI///Cellular responses to external stimuli+++REACTOME_CILIUM_ASSEMBLY///Cilium Assembly+++REACTOME_COOPERATION_OF_PREFOLDIN_AND_TRIC_CCT_IN_ACTIN_AND_TUBULIN_FOLDING///Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding+++REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC///COPI-dependent Golgi-to-ER retrograde traffic+++REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC///COPI-independent Golgi-to-ER retrograde traffic+++REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT///COPI-mediated anterograde transport+++REACTOME_DEVELOPMENTAL_BIOLOGY///Developmental Biology+++REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT///ER to Golgi Anterograde Transport+++REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION///Factors involved in megakaryocyte development and platelet production+++REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC///Formation of tubulin folding intermediates by CCT/TriC+++REACTOME_GAP_JUNCTION_ASSEMBLY///Gap junction assembly+++REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION///Gap junction trafficking and regulation+++REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT///Golgi-to-ER retrograde transport+++REACTOME_HCMV_EARLY_EVENTS///HCMV Early Events+++REACTOME_HCMV_INFECTION///HCMV Infection+++REACTOME_HEDGEHOG_OFF_STATE///Hedgehog 'off' state+++REACTOME_HEMOSTASIS///Hemostasis+++REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR///HSP90 chaperone cycle for steroid hormone receptors (SHR)+++REACTOME_INFECTIOUS_DISEASE///Infectious disease+++REACTOME_INTRAFLAGELLAR_TRANSPORT///Intraflagellar transport+++REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC///Intra-Golgi and retrograde Golgi-to-ER traffic+++REACTOME_KINESINS///Kinesins+++REACTOME_L1CAM_INTERACTIONS///L1CAM interactions+++REACTOME_MEMBRANE_TRAFFICKING///Membrane Trafficking+++REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION///MHC class II antigen presentation+++REACTOME_MITOTIC_G2_G2_M_PHASES///Mitotic G2-G2/M phases+++REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE///Mitotic Metaphase and Anaphase+++REACTOME_MITOTIC_PROMETAPHASE///Mitotic Prometaphase+++REACTOME_M_PHASE///M Phase+++REACTOME_NERVOUS_SYSTEM_DEVELOPMENT///Nervous system development+++REACTOME_NEURONAL_SYSTEM///Neuronal System+++REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION///Neurotransmitter receptors and postsynaptic signal transmission+++REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY///Nuclear Envelope (NE) Reassembly+++REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE///Organelle biogenesis and maintenance+++REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION///Platelet activation, signaling and aggregation+++REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY///Post-chaperonin tubulin folding pathway+++REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION///Post-translational protein modification+++REACTOME_PROTEIN_FOLDING///Protein folding+++REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES///Recruitment of mitotic centrosome proteins and complexes+++REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES///Recruitment of NuMA to mitotic centrosomes+++REACTOME_RECYCLING_PATHWAY_OF_L1///Recycling pathway of L1+++REACTOME_REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION///Regulation of PLK1 Activity at G2/M Transition+++REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION///Resolution of Sister Chromatid Cohesion+++REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2///Response to elevated platelet cytosolic Ca2++++REACTOME_RHO_GTPASE_EFFECTORS///RHO GTPase Effectors+++REACTOME_RHO_GTPASES_ACTIVATE_FORMINS///RHO GTPases Activate Formins+++REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS///RHO GTPases activate IQGAPs+++REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III///Sealing of the nuclear envelope (NE) by ESCRT-III+++REACTOME_SELECTIVE_AUTOPHAGY///Selective autophagy+++REACTOME_SEPARATION_OF_SISTER_CHROMATIDS///Separation of Sister Chromatids+++REACTOME_SIGNALING_BY_HEDGEHOG///Signaling by Hedgehog+++REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3///Signaling by Rho GTPases, Miro GTPases and RHOBTB3+++REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT///The role of GTSE1 in G2/M progression after G2 checkpoint+++REACTOME_TRANSLOCATION_OF_SLC2A4_GLUT4_TO_THE_PLASMA_MEMBRANE///Translocation of SLC2A4 (GLUT4) to the plasma membrane+++REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES///Transmission across Chemical Synapses+++REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE///Transport of connexons to the plasma membrane+++REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION///Transport to the Golgi and subsequent modification+++REACTOME_VESICLE_MEDIATED_TRANSPORT///Vesicle-mediated transport"			MIR15A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-15a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR15B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-15b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR16_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-16-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR195_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-195-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3202///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3202 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR424_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-424-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR450B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-450b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR497_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-497-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR520A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-520a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR525_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-525-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6838_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6838-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).	AMEF2_Q6///Genes having at least one occurence of the transcription factor binding site V$AMEF2_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++AP1_01///Genes having at least one occurence of the transcription factor binding site V$AP1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++AP1_C///Genes having at least one occurence of the transcription factor binding site V$AP1_C (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++AP1_Q6_01///Genes having at least one occurence of the transcription factor binding site V$AP1_Q6_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++AP1_Q6///Genes having at least one occurence of the transcription factor binding site V$AP1_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++AP4_Q6_01///Genes having at least one occurence of the transcription factor binding site V$AP4_Q6_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++AREB6_01///Genes having at least one occurence of the transcription factor binding site V$AREB6_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++AREB6_02///Genes having at least one occurence of the transcription factor binding site V$AREB6_02 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++ARGGGTTAA_UNKNOWN///Genes having at least one occurence of the highly conserved motif M65 ARGGGTTAA in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++ARNT_02///Genes having at least one occurence of the transcription factor binding site V$ARNT_02 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++CACGTG_MYC_Q2///Genes having at least one occurence of the highly conserved motif M2 CACGTG sites. The motif matches transcription factor binding site V$MYC_Q2 (v7.4 TRANSFAC).+++CAGCTG_AP4_Q5///Genes having at least one occurence of the highly conserved motif M15 CAGCTG sites. The motif matches transcription factor binding site V$AP4_Q5 (v7.4 TRANSFAC).+++CDPCR1_01///Genes having at least one occurence of the transcription factor binding site V$CDPCR1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++CDPCR3HD_01///Genes having at least one occurence of the transcription factor binding site V$CDPCR3HD_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++CTAWWWATA_RSRFC4_Q2///Genes having at least one occurence of the highly conserved motif M28 CTAWWWATA sites. The motif matches transcription factor binding site V$RSRFC4_Q2 (v7.4 TRANSFAC).+++CTGCAGY_UNKNOWN///Genes having at least one occurence of the highly conserved motif M101 CTGCAGY in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++E2A_Q2///Genes having at least one occurence of the transcription factor binding site V$E2A_Q2 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++GGGTGGRR_PAX4_03///Genes having at least one occurence of the highly conserved motif M56 GGGTGGRR sites. The motif matches transcription factor binding site V$PAX4_03 (v7.4 TRANSFAC).+++HEB_Q6///Genes having at least one occurence of the transcription factor binding site V$HEB_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++KTGGYRSGAA_UNKNOWN///Genes having at least one occurence of the highly conserved motif M112 KTGGYRSGAA in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++LFA1_Q6///Genes having at least one occurence of the transcription factor binding site V$LFA1_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++MAX_01///Genes having at least one occurence of the transcription factor binding site V$MAX_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++MMEF2_Q6///Genes having at least one occurence of the transcription factor binding site V$MMEF2_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++MYCMAX_01///Genes having at least one occurence of the transcription factor binding site V$MYCMAX_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++MYOD_01///Genes having at least one occurence of the transcription factor binding site V$MYOD_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++MYOD_Q6_01///Genes having at least one occurence of the transcription factor binding site V$MYOD_Q6_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++NFE2_01///Genes having at least one occurence of the transcription factor binding site V$NFE2_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++NRF2_Q4///Genes having at least one occurence of the transcription factor binding site V$NRF2_Q4 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++TATA_01///Genes having at least one occurence of the transcription factor binding site V$TATA_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++TATAAA_TATA_01///Genes having at least one occurence of the highly conserved motif M51 TATAAA sites. The motif matches transcription factor binding site V$TATA_01 (v7.4 TRANSFAC).+++TBP_01///Genes having at least one occurence of the transcription factor binding site V$TBP_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++TGANNYRGCA_TCF11MAFG_01///Genes having at least one occurence of the highly conserved motif M67 TGANNYRGCA sites. The motif matches transcription factor binding site V$TCF11MAFG_01 (v7.4 TRANSFAC).+++TGANTCA_AP1_C///Genes having at least one occurence of the highly conserved motif M7 TGANTCA sites. The motif matches transcription factor binding site V$AP1_C (v7.4 TRANSFAC).+++TGASTMAGC_NFE2_01///Genes having at least one occurence of the highly conserved motif M32 TGASTMAGC sites. The motif matches transcription factor binding site V$NFE2_01 (v7.4 TRANSFAC).	"AHRR_TARGET_GENES///Genes containing one or more binding sites for UniProt:A9YTQ3 (AHRR) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++BACH2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9BYV9 (BACH2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++GLI3_TARGET_GENES///Genes containing one or more binding sites for UniProt:P10071 (GLI3) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ID2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q02363 (ID2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++MAFG_TARGET_GENES///Genes containing one or more binding sites for UniProt:O15525 (MAFG) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NFE2L1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q14494 (NFE2L1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++PHF2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O75151 (PHF2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SUMO1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P63165 (SUMO1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9BSG1 (ZNF2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF528_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q3MIS6 (ZNF528) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF740_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8NDX6 (ZNF740) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF768_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9H5H4 (ZNF768) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."		MODULE_136///Genes in the cancer module 136.+++MODULE_179///Blood cells and cancer expression cancer.+++MODULE_196///Genes in the cancer module 196.+++MODULE_253///Intracellular transport (MT cytoskeleton and motors).+++MODULE_255///Genes in the cancer module 255.+++MODULE_315///Spindle and kinetochore.+++MODULE_317///Genes in the cancer module 317.+++MODULE_32///Genes in the cancer module 32.+++MODULE_378///Genes in the cancer module 378.+++MODULE_37///Genes in the cancer module 37.+++MODULE_395///Genes in the cancer module 395.+++MODULE_438///Intermediate filaments and MT.+++MODULE_459///Genes in the cancer module 459.+++MODULE_509///Genes in the cancer module 509.+++MODULE_532///Blood cells and cancer expression clusters.+++MODULE_533///Genes in the cancer module 533.+++MODULE_54///Cell cycle (expression cluster).+++MODULE_69///Genes in the cancer module 69.+++MODULE_87///Genes in the cancer module 87.	CAMP_UP.V1_DN///Genes down-regulated in primary thyrocyte cultures in response to cAMP signaling pathway activation by thyrotropin (TSH).+++CSR_LATE_UP.V1_UP///Genes up-regulated in late serum response of CRL 2091 cells (foreskin fibroblasts).+++CYCLIN_D1_KE_.V1_DN///Genes down-regulated in MCF-7 cells (breast cancer) over-expressing a mutant K112E form of CCND1 [Gene ID=595] gene.+++CYCLIN_D1_UP.V1_DN///Genes down-regulated in MCF-7 cells (breast cancer) over-expressing CCND1 [Gene ID=595] gene.+++P53_DN.V1_UP///Genes up-regulated in NCI-60 panel of cell lines with mutated TP53 [Gene ID=7157].+++PRC2_EZH2_UP.V1_UP///Genes up-regulated in TIG3 cells (fibroblasts) upon knockdown of EZH2 [Gene ID=2146] gene.+++STK33_SKM_DN///Genes down-regulated in SKM-1 cells (AML) after knockdown of STK33 [Gene ID=65975] by RNAi.	"GSE11864_CSF1_PAM3CYS_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN///Genes down-regulated in comparison of macrophages cultured with M-CSF [GeneID=1435] and Pam3Cyc versus macrophages cultured with M-CSF [GeneID=1435], IFNG [GeneID=3458] and Pam3Cyc.+++GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_DN///Genes down-regulated in comparison of CD4 [GeneID=920] thymocytes versus naive CD4 [GeneID=920] T cells from cord blood.+++GSE1460_DP_VS_CD4_THYMOCYTE_DN///Genes down-regulated in comparison of CD4 [GeneID=920] CD8 thymocytes versus T cells from cord blood.+++GSE1460_INTRATHYMIC_T_PROGENITOR_VS_DP_THYMOCYTE_DN///Genes down-regulated in comparison of intrathymic T progenitor cells (ITTP) versus CD4 [GeneID=920] CD8 thymocytes. +++GSE14908_ATOPIC_VS_NONATOPIC_PATIENT_HDM_STIM_CD4_TCELL_DN///Genes down-regulated in CD4 [GeneID=920] T cells stimulated with allergen (house dust mite): atopy versus healthy.+++GSE16385_IFNG_TNF_VS_UNSTIM_MACROPHAGE_ROSIGLITAZONE_TREATED_DN///Genes down-regulated in macrophages (12h): IFNG, TNF [GeneID=3458;7124] and rosiglitazone [PubChem=77999] versus rosiglitazone [PubChem=77999].+++GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_IFNG_TNF_TREATED_MACROPHAGE_DN///Genes down-regulated in monocytes (12h) versus macrophages (12h) treated with IFNG, TNF [GeneID=3458;7124] and rosiglitazone [PubChem=77999].+++GSE17186_BLOOD_VS_CORD_BLOOD_NAIVE_BCELL_DN///Genes down-regulated in nave B lymphocytes versus those from cord blood.+++GSE17186_MEMORY_VS_NAIVE_BCELL_UP///Genes up-regulated in B lymphocytes: memory versus nave.+++GSE17186_NAIVE_VS_CD21HIGH_TRANSITIONAL_BCELL_CORD_BLOOD_DN///Genes down-regulated in B lymphocytes from cord blood: nave versus transitional CR2 [GeneID=1380] high.+++GSE17186_NAIVE_VS_CD21HIGH_TRANSITIONAL_BCELL_CORD_BLOOD_UP///Genes up-regulated in B lymphocytes from cord blood: nave versus transitional CR2 [GeneID=1380] high.+++GSE17186_NAIVE_VS_CD21LOW_TRANSITIONAL_BCELL_CORD_BLOOD_UP///Genes up-regulated in B lymphocytes from cord blood: nave versus transitional CR2 [GeneID=1380].+++GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_12H_UP///Genes up-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 12 h.+++GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_10H_UP///Genes up-regulated in comparison of control conventional dendritic cells (cDC) at 10 h versus cDCs infected with Newcastle disease virus (NDV) at 10 h.+++GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_18H_UP///Genes up-regulated in comparison of control conventional dendritic cells (cDC) at 18 h versus cDCs infected with Newcastle disease virus (NDV) at 18 h.+++GSE19772_CTRL_VS_HCMV_INF_MONOCYTES_AND_PI3K_INHIBITION_DN///Genes down-regulated in monocytes pre-treated with Ly294002 [PubChem=3973]: control versus HCMV infection.+++GSE22025_TGFB1_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_DN///Genes down-regulated in CD4 [GeneID=920] T cells: TGFB1 [GeneID=7040] versus TGFB1 [GeneID=7040] and progesterone [PubChem=5994].+++GSE22025_UNTREATED_VS_PROGESTERONE_TREATED_CD4_TCELL_DN///Genes down-regulated in CD4 [GeneID=920] T cells: untreated versus progesterone [PubChem=5994].+++GSE22025_UNTREATED_VS_TGFB1_TREATED_CD4_TCELL_UP///Genes up-regulated in CD4 [GeneID=920] T cells: untreated versus TGFB1 [GeneID=7040].+++GSE22611_NOD2_VS_CTRL_TRANSDUCED_HEK293T_CELL_DN///Genes down-regulated in HEK293 cells: over-expressing wildtype NOD2 [GeneID=64127] versus control.+++GSE23321_CENTRAL_VS_EFFECTOR_MEMORY_CD8_TCELL_DN///Genes down-regulated in CD8 T cells: central memory versus effector memory.+++GSE23984_CTRL_VS_HYPOCALEMIC_VITAMIND_ANALOG_TCELL_UP///Genes up-regulated in T cells: control versus TX527 (hypocalemic analog of 25-hydroxyvitamin D3 [PubChem=1593]).+++GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_DN///Genes down-regulated in polymorphonuclear leukocytes (9h): treated by heat killed HC60 cell (promyelocytic leukemia) lysate versus A. phagocytophilum infection.+++GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_6H_UP///Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: IL-12 (6h) versus IL4 [GeneID=3565] (6h).+++GSE2770_UNTREATED_VS_ACT_CD4_TCELL_2H_UP///Genes up-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 (2h).+++GSE2770_UNTREATED_VS_ACT_CD4_TCELL_6H_DN///Genes down-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 (6h).+++GSE29618_BCELL_VS_MDC_UP///Genes up-regulated in comparison of B cells versus myeloid dendritic cells (mDC).+++GSE29618_BCELL_VS_PDC_DAY7_FLU_VACCINE_UP///Genes up-regulated in comparison of B cells from influenza vaccinee at day 7 post-vaccination versus plasmacytoid dendritic cells (pDC) at day 7 post-vaccination.+++GSE29618_BCELL_VS_PDC_UP///Genes up-regulated in comparison of B cells versus plasmacytoid dendritic cells (pDC) .+++GSE29618_MONOCYTE_VS_MDC_UP///Genes up-regulated in comparison of monocytes versus myeloid dendritic cells (mDC).+++GSE29618_MONOCYTE_VS_PDC_DAY7_FLU_VACCINE_UP///Genes up-regulated in comparison of monocytes from influenza vaccinee at day 7 post-vaccination versus plasmacytoid dendritic cells (mDC) at day 7 post-vaccination.+++GSE29618_PDC_VS_MDC_DAY7_FLU_VACCINE_DN///Genes down-regulated in comparison of plasmacytoid dendritic cells (DC) from influenza vaccinee at day 7 post-vaccination versus myeloid DCs at day 7 post-vaccination.+++GSE29618_PRE_VS_DAY7_FLU_VACCINE_MONOCYTE_DN///Genes down-regulated in comparison of monocytes from influenza vaccinee pre-vaccination versus those at day 7 post-vaccination.+++GSE34515_CD16_NEG_MONOCYTE_VS_DC_UP///Genes up-regulated in CD16- monocytes versus dendritic cells.+++GSE3982_DC_VS_NEUTROPHIL_DN///Genes down-regulated in comparison of dendritic cells (DC) versus neutrophils.+++GSE3982_DC_VS_NKCELL_UP///Genes up-regulated in comparison of dendritic cells (DC) versus NK cells.+++GSE3982_DC_VS_TH2_DN///Genes down-regulated in comparison of dendritic cells (DC) versus Th2 cells.+++GSE44732_UNSTIM_VS_IL27_STIM_IMATURE_DC_UP///Genes up-regulated in immature dendritic cells: untreated versus IL27 [GeneID=246778].+++GSE44955_MCSF_VS_MCSF_AND_IL27_STIM_MACROPHAGE_DN///Genes down-regulated in macrophage differentiated by: CSF1 [GeneID=1435] versus CSF1 [GeneID=1435] and IL27 [GeneID=246778].+++GSE4748_CYANOBACTERIUM_LPSLIKE_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_DN///Genes down-regulated in monocyte-derived dendritic cells: LPS like antigen from O. planktothrix (3h) versus LPS and LPS like antigen from O. planktothrix (3h).+++GSE4748_LPS_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP///Genes up-regulated in monocyte-derived dendritic cells: LPS (3h) versus LPS and LPS like antigen from O. planktothrix (3h).+++GSE5099_CLASSICAL_M1_VS_ALTERNATIVE_M2_MACROPHAGE_UP///Genes up-regulated in macrophages: classical (M1) versus alternative (M2).+++GSE5099_DAY3_VS_DAY7_MCSF_TREATED_MACROPHAGE_UP///Genes up-regulated upon CSF1 [GeneID=1435] treatment: monocytes (3 days) versus macrophages (7 days).+++GSE8685_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_UP///Genes up-regulated in Sez-2 cells (T cell lymphoma): untreated versus IL5 [GeneID=3567].+++NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN///Genes down-regulated in plasmacytoid dendritic cell 7d vs 0d in young adults (18-50) after exposure to FluMist , time point 7D+++THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_UP///Genes up-regulated in peripheral blood mononuclear cell 7d vs 0d in young adults (21-30) (responders) after exposure to Inactivated influenza vaccine , time point 7D"	HALLMARK_MITOTIC_SPINDLE///Genes important for mitotic spindle assembly.+++HALLMARK_MTORC1_SIGNALING///Genes up-regulated through activation of mTORC1 complex.+++HALLMARK_UV_RESPONSE_UP///Genes up-regulated in response to ultraviolet (UV) radiation.	NM_006000	TUBA4A				
P68036	sp|P68036|UB2L3_HUMAN		UBE2L3		"Ubiquitin-conjugating enzyme E2 L3 OS=Homo sapiens OX=9606 GN=UBE2L3 PE=1 SV=1 >tr|A0A024R1A4|A0A024R1A4_HUMAN Ubiquitin-conjugating enzyme E2L 3, isoform CRA_a OS=Homo sapiens OX=9606 GN=UBE2L3 PE=3 SV=1"	7332	NM_003347	NP_003338	ENST00000342192	K04552			MAASRRLMKELEEIRKCGMKNFRNIQVDEANLLTWQGLIVPDNPPYDKGAFRIEINFPAEYPFKPPKITFKTKIYHPNIDEKGQVCLPVISAENWKPATKTDQVIQSLIALVNDPQPEHPLRADLAEEYSKDRKKFCKNAEEFTKKYGEKRPVD	0.5423586	-0.882681069	0.007891441					4.3534045	5.2161804		2.9306331	5.3185309	5.3509868	4.3192549	5.2430363			3.3569361	3.8011946	4.4123936	3.930639			3.4539015	4.7938977	5.4244195		2.96431119			7.19987	6.3997306	6.257007	6.2843051	4.705632	4.5436708	5.4790393	4.7042529	4.7140409	6.4445504	4.7669981	5.773998	4.2664604	4.97743353	5.3255651	4.1866873	4.90210627	04120///Ubiquitin mediated proteolysis+++05012///Parkinson disease+++05022///Pathways of neurodegeneration - multiple diseases				GO:0000151///ubiquitin ligase complex+++GO:0005634///nucleus+++GO:0005654///nucleoplasm+++GO:0005737///cytoplasm+++GO:0005829///cytosol	GO:0000166///nucleotide binding+++GO:0003713///transcription coactivator activity+++GO:0003723///RNA binding+++GO:0004842///ubiquitin-protein transferase activity+++GO:0005515///protein binding+++GO:0005524///ATP binding+++GO:0016740///transferase activity+++GO:0019899///enzyme binding+++GO:0031625///ubiquitin protein ligase binding+++GO:0061631///ubiquitin conjugating enzyme activity+++GO:0097027///ubiquitin-protein transferase activator activity	"GO:0000209///protein polyubiquitination+++GO:0006355///regulation of transcription, DNA-templated+++GO:0006464///cellular protein modification process+++GO:0006511///ubiquitin-dependent protein catabolic process+++GO:0008283///cell proliferation+++GO:0016567///protein ubiquitination+++GO:0031398///positive regulation of protein ubiquitination+++GO:0044770///cell cycle phase transition+++GO:0045893///positive regulation of transcription, DNA-templated+++GO:0051443///positive regulation of ubiquitin-protein transferase activity+++GO:0070979///protein K11-linked ubiquitination+++GO:0071383///cellular response to steroid hormone stimulus+++GO:0071385///cellular response to glucocorticoid stimulus+++GO:1903955///positive regulation of protein targeting to mitochondrion"	tissueType=Fetal kidney;cancerType=Normal;cellName=Natural killer T (NKT) cell		"Homo sapiens ubiquitin conjugating enzyme E2 L3 (UBE2L3), transcript variant 1, mRNA."		PF00179///Ubiquitin-conjugating enzyme	R-HSA-1280218///Adaptive Immune System+++R-HSA-168256///Immune System+++R-HSA-392499///Metabolism of proteins+++R-HSA-597592///Post-translational protein modification+++R-HSA-8852135///Protein ubiquitination+++R-HSA-8866652///Synthesis of active ubiquitin: roles of E1 and E2 enzymes+++R-HSA-8866654///E3 ubiquitin ligases ubiquitinate target proteins+++R-HSA-983168///Antigen processing: Ubiquitination & Proteasome degradation+++R-HSA-983169///Class I MHC mediated antigen processing & presentation		KOG0422///ISG15 transferase activity		"IPR000608///Ubiquitin-conjugating enzyme E2+++IPR016135///Ubiquitin-conjugating enzyme/RWD-like+++IPR023313///Ubiquitin-conjugating enzyme, active site"	[UB2L3_HUMAN|Reviewed]RecName: Full=Ubiquitin-conjugating enzyme E2 L3; EC=2.3.2.23 {ECO:0000269|PubMed:20061386}; AltName: Full=E2 ubiquitin-conjugating enzyme L3; AltName: Full=L-UBC; AltName: Full=UbcH7; AltName: Full=Ubiquitin carrier protein L3; AltName: Full=Ubiquitin-conjugating enzyme E2-F1; AltName: Full=Ubiquitin-protein ligase L3;	chr22q11///Ensembl 103 genes in cytogenetic band chr22q11		KEGG_PARKINSONS_DISEASE///Parkinson's disease+++KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS///Ubiquitin mediated proteolysis	REACTOME_ADAPTIVE_IMMUNE_SYSTEM///Adaptive Immune System+++REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION///Antigen processing: Ubiquitination &amp; Proteasome degradation+++REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION///Class I MHC mediated antigen processing &amp; presentation+++REACTOME_E3_UBIQUITIN_LIGASES_UBIQUITINATE_TARGET_PROTEINS///E3 ubiquitin ligases ubiquitinate target proteins+++REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION///Post-translational protein modification+++REACTOME_PROTEIN_UBIQUITINATION///Protein ubiquitination+++REACTOME_SYNTHESIS_OF_ACTIVE_UBIQUITIN_ROLES_OF_E1_AND_E2_ENZYMES///Synthesis of active ubiquitin: roles of E1 and E2 enzymes		"ACCATTT_MIR522///Genes having at least one occurence of the motif ACCATTT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-522 (v7.1 miRBase).+++AGGAAGC_MIR5163P///Genes having at least one occurence of the motif AGGAAGC in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-516-3p (v7.1 miRBase).+++CTCAGGG_MIR125B_MIR125A///Genes having at least one occurence of the motif CTCAGGG in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-125b and hsa-miR-125a (v7.1 miRBase).+++GGTAACC_MIR4095P///Genes having at least one occurence of the motif GGTAACC in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-409-5p (v7.1 miRBase).+++TGTGTGA_MIR377///Genes having at least one occurence of the motif TGTGTGA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-377 (v7.1 miRBase).+++TTTGTAG_MIR520D///Genes having at least one occurence of the motif TTTGTAG in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-520d* (v7.1 miRBase)."	MIR1183///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1183 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1261///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1261 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1283///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1283 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4519///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4519 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4699_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4699-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4768_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4768-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR500A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-500a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR544A///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-544a in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6738_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6738-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6838_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6838-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR8068///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-8068 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR9500///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-9500 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).	AACTTT_UNKNOWN///Genes having at least one occurence of the highly conserved motif M17 AACTTT in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++AP2_Q3///Genes having at least one occurence of the transcription factor binding site V$AP2_Q3 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++CTGCAGY_UNKNOWN///Genes having at least one occurence of the highly conserved motif M101 CTGCAGY in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++EFC_Q6///Genes having at least one occurence of the transcription factor binding site V$EFC_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++ELK1_02///Genes having at least one occurence of the transcription factor binding site V$ELK1_02 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++ETS1_B///Genes having at least one occurence of the transcription factor binding site V$ETS1_B (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++ETS_Q4///Genes having at least one occurence of the transcription factor binding site V$ETS_Q4 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++MGGAAGTG_GABP_B///Genes having at least one occurence of the highly conserved motif M11 MGGAAGTG sites. The motif matches transcription factor binding site V$GABP_B (v7.4 TRANSFAC).+++NERF_Q2///Genes having at least one occurence of the transcription factor binding site V$NERF_Q2 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++NRF2_Q4///Genes having at least one occurence of the transcription factor binding site V$NRF2_Q4 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++RORA2_01///Genes having at least one occurence of the transcription factor binding site V$RORA2_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++RYCACNNRNNRNCAG_UNKNOWN///Genes having at least one occurence of the highly conserved motif M128 RYCACNNRNNRNCAG in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++RYTTCCTG_ETS2_B///Genes having at least one occurence of the highly conserved motif M16 RYTTCCTG sites. The motif matches transcription factor binding site V$ETS2_B (v7.4 TRANSFAC).+++STAT_Q6///Genes having at least one occurence of the transcription factor binding site V$STAT_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.	"CIITA_TARGET_GENES///Genes containing one or more binding sites for UniProt:P33076 (CIITA) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++E2F5_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q15329 (E2F5) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ELF5_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9UKW6 (ELF5) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++GTF2E2_TARGET_GENES///Genes containing one or more binding sites for UniProt:P29084 (GTF2E2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HMG20B_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9P0W2 (HMG20B) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HOXC6_TARGET_GENES///Genes containing one or more binding sites for UniProt:P09630 (HOXC6) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++KLF7_TARGET_GENES///Genes containing one or more binding sites for UniProt:O75840 (KLF7) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++MZF1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P28698 (MZF1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NFRKB_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6P4R8 (NFRKB) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++OVOL3_TARGET_GENES///Genes containing one or more binding sites for UniProt:O00110 (OVOL3) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SNRNP70_TARGET_GENES///Genes containing one or more binding sites for UniProt:P08621 (SNRNP70) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SUPT16H_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9Y5B9 (SUPT16H) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++TAF9B_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9HBM6 (TAF9B) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++WRNIP1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96S55 (WRNIP1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF394_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q53GI3 (ZNF394) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF513_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8N8E2 (ZNF513) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."	GCM_NPM1///Neighborhood of NPM1+++MORF_AATF///Neighborhood of AATF+++MORF_ACP1///Neighborhood of ACP1+++MORF_ANP32B///Neighborhood of ANP32B+++MORF_AP2M1///Neighborhood of AP2M1+++MORF_AP3D1///Neighborhood of AP3D1+++MORF_BUB3///Neighborhood of BUB3+++MORF_CSNK2B///Neighborhood of CSNK2B+++MORF_CTBP1///Neighborhood of CTBP1+++MORF_CUL1///Neighborhood of CUL1+++MORF_DAP3///Neighborhood of DAP3+++MORF_DEK///Neighborhood of DEK+++MORF_EIF3S2///Neighborhood of EIF3S2+++MORF_ERH///Neighborhood of ERH+++MORF_FBL///Neighborhood of FBL+++MORF_G22P1///Neighborhood of G22P1+++MORF_GNB1///Neighborhood of GNB1+++MORF_HAT1///Neighborhood of HAT1+++MORF_HDAC1///Neighborhood of HDAC1+++MORF_NPM1///Neighborhood of NPM1+++MORF_PCNA///Neighborhood of PCNA+++MORF_PPP2CA///Neighborhood of PPP2CA+++MORF_RAD21///Neighborhood of RAD21+++MORF_RAD23A///Neighborhood of RAD23A+++MORF_RAN///Neighborhood of RAN+++MORF_SART1///Neighborhood of SART1+++MORF_SKP1A///Neighborhood of SKP1A+++MORF_SMC1L1///Neighborhood of SMC1L1+++MORF_SOD1///Neighborhood of SOD1+++MORF_UBE2I///Neighborhood of UBE2I+++MORF_UBE2N///Neighborhood of UBE2N+++MORF_XRCC5///Neighborhood of XRCC5	MODULE_233///Genes in the cancer module 233.		"FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_DN///Genes down-regulated in blood responders vs poor responders in adults (25-83) (responders) after exposure to Twinrix , time point 0D+++GSE10240_CTRL_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP///Genes up-regulated in primary bronchial epithelial cells: control versus stimulated with IL17A and IL22 [GeneID=3605;50616].+++GSE10325_BCELL_VS_LUPUS_BCELL_DN///Genes down-regulated in comparison of healthy B cells versus systemic lupus erythematosus B cells.+++GSE12198_CTRL_VS_HIGH_IL2_STIM_NK_CELL_UP///Genes up-regulated in NK cells: primary versus stimulated by high dose of IL2 [GeneID=3558].+++GSE12845_IGD_NEG_BLOOD_VS_NAIVE_TONSIL_BCELL_UP///Genes up-regulated in comparison of IgD- peripheral blood B cells versus dark zone germinal center B cells.+++GSE1432_1H_VS_6H_IFNG_MICROGLIA_DN///Genes down-regulated in comparison of microglia cells 1 h after stimulation with IFNG [GeneID=3458] versus microglia cells 6 h after the stimulation.+++GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_DN///Genes down-regulated in comparison of control microglia cells versus those 6 h after stimulation with IFNG [GeneID=3458].+++GSE1460_NAIVE_CD4_TCELL_ADULT_BLOOD_VS_THYMIC_STROMAL_CELL_UP///Genes up-regulated in naive CD4 [GeneID=920] T cells from adult blood versus thymic stromal cells.+++GSE16385_UNTREATED_VS_12H_IL4_TREATED_MACROPHAGE_DN///Genes down-regulated in macrophages (12h): control versus IL4 [GeneID=3565].+++GSE19888_ADENOSINE_A3R_ACT_VS_A3R_ACT_WITH_A3R_INH_PRETREATMENT_IN_MAST_CELL_UP///Genes up-regulated in HMC-1 (mast leukemia) cells: Cl-IB-MECA [PubChem=3035850] versus incubated with the ALL1 peptide followed by treatment with Cl-IB-MECA [PubChem=3035850].+++GSE2405_0H_VS_24H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP///Genes up-regulated in polymorphonuclear leukocytes (24h): control versus infection by A. phagocytophilum.+++GSE2405_0H_VS_9H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN///Genes down-regulated in polymorphonuclear leukocytes (9h): control versus infection by A. phagocytophilum.+++GSE2405_HEAT_KILLED_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_UP///Genes up-regulated in polymorphonuclear leukocytes (9h) infection by A. phagocytophilum: heat killed versus live bacteria.+++GSE24634_NAIVE_CD4_TCELL_VS_DAY5_IL4_CONV_TREG_DN///Genes down-regulated in comparison of naive T cells at day 0 versus CD25+ regulatory T cell (Treg) treated with IL4 [GeneID=3565] at day 5.+++GSE24634_TREG_VS_TCONV_POST_DAY5_IL4_CONVERSION_UP///Genes up-regulated in comparison of CD25+ T cells treated with IL4 [GeneID=3565] versus CD25- T cells treated with IL4 [GeneID=3565] at day 5.+++GSE26928_NAIVE_VS_CENT_MEMORY_CD4_TCELL_DN///Genes down-regulated in comparison of naive CD4 [GeneID=920] T cells versus CD4 [GeneID=920] central memory T cells.+++GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_6H_DN///Genes down-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 [GeneID=7040] and IL-12 (6h) versus untreated (6h).+++GSE29618_BCELL_VS_MDC_DN///Genes down-regulated in comparison of B cells versus myeloid dendritic cells (mDC).+++GSE29618_MONOCYTE_VS_MDC_DN///Genes down-regulated in comparison of monocytes versus myeloid dendritic cells (mDC).+++GSE32901_NAIVE_VS_TH17_NEG_CD4_TCELL_UP///Genes up-regulated in CD4 [GeneID=920] T cells: nave versus Th17 negative.+++GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_DC_UP///Genes up-regulated in comparison of dendritic cells (DC) versus DCs exposed to B. malayi (50 worms/well).+++GSE360_CTRL_VS_M_TUBERCULOSIS_MAC_DN///Genes down-regulated in comparison of macrophages versus macrophages exposed to M. tuberculosis.+++GSE360_DC_VS_MAC_UP///Genes up-regulated in comparison of dendritic cells (DC) versus untreated macrophages.+++GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_DN///Genes down-regulated in comparison of dendritic cells (DC) exposed to 50 worms/well B. malayi versus DC exposed to M. tuberculosis+++GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_MAC_UP///Genes up-regulated in comparison of macrophages exposed to T. gondii versus macrophages exposed to 5 worms/well B. malayi.+++GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_DN///Genes down-regulated in gamma delta T cells: Vd1 versus Vd2.+++GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_WITH_PMA_STIM_UP///Genes up-regulated in gamma delta T cells stimulated by phorbol myristate acetate and ionomycin [PubChem=4792;3733]: Vd1 versus Vd2.+++GSE3982_CTRL_VS_PMA_STIM_EOSINOPHIL_UP///Genes up-regulated in comparison of untreated eosinophils versus eosinophils treated with PMA [PubChem=4792] at 2 h.+++GSE3982_DC_VS_MAC_DN///Genes down-regulated in comparison of dendritic cells (DC) versus macrophages.+++GSE3982_MAST_CELL_VS_DC_UP///Genes up-regulated in comparison of mast cells versus dendritic cells (DC).+++GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY7_UP///Genes up-regulated in unstimulated monocytes versus macrophages incubated with CSF1 [GeneID=435] at day 7.+++GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_6H_DN///Genes down-regulated in monocytes (6h): untreated versus M. tuberculosis 19 kDa lipopeptide.+++GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_AT_DX_UP///Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMCs from patients with type 1 diabetes at the time of diagnosis.+++GSE9006_TYPE_1_VS_TYPE_2_DIABETES_PBMC_AT_DX_DN///Genes down-regulated in peripheral blood mononuclear cells (PBMC) from patients with type 1 diabetes at the time of diagnosis versus those with type 2 diabetes at the time of diagnosis.+++GSE9239_CTRL_VS_TNF_INHIBITOR_TREATED_DC_DN///Genes down-regulated in monocyte-derived dendritic cells: control versus TNF [GeneID=7124] inhibitor etanercept.+++HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_0DY_POSITIVE///Genes positively correlated with memory B cell response at 28d in peripheral blood mononuclear cell in seniors(50-74) after exposure to Fluarix , time point 0D+++HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_3DY_NEGATIVE///Genes negatively correlated with memory B cell response at 28d in peripheral blood mononuclear cell in seniors (50-74) after exposure to Fluarix , time point 3D+++NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_UP///Genes up-regulated in peripheral blood mononuclear cell 3d vs 0d in adults (18-50) after exposure to Fluarix/Fluvirin , time point 3D. Comment: Supplementary Table 1a: All the differentially expressed genes identified in PBMCs of TIV vaccinees.+++NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_UP///Genes up-regulated in peripheral blood mononuclear cell 3d vs 0d in adults (18-50) after exposure to FluMist , time point 3D. Comment: Supplementary Table 1b: All the differentially expressed genes identified in PBMCs of TIV vaccinees.+++NAKAYA_PBMC_FLUMIST_AGE_18_50YO_7DY_UP///Genes up-regulated in peripheral blood mononuclear cell 7d vs 0d in adults (18-50) after exposure to FluMist , time point 7D. Comment: Supplementary Table 1b: All the differentially expressed genes identified in PBMCs of TIV vaccinees.+++NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP///Genes up-regulated in plasmacytoid dendritic cell 7d vs 0d in young adults (18-50) after exposure to FluMist , time point 7D+++OSMAN_BLOOD_CHAD63_KH_AGE_18_50YO_HIGH_DOSE_SUBJECTS_24HR_UP///Genes up-regulated in blood 24hr vs 0hr in adults (18-50) (high dose subjects) after exposure to ChAd63-KH , time point 24H , administered Intramuscular injection. Comment: DE gene list for high dose subjects."	HALLMARK_MYC_TARGETS_V1///A subgroup of genes regulated by MYC - version 1 (v1).	NM_003347	UBE2L3				
P63279	sp|P63279|UBC9_HUMAN		UBE2I		SUMO-conjugating enzyme UBC9 OS=Homo sapiens OX=9606 GN=UBE2I PE=1 SV=1	7329	NM_003345	NP_003336	ENST00000397514	K10577			MSGIALSRLAQERKAWRKDHPFGFVAVPTKNPDGTMNLMNWECAIPGKKGTPWEGGLFKLRMLFKDDYPSSPPKCKFEPPLFHPNVYPSGTVCLSILEEDKDWRPAITIKQILLGIQELLNEPNIQDPAQAEAYTIYCQNRVEYEKRVRAQAKKFAPS	0.4789677	-1.061999748	0.01492822		1.931056							3.437632	4.5690442	3.3875909	4.8983948	2.58120397	2.9737391	3.1741016			3.522892			2.9130321		3.4299508	3.1984773			2.2644677	6.553824	5.1034379	5.526958	5.8565726			3.71729	3.5684625	3.0972148	4.3169351	4.4572276	5.419528	3.4605487	3.54938089	5.5591497		5.73533799	03013///Nucleocytoplasmic transport+++04064///NF-kappa B signaling pathway+++04120///Ubiquitin mediated proteolysis+++05206///MicroRNAs in cancer				GO:0000795///synaptonemal complex+++GO:0005634///nucleus+++GO:0005635///nuclear envelope+++GO:0005654///nucleoplasm+++GO:0005737///cytoplasm+++GO:0005829///cytosol+++GO:0016604///nuclear body+++GO:0016605///PML body+++GO:1990234///transferase complex+++GO:1990356///sumoylated E2 ligase complex	GO:0000166///nucleotide binding+++GO:0001221///transcription cofactor binding+++GO:0003723///RNA binding+++GO:0005515///protein binding+++GO:0005524///ATP binding+++GO:0008134///transcription factor binding+++GO:0016740///transferase activity+++GO:0019789///SUMO transferase activity+++GO:0019899///enzyme binding+++GO:0043398///HLH domain binding+++GO:0044388///small protein activating enzyme binding+++GO:0061656///SUMO conjugating enzyme activity+++GO:0071535///RING-like zinc finger domain binding	"GO:0000122///negative regulation of transcription by RNA polymerase II+++GO:0006464///cellular protein modification process+++GO:0006511///ubiquitin-dependent protein catabolic process+++GO:0007049///cell cycle+++GO:0007059///chromosome segregation+++GO:0007084///mitotic nuclear envelope reassembly+++GO:0016925///protein sumoylation+++GO:0019082///viral protein processing+++GO:0043123///positive regulation of I-kappaB kinase/NF-kappaB signaling+++GO:0045892///negative regulation of transcription, DNA-templated+++GO:0051301///cell division+++GO:1903755///positive regulation of SUMO transferase activity"	tissueType=Fetal kidney;cancerType=Normal;cellName=Natural killer T (NKT) cell		"Homo sapiens ubiquitin conjugating enzyme E2 I (UBE2I), transcript variant 1, mRNA."		PF00179///Ubiquitin-conjugating enzyme	"R-HSA-1221632///Meiotic synapsis+++R-HSA-1430728///Metabolism+++R-HSA-1474165///Reproduction+++R-HSA-1500620///Meiosis+++R-HSA-1640170///Cell Cycle+++R-HSA-1643685///Disease+++R-HSA-196791///Vitamin D (calciferol) metabolism+++R-HSA-212436///Generic Transcription Pathway+++R-HSA-2555396///Mitotic Metaphase and Anaphase+++R-HSA-2990846///SUMOylation+++R-HSA-2995410///Nuclear Envelope (NE) Reassembly+++R-HSA-3065678///SUMO is transferred from E1 to E2 (UBE2I, UBC9)+++R-HSA-3108214///SUMOylation of DNA damage response and repair proteins+++R-HSA-3108232///SUMO E3 ligases SUMOylate target proteins+++R-HSA-3215018///Processing and activation of SUMO+++R-HSA-3232118///SUMOylation of transcription factors+++R-HSA-3232142///SUMOylation of ubiquitinylation proteins+++R-HSA-3899300///SUMOylation of transcription cofactors+++R-HSA-392499///Metabolism of proteins+++R-HSA-4085377///SUMOylation of SUMOylation proteins+++R-HSA-4090294///SUMOylation of intracellular receptors+++R-HSA-4551638///SUMOylation of chromatin organization proteins+++R-HSA-4570464///SUMOylation of RNA binding proteins+++R-HSA-4615885///SUMOylation of DNA replication proteins+++R-HSA-4655427///SUMOylation of DNA methylation proteins+++R-HSA-4755510///SUMOylation of immune response proteins+++R-HSA-556833///Metabolism of lipids+++R-HSA-5663205///Infectious disease+++R-HSA-5693532///DNA Double-Strand Break Repair+++R-HSA-5693538///Homology Directed Repair+++R-HSA-5693565///Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks+++R-HSA-5693567///HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)+++R-HSA-5693606///DNA Double Strand Break Response+++R-HSA-5693607///Processing of DNA double-strand break ends+++R-HSA-5696395///Formation of Incision Complex in GG-NER+++R-HSA-5696398///Nucleotide Excision Repair+++R-HSA-5696399///Global Genome Nucleotide Excision Repair (GG-NER)+++R-HSA-597592///Post-translational protein modification+++R-HSA-68882///Mitotic Anaphase+++R-HSA-68886///M Phase+++R-HSA-69278///Cell Cycle, Mitotic+++R-HSA-73857///RNA Polymerase II Transcription+++R-HSA-73894///DNA Repair+++R-HSA-74160///Gene expression (Transcription)+++R-HSA-8864260///Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors+++R-HSA-8866904///Negative regulation of activity of TFAP2 (AP-2) family transcription factors+++R-HSA-8957322///Metabolism of steroids+++R-HSA-9615933///Postmitotic nuclear pore complex (NPC) reformation+++R-HSA-9678108///SARS-CoV-1 Infection+++R-HSA-9679506///SARS-CoV Infections+++R-HSA-9683610///Maturation of nucleoprotein+++R-HSA-9683701///Translation of Structural Proteins+++R-HSA-9694516///SARS-CoV-2 Infection+++R-HSA-9694631///Maturation of nucleoprotein+++R-HSA-9694635///Translation of Structural Proteins"	COG5078///No_INFO	KOG0424///Belongs to the ubiquitin-conjugating enzyme family		"IPR000608///Ubiquitin-conjugating enzyme E2+++IPR016135///Ubiquitin-conjugating enzyme/RWD-like+++IPR023313///Ubiquitin-conjugating enzyme, active site"	"[UBC9_HUMAN|Reviewed]RecName: Full=SUMO-conjugating enzyme UBC9; EC=2.3.2.- {ECO:0000269|PubMed:26524494}; AltName: Full=RING-type E3 SUMO transferase UBC9; AltName: Full=SUMO-protein ligase; AltName: Full=Ubiquitin carrier protein 9; AltName: Full=Ubiquitin carrier protein I; AltName: Full=Ubiquitin-conjugating enzyme E2 I; AltName: Full=Ubiquitin-protein ligase I; AltName: Full=p18;+++[Q7KZS0_HUMAN|Unreviewed]SubName: Full=Ubiquitin-conjugating enzyme E2I (UBC9 homolog, yeast) {ECO:0000313|EMBL:AAP35656.1}; SubName: Full=Ubiquitin-conjugating enzyme E2I (UBC9 homolog, yeast), isoform CRA_b {ECO:0000313|EMBL:EAW85674.1};"	chr16p13///Ensembl 103 genes in cytogenetic band chr16p13	BIOCARTA_CTBP1_PATHWAY///SUMOylation as a mechanism to modulate CtBP-dependent gene responses+++BIOCARTA_ERAD_PATHWAY///ERbassociated degradation (ERAD) Pathway+++BIOCARTA_SUMO_PATHWAY///Basic Mechanisms of SUMOylation	KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS///Ubiquitin mediated proteolysis	"REACTOME_CELL_CYCLE///Cell Cycle+++REACTOME_CELL_CYCLE_MITOTIC///Cell Cycle, Mitotic+++REACTOME_DNA_DOUBLE_STRAND_BREAK_REPAIR///DNA Double-Strand Break Repair+++REACTOME_DNA_DOUBLE_STRAND_BREAK_RESPONSE///DNA Double Strand Break Response+++REACTOME_DNA_REPAIR///DNA Repair+++REACTOME_FORMATION_OF_INCISION_COMPLEX_IN_GG_NER///Formation of Incision Complex in GG-NER+++REACTOME_GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER///Global Genome Nucleotide Excision Repair (GG-NER)+++REACTOME_HOMOLOGY_DIRECTED_REPAIR///Homology Directed Repair+++REACTOME_INFECTIOUS_DISEASE///Infectious disease+++REACTOME_MATURATION_OF_NUCLEOPROTEIN///Maturation of nucleoprotein+++REACTOME_MEIOSIS///Meiosis+++REACTOME_MEIOTIC_SYNAPSIS///Meiotic synapsis+++REACTOME_METABOLISM_OF_LIPIDS///Metabolism of lipids+++REACTOME_METABOLISM_OF_STEROIDS///Metabolism of steroids+++REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE///Mitotic Metaphase and Anaphase+++REACTOME_M_PHASE///M Phase+++REACTOME_NEGATIVE_REGULATION_OF_ACTIVITY_OF_TFAP2_AP_2_FAMILY_TRANSCRIPTION_FACTORS///Negative regulation of activity of TFAP2 (AP-2) family transcription factors+++REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY///Nuclear Envelope (NE) Reassembly+++REACTOME_NUCLEOTIDE_EXCISION_REPAIR///Nucleotide Excision Repair+++REACTOME_POSTMITOTIC_NUCLEAR_PORE_COMPLEX_NPC_REFORMATION///Postmitotic nuclear pore complex (NPC) reformation+++REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION///Post-translational protein modification+++REACTOME_PROCESSING_AND_ACTIVATION_OF_SUMO///Processing and activation of SUMO+++REACTOME_PROCESSING_OF_DNA_DOUBLE_STRAND_BREAK_ENDS///Processing of DNA double-strand break ends+++REACTOME_REPRODUCTION///Reproduction+++REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION///RNA Polymerase II Transcription+++REACTOME_SARS_COV_1_INFECTION///SARS-CoV-1 Infection+++REACTOME_SARS_COV_2_INFECTION///SARS-CoV-2 Infection+++REACTOME_SARS_COV_INFECTIONS///SARS-CoV Infections+++REACTOME_SUMO_IS_TRANSFERRED_FROM_E1_TO_E2_UBE2I_UBC9///SUMO is transferred from E1 to E2 (UBE2I, UBC9)+++REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS///SUMOylation of chromatin organization proteins+++REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS///SUMOylation of DNA damage response and repair proteins+++REACTOME_SUMOYLATION_OF_DNA_METHYLATION_PROTEINS///SUMOylation of DNA methylation proteins+++REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS///SUMOylation of DNA replication proteins+++REACTOME_SUMOYLATION_OF_IMMUNE_RESPONSE_PROTEINS///SUMOylation of immune response proteins+++REACTOME_SUMOYLATION_OF_INTRACELLULAR_RECEPTORS///SUMOylation of intracellular receptors+++REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS///SUMOylation of RNA binding proteins+++REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS///SUMOylation of SUMOylation proteins+++REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS///SUMOylation of transcription cofactors+++REACTOME_SUMOYLATION_OF_TRANSCRIPTION_FACTORS///SUMOylation of transcription factors+++REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS///SUMOylation of ubiquitinylation proteins+++REACTOME_SUMOYLATION///SUMOylation+++REACTOME_TRANSCRIPTIONAL_REGULATION_BY_THE_AP_2_TFAP2_FAMILY_OF_TRANSCRIPTION_FACTORS///Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors+++REACTOME_TRANSLATION_OF_SARS_COV_1_STRUCTURAL_PROTEINS///Translation of SARS-CoV-1 structural proteins+++REACTOME_TRANSLATION_OF_SARS_COV_2_STRUCTURAL_PROTEINS///Translation of SARS-CoV-2 structural proteins+++REACTOME_VITAMIN_D_CALCIFEROL_METABOLISM///Vitamin D (calciferol) metabolism"		"AAGGGAT_MIR188///Genes having at least one occurence of the motif AAGGGAT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-188 (v7.1 miRBase).+++CAGTATT_MIR200B_MIR200C_MIR429///Genes having at least one occurence of the motif CAGTATT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-200b, hsa-miR-200c and hsa-miR-429 (v7.1 miRBase).+++TGTTTAC_MIR30A5P_MIR30C_MIR30D_MIR30B_MIR30E5P///Genes having at least one occurence of the motif TGTTTAC in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-30a-5p, hsa-miR-30c, hsa-miR-30d, hsa-miR-30b and hsa-miR-30e-5p (v7.1 miRBase)."	"MIR10A_5P_MIR10B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-10a-5p, hsa-miR-10b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR16_2_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-16-2-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR195_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-195-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR2467_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-2467-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR30A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-30a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR30B_5P_MIR30C_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-30b-5p, hsa-miR-30c-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR30D_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-30d-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR30E_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-30e-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3120_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3120-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3188///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3188 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR324_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-324-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3667_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3667-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3913_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3913-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3975///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3975 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR450B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-450b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4649_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4649-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR485_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-485-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5088_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5088-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AW///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548aw in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR587///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-587 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6827_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6827-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6884_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6884-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets)."	NFKAPPAB_01///Genes having at least one occurence of the transcription factor binding site V$NFKAPPAB_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++NFKAPPAB65_01///Genes having at least one occurence of the transcription factor binding site V$NFKAPPAB65_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++NFKB_C///Genes having at least one occurence of the transcription factor binding site V$NFKB_C (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++NFKB_Q6_01///Genes having at least one occurence of the transcription factor binding site V$NFKB_Q6_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++NFKB_Q6///Genes having at least one occurence of the transcription factor binding site V$NFKB_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.	"ADA2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9NZK5 (ADA2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ARHGAP35_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9NRY4 (ARHGAP35) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ARID5B_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q14865 (ARID5B) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ASH1L_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9NR48 (ASH1L) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++BARX2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9UMQ3 (BARX2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++BDP1_TARGET_GENES///Genes containing one or more binding sites for UniProt:A6H8Y1 (BDP1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++CDC5L_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q99459 (CDC5L) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++CREB3L4_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8TEY5 (CREB3L4) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++DIDO1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9BTC0 (DIDO1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++DNMT3A_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9Y6K1 (DNMT3A) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++E2F2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q14209 (E2F2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++FOXG1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P55316 (FOXG1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++FOXP2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O15409 (FOXP2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++GUCY1B1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q02153 (GUCY1B1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++H1_6_TARGET_GENES///Genes containing one or more binding sites for UniProt:P22492 (H1_6) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HMG20B_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9P0W2 (HMG20B) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HMGB1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P09429 (HMGB1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HOXA1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P49639 (HOXA1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HOXC6_TARGET_GENES///Genes containing one or more binding sites for UniProt:P09630 (HOXC6) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++INSM2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96T92 (INSM2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++KAT2A_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q92830 (KAT2A) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++KAT5_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q92993 (KAT5) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++KDM7A_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6ZMT4 (KDM7A) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++MEF2D_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q14814 (MEF2D) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++MIER1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8N108 (MIER1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NAB2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q15742 (NAB2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NCOA2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q15596 (NCOA2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NCOA4_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q13772 (NCOA4) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NCOA6_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q14686 (NCOA6) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NFE2L1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q14494 (NFE2L1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++PAX3_TARGET_GENES///Genes containing one or more binding sites for UniProt:P23760 (PAX3) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++PAX7_TARGET_GENES///Genes containing one or more binding sites for UniProt:P23759 (PAX7) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++PGM3_TARGET_GENES///Genes containing one or more binding sites for UniProt:O95394 (PGM3) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++RFX7_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q2KHR2 (RFX7) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++RYBP_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8N488 (RYBP) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SAFB2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q14151 (SAFB2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SALL4_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9UJQ4 (SALL4) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SETD1A_TARGET_GENES///Genes containing one or more binding sites for UniProt:O15047 (SETD1A) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SKIL_TARGET_GENES///Genes containing one or more binding sites for UniProt:P12757 (SKIL) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SUMO1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P63165 (SUMO1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SUPT16H_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9Y5B9 (SUPT16H) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SUPT20H_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8NEM7 (SUPT20H) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++TET1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8NFU7 (TET1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++WRNIP1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96S55 (WRNIP1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZFP91_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96JP5 (ZFP91) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF10_TARGET_GENES///Genes containing one or more binding sites for UniProt:P21506 (ZNF10) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF146_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q15072 (ZNF146) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF184_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q99676 (ZNF184) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9BSG1 (ZNF2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF30_TARGET_GENES///Genes containing one or more binding sites for UniProt:P17039 (ZNF30) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF561_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8N587 (ZNF561) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF579_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8NAF0 (ZNF579) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF581_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9P0T4 (ZNF581) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF711_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9Y462 (ZNF711) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF740_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8NDX6 (ZNF740) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF777_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9ULD5 (ZNF777) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF830_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96NB3 (ZNF830) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF84_TARGET_GENES///Genes containing one or more binding sites for UniProt:P51523 (ZNF84) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZSCAN29_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8IWY8 (ZSCAN29) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZSCAN2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q7Z7L9 (ZSCAN2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZSCAN30_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q86W11 (ZSCAN30) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZSCAN31_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96LW9 (ZSCAN31) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."	GCM_CBFB///Neighborhood of CBFB+++GNF2_FBL///Neighborhood of FBL+++GNF2_G22P1///Neighborhood of G22P1+++GNF2_UBE2I///Neighborhood of UBE2I+++MORF_AATF///Neighborhood of AATF+++MORF_ACP1///Neighborhood of ACP1+++MORF_ACTG1///Neighborhood of ACTG1+++MORF_ANP32B///Neighborhood of ANP32B+++MORF_AP2M1///Neighborhood of AP2M1+++MORF_CTBP1///Neighborhood of CTBP1+++MORF_DAP3///Neighborhood of DAP3+++MORF_DEK///Neighborhood of DEK+++MORF_EIF3S2///Neighborhood of EIF3S2+++MORF_EIF4A2///Neighborhood of EIF4A2+++MORF_ERH///Neighborhood of ERH+++MORF_FBL///Neighborhood of FBL+++MORF_G22P1///Neighborhood of G22P1+++MORF_NME2///Neighborhood of NME2+++MORF_NPM1///Neighborhood of NPM1+++MORF_PPP2CA///Neighborhood of PPP2CA+++MORF_RAF1///Neighborhood of RAF1+++MORF_RAN///Neighborhood of RAN+++MORF_SART1///Neighborhood of SART1+++MORF_SNRP70///Neighborhood of SNRP70+++MORF_UBE2I///Neighborhood of UBE2I+++MORF_XRCC5///Neighborhood of XRCC5	MODULE_177///Genes in the cancer module 177.+++MODULE_233///Genes in the cancer module 233.+++MODULE_235///AA and sulfur metabolism.+++MODULE_4///Genes in the cancer module 4.+++MODULE_82///Genes in the cancer module 82.		"GSE12366_GC_BCELL_VS_PLASMA_CELL_UP///Genes up-regulated in comparison of germinal center B cells versus plasma cells.+++GSE16450_CTRL_VS_IFNA_6H_STIM_MATURE_NEURON_CELL_LINE_DN///Genes down-regulated in mature neuron cell line: control versus interferon alpha (6h).+++GSE1740_MCSF_VS_MCSF_AND_IFNG_DAY2_DERIVED_MACROPHAGE_WITH_IFNA_STIM_UP///Genes up-regulated in monocyte-derived macrophages: no priming, stimulated by interferon alpha versus primed by IFNG [GeneID=3458] and then stimulated by interferon alpha.+++GSE17974_1H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_DN///Genes down-regulated in comparison of untreated CD4 [GeneID=920] T cells at 1 h versus the untreated cells at 72 h.+++GSE22103_UNSTIM_VS_LPS_STIM_NEUTROPHIL_UP///Genes up-regulated in neutrophils: untreated versus LPS.+++GSE22601_DOUBLE_NEGATIVE_VS_IMMATURE_CD4_SP_THYMOCYTE_UP///Genes up-regulated in double negative thymocyte versus immature CD4 [GeneID=920] single positive cells.+++GSE22611_UNSTIM_VS_2H_MDP_STIM_NOD2_TRANSDUCED_HEK293T_CELL_DN///Genes down-regulated in HEK293 cells over-expressing wildtype NOD2 [GeneID=64127]: untreated versus muramyl dipeptide [PubChem=11620162] for 2h.+++GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH1_DN///Genes down-regulated in comparison of naive CD4 [GeneID=920] T cells versus stimulated CD4 [GeneID=920] Th1 cells at 48 h.+++GSE2405_0H_VS_6H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP///Genes up-regulated in polymorphonuclear leukocytes (6h): control versus infection by A. phagocytophilum.+++GSE24634_NAIVE_CD4_TCELL_VS_DAY3_IL4_CONV_TREG_DN///Genes down-regulated in comparison of naive T cells at day 0 versus CD25+ regulatory T cell (Treg) treated with IL4 [GeneID=3565] at day 3.+++GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_DN///Genes down-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: IL-12 (48h) versus TGFB1 [GeneID=7040] and IL-12 (48h).+++GSE360_CTRL_VS_L_DONOVANI_MAC_UP///Genes up-regulated in comparison of macrophages versus macrophages exposed to L.donovani.+++GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_MAC_DN///Genes down-regulated in comparison of macrophages exposed to L. donovani versus macrophages exposed to 5 worms/well B. malayi.+++GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH1_DN///Genes down-regulated in comparison of effective memory CD4 [GeneID=920] T cells versus Th1 cells.+++GSE3982_MAST_CELL_VS_EFF_MEMORY_CD4_TCELL_UP///Genes up-regulated in comparison of mast cells versus effector memory CD4 [GeneID=920] T cells.+++GSE5542_UNTREATED_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN///Genes down-regulated in epithelial cells (6h): untreated versus interferon alpha and IFNG [GeneID=3458].+++GSE5679_PPARG_LIGAND_ROSIGLITAZONE_VS_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_UP///Genes up-regulated in monocyte-derived dendritic cells: rosiglitazone [PubChem=77999] versus rosiglitazone and AM580 [PubChem=77999;2126].+++GSE6092_UNSTIM_VS_IFNG_STIM_ENDOTHELIAL_CELL_UP///Genes up-regulated in endothelial cells: untreated versus IFNG [GeneID=3458].+++GSE6269_HEALTHY_VS_FLU_INF_PBMC_UP///Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMC from patients with acute influenza infection.+++GSE9960_HEALTHY_VS_SEPSIS_PBMC_UP///Genes up-regulated in peripheral blood monocytes (PMBC): healthy versus sepsis.+++HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_3DY_NEGATIVE///Genes negatively correlated with memory B cell response at 28d in peripheral blood mononuclear cell in seniors (50-74) after exposure to Fluarix , time point 3D+++NAKAYA_MONOCYTE_FLUMIST_AGE_18_50YO_7DY_UP///Genes up-regulated in monocyte 7d vs 0d in young adults (18-50) after exposure to FluMist , time point 7D+++NAKAYA_MYELOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP///Genes up-regulated in myeloid dendritic cell 7d vs 0d in young adults (18-50) after exposure to Fluarix/Fluvirin , time point 7D+++NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_UP///Genes up-regulated in peripheral blood mononuclear cell 3d vs 0d in adults (18-50) after exposure to FluMist , time point 3D. Comment: Supplementary Table 1b: All the differentially expressed genes identified in PBMCs of TIV vaccinees."	HALLMARK_ANDROGEN_RESPONSE///Genes defining response to androgens.	NM_003345	UBE2I				
P63241	sp|P63241|IF5A1_HUMAN				Eukaryotic translation initiation factor 5A-1 OS=Homo sapiens OX=9606 GN=EIF5A PE=1 SV=2								MADDLDFETGDAGASATFPMQCSALRKNGFVVLKGRPCKIVEMSTSKTGKHGHAKVHLVGIDIFTGKKYEDICPSTHNMDVPNIKRNDFQLIGIQDGYLSLLQDSGEVREDLRLPEGDLGKEIEQKYDCGEEILITVLSAMTEEAAVAIKAMAK	0.3678577	-1.442780431	5.61E-04		3.6920376	4.1375254	2.9873467		6.2188822	4.695047356	5.1336589	5.8630829	6.1389742	5.7816415	6.3304437	3.85856824	4.1655738	2.7885257	4.096122					5.0774082	5.1379152	6.4826431	3.842436	5.27507652	4.45371126	3.5900228	8.299021	7.8461951	7.538587	7.4549612	5.433582	5.4842104	6.8878567	7.04099	6.5098401	7.0388814	4.9133824	7.012555	6.5880204	5.92468171	6.9596593		5.6069391																																	C9606_113934					
P63167	sp|P63167|DYL1_HUMAN				"Dynein light chain 1, cytoplasmic OS=Homo sapiens OX=9606 GN=DYNLL1 PE=1 SV=1 >tr|Q6FGH9|Q6FGH9_HUMAN Dynein light chain OS=Homo sapiens OX=9606 GN=DNCL1 PE=2 SV=1"								MCDRKAVIKNADMSEEMQQDSVECATQALEKYNIEKDIAAHIKKEFDKKYNPTWHCIVGRNFGSYVTHETKHFIYFYLGQVAILLFKSG	0.4591187	-1.12306105	5.59E-04				5.1452356	4.6260025	7.2213688	5.035044236	6.1646904	6.4014323	7.4272884	6.7057162	6.3462354	6.2250588	5.9919953	6.0308248	6.5692571	3.923646	6.546442	4.460893538		5.7377947	7.0083601	7.3347467		4.99782916	5.67712884		8.71882	8.1849578	8.676771	7.542826	5.853913	6.7264343	7.0067048	7.6708734	7.2678932	7.6822118	6.4181514	7.571776	7.8862627	6.6752933	7.100925	6.0171782	6.9697318																																	C9606_74698					
P63104	sp|P63104|1433Z_HUMAN		YWHAZ		14-3-3 protein zeta/delta OS=Homo sapiens OX=9606 GN=YWHAZ PE=1 SV=1 >tr|D0PNI1|D0PNI1_HUMAN Epididymis luminal protein 4 OS=Homo sapiens OX=9606 GN=YWHAZ PE=2 SV=1	7534	XM_017013810	XP_016869299		K16197			MDKNELVQKAKLAEQAERYDDMAACMKSVTEQGAELSNEERNLLSVAYKNVVGARRSSWRVVSSIEQKTEGAEKKQQMAREYREKIETELRDICNDVLSLLEKFLIPNASQAESKVFYLKMKGDYYRYLAEVAAGDDKKGIVDQSQQAYQEAFEISKKEMQPTHPIRLGLALNFSVFYYEILNSPEKACSLAKTAFDEAIAELDTLSEESYKDSTLIMQLLRDNLTLWTSDTQGDEAEAGEGGEN	0.5737455	-0.801517136	0.00770133	4.2829737	4.3576017	3.036116	5.3014076	4.7534942	5.6866229	3.676246126		5.5284789	6.5897232	4.200328	5.5975631	4.99374808	6.539138	4.0940806	4.6031314	3.2521725	4.1560207	3.102334635	3.0235645	3.8116686	4.2688035	4.9433246	4.7932794	4.78453566	4.75048418	4.5548355	6.67676	6.6172645	6.582793	5.5955442	5.183587	6.5097428	5.0217291	6.2274472	5.3443702	5.8688498	4.1139124	6.783494	4.199417	5.35897889	5.0017757	3.5832965	4.51008953	04013///MAPK signaling pathway - fly+++04110///Cell cycle+++04114///Oocyte meiosis+++04151///PI3K-Akt signaling pathway+++04212///Longevity regulating pathway - worm+++04390///Hippo signaling pathway+++04391///Hippo signaling pathway - fly+++05160///Hepatitis C+++05161///Hepatitis B+++05203///Viral carcinogenesis				GO:0005615///extracellular space+++GO:0005634///nucleus+++GO:0005654///nucleoplasm+++GO:0005737///cytoplasm+++GO:0005739///mitochondrion+++GO:0005829///cytosol+++GO:0005925///focal adhesion+++GO:0031982///vesicle+++GO:0042470///melanosome+++GO:0070062///extracellular exosome+++GO:0072562///blood microparticle+++GO:0098686///hippocampal mossy fiber to CA3 synapse+++GO:0098978///glutamatergic synapse	GO:0003723///RNA binding+++GO:0004497///monooxygenase activity+++GO:0005515///protein binding+++GO:0008134///transcription factor binding+++GO:0016301///kinase activity+++GO:0019901///protein kinase binding+++GO:0019904///protein domain specific binding+++GO:0031625///ubiquitin protein ligase binding+++GO:0042802///identical protein binding+++GO:0044325///ion channel binding+++GO:0045296///cadherin binding	GO:0001525///angiogenesis+++GO:0002250///adaptive immune response+++GO:0003016///respiratory system process+++GO:0006468///protein phosphorylation+++GO:0006605///protein targeting+++GO:0007165///signal transduction+++GO:0008039///synaptic target recognition+++GO:0010941///regulation of cell death+++GO:0016310///phosphorylation+++GO:0019221///cytokine-mediated signaling pathway+++GO:0030168///platelet activation+++GO:0030324///lung development+++GO:0034613///cellular protein localization+++GO:0035148///tube formation+++GO:0043066///negative regulation of apoptotic process+++GO:0043488///regulation of mRNA stability+++GO:0051683///establishment of Golgi localization+++GO:0070371///ERK1 and ERK2 cascade+++GO:0070372///regulation of ERK1 and ERK2 cascade+++GO:0090128///regulation of synapse maturation+++GO:0090168///Golgi reassembly+++GO:1900740///positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway	tissueType=Fetal kidney;cancerType=Normal;cellName=Natural killer T (NKT) cell		"PREDICTED: Homo sapiens tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta (YWHAZ), transcript variant X1, mRNA."		PF00244///14-3-3 protein	"R-HSA-109581///Apoptosis+++R-HSA-109582///Hemostasis+++R-HSA-109606///Intrinsic Pathway for Apoptosis+++R-HSA-111447///Activation of BAD and translocation to mitochondria +++R-HSA-114452///Activation of BH3-only proteins+++R-HSA-1280215///Cytokine Signaling in Immune system+++R-HSA-1280218///Adaptive Immune System+++R-HSA-1445148///Translocation of SLC2A4 (GLUT4) to the plasma membrane+++R-HSA-157118///Signaling by NOTCH+++R-HSA-162582///Signal Transduction+++R-HSA-1640170///Cell Cycle+++R-HSA-168256///Immune System+++R-HSA-194315///Signaling by Rho GTPases+++R-HSA-195258///RHO GTPase Effectors+++R-HSA-195721///Signaling by WNT+++R-HSA-199991///Membrane Trafficking+++R-HSA-201681///TCF dependent signaling in response to WNT+++R-HSA-212436///Generic Transcription Pathway+++R-HSA-3700989///Transcriptional Regulation by TP53+++R-HSA-3769402///Deactivation of the beta-catenin transactivating complex+++R-HSA-392517///Rap1 signalling+++R-HSA-430116///GP1b-IX-V activation signalling+++R-HSA-449147///Signaling by Interleukins+++R-HSA-450531///Regulation of mRNA stability by proteins that bind AU-rich elements+++R-HSA-450604///KSRP (KHSRP) binds and destabilizes mRNA+++R-HSA-512988///Interleukin-3, Interleukin-5 and GM-CSF signaling+++R-HSA-5357801///Programmed Cell Death+++R-HSA-5625740///RHO GTPases activate PKNs+++R-HSA-5628897///TP53 Regulates Metabolic Genes+++R-HSA-5653656///Vesicle-mediated transport+++R-HSA-69473///G2/M DNA damage checkpoint+++R-HSA-69481///G2/M Checkpoints+++R-HSA-69620///Cell Cycle Checkpoints+++R-HSA-73857///RNA Polymerase II Transcription+++R-HSA-74160///Gene expression (Transcription)+++R-HSA-75035///Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex+++R-HSA-76002///Platelet activation, signaling and aggregation+++R-HSA-8953854///Metabolism of RNA+++R-HSA-9013694///Signaling by NOTCH4+++R-HSA-9013700///NOTCH4 Activation and Transmission of Signal to the Nucleus+++R-HSA-9604323///Negative regulation of NOTCH4 signaling+++R-HSA-9614085///FOXO-mediated transcription+++R-HSA-9614399///Regulation of localization of FOXO transcription factors+++R-HSA-9716542///Signaling by Rho GTPases, Miro GTPases and RHOBTB3"		KOG0841///protein domain specific binding		"IPR000308///14-3-3 protein+++IPR023409///14-3-3 protein, conserved site+++IPR023410///14-3-3 domain+++IPR036815///14-3-3 domain superfamily"	[1433Z_HUMAN|Reviewed]RecName: Full=14-3-3 protein zeta/delta; AltName: Full=Protein kinase C inhibitor protein 1; Short=KCIP-1;	chr8q22///Ensembl 103 genes in cytogenetic band chr8q22		KEGG_CELL_CYCLE///Cell cycle+++KEGG_NEUROTROPHIN_SIGNALING_PATHWAY///Neurotrophin signaling pathway+++KEGG_OOCYTE_MEIOSIS///Oocyte meiosis+++KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION///Pathogenic Escherichia coli infection	"REACTOME_ACTIVATION_OF_BAD_AND_TRANSLOCATION_TO_MITOCHONDRIA///Activation of BAD and translocation to mitochondria +++REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS///Activation of BH3-only proteins+++REACTOME_ADAPTIVE_IMMUNE_SYSTEM///Adaptive Immune System+++REACTOME_APOPTOSIS///Apoptosis+++REACTOME_CELL_CYCLE///Cell Cycle+++REACTOME_CELL_CYCLE_CHECKPOINTS///Cell Cycle Checkpoints+++REACTOME_CHK1_CHK2_CDS1_MEDIATED_INACTIVATION_OF_CYCLIN_B_CDK1_COMPLEX///Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex+++REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM///Cytokine Signaling in Immune system+++REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX///Deactivation of the beta-catenin transactivating complex+++REACTOME_FOXO_MEDIATED_TRANSCRIPTION///FOXO-mediated transcription+++REACTOME_G2_M_CHECKPOINTS///G2/M Checkpoints+++REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT///G2/M DNA damage checkpoint+++REACTOME_GP1B_IX_V_ACTIVATION_SIGNALLING///GP1b-IX-V activation signalling+++REACTOME_HEMOSTASIS///Hemostasis+++REACTOME_INTERLEUKIN_3_INTERLEUKIN_5_AND_GM_CSF_SIGNALING///Interleukin-3, Interleukin-5 and GM-CSF signaling+++REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS///Intrinsic Pathway for Apoptosis+++REACTOME_KSRP_KHSRP_BINDS_AND_DESTABILIZES_MRNA///KSRP (KHSRP) binds and destabilizes mRNA+++REACTOME_MEMBRANE_TRAFFICKING///Membrane Trafficking+++REACTOME_METABOLISM_OF_RNA///Metabolism of RNA+++REACTOME_NEGATIVE_REGULATION_OF_NOTCH4_SIGNALING///Negative regulation of NOTCH4 signaling+++REACTOME_NOTCH4_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS///NOTCH4 Activation and Transmission of Signal to the Nucleus+++REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION///Platelet activation, signaling and aggregation+++REACTOME_PROGRAMMED_CELL_DEATH///Programmed Cell Death+++REACTOME_RAP1_SIGNALLING///Rap1 signalling+++REACTOME_REGULATION_OF_LOCALIZATION_OF_FOXO_TRANSCRIPTION_FACTORS///Regulation of localization of FOXO transcription factors+++REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS///Regulation of mRNA stability by proteins that bind AU-rich elements+++REACTOME_RHO_GTPASE_EFFECTORS///RHO GTPase Effectors+++REACTOME_RHO_GTPASES_ACTIVATE_PKNS///RHO GTPases activate PKNs+++REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION///RNA Polymerase II Transcription+++REACTOME_SIGNALING_BY_INTERLEUKINS///Signaling by Interleukins+++REACTOME_SIGNALING_BY_NOTCH4///Signaling by NOTCH4+++REACTOME_SIGNALING_BY_NOTCH///Signaling by NOTCH+++REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3///Signaling by Rho GTPases, Miro GTPases and RHOBTB3+++REACTOME_SIGNALING_BY_WNT///Signaling by WNT+++REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT///TCF dependent signaling in response to WNT+++REACTOME_TP53_REGULATES_METABOLIC_GENES///TP53 Regulates Metabolic Genes+++REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53///Transcriptional Regulation by TP53+++REACTOME_TRANSLOCATION_OF_SLC2A4_GLUT4_TO_THE_PLASMA_MEMBRANE///Translocation of SLC2A4 (GLUT4) to the plasma membrane+++REACTOME_VESICLE_MEDIATED_TRANSPORT///Vesicle-mediated transport"	SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES///Genes related to the insulin receptor pathway+++SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES///Genes related to PIP3 signaling in cardiac myocytes	"AACGGTT_MIR451///Genes having at least one occurence of the motif AACGGTT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-451 (v7.1 miRBase).+++ACATTCC_MIR1_MIR206///Genes having at least one occurence of the motif ACATTCC in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-1 and hsa-miR-206 (v7.1 miRBase).+++ACCATTT_MIR522///Genes having at least one occurence of the motif ACCATTT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-522 (v7.1 miRBase).+++ACTGCCT_MIR34B///Genes having at least one occurence of the motif ACTGCCT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-34b (v7.1 miRBase).+++AGCACTT_MIR93_MIR302A_MIR302B_MIR302C_MIR302D_MIR372_MIR373_MIR520E_MIR520A_MIR526B_MIR520B_MIR520C_MIR520D///Genes having at least one occurence of the motif AGCACTT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-93, hsa-miR-302a, hsa-miR-302b, hsa-miR-302c, hsa-miR-302d, hsa-miR-372, hsa-miR-373, hsa-miR-520e, hsa-miR-520a, hsa-miR-526b*, hsa-miR-520b, hsa-miR-520c and hsa-miR-520d (v7.1 miRBase).+++AGCATTA_MIR155///Genes having at least one occurence of the motif AGCATTA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-155 (v7.1 miRBase).+++AGGAAGC_MIR5163P///Genes having at least one occurence of the motif AGGAAGC in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-516-3p (v7.1 miRBase).+++AGGGCAG_MIR18A///Genes having at least one occurence of the motif AGGGCAG in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-18a* (v7.1 miRBase).+++AGGGCCA_MIR328///Genes having at least one occurence of the motif AGGGCCA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-328 (v7.1 miRBase).+++CAGCTTT_MIR320///Genes having at least one occurence of the motif CAGCTTT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-320 (v7.1 miRBase).+++CATGTAA_MIR496///Genes having at least one occurence of the motif CATGTAA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-496 (v7.1 miRBase).+++CCTGCTG_MIR214///Genes having at least one occurence of the motif CCTGCTG in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-214 (v7.1 miRBase).+++GAGCCAG_MIR149///Genes having at least one occurence of the motif GAGCCAG in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-149 (v7.1 miRBase).+++GGCCAGT_MIR193A_MIR193B///Genes having at least one occurence of the motif GGCCAGT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-193a and hsa-miR-193b (v7.1 miRBase).+++TAGCTTT_MIR9///Genes having at least one occurence of the motif TAGCTTT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-9* (v7.1 miRBase).+++TGTTTAC_MIR30A5P_MIR30C_MIR30D_MIR30B_MIR30E5P///Genes having at least one occurence of the motif TGTTTAC in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-30a-5p, hsa-miR-30c, hsa-miR-30d, hsa-miR-30b and hsa-miR-30e-5p (v7.1 miRBase)."	"MIR1206///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1206 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1255A_MIR1255B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1255a, hsa-miR-1255b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1302///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1302 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1303///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1303 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR134_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-134-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1827///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1827 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR193A_3P_MIR193B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-193a-3p, hsa-miR-193b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR206///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-206 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR2116_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-2116-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR214_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-214-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3122///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3122 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3123///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3123 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3153///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3153 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3166///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3166 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR34B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-34b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3606_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3606-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3619_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3619-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3671///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3671 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3913_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3913-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4298///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4298 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4325///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4325 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4436B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4436b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR449B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-449b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR449C_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-449c-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4648///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4648 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4668_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4668-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4677_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4677-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4701_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4701-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4786_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4786-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4802_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4802-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4803///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4803 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR497_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-497-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR513A_3P_MIR513C_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-513a-3p, hsa-miR-513c-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AA_MIR548AP_3P_MIR548T_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548aa, hsa-miR-548ap-3p, hsa-miR-548t-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AC///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548ac in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AE_3P_MIR548AQ_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548ae-3p, hsa-miR-548aq-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AH_3P_MIR548AM_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548ah-3p, hsa-miR-548am-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AJ_3P_MIR548X_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548aj-3p, hsa-miR-548x-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AT_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548at-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AV_5P_MIR548K///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548av-5p, hsa-miR-548k in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548BB_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548bb-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548D_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548d-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548H_3P_MIR548Z///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548h-3p, hsa-miR-548z in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548J_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548j-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5582_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5582-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5582_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5582-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR570_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-570-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR588///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-588 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6079///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6079 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR613///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-613 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR636///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-636 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6511A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6511a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6733_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6733-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6738_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6738-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6739_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6739-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6739_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6739-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6744_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6744-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6804_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6804-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6828_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6828-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7154_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7154-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR761///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-761 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR8054///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-8054 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR8060///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-8060 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR892A///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-892a in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR942_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-942-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets)."	AHR_Q5///Genes having at least one occurence of the transcription factor binding site V$AHR_Q5 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++AP1_Q6///Genes having at least one occurence of the transcription factor binding site V$AP1_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++AP4_Q6_01///Genes having at least one occurence of the transcription factor binding site V$AP4_Q6_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++ARGGGTTAA_UNKNOWN///Genes having at least one occurence of the highly conserved motif M65 ARGGGTTAA in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++ATF1_Q6///Genes having at least one occurence of the transcription factor binding site V$ATF1_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++ATF3_Q6///Genes having at least one occurence of the transcription factor binding site V$ATF3_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++ATF_B///Genes having at least one occurence of the transcription factor binding site V$ATF_B (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++ATGGYGGA_UNKNOWN///Genes having at least one occurence of the highly conserved motif M102 ATGGYGGA in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++CAGCTG_AP4_Q5///Genes having at least one occurence of the highly conserved motif M15 CAGCTG sites. The motif matches transcription factor binding site V$AP4_Q5 (v7.4 TRANSFAC).+++CATTGTYY_SOX9_B1///Genes having at least one occurence of the highly conserved motif M49 CATTGTYY sites. The motif matches transcription factor binding site V$SOX9_B1 (v7.4 TRANSFAC).+++CMYB_01///Genes having at least one occurence of the transcription factor binding site V$CMYB_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++CREB_01///Genes having at least one occurence of the transcription factor binding site V$CREB_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++CREB_02///Genes having at least one occurence of the transcription factor binding site V$CREB_02 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++CREBP1CJUN_01///Genes having at least one occurence of the transcription factor binding site V$CREBP1CJUN_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++CREB_Q4_01///Genes having at least one occurence of the transcription factor binding site V$CREB_Q4_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++CREL_01///Genes having at least one occurence of the transcription factor binding site V$CREL_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++GATTGGY_NFY_Q6_01///Genes having at least one occurence of the highly conserved motif M5 GATTGGY sites. The motif matches transcription factor binding site V$NFY_Q6_01 (v7.4 TRANSFAC).+++GCANCTGNY_MYOD_Q6///Genes having at least one occurence of the highly conserved motif M35 GCANCTGNY sites. The motif matches transcription factor binding site V$MYOD_Q6 (v7.4 TRANSFAC).+++GGGTGGRR_PAX4_03///Genes having at least one occurence of the highly conserved motif M56 GGGTGGRR sites. The motif matches transcription factor binding site V$PAX4_03 (v7.4 TRANSFAC).+++GGGYGTGNY_UNKNOWN///Genes having at least one occurence of the highly conserved motif M31 GGGYGTGNY in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++GTTRYCATRR_UNKNOWN///Genes having at least one occurence of the highly conserved motif M37 GTTRYCATRR in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++LXR_DR4_Q3///Genes having at least one occurence of the transcription factor binding site V$LXR_DR4_Q3 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++NFKAPPAB65_01///Genes having at least one occurence of the transcription factor binding site V$NFKAPPAB65_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++PAX4_01///Genes having at least one occurence of the transcription factor binding site V$PAX4_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++PBX1_01///Genes having at least one occurence of the transcription factor binding site V$PBX1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++RGAGGAARY_PU1_Q6///Genes having at least one occurence of the highly conserved motif M50 RGAGGAARY sites. The motif matches transcription factor binding site V$PU1_Q6 (v7.4 TRANSFAC).+++RYTGCNWTGGNR_UNKNOWN///Genes having at least one occurence of the highly conserved motif M87 RYTGCNWTGGNR in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++SRF_C///Genes having at least one occurence of the transcription factor binding site V$SRF_C (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++SYATTGTG_UNKNOWN///Genes having at least one occurence of the highly conserved motif M71 SYATTGTG in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++TFIIA_Q6///Genes having at least one occurence of the transcription factor binding site V$TFIIA_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++TGACGTCA_ATF3_Q6///Genes having at least one occurence of the highly conserved motif M14 TGACGTCA sites. The motif matches transcription factor binding site V$ATF3_Q6 (v7.4 TRANSFAC).+++TGANTCA_AP1_C///Genes having at least one occurence of the highly conserved motif M7 TGANTCA sites. The motif matches transcription factor binding site V$AP1_C (v7.4 TRANSFAC).+++TGAYRTCA_ATF3_Q6///Genes having at least one occurence of the highly conserved motif M9 TGAYRTCA sites. The motif matches transcription factor binding site V$ATF3_Q6 (v7.4 TRANSFAC).	"AHRR_TARGET_GENES///Genes containing one or more binding sites for UniProt:A9YTQ3 (AHRR) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ATF5_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9Y2D1 (ATF5) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++BPTF_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q12830 (BPTF) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++CHAF1B_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q13112 (CHAF1B) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++CIITA_TARGET_GENES///Genes containing one or more binding sites for UniProt:P33076 (CIITA) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++CTR9_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6PD62 (CTR9) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ELF2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q15723 (ELF2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ELF5_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9UKW6 (ELF5) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++FOXD2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O60548 (FOXD2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++FOXH1_TARGET_GENES///Genes containing one or more binding sites for UniProt:O75593 (FOXH1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HMGB1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P09429 (HMGB1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HOXB6_TARGET_GENES///Genes containing one or more binding sites for UniProt:P17509 (HOXB6) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HOXC6_TARGET_GENES///Genes containing one or more binding sites for UniProt:P09630 (HOXC6) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++INSM2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96T92 (INSM2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++JDP2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8WYK2 (JDP2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++KDM7A_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6ZMT4 (KDM7A) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++MAFG_TARGET_GENES///Genes containing one or more binding sites for UniProt:O15525 (MAFG) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++MORC2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9Y6X9 (MORC2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++MSX1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P28360 (MSX1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++MZF1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P28698 (MZF1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NFRKB_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6P4R8 (NFRKB) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NKX2_2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O95096 (NKX2_2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NKX2_8_TARGET_GENES///Genes containing one or more binding sites for UniProt:O15522 (NKX2_8) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++OVOL3_TARGET_GENES///Genes containing one or more binding sites for UniProt:O00110 (OVOL3) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++PAX3_TARGET_GENES///Genes containing one or more binding sites for UniProt:P23760 (PAX3) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++PHF2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O75151 (PHF2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++PRDM4_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9UKN5 (PRDM4) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++RBM34_TARGET_GENES///Genes containing one or more binding sites for UniProt:P42696 (RBM34) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SETD7_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8WTS6 (SETD7) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SFMBT1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9UHJ3 (SFMBT1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SIRT3_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9NTG7 (SIRT3) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SMARCA1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P28370 (SMARCA1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SNRNP70_TARGET_GENES///Genes containing one or more binding sites for UniProt:P08621 (SNRNP70) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++UBN1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9NPG3 (UBN1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZBTB7B_TARGET_GENES///Genes containing one or more binding sites for UniProt:O15156 (ZBTB7B) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF391_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9UJN7 (ZNF391) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF407_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9C0G0 (ZNF407) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF618_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q5T7W0 (ZNF618) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF740_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8NDX6 (ZNF740) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF746_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6NUN9 (ZNF746) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF843_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8N446 (ZNF843) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZSCAN29_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8IWY8 (ZSCAN29) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."	GCM_ACTG1///Neighborhood of ACTG1+++GCM_APEX1///Neighborhood of APEX1+++GCM_CBFB///Neighborhood of CBFB+++GCM_CSNK2B///Neighborhood of CSNK2B+++GCM_DDX5///Neighborhood of DDX5+++GCM_MSN///Neighborhood of MSN+++GCM_PSME1///Neighborhood of PSME1+++GCM_RAD21///Neighborhood of RAD21+++MORF_ACP1///Neighborhood of ACP1+++MORF_ACTG1///Neighborhood of ACTG1+++MORF_ANP32B///Neighborhood of ANP32B+++MORF_AP2M1///Neighborhood of AP2M1+++MORF_CCNI///Neighborhood of CCNI+++MORF_CTBP1///Neighborhood of CTBP1+++MORF_DAP3///Neighborhood of DAP3+++MORF_DEK///Neighborhood of DEK+++MORF_EIF3S6///Neighborhood of EIF3S6+++MORF_EIF4A2///Neighborhood of EIF4A2+++MORF_ERH///Neighborhood of ERH+++MORF_HDAC1///Neighborhood of HDAC1+++MORF_NME2///Neighborhood of NME2+++MORF_NPM1///Neighborhood of NPM1+++MORF_PPP1CA///Neighborhood of PPP1CA+++MORF_PRKAR1A///Neighborhood of PRKAR1A+++MORF_RAB1A///Neighborhood of RAB1A+++MORF_RAF1///Neighborhood of RAF1+++MORF_RAN///Neighborhood of RAN+++MORF_SART1///Neighborhood of SART1+++MORF_SKP1A///Neighborhood of SKP1A+++MORF_UBE2I///Neighborhood of UBE2I		YAP1_UP///Genes up-regulated in MCF10A cells (breast cancer) over-expressing YAP1 [Gene ID=10413] gene.	"ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_1DY_DN///Genes down-regulated in blood 1d vs 0hr in adults (18-45) after exposure to CN54gp140 adjuvanted with GLA-AF , time point 1D , administered i.m.+++GSE1432_6H_VS_24H_IFNG_MICROGLIA_UP///Genes up-regulated in comparison of microglia cells 6 h after stimulation with IFNG [GeneID=3458] versus microglia cells 24 h after the stimulation.+++GSE16450_CTRL_VS_IFNA_6H_STIM_MATURE_NEURON_CELL_LINE_DN///Genes down-regulated in mature neuron cell line: control versus interferon alpha (6h).+++GSE22601_CD4_SINGLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_DN///Genes down-regulated in single positive thymocytes: CD4 [GeneID=920] versus CD8.+++GSE22601_DOUBLE_NEGATIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_DN///Genes down-regulated in thymocytes: double negative versus double positive.+++GSE22611_MUTANT_NOD2_VS_CTRL_TRANSDUCED_HEK293T_CELL_DN///Genes down-regulated in HEK293 cells: expressing mutant NOD2 [GeneID=64127] versus control.+++GSE22886_NAIVE_CD4_TCELL_VS_MEMORY_TCELL_DN///Genes down-regulated in comparison of naive CD4 [GeneID=920] T cells versus unstimulated memory CD4 [GeneID=920] CD8 T cells.+++GSE22886_NAIVE_VS_MEMORY_TCELL_DN///Genes down-regulated in comparison of naive CD4 [GeneID=920] CD8 T cells versus unstimulated memory CD4 [GeneID=920] CD8 T cells.+++GSE23321_CENTRAL_VS_EFFECTOR_MEMORY_CD8_TCELL_DN///Genes down-regulated in CD8 T cells: central memory versus effector memory.+++GSE2405_0H_VS_9H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN///Genes down-regulated in polymorphonuclear leukocytes (9h): control versus infection by A. phagocytophilum.+++GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_2H_DN///Genes down-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 and IL4 [GeneID=7040;3565] (2h) versus IL4 [GeneID=3565] (2h).+++GSE28726_ACT_CD4_TCELL_VS_ACT_VA24NEG_NKTCELL_DN///Genes down-regulated in activated T cells: CD4 [GeneID=920] versus Va24- NKT.+++GSE34156_TLR1_TLR2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_DN///Genes down-regulated in monocytes (24h): M. tuberculosis 19 kDa lipopeptide versus M. tuberculosis 19 kDa lipopeptide and muramyl dipeptide [PubChem=11620162].+++GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_MAC_UP///Genes up-regulated in comparison of macrophages exposed to L. major versus macrophages exposed to 5 worms/well B. malayi.+++GSE3982_BASOPHIL_VS_CENT_MEMORY_CD4_TCELL_UP///Genes up-regulated in comparison of basophils versus central memory CD4 [GeneID=920] T cells.+++GSE3982_BASOPHIL_VS_NKCELL_UP///Genes up-regulated in comparison of basophils versus NK cells.+++GSE42724_NAIVE_VS_MEMORY_BCELL_DN///Genes down-regulated in B lymphocytes: nave versus memory.+++GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_1MONTH_POST_DX_UP///Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMCs from patients with type 1 diabetes at 1 month after the diagnosis.+++GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_4MONTH_POST_DX_UP///Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMCs from patients with type 1 diabetes at 4 month after the diagnosis.+++GSE9006_TYPE_1_DIABETES_AT_DX_VS_1MONTH_POST_DX_PBMC_UP///Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from patients with type 1 diabetes at the time of the diagnosis versus those at 1 month later.+++GSE9006_TYPE_1_DIABETES_AT_DX_VS_4MONTH_POST_DX_PBMC_UP///Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from patients with type 1 diabetes at the time of the diagnosis versus those at 4 months later."	"HALLMARK_UNFOLDED_PROTEIN_RESPONSE///Genes up-regulated during unfolded protein response, a cellular stress response related to the endoplasmic reticulum."	XM_017013810	YWHAZ				
P62942	sp|P62942|FKB1A_HUMAN		FKBP1A		Peptidyl-prolyl cis-trans isomerase FKBP1A OS=Homo sapiens OX=9606 GN=FKBP1A PE=1 SV=2	2280	NM_054014	NP_463460	ENST00000381719				MGVQVETISPGDGRTFPKRGQTCVVHYTGMLEDGKKFDSSRDRNKPFKFMLGKQEVIRGWEEGVAQMSVGQRAKLTISPDYAYGATGHPGIIPPHATLVFDVELLKLE	0.4460362	-1.164767309	0.001094633	4.6165851	6.6101078	6.1059452	5.9853167	5.8900705	7.8407535	5.968444026	6.7643324	6.5951257	5.8726019	7.3408028	7.3393072	4.81391854	6.4558869	6.0803288	6.2960538	3.6553902	5.5479165	3.814874472	4.7156749	5.7866475	6.2113863	7.9189938	4.6344401	5.92627349	6.14774553	5.2068615	9.380492	8.1775764	8.430555	8.8310562	6.883473	7.2222322	7.854839	6.5948066	6.1062023	7.6578191	5.9401645	8.237679	7.7352262	7.21203914	8.089569	5.3867063	6.35760194					GO:0005737///cytoplasm+++GO:0005829///cytosol+++GO:0014802///terminal cisterna+++GO:0016020///membrane+++GO:0016021///integral component of membrane+++GO:0016529///sarcoplasmic reticulum+++GO:0030018///Z disc+++GO:0031312///extrinsic component of organelle membrane+++GO:0033017///sarcoplasmic reticulum membrane+++GO:0098562///cytoplasmic side of membrane+++GO:1990425///ryanodine receptor complex	GO:0003755///peptidyl-prolyl cis-trans isomerase activity+++GO:0005160///transforming growth factor beta receptor binding+++GO:0005515///protein binding+++GO:0005527///macrolide binding+++GO:0005528///FK506 binding+++GO:0016853///isomerase activity+++GO:0019855///calcium channel inhibitor activity+++GO:0034713///type I transforming growth factor beta receptor binding+++GO:0044325///ion channel binding+++GO:0046332///SMAD binding+++GO:0048185///activin binding	GO:0000413///protein peptidyl-prolyl isomerization+++GO:0003007///heart morphogenesis+++GO:0006457///protein folding+++GO:0006458///'de novo' protein folding+++GO:0007179///transforming growth factor beta receptor signaling pathway+++GO:0007183///SMAD protein complex assembly+++GO:0022417///protein maturation by protein folding+++GO:0030512///negative regulation of transforming growth factor beta receptor signaling pathway+++GO:0031398///positive regulation of protein ubiquitination+++GO:0032092///positive regulation of protein binding+++GO:0032515///negative regulation of phosphoprotein phosphatase activity+++GO:0032880///regulation of protein localization+++GO:0032925///regulation of activin receptor signaling pathway+++GO:0042026///protein refolding+++GO:0042110///T cell activation+++GO:0043123///positive regulation of I-kappaB kinase/NF-kappaB signaling+++GO:0050776///regulation of immune response+++GO:0051280///negative regulation of release of sequestered calcium ion into cytosol+++GO:0055010///ventricular cardiac muscle tissue morphogenesis+++GO:0060314///regulation of ryanodine-sensitive calcium-release channel activity+++GO:0060315///negative regulation of ryanodine-sensitive calcium-release channel activity+++GO:0060347///heart trabecula formation+++GO:0061077///chaperone-mediated protein folding+++GO:0070588///calcium ion transmembrane transport+++GO:0097435///supramolecular fiber organization+++GO:1902991///regulation of amyloid precursor protein catabolic process+++GO:1990000///amyloid fibril formation	tissueType=Fetal kidney;cancerType=Normal;cellName=Monocyte+++tissueType=Fetal gonad;cancerType=Normal;cellName=Endothelial cell+++tissueType=Fetal gonad;cancerType=Normal;cellName=Leydig cell+++tissueType=Fetal kidney;cancerType=Normal;cellName=Natural killer T (NKT) cell+++tissueType=Fetal gonad;cancerType=Normal;cellName=Gonadal endothelial cell+++tissueType=Liver;cancerType=Hepatocellular Cancer;cellName=Exhausted CD8+ T cell+++tissueType=Liver;cancerType=Hepatocellular Cancer;cellName=Regulatory T (Treg) cell		"Homo sapiens FKBP prolyl isomerase 1A (FKBP1A), transcript variant 2, mRNA."		PF00254///FKBP-type peptidyl-prolyl cis-trans isomerase	R-HSA-1168372///Downstream signaling events of B Cell Receptor (BCR)+++R-HSA-1280218///Adaptive Immune System+++R-HSA-162582///Signal Transduction+++R-HSA-1643685///Disease+++R-HSA-165159///MTOR signalling+++R-HSA-166208///mTORC1-mediated signalling+++R-HSA-168256///Immune System+++R-HSA-170834///Signaling by TGF-beta Receptor Complex+++R-HSA-2025928///Calcineurin activates NFAT+++R-HSA-2173789///TGF-beta receptor signaling activates SMADs+++R-HSA-2173791///TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)+++R-HSA-3304351///Signaling by TGF-beta Receptor Complex in Cancer+++R-HSA-3656534///Loss of Function of TGFBR1 in Cancer+++R-HSA-3656535///TGFBR1 LBD Mutants in Cancer+++R-HSA-5663202///Diseases of signal transduction by growth factor receptors and second messengers+++R-HSA-5663205///Infectious disease+++R-HSA-9006936///Signaling by TGFB family members+++R-HSA-9679191///Potential therapeutics for SARS+++R-HSA-9679506///SARS-CoV Infections+++R-HSA-983705///Signaling by the B Cell Receptor (BCR)		KOG0544///Peptidyl-prolyl cis-trans isomerase		IPR001179///FKBP-type peptidyl-prolyl cis-trans isomerase domain	"[FKB1A_HUMAN|Reviewed]RecName: Full=Peptidyl-prolyl cis-trans isomerase FKBP1A; Short=PPIase FKBP1A; EC=5.2.1.8 {ECO:0000269|PubMed:1696686, ECO:0000269|PubMed:1701173}; AltName: Full=12 kDa FK506-binding protein; Short=12 kDa FKBP; Short=FKBP-12; AltName: Full=Calstabin-1; AltName: Full=FK506-binding protein 1A; Short=FKBP-1A; AltName: Full=Immunophilin FKBP12; AltName: Full=Rotamase;+++[Q0VDC5_HUMAN|Unreviewed]RecName: Full=Peptidylprolyl isomerase {ECO:0000256|PROSITE-ProRule:PRU00277}; EC=5.2.1.8 {ECO:0000256|PROSITE-ProRule:PRU00277};"	chr20p13///Ensembl 103 genes in cytogenetic band chr20p13			REACTOME_ADAPTIVE_IMMUNE_SYSTEM///Adaptive Immune System+++REACTOME_CALCINEURIN_ACTIVATES_NFAT///Calcineurin activates NFAT+++REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS///Diseases of signal transduction by growth factor receptors and second messengers+++REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR///Downstream signaling events of B Cell Receptor (BCR)+++REACTOME_INFECTIOUS_DISEASE///Infectious disease+++REACTOME_MTORC1_MEDIATED_SIGNALLING///mTORC1-mediated signalling+++REACTOME_MTOR_SIGNALLING///MTOR signalling+++REACTOME_POTENTIAL_THERAPEUTICS_FOR_SARS///Potential therapeutics for SARS+++REACTOME_SARS_COV_INFECTIONS///SARS-CoV Infections+++REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX_IN_CANCER///Signaling by TGF-beta Receptor Complex in Cancer+++REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX///Signaling by TGF-beta Receptor Complex+++REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS///Signaling by TGFB family members+++REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR///Signaling by the B Cell Receptor (BCR)+++REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS///TGF-beta receptor signaling activates SMADs+++REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION///TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)		"AAGCCAT_MIR135A_MIR135B///Genes having at least one occurence of the motif AAGCCAT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-135a and hsa-miR-135b (v7.1 miRBase).+++ACACTAC_MIR1423P///Genes having at least one occurence of the motif ACACTAC in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-142-3p (v7.1 miRBase).+++ATGCTGG_MIR338///Genes having at least one occurence of the motif ATGCTGG in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-338 (v7.1 miRBase).+++CAGCTTT_MIR320///Genes having at least one occurence of the motif CAGCTTT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-320 (v7.1 miRBase).+++CTTTGTA_MIR524///Genes having at least one occurence of the motif CTTTGTA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-524* (v7.1 miRBase).+++GGTGAAG_MIR412///Genes having at least one occurence of the motif GGTGAAG in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-412 (v7.1 miRBase).+++TATTATA_MIR374///Genes having at least one occurence of the motif TATTATA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-374 (v7.1 miRBase).+++TGAATGT_MIR181A_MIR181B_MIR181C_MIR181D///Genes having at least one occurence of the motif TGAATGT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-181a, hsa-miR-181b, hsa-miR-181c and hsa-miR-181d (v7.1 miRBase).+++TTTGTAG_MIR520D///Genes having at least one occurence of the motif TTTGTAG in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-520d* (v7.1 miRBase)."	"MIR1250_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1250-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1277_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1277-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1284///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1284 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR141_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-141-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR181A_5P_MIR181B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-181a-5p, hsa-miR-181b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR181C_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-181c-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR181D_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-181d-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR183_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-183-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR200A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-200a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR2467_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-2467-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR25_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-25-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3065_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3065-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3158_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3158-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR32_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-32-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR338_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-338-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR363_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-363-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3662///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3662 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR367_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-367-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3714///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3714 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR377_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-377-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3978///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3978 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR412_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-412-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4262///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4262 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4271///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4271 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4328///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4328 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4443///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4443 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4717_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4717-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4725_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4725-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4738_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4738-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4796_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4796-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AC///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548ac in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548BB_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548bb-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548D_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548d-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548H_3P_MIR548Z///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548h-3p, hsa-miR-548z in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5582_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5582-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR561_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-561-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR570_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-570-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR577///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-577 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6086///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6086 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6511A_3P_MIR6511B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6511a-3p, hsa-miR-6511b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR655_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-655-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6754_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6754-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6756_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6756-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6766_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6766-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6780B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6780b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6802_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6802-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6835_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6835-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6880_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6880-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR92A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-92a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR92B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-92b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets)."	GGGYGTGNY_UNKNOWN///Genes having at least one occurence of the highly conserved motif M31 GGGYGTGNY in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++TGCTGAY_UNKNOWN///Genes having at least one occurence of the highly conserved motif M92 TGCTGAY in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).	"CBFA2T2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O43439 (CBFA2T2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++CDH4_TARGET_GENES///Genes containing one or more binding sites for UniProt:P55283 (CDH4) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++DNMT3A_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9Y6K1 (DNMT3A) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ELF2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q15723 (ELF2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++EWSR1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q01844 (EWSR1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++FOXP2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O15409 (FOXP2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++FOXR2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6PJQ5 (FOXR2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HBZ_TARGET_GENES///Genes containing one or more binding sites for UniProt:P02008 (HBZ) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HOXA2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O43364 (HOXA2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NCOA6_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q14686 (NCOA6) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++PAX6_TARGET_GENES///Genes containing one or more binding sites for UniProt:P26367 (PAX6) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++PHF2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O75151 (PHF2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SETX_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q7Z333 (SETX) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SIX1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q15475 (SIX1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++TFEB_TARGET_GENES///Genes containing one or more binding sites for UniProt:P19484 (TFEB) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++THAP1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9NVV9 (THAP1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZBTB18_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q99592 (ZBTB18) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9BSG1 (ZNF2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF34_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8IZ26 (ZNF34) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF449_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6P9G9 (ZNF449) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF704_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6ZNC4 (ZNF704) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZSCAN2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q7Z7L9 (ZSCAN2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."	MORF_AP2M1///Neighborhood of AP2M1+++MORF_AP3D1///Neighborhood of AP3D1	MODULE_155///Genes in the cancer module 155.+++MODULE_245///Genes in the cancer module 245.+++MODULE_54///Cell cycle (expression cluster).	CSR_LATE_UP.V1_UP///Genes up-regulated in late serum response of CRL 2091 cells (foreskin fibroblasts).+++RAPA_EARLY_UP.V1_UP///Genes up-regulated in BJAB (lymphoma) cells by rapamycin (sirolimus) [PubChem = 6610346].	"FLETCHER_PBMC_BCG_10W_INFANT_BCG_STIMULATED_VS_UNSTIMULATED_10W_DN///Genes down-regulated in peripheral blood mononuclear cell stimulated vs unstimulated in infants (10w) after exposure to BCG (Danish strain BCG Statens Serum Institut, Denmark) , time point 10W. Comment: PBMCs drawn at 10 weeks following immunization at birth+++FLETCHER_PBMC_BCG_10W_INFANT_PPD_STIMULATED_VS_UNSTIMULATED_10W_DN///Genes down-regulated in peripheral blood mononuclear cell stimulated vs unstimulated in infants (10w) after exposure to BCG (Danish strain BCG Statens Serum Institut, Denmark) , time point 10W. Comment: PBMCs drawn at 10 weeks following immunization at birth+++GSE10240_CTRL_VS_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN///Genes down-regulated in primary bronchial epithelial cells: control versus stimulated with IL22 [GeneID=50616].+++GSE11864_CSF1_IFNG_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP///Genes up-regulated in comparison of macrophages cultured with M-CSF [GeneID=1435] and IFNG [GeneID=3458] versus macrophages cultured with M-CSF [GeneID=1435], IFNG [GeneID=3458] and Pam3Cys (TLR2 agonist).+++GSE11864_CSF1_IFNG_VS_CSF1_PAM3CYS_IN_MAC_UP///Genes up-regulated in comparison of macrophages cultured with M-CSF [GeneID=1435] and IFNG [GeneID=3458] versus macrophages cultured with M-CSF [GeneID=1435] and Pam3Cyc.+++GSE11864_UNTREATED_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP///Genes up-regulated in comparison of untreated macrophages versus those cultured with M-CSF [GeneID=1435], IFNG [GeneID=3458] and Pam3Cys (TLR2 agonist).+++GSE11864_UNTREATED_VS_CSF1_PAM3CYS_IN_MAC_UP///Genes up-regulated in comparison of untreated macrophages versus those cultured with M-CSF [GeneID=1435] and Pam3Cys (TLR2 agonist).+++GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_ATOPIC_PATIENT_UP///Genes up-regulated in CD4 [GeneID=920] T cells from atopic patients: resting versus stimulated with allergen (house dust mite).+++GSE15735_2H_VS_12H_HDAC_INHIBITOR_TREATED_CD4_TCELL_UP///Genes up-regulated in CD4 [GeneID=920] T cells treated with HDAC inhibitors: 2h versus 12h.+++GSE16385_ROSIGLITAZONE_IL4_VS_ROSIGLITAZONE_ALONE_STIM_MACROPHAGE_DN///Genes down-regulated in macrophages (12h): rosiglitazone [PubChem=77999] and IL4 [GeneID=3565] versus rosiglitazone [PubChem=77999].+++GSE18893_TCONV_VS_TREG_2H_CULTURE_UP///Genes up-regulated in lymphocytes treated with medium for 2h: T conv versus T reg cells.+++GSE21774_CD62L_POS_CD56_BRIGHT_VS_CD62L_NEG_CD56_DIM_NK_CELL_UP///Genes up-regulated in NCAM1+ SELL bright [GeneID=4684;6402] versus NCAM1- SELL dim [GeneID=4684;6402].+++GSE22103_LPS_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_DN///Genes down-regulated in neutrophils: LPS versus stimulated by CSF2 and IFNG [GeneID=1437;3458].+++GSE22611_UNSTIM_VS_2H_MDP_STIM_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_DN///Genes down-regulated in HEK293 cells expressing mutant NOD2 [GeneID=64127]: untreated versus muramyl dipeptide [PubChem=11620162] for 2h.+++GSE22886_UNSTIM_VS_STIM_MEMORY_TCELL_DN///Genes down-regulated in comparison of unstimulated memory CD4 [GeneID=920] CD8 T cells versus stimulated CD4 [GeneID=920] CD8 T cells.+++GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_6H_UP///Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: IL-12 (6h) versus IL4 [GeneID=3565] (6h).+++GSE29618_BCELL_VS_MDC_DAY7_FLU_VACCINE_DN///Genes down-regulated in comparison of B cells from influenza vaccinee at day 7 post-vaccination versus myeloid dendritic cells (mDC) at day 7 post-vaccination.+++GSE29618_BCELL_VS_MDC_DN///Genes down-regulated in comparison of B cells versus myeloid dendritic cells (mDC).+++GSE29618_BCELL_VS_MONOCYTE_DAY7_FLU_VACCINE_DN///Genes down-regulated in comparison of B cells from influenza vaccinee at day 7 versus monocytes from influenza vaccinee at day 7.+++GSE29618_BCELL_VS_MONOCYTE_DN///Genes down-regulated in comparison of B cells versus monocytes.+++GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MDC_UP///Genes up-regulated in comparison of myeloid dendritic cells (mDC) from LAIV influenza vaccinee pre-vaccination versus those at day 7 post-vaccination.+++GSE33425_CD161_HIGH_VS_INT_CD8_TCELL_DN///Genes down-regulated in CD8 T cells: KLRB1 high [GeneID=3820] versus KLRB1 int [GeneID=3820].+++GSE360_CTRL_VS_T_GONDII_MAC_UP///Genes up-regulated in comparison of macrophages versus macrophages exposed to T. gondii.+++GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_DC_DN///Genes down-regulated in comparison of dendritic cells (DC) exposed to T. gondii versus DCs exposed to 5 worms/well B. malayi.+++GSE360_T_GONDII_VS_M_TUBERCULOSIS_DC_DN///Genes down-regulated in comparison of dendritic cells (DC) exposed to T. gondii versus DCs exposed to M. tuberculosis.+++GSE360_T_GONDII_VS_M_TUBERCULOSIS_MAC_DN///Genes down-regulated in comparison of macrophages exposed to T. gondii versus macrophages exposed to M. tuberculosis.+++GSE3982_DC_VS_EFF_MEMORY_CD4_TCELL_UP///Genes up-regulated in comparison of dendritic cells (DC) versus effector memory CD4 [GeneID=920] T cells.+++GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH2_DN///Genes down-regulated in comparison of effective memory CD4 [GeneID=920] T cells versus Th2 cells.+++GSE4748_CTRL_VS_LPS_STIM_DC_3H_DN///Genes down-regulated in monocyte-derived dendritic cells: untreated versus LPS (3h).+++GSE4748_CYANOBACTERIUM_LPSLIKE_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_DN///Genes down-regulated in monocyte-derived dendritic cells: LPS like antigen from O. planktothrix (3h) versus LPS and LPS like antigen from O. planktothrix (3h).+++GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY7_DN///Genes down-regulated in unstimulated monocytes versus macrophages incubated with CSF1 [GeneID=435] at day 7.+++GSE5542_UNTREATED_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_DN///Genes down-regulated in epithelial cells (24h): untreated versus interferon alpha and IFNG [GeneID=3458].+++GSE5679_PPARG_LIGAND_ROSIGLITAZONE_VS_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_UP///Genes up-regulated in monocyte-derived dendritic cells: rosiglitazone [PubChem=77999] versus rosiglitazone and AM580 [PubChem=77999;2126].+++GSE6092_UNSTIM_VS_IFNG_STIM_ENDOTHELIAL_CELL_DN///Genes down-regulated in endothelial cells: untreated versus IFNG [GeneID=3458].+++GSE6269_HEALTHY_VS_E_COLI_INF_PBMC_DN///Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMC from patients with acute E. coli infection.+++GSE6269_HEALTHY_VS_FLU_INF_PBMC_DN///Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMC from patients with acute influenza infection.+++GSE7460_CD8_TCELL_VS_CD4_TCELL_ACT_DN///Genes down-regulated in comparsion of ActCD8 versus ActCD4 (see Fig. 1 in the paper for details).+++GSE7509_FCGRIIB_VS_TNFA_IL1B_IL6_PGE_STIM_DC_UP///Genes up-regulated in dendritic cells: anti-FcgRIIB versus inflammatory cytokine cocktail.+++GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_12H_DN///Genes down-regulated in monocytes: untreated versus M. tuberculosis 19 kDa lipopeptide (12h).+++HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_DN///Genes down-regulated in peripheral blood mononuclear cell vaccinated vs unvaccinated in adolescent/young adults (11-22) after exposure to M-M-R II , time point 7Y+++NAKAYA_MONOCYTE_FLUMIST_AGE_18_50YO_7DY_UP///Genes up-regulated in monocyte 7d vs 0d in young adults (18-50) after exposure to FluMist , time point 7D+++NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_UP///Genes up-regulated in peripheral blood mononuclear cell 3d vs 0d in adults (18-50) after exposure to Fluarix/Fluvirin , time point 3D. Comment: Supplementary Table 1a: All the differentially expressed genes identified in PBMCs of TIV vaccinees.+++PATEL_SKIN_OF_BODY_ZOSTAVAX_AGE_70_93YO_VZV_CHALLENGE_3DY_UP///Genes up-regulated in skin of body 3d vs 0hr in adults (70-93) (VZV challenge) after exposure to Zostavax , time point 3D"	HALLMARK_TGF_BETA_SIGNALING///Genes up-regulated in response to TGFB1 [GeneID=7040].	NM_054014	FKBP1A				
P62937	sp|P62937|PPIA_HUMAN		PPIA		Peptidyl-prolyl cis-trans isomerase A OS=Homo sapiens OX=9606 GN=PPIA PE=1 SV=2 >tr|V9HWF5|V9HWF5_HUMAN Peptidyl-prolyl cis-trans isomerase OS=Homo sapiens OX=9606 GN=HEL-S-69p PE=1 SV=1	5478	NM_021130	NP_066953	ENST00000468812	K03767			MVNPTVFFDIAVDGEPLGRVSFELFADKVPKTAENFRALSTGEKGFGYKGSCFHRIIPGFMCQGGDFTRHNGTGGKSIYGEKFEDENFILKHTGPGILSMANAGPNTNGSQFFICTAKTEWLDGKHVVFGKVKEGMNIVEAMERFGSRNGKTSKKITIADCGQLE	0.4998666	-1.000385011	0.00407109	4.7812453	8.6558768	7.1246342	7.0161248	7.562475	8.145406	8.070554055	6.9726593	8.197232	9.4128883	9.5190603	9.1697749	7.70788669	9.0154143	8.4749968	8.7368745	7.6796898	7.6279051		7.5091289	7.3780549	8.3936831	9.9196368	8.5502803	6.32536244	8.05688468	6.92319	10.501295	10.1767065	8.769207	8.6680777	7.551781	8.1552961	8.9297937	8.5848245	9.1828645	9.9650856	8.9066947	10.176763	9.748764	9.6146257	11.4620938	7.8480464	9.10236034	04217///Necroptosis				GO:0005576///extracellular region+++GO:0005615///extracellular space+++GO:0005634///nucleus+++GO:0005737///cytoplasm+++GO:0005829///cytosol+++GO:0005925///focal adhesion+++GO:0016020///membrane+++GO:0031982///vesicle+++GO:0032991///protein-containing complex+++GO:0034774///secretory granule lumen+++GO:0043231///intracellular membrane-bounded organelle+++GO:0070062///extracellular exosome+++GO:1904813///ficolin-1-rich granule lumen	GO:0003723///RNA binding+++GO:0003755///peptidyl-prolyl cis-trans isomerase activity+++GO:0005178///integrin binding+++GO:0005515///protein binding+++GO:0016018///cyclosporin A binding+++GO:0016853///isomerase activity+++GO:0046790///virion binding+++GO:0051082///unfolded protein binding+++GO:1904399///heparan sulfate binding	GO:0000187///activation of MAPK activity+++GO:0000413///protein peptidyl-prolyl isomerization+++GO:0001933///negative regulation of protein phosphorylation+++GO:0001934///positive regulation of protein phosphorylation+++GO:0006278///RNA-dependent DNA biosynthetic process+++GO:0006457///protein folding+++GO:0006469///negative regulation of protein kinase activity+++GO:0006915///apoptotic process+++GO:0019058///viral life cycle+++GO:0019061///uncoating of virus+++GO:0019064///fusion of virus membrane with host plasma membrane+++GO:0019068///virion assembly+++GO:0019076///viral release from host cell+++GO:0030168///platelet activation+++GO:0030182///neuron differentiation+++GO:0030593///neutrophil chemotaxis+++GO:0030595///leukocyte chemotaxis+++GO:0032148///activation of protein kinase B activity+++GO:0032873///negative regulation of stress-activated MAPK cascade+++GO:0034389///lipid droplet organization+++GO:0034599///cellular response to oxidative stress+++GO:0035307///positive regulation of protein dephosphorylation+++GO:0035722///interleukin-12-mediated signaling pathway+++GO:0042118///endothelial cell activation+++GO:0043312///neutrophil degranulation+++GO:0043410///positive regulation of MAPK cascade+++GO:0044409///entry into host+++GO:0045069///regulation of viral genome replication+++GO:0045070///positive regulation of viral genome replication+++GO:0050714///positive regulation of protein secretion+++GO:0050900///leukocyte migration+++GO:0051092///positive regulation of NF-kappaB transcription factor activity+++GO:0060352///cell adhesion molecule production+++GO:0061944///negative regulation of protein K48-linked ubiquitination+++GO:0070527///platelet aggregation+++GO:0075713///establishment of integrated proviral latency+++GO:1902176///negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway+++GO:1903901///negative regulation of viral life cycle+++GO:2001233///regulation of apoptotic signaling pathway	tissueType=Fetal kidney;cancerType=Normal;cellName=Natural killer T (NKT) cell+++tissueType=Liver;cancerType=Normal;cellName=Liver bud hepatic cell		"Homo sapiens peptidylprolyl isomerase A (PPIA), transcript variant 1, mRNA."		PF00160///Cyclophilin type peptidyl-prolyl cis-trans isomerase/CLD	"R-HSA-109582///Hemostasis+++R-HSA-114608///Platelet degranulation +++R-HSA-1168372///Downstream signaling events of B Cell Receptor (BCR)+++R-HSA-1280215///Cytokine Signaling in Immune system+++R-HSA-1280218///Adaptive Immune System+++R-HSA-162585///Uncoating of the HIV Virion+++R-HSA-162587///HIV Life Cycle+++R-HSA-162588///Budding and maturation of HIV virion+++R-HSA-162589///Reverse Transcription of HIV RNA+++R-HSA-162592///Integration of provirus+++R-HSA-162594///Early Phase of HIV Life Cycle+++R-HSA-162599///Late Phase of HIV Life Cycle+++R-HSA-162906///HIV Infection+++R-HSA-162909///Host Interactions of HIV factors+++R-HSA-1643685///Disease+++R-HSA-164516///Minus-strand DNA synthesis+++R-HSA-164525///Plus-strand DNA synthesis+++R-HSA-168249///Innate Immune System+++R-HSA-168256///Immune System+++R-HSA-173107///Binding and entry of HIV virion+++R-HSA-175474///Assembly Of The HIV Virion+++R-HSA-180689///APOBEC3G mediated resistance to HIV-1 infection+++R-HSA-2025928///Calcineurin activates NFAT+++R-HSA-202733///Cell surface interactions at the vascular wall+++R-HSA-210991///Basigin interactions+++R-HSA-447115///Interleukin-12 family signaling+++R-HSA-449147///Signaling by Interleukins+++R-HSA-5663205///Infectious disease+++R-HSA-6798695///Neutrophil degranulation+++R-HSA-76002///Platelet activation, signaling and aggregation+++R-HSA-76005///Response to elevated platelet cytosolic Ca2++++R-HSA-8950505///Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation+++R-HSA-9020591///Interleukin-12 signaling+++R-HSA-983705///Signaling by the B Cell Receptor (BCR)"	COG0652///No_INFO	KOG0865///peptidyl-prolyl cis-trans isomerase activity		"IPR002130///Cyclophilin-type peptidyl-prolyl cis-trans isomerase domain+++IPR020892///Cyclophilin-type peptidyl-prolyl cis-trans isomerase, conserved site+++IPR024936///Cyclophilin-type peptidyl-prolyl cis-trans isomerase+++IPR029000///Cyclophilin-like domain superfamily"	"[PPIA_HUMAN|Reviewed]RecName: Full=Peptidyl-prolyl cis-trans isomerase A; Short=PPIase A; EC=5.2.1.8 {ECO:0000269|PubMed:2001362, ECO:0000269|PubMed:20676357, ECO:0000269|PubMed:21245143, ECO:0000269|PubMed:21593166, ECO:0000269|PubMed:25678563, ECO:0000305|PubMed:19207730, ECO:0000305|PubMed:26095851}; AltName: Full=Cyclophilin A; AltName: Full=Cyclosporin A-binding protein; AltName: Full=Rotamase A; Contains: RecName: Full=Peptidyl-prolyl cis-trans isomerase A, N-terminally processed;"	chr7p13///Ensembl 103 genes in cytogenetic band chr7p13	BIOCARTA_IL2RB_PATHWAY///IL-2 Receptor Beta Chain in T cell Activation		"REACTOME_ADAPTIVE_IMMUNE_SYSTEM///Adaptive Immune System+++REACTOME_APOBEC3G_MEDIATED_RESISTANCE_TO_HIV_1_INFECTION///APOBEC3G mediated resistance to HIV-1 infection+++REACTOME_ASSEMBLY_OF_THE_HIV_VIRION///Assembly Of The HIV Virion+++REACTOME_BASIGIN_INTERACTIONS///Basigin interactions+++REACTOME_BUDDING_AND_MATURATION_OF_HIV_VIRION///Budding and maturation of HIV virion+++REACTOME_CALCINEURIN_ACTIVATES_NFAT///Calcineurin activates NFAT+++REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL///Cell surface interactions at the vascular wall+++REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM///Cytokine Signaling in Immune system+++REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR///Downstream signaling events of B Cell Receptor (BCR)+++REACTOME_EARLY_PHASE_OF_HIV_LIFE_CYCLE///Early Phase of HIV Life Cycle+++REACTOME_GENE_AND_PROTEIN_EXPRESSION_BY_JAK_STAT_SIGNALING_AFTER_INTERLEUKIN_12_STIMULATION///Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation+++REACTOME_HEMOSTASIS///Hemostasis+++REACTOME_HIV_INFECTION///HIV Infection+++REACTOME_HIV_LIFE_CYCLE///HIV Life Cycle+++REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS///Host Interactions of HIV factors+++REACTOME_INFECTIOUS_DISEASE///Infectious disease+++REACTOME_INNATE_IMMUNE_SYSTEM///Innate Immune System+++REACTOME_INTEGRATION_OF_PROVIRUS///Integration of provirus+++REACTOME_INTERLEUKIN_12_FAMILY_SIGNALING///Interleukin-12 family signaling+++REACTOME_INTERLEUKIN_12_SIGNALING///Interleukin-12 signaling+++REACTOME_NEUTROPHIL_DEGRANULATION///Neutrophil degranulation+++REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION///Platelet activation, signaling and aggregation+++REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2///Response to elevated platelet cytosolic Ca2++++REACTOME_SIGNALING_BY_INTERLEUKINS///Signaling by Interleukins+++REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR///Signaling by the B Cell Receptor (BCR)"			MIR1199_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1199-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4456///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4456 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4728_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4728-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6751_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6751-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR876_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-876-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR892A///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-892a in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).	CAGGTA_AREB6_01///Genes having at least one occurence of the highly conserved motif M76 CAGGTA sites. The motif matches transcription factor binding site V$AREB6_01 (v7.4 TRANSFAC).+++HNF4ALPHA_Q6///Genes having at least one occurence of the transcription factor binding site V$HNF4ALPHA_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.	"AEBP2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6ZN18 (AEBP2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++AHRR_TARGET_GENES///Genes containing one or more binding sites for UniProt:A9YTQ3 (AHRR) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ASH1L_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9NR48 (ASH1L) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++BRCA2_TARGET_GENES///Genes containing one or more binding sites for UniProt:P51587 (BRCA2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++CEBPZ_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q03701 (CEBPZ) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++CREB3L4_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8TEY5 (CREB3L4) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++DMRT1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9Y5R6 (DMRT1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++EWSR1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q01844 (EWSR1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++FOXO4_TARGET_GENES///Genes containing one or more binding sites for UniProt:P98177 (FOXO4) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++GCM2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O75603 (GCM2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++GLI3_TARGET_GENES///Genes containing one or more binding sites for UniProt:P10071 (GLI3) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++GTF2A2_TARGET_GENES///Genes containing one or more binding sites for UniProt:P52657 (GTF2A2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HDGF_TARGET_GENES///Genes containing one or more binding sites for UniProt:P51858 (HDGF) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HMBOX1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6NT76 (HMBOX1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HMG20B_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9P0W2 (HMG20B) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++KAT5_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q92993 (KAT5) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++KDM5D_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9BY66 (KDM5D) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++KMT2D_TARGET_GENES///Genes containing one or more binding sites for UniProt:O14686 (KMT2D) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++MAPK3_TARGET_GENES///Genes containing one or more binding sites for UniProt:P27361 (MAPK3) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++MORC2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9Y6X9 (MORC2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NKX2_2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O95096 (NKX2_2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NPM1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P06748 (NPM1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NR1I2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O75469 (NR1I2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++PPARA_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q07869 (PPARA) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++PRKDC_TARGET_GENES///Genes containing one or more binding sites for UniProt:P78527 (PRKDC) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SKIL_TARGET_GENES///Genes containing one or more binding sites for UniProt:P12757 (SKIL) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SNIP1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8TAD8 (SNIP1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++STN1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9H668 (STN1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++TEAD2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q15562 (TEAD2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++THAP1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9NVV9 (THAP1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++UBP1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9NZI7 (UBP1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZFHX3_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q15911 (ZFHX3) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZMYM2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9UBW7 (ZMYM2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF224_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9NZL3 (ZNF224) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF250_TARGET_GENES///Genes containing one or more binding sites for UniProt:P15622 (ZNF250) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF322_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6U7Q0 (ZNF322) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF579_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8NAF0 (ZNF579) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF92_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q03936 (ZNF92) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZSCAN30_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q86W11 (ZSCAN30) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."	GCM_ACTG1///Neighborhood of ACTG1+++GCM_ANP32B///Neighborhood of ANP32B+++GCM_APEX1///Neighborhood of APEX1+++GCM_CBFB///Neighborhood of CBFB+++GCM_CSNK2B///Neighborhood of CSNK2B+++GCM_NPM1///Neighborhood of NPM1+++GCM_PFN1///Neighborhood of PFN1+++GCM_PPP1CC///Neighborhood of PPP1CC+++GCM_PSME1///Neighborhood of PSME1+++GCM_TPT1///Neighborhood of TPT1+++GNF2_APEX1///Neighborhood of APEX1+++GNF2_DAP3///Neighborhood of DAP3+++GNF2_DENR///Neighborhood of DENR+++GNF2_FBL///Neighborhood of FBL+++GNF2_NPM1///Neighborhood of NPM1+++MORF_ACTG1///Neighborhood of ACTG1+++MORF_AP2M1///Neighborhood of AP2M1+++MORF_NME2///Neighborhood of NME2+++MORF_NPM1///Neighborhood of NPM1+++MORF_RAN///Neighborhood of RAN+++MORF_TPT1///Neighborhood of TPT1+++MORF_UBE2I///Neighborhood of UBE2I	MODULE_299///Genes in the cancer module 299.+++MODULE_355///Protein folding.		"GSE10240_CTRL_VS_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN///Genes down-regulated in primary bronchial epithelial cells: control versus stimulated with IL17A [GeneID=3605].+++GSE12484_HEALTHY_VS_PERIDONTITIS_NEUTROPHILS_DN///Genes down-regulated in neutrophils isolated from: healthy versus patients with peridontitis.+++GSE12845_IGD_POS_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_DN///Genes down-regulated in comparison of IgD+ peripheral blood B cells versus dark zone germincal center B cells.+++GSE12845_IGD_POS_BLOOD_VS_PRE_GC_TONSIL_BCELL_DN///Genes down-regulated in comparison of IgD+ B cells from peripheral blood versus CD19 pre-germinal center tonsil B cell+++GSE13762_CTRL_VS_125_VITAMIND_DAY12_DC_UP///Genes up-regulated in dendritic cells (12 days): control versus 25-hydroxyvitamin D3 [PubChem=1593].+++GSE1432_6H_VS_24H_IFNG_MICROGLIA_UP///Genes up-regulated in comparison of microglia cells 6 h after stimulation with IFNG [GeneID=3458] versus microglia cells 24 h after the stimulation.+++GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP///Genes up-regulated in comparison of CD4 [GeneID=920] CD8 thymocytes versus naive CD4 [GeneID=920] T cells from adult blood.+++GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_UP///Genes up-regulated in comparison of CD4 [GeneID=920] CD8 thymocytes versus naive CD4 [GeneID=920] T cells from cord blood.+++GSE1460_NAIVE_CD4_TCELL_CORD_BLOOD_VS_THYMIC_STROMAL_CELL_DN///Genes down-regulated in naive CD4 [GeneID=920] T cells from cord blood versus thymic stromal cells.+++GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_IL4_TREATED_MACROPHAGE_UP///Genes up-regulated in monocytes (12h) versus macrophages (12h) treated with IL4 [GeneID=3565] and rosiglitazone [PubChem=77999].+++GSE18893_CTRL_VS_TNF_TREATED_TCONV_24H_UP///Genes up-regulated in T conv cells (24h): medium versus TNF [GeneID=7124].+++GSE18893_CTRL_VS_TNF_TREATED_TCONV_2H_DN///Genes down-regulated in T conv cells (2h): medium versus TNF [GeneID=7124].+++GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_24H_IFNG_STIM_DN///Genes down-regulated in macrophages stimulated by IFNG [GeneID=3458] for 24h: control versus primed by IFNG [GeneID=3458].+++GSE22611_UNSTIM_VS_6H_MDP_STIM_NOD2_TRANSDUCED_HEK293T_CELL_UP///Genes up-regulated in HEK293 cells over-expressing wildtype NOD2 [GeneID=64127]: untreated versus muramyl dipeptide [PubChem=11620162] for 6h.+++GSE22886_DAY1_VS_DAY7_MONOCYTE_IN_CULTURE_DN///Genes down-regulated in comparison of monocytes cultured for 1 day versus those cultured for 7 days.+++GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH1_DN///Genes down-regulated in comparison of naive CD4 [GeneID=920] T cells versus stimulated CD4 [GeneID=920] Th1 cells at 48 h.+++GSE22919_RESTING_VS_IL2_IL12_IL15_STIM_NK_CELL_UP///Genes up-regulated in NK cells: fresh versus stimulated with IL2 [GeneID=3558], IL-12 and IL15 [GeneID=3600].+++GSE23321_CD8_STEM_CELL_MEMORY_VS_EFFECTOR_MEMORY_CD8_TCELL_UP///Genes up-regulated in CD8 T cells: stem cell memory versus effector memory.+++GSE2405_0H_VS_24H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP///Genes up-regulated in polymorphonuclear leukocytes (24h): control versus infection by A. phagocytophilum.+++GSE2405_0H_VS_9H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN///Genes down-regulated in polymorphonuclear leukocytes (9h): control versus infection by A. phagocytophilum.+++GSE24081_CONTROLLER_VS_PROGRESSOR_HIV_SPECIFIC_CD8_TCELL_DN///Genes down-regulated in comparison of CD8 T cells with progressing HIV infection versus those with controlled HIV infection.+++GSE24634_NAIVE_CD4_TCELL_VS_DAY5_IL4_CONV_TREG_DN///Genes down-regulated in comparison of naive T cells at day 0 versus CD25+ regulatory T cell (Treg) treated with IL4 [GeneID=3565] at day 5.+++GSE24634_NAIVE_CD4_TCELL_VS_DAY7_IL4_CONV_TREG_DN///Genes down-regulated in comparison of naive T cells at day 0 versus CD25+ regulatory T cell (Treg) treated with IL4 [GeneID=3565] at day 7.+++GSE26351_UNSTIM_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_DN///Genes down-regulated in CD34+ [GeneID=947] cells: control versus stimulated by BMP4 [GeneID=652].+++GSE30153_LUPUS_VS_HEALTHY_DONOR_BCELL_UP///Genes up-regulated in B lymphocytes: systemic lupus erythematosous (SLE) versus healthy.+++GSE32164_ALTERNATIVELY_ACT_M2_VS_CMYC_INHIBITED_MACROPHAGE_DN///Genes down-regulated in macrophages: alternatively activated M2 versus MYC [GeneID=4609] inhibited.+++GSE33424_CD161_HIGH_VS_INT_CD8_TCELL_DN///Genes down-regulated in CD8 T cells: KLRB1 high [GeneID=3820] versus KLRB1 int [GeneID=3820].+++GSE33425_CD161_HIGH_VS_INT_CD8_TCELL_DN///Genes down-regulated in CD8 T cells: KLRB1 high [GeneID=3820] versus KLRB1 int [GeneID=3820].+++GSE3982_EFF_MEMORY_VS_CENT_MEMORY_CD4_TCELL_UP///Genes up-regulated in comparison of effective memory CD4 [GeneID=920] T cells versus central memory CD4 [GeneID=920] T cells.+++GSE3982_EOSINOPHIL_VS_BASOPHIL_DN///Genes down-regulated in comparison of eosinophils versus basophils.+++GSE3982_EOSINOPHIL_VS_MAST_CELL_DN///Genes down-regulated in comparison of eosinophils versus mast cells.+++GSE3982_NEUTROPHIL_VS_BASOPHIL_DN///Genes down-regulated in comparison of neutrophils versus basophils.+++GSE3982_NEUTROPHIL_VS_BCELL_DN///Genes down-regulated in comparison of neutrophils versus B cells.+++GSE7568_IL4_VS_IL4_AND_DEXAMETHASONE_TREATED_MACROPHAGE_UP///Genes up-regulated in macrophages differentiated for 5 days in the presence of: IL4 [GeneID=3565] versus IL4 [GeneID=3565] and dexamethasone [PubChem=5743].+++HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_0DY_POSITIVE///Genes positively correlated with memory B cell response at 28d in peripheral blood mononuclear cell in seniors(50-74) after exposure to Fluarix , time point 0D+++NAKAYA_MYELOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP///Genes up-regulated in myeloid dendritic cell 7d vs 0d in young adults (18-50) after exposure to FluMist , time point 7D+++NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN///Genes down-regulated in peripheral blood mononuclear cell 3d vs 0d in adults (18-50) after exposure to Fluarix/Fluvirin , time point 3D. Comment: Supplementary Table 1a: All the differentially expressed genes identified in PBMCs of TIV vaccinees.+++NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE///Genes negatively correlated with HAI response at 28d in peripheral blood mononuclear cell in adults (18-50) after exposure to Fluarix/Fluvirin , time point 7D. Comment: Supplementary Table 5: All genes whose expression (d3/d0 or d7/d0) correlates to the fold increase in HAI titers (d28/d0).+++NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP///Genes up-regulated in plasmacytoid dendritic cell 7d vs 0d in young adults (18-50) after exposure to Fluarix/Fluvirin , time point 7D+++NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN///Genes down-regulated in plasmacytoid dendritic cell 7d vs 0d in young adults (18-50) after exposure to FluMist , time point 7D+++ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_DN///Genes down-regulated in peripheral blood mononuclear cell 1d vs 0d in adults (20-50) after exposure to MRKAd5 HIV-1 gag/pol/nef , time point 1D. Comment: Table includes specific cell types"	HALLMARK_GLYCOLYSIS///Genes encoding proteins involved in glycolysis and gluconeogenesis.+++HALLMARK_MTORC1_SIGNALING///Genes up-regulated through activation of mTORC1 complex.+++HALLMARK_MYC_TARGETS_V1///A subgroup of genes regulated by MYC - version 1 (v1).	NM_021130	PPIA				
P61970	sp|P61970|NTF2_HUMAN				"Nuclear transport factor 2 OS=Homo sapiens OX=9606 GN=NUTF2 PE=1 SV=1 >tr|A0A024R6Y2|A0A024R6Y2_HUMAN Nuclear transport factor 2, isoform CRA_a OS=Homo sapiens OX=9606 GN=NUTF2 PE=4 SV=1"								MGDKPIWEQIGSSFIQHYYQLFDNDRTQLGAIYIDASCLTWEGQQFQGKAAIVEKLSSLPFQKIQHSITAQDHQPTPDSCIISMVVGQLKADEDPIMGFHQMFLLKNINDAWVCTNDMFRLALHNFG	0.5895138	-0.762402424	0.004423464	5.715003		4.5957196	5.2835984	5.0687853	6.7535967	6.178401554	5.9182874	5.0003936	5.9512281	5.9380584	6.1898458	5.87259739	5.8509139				4.7879585		5.0739368	6.8000104	5.1771325	6.9300209	6.0665526	6.45212582	5.97080005	6.4869612	8.598993	6.9341754	7.501603	6.342206	4.574902	6.8342083	6.7282443	7.2192123	5.8608218	7.1085202	6.0059847	7.314126	6.2973591	5.0421226	6.6747243	4.8403582	5.42531796																																	C9606_11044					
P61106	sp|P61106|RAB14_HUMAN		RAB14		Ras-related protein Rab-14 OS=Homo sapiens OX=9606 GN=RAB14 PE=1 SV=4 >tr|A0A024R845|A0A024R845_HUMAN Ras-related protein Rab-14 OS=Homo sapiens OX=9606 GN=RAB14 PE=3 SV=1	51552	NM_016322	NP_057406	ENST00000373840	K07881			MATAPYNYSYIFKYIIIGDMGVGKSCLLHQFTEKKFMADCPHTIGVEFGTRIIEVSGQKIKLQIWDTAGQERFRAVTRSYYRGAAGALMVYDITRRSTYNHLSSWLTDARNLTNPNTVIILIGNKADLEAQRDVTYEEAKQFAEENGLLFLEASAKTGENVEDAFLEAAKKIYQNIQDGSLDLNAAESGVQHKPSAPQGGRLTSEPQPQREGCGC	0.4091488	-1.289302588	3.15E-04				4.5667244		6.4623654		4.4720888	6.3980637	6.1391851	6.0439256	6.7549549				5.7477405						6.0406899	7.2098835					8.252109	7.6500599	8.472535	8.1079674	6.071464	6.3319031	7.2729154	6.5010617		7.5079537	5.9951635	8.165499	6.4927247	6.22979904	7.2199285		6.70474209	04152///AMPK signaling pathway				GO:0000139///Golgi membrane+++GO:0005764///lysosome+++GO:0005765///lysosomal membrane+++GO:0005768///endosome+++GO:0005769///early endosome+++GO:0005770///late endosome+++GO:0005791///rough endoplasmic reticulum+++GO:0005794///Golgi apparatus+++GO:0005795///Golgi stack+++GO:0005802///trans-Golgi network+++GO:0005829///cytosol+++GO:0005886///plasma membrane+++GO:0005929///cilium+++GO:0010008///endosome membrane+++GO:0012505///endomembrane system+++GO:0016020///membrane+++GO:0030140///trans-Golgi network transport vesicle+++GO:0031410///cytoplasmic vesicle+++GO:0031901///early endosome membrane+++GO:0042175///nuclear outer membrane-endoplasmic reticulum membrane network+++GO:0043231///intracellular membrane-bounded organelle+++GO:0045335///phagocytic vesicle+++GO:0048471///perinuclear region of cytoplasm+++GO:0055037///recycling endosome+++GO:0055038///recycling endosome membrane+++GO:0070062///extracellular exosome+++GO:0070821///tertiary granule membrane	GO:0000166///nucleotide binding+++GO:0003924///GTPase activity+++GO:0005515///protein binding+++GO:0005525///GTP binding+++GO:0019003///GDP binding+++GO:0031489///myosin V binding	GO:0006661///phosphatidylinositol biosynthetic process+++GO:0006886///intracellular protein transport+++GO:0006895///Golgi to endosome transport+++GO:0008543///fibroblast growth factor receptor signaling pathway+++GO:0015031///protein transport+++GO:0016192///vesicle-mediated transport+++GO:0032456///endocytic recycling+++GO:0032880///regulation of protein localization+++GO:0042742///defense response to bacterium+++GO:0043312///neutrophil degranulation+++GO:0045995///regulation of embryonic development+++GO:0046907///intracellular transport+++GO:0090382///phagosome maturation+++GO:0090387///phagolysosome assembly involved in apoptotic cell clearance	tissueType=Fetal kidney;cancerType=Normal;cellName=Natural killer T (NKT) cell		"Homo sapiens RAB14, member RAS oncogene family (RAB14), mRNA."		PF00071///Ras family	R-HSA-1430728///Metabolism+++R-HSA-1445148///Translocation of SLC2A4 (GLUT4) to the plasma membrane+++R-HSA-1483255///PI Metabolism+++R-HSA-1483257///Phospholipid metabolism+++R-HSA-1660499///Synthesis of PIPs at the plasma membrane+++R-HSA-168249///Innate Immune System+++R-HSA-168256///Immune System+++R-HSA-199991///Membrane Trafficking+++R-HSA-392499///Metabolism of proteins+++R-HSA-556833///Metabolism of lipids+++R-HSA-5653656///Vesicle-mediated transport+++R-HSA-597592///Post-translational protein modification+++R-HSA-6798695///Neutrophil degranulation+++R-HSA-8873719///RAB geranylgeranylation+++R-HSA-8876198///RAB GEFs exchange GTP for GDP on RABs+++R-HSA-9007101///Rab regulation of trafficking		KOG0097///Golgi to endosome transport		IPR001806///Small GTPase+++IPR005225///Small GTP-binding protein domain+++IPR027417///P-loop containing nucleoside triphosphate hydrolase+++IPR030702///Ras-related protein Rab14	[RAB14_HUMAN|Reviewed]RecName: Full=Ras-related protein Rab-14;	chr9q33///Ensembl 103 genes in cytogenetic band chr9q33			REACTOME_INNATE_IMMUNE_SYSTEM///Innate Immune System+++REACTOME_MEMBRANE_TRAFFICKING///Membrane Trafficking+++REACTOME_METABOLISM_OF_LIPIDS///Metabolism of lipids+++REACTOME_NEUTROPHIL_DEGRANULATION///Neutrophil degranulation+++REACTOME_PHOSPHOLIPID_METABOLISM///Phospholipid metabolism+++REACTOME_PI_METABOLISM///PI Metabolism+++REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION///Post-translational protein modification+++REACTOME_RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS///RAB GEFs exchange GTP for GDP on RABs+++REACTOME_RAB_GERANYLGERANYLATION///RAB geranylgeranylation+++REACTOME_RAB_REGULATION_OF_TRAFFICKING///Rab regulation of trafficking+++REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE///Synthesis of PIPs at the plasma membrane+++REACTOME_TRANSLOCATION_OF_SLC2A4_GLUT4_TO_THE_PLASMA_MEMBRANE///Translocation of SLC2A4 (GLUT4) to the plasma membrane+++REACTOME_VESICLE_MEDIATED_TRANSPORT///Vesicle-mediated transport		"AAAGGGA_MIR204_MIR211///Genes having at least one occurence of the motif AAAGGGA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-204 and hsa-miR-211 (v7.1 miRBase).+++AACTGGA_MIR145///Genes having at least one occurence of the motif AACTGGA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-145 (v7.1 miRBase).+++AAGGGAT_MIR188///Genes having at least one occurence of the motif AAGGGAT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-188 (v7.1 miRBase).+++ACTGCCT_MIR34B///Genes having at least one occurence of the motif ACTGCCT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-34b (v7.1 miRBase).+++AGGTGCA_MIR500///Genes having at least one occurence of the motif AGGTGCA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-500 (v7.1 miRBase).+++ATGTTAA_MIR302C///Genes having at least one occurence of the motif ATGTTAA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-302c* (v7.1 miRBase).+++CCTGCTG_MIR214///Genes having at least one occurence of the motif CCTGCTG in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-214 (v7.1 miRBase).+++GGGACCA_MIR133A_MIR133B///Genes having at least one occurence of the motif GGGACCA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-133a and hsa-miR-133b (v7.1 miRBase).+++GTGCAAT_MIR25_MIR32_MIR92_MIR363_MIR367///Genes having at least one occurence of the motif GTGCAAT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-25, hsa-miR-32, hsa-miR-92, hsa-miR-363 and hsa-miR-367 (v7.1 miRBase).+++GTTAAAG_MIR302B///Genes having at least one occurence of the motif GTTAAAG in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-302b* (v7.1 miRBase).+++TAGCTTT_MIR9///Genes having at least one occurence of the motif TAGCTTT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-9* (v7.1 miRBase).+++TCTCTCC_MIR185///Genes having at least one occurence of the motif TCTCTCC in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-185 (v7.1 miRBase).+++TGCCTTA_MIR124A///Genes having at least one occurence of the motif TGCCTTA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-124a (v7.1 miRBase)."	"LET_7A_2_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-let-7a-2-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++LET_7A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-let-7a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++LET_7B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-let-7b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++LET_7F_1_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-let-7f-1-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++LET_7F_2_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-let-7f-2-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++LET_7G_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-let-7g-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR10523_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-10523-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR10527_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-10527-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1185_1_3P_MIR1185_2_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1185-1-3p, hsa-miR-1185-2-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR12136///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-12136 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1246///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1246 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1253///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1253 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1286///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1286 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1293///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1293 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1324///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1324 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR138_2_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-138-2-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR145_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-145-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR148A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-148a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR148B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-148b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR152_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-152-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1537_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1537-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1827///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1827 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1915_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1915-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR19A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-19a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR19B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-19b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR204_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-204-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR211_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-211-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR214_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-214-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR216B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-216b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR223_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-223-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR224_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-224-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR25_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-25-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR302B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-302b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR302D_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-302d-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3119///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3119 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3120_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3120-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3130_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3130-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3182///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3182 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR320A_3P_MIR320B_MIR320C_MIR320D///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-320a-3p, hsa-miR-320b, hsa-miR-320c, hsa-miR-320d in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR32_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-32-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR338_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-338-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3619_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3619-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR363_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-363-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR367_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-367-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR374B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-374b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3974///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3974 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4274///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4274 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4311///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4311 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4316///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4316 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4426///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4426 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4429///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4429 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4446_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4446-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4482_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4482-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4503///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4503 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4519///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4519 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4647_MIR4662B///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4647, hsa-miR-4662b in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4652_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4652-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4659A_3P_MIR4659B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4659a-3p, hsa-miR-4659b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4672///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4672 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4699_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4699-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4704_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4704-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4716_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4716-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4722_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4722-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4777_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4777-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4789_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4789-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR490_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-490-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR498_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-498-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR500A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-500a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR513A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-513a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5195_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5195-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR520D_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-520d-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR522_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-522-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR524_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-524-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548G_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548g-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5587_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5587-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR627_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-627-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR649///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-649 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR652_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-652-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6730_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6730-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6768_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6768-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6794_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6794-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6818_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6818-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR761///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-761 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7854_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7854-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR92A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-92a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR92B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-92b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR9_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-9-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR98_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-98-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets)."		"BRCA2_TARGET_GENES///Genes containing one or more binding sites for UniProt:P51587 (BRCA2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++CHAF1B_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q13112 (CHAF1B) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++CREB3L4_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8TEY5 (CREB3L4) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++FOXG1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P55316 (FOXG1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HOXA1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P49639 (HOXA1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HOXA2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O43364 (HOXA2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ID2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q02363 (ID2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NFRKB_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6P4R8 (NFRKB) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NUP153_TARGET_GENES///Genes containing one or more binding sites for UniProt:P49790 (NUP153) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++RFX7_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q2KHR2 (RFX7) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SFMBT1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9UHJ3 (SFMBT1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++THAP1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9NVV9 (THAP1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF563_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8TA94 (ZNF563) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF597_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96LX8 (ZNF597) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF92_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q03936 (ZNF92) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZSCAN29_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8IWY8 (ZSCAN29) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."	GCM_BAG5///Neighborhood of BAG5+++GCM_DEAF1///Neighborhood of DEAF1+++GCM_NF2///Neighborhood of NF2+++GCM_RAB10///Neighborhood of RAB10+++MORF_ACP1///Neighborhood of ACP1+++MORF_SKP1A///Neighborhood of SKP1A	MODULE_159///Translation regulation.+++MODULE_32///Genes in the cancer module 32.		GSE12198_NK_VS_NK_ACT_EXPANSION_SYSTEM_DERIVED_NK_CELL_DN///Genes down-regulated in NK cells: primary versus activated and expanded.+++GSE12366_PLASMA_CELL_VS_MEMORY_BCELL_DN///Genes down-regulated in plasma cells versus memory B cells.+++GSE12366_PLASMA_CELL_VS_NAIVE_BCELL_DN///Genes down-regulated in plasma cells versus naive B cells.+++GSE15139_GMCSF_TREATED_VS_UNTREATED_NEUTROPHILS_DN///Genes down-regulated in neutrophils treated with CSF2 [GeneID=1437] versus control.+++GSE16385_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_UP///Genes up-regulated in macrophages (12h): IFNG and TNF [GeneID=3458;7124] versus IL4 [GeneID=3565].+++GSE16385_MONOCYTE_VS_12H_IFNG_TNF_TREATED_MACROPHAGE_DN///Genes down-regulated in monocytes (12h) versus macrophages (12h) treated with IFNG and TNF [GeneID=3458;7124].+++GSE17186_BLOOD_VS_CORD_BLOOD_CD21LOW_TRANSITIONAL_BCELL_DN///Genes down-regulated in transitional CR2 [GeneID=1380] low B lymphocytes versus those from cord blood.+++GSE17186_NAIVE_VS_CD21HIGH_TRANSITIONAL_BCELL_DN///Genes down-regulated in B lymphocytes: nave versus transitional CR2 [GeneID=1380] high.+++GSE17186_NAIVE_VS_CD21LOW_TRANSITIONAL_BCELL_CORD_BLOOD_DN///Genes down-regulated in B lymphocytes from cord blood: nave versus transitional CR2 [GeneID=1380].+++GSE17301_IFNA2_VS_IFNA2_AND_ACD3_ACD28_STIM_CD8_TCELL_DN///Genes down-regulated in CD8 T cells stimulated by IFNA2 [GeneID=3440] versus those activated by anti-CD3 and anti-CD28.+++GSE18893_TCONV_VS_TREG_2H_CULTURE_DN///Genes down-regulated in lymphocytes treated with medium for 2h: T conv versus T reg cells.+++GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_IN_MAST_CELL_DN///Genes down-regulated in HMC-1 (mast leukemia) cells: Cl-IB-MECA [PubChem=3035850] versus T cell membranes.+++GSE22589_HEALTHY_VS_HIV_INFECTED_DC_UP///Genes up-regulated in monocyte-derived dendritic cells: control versus HIV infection.+++GSE22611_NOD2_TRANSD_VS_CTRL_TRANSD_HEK293_MDP_STIM_2H_UP///Genes up-regulated in HEK293 cells at 2h after stimulation by muramyl dipeptide [PubChem=11620162]: over-expressing mutant NOD2 [GeneID=64127] versus control.+++GSE22611_NOD2_TRANSD_VS_CTRL_TRANSD_HEK293_MDP_STIM_6H_UP///Genes up-regulated in HEK293 cells at 6h after stimulation by muramyl dipeptide [PubChem=11620162]: over-expressing wildtype NOD2 [GeneID=64127] versus control.+++GSE22886_NAIVE_BCELL_VS_MONOCYTE_DN///Genes down-regulated in comparison of naive B cells versus day 0 monocytes.+++GSE22886_NAIVE_CD8_TCELL_VS_MEMORY_TCELL_DN///Genes down-regulated in comparison of naive CD8 T cells versus naive CD4 [GeneID=920] CD8 T cells.+++GSE22886_NAIVE_CD8_TCELL_VS_NKCELL_DN///Genes down-regulated in comparison of naive CD8 T cells versus unstimulated NK cells.+++GSE23321_CD8_STEM_CELL_MEMORY_VS_EFFECTOR_MEMORY_CD8_TCELL_DN///Genes down-regulated in CD8 T cells: stem cell memory versus effector memory.+++GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_48H_DN///Genes down-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 and then stimulated by TGFB1 and IL4 [GeneID=7040;3565] (48h).+++GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MDC_UP///Genes up-regulated in comparison of myeloid dendritic cells (mDC) from LAIV influenza vaccinee pre-vaccination versus those at day 7 post-vaccination.+++GSE32164_ALTERNATIVELY_ACT_M2_VS_CMYC_INHIBITED_MACROPHAGE_UP///Genes up-regulated in macrophages: alternatively activated M2 versus MYC [GeneID=4609] inhibited.+++GSE32164_RESTING_DIFFERENTIATED_VS_ALTERNATIVELY_ACT_M2_MACROPHAGE_DN///Genes down-regulated in macrophages: resting differentiated versus alternatively activated M2.+++GSE33424_CD161_HIGH_VS_NEG_CD8_TCELL_UP///Genes up-regulated in CD8 T cells: KLRB1 high [GeneID=3820] versus KLRB1- [GeneID=3820].+++GSE33425_CD161_HIGH_VS_INT_CD8_TCELL_UP///Genes up-regulated in CD8 T cells: KLRB1 high [GeneID=3820] versus KLRB1 int [GeneID=3820].+++GSE33425_CD161_INT_VS_NEG_CD8_TCELL_DN///Genes down-regulated in CD8 T cells: KLRB1 int [GeneID=3820] versus KLRB1- [GeneID=3820].+++GSE33425_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_UP///Genes up-regulated in KLRB1 high [GeneID=3820] T cells: CD8A [GeneID=925] versus CD8A CD8B [GeneID=925;926].+++GSE34156_UNTREATED_VS_6H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN///Genes down-regulated in monocytes (6h): untreated versus M. tuberculosis 19 kDa lipopeptide.+++GSE34205_HEALTHY_VS_FLU_INF_INFANT_PBMC_UP///Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMCs from infanct with acute influenza infection.+++GSE34205_RSV_VS_FLU_INF_INFANT_PBMC_DN///Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from infancts with acute RSV infection versus PBMCs from infants with acute influenza infection.+++GSE34515_CD16_NEG_MONOCYTE_VS_DC_UP///Genes up-regulated in CD16- monocytes versus dendritic cells.+++GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_DC_UP///Genes up-regulated in comparison of dendritic cells (DC) versus DCs exposed to B. malayi (5 worms/well).+++GSE360_CTRL_VS_T_GONDII_DC_UP///Genes up-regulated in untreated dendritic cells (DC) versus DCs exposed to parasite Toxoplasma gondii.+++GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_MAC_DN///Genes down-regulated in comparison of macrophages exposed to L. major versus macrophages exposed to 5 worms/well B. malayi.+++GSE3920_UNTREATED_VS_IFNA_TREATED_ENDOTHELIAL_CELL_UP///Genes up-regulated in ndothelial cells: untreated versus interferon alpha.+++GSE3982_BCELL_VS_EFF_MEMORY_CD4_TCELL_UP///Genes up-regulated in comparison of B cells versus effector memory CD4 [GeneID=920] T cells.+++GSE3982_CTRL_VS_PMA_STIM_EOSINOPHIL_UP///Genes up-regulated in comparison of untreated eosinophils versus eosinophils treated with PMA [PubChem=4792] at 2 h.+++GSE3982_DC_VS_EFF_MEMORY_CD4_TCELL_UP///Genes up-regulated in comparison of dendritic cells (DC) versus effector memory CD4 [GeneID=920] T cells.+++GSE3982_EOSINOPHIL_VS_EFF_MEMORY_CD4_TCELL_UP///Genes up-regulated in comparison of eosinophils versus effector memory CD4 [GeneID=920] T cells.+++GSE7509_DC_VS_MONOCYTE_WITH_FCGRIIB_STIM_DN///Genes down-regulated in response to anti-FcgRIIB: dendritic cells versus monocytes.+++GSE8515_CTRL_VS_IL6_4H_STIM_MAC_UP///Genes up-regulated in comparison of untreated macrophages versus those treated with IL6 [GeneID=3569].+++GSE8835_HEALTHY_VS_CLL_CD8_TCELL_UP///Genes up-regulated in CD8 T cells: healthy versus CLL (chronic lymphocytic leukemia).+++GSE9960_HEALTHY_VS_GRAM_POS_SEPSIS_PBMC_UP///Genes up-regulated in peripheral blood monocytes (PMBC):healthy versus Gram positive sepsis.	HALLMARK_PROTEIN_SECRETION///Genes involved in protein secretion pathway.	NM_016322	RAB14				
P61088	sp|P61088|UBE2N_HUMAN		UBE2N		Ubiquitin-conjugating enzyme E2 N OS=Homo sapiens OX=9606 GN=UBE2N PE=1 SV=1 >tr|V9HW41|V9HW41_HUMAN Epididymis secretory protein Li 71 OS=Homo sapiens OX=9606 GN=HEL-S-71 PE=2 SV=1	7334	NM_003348	NP_003339	ENST00000318066	K10580			MAGLPRRIIKETQRLLAEPVPGIKAEPDESNARYFHVVIAGPQDSPFEGGTFKLELFLPEEYPMAAPKVRFMTKIYHPNVDKLGRICLDILKDKWSPALQIRTVLLSIQALLSAPNPDDPLANDVAEQWKTNEAQAIETARAWTRLYAMNNI	0.4586149	-1.124645012	4.77E-04		6.1053313	4.9971169	6.2265243	6.5049299	8.0220428	6.778992263	6.0682146	6.6913468	7.6049028	7.448218	7.5094956	5.58648185	6.9494572	6.6412904	7.1812334	5.3570165	7.0920928		6.0199401	7.0247108	7.2637978	8.0728167	5.0798914	7.22562326		7.4261814	10.440594	8.7279681	9.2629	8.4767432	6.318344	6.67211	8.3684408	8.093242	7.4221755	8.1443898	7.1011217	8.415943	7.8082987	7.53531893	8.5085227	6.1621648	8.08154765	04120///Ubiquitin mediated proteolysis+++04624///Toll and Imd signaling pathway+++05131///Shigellosis				GO:0000151///ubiquitin ligase complex+++GO:0001650///fibrillar center+++GO:0005634///nucleus+++GO:0005654///nucleoplasm+++GO:0005737///cytoplasm+++GO:0005829///cytosol+++GO:0031372///UBC13-MMS2 complex+++GO:0032991///protein-containing complex+++GO:0035370///UBC13-UEV1A complex+++GO:0070062///extracellular exosome	GO:0000166///nucleotide binding+++GO:0003723///RNA binding+++GO:0004842///ubiquitin-protein transferase activity+++GO:0005515///protein binding+++GO:0005524///ATP binding+++GO:0016740///transferase activity+++GO:0031625///ubiquitin protein ligase binding+++GO:0043130///ubiquitin binding+++GO:0061631///ubiquitin conjugating enzyme activity	GO:0000187///activation of MAPK activity+++GO:0000209///protein polyubiquitination+++GO:0000724///double-strand break repair via homologous recombination+++GO:0000729///DNA double-strand break processing+++GO:0006281///DNA repair+++GO:0006282///regulation of DNA repair+++GO:0006301///postreplication repair+++GO:0006302///double-strand break repair+++GO:0006303///double-strand break repair via nonhomologous end joining+++GO:0006511///ubiquitin-dependent protein catabolic process+++GO:0006974///cellular response to DNA damage stimulus+++GO:0007254///JNK cascade+++GO:0016567///protein ubiquitination+++GO:0016574///histone ubiquitination+++GO:0031058///positive regulation of histone modification+++GO:0033182///regulation of histone ubiquitination+++GO:0035973///aggrephagy+++GO:0043123///positive regulation of I-kappaB kinase/NF-kappaB signaling+++GO:0045739///positive regulation of DNA repair+++GO:0050852///T cell receptor signaling pathway+++GO:0051092///positive regulation of NF-kappaB transcription factor activity+++GO:0051443///positive regulation of ubiquitin-protein transferase activity+++GO:0070423///nucleotide-binding oligomerization domain containing signaling pathway+++GO:0070498///interleukin-1-mediated signaling pathway+++GO:0070534///protein K63-linked ubiquitination	tissueType=Liver;cancerType=Hepatocellular Cancer;cellName=Regulatory T (Treg) cell+++tissueType=Kidney;cancerType=Normal;cellName=B cell+++tissueType=Fetal kidney;cancerType=Normal;cellName=Natural killer T (NKT) cell		"Homo sapiens ubiquitin conjugating enzyme E2 N (UBE2N), mRNA."		PF00179///Ubiquitin-conjugating enzyme	"R-HSA-1169408///ISG15 antiviral mechanism+++R-HSA-1169410///Antiviral mechanism by IFN-stimulated genes+++R-HSA-1280215///Cytokine Signaling in Immune system+++R-HSA-1280218///Adaptive Immune System+++R-HSA-1632852///Macroautophagy+++R-HSA-1640170///Cell Cycle+++R-HSA-166016///Toll Like Receptor 4 (TLR4) Cascade+++R-HSA-166058///MyD88:MAL(TIRAP) cascade initiated on plasma membrane+++R-HSA-166166///MyD88-independent TLR4 cascade +++R-HSA-168138///Toll Like Receptor 9 (TLR9) Cascade+++R-HSA-168142///Toll Like Receptor 10 (TLR10) Cascade+++R-HSA-168164///Toll Like Receptor 3 (TLR3) Cascade+++R-HSA-168176///Toll Like Receptor 5 (TLR5) Cascade+++R-HSA-168179///Toll Like Receptor TLR1:TLR2 Cascade+++R-HSA-168181///Toll Like Receptor 7/8 (TLR7/8) Cascade+++R-HSA-168188///Toll Like Receptor TLR6:TLR2 Cascade+++R-HSA-168249///Innate Immune System+++R-HSA-168256///Immune System+++R-HSA-168638///NOD1/2 Signaling Pathway+++R-HSA-168643///Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways+++R-HSA-168898///Toll-like Receptor Cascades+++R-HSA-168927///TICAM1, RIP1-mediated IKK complex recruitment+++R-HSA-181438///Toll Like Receptor 2 (TLR2) Cascade+++R-HSA-202403///TCR signaling+++R-HSA-202424///Downstream TCR signaling+++R-HSA-2454202///Fc epsilon receptor (FCERI) signaling+++R-HSA-2871837///FCERI mediated NF-kB activation+++R-HSA-392499///Metabolism of proteins+++R-HSA-445989///TAK1 activates NFkB by phosphorylation and activation of IKKs complex+++R-HSA-446652///Interleukin-1 family signaling+++R-HSA-448424///Interleukin-17 signaling+++R-HSA-449147///Signaling by Interleukins+++R-HSA-450294///MAP kinase activation+++R-HSA-450302///activated TAK1 mediates p38 MAPK activation+++R-HSA-450321///JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1+++R-HSA-5607764///CLEC7A (Dectin-1) signaling+++R-HSA-5621481///C-type lectin receptors (CLRs)+++R-HSA-5693532///DNA Double-Strand Break Repair+++R-HSA-5693538///Homology Directed Repair+++R-HSA-5693565///Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks+++R-HSA-5693567///HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)+++R-HSA-5693571///Nonhomologous End-Joining (NHEJ)+++R-HSA-5693606///DNA Double Strand Break Response+++R-HSA-5693607///Processing of DNA double-strand break ends+++R-HSA-5696395///Formation of Incision Complex in GG-NER+++R-HSA-5696398///Nucleotide Excision Repair+++R-HSA-5696399///Global Genome Nucleotide Excision Repair (GG-NER)+++R-HSA-597592///Post-translational protein modification+++R-HSA-69473///G2/M DNA damage checkpoint+++R-HSA-69481///G2/M Checkpoints+++R-HSA-69620///Cell Cycle Checkpoints+++R-HSA-73894///DNA Repair+++R-HSA-8852135///Protein ubiquitination+++R-HSA-8866654///E3 ubiquitin ligases ubiquitinate target proteins+++R-HSA-9020702///Interleukin-1 signaling+++R-HSA-913531///Interferon Signaling+++R-HSA-937039///IRAK1 recruits IKK complex+++R-HSA-937041///IKK complex recruitment mediated by RIP1+++R-HSA-937061///TRIF(TICAM1)-mediated TLR4 signaling +++R-HSA-9612973///Autophagy+++R-HSA-9646399///Aggrephagy+++R-HSA-9663891///Selective autophagy+++R-HSA-975110///TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling+++R-HSA-975138///TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation+++R-HSA-975144///IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation+++R-HSA-975155///MyD88 dependent cascade initiated on endosome+++R-HSA-975871///MyD88 cascade initiated on plasma membrane+++R-HSA-983168///Antigen processing: Ubiquitination & Proteasome degradation+++R-HSA-983169///Class I MHC mediated antigen processing & presentation"	COG5078///No_INFO	KOG0417///protein modification by small protein conjugation		"IPR000608///Ubiquitin-conjugating enzyme E2+++IPR016135///Ubiquitin-conjugating enzyme/RWD-like+++IPR023313///Ubiquitin-conjugating enzyme, active site"	[UBE2N_HUMAN|Reviewed]RecName: Full=Ubiquitin-conjugating enzyme E2 N; EC=2.3.2.23 {ECO:0000269|PubMed:20061386}; AltName: Full=Bendless-like ubiquitin-conjugating enzyme; AltName: Full=E2 ubiquitin-conjugating enzyme N; AltName: Full=Ubc13; AltName: Full=UbcH13; AltName: Full=Ubiquitin carrier protein N; AltName: Full=Ubiquitin-protein ligase N;	chr12q22///Ensembl 103 genes in cytogenetic band chr12q22		KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS///Ubiquitin mediated proteolysis	"REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION///activated TAK1 mediates p38 MAPK activation+++REACTOME_ADAPTIVE_IMMUNE_SYSTEM///Adaptive Immune System+++REACTOME_AGGREPHAGY///Aggrephagy+++REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION///Antigen processing: Ubiquitination &amp; Proteasome degradation+++REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES///Antiviral mechanism by IFN-stimulated genes+++REACTOME_AUTOPHAGY///Autophagy+++REACTOME_CELL_CYCLE///Cell Cycle+++REACTOME_CELL_CYCLE_CHECKPOINTS///Cell Cycle Checkpoints+++REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION///Class I MHC mediated antigen processing &amp; presentation+++REACTOME_CLEC7A_DECTIN_1_SIGNALING///CLEC7A (Dectin-1) signaling+++REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS///C-type lectin receptors (CLRs)+++REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM///Cytokine Signaling in Immune system+++REACTOME_DNA_DOUBLE_STRAND_BREAK_REPAIR///DNA Double-Strand Break Repair+++REACTOME_DNA_DOUBLE_STRAND_BREAK_RESPONSE///DNA Double Strand Break Response+++REACTOME_DNA_REPAIR///DNA Repair+++REACTOME_E3_UBIQUITIN_LIGASES_UBIQUITINATE_TARGET_PROTEINS///E3 ubiquitin ligases ubiquitinate target proteins+++REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING///Fc epsilon receptor (FCERI) signaling+++REACTOME_FCERI_MEDIATED_NF_KB_ACTIVATION///FCERI mediated NF-kB activation+++REACTOME_FORMATION_OF_INCISION_COMPLEX_IN_GG_NER///Formation of Incision Complex in GG-NER+++REACTOME_G2_M_CHECKPOINTS///G2/M Checkpoints+++REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT///G2/M DNA damage checkpoint+++REACTOME_GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER///Global Genome Nucleotide Excision Repair (GG-NER)+++REACTOME_HOMOLOGY_DIRECTED_REPAIR///Homology Directed Repair+++REACTOME_IKK_COMPLEX_RECRUITMENT_MEDIATED_BY_RIP1///IKK complex recruitment mediated by RIP1+++REACTOME_INNATE_IMMUNE_SYSTEM///Innate Immune System+++REACTOME_INTERFERON_SIGNALING///Interferon Signaling+++REACTOME_INTERLEUKIN_17_SIGNALING///Interleukin-17 signaling+++REACTOME_INTERLEUKIN_1_FAMILY_SIGNALING///Interleukin-1 family signaling+++REACTOME_INTERLEUKIN_1_SIGNALING///Interleukin-1 signaling+++REACTOME_IRAK1_RECRUITS_IKK_COMPLEX///IRAK1 recruits IKK complex+++REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1///JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1+++REACTOME_MYD88_INDEPENDENT_TLR4_CASCADE///MyD88-independent TLR4 cascade +++REACTOME_NOD1_2_SIGNALING_PATHWAY///NOD1/2 Signaling Pathway+++REACTOME_NONHOMOLOGOUS_END_JOINING_NHEJ///Nonhomologous End-Joining (NHEJ)+++REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS///Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways+++REACTOME_NUCLEOTIDE_EXCISION_REPAIR///Nucleotide Excision Repair+++REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION///Post-translational protein modification+++REACTOME_PROCESSING_OF_DNA_DOUBLE_STRAND_BREAK_ENDS///Processing of DNA double-strand break ends+++REACTOME_PROTEIN_UBIQUITINATION///Protein ubiquitination+++REACTOME_SELECTIVE_AUTOPHAGY///Selective autophagy+++REACTOME_SIGNALING_BY_INTERLEUKINS///Signaling by Interleukins+++REACTOME_TAK1_ACTIVATES_NFKB_BY_PHOSPHORYLATION_AND_ACTIVATION_OF_IKKS_COMPLEX///TAK1 activates NFkB by phosphorylation and activation of IKKs complex+++REACTOME_TCR_SIGNALING///TCR signaling+++REACTOME_TICAM1_RIP1_MEDIATED_IKK_COMPLEX_RECRUITMENT///TICAM1, RIP1-mediated IKK complex recruitment+++REACTOME_TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE///Toll Like Receptor 9 (TLR9) Cascade+++REACTOME_TOLL_LIKE_RECEPTOR_CASCADES///Toll-like Receptor Cascades+++REACTOME_TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE///Toll Like Receptor TLR1:TLR2 Cascade+++REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION_IN_TLR7_8_OR_9_SIGNALING///TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling"		"ACCATTT_MIR522///Genes having at least one occurence of the motif ACCATTT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-522 (v7.1 miRBase).+++ACTGTGA_MIR27A_MIR27B///Genes having at least one occurence of the motif ACTGTGA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-27a and hsa-miR-27b (v7.1 miRBase).+++ATGAAGG_MIR205///Genes having at least one occurence of the motif ATGAAGG in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-205 (v7.1 miRBase).+++CACTGTG_MIR128A_MIR128B///Genes having at least one occurence of the motif CACTGTG in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-128a and hsa-miR-128b (v7.1 miRBase).+++CTTTGTA_MIR524///Genes having at least one occurence of the motif CTTTGTA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-524* (v7.1 miRBase).+++GACAATC_MIR219///Genes having at least one occurence of the motif GACAATC in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-219 (v7.1 miRBase)."	"MIR128_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-128-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR186_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-186-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR208A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-208a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR208B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-208b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR216A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-216a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR27A_3P_MIR27B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-27a-3p, hsa-miR-27b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3140_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3140-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3143///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3143 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3149///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3149 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR33A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-33a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR34B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-34b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3681_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3681-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR378G///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-378g in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3912_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3912-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4436A///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4436a in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4729///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4729 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4768_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4768-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4778_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4778-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5000_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5000-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR508_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-508-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR625_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-625-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR633///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-633 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6828_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6828-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6847_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6847-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7150///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7150 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR767_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-767-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR8064///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-8064 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR8068///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-8068 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR885_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-885-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR9985///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-9985 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets)."	ACTAYRNNNCCCR_UNKNOWN///Genes having at least one occurence of the highly conserved motif M4 ACTAYRNNNCCCR in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++CCCNNGGGAR_OLF1_01///Genes having at least one occurence of the highly conserved motif M130 CCCNNGGGAR sites. The motif matches transcription factor binding site V$OLF1_01 (v7.4 TRANSFAC).+++ELK1_02///Genes having at least one occurence of the transcription factor binding site V$ELK1_02 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++GABP_B///Genes having at least one occurence of the transcription factor binding site V$GABP_B (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++GGAMTNNNNNTCCY_UNKNOWN///Genes having at least one occurence of the highly conserved motif M74 GGAMTNNNNNTCCY in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++MGGAAGTG_GABP_B///Genes having at least one occurence of the highly conserved motif M11 MGGAAGTG sites. The motif matches transcription factor binding site V$GABP_B (v7.4 TRANSFAC).+++NRF2_01///Genes having at least one occurence of the transcription factor binding site V$NRF2_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++OLF1_01///Genes having at least one occurence of the transcription factor binding site V$OLF1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++PAX6_01///Genes having at least one occurence of the transcription factor binding site V$PAX6_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++PAX8_01///Genes having at least one occurence of the transcription factor binding site V$PAX8_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++PITX2_Q2///Genes having at least one occurence of the transcription factor binding site V$PITX2_Q2 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++RACTNNRTTTNC_UNKNOWN///Genes having at least one occurence of the highly conserved motif M66 RACTNNRTTTNC in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++SCGGAAGY_ELK1_02///Genes having at least one occurence of the highly conserved motif M3 SCGGAAGY sites. The motif matches transcription factor binding site V$ELK1_02 (v7.4 TRANSFAC).+++STAT1_02///Genes having at least one occurence of the transcription factor binding site V$STAT1_02 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++STAT1_03///Genes having at least one occurence of the transcription factor binding site V$STAT1_03 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++TEL2_Q6///Genes having at least one occurence of the transcription factor binding site V$TEL2_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++TNCATNTCCYR_UNKNOWN///Genes having at least one occurence of the highly conserved motif M75 TNCATNTCCYR in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++YKACATTT_UNKNOWN///Genes having at least one occurence of the highly conserved motif M145 YKACATTT in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++YYCATTCAWW_UNKNOWN///Genes having at least one occurence of the highly conserved motif M52 YYCATTCAWW in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++ZF5_01///Genes having at least one occurence of the transcription factor binding site V$ZF5_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++ZID_01///Genes having at least one occurence of the transcription factor binding site V$ZID_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.	"AHRR_TARGET_GENES///Genes containing one or more binding sites for UniProt:A9YTQ3 (AHRR) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++CIITA_TARGET_GENES///Genes containing one or more binding sites for UniProt:P33076 (CIITA) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++E2F2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q14209 (E2F2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++KDM7A_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6ZMT4 (KDM7A) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++PHF2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O75151 (PHF2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++PPARA_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q07869 (PPARA) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++PRDM4_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9UKN5 (PRDM4) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++RAX2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96IS3 (RAX2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZFP91_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96JP5 (ZFP91) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF407_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9C0G0 (ZNF407) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF618_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q5T7W0 (ZNF618) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF8_TARGET_GENES///Genes containing one or more binding sites for UniProt:P17098 (ZNF8) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."	GCM_MLL///Neighborhood of MLL+++GCM_MYST2///Neighborhood of MYST2+++GCM_NCAM1///Neighborhood of NCAM1+++GCM_NF2///Neighborhood of NF2+++GCM_RAN///Neighborhood of RAN+++GCM_RBM8A///Neighborhood of RBM8A+++GCM_SUFU///Neighborhood of SUFU+++GCM_UBE2N///Neighborhood of UBE2N+++GCM_ZNF198///Neighborhood of ZNF198+++MORF_ACP1///Neighborhood of ACP1+++MORF_BUB3///Neighborhood of BUB3+++MORF_HAT1///Neighborhood of HAT1+++MORF_HDAC1///Neighborhood of HDAC1+++MORF_PTPN11///Neighborhood of PTPN11+++MORF_RAD23A///Neighborhood of RAD23A+++MORF_SKP1A///Neighborhood of SKP1A+++MORF_UBE2N///Neighborhood of UBE2N	MODULE_233///Genes in the cancer module 233.+++MODULE_278///Ubiquitin ligases.+++MODULE_4///Genes in the cancer module 4.+++MODULE_72///Testis genes.+++MODULE_82///Genes in the cancer module 82.+++MODULE_8///Genes in the cancer module 8.	BCAT_GDS748_UP///Genes up-regulated in HEK293 cells (kidney fibroblasts) expressing constitutively active form of CTNNB1 [Gene ID=1499] gene.+++CSR_EARLY_UP.V1_UP///Genes up-regulated in early serum response of CRL 2091 cells (foreskin fibroblasts).	"DHIMAN_PBMC_ATTENUVAX_AGE_15_25YO_SUBQ_7_OR_14DY_UP///Genes up-regulated in peripheral blood mononuclear cell 7d or 14d vs 0d in adults (15-25) after exposure to Attenuvax , time point 7 or 14D , administered subcutaneous+++GSE13887_HEALTHY_VS_LUPUS_RESTING_CD4_TCELL_DN///Genes down-regulated in resting CD4 [GeneID=920] T cells: healthy versus systemic lupus erythrematosus (SLE).+++GSE14000_UNSTIM_VS_4H_LPS_DC_DN///Genes down-regulated in comparison of dendritic cells (DC) before and 4 h after LPS (TLR4 agonist) stimulation.+++GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_DN///Genes down-regulated in comparison of control microglia cells versus those 24 h after stimulation with IFNG [GeneID=3458].+++GSE16385_MONOCYTE_VS_12H_IL4_TREATED_MACROPHAGE_UP///Genes up-regulated in monocytes (12h) versus macrophages (12h) treated with IL4 [GeneID=3565].+++GSE16386_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_6H_UP///Genes up-regulated in macrophages (6h): IL4 [GeneID=3565] versus IL4 [GeneID=3565] and rosiglitazone [PubChem=77999].+++GSE18893_CTRL_VS_TNF_TREATED_TREG_24H_UP///Genes up-regulated in T reg cells: 2h versus 24h medium treatment.+++GSE20198_IL12_VS_IFNA_TREATED_ACT_CD4_TCELL_DN///Genes down-regulated in the activated CD4 [GeneID=920] T cells (48h): IL-12 versus interferon alpha.+++GSE20198_UNTREATED_VS_IL12_IL18_TREATED_ACT_CD4_TCELL_DN///Genes down-regulated in the activated CD4 [GeneID=920] T cells (48h): control versus IL-12 and IL18 [GeneID=3606].+++GSE22611_NOD2_VS_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_UP///Genes up-regulated in HEK293 cells expressing: wildtype NOD2 [GeneID=64127] versus mutant NOD2 [GeneID=64127].+++GSE22886_IGA_VS_IGM_MEMORY_BCELL_UP///Genes up-regulated in comparison of memory IgG IgA B cells versus memory IgM B cells.+++GSE22886_NAIVE_VS_IGG_IGA_MEMORY_BCELL_DN///Genes down-regulated in comparison of naive B cells versus memory IgG IgA B cells.+++GSE22886_UNSTIM_VS_IL15_STIM_NKCELL_DN///Genes down-regulated in comparison of unstimulated NK cells versus those stimulated with IL2 [GeneID=3600] at 16 h.+++GSE22886_UNSTIM_VS_IL2_STIM_NKCELL_DN///Genes down-regulated in comparison of unstimulated NK cells versus those stimulated with IL2 [GeneID=3558] at 16 h.+++GSE24634_NAIVE_CD4_TCELL_VS_DAY5_IL4_CONV_TREG_DN///Genes down-regulated in comparison of naive T cells at day 0 versus CD25+ regulatory T cell (Treg) treated with IL4 [GeneID=3565] at day 5.+++GSE24634_TREG_VS_TCONV_POST_DAY10_IL4_CONVERSION_UP///Genes up-regulated in comparison of CD25+ regulatory T cell (Treg) treated with IL4 [GeneID=3565] at day 10 versus CD25- T cells treated with IL4 [GeneID=3565] at 10 h.+++GSE24634_TREG_VS_TCONV_POST_DAY5_IL4_CONVERSION_UP///Genes up-regulated in comparison of CD25+ T cells treated with IL4 [GeneID=3565] versus CD25- T cells treated with IL4 [GeneID=3565] at day 5.+++GSE25085_FETAL_LIVER_VS_FETAL_BM_SP4_THYMIC_IMPLANT_UP///Genes up-regulated in thymic implants from fetal liver versus those from fetal bone marrow.+++GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_6H_DN///Genes down-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 [GeneID=7040] and IL-12 (6h) versus untreated (6h).+++GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_48H_UP///Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: IL4 [GeneID=3565] (48h) versus untreated (48h).+++GSE360_DC_VS_MAC_B_MALAYI_LOW_DOSE_UP///Genes up-regulated in comparison of dendritic cells (DC) exposed to 5 worm/well B. malayi versus macrophages exposed to 5 worms/well B. malayi.+++GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_MAC_UP///Genes up-regulated in comparison of macrophages exposed to 50 worms/well B. malayi versus those exposed to 5 worms/well B. malayi.+++GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_MAC_UP///Genes up-regulated in comparison of macrophages exposed to T. gondii versus macrophages exposed to 50 worms/well B. malayi.+++GSE3982_BCELL_VS_NKCELL_UP///Genes up-regulated in comparison of B cells versus NK cells.+++GSE3982_MAC_VS_BCELL_DN///Genes down-regulated in comparison of macrophages versus B cells.+++GSE3982_MAC_VS_CENT_MEMORY_CD4_TCELL_DN///Genes down-regulated in comparison of macrophages versus central memory CD4 [GeneID=920] T cells.+++GSE3982_MAST_CELL_VS_NKCELL_UP///Genes up-regulated in comparison of mast cells versus NK cells.+++GSE3982_NKCELL_VS_TH2_DN///Genes down-regulated in comparison of NK cells versus Th2 cells.+++GSE4984_UNTREATED_VS_VEHICLE_CTRL_TREATED_DC_DN///Genes down-regulated in monocyte-derived dendritic cells: untreated versus vehicle.+++GSE5542_IFNG_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_UP///Genes up-regulated in epithelial cells (6h): IFNG [GeneID=3458] versus interferon alpha.+++GSE7460_CTRL_VS_TGFB_TREATED_ACT_TREG_UP///Genes up-regulated in comparsion of ActTreg versus ActTregTGF (see Fig. 1 in the paper for details)."	HALLMARK_ALLOGRAFT_REJECTION///Genes up-regulated during transplant rejection.+++HALLMARK_PI3K_AKT_MTOR_SIGNALING///Genes up-regulated by activation of the PI3K/AKT/mTOR pathway.	NM_003348	UBE2N				
P61077	sp|P61077|UB2D3_HUMAN		UBE2D3		"Ubiquitin-conjugating enzyme E2 D3 OS=Homo sapiens OX=9606 GN=UBE2D3 PE=1 SV=1 >tr|A0A024RDH2|A0A024RDH2_HUMAN Ubiquitin-conjugating enzyme E2D 3 (UBC4/5 homolog, yeast), isoform CRA_a OS=Homo sapiens OX=9606 GN=UBE2D3 PE=3 SV=1"	7323	URS00009B68A9						MALKRINKELSDLARDPPAQCSAGPVGDDMFHWQATIMGPNDSPYQGGVFFLTIHFPTDYPFKPPKVAFTTRIYHPNINSNGSICLDILRSQWSPALTISKVLLSICSLLCDPNPDDPLVPEIARIYKTDRDKYNRISREWTQKYAM	0.4106982	-1.283849321	0.005993286		3.9179756	2.955187		4.4033143	6.2896117		5.3560654	4.6484961	4.9187079	4.9746746	5.2672711		4.2954075							3.9766856	3.7030834	7.8356953			4.39870992	3.9905291	8.535565	7.3728789	7.112634	6.0058949		5.4618553	4.4737043	6.4383848	4.9449594	7.4669902	4.0384896	5.830286	5.8166797	4.74969107	6.119078		4.57698253																																	URS00009B68A9	UBE2D3				
P55145	sp|P55145|MANF_HUMAN		MANF		Mesencephalic astrocyte-derived neurotrophic factor OS=Homo sapiens OX=9606 GN=MANF PE=1 SV=3	7873	NM_006010	NP_006001	ENST00000528157				MRRMWATQGLAVALALSVLPGSRALRPGDCEVCISYLGRFYQDLKDRDVTFSPATIENELIKFCREARGKENRLCYYIGATDDAATKIINEVSKPLAHHIPVEKICEKLKKKDSQICELKYDKQIDLSTVDLKKLRVKELKKILDDWGETCKGCAEKSDYIRKINELMPKYAPKAASARTDL	0.5231647	-0.934663022	0.006040783	3.9525126	5.6599207	4.6265495	4.2107793		4.5366104	4.726515872	5.0309285	4.7598887	6.442255	6.0826929	4.9519314	3.48452718	4.4297845	4.3758968	4.6199375	4.2586414		3.846125576			5.9601131	6.4872107	4.0232381	3.41895182			7.369559	6.7988436	6.362364	7.0117527	5.226753		6.4439601	5.8857938	6.1340728	6.2148109	5.1229735	6.817526	4.1234493	4.00951648	5.4895712		5.83919792					GO:0005576///extracellular region+++GO:0005615///extracellular space+++GO:0005634///nucleus+++GO:0005783///endoplasmic reticulum+++GO:0005788///endoplasmic reticulum lumen+++GO:0005829///cytosol+++GO:0016529///sarcoplasmic reticulum+++GO:0033018///sarcoplasmic reticulum lumen+++GO:0048471///perinuclear region of cytoplasm	GO:0003723///RNA binding+++GO:0005515///protein binding+++GO:0008083///growth factor activity+++GO:0008289///lipid binding+++GO:0120146///sulfatide binding	GO:0006986///response to unfolded protein+++GO:0007165///signal transduction+++GO:0031175///neuron projection development+++GO:0071542///dopaminergic neuron differentiation+++GO:1905897///regulation of response to endoplasmic reticulum stress	tissueType=Fetal kidney;cancerType=Normal;cellName=Natural killer T (NKT) cell		"Homo sapiens mesencephalic astrocyte derived neurotrophic factor (MANF), mRNA."			"R-HSA-109582///Hemostasis+++R-HSA-114608///Platelet degranulation +++R-HSA-76002///Platelet activation, signaling and aggregation+++R-HSA-76005///Response to elevated platelet cytosolic Ca2+"					[MANF_HUMAN|Reviewed]RecName: Full=Mesencephalic astrocyte-derived neurotrophic factor; AltName: Full=Arginine-rich protein; AltName: Full=Protein ARMET; Flags: Precursor;	chr3p21///Ensembl 103 genes in cytogenetic band chr3p21			"REACTOME_HEMOSTASIS///Hemostasis+++REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION///Platelet activation, signaling and aggregation+++REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2///Response to elevated platelet cytosolic Ca2+"				AAAYRNCTG_UNKNOWN///Genes having at least one occurence of the highly conserved motif M77 AAAYRNCTG in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++AACTTT_UNKNOWN///Genes having at least one occurence of the highly conserved motif M17 AACTTT in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++AREB6_01///Genes having at least one occurence of the transcription factor binding site V$AREB6_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++ARNT_01///Genes having at least one occurence of the transcription factor binding site V$ARNT_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++ARNT_02///Genes having at least one occurence of the transcription factor binding site V$ARNT_02 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++AR_Q6///Genes having at least one occurence of the transcription factor binding site V$AR_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++CACGTG_MYC_Q2///Genes having at least one occurence of the highly conserved motif M2 CACGTG sites. The motif matches transcription factor binding site V$MYC_Q2 (v7.4 TRANSFAC).+++CAGGTA_AREB6_01///Genes having at least one occurence of the highly conserved motif M76 CAGGTA sites. The motif matches transcription factor binding site V$AREB6_01 (v7.4 TRANSFAC).+++CMYB_01///Genes having at least one occurence of the transcription factor binding site V$CMYB_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++ER_Q6_02///Genes having at least one occurence of the transcription factor binding site V$ER_Q6_02 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++GCCATNTTG_YY1_Q6///Genes having at least one occurence of the highly conserved motif M10 GCCATNTTG sites. The motif matches transcription factor binding site V$YY1_Q6 (v7.4 TRANSFAC).+++MAX_01///Genes having at least one occurence of the transcription factor binding site V$MAX_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++MMEF2_Q6///Genes having at least one occurence of the transcription factor binding site V$MMEF2_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++MYB_Q5_01///Genes having at least one occurence of the transcription factor binding site V$MYB_Q5_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++MYCMAX_01///Genes having at least one occurence of the transcription factor binding site V$MYCMAX_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++MYCMAX_03///Genes having at least one occurence of the transcription factor binding site V$MYCMAX_03 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++OCT1_05///Genes having at least one occurence of the transcription factor binding site V$OCT1_05 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++OCT1_Q5_01///Genes having at least one occurence of the transcription factor binding site V$OCT1_Q5_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++OCT1_Q6///Genes having at least one occurence of the transcription factor binding site V$OCT1_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++OCT_C///Genes having at least one occurence of the transcription factor binding site V$OCT_C (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++PIT1_Q6///Genes having at least one occurence of the transcription factor binding site V$PIT1_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++PXR_Q2///Genes having at least one occurence of the transcription factor binding site V$PXR_Q2 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++RYAAAKNNNNNNTTGW_UNKNOWN///Genes having at least one occurence of the highly conserved motif M151 RYAAAKNNNNNNTTGW in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++T3R_Q6///Genes having at least one occurence of the transcription factor binding site V$T3R_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++TATAAA_TATA_01///Genes having at least one occurence of the highly conserved motif M51 TATAAA sites. The motif matches transcription factor binding site V$TATA_01 (v7.4 TRANSFAC).+++TGACCTY_ERR1_Q2///Genes having at least one occurence of the highly conserved motif M25 TGACCTY sites. The motif matches transcription factor binding site V$ERR1_Q2 (v7.4 TRANSFAC).+++TGGAAA_NFAT_Q4_01///Genes having at least one occurence of the highly conserved motif M55 TGGAAA sites. The motif matches transcription factor binding site V$NFAT_Q4_01 (v7.4 TRANSFAC).+++USF_01///Genes having at least one occurence of the transcription factor binding site V$USF_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++USF_02///Genes having at least one occurence of the transcription factor binding site V$USF_02 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++WGTTNNNNNAAA_UNKNOWN///Genes having at least one occurence of the highly conserved motif M155 WGTTNNNNNAAA in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++XBP1_01///Genes having at least one occurence of the transcription factor binding site V$XBP1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++YATTNATC_UNKNOWN///Genes having at least one occurence of the highly conserved motif M97 YATTNATC in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++YGTCCTTGR_UNKNOWN///Genes having at least one occurence of the highly conserved motif M109 YGTCCTTGR in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).	"ASH1L_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9NR48 (ASH1L) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++BARX2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9UMQ3 (BARX2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++CEBPZ_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q03701 (CEBPZ) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++E2F2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q14209 (E2F2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++FEV_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q99581 (FEV) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++FOXD2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O60548 (FOXD2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++FOXO4_TARGET_GENES///Genes containing one or more binding sites for UniProt:P98177 (FOXO4) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ID1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P41134 (ID1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++MAFG_TARGET_GENES///Genes containing one or more binding sites for UniProt:O15525 (MAFG) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++MYOCD_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8IZQ8 (MYOCD) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NAB2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q15742 (NAB2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NFE2L1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q14494 (NFE2L1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NFRKB_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6P4R8 (NFRKB) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++PHF2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O75151 (PHF2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SKIL_TARGET_GENES///Genes containing one or more binding sites for UniProt:P12757 (SKIL) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SRSF9_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q13242 (SRSF9) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++TERF2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q15554 (TERF2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++THAP1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9NVV9 (THAP1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++TP73_TARGET_GENES///Genes containing one or more binding sites for UniProt:O15350 (TP73) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++UBP1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9NZI7 (UBP1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF513_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8N8E2 (ZNF513) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF84_TARGET_GENES///Genes containing one or more binding sites for UniProt:P51523 (ZNF84) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."		MODULE_212///Catalytic activities / metabolism.+++MODULE_239///Genes in the cancer module 239.+++MODULE_54///Cell cycle (expression cluster).		"GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_14DY_UP///Genes up-regulated in peripheral blood mononuclear cell 14d vs 0d in unknown after exposure to YF-Vax/Stamaril , time point 14D+++GSE10147_IL3_VS_IL3_AND_HIVP17_STIM_PDC_DN///Genes down-regulated in plasmacytoid dendritic cells: IL3 [GeneID=3562] versus IL3 [GeneID=3562] and the HIV matrix protein p17.+++GSE12845_IGD_POS_BLOOD_VS_PRE_GC_TONSIL_BCELL_DN///Genes down-regulated in comparison of IgD+ B cells from peripheral blood versus CD19 pre-germinal center tonsil B cell+++GSE12845_IGD_POS_VS_NEG_BLOOD_BCELL_DN///Genes down-regulated in comparison of IgD+ B cells versus IgD- B cells.+++GSE13411_IGM_VS_SWITCHED_MEMORY_BCELL_UP///Genes up-regulated in comparison of IgM-memory B cells versus Ig isotype switched memory B cells.+++GSE13411_NAIVE_BCELL_VS_PLASMA_CELL_DN///Genes down-regulated in comparison of naive B cells versus plasma cells.+++GSE13411_PLASMA_CELL_VS_MEMORY_BCELL_UP///Genes up-regulated in comparison of plasma cells versus memory B cells.+++GSE13762_CTRL_VS_125_VITAMIND_DAY12_DC_DN///Genes down-regulated in dendritic cells (12 days): control versus 25-hydroxyvitamin D3 [PubChem=1593].+++GSE17186_NAIVE_VS_CD21LOW_TRANSITIONAL_BCELL_UP///Genes up-regulated in B lymphocytes: nave versus transitional CR2 [GeneID=1380] low.+++GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_UP///Genes up-regulated in comparison of control conventional dendritic cells (cDC) at 6 h versus cDCs infected with Newcastle disease virus (NDV) at 6 h.+++GSE18893_TCONV_VS_TREG_2H_TNF_STIM_UP///Genes up-regulated in lymphocytes treated with TNF [GeneID=7124] for 2h: T conv versus T reg cells.+++GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_AND_A3R_INH_PRETREAT_IN_MAST_CELL_UP///Genes up-regulated in HMC-1 (mast leukemia) cells: Cl-IB-MECA [PubChem=3035850] versus incubated with the peptide ALL1 followed by stimulation with T cell membranes.+++GSE20151_CTRL_VS_FUSOBACT_NUCLEATUM_NEUTROPHIL_UP///Genes up-regulated in comparison of contols neutrophils versus those infected with a bacterium (F. nucleatum).+++GSE20198_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_UP///Genes up-regulated in the activated CD4 [GeneID=920] T cells (48h): control versus IL-12.+++GSE22025_PROGESTERONE_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_DN///Genes down-regulated in CD4 [GeneID=920] T cells: progesterone [PubChem=5994] versus TGFB1 [GeneID=7040] and progesterone [PubChem=5994].+++GSE22589_HEALTHY_VS_HIV_AND_SIV_INFECTED_DC_UP///Genes up-regulated in monocyte-derived dendritic cells: control versus HIV and SIV infection.+++GSE22886_DAY0_VS_DAY1_MONOCYTE_IN_CULTURE_DN///Genes down-regulated in comparison of monocytes cultured for 0 days versus those cultured for 1 day.+++GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH2_DN///Genes down-regulated in comparison of naive CD4 [GeneID=920] T cells versus stimulated CD4 [GeneID=920] Th2 cells at 12 h.+++GSE22886_UNSTIM_VS_IL15_STIM_NKCELL_DN///Genes down-regulated in comparison of unstimulated NK cells versus those stimulated with IL2 [GeneID=3600] at 16 h.+++GSE2405_HEAT_KILLED_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_UP///Genes up-regulated in polymorphonuclear leukocytes (9h) infection by A. phagocytophilum: heat killed versus live bacteria.+++GSE2405_S_AUREUS_VS_UNTREATED_NEUTROPHIL_UP///Genes up-regulated in polymorphonuclear leukocytes (9h): S. aureus infection versus control.+++GSE24634_NAIVE_CD4_TCELL_VS_DAY5_IL4_CONV_TREG_DN///Genes down-regulated in comparison of naive T cells at day 0 versus CD25+ regulatory T cell (Treg) treated with IL4 [GeneID=3565] at day 5.+++GSE25085_FETAL_BM_VS_ADULT_BM_SP4_THYMIC_IMPLANT_DN///Genes down-regulated in thymic implants from fetal versus those from adult bone marrow.+++GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_6H_DN///Genes down-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 [GeneID=7040] and IL-12 (6h) versus untreated (6h).+++GSE2770_UNTREATED_VS_ACT_CD4_TCELL_2H_DN///Genes down-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 (2h).+++GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_48H_DN///Genes down-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 and then stimulated by IL-12 (48h).+++GSE29614_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_DN///Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from TIV influenza vaccinee pre-vaccination versus those from day 7 post-vaccination.+++GSE29614_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_DN///Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from TIV influenza vaccinee at day 3 post-vaccination versus those at day 7 post-vaccination.+++GSE29617_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_DN///Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from TIV influenza vaccinee pre-vaccination versus those at day 7 post-vaccination.+++GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_BCELL_UP///Genes up-regulated in comparison of B cells from LAIV influenza vaccinee pre-vaccination versus those at day 7 post-vaccination.+++GSE35685_CD34POS_CD10NEG_CD62LPOS_VS_CD34POS_CD10POS_BONE_MARROW_DN///Genes down-regulated in the bone marrow CD34+ [GeneID=947] cells: MME- SELL+[GeneID=4311;6402] versus MME+ [GeneID=4311].+++GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10NEG_CD62LPOS_BONE_MARROW_DN///Genes down-regulated in the bone marrow CD34+ [GeneID=947] cells: CD38- [GeneID=952] versus MME- SELL+ [GeneID=4311;6402].+++GSE360_CTRL_VS_M_TUBERCULOSIS_DC_DN///Genes down-regulated in comparison of dendritic cells (DC) versus DCs exposed to M.tuberculosis.+++GSE360_DC_VS_MAC_L_DONOVANI_DN///Genes down-regulated in comparison of dendritic cells (DC) exposed to L. donovani versus macrophages exposed to L. donovani.+++GSE360_DC_VS_MAC_T_GONDII_DN///Genes down-regulated in comparison of dendritic cells (DC) exposed to T. gondii versus macrophages exposed to T. gondii.+++GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_DN///Genes down-regulated in comparison of dendritic cells (DC) exposed to 50 worms/well B. malayi versus DC exposed to M. tuberculosis+++GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_MAC_UP///Genes up-regulated in comparison of macrophages exposed to L. donovani versus macrophages exposed to M. tuberculosis.+++GSE360_T_GONDII_VS_M_TUBERCULOSIS_DC_DN///Genes down-regulated in comparison of dendritic cells (DC) exposed to T. gondii versus DCs exposed to M. tuberculosis.+++GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_WITH_LPS_STIM_DN///Genes down-regulated in gamma delta T cells stimulated by LPS: Vd1 versus Vd2.+++GSE37416_CTRL_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_DN///Genes down-regulated in comparison of control polymorphonuclear leukocytes (PMN) at 48 h versus PMN treated with F. tularensis vaccine at 48 h.+++GSE3982_BASOPHIL_VS_CENT_MEMORY_CD4_TCELL_UP///Genes up-regulated in comparison of basophils versus central memory CD4 [GeneID=920] T cells.+++GSE3982_BASOPHIL_VS_NKCELL_UP///Genes up-regulated in comparison of basophils versus NK cells.+++GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH1_DN///Genes down-regulated in comparison of central memory CD4 [GeneID=920] T cells versus Th1 cells.+++GSE3982_EOSINOPHIL_VS_BCELL_DN///Genes down-regulated in comparison of eosinophils versus B cells.+++GSE3982_EOSINOPHIL_VS_MAC_DN///Genes down-regulated in comparison of eosinophils versus macrophages.+++GSE3982_EOSINOPHIL_VS_MAST_CELL_DN///Genes down-regulated in comparison of eosinophils versus mast cells.+++GSE3982_EOSINOPHIL_VS_NKCELL_DN///Genes down-regulated in comparison of eosinophils versus NK cells.+++GSE3982_EOSINOPHIL_VS_TH1_DN///Genes down-regulated in comparison of eosinophils versus Th1 cells.+++GSE3982_EOSINOPHIL_VS_TH2_DN///Genes down-regulated in comparison of eosinophils versus Th2 cells.+++GSE3982_MAC_VS_BASOPHIL_DN///Genes down-regulated in comparison of macrophages versus basophils.+++GSE3982_NEUTROPHIL_VS_TH1_DN///Genes down-regulated in comparison of neutrophils versus Th1 cells.+++GSE3982_NKCELL_VS_TH1_DN///Genes down-regulated in comparison of NK cells versus Th1 cells.+++GSE3982_NKCELL_VS_TH2_DN///Genes down-regulated in comparison of NK cells versus Th2 cells.+++GSE5542_IFNA_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_UP///Genes up-regulated in epithelial cells (24h): interferon alpha versus interferon alpha and IFNG [GeneID=3458].+++GSE5542_IFNA_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN///Genes down-regulated in epithelial cells (6h): interferon alpha versus interferon alpha and IFNG [GeneID=3458].+++GSE9239_CTRL_VS_TNF_INHIBITOR_TREATED_DC_UP///Genes up-regulated in monocyte-derived dendritic cells: control versus TNF [GeneID=7124] inhibitor etanercept.+++NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP///Genes up-regulated in peripheral blood mononuclear cell 7d vs 0d in adults (18-50) after exposure to Fluarix/Fluvirin , time point 7D. Comment: Supplementary Table 1b: All the differentially expressed genes identified in PBMCs of TIV vaccinees.+++NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_POSITIVE///Genes positively correlated with HAI response at 28d in peripheral blood mononuclear cell in adults (18-50) after exposure to Fluarix/Fluvirin , time point 7D. Comment: Supplementary Table 5: All genes whose expression (d3/d0 or d7/d0) correlates to the fold increase in HAI titers (d28/d0).+++NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_UP///Genes up-regulated in peripheral blood mononuclear cell 3d vs 0d in adults (18-50) after exposure to FluMist , time point 3D. Comment: Supplementary Table 1b: All the differentially expressed genes identified in PBMCs of TIV vaccinees.+++NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP///Genes up-regulated in plasmacytoid dendritic cell 7d vs 0d in young adults (18-50) after exposure to FluMist , time point 7D+++SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_RESPONDERS_VS_NONRESPONDERS_7DY_UP///Genes up-regulated in peripheral blood mononuclear cell responders vs nonresponders in adults (18-64) after exposure to Pandemrix , time point 7D+++THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_UP///Genes up-regulated in peripheral blood mononuclear cell 7d vs 0d in young adults (21-30) (responders) after exposure to Inactivated influenza vaccine , time point 7D"		NM_006010	MANF				
P54727	sp|P54727|RD23B_HUMAN		RAD23B		UV excision repair protein RAD23 homolog B OS=Homo sapiens OX=9606 GN=RAD23B PE=1 SV=1	5887	NM_002874	NP_002865	ENST00000358015	K10839			MQVTLKTLQQQTFKIDIDPEETVKALKEKIESEKGKDAFPVAGQKLIYAGKILNDDTALKEYKIDEKNFVVVMVTKPKAVSTPAPATTQQSAPASTTAVTSSTTTTVAQAPTPVPALAPTSTPASITPASATASSEPAPASAAKQEKPAEKPAETPVATSPTATDSTSGDSSRSNLFEDATSALVTGQSYENMVTEIMSMGYEREQVIAALRASFNNPDRAVEYLLMGIPGDRESQAVVDPPQAASTGAPQSSAVAAAAATTTATTTTTSSGGHPLEFLRNQPQFQQMRQIIQQNPSLLPALLQQIGRENPQLLQQISQHQEHFIQMLNEPVQEAGGQGGGGGGGSGGIAEAGSGHMNYIQVTPQEKEAIERLKALGFPEGLVIQAYFACEKNENLAANFLLQQNFDED	0.4195539	-1.253071844	0.04038754						5.5791812			2.6939441		2.9074048	2.6803698										2.1977473	5.0134391					6.215924	4.8419004	5.16617	3.8138973			4.2951308	2.7513865		4.1757309		4.559441			4.4077501		3.87204383	03420///Nucleotide excision repair+++04141///Protein processing in endoplasmic reticulum				GO:0000502///proteasome complex+++GO:0005634///nucleus+++GO:0005654///nucleoplasm+++GO:0005737///cytoplasm+++GO:0005829///cytosol+++GO:0071942///XPC complex	GO:0000976///transcription regulatory region sequence-specific DNA binding+++GO:0000978///RNA polymerase II proximal promoter sequence-specific DNA binding+++GO:0003684///damaged DNA binding+++GO:0003697///single-stranded DNA binding+++GO:0005515///protein binding+++GO:0031593///polyubiquitin modification-dependent protein binding+++GO:0043130///ubiquitin binding+++GO:0070628///proteasome binding	"GO:0000715///nucleotide-excision repair, DNA damage recognition+++GO:0000717///nucleotide-excision repair, DNA duplex unwinding+++GO:0006281///DNA repair+++GO:0006289///nucleotide-excision repair+++GO:0006294///nucleotide-excision repair, preincision complex assembly+++GO:0006457///protein folding+++GO:0006974///cellular response to DNA damage stimulus+++GO:0007283///spermatogenesis+++GO:0016579///protein deubiquitination+++GO:0032434///regulation of proteasomal ubiquitin-dependent protein catabolic process+++GO:0043161///proteasome-mediated ubiquitin-dependent protein catabolic process+++GO:0048568///embryonic organ development+++GO:0070911///global genome nucleotide-excision repair+++GO:0098761///cellular response to interleukin-7"	tissueType=Fetal kidney;cancerType=Normal;cellName=Natural killer T (NKT) cell		"Homo sapiens RAD23 homolog B, nucleotide excision repair protein (RAD23B), transcript variant 1, mRNA."		PF00240///Ubiquitin family+++PF00627///UBA/TS-N domain+++PF09280///XPC-binding domain	R-HSA-392499///Metabolism of proteins+++R-HSA-446203///Asparagine N-linked glycosylation+++R-HSA-532668///N-glycan trimming in the ER and Calnexin/Calreticulin cycle+++R-HSA-5688426///Deubiquitination+++R-HSA-5689877///Josephin domain DUBs+++R-HSA-5696394///DNA Damage Recognition in GG-NER+++R-HSA-5696395///Formation of Incision Complex in GG-NER+++R-HSA-5696398///Nucleotide Excision Repair+++R-HSA-5696399///Global Genome Nucleotide Excision Repair (GG-NER)+++R-HSA-597592///Post-translational protein modification+++R-HSA-73894///DNA Repair		KOG0011///damaged DNA binding		"IPR000626///Ubiquitin-like domain+++IPR004806///UV excision repair protein Rad23+++IPR006636///Heat shock chaperonin-binding+++IPR009060///UBA-like superfamily+++IPR015360///XPC-binding domain+++IPR015940///Ubiquitin-associated domain+++IPR029071///Ubiquitin-like domain superfamily+++IPR036353///XPC-binding domain superfamily+++IPR041811///RAD23A/RAD23B, UBA1 domain"	[RD23B_HUMAN|Reviewed]RecName: Full=UV excision repair protein RAD23 homolog B; Short=HR23B; Short=hHR23B; AltName: Full=XP-C repair-complementing complex 58 kDa protein; Short=p58;+++[L8EA19_HUMAN|Unreviewed]SubName: Full=Alternative protein RAD23B {ECO:0000313|EMBL:CCQ43193.1};	chr9q31///Ensembl 103 genes in cytogenetic band chr9q31		KEGG_NUCLEOTIDE_EXCISION_REPAIR///Nucleotide excision repair	REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION///Asparagine N-linked glycosylation+++REACTOME_DEUBIQUITINATION///Deubiquitination+++REACTOME_DNA_DAMAGE_RECOGNITION_IN_GG_NER///DNA Damage Recognition in GG-NER+++REACTOME_DNA_REPAIR///DNA Repair+++REACTOME_FORMATION_OF_INCISION_COMPLEX_IN_GG_NER///Formation of Incision Complex in GG-NER+++REACTOME_GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER///Global Genome Nucleotide Excision Repair (GG-NER)+++REACTOME_JOSEPHIN_DOMAIN_DUBS///Josephin domain DUBs+++REACTOME_N_GLYCAN_TRIMMING_IN_THE_ER_AND_CALNEXIN_CALRETICULIN_CYCLE///N-glycan trimming in the ER and Calnexin/Calreticulin cycle+++REACTOME_NUCLEOTIDE_EXCISION_REPAIR///Nucleotide Excision Repair+++REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION///Post-translational protein modification		"AATGTGA_MIR23A_MIR23B///Genes having at least one occurence of the motif AATGTGA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-23a and hsa-miR-23b (v7.1 miRBase).+++ACACTGG_MIR199A_MIR199B///Genes having at least one occurence of the motif ACACTGG in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-199a and hsa-miR-199b (v7.1 miRBase).+++AGCACTT_MIR93_MIR302A_MIR302B_MIR302C_MIR302D_MIR372_MIR373_MIR520E_MIR520A_MIR526B_MIR520B_MIR520C_MIR520D///Genes having at least one occurence of the motif AGCACTT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-93, hsa-miR-302a, hsa-miR-302b, hsa-miR-302c, hsa-miR-302d, hsa-miR-372, hsa-miR-373, hsa-miR-520e, hsa-miR-520a, hsa-miR-526b*, hsa-miR-520b, hsa-miR-520c and hsa-miR-520d (v7.1 miRBase).+++AGGGCAG_MIR18A///Genes having at least one occurence of the motif AGGGCAG in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-18a* (v7.1 miRBase).+++CAGTGTT_MIR141_MIR200A///Genes having at least one occurence of the motif CAGTGTT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-141 and hsa-miR-200a (v7.1 miRBase).+++CCACACA_MIR147///Genes having at least one occurence of the motif CCACACA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-147 (v7.1 miRBase).+++TACAATC_MIR508///Genes having at least one occurence of the motif TACAATC in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-508 (v7.1 miRBase).+++TCTGATA_MIR361///Genes having at least one occurence of the motif TCTGATA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-361 (v7.1 miRBase).+++TGCTGCT_MIR15A_MIR16_MIR15B_MIR195_MIR424_MIR497///Genes having at least one occurence of the motif TGCTGCT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-15a, hsa-miR-16, hsa-miR-15b, hsa-miR-195, hsa-miR-424 and hsa-miR-497 (v7.1 miRBase).+++TGTTTAC_MIR30A5P_MIR30C_MIR30D_MIR30B_MIR30E5P///Genes having at least one occurence of the motif TGTTTAC in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-30a-5p, hsa-miR-30c, hsa-miR-30d, hsa-miR-30b and hsa-miR-30e-5p (v7.1 miRBase).+++TTGGGAG_MIR150///Genes having at least one occurence of the motif TTGGGAG in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-150 (v7.1 miRBase)."	"MIR10523_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-10523-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1225_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1225-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1233_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1233-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1287_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1287-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR150_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-150-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR15A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-15a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR15B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-15b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR16_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-16-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1825///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1825 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR182_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-182-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR195_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-195-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR199A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-199a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR199B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-199b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR2115_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-2115-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR30A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-30a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR30B_5P_MIR30C_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-30b-5p, hsa-miR-30c-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR30D_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-30d-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR30E_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-30e-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR335_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-335-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3658///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3658 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR372_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-372-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR410_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-410-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR424_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-424-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4659A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4659a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4659B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4659b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4686///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4686 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4704_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4704-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4712_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4712-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4729///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4729 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4752///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4752 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4776_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4776-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4782_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4782-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR494_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-494-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR497_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-497-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR508_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-508-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR510_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-510-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AO_5P_MIR548AX///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548ao-5p, hsa-miR-548ax in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5586_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5586-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5706///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5706 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6071///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6071 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6737_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6737-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6752_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6752-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6838_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6838-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7157_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7157-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR744_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-744-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR770_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-770-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7856_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7856-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7978///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7978 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR874_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-874-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR944///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-944 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR96_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-96-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets)."	AP1FJ_Q2///Genes having at least one occurence of the transcription factor binding site V$AP1FJ_Q2 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++AP1_Q2///Genes having at least one occurence of the transcription factor binding site V$AP1_Q2 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++AP1_Q4///Genes having at least one occurence of the transcription factor binding site V$AP1_Q4 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++CACCCBINDINGFACTOR_Q6///Genes having at least one occurence of the transcription factor binding site V$CACCCBINDINGFACTOR_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++CEBPB_02///Genes having at least one occurence of the transcription factor binding site V$CEBPB_02 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++CEBP_C///Genes having at least one occurence of the transcription factor binding site V$CEBP_C (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++GGGTGGRR_PAX4_03///Genes having at least one occurence of the highly conserved motif M56 GGGTGGRR sites. The motif matches transcription factor binding site V$PAX4_03 (v7.4 TRANSFAC).+++PPARA_02///Genes having at least one occurence of the transcription factor binding site V$PPARA_02 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++RCGCANGCGY_NRF1_Q6///Genes having at least one occurence of the highly conserved motif M1 RCGCANGCGY sites. The motif matches transcription factor binding site V$NRF1_Q6 (v7.4 TRANSFAC).+++RREB1_01///Genes having at least one occurence of the transcription factor binding site V$RREB1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.	"BPTF_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q12830 (BPTF) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++EPC1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9H2F5 (EPC1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++FOXH1_TARGET_GENES///Genes containing one or more binding sites for UniProt:O75593 (FOXH1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HOXA1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P49639 (HOXA1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HOXA7_TARGET_GENES///Genes containing one or more binding sites for UniProt:P31268 (HOXA7) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HOXC6_TARGET_GENES///Genes containing one or more binding sites for UniProt:P09630 (HOXC6) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++IRF9_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q00978 (IRF9) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++JDP2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8WYK2 (JDP2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++KAT5_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q92993 (KAT5) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++KDM7A_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6ZMT4 (KDM7A) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++KMT2D_TARGET_GENES///Genes containing one or more binding sites for UniProt:O14686 (KMT2D) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NAB2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q15742 (NAB2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NFE2L1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q14494 (NFE2L1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NFRKB_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6P4R8 (NFRKB) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++PAF1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8N7H5 (PAF1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SFMBT1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9UHJ3 (SFMBT1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SUPT16H_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9Y5B9 (SUPT16H) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZBTB7B_TARGET_GENES///Genes containing one or more binding sites for UniProt:O15156 (ZBTB7B) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF282_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9UDV7 (ZNF282) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF563_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8TA94 (ZNF563) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF711_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9Y462 (ZNF711) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZSCAN29_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8IWY8 (ZSCAN29) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."	MORF_ATOX1///Neighborhood of ATOX1+++MORF_BAG5///Neighborhood of BAG5+++MORF_CSNK2B///Neighborhood of CSNK2B+++MORF_DAP///Neighborhood of DAP+++MORF_GSPT1///Neighborhood of GSPT1+++MORF_HAT1///Neighborhood of HAT1+++MORF_MBD4///Neighborhood of MBD4+++MORF_MTA1///Neighborhood of MTA1+++MORF_PPP1CA///Neighborhood of PPP1CA+++MORF_PPP2R4///Neighborhood of PPP2R4+++MORF_PPP6C///Neighborhood of PPP6C+++MORF_PRDX3///Neighborhood of PRDX3+++MORF_PRKAR1A///Neighborhood of PRKAR1A+++MORF_PSMC1///Neighborhood of PSMC1+++MORF_PSMC2///Neighborhood of PSMC2+++MORF_RAB1A///Neighborhood of RAB1A+++MORF_RAB5A///Neighborhood of RAB5A+++MORF_RAC1///Neighborhood of RAC1+++MORF_RAD21///Neighborhood of RAD21+++MORF_RAD23B///Neighborhood of RAD23B+++MORF_RPA1///Neighborhood of RPA1+++MORF_SKP1A///Neighborhood of SKP1A+++MORF_SOD1///Neighborhood of SOD1+++MORF_SP3///Neighborhood of SP3+++MORF_UNG///Neighborhood of UNG+++MORF_XPC///Neighborhood of XPC			"GSE11864_CSF1_PAM3CYS_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP///Genes up-regulated in comparison of macrophages cultured with M-CSF [GeneID=1435] and Pam3Cyc versus macrophages cultured with M-CSF [GeneID=1435], IFNG [GeneID=3458] and Pam3Cyc.+++GSE11864_CSF1_VS_CSF1_PAM3CYS_IN_MAC_DN///Genes down-regulated in comparison of macrophages cultured with M-CSF[GeneID=1435] versus macrophages cultured with M-CSF [GeneID=1435] and Pam3Cyc.+++GSE13485_CTRL_VS_DAY21_YF17D_VACCINE_PBMC_UP///Genes up-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) versus PBMC 21 days after stimulation with YF17D vaccine.+++GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP///Genes up-regulated in comparison of CD4 [GeneID=920] thymocytes versus naive CD4 [GeneID=920] T cells from adult blood.+++GSE1460_CD4_THYMOCYTE_VS_THYMIC_STROMAL_CELL_DN///Genes down-regulated in comparison of CD4 [GeneID=920] thymocytes versus thymic stromal cells.+++GSE1460_NAIVE_CD4_TCELL_ADULT_BLOOD_VS_THYMIC_STROMAL_CELL_DN///Genes down-regulated in naive CD4 [GeneID=920] T cells from adult blood versus thymic stromal cells.+++GSE1460_NAIVE_CD4_TCELL_CORD_BLOOD_VS_THYMIC_STROMAL_CELL_DN///Genes down-regulated in naive CD4 [GeneID=920] T cells from cord blood versus thymic stromal cells.+++GSE15271_CXCR4_POS_VS_NEG_GC_BCELL_UP///Genes up-regulated in centroblasts versus centrocytes.+++GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_IL4_TREATED_MACROPHAGE_DN///Genes down-regulated in monocytes (12h) versus macrophages (12h) treated with IL4 [GeneID=3565] and rosiglitazone [PubChem=77999].+++GSE16385_UNTREATED_VS_12H_IFNG_TNF_TREATED_MACROPHAGE_DN///Genes down-regulated in macrophages (12h): control versus IFNG and TNF [GeneID=3458;7124].+++GSE17301_CTRL_VS_48H_ACD3_ACD28_STIM_CD8_TCELL_DN///Genes down-regulated in CD8 T lymphocytes: control versus activated by anti-CD3 and anti-CD28.+++GSE1740_MCSF_VS_MCSF_AND_IFNG_DAY2_DERIVED_MACROPHAGE_DN///Genes down-regulated in monocyte-derived macrophages: no priming versus primed by IFNG [GeneID=3458].+++GSE18893_TCONV_VS_TREG_2H_CULTURE_DN///Genes down-regulated in lymphocytes treated with medium for 2h: T conv versus T reg cells.+++GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_3H_IFNG_STIM_UP///Genes up-regulated in macrophages stimulated by IFNG [GeneID=3458] for 3h: control versus primed by IFNG [GeneID=3458].+++GSE22886_NAIVE_CD4_TCELL_VS_NKCELL_DN///Genes down-regulated in comparison of naive CD4 [GeneID=920] T cells versus unstimulated NK cells.+++GSE22886_NAIVE_CD8_TCELL_VS_MEMORY_TCELL_DN///Genes down-regulated in comparison of naive CD8 T cells versus naive CD4 [GeneID=920] CD8 T cells.+++GSE22886_NAIVE_CD8_TCELL_VS_NKCELL_DN///Genes down-regulated in comparison of naive CD8 T cells versus unstimulated NK cells.+++GSE22886_NAIVE_TCELL_VS_NKCELL_DN///Genes down-regulated in comparison of naive CD4 [GeneID=920] CD8 T cells versus unstimulated NK cells.+++GSE22886_NAIVE_VS_MEMORY_TCELL_DN///Genes down-regulated in comparison of naive CD4 [GeneID=920] CD8 T cells versus unstimulated memory CD4 [GeneID=920] CD8 T cells.+++GSE29617_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_2008_UP///Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from TIV influenza vaccinee pre-vaccination versus those at day 3 post-vaccination.+++GSE29618_PDC_VS_MDC_DN///Genes down-regulated in comparison of plasmacytoid dendritic cells (DC) versus myeloid DCs.+++GSE360_DC_VS_MAC_B_MALAYI_LOW_DOSE_UP///Genes up-regulated in comparison of dendritic cells (DC) exposed to 5 worm/well B. malayi versus macrophages exposed to 5 worms/well B. malayi.+++GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_16H_TSST_ACT_DN///Genes down-regulated in comparison of memory CD4 [GeneID=920] T cells from young donors treated with TSST at 16 h versus those from old donors treated with TSST at 16 h.+++GSE3982_BCELL_VS_NKCELL_UP///Genes up-regulated in comparison of B cells versus NK cells.+++GSE3982_BCELL_VS_TH1_DN///Genes down-regulated in comparison of B cells versus Th1 cells.+++GSE3982_BCELL_VS_TH2_DN///Genes down-regulated in comparison of B cells versus Th2 cells.+++GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH1_DN///Genes down-regulated in comparison of central memory CD4 [GeneID=920] T cells versus Th1 cells.+++GSE3982_MAST_CELL_VS_BCELL_UP///Genes up-regulated in comparison of mast cells versus B cells.+++GSE3982_NKCELL_VS_TH1_DN///Genes down-regulated in comparison of NK cells versus Th1 cells.+++GSE7460_FOXP3_MUT_VS_WT_ACT_WITH_TGFB_TCONV_UP///Genes up-regulated in comparsion of sfActCD4TGF versus ActCD4TGF (see Fig. 1 in the paper for details).+++HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_POSITIVE///Genes positively correlated with memory B cell response at 28d in peripheral blood mononuclear cell in seniors (50-74) after exposure to Fluarix , time point 28D+++NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN///Genes down-regulated in peripheral blood mononuclear cell 3d vs 0d in adults (18-50) after exposure to Fluarix/Fluvirin , time point 3D. Comment: Supplementary Table 1a: All the differentially expressed genes identified in PBMCs of TIV vaccinees.+++NAKAYA_PBMC_FLUMIST_AGE_18_50YO_7DY_DN///Genes down-regulated in peripheral blood mononuclear cell 7d vs 0d in adults (18-50) after exposure to FluMist , time point 7D. Comment: Supplementary Table 1a: All the differentially expressed genes identified in PBMCs of TIV vaccinees.+++NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN///Genes down-regulated in plasmacytoid dendritic cell 7d vs 0d in young adults (18-50) after exposure to FluMist , time point 7D"	"HALLMARK_G2M_CHECKPOINT///Genes involved in the G2/M checkpoint, as in progression through the cell division cycle.+++HALLMARK_MYC_TARGETS_V1///A subgroup of genes regulated by MYC - version 1 (v1)."	NM_002874	RAD23B				
P50552	sp|P50552|VASP_HUMAN		VASP		Vasodilator-stimulated phosphoprotein OS=Homo sapiens OX=9606 GN=VASP PE=1 SV=3 >tr|A0A024R0V4|A0A024R0V4_HUMAN Vasodilator-stimulated phosphoprotein isoform 1 OS=Homo sapiens OX=9606 GN=VASP PE=2 SV=1	7408	NM_003370	NP_003361	ENST00000245932	K06274			MSETVICSSRATVMLYDDGNKRWLPAGTGPQAFSRVQIYHNPTANSFRVVGRKMQPDQQVVINCAIVRGVKYNQATPNFHQWRDARQVWGLNFGSKEDAAQFAAGMASALEALEGGGPPPPPALPTWSVPNGPSPEEVEQQKRQQPGPSEHIERRVSNAGGPPAPPAGGPPPPPGPPPPPGPPPPPGLPPSGVPAAAHGAGGGPPPAPPLPAAQGPGGGGAGAPGLAAAIAGAKLRKVSKQEEASGGPTAPKAESGRSGGGGLMEEMNAMLARRRKATQVGEKTPKDESANQEEPEARVPAQSESVRRPWEKNSTTLPRMKSSSSVTTSETQPCTPSSSDYSDLQRVKQELLEEVKKELQKVKEEIIEAFVQELRKRGSP	0.2598322	-1.94434771	0.004471215		7.3457858	4.6078647	4.9801861	5.4119448	9.6416481	5.382331912	7.0220821	9.4387421	11.1056415	9.5515918	9.8026636	6.45947549	8.6933313	9.1448548	10.0771943	3.9723475	8.2152302			9.4550145	10.0923851	6.2938561				4.495174	11.713568	11.7509775	12.113145	11.6126369	10.058011	9.6833533	10.3293385	10.1144329	8.6779351	11.2857941	10.2775768	10.899396	6.6287503	10.87101141	11.0684248	9.2694391	10.2001009	04015///Rap1 signaling pathway+++04022///cGMP-PKG signaling pathway+++04510///Focal adhesion+++04530///Tight junction+++04611///Platelet activation+++04666///Fc gamma R-mediated phagocytosis+++04670///Leukocyte transendothelial migration				GO:0005737///cytoplasm+++GO:0005829///cytosol+++GO:0005856///cytoskeleton+++GO:0005886///plasma membrane+++GO:0005923///bicellular tight junction+++GO:0005925///focal adhesion+++GO:0015629///actin cytoskeleton+++GO:0016020///membrane+++GO:0030027///lamellipodium+++GO:0030054///cell junction+++GO:0030175///filopodium+++GO:0031258///lamellipodium membrane+++GO:0031527///filopodium membrane+++GO:0042995///cell projection+++GO:0070062///extracellular exosome	GO:0003779///actin binding+++GO:0005515///protein binding+++GO:0005522///profilin binding+++GO:0017124///SH3 domain binding+++GO:0045296///cadherin binding	GO:0001843///neural tube closure+++GO:0007411///axon guidance+++GO:0008154///actin polymerization or depolymerization+++GO:0030036///actin cytoskeleton organization+++GO:0030838///positive regulation of actin filament polymerization+++GO:0034329///cell junction assembly+++GO:0051289///protein homotetramerization	tissueType=Blood;cancerType=Normal;cellName=CD1C-CD141- dendritic cell+++tissueType=Fetal kidney;cancerType=Normal;cellName=Natural killer T (NKT) cell+++tissueType=Fetal kidney;cancerType=Normal;cellName=Monocyte		"Homo sapiens vasodilator stimulated phosphoprotein (VASP), mRNA."		PF00568///WH1 domain+++PF08776///VASP tetramerisation domain	R-HSA-1266738///Developmental Biology+++R-HSA-1280218///Adaptive Immune System+++R-HSA-1500931///Cell-Cell communication+++R-HSA-168256///Immune System+++R-HSA-202403///TCR signaling+++R-HSA-202433///Generation of second messenger molecules+++R-HSA-376176///Signaling by ROBO receptors+++R-HSA-422475///Axon guidance+++R-HSA-446353///Cell-extracellular matrix interactions+++R-HSA-446728///Cell junction organization+++R-HSA-9675108///Nervous system development		KOG4590///profilin binding		IPR000697///WH1/EVH1 domain+++IPR011993///PH-like domain superfamily+++IPR014885///VASP tetramerisation+++IPR017354///Vasodilator-stimulated phosphoprotein/ENA/VASP-like+++IPR034367///Vasodilator-stimulated phosphoprotein+++IPR038023///VASP tetramerisation domain superfamily	[VASP_HUMAN|Reviewed]RecName: Full=Vasodilator-stimulated phosphoprotein; Short=VASP;+++[A0A0S2Z4H6_HUMAN|Unreviewed]SubName: Full=Vasodilator-stimulated phosphoprotein isoform 5 {ECO:0000313|EMBL:ALQ33843.1};+++[A0A0S2Z4I7_HUMAN|Unreviewed]SubName: Full=Vasodilator-stimulated phosphoprotein isoform 4 {ECO:0000313|EMBL:ALQ33842.1}; Flags: Fragment;+++[A0A0S2Z4I9_HUMAN|Unreviewed]SubName: Full=Vasodilator-stimulated phosphoprotein isoform 3 {ECO:0000313|EMBL:ALQ33841.1}; Flags: Fragment;+++[A0A0S2Z4N8_HUMAN|Unreviewed]SubName: Full=Vasodilator-stimulated phosphoprotein isoform 2 {ECO:0000313|EMBL:ALQ33840.1}; Flags: Fragment;	chr19q13///Ensembl 103 genes in cytogenetic band chr19q13		KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS///Fc gamma R-mediated phagocytosis+++KEGG_FOCAL_ADHESION///Focal adhesion+++KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION///Leukocyte transendothelial migration	REACTOME_ADAPTIVE_IMMUNE_SYSTEM///Adaptive Immune System+++REACTOME_CELL_CELL_COMMUNICATION///Cell-Cell communication+++REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS///Cell-extracellular matrix interactions+++REACTOME_CELL_JUNCTION_ORGANIZATION///Cell junction organization+++REACTOME_DEVELOPMENTAL_BIOLOGY///Developmental Biology+++REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES///Generation of second messenger molecules+++REACTOME_NERVOUS_SYSTEM_DEVELOPMENT///Nervous system development+++REACTOME_SIGNALING_BY_ROBO_RECEPTORS///Signaling by ROBO receptors+++REACTOME_TCR_SIGNALING///TCR signaling	SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES///Genes related to regulation of the actin cytoskeleton	"ACAACCT_MIR453///Genes having at least one occurence of the motif ACAACCT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-453 (v7.1 miRBase).+++AGGAAGC_MIR5163P///Genes having at least one occurence of the motif AGGAAGC in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-516-3p (v7.1 miRBase).+++ATGCTGG_MIR338///Genes having at least one occurence of the motif ATGCTGG in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-338 (v7.1 miRBase).+++TTGCCAA_MIR182///Genes having at least one occurence of the motif TTGCCAA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-182 (v7.1 miRBase)."	"MIR106B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-106b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1207_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1207-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1238_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1238-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1277_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1277-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1323///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1323 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1913///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1913 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR20A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-20a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR2355_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-2355-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3059_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3059-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3609///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3609 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3691_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3691-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3910///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3910 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4291///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4291 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4455///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4455 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4763_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4763-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4796_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4796-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AA_MIR548AP_3P_MIR548T_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548aa, hsa-miR-548ap-3p, hsa-miR-548t-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AE_3P_MIR548AQ_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548ae-3p, hsa-miR-548aq-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AH_3P_MIR548AM_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548ah-3p, hsa-miR-548am-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AH_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548ah-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AJ_3P_MIR548X_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548aj-3p, hsa-miR-548x-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AR_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548ar-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AZ_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548az-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548BC///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548bc in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548E_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548e-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548F_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548f-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548J_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548j-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548O_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548o-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6126///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6126 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR670_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-670-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6881_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6881-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets)."	AP1_01///Genes having at least one occurence of the transcription factor binding site V$AP1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++AP1_C///Genes having at least one occurence of the transcription factor binding site V$AP1_C (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++AP1_Q2_01///Genes having at least one occurence of the transcription factor binding site V$AP1_Q2_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++AP1_Q4_01///Genes having at least one occurence of the transcription factor binding site V$AP1_Q4_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++AP1_Q6///Genes having at least one occurence of the transcription factor binding site V$AP1_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++ATGGYGGA_UNKNOWN///Genes having at least one occurence of the highly conserved motif M102 ATGGYGGA in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++BACH2_01///Genes having at least one occurence of the transcription factor binding site V$BACH2_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++CCCNNGGGAR_OLF1_01///Genes having at least one occurence of the highly conserved motif M130 CCCNNGGGAR sites. The motif matches transcription factor binding site V$OLF1_01 (v7.4 TRANSFAC).+++CRX_Q4///Genes having at least one occurence of the transcription factor binding site V$CRX_Q4 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++CTTTAAR_UNKNOWN///Genes having at least one occurence of the highly conserved motif M29 CTTTAAR in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++ELK1_01///Genes having at least one occurence of the transcription factor binding site V$ELK1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++ERR1_Q2///Genes having at least one occurence of the transcription factor binding site V$ERR1_Q2 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++ETS2_B///Genes having at least one occurence of the transcription factor binding site V$ETS2_B (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++GATA2_01///Genes having at least one occurence of the transcription factor binding site V$GATA2_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++GCCNNNWTAAR_UNKNOWN///Genes having at least one occurence of the highly conserved motif M95 GCCNNNWTAAR in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++LFA1_Q6///Genes having at least one occurence of the transcription factor binding site V$LFA1_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++MAZR_01///Genes having at least one occurence of the transcription factor binding site V$MAZR_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++MCAATNNNNNGCG_UNKNOWN///Genes having at least one occurence of the highly conserved motif M110 MCAATNNNNNGCG in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++MGGAAGTG_GABP_B///Genes having at least one occurence of the highly conserved motif M11 MGGAAGTG sites. The motif matches transcription factor binding site V$GABP_B (v7.4 TRANSFAC).+++MZF1_02///Genes having at least one occurence of the transcription factor binding site V$MZF1_02 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++NFE2_01///Genes having at least one occurence of the transcription factor binding site V$NFE2_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++RGAGGAARY_PU1_Q6///Genes having at least one occurence of the highly conserved motif M50 RGAGGAARY sites. The motif matches transcription factor binding site V$PU1_Q6 (v7.4 TRANSFAC).+++RORA1_01///Genes having at least one occurence of the transcription factor binding site V$RORA1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++RYTTCCTG_ETS2_B///Genes having at least one occurence of the highly conserved motif M16 RYTTCCTG sites. The motif matches transcription factor binding site V$ETS2_B (v7.4 TRANSFAC).+++SF1_Q6///Genes having at least one occurence of the transcription factor binding site V$SF1_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++SP1_Q6_01///Genes having at least one occurence of the transcription factor binding site V$SP1_Q6_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++SRF_Q4///Genes having at least one occurence of the transcription factor binding site V$SRF_Q4 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++SRF_Q5_01///Genes having at least one occurence of the transcription factor binding site V$SRF_Q5_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++STAT6_02///Genes having at least one occurence of the transcription factor binding site V$STAT6_02 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++TFIIA_Q6///Genes having at least one occurence of the transcription factor binding site V$TFIIA_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++TGACATY_UNKNOWN///Genes having at least one occurence of the highly conserved motif M42 TGACATY in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++TGACCTTG_SF1_Q6///Genes having at least one occurence of the highly conserved motif M38 TGACCTTG sites. The motif matches transcription factor binding site V$SF1_Q6 (v7.4 TRANSFAC).+++TGACCTY_ERR1_Q2///Genes having at least one occurence of the highly conserved motif M25 TGACCTY sites. The motif matches transcription factor binding site V$ERR1_Q2 (v7.4 TRANSFAC).+++TGANNYRGCA_TCF11MAFG_01///Genes having at least one occurence of the highly conserved motif M67 TGANNYRGCA sites. The motif matches transcription factor binding site V$TCF11MAFG_01 (v7.4 TRANSFAC).+++TGANTCA_AP1_C///Genes having at least one occurence of the highly conserved motif M7 TGANTCA sites. The motif matches transcription factor binding site V$AP1_C (v7.4 TRANSFAC).+++TGASTMAGC_NFE2_01///Genes having at least one occurence of the highly conserved motif M32 TGASTMAGC sites. The motif matches transcription factor binding site V$NFE2_01 (v7.4 TRANSFAC).+++WWTAAGGC_UNKNOWN///Genes having at least one occurence of the highly conserved motif M127 WWTAAGGC in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++YKACATTT_UNKNOWN///Genes having at least one occurence of the highly conserved motif M145 YKACATTT in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++YY1_02///Genes having at least one occurence of the transcription factor binding site V$YY1_02 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.	"AEBP2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6ZN18 (AEBP2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++BDP1_TARGET_GENES///Genes containing one or more binding sites for UniProt:A6H8Y1 (BDP1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++CHAF1B_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q13112 (CHAF1B) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++CREB3_TARGET_GENES///Genes containing one or more binding sites for UniProt:O43889 (CREB3) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++DLX4_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q92988 (DLX4) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++DLX6_TARGET_GENES///Genes containing one or more binding sites for UniProt:P56179 (DLX6) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++E2F2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q14209 (E2F2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ELF2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q15723 (ELF2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++LHX2_TARGET_GENES///Genes containing one or more binding sites for UniProt:P50458 (LHX2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++MZF1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P28698 (MZF1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NAB2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q15742 (NAB2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++PCGF1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9BSM1 (PCGF1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++RAG1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P15918 (RAG1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SNIP1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8TAD8 (SNIP1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SUPT16H_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9Y5B9 (SUPT16H) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZFHX3_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q15911 (ZFHX3) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZFP91_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96JP5 (ZFP91) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF274_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96GC6 (ZNF274) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF362_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q5T0B9 (ZNF362) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF528_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q3MIS6 (ZNF528) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF561_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8N587 (ZNF561) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF579_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8NAF0 (ZNF579) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF84_TARGET_GENES///Genes containing one or more binding sites for UniProt:P51523 (ZNF84) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."	GNF2_SPI1///Neighborhood of SPI1		CYCLIN_D1_UP.V1_DN///Genes down-regulated in MCF-7 cells (breast cancer) over-expressing CCND1 [Gene ID=595] gene.+++ERBB2_UP.V1_UP///Genes up-regulated in MCF-7 cells (breast cancer) positive for ESR1 [Gene ID=2099] and engineered to express ligand-activatable ERBB2 [Gene ID=2064].+++JNK_DN.V1_DN///Genes down-regulated in JNK inhibitor-treated (SP600125[PubChem=8515]) keratinocytes.+++MEK_UP.V1_UP///Genes up-regulated in MCF-7 cells (breast cancer) positive for ESR1 [Gene ID=2099] MCF-7 cells (breast cancer) stably over-expressing constitutively active MAP2K1 [Gene ID=5604] gene.+++P53_DN.V1_UP///Genes up-regulated in NCI-60 panel of cell lines with mutated TP53 [Gene ID=7157].	"GSE10240_CTRL_VS_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN///Genes down-regulated in primary bronchial epithelial cells: control versus stimulated with IL22 [GeneID=50616].+++GSE12366_GC_BCELL_VS_PLASMA_CELL_UP///Genes up-regulated in comparison of germinal center B cells versus plasma cells.+++GSE12366_PLASMA_CELL_VS_MEMORY_BCELL_DN///Genes down-regulated in plasma cells versus memory B cells.+++GSE12845_IGD_POS_BLOOD_VS_NAIVE_TONSIL_BCELL_DN///Genes down-regulated in comparison of IgD+ peripheral blood B cells versus IgD- naive tonsil B cells.+++GSE1460_INTRATHYMIC_T_PROGENITOR_VS_DP_THYMOCYTE_DN///Genes down-regulated in comparison of intrathymic T progenitor cells (ITTP) versus CD4 [GeneID=920] CD8 thymocytes. +++GSE14908_ATOPIC_VS_NONATOPIC_PATIENT_RESTING_CD4_TCELL_UP///Genes up-regulated in resting CD4 [GeneID=920] T cells: atopy versus healthy.+++GSE16385_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_UP///Genes up-regulated in macrophages (12h): IFNG and TNF [GeneID=3458;7124] versus IL4 [GeneID=3565].+++GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_DN///Genes down-regulated in transitional B lymphocytes: CR2 [GeneID=1380] low versus CR2 [GeneID=1380] high.+++GSE17301_CTRL_VS_48H_ACD3_ACD28_STIM_CD8_TCELL_DN///Genes down-regulated in CD8 T lymphocytes: control versus activated by anti-CD3 and anti-CD28.+++GSE17974_0H_VS_2H_IN_VITRO_ACT_CD4_TCELL_DN///Genes down-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the untreated cells at 2 h.+++GSE19888_ADENOSINE_A3R_INH_VS_TCELL_MEMBRANES_ACT_MAST_CELL_DN///Genes down-regulated in HMC-1 (mast leukemia) cells: incubated with the peptide ALL1 versus stimulated with T cell membranes.+++GSE22103_UNSTIM_VS_LPS_STIM_NEUTROPHIL_UP///Genes up-regulated in neutrophils: untreated versus LPS.+++GSE22601_DOUBLE_NEGATIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN///Genes down-regulated in thymocytes: double negative versus CD4 [GeneID=920] single positive.+++GSE22886_NAIVE_BCELL_VS_MONOCYTE_DN///Genes down-regulated in comparison of naive B cells versus day 0 monocytes.+++GSE22886_NAIVE_BCELL_VS_NEUTROPHIL_DN///Genes down-regulated in comparison of naive B cells versus unstimulated neutrophils.+++GSE26890_CXCR1_NEG_VS_POS_EFFECTOR_CD8_TCELL_DN///Genes down-regulated in effector CD8 T cells: CXCR1+ [GeneID=3577] versus CXCR1- [GeneID=3577].+++GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_6H_DN///Genes down-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: IL-12 (6h) versus IL4 [GeneID=3565] (6h).+++GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_6H_DN///Genes down-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: IL4 [GeneID=3565] (6h) versus untreated (6h).+++GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_2H_DN///Genes down-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 and then stimulated by TGFB1 and IL4 [GeneID=7040;3565] (2h).+++GSE28726_NAIVE_CD4_TCELL_VS_NAIVE_NKTCELL_UP///Genes up-regulated in nave T cells: CD4 [GeneID=920] versus NK.+++GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MONOCYTE_DN///Genes down-regulated in comparison of monocytes from LAIV influenza vaccinee at day 7 post-vaccination vesus those from TIV influenza vaccinee at day 7.+++GSE33425_CD161_HIGH_VS_NEG_CD8_TCELL_UP///Genes up-regulated in CD8 T cells: KLRB1 high [GeneID=3820] versus KLRB1- [GeneID=3820].+++GSE34156_TLR1_TLR2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_UP///Genes up-regulated in monocytes (6h): M. tuberculosis 19 kDa lipopeptide versus M. tuberculosis 19 kDa lipopeptide and muramyl dipeptide [PubChem=11620162].+++GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_DN///Genes down-regulated in comparison of macrophages exposed to 50 worms/well B. malayi versus macrophages exposed to M. tuberculosis.+++GSE3982_BASOPHIL_VS_EFF_MEMORY_CD4_TCELL_DN///Genes down-regulated in comparison of basophils versus effector memory CD4 [GeneID=920] T cells.+++GSE3982_EOSINOPHIL_VS_BASOPHIL_UP///Genes up-regulated in comparison of eosinophils versus basophils.+++GSE3982_MAC_VS_BASOPHIL_UP///Genes up-regulated in comparison of macrophages versus basophils.+++GSE3982_MAST_CELL_VS_NEUTROPHIL_DN///Genes down-regulated in comparison of mast cells versus neutrophils.+++GSE42088_UNINF_VS_LEISHMANIA_INF_DC_24H_DN///Genes down-regulated in dendritic cells: untreated versus 24h after infection of Leishmania major.+++GSE42724_NAIVE_VS_B1_BCELL_UP///Genes up-regulated in B lymphocytes: nave versus B1.+++GSE44955_MCSF_VS_MCSF_AND_IL27_STIM_MACROPHAGE_DN///Genes down-regulated in macrophage differentiated by: CSF1 [GeneID=1435] versus CSF1 [GeneID=1435] and IL27 [GeneID=246778].+++GSE4590_SMALL_VS_LARGE_PRE_BCELL_UP///Genes up-regulated during B lymphocyte differentiation: small pre-B II versus large pre-B II.+++GSE4748_CYANOBACTERIUM_LPSLIKE_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_DN///Genes down-regulated in monocyte-derived dendritic cells: LPS like antigen from O. planktothrix (3h) versus LPS and LPS like antigen from O. planktothrix (3h).+++GSE4984_GALECTIN1_VS_LPS_STIM_DC_UP///Genes up-regulated in monocyte-derived dendritic cells: LGALS1 [GeneID=3956] versus LPS.+++GSE4984_UNTREATED_VS_GALECTIN1_TREATED_DC_UP///Genes up-regulated in monocyte-derived dendritic cells: control versus treated with LGALS1 [GeneID=3956].+++GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY3_DN///Genes down-regulated in monocytes: untreated versus CSF1 [GeneID=1435] knockout at day 3.+++GSE5542_IFNG_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_UP///Genes up-regulated in epithelial cells (24h): IFNG [GeneID=3458] versus IFNG [GeneID=3458] and interferon alpha.+++GSE5542_IFNG_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_UP///Genes up-regulated in epithelial cells (6h): IFNG [GeneID=3458] versus IFNG [GeneID=3458] and interferon alpha.+++GSE7460_CTRL_VS_TGFB_TREATED_ACT_TCONV_DN///Genes down-regulated in comparsion of ActCD4 versus ActCD4TGF (see Fig. 1 in the paper for details).+++GSE9006_TYPE_1_DIABETES_AT_DX_VS_4MONTH_POST_DX_PBMC_UP///Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from patients with type 1 diabetes at the time of the diagnosis versus those at 4 months later.+++GSE9239_CTRL_VS_TNF_INHIBITOR_TREATED_DC_UP///Genes up-regulated in monocyte-derived dendritic cells: control versus TNF [GeneID=7124] inhibitor etanercept.+++GSE9988_LOW_LPS_VS_ANTI_TREM1_AND_LPS_MONOCYTE_UP///Genes up-regulated in comparison of monocytes treated with 1 ng/ml LPS (TLR4 agonist) versus monocytes treated with anti-TREM1 [GeneID=54210] and 5000 ng/ml LPS (TLR4 agonist).+++GSE9988_LPS_VS_LPS_AND_ANTI_TREM1_MONOCYTE_UP///Genes up-regulated in comparison of monocytes treated with 5000 ng/ml LPS (TLR4 agonist) versus monocytes treated with anti-TREM1 [GeneID=54210].+++OSMAN_BLOOD_CHAD63_KH_AGE_18_50YO_HIGH_DOSE_SUBJECTS_24HR_UP///Genes up-regulated in blood 24hr vs 0hr in adults (18-50) (high dose subjects) after exposure to ChAd63-KH , time point 24H , administered Intramuscular injection. Comment: DE gene list for high dose subjects.+++THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_UP///Genes up-regulated in peripheral blood mononuclear cell 28d vs 0d in young adults (21-30) (responders) after exposure to Inactivated influenza vaccine , time point 28D"	HALLMARK_APICAL_JUNCTION///Genes encoding components of apical junction complex.	NM_003370	VASP				
P46109	sp|P46109|CRKL_HUMAN		CRKL		Crk-like protein OS=Homo sapiens OX=9606 GN=CRKL PE=1 SV=1	1399	NR_156180						MSSARFDSSDRSAWYMGPVSRQEAQTRLQGQRHGMFLVRDSSTCPGDYVLSVSENSRVSHYIINSLPNRRFKIGDQEFDHLPALLEFYKIHYLDTTTLIEPAPRYPSPPMGSVSAPNLPTAEDNLEYVRTLYDFPGNDAEDLPFKKGEILVIIEKPEEQWWSARNKDGRVGMIPVPYVEKLVRSSPHGKHGNRNSNSYGIPEPAHAYAQPQTTTPLPAVSGSPGAAITPLPSTQNGPVFAKAIQKRVPCAYDKTALALEVGDIVKVTRMNINGQWEGEVNGRKGLFPFTHVKIFDPQNPDENE	0.3915458	-1.352746942	2.41E-04		3.7789436	3.9348198	3.6308297		6.2567393	4.246193499	4.9586781	3.790033	5.4814313	6.227213	6.1176794		5.6472635	4.7940688	5.9323898		5.9854942				6.656734	5.9721046	4.7080613				9.017028	7.4971283	6.971199	5.8655252		5.1469811	6.1686959	6.3818969	6.5893455	6.6791187	5.4853536	6.62181	7.4591777	6.09067822	7.2717414	6.2900968	7.05971615										"Homo sapiens CRK like proto-oncogene, adaptor protein (CRKL), transcript variant 2, non-coding RNA."																							NR_156180	CRKL				
P41240	sp|P41240|CSK_HUMAN				Tyrosine-protein kinase CSK OS=Homo sapiens OX=9606 GN=CSK PE=1 SV=1 >tr|B2R6Q4|B2R6Q4_HUMAN Tyrosine-protein kinase OS=Homo sapiens OX=9606 GN=CSK PE=2 SV=1								MSAIQAAWPSGTECIAKYNFHGTAEQDLPFCKGDVLTIVAVTKDPNWYKAKNKVGREGIIPANYVQKREGVKAGTKLSLMPWFHGKITREQAERLLYPPETGLFLVRESTNYPGDYTLCVSCDGKVEHYRIMYHASKLSIDEEVYFENLMQLVEHYTSDADGLCTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHELHL	0.4121355	-1.278809464	0.003313676						4.3372279		3.1678421	4.6040269	5.802318	4.8809035	4.8197142										3.7656489	5.2679296					7.143291	6.8312984	6.861247	6.504352	4.469627	4.2985723	6.2802007	5.070226	5.2188466	5.9012968	4.4783388	7.129075	5.9861786	4.7139561	6.7816747		5.00659138																																	C9606_136361					
P37840	sp|P37840|SYUA_HUMAN		SNCA		Alpha-synuclein OS=Homo sapiens OX=9606 GN=SNCA PE=1 SV=1	6622	XM_017008563	XP_016864052	ENST00000505199	K04528			MDVFMKGLSKAKEGVVAAAEKTKQGVAEAAGKTKEGVLYVGSKTKEGVVHGVATVAEKTKEQVTNVGGAVVTGVTAVAQKTVEGAGSIAAATGFVKKDQLGKNEEGAPQEGILEDMPVDPDNEAYEMPSEEGYQDYEPEA	0.4418163	-1.178481516	0.02903798					7.7157555			8.2290992		7.7558118		8.6610891			8.2966791	9.4946166						10.4267701	11.4640552	8.1809033										8.764882				10.9774992	9.211266	9.0727555		10.5071333	9.5953971	10.72078441	05010///Alzheimer disease+++05012///Parkinson disease+++05022///Pathways of neurodegeneration - multiple diseases	H00057///Parkinson disease+++H00066///Lewy body dementia (LBD)+++H01600///Parkinsonian syndrome			GO:0005576///extracellular region+++GO:0005615///extracellular space+++GO:0005634///nucleus+++GO:0005640///nuclear outer membrane+++GO:0005737///cytoplasm+++GO:0005739///mitochondrion+++GO:0005741///mitochondrial outer membrane+++GO:0005743///mitochondrial inner membrane+++GO:0005758///mitochondrial intermembrane space+++GO:0005759///mitochondrial matrix+++GO:0005764///lysosome+++GO:0005791///rough endoplasmic reticulum+++GO:0005794///Golgi apparatus+++GO:0005829///cytosol+++GO:0005840///ribosome+++GO:0005856///cytoskeleton+++GO:0005886///plasma membrane+++GO:0005938///cell cortex+++GO:0008021///synaptic vesicle+++GO:0015629///actin cytoskeleton+++GO:0016020///membrane+++GO:0016234///inclusion body+++GO:0030054///cell junction+++GO:0030424///axon+++GO:0030426///growth cone+++GO:0030659///cytoplasmic vesicle membrane+++GO:0030672///synaptic vesicle membrane+++GO:0031092///platelet alpha granule membrane+++GO:0032991///protein-containing complex+++GO:0043025///neuronal cell body+++GO:0043195///terminal bouton+++GO:0043231///intracellular membrane-bounded organelle+++GO:0043679///axon terminus+++GO:0045202///synapse+++GO:0048471///perinuclear region of cytoplasm+++GO:0098793///presynapse+++GO:0098794///postsynapse+++GO:0099512///supramolecular fiber	GO:0000149///SNARE binding+++GO:0000287///magnesium ion binding+++GO:0000976///transcription regulatory region sequence-specific DNA binding+++GO:0003779///actin binding+++GO:0004860///protein kinase inhibitor activity+++GO:0005504///fatty acid binding+++GO:0005507///copper ion binding+++GO:0005509///calcium ion binding+++GO:0005515///protein binding+++GO:0005543///phospholipid binding+++GO:0008017///microtubule binding+++GO:0008198///ferrous iron binding+++GO:0008270///zinc ion binding+++GO:0016491///oxidoreductase activity+++GO:0019894///kinesin binding+++GO:0019899///enzyme binding+++GO:0019904///protein domain specific binding+++GO:0030544///Hsp70 protein binding+++GO:0042393///histone binding+++GO:0042802///identical protein binding+++GO:0043014///alpha-tubulin binding+++GO:0043027///cysteine-type endopeptidase inhibitor activity involved in apoptotic process+++GO:0043274///phospholipase binding+++GO:0046872///metal ion binding+++GO:0047485///protein N-terminus binding+++GO:0048156///tau protein binding+++GO:0048487///beta-tubulin binding+++GO:0051219///phosphoprotein binding+++GO:0060961///phospholipase D inhibitor activity+++GO:0070840///dynein complex binding+++GO:1903136///cuprous ion binding	"GO:0000122///negative regulation of transcription by RNA polymerase II+++GO:0001774///microglial cell activation+++GO:0001921///positive regulation of receptor recycling+++GO:0001933///negative regulation of protein phosphorylation+++GO:0001956///positive regulation of neurotransmitter secretion+++GO:0001963///synaptic transmission, dopaminergic+++GO:0006469///negative regulation of protein kinase activity+++GO:0006631///fatty acid metabolic process+++GO:0006638///neutral lipid metabolic process+++GO:0006644///phospholipid metabolic process+++GO:0006915///apoptotic process+++GO:0006919///activation of cysteine-type endopeptidase activity involved in apoptotic process+++GO:0007006///mitochondrial membrane organization+++GO:0007268///chemical synaptic transmission+++GO:0007568///aging+++GO:0008344///adult locomotory behavior+++GO:0009410///response to xenobiotic stimulus+++GO:0010040///response to iron(II) ion+++GO:0010517///regulation of phospholipase activity+++GO:0010642///negative regulation of platelet-derived growth factor receptor signaling pathway+++GO:0014048///regulation of glutamate secretion+++GO:0014059///regulation of dopamine secretion+++GO:0016079///synaptic vesicle exocytosis+++GO:0016082///synaptic vesicle priming+++GO:0022898///regulation of transmembrane transporter activity+++GO:0031115///negative regulation of microtubule polymerization+++GO:0031623///receptor internalization+++GO:0031648///protein destabilization+++GO:0032026///response to magnesium ion+++GO:0032410///negative regulation of transporter activity+++GO:0032496///response to lipopolysaccharide+++GO:0032769///negative regulation of monooxygenase activity+++GO:0033138///positive regulation of peptidyl-serine phosphorylation+++GO:0034341///response to interferon-gamma+++GO:0034599///cellular response to oxidative stress+++GO:0035067///negative regulation of histone acetylation+++GO:0035493///SNARE complex assembly+++GO:0035543///positive regulation of SNARE complex assembly+++GO:0040012///regulation of locomotion+++GO:0042220///response to cocaine+++GO:0042416///dopamine biosynthetic process+++GO:0042417///dopamine metabolic process+++GO:0042493///response to drug+++GO:0042775///mitochondrial ATP synthesis coupled electron transport+++GO:0043030///regulation of macrophage activation+++GO:0043065///positive regulation of apoptotic process+++GO:0043066///negative regulation of apoptotic process+++GO:0043154///negative regulation of cysteine-type endopeptidase activity involved in apoptotic process+++GO:0043524///negative regulation of neuron apoptotic process+++GO:0044344///cellular response to fibroblast growth factor stimulus+++GO:0045807///positive regulation of endocytosis+++GO:0045920///negative regulation of exocytosis+++GO:0045921///positive regulation of exocytosis+++GO:0045963///negative regulation of dopamine metabolic process+++GO:0046928///regulation of neurotransmitter secretion+++GO:0048148///behavioral response to cocaine+++GO:0048168///regulation of neuronal synaptic plasticity+++GO:0048169///regulation of long-term neuronal synaptic plasticity+++GO:0048488///synaptic vesicle endocytosis+++GO:0048489///synaptic vesicle transport+++GO:0050729///positive regulation of inflammatory response+++GO:0050806///positive regulation of synaptic transmission+++GO:0050808///synapse organization+++GO:0050812///regulation of acyl-CoA biosynthetic process+++GO:0051259///protein complex oligomerization+++GO:0051262///protein tetramerization+++GO:0051281///positive regulation of release of sequestered calcium ion into cytosol+++GO:0051583///dopamine uptake involved in synaptic transmission+++GO:0051585///negative regulation of dopamine uptake involved in synaptic transmission+++GO:0051612///negative regulation of serotonin uptake+++GO:0051621///regulation of norepinephrine uptake+++GO:0051622///negative regulation of norepinephrine uptake+++GO:0055074///calcium ion homeostasis+++GO:0060079///excitatory postsynaptic potential+++GO:0060291///long-term synaptic potentiation+++GO:0060732///positive regulation of inositol phosphate biosynthetic process+++GO:0061024///membrane organization+++GO:0070495///negative regulation of thrombin-activated receptor signaling pathway+++GO:0070555///response to interleukin-1+++GO:0071280///cellular response to copper ion+++GO:0071872///cellular response to epinephrine stimulus+++GO:0071902///positive regulation of protein serine/threonine kinase activity+++GO:0097435///supramolecular fiber organization+++GO:1901214///regulation of neuron death+++GO:1901215///negative regulation of neuron death+++GO:1901216///positive regulation of neuron death+++GO:1902957///negative regulation of mitochondrial electron transport, NADH to ubiquinone+++GO:1903284///positive regulation of glutathione peroxidase activity+++GO:1903285///positive regulation of hydrogen peroxide catabolic process+++GO:1903421///regulation of synaptic vesicle recycling+++GO:1903426///regulation of reactive oxygen species biosynthetic process+++GO:1904307///response to desipramine+++GO:1904715///negative regulation of chaperone-mediated autophagy+++GO:1905606///regulation of presynapse assembly+++GO:1990000///amyloid fibril formation+++GO:2000377///regulation of reactive oxygen species metabolic process"			"PREDICTED: Homo sapiens synuclein alpha (SNCA), transcript variant X8, mRNA."		PF01387///Synuclein	R-HSA-392499///Metabolism of proteins+++R-HSA-977225///Amyloid fiber formation		ENOG502S0Q7///No_INFO		IPR001058///Synuclein+++IPR002460///Alpha-synuclein	[SYUA_HUMAN|Reviewed]RecName: Full=Alpha-synuclein; AltName: Full=Non-A beta component of AD amyloid; AltName: Full=Non-A4 component of amyloid precursor; Short=NACP;	chr4q22///Ensembl 103 genes in cytogenetic band chr4q22	BIOCARTA_PARKIN_PATHWAY///Role of Parkin in the Ubiquitin-Proteasomal Pathway	KEGG_ALZHEIMERS_DISEASE///Alzheimer's disease+++KEGG_PARKINSONS_DISEASE///Parkinson's disease	REACTOME_AMYLOID_FIBER_FORMATION///Amyloid fiber formation		"CTATGCA_MIR153///Genes having at least one occurence of the motif CTATGCA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-153 (v7.1 miRBase)."	"MIR106A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-106a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1178_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1178-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1229_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1229-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR335_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-335-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3606_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3606-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4277///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4277 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR450B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-450b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4786_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4786-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4795_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4795-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR513A_3P_MIR513C_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-513a-3p, hsa-miR-513c-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5680///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5680 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6509_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6509-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6511A_3P_MIR6511B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6511a-3p, hsa-miR-6511b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6515_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6515-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6873_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6873-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6890_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6890-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7_1_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7-1-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7_2_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7-2-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7843_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7843-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR8075///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-8075 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets)."	AACTTT_UNKNOWN///Genes having at least one occurence of the highly conserved motif M17 AACTTT in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++ACCTGTTG_UNKNOWN///Genes having at least one occurence of the highly conserved motif M57 ACCTGTTG in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++ALPHACP1_01///Genes having at least one occurence of the transcription factor binding site V$ALPHACP1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++AP4_01///Genes having at least one occurence of the transcription factor binding site V$AP4_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++GATA1_01///Genes having at least one occurence of the transcription factor binding site V$GATA1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++GATA1_02///Genes having at least one occurence of the transcription factor binding site V$GATA1_02 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++GATA1_03///Genes having at least one occurence of the transcription factor binding site V$GATA1_03 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++GATA3_01///Genes having at least one occurence of the transcription factor binding site V$GATA3_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++GATTGGY_NFY_Q6_01///Genes having at least one occurence of the highly conserved motif M5 GATTGGY sites. The motif matches transcription factor binding site V$NFY_Q6_01 (v7.4 TRANSFAC).+++GCTNWTTGK_UNKNOWN///Genes having at least one occurence of the highly conserved motif M78 GCTNWTTGK in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++HAND1E47_01///Genes having at least one occurence of the transcription factor binding site V$HAND1E47_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++TGATTTRY_GFI1_01///Genes having at least one occurence of the highly conserved motif M94 TGATTTRY sites. The motif matches transcription factor binding site V$GFI1_01 (v7.4 TRANSFAC).	"BPTF_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q12830 (BPTF) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++CBX7_TARGET_GENES///Genes containing one or more binding sites for UniProt:O95931 (CBX7) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HSD17B8_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q92506 (HSD17B8) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NFXL1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6ZNB6 (NFXL1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++PHF2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O75151 (PHF2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SMN1_SMN2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q16637 (SMN1_SMN2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++TCF7_TARGET_GENES///Genes containing one or more binding sites for UniProt:P36402 (TCF7) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF329_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q86UD4 (ZNF329) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF350_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9GZX5 (ZNF350) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF513_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8N8E2 (ZNF513) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZSCAN30_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q86W11 (ZSCAN30) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."	GNF2_ANK1///Neighborhood of ANK1+++GNF2_BNIP3L///Neighborhood of BNIP3L+++GNF2_MAP2K3///Neighborhood of MAP2K3+++GNF2_RAD23A///Neighborhood of RAD23A+++GNF2_SPTA1///Neighborhood of SPTA1+++GNF2_SPTB///Neighborhood of SPTB+++GNF2_TAL1///Neighborhood of TAL1	MODULE_497///CNS development.	TBK1.DF_UP///Genes up-regulated in epithelial lung cancer cell lines upon over-expression of an oncogenic form of KRAS [Gene ID=3845] gene and knockdown of TBK1 [Gene ID=29110] gene by RNAi.	"GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_12MO_CORRELATED_WITH_ANTIBODY_RESPONSE_NEGATIVE///Genes negatively correlated with antibody response in peripheral blood mononuclear cell in young adults (18-25) after exposure to HPV-16 L1 VLP , time point 12M. Comment: Spearman Correlation of Gene Expression with Neutralizing Antibody Levels+++GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_2MO_DN///Genes down-regulated in peripheral blood mononuclear cell 2m vs 0m in young adults (18-25) after exposure to HPV-16 L1 VLP , time point 2M. Comment: Gene Expression with Neutralizing Antibody Levels+++GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_STIMULATED_VS_UNSTIMULATED_0DY_VACCINATION_INDEPENDENT_DN///Genes down-regulated in peripheral blood mononuclear cell stimulated vs unstimulated in young adults (18-25) after exposure to HPV-16 L1 VLP , time point 0D. Comment: List of Genes induced by VLP directly, independently of vaccination (p&lt;0.05 and FC&gt;1.30)+++GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_10DY_DN///Genes down-regulated in peripheral blood mononuclear cell 10d vs 0d in unknown after exposure to YF-Vax/Stamaril , time point 10D+++GSE1432_1H_VS_24H_IFNG_MICROGLIA_UP///Genes up-regulated in comparison of microglia cells 1 h after stimulation with IFNG [GeneID=3458] versus microglia cells 24 h after the stimulation.+++GSE1432_1H_VS_6H_IFNG_MICROGLIA_UP///Genes up-regulated in comparison of microglia cells 1 h after stimulation with IFNG [GeneID=3458] versus microglia cells 6 h after the stimulation.+++GSE1432_6H_VS_24H_IFNG_MICROGLIA_UP///Genes up-regulated in comparison of microglia cells 6 h after stimulation with IFNG [GeneID=3458] versus microglia cells 24 h after the stimulation.+++GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP///Genes up-regulated in comparison of intrathymic T progenitor cells (ITTP) versus naive CD4 [GeneID=920] T cells from adult blood.+++GSE15659_NAIVE_CD4_TCELL_VS_RESTING_TREG_DN///Genes down-regulated in comparison of naive CD4 [GeneID=920] T cells versus resting regulatory T cell (Treg).+++GSE21774_CD56_BRIGHT_VS_DIM_CD62L_POSITIVE_NK_CELL_DN///Genes down-regulated in NCAM+ [GeneID=4684] NK cells: SELL bright [GeneID=6402] versus SELL dim [GeneID=6402].+++GSE22886_NAIVE_CD8_TCELL_VS_MONOCYTE_DN///Genes down-regulated in comparison of naive CD8 T cells versus day 0 monocytes.+++GSE23321_CD8_STEM_CELL_MEMORY_VS_EFFECTOR_MEMORY_CD8_TCELL_UP///Genes up-regulated in CD8 T cells: stem cell memory versus effector memory.+++GSE2405_0H_VS_1.5H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP///Genes up-regulated in polymorphonuclear leukocytes (1.5h): control versus infection by A. phagocytophilum.+++GSE24634_TEFF_VS_TCONV_DAY3_IN_CULTURE_DN///Genes down-regulated in comparison of CD25+ T effector cells treated with IL4 [GeneID=3565] at day 3 versus untreated CD25- T cells at day 3.+++GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_6H_DN///Genes down-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 [GeneID=7040] and IL-12 (6h) versus untreated (6h).+++GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_6H_DN///Genes down-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 [GeneID=7040] and IL-12 (6h) versus IL4 [GeneID=3565] (6h).+++GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP///Genes up-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 and then stimulated by IL4 [GeneID=3565] (2h).+++GSE33374_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_UP///Genes up-regulated in KLRB1 high [GeneID=3820] T cells: CD8A [GeneID=925] versus CD8A CD8B [GeneID=925;926].+++GSE34205_HEALTHY_VS_RSV_INF_INFANT_PBMC_DN///Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMCs from infanct with acute RSV infection.+++GSE34205_RSV_VS_FLU_INF_INFANT_PBMC_UP///Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from infancts with acute RSV infection versus PBMCs from infants with acute influenza infection.+++GSE3982_DC_VS_MAC_DN///Genes down-regulated in comparison of dendritic cells (DC) versus macrophages.+++GSE40184_HEALTHY_VS_HCV_INFECTED_DONOR_PBMC_UP///Genes up-regulated in peripheral blood monocytes (PBMC): healthy donors versus patients with HCV infection.+++GSE41087_WT_VS_FOXP3_MUT_ANTI_CD3_CD28_STIM_CD4_TCELL_DN///Genes down-regulated in activated CD4 [GeneID=920] T cells expressing: wildtype versus mutant form of FOXP3 [GeneID=50943].+++GSE6092_CTRL_VS_BORRELIA_BIRGDOFERI_INF_ENDOTHELIAL_CELL_UP///Genes up-regulated in endothelial cells: untreated versus exposed to E. burgdoferi.+++GSE6269_FLU_VS_STREP_PNEUMO_INF_PBMC_DN///Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from patients with acute influenza infection versus PBMC from patients with acute S. pneumoniae infection.+++GSE6269_HEALTHY_VS_STAPH_AUREUS_INF_PBMC_DN///Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from patients with acute influenza infection versus PBMC from patients with acute S. aureus infection.+++GSE6269_HEALTHY_VS_STAPH_PNEUMO_INF_PBMC_DN///Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMC from patients with acute S. pneumoniae infection.+++GSE7460_FOXP3_MUT_VS_HET_ACT_TCONV_UP///Genes up-regulated in comparsion of sfActCD4 versus WTActCD4 (see Fig. 1 in the paper for details).+++GSE8835_HEALTHY_VS_CLL_CD8_TCELL_DN///Genes down-regulated in CD8 T cells: healthy versus CLL (chronic lymphocytic leukemia).+++GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_12H_UP///Genes up-regulated in monocytes (12h): untreated versus M. tuberculosis 19 kDa lipopeptide.+++GSE9946_IMMATURE_VS_MATURE_STIMULATORY_DC_UP///Genes up-regulated in dendritic cells: immature versus mature stimulatory.+++HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_DN///Genes down-regulated in peripheral blood mononuclear cell vaccinated vs unvaccinated in adolescent/young adults (11-22) after exposure to M-M-R II , time point 7Y+++NAKAYA_MONOCYTE_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP///Genes up-regulated in monocyte 7d vs 0d in young adults (18-50) after exposure to Fluarix/Fluvirin , time point 7D+++NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_NEGATIVE///Genes negatively correlated with HAI response at 28d in peripheral blood mononuclear cell in adults (18-50) after exposure to Fluarix/Fluvirin , time point 3D. Comment: Supplementary Table 5: All genes whose expression (d3/d0 or d7/d0) correlates to the fold increase in HAI titers (d28/d0).+++NAKAYA_PBMC_FLUMIST_AGE_18_50YO_7DY_DN///Genes down-regulated in peripheral blood mononuclear cell 7d vs 0d in adults (18-50) after exposure to FluMist , time point 7D. Comment: Supplementary Table 1a: All the differentially expressed genes identified in PBMCs of TIV vaccinees.+++NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN///Genes down-regulated in plasmacytoid dendritic cell 7d vs 0d in young adults (18-50) after exposure to FluMist , time point 7D+++NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP///Genes up-regulated in plasmacytoid dendritic cell 7d vs 0d in young adults (18-50) after exposure to FluMist , time point 7D+++QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_CONTRACTION_OF_VZV_SPECIFIC_T_CELLS_PEAK_TO_28DY_AT_1DYPOSITIVE///Genes positively correlated with contraction of VZV specific T cells (peak to 28d) in peripheral blood mononuclear cell in seniors (50-75) after exposure to Zostavax , time point 1D+++QIU_PBMC_HEPTATITIS_B_SURFACE_ANTIGEN_AGE_UNDER50_NON_RESPONDERS_VS_RESPONDERS_28DY_DN///Genes down-regulated in peripheral blood mononuclear cell non-responders vs responders in adults (&lt;50) after exposure to Heptatitis B surface antigen vaccine (HBsAg) , time point 28D+++THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_UP///Genes up-regulated in peripheral blood mononuclear cell 28d vs 0d in young adults (21-30) (responders) after exposure to Inactivated influenza vaccine , time point 28D+++ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_UP///Genes up-regulated in peripheral blood mononuclear cell 1d vs 0d in adults (20-50) after exposure to MRKAd5 HIV-1 gag/pol/nef , time point 1D. Comment: Table includes specific cell types"	HALLMARK_HEME_METABOLISM///Genes involved in metabolism of heme (a cofactor consisting of iron and porphyrin) and erythroblast differentiation.	XM_017008563	SNCA				
P37802	sp|P37802|TAGL2_HUMAN				Transgelin-2 OS=Homo sapiens OX=9606 GN=TAGLN2 PE=1 SV=3 >tr|A0A384MTL2|A0A384MTL2_HUMAN Transgelin OS=Homo sapiens OX=9606 PE=2 SV=1								MANRGPAYGLSREVQQKIEKQYDADLEQILIQWITTQCRKDVGRPQPGRENFQNWLKDGTVLCELINALYPEGQAPVKKIQASTMAFKQMEQISQFLQAAERYGINTTDIFQTVDLWEGKNMACVQRTLMNLGGLAVARDDGLFSGDPNWFPKKSKENPRNFSDNQLQEGKNVIGLQMGTNRGASQAGMTGYGMPRQIL	0.2329074	-2.102171444	2.88E-04	4.7725708	7.6300418	6.3358558	7.22513	9.8820606	9.0393952	6.521735243	8.104259	8.9107849	9.8457576	9.0930054	10.1083519	6.50615205	7.6149208	7.7056036	9.1065121	6.5846074	7.3597959	2.022193211	4.3135071	7.7058222	10.0526563	9.877011	6.4687781	6.52517155	6.69838077	6.8677224	12.155951	11.5589617	11.414597	11.3710659	9.221691	9.1235317	10.6005552	10.0057328	9.3544954	10.589968	9.5054487	11.302919	9.9238881	9.85667945	11.3778744	8.4940092	10.3940583																																	C9606_40531					
P35579	sp|P35579|MYH9_HUMAN		MYH9		"Myosin-9 OS=Homo sapiens OX=9606 GN=MYH9 PE=1 SV=4 >tr|A0A024R1N1|A0A024R1N1_HUMAN Myosin, heavy polypeptide 9, non-muscle, isoform CRA_a OS=Homo sapiens OX=9606 GN=MYH9 PE=3 SV=1"								MAQQAADKYLYVDKNFINNPLAQADWAAKKLVWVPSDKSGFEPASLKEEVGEEAIVELVENGKKVKVNKDDIQKMNPPKFSKVEDMAELTCLNEASVLHNLKERYYSGLIYTYSGLFCVVINPYKNLPIYSEEIVEMYKGKKRHEMPPHIYAITDTAYRSMMQDREDQSILCTGESGAGKTENTKKVIQYLAYVASSHKSKKDQGELERQLLQANPILEAFGNAKTVKNDNSSRFGKFIRINFDVNGYIVGANIETYLLEKSRAIRQAKEERTFHIFYYLLSGAGEHLKTDLLLEPYNKYRFLSNGHVTIPGQQDKDMFQETMEAMRIMGIPEEEQMGLLRVISGVLQLGNIVFKKERNTDQASMPDNTAAQKVSHLLGINVTDFTRGILTPRIKVGRDYVQKAQTKEQADFAIEALAKATYERMFRWLVLRINKALDKTKRQGASFIGILDIAGFEIFDLNSFEQLCINYTNEKLQQLFNHTMFILEQEEYQREGIEWNFIDFGLDLQPCIDLIEKPAGPPGILALLDEECWFPKATDKSFVEKVMQEQGTHPKFQKPKQLKDKADFCIIHYAGKVDYKADEWLMKNMDPLNDNIATLLHQSSDKFVSELWKDVDRIIGLDQVAGMSETALPGAFKTRKGMFRTVGQLYKEQLAKLMATLRNTNPNFVRCIIPNHEKKAGKLDPHLVLDQLRCNGVLEGIRICRQGFPNRVVFQEFRQRYEILTPNSIPKGFMDGKQACVLMIKALELDSNLYRIGQSKVFFRAGVLAHLEEERDLKITDVIIGFQACCRGYLARKAFAKRQQQLTAMKVLQRNCAAYLKLRNWQWWRLFTKVKPLLQVSRQEEEMMAKEEELVKVREKQLAAENRLTEMETLQSQLMAEKLQLQEQLQAETELCAEAEELRARLTAKKQELEEICHDLEARVEEEEERCQHLQAEKKKMQQNIQELEEQLEEEESARQKLQLEKVTTEAKLKKLEEEQIILEDQNCKLAKEKKLLEDRIAEFTTNLTEEEEKSKSLAKLKNKHEAMITDLEERLRREEKQRQELEKTRRKLEGDSTDLSDQIAELQAQIAELKMQLAKKEEELQAALARVEEEAAQKNMALKKIRELESQISELQEDLESERASRNKAEKQKRDLGEELEALKTELEDTLDSTAAQQELRSKREQEVNILKKTLEEEAKTHEAQIQEMRQKHSQAVEELAEQLEQTKRVKANLEKAKQTLENERGELANEVKVLLQGKGDSEHKRKKVEAQLQELQVKFNEGERVRTELADKVTKLQVELDNVTGLLSQSDSKSSKLTKDFSALESQLQDTQELLQEENRQKLSLSTKLKQVEDEKNSFREQLEEEEEAKHNLEKQIATLHAQVADMKKKMEDSVGCLETAEEVKRKLQKDLEGLSQRHEEKVAAYDKLEKTKTRLQQELDDLLVDLDHQRQSACNLEKKQKKFDQLLAEEKTISAKYAEERDRAEAEAREKETKALSLARALEEAMEQKAELERLNKQFRTEMEDLMSSKDDVGKSVHELEKSKRALEQQVEEMKTQLEELEDELQATEDAKLRLEVNLQAMKAQFERDLQGRDEQSEEKKKQLVRQVREMEAELEDERKQRSMAVAARKKLEMDLKDLEAHIDSANKNRDEAIKQLRKLQAQMKDCMRELDDTRASREEILAQAKENEKKLKSMEAEMIQLQEELAAAERAKRQAQQERDELADEIANSSGKGALALEEKRRLEARIAQLEEELEEEQGNTELINDRLKKANLQIDQINTDLNLERSHAQKNENARQQLERQNKELKVKLQEMEGTVKSKYKASITALEAKIAQLEEQLDNETKERQAACKQVRRTEKKLKDVLLQVDDERRNAEQYKDQADKASTRLKQLKRQLEEAEEEAQRANASRRKLQRELEDATETADAMNREVSSLKNKLRRGDLPFVVPRRMARKGAGDGSDEEVDGKADGAEAKPAE	0.4222218	-1.243926946	0.00820468		5.4188071		3.2416395	6.0988068	6.2663519	3.415596163		4.8513015	3.7509417	6.4275936	6.4607511			4.8999063	5.8147644					5.4381904	7.2708472	7.6114888	4.9329937		3.81406672		8.415427	8.0745981	5.709382	7.3461333		4.2575277	7.378057	6.8921187	7.0090503	7.0903212	6.1876091	6.42615	7.227017	5.43284655	7.8662132	5.0146698	8.3146692																																	C9606_80151					
P35052	sp|P35052|GPC1_HUMAN		GPC1		Glypican-1 OS=Homo sapiens OX=9606 GN=GPC1 PE=1 SV=2 >tr|A0A384NPH9|A0A384NPH9_HUMAN Glypican-1 OS=Homo sapiens OX=9606 PE=2 SV=1	2817	NM_002081	NP_002072	ENST00000264039	K08107			MELRARGWWLLCAAAALVACARGDPASKSRSCGEVRQIYGAKGFSLSDVPQAEISGEHLRICPQGYTCCTSEMEENLANRSHAELETALRDSSRVLQAMLATQLRSFDDHFQHLLNDSERTLQATFPGAFGELYTQNARAFRDLYSELRLYYRGANLHLEETLAEFWARLLERLFKQLHPQLLLPDDYLDCLGKQAEALRPFGEAPRELRLRATRAFVAARSFVQGLGVASDVVRKVAQVPLGPECSRAVMKLVYCAHCLGVPGARPCPDYCRNVLKGCLANQADLDAEWRNLLDSMVLITDKFWGTSGVESVIGSVHTWLAEAINALQDNRDTLTAKVIQGCGNPKVNPQGPGPEEKRRRGKLAPRERPPSGTLEKLVSEAKAQLRDVQDFWISLPGTLCSEKMALSTASDDRCWNGMARGRYLPEVMGDGLANQINNPEVEVDITKPDMTIRQQIMQLKIMTNRLRSAYNGNDVDFQDASDDGSGSGSGDGCLDDLCSRKVSRKSSSSRTPLTHALPGLSEQEGQKTSAASCPQPPTFLLPLLLFLALTVARPRWR	13.0659917	3.707744718	0.01521666					3.9139843				4.6258002			4.8204142		3.7886566			4.6505801																									0.6521424			05205///Proteoglycans in cancer+++05418///Fluid shear stress and atherosclerosis				GO:0005576///extracellular region+++GO:0005615///extracellular space+++GO:0005654///nucleoplasm+++GO:0005768///endosome+++GO:0005796///Golgi lumen+++GO:0005829///cytosol+++GO:0005886///plasma membrane+++GO:0009986///cell surface+++GO:0016020///membrane+++GO:0031012///extracellular matrix+++GO:0031225///anchored component of membrane+++GO:0031226///intrinsic component of plasma membrane+++GO:0043202///lysosomal lumen+++GO:0045121///membrane raft+++GO:0045202///synapse+++GO:0046658///anchored component of plasma membrane+++GO:0062023///collagen-containing extracellular matrix+++GO:0070062///extracellular exosome	GO:0005507///copper ion binding+++GO:0017134///fibroblast growth factor binding+++GO:0043236///laminin binding	GO:0001523///retinoid metabolic process+++GO:0006024///glycosaminoglycan biosynthetic process+++GO:0006027///glycosaminoglycan catabolic process+++GO:0007411///axon guidance+++GO:0009966///regulation of signal transduction+++GO:0014037///Schwann cell differentiation+++GO:0016477///cell migration+++GO:0030200///heparan sulfate proteoglycan catabolic process+++GO:0032288///myelin assembly+++GO:0040037///negative regulation of fibroblast growth factor receptor signaling pathway+++GO:0050900///leukocyte migration+++GO:1905475///regulation of protein localization to membrane+++GO:2001016///positive regulation of skeletal muscle cell differentiation	tissueType=Esophagus;cancerType=Normal;cellName=FGFR1LowNME5- epithelial cell+++tissueType=Lung;cancerType=Normal;cellName=Basal cell+++tissueType=Fetal gonad;cancerType=Normal;cellName=Sertoli cell		"Homo sapiens glypican 1 (GPC1), mRNA."		PF01153///Glypican	"R-HSA-109582///Hemostasis+++R-HSA-1266738///Developmental Biology+++R-HSA-1430728///Metabolism+++R-HSA-1630316///Glycosaminoglycan metabolism+++R-HSA-1638091///Heparan sulfate/heparin (HS-GAG) metabolism+++R-HSA-1643685///Disease+++R-HSA-1793185///Chondroitin sulfate/dermatan sulfate metabolism+++R-HSA-196854///Metabolism of vitamins and cofactors+++R-HSA-1971475///A tetrasaccharide linker sequence is required for GAG synthesis+++R-HSA-2022928///HS-GAG biosynthesis+++R-HSA-2024096///HS-GAG degradation+++R-HSA-202733///Cell surface interactions at the vascular wall+++R-HSA-2187338///Visual phototransduction+++R-HSA-3560782///Diseases associated with glycosaminoglycan metabolism+++R-HSA-3560783///Defective B4GALT7 causes EDS, progeroid type+++R-HSA-3560801///Defective B3GAT3 causes JDSSDHD+++R-HSA-3656237///Defective EXT2 causes exostoses 2+++R-HSA-3656253///Defective EXT1 causes exostoses 1, TRPS2 and CHDS+++R-HSA-376176///Signaling by ROBO receptors+++R-HSA-3781865///Diseases of glycosylation+++R-HSA-422475///Axon guidance+++R-HSA-4420332///Defective B3GALT6 causes EDSP2 and SEMDJL1+++R-HSA-5668914///Diseases of metabolism+++R-HSA-6806667///Metabolism of fat-soluble vitamins+++R-HSA-71387///Metabolism of carbohydrates+++R-HSA-9675108///Nervous system development+++R-HSA-9709957///Sensory Perception+++R-HSA-975634///Retinoid metabolism and transport"		KOG3821///peptidyl-dipeptidase inhibitor activity		"IPR001863///Glypican+++IPR015502///Glypican-1+++IPR019803///Glypican, conserved site"	[GPC1_HUMAN|Reviewed]RecName: Full=Glypican-1; Contains: RecName: Full=Secreted glypican-1; Flags: Precursor;+++[A0A024R4D5_HUMAN|Unreviewed]RecName: Full=Glypican-1 {ECO:0000256|ARBA:ARBA00014714}; AltName: Full=Secreted glypican-1 {ECO:0000256|ARBA:ARBA00022140};				"REACTOME_A_TETRASACCHARIDE_LINKER_SEQUENCE_IS_REQUIRED_FOR_GAG_SYNTHESIS///A tetrasaccharide linker sequence is required for GAG synthesis+++REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL///Cell surface interactions at the vascular wall+++REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM///Chondroitin sulfate/dermatan sulfate metabolism+++REACTOME_DEFECTIVE_B4GALT7_CAUSES_EDS_PROGEROID_TYPE///Defective B4GALT7 causes EDS, progeroid type+++REACTOME_DEFECTIVE_EXT2_CAUSES_EXOSTOSES_2///Defective EXT2 causes exostoses 2+++REACTOME_DEVELOPMENTAL_BIOLOGY///Developmental Biology+++REACTOME_DISEASES_ASSOCIATED_WITH_GLYCOSAMINOGLYCAN_METABOLISM///Diseases associated with glycosaminoglycan metabolism+++REACTOME_DISEASES_OF_GLYCOSYLATION///Diseases of glycosylation+++REACTOME_DISEASES_OF_METABOLISM///Diseases of metabolism+++REACTOME_GLYCOSAMINOGLYCAN_METABOLISM///Glycosaminoglycan metabolism+++REACTOME_HEMOSTASIS///Hemostasis+++REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM///Heparan sulfate/heparin (HS-GAG) metabolism+++REACTOME_HS_GAG_BIOSYNTHESIS///HS-GAG biosynthesis+++REACTOME_HS_GAG_DEGRADATION///HS-GAG degradation+++REACTOME_METABOLISM_OF_CARBOHYDRATES///Metabolism of carbohydrates+++REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS///Metabolism of fat-soluble vitamins+++REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS///Metabolism of vitamins and cofactors+++REACTOME_NERVOUS_SYSTEM_DEVELOPMENT///Nervous system development+++REACTOME_SENSORY_PERCEPTION///Sensory Perception+++REACTOME_SIGNALING_BY_ROBO_RECEPTORS///Signaling by ROBO receptors+++REACTOME_VISUAL_PHOTOTRANSDUCTION///Visual phototransduction"	"NABA_ECM_AFFILIATED///Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins+++NABA_MATRISOME_ASSOCIATED///Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors+++NABA_MATRISOME///Ensemble of genes encoding extracellular matrix and extracellular matrix-associated proteins "		MIR182_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-182-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR345_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-345-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4505///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4505 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5787///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5787 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6849_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6849-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7854_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7854-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).		"KDM7A_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6ZMT4 (KDM7A) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++KMT2D_TARGET_GENES///Genes containing one or more binding sites for UniProt:O14686 (KMT2D) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NAB2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q15742 (NAB2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SALL4_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9UJQ4 (SALL4) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SIX1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q15475 (SIX1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SUPT16H_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9Y5B9 (SUPT16H) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF563_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8TA94 (ZNF563) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."		MODULE_342///Genes in the cancer module 342.		GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_UP///Genes up-regulated in comparison of control microglia cells versus those 1 h after stimulation with IFNG [GeneID=3458].+++GSE21774_CD62L_POS_CD56_BRIGHT_VS_CD62L_NEG_CD56_DIM_NK_CELL_UP///Genes up-regulated in NCAM1+ SELL bright [GeneID=4684;6402] versus NCAM1- SELL dim [GeneID=4684;6402].+++GSE22229_RENAL_TRANSPLANT_IMMUNOSUPP_THERAPY_VS_HEALTHY_PBMC_DN///Genes down-regulated in periperal blood monocytes (PBMC): kidney transplant recipients receiving immunosuppression therapy versus healthy controls.+++GSE22589_HEALTHY_VS_SIV_INFECTED_DC_DN///Genes down-regulated in monocyte-derived dendritic cells: control versus SIV infection.+++GSE22611_NOD2_VS_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_DN///Genes down-regulated in HEK293 cells expressing: wildtype NOD2 [GeneID=64127] versus mutant NOD2 [GeneID=64127].+++GSE2405_0H_VS_3H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP///Genes up-regulated in polymorphonuclear leukocytes (3h): control versus infection by A. phagocytophilum.+++GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_24H_UP///Genes up-regulated in polymorphonuclear leukocytes (24h): treated by heat killed HC60 cell (promyelocytic leukemia) lysate versus A. phagocytophilum infection.+++GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_6H_UP///Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: IL-12 (6h) versus untreated (6h).+++GSE29618_PRE_VS_DAY7_FLU_VACCINE_BCELL_UP///Genes up-regulated in comparison of B cells from influenza vaccinee pre-vaccination versus those at day 7 post-vaccination.+++GSE32164_ALTERNATIVELY_ACT_M2_VS_CMYC_INHIBITED_MACROPHAGE_UP///Genes up-regulated in macrophages: alternatively activated M2 versus MYC [GeneID=4609] inhibited.+++GSE32164_RESTING_DIFFERENTIATED_VS_ALTERNATIVELY_ACT_M2_MACROPHAGE_DN///Genes down-regulated in macrophages: resting differentiated versus alternatively activated M2.+++GSE32164_RESTING_DIFFERENTIATED_VS_CMYC_INHIBITED_MACROPHAGE_DN///Genes down-regulated in macrophages: resting differentiated versus MYC [GeneID=4609] inhibited.+++GSE33374_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_DN///Genes down-regulated in KLRB1 high [GeneID=3820] T cells: CD8A [GeneID=925] versus CD8A CD8B [GeneID=925;926].+++GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_DC_DN///Genes down-regulated in comparison of dendritic cells (DC) versus DCs exposed to B. malayi (50 worms/well).+++GSE360_DC_VS_MAC_T_GONDII_DN///Genes down-regulated in comparison of dendritic cells (DC) exposed to T. gondii versus macrophages exposed to T. gondii.+++GSE360_L_DONOVANI_VS_L_MAJOR_DC_DN///Genes down-regulated in comparison of dendritic cells (DC) exposed to L. donovani versus DCs exposed to L. major.+++GSE360_L_DONOVANI_VS_T_GONDII_DC_UP///Genes up-regulated in comparison of dendritic cells (DC) exposed to L. donovani versus DCs exposed to T. gondii.+++GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_DC_DN///Genes down-regulated in comparison of dendritic cells (DC) exposed to T. gondii versus DCs exposed to 50 worms/well B. malayi.+++GSE3720_UNSTIM_VS_LPS_STIM_VD1_GAMMADELTA_TCELL_UP///Genes up-regulated in Vd1 gamma delta T cells: untreated versus LPS.+++GSE3920_IFNA_VS_IFNG_TREATED_ENDOTHELIAL_CELL_DN///Genes down-regulated in endothelial cells: interferon alpha versus IFNG [GeneID=3458].+++GSE3982_DC_VS_TH1_UP///Genes up-regulated in comparison of dendritic cells (DC) versus Th1 cells.+++GSE3982_MAST_CELL_VS_DC_DN///Genes down-regulated in comparison of mast cells versus dendritic cells (DC).+++GSE40184_HEALTHY_VS_HCV_INFECTED_DONOR_PBMC_DN///Genes down-regulated in peripheral blood monocytes (PBMC): healthy donors versus patients with HCV infection.+++GSE5542_UNTREATED_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_UP///Genes up-regulated in epithelial cells (24h): untreated versus interferon alpha and IFNG [GeneID=3458].+++GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_UP///Genes up-regulated in monocyte-derived dendritic cells: untreated versus rosiglitazone and AM580 [PubChem=77999;2126].+++GSE6269_STAPH_AUREUS_VS_STREP_PNEUMO_INF_PBMC_UP///Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from patients with acute infection: S. aureus versus S. pneumoniae.+++GSE8835_CD4_VS_CD8_TCELL_DN///Genes down-regulated in T cells: CD4 [GeneID=920] versus CD8.	"HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION///Genes defining epithelial-mesenchymal transition, as in wound healing, fibrosis and metastasis.+++HALLMARK_GLYCOLYSIS///Genes encoding proteins involved in glycolysis and gluconeogenesis.+++HALLMARK_HYPOXIA///Genes up-regulated in response to low oxygen levels (hypoxia)."	NM_002081	GPC1				
P31146	sp|P31146|COR1A_HUMAN		CORO1A		Coronin-1A OS=Homo sapiens OX=9606 GN=CORO1A PE=1 SV=4 >tr|A0A024R611|A0A024R611_HUMAN Coronin OS=Homo sapiens OX=9606 GN=CORO1A PE=3 SV=1	11151	XM_011545714	XP_011544016		K13882			MSRQVVRSSKFRHVFGQPAKADQCYEDVRVSQTTWDSGFCAVNPKFVALICEASGGGAFLVLPLGKTGRVDKNAPTVCGHTAPVLDIAWCPHNDNVIASGSEDCTVMVWEIPDGGLMLPLREPVVTLEGHTKRVGIVAWHTTAQNVLLSAGCDNVIMVWDVGTGAAMLTLGPEVHPDTIYSVDWSRDGGLICTSCRDKRVRIIEPRKGTVVAEKDRPHEGTRPVRAVFVSEGKILTTGFSRMSERQVALWDTKHLEEPLSLQELDTSSGVLLPFFDPDTNIVYLCGKGDSSIRYFEITSEAPFLHYLSMFSSKESQRGMGYMPKRGLEVNKCEIARFYKLHERRCEPIAMTVPRKSDLFQEDLYPPTAGPDPALTAEEWLGGRDAGPLLISLKDGYVPPKSRELRVNRGLDTGRRRAAPEASGTPSSDAVSRLEEEMRKLQATVQELQKRLDRLEETVQAK	0.4071718	-1.296290332	0.00320796	4.1960579	4.1091784	3.9100337	3.1674697	6.0913922	5.3961042	3.90692105	5.1175909	5.8038681	6.7681711	6.0989759	6.1727039	3.91063635		4.7438201	5.4909033	5.0985878	2.9848019	2.335955371	2.4242877	5.4807068	5.7459684	6.7258944	2.6509716	4.32326209	3.40617708	2.6754641	8.674087	6.8907626	6.857776	7.5209111	6.081992	5.9982131	6.1313808	6.4250129	6.435704	6.5065427	5.8034559	7.197995	7.7379465	6.35027869	6.7999471	4.3225686	6.6682803	04145///Phagosome+++05152///Tuberculosis	H00091///T-B+Severe combined immunodeficiency			GO:0001772///immunological synapse+++GO:0001891///phagocytic cup+++GO:0005634///nucleus+++GO:0005737///cytoplasm+++GO:0005769///early endosome+++GO:0005829///cytosol+++GO:0005856///cytoskeleton+++GO:0005884///actin filament+++GO:0005886///plasma membrane+++GO:0005911///cell-cell junction+++GO:0005938///cell cortex+++GO:0015629///actin cytoskeleton+++GO:0016020///membrane+++GO:0030027///lamellipodium+++GO:0030424///axon+++GO:0030670///phagocytic vesicle membrane+++GO:0030864///cortical actin cytoskeleton+++GO:0031252///cell leading edge+++GO:0031410///cytoplasmic vesicle+++GO:0032991///protein-containing complex+++GO:0045202///synapse+++GO:0045335///phagocytic vesicle+++GO:0070062///extracellular exosome+++GO:0098978///glutamatergic synapse	GO:0003723///RNA binding+++GO:0003779///actin binding+++GO:0003785///actin monomer binding+++GO:0005515///protein binding+++GO:0008022///protein C-terminus binding+++GO:0008092///cytoskeletal protein binding+++GO:0032036///myosin heavy chain binding+++GO:0042802///identical protein binding+++GO:0042803///protein homodimerization activity+++GO:0043548///phosphatidylinositol 3-kinase binding+++GO:0051015///actin filament binding	GO:0001771///immunological synapse formation+++GO:0001845///phagolysosome assembly+++GO:0006816///calcium ion transport+++GO:0006909///phagocytosis+++GO:0007015///actin filament organization+++GO:0008064///regulation of actin polymerization or depolymerization+++GO:0008360///regulation of cell shape+++GO:0016477///cell migration+++GO:0030036///actin cytoskeleton organization+++GO:0030335///positive regulation of cell migration+++GO:0030595///leukocyte chemotaxis+++GO:0030833///regulation of actin filament polymerization+++GO:0031339///negative regulation of vesicle fusion+++GO:0031589///cell-substrate adhesion+++GO:0032796///uropod organization+++GO:0032956///regulation of actin cytoskeleton organization+++GO:0034097///response to cytokine+++GO:0038180///nerve growth factor signaling pathway+++GO:0042102///positive regulation of T cell proliferation+++GO:0043029///T cell homeostasis+++GO:0043320///natural killer cell degranulation+++GO:0043524///negative regulation of neuron apoptotic process+++GO:0045087///innate immune response+++GO:0048873///homeostasis of number of cells within a tissue+++GO:0050870///positive regulation of T cell activation+++GO:0050918///positive chemotaxis+++GO:0051126///negative regulation of actin nucleation+++GO:0051279///regulation of release of sequestered calcium ion into cytosol+++GO:0061502///early endosome to recycling endosome transport+++GO:0071353///cellular response to interleukin-4	tissueType=Fetal kidney;cancerType=Normal;cellName=Natural killer T (NKT) cell+++tissueType=Fetal kidney;cancerType=Normal;cellName=Monocyte+++tissueType=Embryonic prefrontal cortex;cancerType=Normal;cellName=Microglial cell		"PREDICTED: Homo sapiens coronin 1A (CORO1A), transcript variant X3, mRNA."		"PF00400///WD domain, G-beta repeat+++PF08953///Domain of unknown function (DUF1899)+++PF08954///Trimerisation motif+++PF16300///Type of WD40 repeat"	R-HSA-1643685///Disease+++R-HSA-5663205///Infectious disease+++R-HSA-9635486///Infection with Mycobacterium tuberculosis+++R-HSA-9636383///Prevention of phagosomal-lysosomal fusion+++R-HSA-9637687///Suppression of phagosomal maturation+++R-HSA-9637690///Response of Mtb to phagocytosis		KOG0303///actin filament binding		"IPR001680///WD40 repeat+++IPR015048///Domain of unknown function DUF1899+++IPR015049///Trimerisation motif+++IPR015505///Coronin+++IPR015943///WD40/YVTN repeat-like-containing domain superfamily+++IPR019775///WD40 repeat, conserved site+++IPR029508///Coronin 1A+++IPR036322///WD40-repeat-containing domain superfamily"	[COR1A_HUMAN|Reviewed]RecName: Full=Coronin-1A; AltName: Full=Coronin-like protein A; Short=Clipin-A; AltName: Full=Coronin-like protein p57; AltName: Full=Tryptophan aspartate-containing coat protein; Short=TACO;	chr16p11///Ensembl 103 genes in cytogenetic band chr16p11			REACTOME_INFECTION_WITH_MYCOBACTERIUM_TUBERCULOSIS///Infection with Mycobacterium tuberculosis+++REACTOME_INFECTIOUS_DISEASE///Infectious disease+++REACTOME_PREVENTION_OF_PHAGOSOMAL_LYSOSOMAL_FUSION///Prevention of phagosomal-lysosomal fusion+++REACTOME_RESPONSE_OF_MTB_TO_PHAGOCYTOSIS///Response of Mtb to phagocytosis+++REACTOME_SUPPRESSION_OF_PHAGOSOMAL_MATURATION///Suppression of phagosomal maturation			MIR4455///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4455 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4505///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4505 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5787///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5787 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR9902///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-9902 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).	CAGGTA_AREB6_01///Genes having at least one occurence of the highly conserved motif M76 CAGGTA sites. The motif matches transcription factor binding site V$AREB6_01 (v7.4 TRANSFAC).+++CATTGTYY_SOX9_B1///Genes having at least one occurence of the highly conserved motif M49 CATTGTYY sites. The motif matches transcription factor binding site V$SOX9_B1 (v7.4 TRANSFAC).+++E47_01///Genes having at least one occurence of the transcription factor binding site V$E47_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++ETS1_B///Genes having at least one occurence of the transcription factor binding site V$ETS1_B (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++ETS_Q4///Genes having at least one occurence of the transcription factor binding site V$ETS_Q4 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++GGGTGGRR_PAX4_03///Genes having at least one occurence of the highly conserved motif M56 GGGTGGRR sites. The motif matches transcription factor binding site V$PAX4_03 (v7.4 TRANSFAC).+++HSF_Q6///Genes having at least one occurence of the transcription factor binding site V$HSF_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++NERF_Q2///Genes having at least one occurence of the transcription factor binding site V$NERF_Q2 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++SREBP1_02///Genes having at least one occurence of the transcription factor binding site V$SREBP1_02 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++SREBP1_Q6///Genes having at least one occurence of the transcription factor binding site V$SREBP1_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++TGACATY_UNKNOWN///Genes having at least one occurence of the highly conserved motif M42 TGACATY in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++TTF1_Q6///Genes having at least one occurence of the transcription factor binding site V$TTF1_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++YYCATTCAWW_UNKNOWN///Genes having at least one occurence of the highly conserved motif M52 YYCATTCAWW in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).	"BACH2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9BYV9 (BACH2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++CBX5_TARGET_GENES///Genes containing one or more binding sites for UniProt:P45973 (CBX5) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HMGB1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P09429 (HMGB1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++KAT5_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q92993 (KAT5) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NFRKB_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6P4R8 (NFRKB) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NFXL1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6ZNB6 (NFXL1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SKIL_TARGET_GENES///Genes containing one or more binding sites for UniProt:P12757 (SKIL) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++TAZ_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q16635 (TAZ) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF10_TARGET_GENES///Genes containing one or more binding sites for UniProt:P21506 (ZNF10) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF197_TARGET_GENES///Genes containing one or more binding sites for UniProt:O14709 (ZNF197) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9BSG1 (ZNF2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF513_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8N8E2 (ZNF513) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF766_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q5HY98 (ZNF766) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF8_TARGET_GENES///Genes containing one or more binding sites for UniProt:P17098 (ZNF8) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."	GNF2_CD48///Neighborhood of CD48+++GNF2_CD53///Neighborhood of CD53+++GNF2_HLA_C///Neighborhood of HLA-C+++GNF2_INPP5D///Neighborhood of INPP5D+++GNF2_MYD88///Neighborhood of MYD88+++GNF2_PTPN6///Neighborhood of PTPN6+++GNF2_PTPRC///Neighborhood of PTPRC+++GNF2_SELL///Neighborhood of SELL+++GNF2_STAT6///Neighborhood of STAT6+++GNF2_TYK2///Neighborhood of TYK2+++GNF2_VAV1///Neighborhood of VAV1	"MODULE_100///Genes in the cancer module 100.+++MODULE_117///Signaling.+++MODULE_118///cell line expressed genes.+++MODULE_11///Genes in the cancer module 11.+++MODULE_124///Transcription.+++MODULE_137///CNS genes.+++MODULE_15///Genes in the cancer module 14.+++MODULE_16///Genes in the cancer module 15.+++MODULE_197///Genes in the cancer module 197.+++MODULE_308///Pol II transcription.+++MODULE_33///Immune / stress response genes.+++MODULE_419///Genes in the cancer module 419.+++MODULE_430///Genes in the cancer module 430.+++MODULE_438///Intermediate filaments and MT.+++MODULE_44///Thymus genes.+++MODULE_45///Whole blood genes.+++MODULE_484///Genes in the cancer module 484.+++MODULE_533///Genes in the cancer module 533.+++MODULE_53///Cell line expressed genes.+++MODULE_5///Lung genes.+++MODULE_60///Heart genes.+++MODULE_66///Genes in the cancer module 66.+++MODULE_84///Immune (humoral) and inflammatory response.+++MODULE_88///Heart, liver, kidney and pancreas metabolic and xenobiotic response genes."	KRAS.DF.V1_UP///Genes up-regulated in epithelial lung cancer cell lines over-expressing an oncogenic form of KRAS [Gene ID=3845] gene.+++MEK_UP.V1_UP///Genes up-regulated in MCF-7 cells (breast cancer) positive for ESR1 [Gene ID=2099] MCF-7 cells (breast cancer) stably over-expressing constitutively active MAP2K1 [Gene ID=5604] gene.+++PRC1_BMI_UP.V1_DN///Genes down-regulated in TIG3 cells (fibroblasts) upon knockdown of BMI1 [Gene ID=648] gene.+++PRC2_EED_UP.V1_DN///Genes down-regulated in TIG3 cells (fibroblasts) upon knockdown of EED [Gene ID=8726] gene.+++PRC2_EZH2_UP.V1_DN///Genes down-regulated in TIG3 cells (fibroblasts) upon knockdown of EZH2 [Gene ID=2146] gene.+++PRC2_SUZ12_UP.V1_DN///Genes down-regulated in TIG3 cells (fibroblasts) upon knockdown of SUZ12 [Gene ID=23512] gene.+++RAF_UP.V1_UP///Genes up-regulated in MCF-7 cells (breast cancer) positive for ESR1 [Gene ID=2099] MCF-7 cells (breast cancer) stably over-expressing constitutively active RAF1 [Gene ID=5894] gene.+++TBK1.DF_UP///Genes up-regulated in epithelial lung cancer cell lines upon over-expression of an oncogenic form of KRAS [Gene ID=3845] gene and knockdown of TBK1 [Gene ID=29110] gene by RNAi.	"ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_3DY_DN///Genes down-regulated in blood 3d vs 0hr in adults (18-45) after exposure to CN54gp140 adjuvanted with GLA-AF , time point 3D , administered i.m.+++BUCASAS_PBMC_FLUARIX_FLUVIRIN_CAUCASIAN_MALE_AGE_18_40YO_HIGH_RESPONDERS_1DY_TOP_FUNCTIONAL_NETWORK_POSITIVE///Genes positively correlated with a functional network in peripheral blood mononuclear cell in Caucasian male adults (18-40) (high responders) after exposure to Fluarix/Fluvirin , time point 1D. Comment: Top functional network for genes preferentially upregulated in the high responder group+++GSE13411_IGM_MEMORY_BCELL_VS_PLASMA_CELL_UP///Genes up-regulated in comparison of IgM-memory B cells versus plasma cells.+++GSE13411_NAIVE_BCELL_VS_PLASMA_CELL_UP///Genes up-regulated in comparison of naive B cells versus plasma cells.+++GSE13411_NAIVE_VS_MEMORY_BCELL_UP///Genes up-regulated in comparison of naive B cells versus memory B cells.+++GSE13411_PLASMA_CELL_VS_MEMORY_BCELL_DN///Genes down-regulated in comparison of plasma cells versus memory B cells.+++GSE13411_SWITCHED_MEMORY_BCELL_VS_PLASMA_CELL_UP///Genes up-regulated in comparison of Ig isotype switched memory B cells versus plasma cells.+++GSE13484_UNSTIM_VS_12H_YF17D_VACCINE_STIM_PBMC_UP///Genes up-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) cultured for 0 h versus PBMC cultured for 12 h with YF17D vaccine.+++GSE16385_MONOCYTE_VS_12H_IL4_TREATED_MACROPHAGE_DN///Genes down-regulated in monocytes (12h) versus macrophages (12h) treated with IL4 [GeneID=3565].+++GSE16385_ROSIGLITAZONE_VS_UNTREATED_IFNG_TNF_STIM_MACROPHAGE_DN///Genes down-regulated in macrophages (12h): IFNG, TNF [GeneID=3458;7124] and rosiglitazone [PubChem=77999] versus IFNG and TNF [GeneID=3458;7124].+++GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_14H_UP///Genes up-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 14 h.+++GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_18H_UP///Genes up-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 18 h.+++GSE20151_CTRL_VS_FUSOBACT_NUCLEATUM_NEUTROPHIL_DN///Genes down-regulated in comparison of contols neutrophils versus those infected with a bacterium (F. nucleatum).+++GSE21774_CD62L_POS_CD56_DIM_VS_CD62L_NEG_CD56_DIM_NK_CELL_UP///Genes up-regulated in SELL dim [GeneID=6402] NK cells: NCAM1+ [GeneID=4684] versus NCAM1- [GeneID=4684].+++GSE22601_DOUBLE_NEGATIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_UP///Genes up-regulated in thymocytes: double negative versus double positive.+++GSE22601_DOUBLE_NEGATIVE_VS_IMMATURE_CD4_SP_THYMOCYTE_DN///Genes down-regulated in double negative thymocyte versus immature CD4 [GeneID=920] single positive cells.+++GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_UP///Genes up-regulated in CD4 [GeneID=920] single positive cells: immature versus thymocytes.+++GSE22611_NOD2_VS_CTRL_TRANSDUCED_HEK293T_CELL_DN///Genes down-regulated in HEK293 cells: over-expressing wildtype NOD2 [GeneID=64127] versus control.+++GSE22611_UNSTIM_VS_6H_MDP_STIM_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_DN///Genes down-regulated in HEK293 cells expressing mutant NOD2 [GeneID=64127]: untreated versus muramyl dipeptide [PubChem=11620162] for 6h.+++GSE22886_DC_VS_MONOCYTE_DN///Genes down-regulated in comparison of dendritic cells (DC) versus monocytes.+++GSE22886_IGG_IGA_MEMORY_BCELL_VS_BM_PLASMA_CELL_UP///Genes up-regulated in comparison of memory IgG IgA B cells versus plasma cells from bone marrow and blood.+++GSE22886_IGM_MEMORY_BCELL_VS_BM_PLASMA_CELL_UP///Genes up-regulated in comparison of memory IgM B cells versus plasma cells from bone marrow and blood.+++GSE22886_NAIVE_BCELL_VS_BM_PLASMA_CELL_UP///Genes up-regulated in comparison of naive B cells versus plasma cells from bone marrow and blood.+++GSE2405_0H_VS_24H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP///Genes up-regulated in polymorphonuclear leukocytes (24h): control versus infection by A. phagocytophilum.+++GSE24634_TREG_VS_TCONV_POST_DAY7_IL4_CONVERSION_UP///Genes up-regulated in comparison of CD25+ regulatory T cell (Treg) treated with IL4 [GeneID=3565] at day 7 versus CD25- T cells treated with IL4 [GeneID=3565] at day 7.+++GSE25085_FETAL_LIVER_VS_FETAL_BM_SP4_THYMIC_IMPLANT_UP///Genes up-regulated in thymic implants from fetal liver versus those from fetal bone marrow.+++GSE26351_UNSTIM_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_DN///Genes down-regulated in CD34+ [GeneID=947] cells: control versus stimulated by BMP4 [GeneID=652].+++GSE26351_UNSTIM_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_UP///Genes up-regulated in CD34+ [GeneID=947] cells: control versus stimulated by BMP4 [GeneID=652].+++GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_48H_DN///Genes down-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: IL-12 (48h) versus untreated (48h).+++GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_6H_UP///Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: IL-12 (6h) versus untreated (6h).+++GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_2H_DN///Genes down-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 and then stimulated by TGFB1 and IL4 [GeneID=7040;3565] (2h).+++GSE28726_NAIVE_CD4_TCELL_VS_NAIVE_NKTCELL_DN///Genes down-regulated in nave T cells: CD4 [GeneID=920] versus NK.+++GSE28726_NAIVE_CD4_TCELL_VS_NAIVE_VA24NEG_NKTCELL_DN///Genes down-regulated in nave T cells: CD4 [GeneID=920] versus Va24- NKT.+++GSE28726_NAIVE_VS_ACTIVATED_CD4_TCELL_UP///Genes up-regulated in CD4 [GeneID=920] T cells: nave versus activated.+++GSE29618_BCELL_VS_MDC_DN///Genes down-regulated in comparison of B cells versus myeloid dendritic cells (mDC).+++GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_BCELL_DN///Genes down-regulated in comparison of B cells from LAIV influenza vaccinee at day 7 post-vaccination versus those from TIV influenza vaccinee at day 7 post-vaccination.+++GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MDC_DN///Genes down-regulated in comparison of myeloid dendritic cells (mDC) from LAIV influenza vaccinee pre-vaccination versus those at day 7 post-vaccination.+++GSE32901_TH1_VS_TH17_ENRICHED_CD4_TCELL_UP///Genes up-regulated in CD4 [GeneID=920] T cells: Th1 versus Th17 enriched.+++GSE35685_CD34POS_CD10NEG_CD62LPOS_VS_CD34POS_CD10POS_BONE_MARROW_UP///Genes up-regulated in the bone marrow CD34+ [GeneID=947] cells: MME- SELL+[GeneID=4311;6402] versus MME+ [GeneID=4311].+++GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_MAC_DN///Genes down-regulated in comparison of macrophages exposed to L. donovani versus macrophages exposed to 50 worms/well B. malayi.+++GSE37416_CTRL_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP///Genes up-regulated in comparison of control polymorphonuclear leukocytes (PMN) at 24 h versus PMN treated with F. tularensis vaccine at 24 h.+++GSE37416_CTRL_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_UP///Genes up-regulated in comparison of control polymorphonuclear leukocytes (PMN) at 3 h versus PMN treated with F. tularensis vaccine at 3 h.+++GSE6090_UNSTIM_VS_DC_SIGN_STIM_DC_DN///Genes down-regulated in dendritic cells: control versus stimulated with anti-CD209 [GeneID=30835] antibody.+++GSE7509_UNSTIM_VS_IFNA_STIM_IMMATURE_DC_DN///Genes down-regulated in immature dendritic cells: untreated versus interferon alpha.+++GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_AT_DX_DN///Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMCs from patients with type 1 diabetes at the time of diagnosis.+++GSE9006_TYPE_1_VS_TYPE_2_DIABETES_PBMC_AT_DX_UP///Genes up-regulated in peripheral blood mononuclear cells (PBMC) from patients with type 1 diabetes at the time of diagnosis versus those with type 2 diabetes at the time of diagnosis.+++GSE9601_UNTREATED_VS_PI3K_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_UP///Genes up-regulated in monocytes after HCMV infection: untreated versus Ly294002 [PubChem=3973].+++GSE9988_ANTI_TREM1_AND_LPS_VS_CTRL_TREATED_MONOCYTES_DN///Genes down-regulated in comparison of monocytes treated with anti-TREM1 [GeneID=54210] and 5000 ng/ml LPS (TLR4 agonist) versus monocytes treated with control IgG.+++GSE9988_ANTI_TREM1_AND_LPS_VS_VEHICLE_TREATED_MONOCYTES_DN///Genes down-regulated in comparison of monocytes treated with anti-TREM1 [GeneID=54210] and 5000 ng/ml LPS (TLR4 agonist) versus untreated monocytes.+++GSE9988_ANTI_TREM1_VS_VEHICLE_TREATED_MONOCYTES_DN///Genes down-regulated in comparison of monocytes treated with anti-TREM1 [GeneID=54210] versus untreated monocytes.+++GSE9988_LPS_VS_VEHICLE_TREATED_MONOCYTE_DN///Genes down-regulated in comparison of monocytes treated with 1 ng/ml LPS (TLR4 agonist) versus untreated monocytes.+++NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_UP///Genes up-regulated in peripheral blood mononuclear cell 3d vs 0d in adults (18-50) after exposure to Fluarix/Fluvirin , time point 3D. Comment: Supplementary Table 1a: All the differentially expressed genes identified in PBMCs of TIV vaccinees.+++NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_POSITIVE///Genes positively correlated with HAI response at 28d in peripheral blood mononuclear cell in adults (18-50) after exposure to Fluarix/Fluvirin , time point 3D. Comment: Supplementary Table 5: All genes whose expression (d3/d0 or d7/d0) correlates to the fold increase in HAI titers (d28/d0).+++SCHERER_PBMC_APSV_WETVAX_AGE_18_32YO_50_TO_60DY_DN///Genes down-regulated in peripheral blood mononuclear cell (50 to 60)d vs 0d in adults (18-32) after exposure to APSV Wetvax , time point 50 to 60D+++SCHERER_PBMC_YF_VAX_AGE_18_40YO_4_TO_7DY_DN///Genes down-regulated in peripheral blood mononuclear cell (4 to 7)d vs 0d in adults (18-40) after exposure to YF-Vax , time point 4 to 7D+++SCHERER_PBMC_YF_VAX_AGE_18_40YO_ANYD_DN///Genes down-regulated in peripheral blood mononuclear cell in adults (18-40) after exposure to YF-Vax , time point anyD"	HALLMARK_MTORC1_SIGNALING///Genes up-regulated through activation of mTORC1 complex.	XM_011545714	CORO1A				
P26641	sp|P26641|EF1G_HUMAN		EEF1G		Elongation factor 1-gamma OS=Homo sapiens OX=9606 GN=EEF1G PE=1 SV=3 >tr|Q53YD7|Q53YD7_HUMAN Elongation factor 1-gamma OS=Homo sapiens OX=9606 GN=EEF1G PE=2 SV=1	1937	NM_001404	NP_001395	ENST00000329251	K03233			MAAGTLYTYPENWRAFKALIAAQYSGAQVRVLSAPPHFHFGQTNRTPEFLRKFPAGKVPAFEGDDGFCVFESNAIAYYVSNEELRGSTPEAAAQVVQWVSFADSDIVPPASTWVFPTLGIMHHNKQATENAKEEVRRILGLLDAYLKTRTFLVGERVTLADITVVCTLLWLYKQVLEPSFRQAFPNTNRWFLTCINQPQFRAVLGEVKLCEKMAQFDAKKFAETQPKKDTPRKEKGSREEKQKPQAERKEEKKAAAPAPEEEMDECEQALAAEPKAKDPFAHLPKSTFVLDEFKRKYSNEDTLSVALPYFWEHFDKDGWSLWYSEYRFPEELTQTFMSCNLITGMFQRLDKLRKNAFASVILFGTNNSSSISGVWVFRGQELAFPLSPDWQVDYESYTWRKLDPGSEETQTLVREYFSWEGAFQHVGKAFNQGKIFK	0.3373568	-1.567652989	0.001262798		5.5734941	3.8092309	4.3910603	5.7963144	7.6785781	4.965504808	6.287911	7.5826949	7.8607198	7.5277488	8.053566		5.0408128	6.0871131	7.0797823		5.1439955			7.4012191	7.9533354	5.4939294		3.73102593			9.45867	9.2447418	8.665459	9.3380563	7.187134	7.3407494	8.411392	7.8100814	7.7999662	8.377442	7.8671568	9.137298	8.9555978	7.85414689	9.3117824	5.9621384	8.80502463	05134///Legionellosis				GO:0005634///nucleus+++GO:0005737///cytoplasm+++GO:0005783///endoplasmic reticulum+++GO:0005829///cytosol+++GO:0016020///membrane+++GO:0070062///extracellular exosome	GO:0003746///translation elongation factor activity+++GO:0005515///protein binding+++GO:0045296///cadherin binding	GO:0006412///translation+++GO:0006414///translational elongation+++GO:0006749///glutathione metabolic process+++GO:0009615///response to virus	tissueType=Fetal gonad;cancerType=Normal;cellName=Mitotic fetal germ cell+++tissueType=Fetal kidney;cancerType=Normal;cellName=Natural killer T (NKT) cell+++tissueType=Kidney;cancerType=Normal;cellName=B cell+++tissueType=Fetal gonad;cancerType=Normal;cellName=Leydig precursor cell		"Homo sapiens eukaryotic translation elongation factor 1 gamma (EEF1G), mRNA."		"PF00043///Glutathione S-transferase, C-terminal domain+++PF00647///Elongation factor 1 gamma, conserved domain+++PF02798///Glutathione S-transferase, N-terminal domain"	R-HSA-156842///Eukaryotic Translation Elongation+++R-HSA-1643685///Disease+++R-HSA-392499///Metabolism of proteins+++R-HSA-5663202///Diseases of signal transduction by growth factor receptors and second messengers+++R-HSA-72766///Translation+++R-HSA-9700206///Signaling by ALK in cancer+++R-HSA-9725370///Signaling by ALK fusions and activated point mutants		KOG0867///Belongs to the GST superfamily+++KOG1627///translation elongation factor activity		"IPR001662///Elongation factor 1B gamma, C-terminal+++IPR004045///Glutathione S-transferase, N-terminal+++IPR004046///Glutathione S-transferase, C-terminal+++IPR010987///Glutathione S-transferase, C-terminal-like+++IPR036249///Thioredoxin-like superfamily+++IPR036282///Glutathione S-transferase, C-terminal domain superfamily+++IPR036433///Elongation factor EF1B gamma, C-terminal domain superfamily+++IPR040079///Glutathione Transferase family"	[EF1G_HUMAN|Reviewed]RecName: Full=Elongation factor 1-gamma; Short=EF-1-gamma; AltName: Full=eEF-1B gamma;	chr11q12///Ensembl 103 genes in cytogenetic band chr11q12			REACTOME_EUKARYOTIC_TRANSLATION_ELONGATION///Eukaryotic Translation Elongation+++REACTOME_TRANSLATION///Translation				CACBINDINGPROTEIN_Q6///Genes having at least one occurence of the transcription factor binding site V$CACBINDINGPROTEIN_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++GGGTGGRR_PAX4_03///Genes having at least one occurence of the highly conserved motif M56 GGGTGGRR sites. The motif matches transcription factor binding site V$PAX4_03 (v7.4 TRANSFAC).+++TGACCTY_ERR1_Q2///Genes having at least one occurence of the highly conserved motif M25 TGACCTY sites. The motif matches transcription factor binding site V$ERR1_Q2 (v7.4 TRANSFAC).+++YYCATTCAWW_UNKNOWN///Genes having at least one occurence of the highly conserved motif M52 YYCATTCAWW in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).	"BANP_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8N9N5 (BANP) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++DMRT1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9Y5R6 (DMRT1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++EWSR1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q01844 (EWSR1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++FOXE1_TARGET_GENES///Genes containing one or more binding sites for UniProt:O00358 (FOXE1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++GUCY1B1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q02153 (GUCY1B1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HOXA10_TARGET_GENES///Genes containing one or more binding sites for UniProt:P31260 (HOXA10) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ID1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P41134 (ID1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++MORC2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9Y6X9 (MORC2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NFE2L1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q14494 (NFE2L1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NOTCH3_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9UM47 (NOTCH3) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++RAX2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96IS3 (RAX2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SETBP1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9Y6X0 (SETBP1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SETX_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q7Z333 (SETX) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SNAI1_TARGET_GENES///Genes containing one or more binding sites for UniProt:O95863 (SNAI1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++TAF9B_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9HBM6 (TAF9B) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++TASOR_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9UK61 (TASOR) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++TEAD2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q15562 (TEAD2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++UBP1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9NZI7 (UBP1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++WRNIP1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96S55 (WRNIP1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZFHX3_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q15911 (ZFHX3) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF274_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96GC6 (ZNF274) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."	GCM_ACTG1///Neighborhood of ACTG1+++GCM_ANP32B///Neighborhood of ANP32B+++GCM_APEX1///Neighborhood of APEX1+++GCM_CSNK2B///Neighborhood of CSNK2B+++GCM_NPM1///Neighborhood of NPM1+++GCM_TPT1///Neighborhood of TPT1+++GNF2_EIF3S6///Neighborhood of EIF3S6+++GNF2_FBL///Neighborhood of FBL+++GNF2_GLTSCR2///Neighborhood of GLTSCR2+++GNF2_ST13///Neighborhood of ST13+++GNF2_TPT1///Neighborhood of TPT1+++MORF_ACTG1///Neighborhood of ACTG1+++MORF_ANP32B///Neighborhood of ANP32B+++MORF_CCNI///Neighborhood of CCNI+++MORF_EIF4A2///Neighborhood of EIF4A2+++MORF_JUND///Neighborhood of JUND+++MORF_NME2///Neighborhood of NME2+++MORF_NPM1///Neighborhood of NPM1+++MORF_RAN///Neighborhood of RAN+++MORF_TPT1///Neighborhood of TPT1+++MORF_UBE2I///Neighborhood of UBE2I	MODULE_114///Protein biosynthesis and ribosomes.+++MODULE_115///Genes in the cancer module 115.+++MODULE_149///Translation factors.+++MODULE_150///Ttranslation elongation.+++MODULE_151///Genes in the cancer module 151.+++MODULE_159///Translation regulation.+++MODULE_163///Genes in the cancer module 163.+++MODULE_26///Genes in the cancer module 26.+++MODULE_32///Genes in the cancer module 32.+++MODULE_48///Genes in the cancer module 48.+++MODULE_83///Genes in the cancer module 83.+++MODULE_95///Genes in the cancer module 95.	JAK2_DN.V1_DN///Genes down-regulated in HEL cells (erythroleukemia) after knockdown of JAK2 [Gene ID=3717] gene by RNAi.	"FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_UP///Genes up-regulated in blood responders vs poor responders in adults (25-83) (responders) after exposure to Twinrix , time point 0D+++GSE11057_NAIVE_VS_EFF_MEMORY_CD4_TCELL_UP///Genes up-regulated in comparison of naive T cells versus effector memory T cells.+++GSE12845_IGD_POS_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_UP///Genes up-regulated in comparison of IgD+ peripheral blood B cells versus dark zone germincal center B cells.+++GSE13484_UNSTIM_VS_12H_YF17D_VACCINE_STIM_PBMC_UP///Genes up-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) cultured for 0 h versus PBMC cultured for 12 h with YF17D vaccine.+++GSE13485_CTRL_VS_DAY7_YF17D_VACCINE_PBMC_UP///Genes up-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) versus PBMC 7 days after stimulation with YF17D vaccine.+++GSE13485_DAY1_VS_DAY7_YF17D_VACCINE_PBMC_UP///Genes up-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) 1 day after stimulation with YF17D vaccine versus PBMC 7 days after the stimulation.+++GSE14000_TRANSLATED_RNA_VS_MRNA_4H_LPS_DC_DN///Genes down-regulated in comparison of polysome bound (translated) mRNA versus total mRNA 4 h after LPS (TLR4 agonist) stimulation.+++GSE1460_INTRATHYMIC_T_PROGENITOR_VS_DP_THYMOCYTE_UP///Genes up-regulated in comparison of intrathymic T progenitor cells (ITTP) versus CD4 [GeneID=920] CD8 thymocytes. +++GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_DN///Genes down-regulated in comparison of intrathymic T progenitor cells (ITTP) versus naive CD4 [GeneID=920] T cells from adult blood.+++GSE1460_NAIVE_CD4_TCELL_ADULT_BLOOD_VS_THYMIC_STROMAL_CELL_UP///Genes up-regulated in naive CD4 [GeneID=920] T cells from adult blood versus thymic stromal cells.+++GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_IMMATURE_NEURON_CELL_LINE_UP///Genes up-regulated in the immature neuron cell line: control versus infected with western equine encephalitis viruss.+++GSE17186_MEMORY_VS_CD21LOW_TRANSITIONAL_BCELL_DN///Genes down-regulated in B lymphocytes: memory versus transitional CR2 [GeneID=1380] low.+++GSE18893_CTRL_VS_TNF_TREATED_TREG_2H_UP///Genes up-regulated in T reg cells (2h): medium versus TNF [GeneID=7124].+++GSE18893_TCONV_VS_TREG_24H_TNF_STIM_DN///Genes down-regulated in lymphocytes treated with TNF [GeneID=7124] for 24h: T conv versus T reg cells.+++GSE18893_TCONV_VS_TREG_2H_CULTURE_UP///Genes up-regulated in lymphocytes treated with medium for 2h: T conv versus T reg cells.+++GSE20198_UNTREATED_VS_IFNA_TREATED_ACT_CD4_TCELL_DN///Genes down-regulated in the activated CD4 [GeneID=920] T cells (48h): control versus interferon alpha.+++GSE22601_CD4_SINGLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_UP///Genes up-regulated in single positive thymocytes: CD4 [GeneID=920] versus CD8.+++GSE22601_DOUBLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_DN///Genes down-regulated in thymocytes: double positive versus CD8 single positive.+++GSE22886_NAIVE_CD4_TCELL_VS_DC_UP///Genes up-regulated in comparison of naive CD4 [GeneID=920] T cells versus unstimulatd dendritic cells (DC).+++GSE22886_NAIVE_TCELL_VS_DC_UP///Genes up-regulated in comparison of naive CD4 [GeneID=920] CD8 T cells versus unstimulated dendritic cells (DC).+++GSE2405_0H_VS_24H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP///Genes up-regulated in polymorphonuclear leukocytes (24h): control versus infection by A. phagocytophilum.+++GSE2405_0H_VS_9H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN///Genes down-regulated in polymorphonuclear leukocytes (9h): control versus infection by A. phagocytophilum.+++GSE24634_NAIVE_CD4_TCELL_VS_DAY10_IL4_CONV_TREG_UP///Genes up-regulated in comparison of naive T cells at day 0 versus CD25+ regulatory T cell (Treg) treated with IL4 [GeneID=3565] at day 10.+++GSE25085_FETAL_LIVER_VS_ADULT_BM_SP4_THYMIC_IMPLANT_DN///Genes down-regulated in thymic implants from fetal liver versus those from adult bone marrow.+++GSE2706_2H_VS_8H_R848_AND_LPS_STIM_DC_UP///Genes up-regulated in comparison of dendritic cells (DC) stimulated with R848 at 2 h versus DCs stimulated with LPS (TLR4 agonist) at 8 h.+++GSE34156_UNTREATED_VS_6H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN///Genes down-regulated in monocytes (6h): untreated versus M. tuberculosis 19 kDa lipopeptide.+++GSE34205_HEALTHY_VS_FLU_INF_INFANT_PBMC_UP///Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMCs from infanct with acute influenza infection.+++GSE34205_HEALTHY_VS_RSV_INF_INFANT_PBMC_UP///Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMCs from infanct with acute RSV infection.+++GSE360_CTRL_VS_M_TUBERCULOSIS_MAC_UP///Genes up-regulated in comparison of macrophages versus macrophages exposed to M. tuberculosis.+++GSE360_DC_VS_MAC_M_TUBERCULOSIS_DN///Genes down-regulated in comparison of dendritic cells (DC) exposed to M. tuberculosis versus macrophages exposed to L. major.+++GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_UP///Genes up-regulated in comparison of dendritic cells (DC) exposed to 5 worms/well B. malayi versus DC exposed to M. tuberculosis+++GSE3982_EOSINOPHIL_VS_BCELL_DN///Genes down-regulated in comparison of eosinophils versus B cells.+++GSE3982_EOSINOPHIL_VS_CENT_MEMORY_CD4_TCELL_DN///Genes down-regulated in comparison of eosinophils versus central memory CD4 [GeneID=920] T cells.+++GSE3982_MAC_VS_CENT_MEMORY_CD4_TCELL_DN///Genes down-regulated in comparison of macrophages versus central memory CD4 [GeneID=920] T cells.+++GSE3982_MAST_CELL_VS_EFF_MEMORY_CD4_TCELL_DN///Genes down-regulated in comparison of mast cells versus effector memory CD4 [GeneID=920] T cells.+++GSE3982_NEUTROPHIL_VS_BCELL_DN///Genes down-regulated in comparison of neutrophils versus B cells.+++GSE42088_UNINF_VS_LEISHMANIA_INF_DC_2H_DN///Genes down-regulated in dendritic cells: untreated versus 2h after infection of Leishmania major.+++GSE42088_UNINF_VS_LEISHMANIA_INF_DC_4H_DN///Genes down-regulated in dendritic cells: untreated versus 4h after infection of Leishmania major.+++GSE5099_CLASSICAL_M1_VS_ALTERNATIVE_M2_MACROPHAGE_UP///Genes up-regulated in macrophages: classical (M1) versus alternative (M2).+++GSE5099_DAY3_VS_DAY7_MCSF_TREATED_MACROPHAGE_UP///Genes up-regulated upon CSF1 [GeneID=1435] treatment: monocytes (3 days) versus macrophages (7 days).+++GSE5542_UNTREATED_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_DN///Genes down-regulated in epithelial cells (24h): untreated versus interferon alpha and IFNG [GeneID=3458].+++GSE6269_HEALTHY_VS_FLU_INF_PBMC_UP///Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMC from patients with acute influenza infection.+++GSE7400_CTRL_VS_CSF3_IN_VIVO_TREATED_PBMC_UP///Genes up-regulated in comparison of untreated peripheral blood mononuclear cells (PBMC) versus PBMCs treated with CSF3 [GeneID=1440].+++GSE7460_TREG_VS_TCONV_ACT_WITH_TGFB_DN///Genes down-regulated in comparsion of ActTregTGF versus ActCD4TGF (see Fig. 1 in the paper for details).+++GSE7568_IL4_VS_IL4_AND_DEXAMETHASONE_TREATED_MACROPHAGE_UP///Genes up-regulated in macrophages differentiated for 5 days in the presence of: IL4 [GeneID=3565] versus IL4 [GeneID=3565] and dexamethasone [PubChem=5743].+++GSE8685_IL2_ACT_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_DN///Genes down-regulated in Sez-2 cells (T cell lymphoma): untreated versus IL15 [GeneID=3600].+++GSE9960_HEALTHY_VS_GRAM_NEG_SEPSIS_PBMC_UP///Genes up-regulated in peripheral blood monocytes (PMBC): healthy versus Gram negative sepsis.+++SCHERER_PBMC_YF_VAX_AGE_18_40YO_4_TO_7DY_DN///Genes down-regulated in peripheral blood mononuclear cell (4 to 7)d vs 0d in adults (18-40) after exposure to YF-Vax , time point 4 to 7D+++ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_DN///Genes down-regulated in peripheral blood mononuclear cell 1d vs 0d in adults (20-50) after exposure to MRKAd5 HIV-1 gag/pol/nef , time point 1D. Comment: Table includes specific cell types"		NM_001404	EEF1G				
P23528	sp|P23528|COF1_HUMAN		CFL1		"Cofilin-1 OS=Homo sapiens OX=9606 GN=CFL1 PE=1 SV=3 >tr|V9HWI5|V9HWI5_HUMAN Cofilin, non-muscle isoform OS=Homo sapiens OX=9606 GN=HEL-S-15 PE=2 SV=1"								MASGVAVSDGVIKVFNDMKVRKSSTPEEVKKRKKAVLFCLSEDKKNIILEEGKEILVGDVGQTVDDPYATFVKMLPDKDCRYALYDATYETKESKKEDLVFIFWAPESAPLKSKMIYASSKDAIKKKLTGIKHELQANCYEEVKDRCTLAEKLGGSAVISLEGKPL	0.3457076	-1.532375713	0.002900479				4.2491755		4.9311788			6.6651795	5.1942508		5.4596248		4.1514347	4.6151645	3.66217					4.0715844	5.0805788	4.0110546					8.093164	7.2234761	7.754964	8.1053618		6.7713846	6.5268117	4.0818527		6.0983664		8.010507	5.7164017	4.71931378	6.2468762		5.4062034																																	C9606_108089					
P23381	sp|P23381|SYWC_HUMAN				"Tryptophan--tRNA ligase, cytoplasmic OS=Homo sapiens OX=9606 GN=WARS1 PE=1 SV=2 >tr|A0A024R6K8|A0A024R6K8_HUMAN Tryptophan--tRNA ligase, cytoplasmic OS=Homo sapiens OX=9606 GN=WARS PE=2 SV=1"								MPNSEPASLLELFNSIATQGELVRSLKAGNASKDEIDSAVKMLVSLKMSYKAAAGEDYKADCPPGNPAPTSNHGPDATEAEEDFVDPWTVQTSSAKGIDYDKLIVRFGSSKIDKELINRIERATGQRPHHFLRRGIFFSHRDMNQVLDAYENKKPFYLYTGRGPSSEAMHVGHLIPFIFTKWLQDVFNVPLVIQMTDDEKYLWKDLTLDQAYSYAVENAKDIIACGFDINKTFIFSDLDYMGMSSGFYKNVVKIQKHVTFNQVKGIFGFTDSDCIGKISFPAIQAAPSFSNSFPQIFRDRTDIQCLIPCAIDQDPYFRMTRDVAPRIGYPKPALLHSTFFPALQGAQTKMSASDPNSSIFLTDTAKQIKTKVNKHAFSGGRDTIEEHRQFGGNCDVDVSFMYLTFFLEDDDKLEQIRKDYTSGAMLTGELKKALIEVLQPLIAEHQARRKEVTDEIVKEFMTPRKLSFDFQ	0.6519002	-0.617276972	0.0428976	6.7591435	6.5264305	6.0440308	6.2674965	7.3715685	7.1550751	7.065137792	5.7243078	3.7430428	4.2332507	6.5810095	4.7594776	6.08006521	6.6757003	6.2617615	6.3768533	6.1660245	6.1074	3.841767724	4.8998157	5.4205886	5.8809775	7.5191829	7.1560296	6.48616591	8.32001408	7.0419982	8.261693	7.2544249	6.463843	4.5659648	4.347831	5.779572	6.0083573	7.5206907	6.7279492	6.753425	5.8920101	6.544708	7.0512572	5.23005697	6.6490896	5.2993373	6.6474178																																	C9606_78226					
P22792	sp|P22792|CPN2_HUMAN		CPN2		Carboxypeptidase N subunit 2 OS=Homo sapiens OX=9606 GN=CPN2 PE=1 SV=3	1370	NM_001080513	NP_001073982	ENST00000323830				MLPGAWLLWTSLLLLARPAQPCPMGCDCFVQEVFCSDEELATVPLDIPPYTKNIIFVETSFTTLETRAFGSNPNLTKVVFLNTQLCQFRPDAFGGLPRLEDLEVTGSSFLNLSTNIFSNLTSLGKLTLNFNMLEALPEGLFQHLAALESLHLQGNQLQALPRRLFQPLTHLKTLNLAQNLLAQLPEELFHPLTSLQTLKLSNNALSGLPQGVFGKLGSLQELFLDSNNISELPPQVFSQLFCLERLWLQRNAITHLPLSIFASLGNLTFLSLQWNMLRVLPAGLFAHTPCLVGLSLTHNQLETVAEGTFAHLSNLRSLMLSYNAITHLPAGIFRDLEELVKLYLGSNNLTALHPALFQNLSKLELLSLSKNQLTTLPEGIFDTNYNLFNLALHGNPWQCDCHLAYLFNWLQQYTDRLLNIQTYCAGPAYLKGQVVPALNEKQLVCPVTRDHLGFQVTWPDESKAGGSWDLAVQERAARSQCTYSNPEGTVVLACDQAQCRWLNVQLSPQQGSLGLQYNASQEWDLRSSCGSLRLTVSIEARAAGP	1.6486569	0.721291177	0.03748094	8.0805298	6.1310238	6.0957184	6.6261504	7.7133486	6.3325579	8.037871578	8.3349398	8.1878416	5.5373089	6.9116834	8.2194591	6.96714528	8.3165157	7.3424356	7.7298154	8.0235462	9.3457748	9.09502294	9.7943145	7.5401335	10.1355025	8.1273152	7.8140692	6.89484827	6.75383826	7.898572	7.594154	7.9936603	6.604612	5.8949754	6.225825	7.2420455	6.652855	5.6800123	8.515718	6.759928	7.0995394	6.388482	6.2503943	4.83986429	10.1292466	6.983981	6.2862979					GO:0005576///extracellular region+++GO:0005615///extracellular space+++GO:0031012///extracellular matrix+++GO:0070062///extracellular exosome+++GO:0072562///blood microparticle	GO:0030234///enzyme regulator activity	GO:0030449///regulation of complement activation+++GO:0050790///regulation of catalytic activity+++GO:0050821///protein stabilization			"Homo sapiens carboxypeptidase N subunit 2 (CPN2), transcript variant 1, mRNA."		PF13855///Leucine rich repeat	R-HSA-166658///Complement cascade+++R-HSA-168249///Innate Immune System+++R-HSA-168256///Immune System+++R-HSA-977606///Regulation of Complement cascade		KOG0619///regulation of response to stimulus		"IPR000372///Leucine-rich repeat N-terminal domain+++IPR000483///Cysteine-rich flanking region, C-terminal+++IPR001611///Leucine-rich repeat+++IPR003591///Leucine-rich repeat, typical subtype+++IPR032675///Leucine-rich repeat domain superfamily"	[CPN2_HUMAN|Reviewed]RecName: Full=Carboxypeptidase N subunit 2; AltName: Full=Carboxypeptidase N 83 kDa chain; AltName: Full=Carboxypeptidase N large subunit; AltName: Full=Carboxypeptidase N polypeptide 2; AltName: Full=Carboxypeptidase N regulatory subunit; Flags: Precursor;	chr3q29///Ensembl 103 genes in cytogenetic band chr3q29			REACTOME_COMPLEMENT_CASCADE///Complement cascade+++REACTOME_INNATE_IMMUNE_SYSTEM///Innate Immune System	"NABA_ECM_REGULATORS///Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix+++NABA_MATRISOME_ASSOCIATED///Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors+++NABA_MATRISOME///Ensemble of genes encoding extracellular matrix and extracellular matrix-associated proteins "		MIR1199_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1199-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR380_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-380-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4708_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4708-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4709_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4709-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR563///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-563 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6751_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6751-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6751_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6751-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6803_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6803-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7113_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7113-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).		"CBX5_TARGET_GENES///Genes containing one or more binding sites for UniProt:P45973 (CBX5) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++FOXJ2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9P0K8 (FOXJ2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++TCF7_TARGET_GENES///Genes containing one or more binding sites for UniProt:P36402 (TCF7) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZFP3_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96NJ6 (ZFP3) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF223_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9UK11 (ZNF223) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF514_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96K75 (ZNF514) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."	GNF2_GSTM1///Neighborhood of GSTM1+++GNF2_HPN///Neighborhood of HPN+++GNF2_HPX///Neighborhood of HPX+++GNF2_LCAT///Neighborhood of LCAT	"MODULE_23///Liver genes - metabolism and xenobiotics.+++MODULE_481///Genes in the cancer module 481.+++MODULE_544///Genes in the cancer module 544.+++MODULE_55///Genes in the cancer module 55.+++MODULE_88///Heart, liver, kidney and pancreas metabolic and xenobiotic response genes."		"GSE12845_NAIVE_VS_PRE_GC_TONSIL_BCELL_UP///Genes up-regulated in comparison of naive B cell versus pre-germinal tonsil B cells.+++GSE13485_CTRL_VS_DAY1_YF17D_VACCINE_PBMC_DN///Genes down-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) versus PBMC 1 day after stimulation with YF17D vaccine.+++GSE13485_CTRL_VS_DAY21_YF17D_VACCINE_PBMC_DN///Genes down-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) versus PBMC 21 days after stimulation with YF17D vaccine.+++GSE13485_DAY1_VS_DAY3_YF17D_VACCINE_PBMC_UP///Genes up-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) 1 day after stimulation with YF17D vaccine versus PBMC 3 days after the stimulation.+++GSE13485_DAY3_VS_DAY21_YF17D_VACCINE_PBMC_DN///Genes down-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) 3 days after stimulation with YF17D vaccine versus PBMC 21 days after the stimulation.+++GSE16385_ROSIGLITAZONE_VS_UNTREATED_IFNG_TNF_STIM_MACROPHAGE_DN///Genes down-regulated in macrophages (12h): IFNG, TNF [GeneID=3458;7124] and rosiglitazone [PubChem=77999] versus IFNG and TNF [GeneID=3458;7124].+++GSE16386_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_6H_UP///Genes up-regulated in macrophages (6h): IL4 [GeneID=3565] versus IL4 [GeneID=3565] and rosiglitazone [PubChem=77999].+++GSE17186_BLOOD_VS_CORD_BLOOD_NAIVE_BCELL_DN///Genes down-regulated in nave B lymphocytes versus those from cord blood.+++GSE22611_NOD2_TRANSD_VS_CTRL_TRANSD_HEK293_MDP_STIM_2H_UP///Genes up-regulated in HEK293 cells at 2h after stimulation by muramyl dipeptide [PubChem=11620162]: over-expressing mutant NOD2 [GeneID=64127] versus control.+++GSE22886_IL2_VS_IL15_STIM_NKCELL_DN///Genes down-regulated in comparison of NK cells stimulated with IL2 [GeneID=3558] at 16 h versus NK cells stimulated with IL15 [GeneID=3600] at 16 h.+++GSE22886_TH1_VS_TH2_48H_ACT_UP///Genes up-regulated in comparison of stimulated CD4 [GeneID=920] Th1 cells at 48 h versus stimulated CD4 [GeneID=920] Th2 cells at 48 h.+++GSE2706_R848_VS_LPS_2H_STIM_DC_UP///Genes up-regulated in comparison of dendritic cells (DC) stimulated with R848 at 2 h versus DCs stimulated with LPS (TLR4 agonist) for 2 h.+++GSE29618_PRE_VS_DAY7_FLU_VACCINE_BCELL_UP///Genes up-regulated in comparison of B cells from influenza vaccinee pre-vaccination versus those at day 7 post-vaccination.+++GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_PDC_UP///Genes up-regulated in comparison of plasmacytoid dendritic cells (pDC) from TIV influenza vaccinee pre-vaccination versus those at day 7 post-vaccination.+++GSE3982_BASOPHIL_VS_EFF_MEMORY_CD4_TCELL_DN///Genes down-regulated in comparison of basophils versus effector memory CD4 [GeneID=920] T cells.+++GSE3982_BASOPHIL_VS_NKCELL_DN///Genes down-regulated in comparison of basophils versus NK cells.+++GSE3982_BASOPHIL_VS_TH2_DN///Genes down-regulated in comparison of basophils versus Th2 cells.+++GSE3982_MAST_CELL_VS_EFF_MEMORY_CD4_TCELL_DN///Genes down-regulated in comparison of mast cells versus effector memory CD4 [GeneID=920] T cells.+++GSE3982_MAST_CELL_VS_NKCELL_DN///Genes down-regulated in comparison of mast cells versus NK cells.+++GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_1MONTH_POST_DX_DN///Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMCs from patients with type 1 diabetes at 1 month after the diagnosis."		NM_001080513	CPN2				
P21333	sp|P21333|FLNA_HUMAN				Filamin-A OS=Homo sapiens OX=9606 GN=FLNA PE=1 SV=4								MSSSHSRAGQSAAGAAPGGGVDTRDAEMPATEKDLAEDAPWKKIQQNTFTRWCNEHLKCVSKRIANLQTDLSDGLRLIALLEVLSQKKMHRKHNQRPTFRQMQLENVSVALEFLDRESIKLVSIDSKAIVDGNLKLILGLIWTLILHYSISMPMWDEEEDEEAKKQTPKQRLLGWIQNKLPQLPITNFSRDWQSGRALGALVDSCAPGLCPDWDSWDASKPVTNAREAMQQADDWLGIPQVITPEEIVDPNVDEHSVMTYLSQFPKAKLKPGAPLRPKLNPKKARAYGPGIEPTGNMVKKRAEFTVETRSAGQGEVLVYVEDPAGHQEEAKVTANNDKNRTFSVWYVPEVTGTHKVTVLFAGQHIAKSPFEVYVDKSQGDASKVTAQGPGLEPSGNIANKTTYFEIFTAGAGTGEVEVVIQDPMGQKGTVEPQLEARGDSTYRCSYQPTMEGVHTVHVTFAGVPIPRSPYTVTVGQACNPSACRAVGRGLQPKGVRVKETADFKVYTKGAGSGELKVTVKGPKGEERVKQKDLGDGVYGFEYYPMVPGTYIVTITWGGQNIGRSPFEVKVGTECGNQKVRAWGPGLEGGVVGKSADFVVEAIGDDVGTLGFSVEGPSQAKIECDDKGDGSCDVRYWPQEAGEYAVHVLCNSEDIRLSPFMADIRDAPQDFHPDRVKARGPGLEKTGVAVNKPAEFTVDAKHGGKAPLRVQVQDNEGCPVEALVKDNGNGTYSCSYVPRKPVKHTAMVSWGGVSIPNSPFRVNVGAGSHPNKVKVYGPGVAKTGLKAHEPTYFTVDCAEAGQGDVSIGIKCAPGVVGPAEADIDFDIIRNDNDTFTVKYTPRGAGSYTIMVLFADQATPTSPIRVKVEPSHDASKVKAEGPGLSRTGVELGKPTHFTVNAKAAGKGKLDVQFSGLTKGDAVRDVDIIDHHDNTYTVKYTPVQQGPVGVNVTYGGDPIPKSPFSVAVSPSLDLSKIKVSGLGEKVDVGKDQEFTVKSKGAGGQGKVASKIVGPSGAAVPCKVEPGLGADNSVVRFLPREEGPYEVEVTYDGVPVPGSPFPLEAVAPTKPSKVKAFGPGLQGGSAGSPARFTIDTKGAGTGGLGLTVEGPCEAQLECLDNGDGTCSVSYVPTEPGDYNINILFADTHIPGSPFKAHVVPCFDASKVKCSGPGLERATAGEVGQFQVDCSSAGSAELTIEICSEAGLPAEVYIQDHGDGTHTITYIPLCPGAYTVTIKYGGQPVPNFPSKLQVEPAVDTSGVQCYGPGIEGQGVFREATTEFSVDARALTQTGGPHVKARVANPSGNLTETYVQDRGDGMYKVEYTPYEEGLHSVDVTYDGSPVPSSPFQVPVTEGCDPSRVRVHGPGIQSGTTNKPNKFTVETRGAGTGGLGLAVEGPSEAKMSCMDNKDGSCSVEYIPYEAGTYSLNVTYGGHQVPGSPFKVPVHDVTDASKVKCSGPGLSPGMVRANLPQSFQVDTSKAGVAPLQVKVQGPKGLVEPVDVVDNADGTQTVNYVPSREGPYSISVLYGDEEVPRSPFKVKVLPTHDASKVKASGPGLNTTGVPASLPVEFTIDAKDAGEGLLAVQITDPEGKPKKTHIQDNHDGTYTVAYVPDVTGRYTILIKYGGDEIPFSPYRVRAVPTGDASKCTVTVSIGGHGLGAGIGPTIQIGEETVITVDTKAAGKGKVTCTVCTPDGSEVDVDVVENEDGTFDIFYTAPQPGKYVICVRFGGEHVPNSPFQVTALAGDQPSVQPPLRSQQLAPQYTYAQGGQQTWAPERPLVGVNGLDVTSLRPFDLVIPFTIKKGEITGEVRMPSGKVAQPTITDNKDGTVTVRYAPSEAGLHEMDIRYDNMHIPGSPLQFYVDYVNCGHVTAYGPGLTHGVVNKPATFTVNTKDAGEGGLSLAIEGPSKAEISCTDNQDGTCSVSYLPVLPGDYSILVKYNEQHVPGSPFTARVTGDDSMRMSHLKVGSAADIPINISETDLSLLTATVVPPSGREEPCLLKRLRNGHVGISFVPKETGEHLVHVKKNGQHVASSPIPVVISQSEIGDASRVRVSGQGLHEGHTFEPAEFIIDTRDAGYGGLSLSIEGPSKVDINTEDLEDGTCRVTYCPTEPGNYIINIKFADQHVPGSPFSVKVTGEGRVKESITRRRRAPSVANVGSHCDLSLKIPEISIQDMTAQVTSPSGKTHEAEIVEGENHTYCIRFVPAEMGTHTVSVKYKGQHVPGSPFQFTVGPLGEGGAHKVRAGGPGLERAEAGVPAEFSIWTREAGAGGLAIAVEGPSKAEISFEDRKDGSCGVAYVVQEPGDYEVSVKFNEEHIPDSPFVVPVASPSGDARRLTVSSLQESGLKVNQPASFAVSLNGAKGAIDAKVHSPSGALEECYVTEIDQDKYAVRFIPRENGVYLIDVKFNGTHIPGSPFKIRVGEPGHGGDPGLVSAYGAGLEGGVTGNPAEFVVNTSNAGAGALSVTIDGPSKVKMDCQECPEGYRVTYTPMAPGSYLISIKYGGPYHIGGSPFKAKVTGPRLVSNHSLHETSSVFVDSLTKATCAPQHGAPGPGPADASKVVAKGLGLSKAYVGQKSSFTVDCSKAGNNMLLVGVHGPRTPCEEILVKHVGSRLYSVSYLLKDKGEYTLVVKWGDEHIPGSPYRVVVP	0.2263602	-2.143307835	4.86E-04	7.4785141	10.1807479	9.7830598	9.7820719	9.7162657	12.1825083	9.527680185	10.7383099	12.7538012	12.8318403	12.271164	12.5327053	7.64058586	10.1661323	11.4012331	12.0209029	6.9190334	10.5758398	5.333347311	5.177191	11.952526	12.0427849	13.1990909	9.2347711	9.73522265	9.44021206	9.0025816	14.757577	13.7496636	13.940455	14.4435323	11.91455	12.1707318	12.7772573	12.6518195	12.4949503	12.7773886	11.9340429	13.510205	12.8122447	12.27239108	12.9814667	11.4229954	12.93786757																																	C9606_108331					
P21291	sp|P21291|CSRP1_HUMAN		CSRP1		Cysteine and glycine-rich protein 1 OS=Homo sapiens OX=9606 GN=CSRP1 PE=1 SV=3 >tr|A0A384P5K2|A0A384P5K2_HUMAN Epididymis secretory sperm binding protein OS=Homo sapiens OX=9606 PE=2 SV=1	1465	NM_004078	NP_004069	ENST00000340006				MPNWGGGKKCGVCQKTVYFAEEVQCEGNSFHKSCFLCMVCKKNLDSTTVAVHGEEIYCKSCYGKKYGPKGYGYGQGAGTLSTDKGESLGIKHEEAPGHRPTTNPNASKFAQKIGGSERCPRCSQAVYAAEKVIGAGKSWHKACFRCAKCGKGLESTTLADKDGEIYCKGCYAKNFGPKGFGFGQGAGALVHSE	0.4782695	-1.064104439	0.01083121		3.0809833			1.4556824	4.2518802		3.9116373	3.7357548	3.9242633	4.1966651	4.6037379			3.0412415	3.6881048					4.4239127	5.5663736	3.6644934	1.8737732				6.556352	5.879783	6.229326	6.0012034	3.591708	4.4718268	4.4428461	4.6659864	3.8453684	5.2936994	4.0880353	6.429089	5.500267	4.60251854	6.457967	4.0612171	5.20623274		H00292///Hypertrophic cardiomyopathy+++H00294///Dilated cardiomyopathy			GO:0005634///nucleus+++GO:0005737///cytoplasm+++GO:0005925///focal adhesion+++GO:0030018///Z disc+++GO:0070062///extracellular exosome	GO:0003723///RNA binding+++GO:0005515///protein binding+++GO:0008270///zinc ion binding+++GO:0008307///structural constituent of muscle+++GO:0042805///actinin binding+++GO:0046872///metal ion binding	GO:0030036///actin cytoskeleton organization+++GO:0045214///sarcomere organization+++GO:0060537///muscle tissue development+++GO:0070527///platelet aggregation	tissueType=Liver;cancerType=Normal;cellName=Liver bud hepatic cell+++tissueType=Fetal gonad;cancerType=Normal;cellName=Gonadal endothelial cell+++tissueType=Blood;cancerType=Normal;cellName=CD141+CLEC9A+ dendritic cell		"Homo sapiens cysteine and glycine rich protein 1 (CSRP1), transcript variant 1, mRNA."		PF00412///LIM domain	R-HSA-5660489///MTF1 activates gene expression+++R-HSA-5660526///Response to metal ions+++R-HSA-8953897///Cellular responses to stimuli		KOG1700///sulfur oxidation		"IPR001781///Zinc finger, LIM-type"	[CSRP1_HUMAN|Reviewed]RecName: Full=Cysteine and glycine-rich protein 1; AltName: Full=Cysteine-rich protein 1; Short=CRP; Short=CRP1; AltName: Full=Epididymis luminal protein 141; Short=HEL-141;+++[Q9BTA4_HUMAN|Unreviewed]SubName: Full=Epididymis secretory protein Li 286 {ECO:0000313|EMBL:ACV87179.1}; SubName: Full=Similar to cysteine and glycine-rich protein 1 {ECO:0000313|EMBL:AAH04265.1}; Flags: Fragment;	chr1q32///Ensembl 103 genes in cytogenetic band chr1q32			REACTOME_CELLULAR_RESPONSES_TO_EXTERNAL_STIMULI///Cellular responses to external stimuli+++REACTOME_RESPONSE_TO_METAL_IONS///Response to metal ions		"TCCCCAC_MIR491///Genes having at least one occurence of the motif TCCCCAC in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-491 (v7.1 miRBase)."	"MIR1207_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1207-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR129_1_3P_MIR129_2_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-129-1-3p, hsa-miR-129-2-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR224_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-224-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3606_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3606-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3934_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3934-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4471///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4471 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4651///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4651 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4763_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4763-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR491_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-491-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR608///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-608 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR615_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-615-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR8059///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-8059 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR921///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-921 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets)."	CCAWWNAAGG_SRF_Q4///Genes having at least one occurence of the highly conserved motif M121 CCAWWNAAGG sites. The motif matches transcription factor binding site V$SRF_Q4 (v7.4 TRANSFAC).+++E2F_Q2///Genes having at least one occurence of the transcription factor binding site V$E2F_Q2 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++SRF_Q4///Genes having at least one occurence of the transcription factor binding site V$SRF_Q4 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++SRF_Q5_01///Genes having at least one occurence of the transcription factor binding site V$SRF_Q5_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.	"ATF6_TARGET_GENES///Genes containing one or more binding sites for UniProt:P18850 (ATF6) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++DLX6_TARGET_GENES///Genes containing one or more binding sites for UniProt:P56179 (DLX6) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++GTF2A2_TARGET_GENES///Genes containing one or more binding sites for UniProt:P52657 (GTF2A2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HMGB1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P09429 (HMGB1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++IRF9_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q00978 (IRF9) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++MORC2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9Y6X9 (MORC2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++PHF2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O75151 (PHF2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++UBN1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9NPG3 (UBN1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZMYM2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9UBW7 (ZMYM2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF592_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q92610 (ZNF592) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF766_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q5HY98 (ZNF766) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF8_TARGET_GENES///Genes containing one or more binding sites for UniProt:P17098 (ZNF8) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZSCAN5DP_TARGET_GENES///Genes containing one or more binding sites for UniProt:P0CG00 (ZSCAN5DP) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."		MODULE_1///Ovary genes.+++MODULE_2///DRG (dorsal root ganglia) genes.+++MODULE_5///Lung genes.		"GSE12198_LOW_IL2_STIM_NK_CELL_VS_HIGH_IL2_STIM_NK_CELL_DN///Genes down-regulated in NK cells: low dose versus high dose of IL2 [GeneID=3558].+++GSE12845_IGD_POS_VS_NEG_BLOOD_BCELL_DN///Genes down-regulated in comparison of IgD+ B cells versus IgD- B cells.+++GSE13484_12H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_UP///Genes up-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) cultured for 12 h versus PBMC cultured for 12 h with YF17D vaccine.+++GSE15139_GMCSF_TREATED_VS_UNTREATED_NEUTROPHILS_UP///Genes up-regulated in neutrophils treated with CSF2 [GeneID=1437] versus control.+++GSE16385_MONOCYTE_VS_12H_IL4_TREATED_MACROPHAGE_UP///Genes up-regulated in monocytes (12h) versus macrophages (12h) treated with IL4 [GeneID=3565].+++GSE16385_ROSIGLITAZONE_VS_UNTREATED_IFNG_TNF_STIM_MACROPHAGE_UP///Genes up-regulated in macrophages (12h): IFNG, TNF [GeneID=3458;7124] and rosiglitazone [PubChem=77999] versus IFNG and TNF [GeneID=3458;7124].+++GSE16450_CTRL_VS_IFNA_6H_STIM_MATURE_NEURON_CELL_LINE_DN///Genes down-regulated in mature neuron cell line: control versus interferon alpha (6h).+++GSE17186_MEMORY_VS_CD21HIGH_TRANSITIONAL_BCELL_DN///Genes down-regulated in B lymphocytes: memory versus transitional CR2 [GeneID=1380] high.+++GSE17974_0H_VS_4H_IN_VITRO_ACT_CD4_TCELL_UP///Genes up-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the untreated cells at 4 h.+++GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_10H_UP///Genes up-regulated in comparison of control conventional dendritic cells (cDC) at 10 h versus cDCs infected with Newcastle disease virus (NDV) at 10 h.+++GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_18H_UP///Genes up-regulated in comparison of control conventional dendritic cells (cDC) at 18 h versus cDCs infected with Newcastle disease virus (NDV) at 18 h.+++GSE20198_IL12_VS_IL12_IL18_TREATED_ACT_CD4_TCELL_UP///Genes up-regulated in the activated CD4 [GeneID=920] T cells (48h): IL-12 versus IL-12 and IL18 [GeneID=3606].+++GSE20198_UNTREATED_VS_IFNA_TREATED_ACT_CD4_TCELL_DN///Genes down-regulated in the activated CD4 [GeneID=920] T cells (48h): control versus interferon alpha.+++GSE22601_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN///Genes down-regulated in thymocytes: double positive versus CD4 [GeneID=920] single positive.+++GSE22886_DAY0_VS_DAY7_MONOCYTE_IN_CULTURE_DN///Genes down-regulated in comparison of monocytes cultured for 0 days versus those cultured for 7 days.+++GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_6H_UP///Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: IL-12 (6h) versus IL4 [GeneID=3565] (6h).+++GSE29617_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_2008_DN///Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from TIV influenza vaccinee pre-vaccination versus those at day 3 post-vaccination.+++GSE29618_MONOCYTE_VS_PDC_UP///Genes up-regulated in comparison of monocytes versus plasmacytoid dendritic cells (pDC).+++GSE29618_PDC_VS_MDC_DAY7_FLU_VACCINE_DN///Genes down-regulated in comparison of plasmacytoid dendritic cells (DC) from influenza vaccinee at day 7 post-vaccination versus myeloid DCs at day 7 post-vaccination.+++GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_DN///Genes down-regulated in comparison of macrophages exposed to 50 worms/well B. malayi versus macrophages exposed to M. tuberculosis.+++GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_DC_DN///Genes down-regulated in comparison of dendritic cells (DC) exposed to L. donovani versus DCs exposed to 5 worm/well B. malayi.+++GSE360_L_MAJOR_VS_M_TUBERCULOSIS_MAC_DN///Genes down-regulated in comparison of macrophages exposed to L. major versus macrophages exposed to M. tuberculosis.+++GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_UP///Genes up-regulated in comparison of dendritic cells (DC) exposed to 5 worms/well B. malayi versus DC exposed to M. tuberculosis+++GSE3920_UNTREATED_VS_IFNG_TREATED_ENDOTHELIAL_CELL_UP///Genes up-regulated in endothelial cells: untreated versus IFNG [GeneID=3458].+++GSE3982_CTRL_VS_IGE_STIM_MAST_CELL_DN///Genes down-regulated in comparison of untreated mast cells versus mast cells treated with IgE at 2 h.+++GSE3982_EOSINOPHIL_VS_NEUTROPHIL_UP///Genes up-regulated in comparison of eosinophils versus neutrophils.+++GSE3982_MAC_VS_NEUTROPHIL_UP///Genes up-regulated in comparison of macrophages versus neutrophils.+++GSE3982_NEUTROPHIL_VS_EFF_MEMORY_CD4_TCELL_DN///Genes down-regulated in comparison of neutrophils versus effector memory CD4 [GeneID=920] T cells.+++GSE8685_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_DN///Genes down-regulated in Sez-2 cells (T cell lymphoma): untreated versus IL5 [GeneID=3567].+++GSE8685_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_DN///Genes down-regulated in Sez-2 cells (T cell lymphoma): untreated versus IL21 [GeneID=59067].+++GSE9601_UNTREATED_VS_PI3K_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_UP///Genes up-regulated in monocytes after HCMV infection: untreated versus Ly294002 [PubChem=3973].+++NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_UP///Genes up-regulated in peripheral blood mononuclear cell 3d vs 0d in adults (18-50) after exposure to Fluarix/Fluvirin , time point 3D. Comment: Supplementary Table 1a: All the differentially expressed genes identified in PBMCs of TIV vaccinees.+++ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_UP///Genes up-regulated in peripheral blood mononuclear cell 1d vs 0d in adults (20-50) after exposure to MRKAd5 HIV-1 gag/pol/nef , time point 1D. Comment: Table includes specific cell types"	"HALLMARK_COAGULATION///Genes encoding components of blood coagulation system; also up-regulated in platelets.+++HALLMARK_COMPLEMENT///Genes encoding components of the complement system, which is part of the innate immune system."	NM_004078	CSRP1				
P14317	sp|P14317|HCLS1_HUMAN				Hematopoietic lineage cell-specific protein OS=Homo sapiens OX=9606 GN=HCLS1 PE=1 SV=3								MWKSVVGHDVSVSVETQGDDWDTDPDFVNDISEKEQRWGAKTIEGSGRTEHINIHQLRNKVSEEHDVLRKKEMESGPKASHGYGGRFGVERDRMDKSAVGHEYVAEVEKHSSQTDAAKGFGGKYGVERDRADKSAVGFDYKGEVEKHTSQKDYSRGFGGRYGVEKDKWDKAALGYDYKGETEKHESQRDYAKGFGGQYGIQKDRVDKSAVGFNEMEAPTTAYKKTTPIEAASSGTRGLKAKFESMAEEKRKREEEEKAQQVARRQQERKAVTKRSPEAPQPVIAMEEPAVPAPLPKKISSEAWPPVGTPPSSESEPVRTSREHPVPLLPIRQTLPEDNEEPPALPPRTLEGLQVEEEPVYEAEPEPEPEPEPEPENDYEDVEEMDRHEQEDEPEGDYEEVLEPEDSSFSSALAGSSGCPAGAGAGAVALGISAVAVYDYQGEGSDELSFDPDDVITDIEMVDEGWWRGRCHGHFGLFPANYVKLLE	0.6069294	-0.720399298	0.03599108						3.9398345		3.7958117	4.21078	4.6726756	4.1743851	4.6539038				4.67909					4.4429573	5.4006652	3.4487981					7.0111	5.4861737	5.802018	4.9008946		3.5096831	4.6209708	4.2822659	5.4055341	5.7230819		5.846675	5.6066324	4.87899406	5.1219395		5.77806741																																	C9606_85951					
P14174	sp|P14174|MIF_HUMAN		MIF		Macrophage migration inhibitory factor OS=Homo sapiens OX=9606 GN=MIF PE=1 SV=4 >tr|I4AY87|I4AY87_HUMAN Epididymis secretory sperm binding protein (Fragment) OS=Homo sapiens OX=9606 GN=MIF PE=2 SV=1	4282	rna-NM_002415.2-2						MPMFIVNTNVPRASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPCALCSLHSIGKIGGAQNRSYSKLLCGLLAERLRISPDRVYINYYDMNAANVGWNNSTFA	0.4467747	-1.162380665	0.001709786	6.6160054	6.9986113	6.7336888	7.5468156	7.280535	9.4515156	7.672312365	8.800052	7.0275222	8.6814632	9.2006565	8.8770308	7.98198333	8.7671029	6.942111	7.7606976	7.4799354	8.1163342	6.722361985	7.5259879	8.4198336	9.8727359	9.4927333	7.8732334	6.19363536	7.39031106	7.5420172	12.275826	9.723608	10.694907	10.1971596	7.22726	9.2220602	9.1881037	10.0033132	8.2920432	9.5050341	8.0280057	10.311235	9.9356828	9.20968276	10.0883193	7.3369215	10.31657431																																	rna-NM_002415.2-2	MIF				
P11940	sp|P11940|PABP1_HUMAN		PABPC1		Polyadenylate-binding protein 1 OS=Homo sapiens OX=9606 GN=PABPC1 PE=1 SV=2 >tr|A0A024R9C1|A0A024R9C1_HUMAN Polyadenylate-binding protein OS=Homo sapiens OX=9606 GN=PABPC1 PE=3 SV=1								MNPSAPSYPMASLYVGDLHPDVTEAMLYEKFSPAGPILSIRVCRDMITRRSLGYAYVNFQQPADAERALDTMNFDVIKGKPVRIMWSQRDPSLRKSGVGNIFIKNLDKSIDNKALYDTFSAFGNILSCKVVCDENGSKGYGFVHFETQEAAERAIEKMNGMLLNDRKVFVGRFKSRKEREAELGARAKEFTNVYIKNFGEDMDDERLKDLFGKFGPALSVKVMTDESGKSKGFGFVSFERHEDAQKAVDEMNGKELNGKQIYVGRAQKKVERQTELKRKFEQMKQDRITRYQGVNLYVKNLDDGIDDERLRKEFSPFGTITSAKVMMEGGRSKGFGFVCFSSPEEATKAVTEMNGRIVATKPLYVALAQRKEERQAHLTNQYMQRMASVRAVPNPVINPYQPAPPSGYFMAAIPQTQNRAAYYPPSQIAQLRPSPRWTAQGARPHPFQNMPGAIRPAAPRPPFSTMRPASSQVPRVMSTQRVANTSTQTMGPRPAAAAAAATPAVRTVPQYKYAAGVRNPQQHLNAQPQVTMQQPAVHVQGQEPLTASMLASAPPQEQKQMLGERLFPLIQAMHPTLAGKITGMLLEIDNSELLHMLESPESLRSKVDEAVAVLQAHQAKEAAQKAVNSATGVPTV	0.3200955	-1.643425766	2.70E-05		3.0626683	4.2642327	4.2301521	4.6415458	5.5142142		4.6976355	5.9198383	6.5607126	5.0121167	5.9394326	4.30907433	4.1160771	4.3364893	5.6159729		4.4624064	3.19329728		5.5861924	6.1334371	5.9835559	4.3288822				8.78853	7.9880694	7.888198	7.9460465	5.15708	6.1383285	5.6832303	5.5264218	5.4017452	6.9136705	5.9140016	7.471099	6.7944406	5.71060284	7.6095081	5.0950943	7.34849724																																	C9606_29939					
P10645	sp|P10645|CMGA_HUMAN		CHGA		Chromogranin-A OS=Homo sapiens OX=9606 GN=CHGA PE=1 SV=7	1113	XM_011536370	XP_011534672					MRSAAVLALLLCAGQVTALPVNSPMNKGDTEVMKCIVEVISDTLSKPSPMPVSQECFETLRGDERILSILRHQNLLKELQDLALQGAKERAHQQKKHSGFEDELSEVLENQSSQAELKEAVEEPSSKDVMEKREDSKEAEKSGEATDGARPQALPEPMQESKAEGNNQAPGEEEEEEEEATNTHPPASLPSQKYPGPQAEGDSEGLSQGLVDREKGLSAEPGWQAKREEEEEEEEEAEAGEEAVPEEEGPTVVLNPHPSLGYKEIRKGESRSEALAVDGAGKPGAEEAQDPEGKGEQEHSQQKEEEEEMAVVPQGLFRGGKSGELEQEEERLSKEWEDSKRWSKMDQLAKELTAEKRLEGQEEEEDNRDSSMKLSFRARAYGFRGPGPQLRRGWRPSSREDSLEAGLPLQVRGYPEEKKEEEGSANRRPEDQELESLSAIEAELEKVAHQLQALRRG	1.7003234	0.765809148	0.04356863					5.0228736			6.6401493	5.7343576	6.0732734	5.302388	5.1318025		5.6937549			8.5097927	5.3562941		5.7252736	4.9560206	4.668228	5.2577641		5.05357064											5.4484278			5.141099	4.2675906	4.90456296	4.9906794		4.68597073					GO:0005576///extracellular region+++GO:0005615///extracellular space+++GO:0005796///Golgi lumen+++GO:0016914///follicle-stimulating hormone complex+++GO:0030133///transport vesicle+++GO:0030141///secretory granule+++GO:0031410///cytoplasmic vesicle+++GO:0042583///chromaffin granule+++GO:0048471///perinuclear region of cytoplasm+++GO:0098992///neuronal dense core vesicle	GO:0005179///hormone activity+++GO:0005515///protein binding+++GO:0016913///follicle-stimulating hormone activity	GO:0002026///regulation of the force of heart contraction+++GO:0002551///mast cell chemotaxis+++GO:0006590///thyroid hormone generation+++GO:0006996///organelle organization+++GO:0007165///signal transduction+++GO:0007186///G protein-coupled receptor signaling pathway+++GO:0008217///regulation of blood pressure+++GO:0008284///positive regulation of cell proliferation+++GO:0008406///gonad development+++GO:0010469///regulation of signaling receptor activity+++GO:0010893///positive regulation of steroid biosynthetic process+++GO:0019730///antimicrobial humoral response+++GO:0030335///positive regulation of cell migration+++GO:0030878///thyroid gland development+++GO:0031640///killing of cells of other organism+++GO:0032275///luteinizing hormone secretion+++GO:0032870///cellular response to hormone stimulus+++GO:0033366///protein localization to secretory granule+++GO:0033604///negative regulation of catecholamine secretion+++GO:0042742///defense response to bacterium+++GO:0043303///mast cell degranulation+++GO:0045087///innate immune response+++GO:0045576///mast cell activation+++GO:0045944///positive regulation of transcription by RNA polymerase II+++GO:0046621///negative regulation of organ growth+++GO:0046676///negative regulation of insulin secretion+++GO:0046884///follicle-stimulating hormone secretion+++GO:0048589///developmental growth+++GO:0050829///defense response to Gram-negative bacterium+++GO:0050830///defense response to Gram-positive bacterium+++GO:0050832///defense response to fungus+++GO:0060452///positive regulation of cardiac muscle contraction+++GO:0086030///adenylate cyclase-activating adrenergic receptor signaling pathway involved in cardiac muscle relaxation+++GO:1900738///positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathway+++GO:1901215///negative regulation of neuron death+++GO:1901899///positive regulation of relaxation of cardiac muscle+++GO:2000707///positive regulation of dense core granule biogenesis	tissueType=Large intestine;cancerType=Normal;cellName=Goblet cell		"PREDICTED: Homo sapiens chromogranin A (CHGA), transcript variant X1, mRNA."		PF01271///Granin (chromogranin or secretogranin)	R-HSA-168249///Innate Immune System+++R-HSA-168256///Immune System+++R-HSA-6803157///Antimicrobial peptides		ENOG502RZBD///No_INFO		"IPR001819///Chromogranin A/B+++IPR001990///Chromogranin A/B/C+++IPR018054///Chromogranin, conserved site"	"[CMGA_HUMAN|Reviewed]RecName: Full=Chromogranin-A; Short=CgA; AltName: Full=Pituitary secretory protein I; Short=SP-I; Contains: RecName: Full=Vasostatin-1; AltName: Full=Vasostatin I; Contains: RecName: Full=Vasostatin-2; AltName: Full=Vasostatin II; Contains: RecName: Full=EA-92; Contains: RecName: Full=ES-43; Contains: RecName: Full=Pancreastatin; Contains: RecName: Full=SS-18; Contains: RecName: Full=WA-8; Contains: RecName: Full=WE-14; Contains: RecName: Full=LF-19; Contains: RecName: Full=Catestatin {ECO:0000303|PubMed:10781584, ECO:0000303|PubMed:17991725}; AltName: Full=SL21 {ECO:0000303|PubMed:24723458}; Contains: RecName: Full=AL-11; Contains: RecName: Full=GV-19; Contains: RecName: Full=GR-44; Contains: RecName: Full=ER-37; Contains: RecName: Full=GE-25 {ECO:0000303|PubMed:7535395}; Contains: RecName: Full=Serpinin-RRG; Contains: RecName: Full=Serpinin; Contains: RecName: Full=p-Glu serpinin precursor; Flags: Precursor;+++[C0KRQ8_HUMAN|Unreviewed]RecName: Full=Glycoprotein hormones alpha chain {ECO:0000256|RuleBase:RU362129}; Flags: Fragment;+++[Q96QJ4_HUMAN|Unreviewed]RecName: Full=Glycoprotein hormones alpha chain {ECO:0000256|RuleBase:RU362129};"	chr14q32///Ensembl 103 genes in cytogenetic band chr14q32			REACTOME_ANTIMICROBIAL_PEPTIDES///Antimicrobial peptides+++REACTOME_INNATE_IMMUNE_SYSTEM///Innate Immune System			MIR3173_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3173-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4433A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4433a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4685_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4685-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5191///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5191 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6508_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6508-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6721_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6721-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6799_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6799-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6811_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6811-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6837_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6837-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6882_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6882-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).	CAGNWMCNNNGAC_UNKNOWN///Genes having at least one occurence of the highly conserved motif M143 CAGNWMCNNNGAC in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++CATRRAGC_UNKNOWN///Genes having at least one occurence of the highly conserved motif M134 CATRRAGC in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++CTGCAGY_UNKNOWN///Genes having at least one occurence of the highly conserved motif M101 CTGCAGY in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++CTTTGA_LEF1_Q2///Genes having at least one occurence of the highly conserved motif M73 CTTTGA sites. The motif matches transcription factor binding site V$LEF1_Q2 (v7.4 TRANSFAC).+++MYB_Q3///Genes having at least one occurence of the transcription factor binding site V$MYB_Q3 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++NF1_Q6_01///Genes having at least one occurence of the transcription factor binding site V$NF1_Q6_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++NF1_Q6///Genes having at least one occurence of the transcription factor binding site V$NF1_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++NRSF_01///Genes having at least one occurence of the transcription factor binding site V$NRSF_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++SF1_Q6///Genes having at least one occurence of the transcription factor binding site V$SF1_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++TGACCTTG_SF1_Q6///Genes having at least one occurence of the highly conserved motif M38 TGACCTTG sites. The motif matches transcription factor binding site V$SF1_Q6 (v7.4 TRANSFAC).+++TGACCTY_ERR1_Q2///Genes having at least one occurence of the highly conserved motif M25 TGACCTY sites. The motif matches transcription factor binding site V$ERR1_Q2 (v7.4 TRANSFAC).	"ZNF768_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9H5H4 (ZNF768) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF7_TARGET_GENES///Genes containing one or more binding sites for UniProt:P17097 (ZNF7) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."		"MODULE_100///Genes in the cancer module 100.+++MODULE_112///Genes in the cancer module 112.+++MODULE_11///Genes in the cancer module 11.+++MODULE_137///CNS genes.+++MODULE_176///Signaling.+++MODULE_19///Adrenal gland - metabolic genes.+++MODULE_1///Ovary genes.+++MODULE_213///NCI cell lines expression clusters.+++MODULE_324///Metal / Ca ion binding.+++MODULE_33///Immune / stress response genes.+++MODULE_381///Genes in the cancer module 381.+++MODULE_55///Genes in the cancer module 55.+++MODULE_66///Genes in the cancer module 66.+++MODULE_72///Testis genes.+++MODULE_88///Heart, liver, kidney and pancreas metabolic and xenobiotic response genes.+++MODULE_94///Signaling."	CYCLIN_D1_UP.V1_UP///Genes up-regulated in MCF-7 cells (breast cancer) over-expressing CCND1 [Gene ID=595] gene.+++KRAS.300_UP.V1_UP///Genes up-regulated in four lineages of epithelial cell lines over-expressing an oncogenic form of KRAS [Gene ID=3845] gene.+++KRAS.600_UP.V1_UP///Genes up-regulated in four lineages of epithelial cell lines over-expressing an oncogenic form of KRAS [Gene ID=3845] gene.+++KRAS.KIDNEY_UP.V1_UP///Genes up-regulated in epithelial kidney cancer cell lines over-expressing an oncogenic form of KRAS [Gene ID=3845] gene.+++P53_DN.V1_DN///Genes down-regulated in NCI-60 panel of cell lines with mutated TP53 [Gene ID=7157].	"GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_2MO_DN///Genes down-regulated in peripheral blood mononuclear cell 2m vs 0m in young adults (18-25) after exposure to HPV-16 L1 VLP , time point 2M. Comment: Gene Expression with Neutralizing Antibody Levels+++GSE13887_ACT_CD4_VS_NO_TREATED_CD4_TCELL_UP///Genes up-regulated in CD4 [GeneID=920] T cells from healthy donors: activated by anti-CD3 and anti-CD28 versus nitric oxide [PubChem=145068] treatment.+++GSE16385_UNTREATED_VS_12H_IL4_TREATED_MACROPHAGE_UP///Genes up-regulated in macrophages (12h): control versus IL4 [GeneID=3565].+++GSE19888_ADENOSINE_A3R_INH_VS_ACT_IN_MAST_CELL_UP///Genes up-regulated in HMC-1 (mast leukemia) cells incubated with: the peptide ALL1 versus Cl-IB-MECA [PubChem=3035850].+++GSE22229_RENAL_TRANSPLANT_IMMUNOSUPP_THERAPY_VS_HEALTHY_PBMC_UP///Genes up-regulated in periperal blood monocytes (PBMC): kidney transplant recipients receiving immunosuppression therapy versus healthy controls.+++GSE2706_R848_VS_R848_AND_LPS_8H_STIM_DC_UP///Genes up-regulated in comparison of dendritic cells (DC) stimulated with R848 at 8 h versus DCs stimulated with LPS (TLR4 agonist) and R848 for 8 h.+++GSE360_L_MAJOR_VS_T_GONDII_DC_DN///Genes down-regulated in comparison of dendritic cells (DC) exposed to L. major versus DCs exposed to T. gondii.+++GSE3982_CTRL_VS_LPS_1H_NEUTROPHIL_DN///Genes down-regulated in comparison of untreated neutrophils versus neutrophils treated with LPS (TLR4 agonist) at 1 h.+++GSE42088_2H_VS_24H_LEISHMANIA_INF_DC_DN///Genes down-regulated in dendritic cells infected by Leishmania major: 2h versus 24h.+++GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_1_UP///Genes up-regulated in comparison of CTRLrv versus FOXP3rv (see Fig. 1 for details).+++OSMAN_BLOOD_CHAD63_KH_AGE_18_50YO_HIGH_DOSE_SUBJECTS_24HR_UP///Genes up-regulated in blood 24hr vs 0hr in adults (18-50) (high dose subjects) after exposure to ChAd63-KH , time point 24H , administered Intramuscular injection. Comment: DE gene list for high dose subjects.+++SCHERER_PBMC_YF_VAX_AGE_18_40YO_4_TO_7DY_DN///Genes down-regulated in peripheral blood mononuclear cell (4 to 7)d vs 0d in adults (18-40) after exposure to YF-Vax , time point 4 to 7D"	HALLMARK_PANCREAS_BETA_CELLS///Genes specifically up-regulated in pancreatic beta cells.	XM_011536370	CHGA				
P09211	sp|P09211|GSTP1_HUMAN		GSTP1		Glutathione S-transferase P OS=Homo sapiens OX=9606 GN=GSTP1 PE=1 SV=2 >tr|V9HWE9|V9HWE9_HUMAN GST class-pi OS=Homo sapiens OX=9606 GN=HEL-S-22 PE=2 SV=1	2950	URS00019C3BF5						MPPYTVVYFPVRGRCAALRMLLADQGQSWKEEVVTVETWQEGSLKASCLYGQLPKFQDGDLTLYQSNTILRHLGRTLGLYGKDQQEAALVDMVNDGVEDLRCKYISLIYTNYEAGKDDYVKALPGQLKPFETLLSQNQGGKTFIVGDQISFADYNLLDLLLIHEVLAPGCLDAFPLLSAYVGRLSARPKLKAFLASPEYVNLPINGNGKQ	0.4764026	-1.06974678	0.001031155	5.4895719	7.2500996	6.166314	7.3914404	6.4989409	8.1743393	7.269851444	6.5867342	7.9225096	8.3683864	7.6930152	8.1731298	6.00148257	7.2820693	6.6550876	8.1385351	6.4555721	7.9070867		6.5762651	7.4369207	8.266964	8.0440262	6.4151639	5.88374482	7.13864909	7.1445959	10.808424	9.9637676	10.061069	9.9435691	7.797649	8.1108014	9.4096526	8.1850504	7.4409318	8.6566386	8.1762835	8.866302	8.3243678	8.02489786	8.8883974	7.0359483	8.14282822																																	URS00019C3BF5	GSTP1				
P08567	sp|P08567|PLEK_HUMAN		PLEK		Pleckstrin OS=Homo sapiens OX=9606 GN=PLEK PE=1 SV=3	5341	NM_002664	NP_002655	ENST00000234313				MEPKRIREGYLVKKGSVFNTWKPMWVVLLEDGIEFYKKKSDNSPKGMIPLKGSTLTSPCQDFGKRMFVFKITTTKQQDHFFQAAFLEERDAWVRDIKKAIKCIEGGQKFARKSTRRSIRLPETIDLGALYLSMKDTEKGIKELNLEKDKKIFNHCFTGNCVIDWLVSNQSVRNRQEGLMIASSLLNEGYLQPAGDMSKSAVDGTAENPFLDNPDAFYYFPDSGFFCEENSSDDDVILKEEFRGVIIKQGCLLKQGHRRKNWKVRKFILREDPAYLHYYDPAGAEDPLGAIHLRGCVVTSVESNSNGRKSEEENLFEIITADEVHYFLQAATPKERTEWIRAIQMASRTGK	0.4099158	-1.286600432	0.02109804		8.3860427	7.2432066	7.3497456	7.4425992	7.861361	5.099781342	7.2245334	9.7957489	9.2496861	8.0360608	10.2270098	4.74649936	6.7300207	8.2099872	8.4084445	3.9927603	5.390593			9.2780311	8.2589011	7.9234415	5.7048559	6.93621366	5.99020838	5.6168979	10.615643	11.2791065	11.842165	11.8852706	8.742914	10.1141893	9.8229031	7.4015293	7.4621509	9.7256158	8.5931198	11.199557	8.5727893	8.49060317	9.8292382	7.8063251	8.24954082					GO:0005576///extracellular region+++GO:0005737///cytoplasm+++GO:0005829///cytosol+++GO:0005886///plasma membrane+++GO:0016020///membrane+++GO:0032587///ruffle membrane	"GO:0005080///protein kinase C binding+++GO:0005515///protein binding+++GO:0042803///protein homodimerization activity+++GO:0043325///phosphatidylinositol-3,4-bisphosphate binding"	GO:0002244///hematopoietic progenitor cell differentiation+++GO:0002576///platelet degranulation+++GO:0006904///vesicle docking involved in exocytosis+++GO:0007229///integrin-mediated signaling pathway+++GO:0010572///positive regulation of platelet activation+++GO:0010920///negative regulation of inositol phosphate biosynthetic process+++GO:0010925///positive regulation of inositol-polyphosphate 5-phosphatase activity+++GO:0030030///cell projection organization+++GO:0030836///positive regulation of actin filament depolymerization+++GO:0030845///phospholipase C-inhibiting G protein-coupled receptor signaling pathway+++GO:0030866///cortical actin cytoskeleton organization+++GO:0031529///ruffle organization+++GO:0031532///actin cytoskeleton reorganization+++GO:0032233///positive regulation of actin filament bundle assembly+++GO:0033625///positive regulation of integrin activation+++GO:0035556///intracellular signal transduction+++GO:0045744///negative regulation of G protein-coupled receptor signaling pathway+++GO:0046488///phosphatidylinositol metabolic process+++GO:0050849///negative regulation of calcium-mediated signaling+++GO:0060305///regulation of cell diameter+++GO:0070493///thrombin-activated receptor signaling pathway+++GO:0070527///platelet aggregation+++GO:0070528///protein kinase C signaling+++GO:0070560///protein secretion by platelet	tissueType=Large intestine;cancerType=Normal;cellName=Paneth cell+++tissueType=Peripheral blood;cancerType=Normal;cellName=Effector CD8+ memory T (Tem) cell+++tissueType=Fetal kidney;cancerType=Normal;cellName=Monocyte+++tissueType=Fetal kidney;cancerType=Normal;cellName=Natural killer T (NKT) cell+++tissueType=Fetal kidney;cancerType=Normal;cellName=Megakaryocyte+++tissueType=Umbilical cord blood;cancerType=Normal;cellName=Granulocyte-monocyte progenitor+++tissueType=Liver;cancerType=Normal;cellName=CD4+ cytotoxic T cell+++tissueType=Embryonic prefrontal cortex;cancerType=Normal;cellName=Microglial cell		"Homo sapiens pleckstrin (PLEK), mRNA."	Others///Others	"PF00169///PH domain+++PF00610///Domain found in Dishevelled, Egl-10, and Pleckstrin (DEP)"	"R-HSA-109582///Hemostasis+++R-HSA-114608///Platelet degranulation +++R-HSA-76002///Platelet activation, signaling and aggregation+++R-HSA-76005///Response to elevated platelet cytosolic Ca2+"		ENOG502QQIA///No_INFO		"IPR000591///DEP domain+++IPR001849///Pleckstrin homology domain+++IPR011993///PH-like domain superfamily+++IPR036388///Winged helix-like DNA-binding domain superfamily+++IPR036390///Winged helix DNA-binding domain superfamily+++IPR037371///Pleckstrin 1, DEP domain"	[PLEK_HUMAN|Reviewed]RecName: Full=Pleckstrin; AltName: Full=Platelet 47 kDa protein; Short=p47;	chr2p14///Ensembl 103 genes in cytogenetic band chr2p14			"REACTOME_HEMOSTASIS///Hemostasis+++REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION///Platelet activation, signaling and aggregation+++REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2///Response to elevated platelet cytosolic Ca2+"			MIR141_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-141-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR200A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-200a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3915///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3915 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3919///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3919 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3925_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3925-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3928_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3928-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR486_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-486-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR645///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-645 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).	CEBP_01///Genes having at least one occurence of the transcription factor binding site V$CEBP_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.	"BACH2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9BYV9 (BACH2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++MAML1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q92585 (MAML1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++TCF7_TARGET_GENES///Genes containing one or more binding sites for UniProt:P36402 (TCF7) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++TERF1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P54274 (TERF1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF597_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96LX8 (ZNF597) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."		MODULE_15///Genes in the cancer module 14.+++MODULE_165///Genes in the cancer module 165.+++MODULE_16///Genes in the cancer module 15.+++MODULE_248///Genes in the cancer module 248.+++MODULE_45///Whole blood genes.+++MODULE_84///Immune (humoral) and inflammatory response.	CAMP_UP.V1_DN///Genes down-regulated in primary thyrocyte cultures in response to cAMP signaling pathway activation by thyrotropin (TSH).+++IL21_UP.V1_DN///Genes down-regulated in Sez-4 cells (T lymphocyte) that were first starved of IL2 [Gene ID=3558] and then stimulated with IL21 [Gene ID=59067].+++IL2_UP.V1_DN///Genes down-regulated in Sez-4 cells (T lymphocyte) that were first starved of IL2 [Gene ID=3558] and then stimulated with IL2 [Gene ID=3558].	"GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_2MO_UP///Genes up-regulated in peripheral blood mononuclear cell 2m vs 0m in young adults (18-25) after exposure to HPV-16 L1 VLP , time point 2M. Comment: List of DE Genes After Vaccination Using p&lt;0.05 as Cutoff+++GSE10325_CD4_TCELL_VS_MYELOID_DN///Genes down-regulated in comparison of healthy CD4 [GeneID=920] T cells versus healthy myeloid cells.+++GSE10325_MYELOID_VS_LUPUS_MYELOID_DN///Genes down-regulated in comparison of healthy myeloid cells versus systemic lupus erythematosus myeloid cells.+++GSE11057_CD4_CENT_MEM_VS_PBMC_DN///Genes down-regulated in comparison of central memory T cells versus peripheral blood mononuclear cells (PBMC).+++GSE11057_CD4_EFF_MEM_VS_PBMC_DN///Genes down-regulated in comarison of effector memory T cells versus peripheral blood mononuclear cells (PBMC).+++GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_UP///Genes up-regulated in comparison of effector memory T cells versus central memory T cells from peripheral blood mononuclear cells (PBMC).+++GSE12366_GC_VS_NAIVE_BCELL_UP///Genes up-regulated in comparison of germinal center B cells versus naive B cells.+++GSE12366_NAIVE_VS_MEMORY_BCELL_DN///Genes down-regulated in comparison of naive B cells versus memory B cells.+++GSE12845_IGD_POS_BLOOD_VS_NAIVE_TONSIL_BCELL_UP///Genes up-regulated in comparison of IgD+ peripheral blood B cells versus IgD- naive tonsil B cells.+++GSE12845_NAIVE_VS_DARKZONE_GC_TONSIL_BCELL_DN///Genes down-regulated in comparison of naive B cell versus dark zone germinal center B cells.+++GSE14000_UNSTIM_VS_4H_LPS_DC_DN///Genes down-regulated in comparison of dendritic cells (DC) before and 4 h after LPS (TLR4 agonist) stimulation.+++GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_DN///Genes down-regulated in comparison of control microglia cells versus those 1 h after stimulation with IFNG [GeneID=3458].+++GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_DN///Genes down-regulated in comparison of control microglia cells versus those 24 h after stimulation with IFNG [GeneID=3458].+++GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_DN///Genes down-regulated in comparison of control microglia cells versus those 6 h after stimulation with IFNG [GeneID=3458].+++GSE15735_CTRL_VS_HDAC_INHIBITOR_TREATED_CD4_TCELL_2H_DN///Genes down-regulated in CD4 [GeneID=920] T cells: control versus treated with HDAC inhibitors for 2h.+++GSE15735_CTRL_VS_HDAC_INHIBITOR_TREATED_CD4_TCELL_2H_UP///Genes up-regulated in CD4 [GeneID=920] T cells: control versus treated with HDAC inhibitors for 2h.+++GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_CELL_LINE_UP///Genes up-regulated in immature neuron cell line: control versus interferon alpha (6h).+++GSE17974_0H_VS_12H_IN_VITRO_ACT_CD4_TCELL_UP///Genes up-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the untreated cells at 12 h.+++GSE17974_0H_VS_48H_IN_VITRO_ACT_CD4_TCELL_UP///Genes up-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the untreated cells at 48 h.+++GSE17974_2.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP///Genes up-regulated in comparison of CD4 [GeneID=920] T cells treated with IL4 [GeneID=3565] and anti-IL12 at 2 h versus those at 72 h.+++GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_0.5H_CD4_TCELL_UP///Genes up-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the cells treated with IL4 [GeneID=3565] and anti-IL12 at 0.5 h.+++GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_48H_CD4_TCELL_UP///Genes up-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the cells treated with IL4 [GeneID=3565] and anti-IL12 at 48 h.+++GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_72H_CD4_TCELL_UP///Genes up-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the cells treated with IL4 [GeneID=3565] and anti-IL12 at 72 h.+++GSE18893_TCONV_VS_TREG_2H_TNF_STIM_DN///Genes down-regulated in lymphocytes treated with TNF [GeneID=7124] for 2h: T conv versus T reg cells.+++GSE22025_TGFB1_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP///Genes up-regulated in CD4 [GeneID=920] T cells: TGFB1 [GeneID=7040] versus TGFB1 [GeneID=7040] and progesterone [PubChem=5994].+++GSE22342_CD11C_HIGH_VS_LOW_DECIDUAL_MACROPHAGES_UP///Genes up-regulated in decidual macrophages with ITGAX [GeneID=3687] high versus low.+++GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_DN///Genes down-regulated in immature CD4 [GeneID=920] single positive cells versus double positive thymocytes.+++GSE22886_IGA_VS_IGM_MEMORY_BCELL_DN///Genes down-regulated in comparison of memory IgG IgA B cells versus memory IgM B cells.+++GSE22886_NAIVE_BCELL_VS_NEUTROPHIL_DN///Genes down-regulated in comparison of naive B cells versus unstimulated neutrophils.+++GSE22886_NAIVE_CD8_TCELL_VS_MEMORY_TCELL_UP///Genes up-regulated in comparison of naive CD8 T cells versus naive CD4 [GeneID=920] CD8 T cells.+++GSE22886_NAIVE_VS_IGM_MEMORY_BCELL_DN///Genes down-regulated in comparison of naive B cells versus memory IgM B cells.+++GSE23321_CD8_STEM_CELL_MEMORY_VS_EFFECTOR_MEMORY_CD8_TCELL_DN///Genes down-regulated in CD8 T cells: stem cell memory versus effector memory.+++GSE23321_EFFECTOR_MEMORY_VS_NAIVE_CD8_TCELL_UP///Genes up-regulated in CD8 T cells: effector memory versus nave.+++GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_24H_UP///Genes up-regulated in polymorphonuclear leukocytes (24h): treated by heat killed HC60 cell (promyelocytic leukemia) lysate versus A. phagocytophilum infection.+++GSE2405_S_AUREUS_VS_A_PHAGOCYTOPHILUM_NEUTROPHIL_UP///Genes up-regulated in polymorphonuclear leukocytes 9h after infection by: S. aureus versus A. phagocytophilum.+++GSE24081_CONTROLLER_VS_PROGRESSOR_HIV_SPECIFIC_CD8_TCELL_DN///Genes down-regulated in comparison of CD8 T cells with progressing HIV infection versus those with controlled HIV infection.+++GSE24634_TEFF_VS_TCONV_DAY7_IN_CULTURE_DN///Genes down-regulated in comparison of untreated CD25+ T effector cells at day 7 versus untreated CD25- T cells at day 7.+++GSE24634_TREG_VS_TCONV_POST_DAY3_IL4_CONVERSION_DN///Genes down-regulated in comparison of CD25+ regulatory T cell (Treg) treated with IL4 [GeneID=3565] at day 3 versus CD25- T cells incubated with IL4 [GeneID=3565] at day 3.+++GSE24634_TREG_VS_TCONV_POST_DAY5_IL4_CONVERSION_DN///Genes down-regulated in comparison of CD25+ T cells treated with IL4 [GeneID=3565] versus CD25- T cells treated with IL4 [GeneID=3565] at day 5.+++GSE25085_FETAL_BM_VS_ADULT_BM_SP4_THYMIC_IMPLANT_DN///Genes down-regulated in thymic implants from fetal versus those from adult bone marrow.+++GSE2706_2H_VS_8H_LPS_STIM_DC_UP///Genes up-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 2 h versus DCs stimulated with LPS (TLR4 agonist) at 8 h.+++GSE2706_2H_VS_8H_R848_STIM_DC_UP///Genes up-regulated in comparison of dendritic cells (DC) stimulated with R848 at 2 h versus DCs stimulatd with R848 for 8 h.+++GSE2706_LPS_VS_R848_AND_LPS_2H_STIM_DC_UP///Genes up-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 2 h versus DCs stimulated with LPS (TLR4 agonist) and R848 for 2 h.+++GSE2706_UNSTIM_VS_2H_R848_DC_DN///Genes down-regulated in comparison of unstimulated dendritic cells (DC) at 0 h versus DCs stimulated with R848 for 2 h.+++GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_2H_DN///Genes down-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: IL4 [GeneID=3565] (2h) versus untreated (2h).+++GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_6H_UP///Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 and IL4 [GeneID=7040;3565] (6h) versus IL4 [GeneID=3565] (6h).+++GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_DN///Genes down-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 and then stimulated by TGFB1 [GeneID=7040] and IL-12 (48h).+++GSE29617_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_UP///Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from TIV influenza vaccinee at day 3 post-vaccination versus those at day 7 post-vaccination.+++GSE29618_BCELL_VS_MONOCYTE_DN///Genes down-regulated in comparison of B cells versus monocytes.+++GSE29618_BCELL_VS_PDC_DN///Genes down-regulated in comparison of B cells versus plasmacytoid dendritic cells (pDC) .+++GSE29618_PDC_VS_MDC_DAY7_FLU_VACCINE_UP///Genes up-regulated in comparison of plasmacytoid dendritic cells (DC) from influenza vaccinee at day 7 post-vaccination versus myeloid DCs at day 7 post-vaccination.+++GSE32901_NAIVE_VS_TH1_CD4_TCELL_DN///Genes down-regulated in CD4 [GeneID=920] T cells: nave versus Th1.+++GSE34156_UNTREATED_VS_6H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN///Genes down-regulated in monocytes (6h): untreated versus M. tuberculosis 19 kDa lipopeptide.+++GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_DC_DN///Genes down-regulated in comparison of dendritic cells (DC) exposed to L. donovani versus DCs exposed to M. tuberculosis.+++GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_72H_TSST_ACT_DN///Genes down-regulated in comparison of memory CD4 [GeneID=920] T cells from young donors treated with TSST at 72 h versus those from old donors treated with TSST at 72 h.+++GSE3720_UNSTIM_VS_PMA_STIM_VD2_GAMMADELTA_TCELL_DN///Genes down-regulated in Vd2 gamma delta T cells: untreated versus phorbol myristate acetate and ionomycin [PubChem=4792;3733].+++GSE3920_IFNA_VS_IFNG_TREATED_ENDOTHELIAL_CELL_DN///Genes down-regulated in endothelial cells: interferon alpha versus IFNG [GeneID=3458].+++GSE3920_UNTREATED_VS_IFNA_TREATED_ENDOTHELIAL_CELL_UP///Genes up-regulated in ndothelial cells: untreated versus interferon alpha.+++GSE3982_BCELL_VS_CENT_MEMORY_CD4_TCELL_UP///Genes up-regulated in comparison of B cells versus central memory CD4 [GeneID=920] T cells.+++GSE3982_CENT_MEMORY_CD4_TCELL_VS_NKCELL_DN///Genes down-regulated in comparison of central memory CD4 [GeneID=920] T cells versus NK cells.+++GSE3982_CTRL_VS_LPS_4H_MAC_DN///Genes down-regulated in comparison of untreated macrophages versus macrophages treated with LPS (TLR4 agonist) at 4 h.+++GSE3982_DC_VS_MAC_DN///Genes down-regulated in comparison of dendritic cells (DC) versus macrophages.+++GSE3982_EOSINOPHIL_VS_NEUTROPHIL_DN///Genes down-regulated in comparison of eosinophils versus neutrophils.+++GSE4984_UNTREATED_VS_LPS_TREATED_DC_DN///Genes down-regulated in monocyte-derived dendritic cells: control versus LPS.+++GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_TREATED_DC_UP///Genes up-regulated in monocyte-derived dendritic cells: untreated versus rosiglitazone [PubChem=77999].+++GSE5679_CTRL_VS_RARA_AGONIST_AM580_TREATED_DC_UP///Genes up-regulated in monocyte-derived dendritic cells: untreated versus AM580 [PubChem=2126].+++GSE6269_FLU_VS_STAPH_AUREUS_INF_PBMC_DN///Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMC from patients with acute S. aureus infection.+++GSE6269_HEALTHY_VS_E_COLI_INF_PBMC_DN///Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMC from patients with acute E. coli infection.+++GSE6269_HEALTHY_VS_STAPH_PNEUMO_INF_PBMC_DN///Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMC from patients with acute S. pneumoniae infection.+++GSE7460_CD8_TCELL_VS_CD4_TCELL_ACT_UP///Genes up-regulated in comparsion of ActCD8 versus ActCD4 (see Fig. 1 in the paper for details).+++GSE8515_CTRL_VS_IL1_4H_STIM_MAC_DN///Genes down-regulated in comparison of untreated macrophages versus those treated with IL1.+++GSE8515_IL1_VS_IL6_4H_STIM_MAC_UP///Genes up-regulated in comparison of untreated macrophages versus those treated with IL1 and IL6 [GeneID=3569].+++GSE9988_ANTI_TREM1_AND_LPS_VS_VEHICLE_TREATED_MONOCYTES_UP///Genes up-regulated in comparison of monocytes treated with anti-TREM1 [GeneID=54210] and 5000 ng/ml LPS (TLR4 agonist) versus untreated monocytes.+++GSE9988_ANTI_TREM1_VS_ANTI_TREM1_AND_LPS_MONOCYTE_DN///Genes down-regulated in comparison of monocytes treated with anti-TREM1 [GeneID=54210] versus monocytes treated with anti-TREM1 [GeneID=54210] and 5000 ng/ml LPS (TLR4 agonist).+++GSE9988_LOW_LPS_VS_CTRL_TREATED_MONOCYTE_UP///Genes up-regulated in comparison of monocytes treated with 1 ng/ml LPS (TLR4 agonist) versus monocytes treated with control IgG.+++GSE9988_LOW_LPS_VS_VEHICLE_TREATED_MONOCYTE_UP///Genes up-regulated in comparison of monocytes treated with 1 ng/ml LPS (TLR4 agonist) versus untreated monocytes.+++GSE9988_LPS_VS_CTRL_TREATED_MONOCYTE_UP///Genes up-regulated in comparison of monocytes treated with 5000 ng/ml LPS (TLR4 agonist) versus monocytes treated with control IgG.+++GSE9988_LPS_VS_VEHICLE_TREATED_MONOCYTE_UP///Genes up-regulated in comparison of monocytes treated with 1 ng/ml LPS (TLR4 agonist) versus untreated monocytes.+++HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_0DY_NEGATIVE///Genes negatively correlated with memory B cell response at 28d in peripheral blood mononuclear cell in seniors (50-74) after exposure to Fluarix , time point 0D+++HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_POSITIVE///Genes positively correlated with memory B cell response at 28d in peripheral blood mononuclear cell in seniors (50-74) after exposure to Fluarix , time point 28D+++MATSUMIYA_PBMC_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_18_55YO_VACCINATED_VS_CONTROL_TREATED_IN_VITRO_WITH_MVA85A_6HR_UP///Genes up-regulated in peripheral blood mononuclear cell vaccinated vs control in adults (18-55) (treated in vitro with MVA85A) after exposure to Modified Vaccinia Ankara (MVA) virus vaccine vector , time point 6H+++NAKAYA_MONOCYTE_FLUMIST_AGE_18_50YO_7DY_DN///Genes down-regulated in monocyte 7d vs 0d in young adults (18-50) after exposure to FluMist , time point 7D+++OSMAN_BLOOD_CHAD63_KH_AGE_18_50YO_HIGH_DOSE_SUBJECTS_24HR_UP///Genes up-regulated in blood 24hr vs 0hr in adults (18-50) (high dose subjects) after exposure to ChAd63-KH , time point 24H , administered Intramuscular injection. Comment: DE gene list for high dose subjects.+++PATEL_SKIN_OF_BODY_ZOSTAVAX_AGE_70_93YO_VZV_CHALLENGE_6HR_UP///Genes up-regulated in skin of body 6hr vs 0hr in adults (70-93) (VZV challenge) after exposure to Zostavax , time point 6H+++SCHERER_PBMC_YF_VAX_AGE_18_40YO_4_TO_7DY_UP///Genes up-regulated in peripheral blood mononuclear cell (4 to 7)d vs 0d in adults (18-40) after exposure to YF-Vax , time point 4 to 7D+++ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_UP///Genes up-regulated in peripheral blood mononuclear cell 1d vs 0d in adults (20-50) after exposure to MRKAd5 HIV-1 gag/pol/nef , time point 1D. Comment: Table includes specific cell types"	"HALLMARK_COAGULATION///Genes encoding components of blood coagulation system; also up-regulated in platelets.+++HALLMARK_COMPLEMENT///Genes encoding components of the complement system, which is part of the innate immune system.+++HALLMARK_TNFA_SIGNALING_VIA_NFKB///Genes regulated by NF-kB in response to TNF [GeneID=7124]."	NM_002664	PLEK				
P08238	sp|P08238|HS90B_HUMAN		HSP90AB1		"Heat shock protein HSP 90-beta OS=Homo sapiens OX=9606 GN=HSP90AB1 PE=1 SV=4 >tr|A0A024RD80|A0A024RD80_HUMAN Heat shock protein 90kDa alpha (Cytosolic), class B member 1, isoform CRA_a OS=Homo sapiens OX=9606 GN=HSP90AB1 PE=3 SV=1"	3326	NM_007355	NP_031381	ENST00000371646	K04079			MPEEVHHGEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNASDALDKIRYESLTDPSKLDSGKELKIDIIPNPQERTLTLVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVVVITKHNDDEQYAWESSAGGSFTVRADHGEPIGRGTKVILHLKEDQTEYLEERRVKEVVKKHSQFIGYPITLYLEKEREKEISDDEAEEEKGEKEEEDKDDEEKPKIEDVGSDEEDDSGKDKKKKTKKIKEKYIDQEELNKTKPIWTRNPDDITQEEYGEFYKSLTNDWEDHLAVKHFSVEGQLEFRALLFIPRRAPFDLFENKKKKNNIKLYVRRVFIMDSCDELIPEYLNFIRGVVDSEDLPLNISREMLQQSKILKVIRKNIVKKCLELFSELAEDKENYKKFYEAFSKNLKLGIHEDSTNRRRLSELLRYHTSQSGDEMTSLSEYVSRMKETQKSIYYITGESKEQVANSAFVERVRKRGFEVVYMTEPIDEYCVQQLKEFDGKSLVSVTKEGLELPEDEEEKKKMEESKAKFENLCKLMKEILDKKVEKVTISNRLVSSPCCIVTSTYGWTANMERIMKAQALRDNSTMGYMMAKKHLEINPDHPIVETLRQKAEADKNDKAVKDLVVLLFETALLSSGFSLEDPQTHSNRIYRMIKLGLGIDEDEVAAEEPNAAVPDEIPPLEGDEDASRMEEVD	0.4650403	-1.104572406	0.01745394										7.079507	4.9498202	7.2712185			6.1083733	6.1981975						6.5451526	7.8415321					9.368705	7.4493156	6.797574	9.3715558	6.210893		6.5826123	6.8110565	6.5204957	6.8999921	6.7519423	8.586398	8.1357324	6.46486373	7.8663304		7.75354421	04141///Protein processing in endoplasmic reticulum+++04151///PI3K-Akt signaling pathway+++04217///Necroptosis+++04612///Antigen processing and presentation+++04621///NOD-like receptor signaling pathway+++04657///IL-17 signaling pathway+++04659///Th17 cell differentiation+++04914///Progesterone-mediated oocyte maturation+++04915///Estrogen signaling pathway+++05132///Salmonella infection+++05200///Pathways in cancer+++05207///Chemical carcinogenesis - receptor activation+++05215///Prostate cancer+++05417///Lipid and atherosclerosis+++05418///Fluid shear stress and atherosclerosis				GO:0005576///extracellular region+++GO:0005634///nucleus+++GO:0005654///nucleoplasm+++GO:0005737///cytoplasm+++GO:0005739///mitochondrion+++GO:0005765///lysosomal membrane+++GO:0005829///cytosol+++GO:0005886///plasma membrane+++GO:0008180///COP9 signalosome+++GO:0009986///cell surface+++GO:0016020///membrane+++GO:0016234///inclusion body+++GO:0016323///basolateral plasma membrane+++GO:0016324///apical plasma membrane+++GO:0031526///brush border membrane+++GO:0032991///protein-containing complex+++GO:0034751///aryl hydrocarbon receptor complex+++GO:0034774///secretory granule lumen+++GO:0042470///melanosome+++GO:0043025///neuronal cell body+++GO:0044294///dendritic growth cone+++GO:0044295///axonal growth cone+++GO:0048471///perinuclear region of cytoplasm+++GO:0070062///extracellular exosome+++GO:1904813///ficolin-1-rich granule lumen+++GO:1990565///HSP90-CDC37 chaperone complex+++GO:1990913///sperm head plasma membrane+++GO:1990917///ooplasm	GO:0000166///nucleotide binding+++GO:0002134///UTP binding+++GO:0002135///CTP binding+++GO:0003723///RNA binding+++GO:0003725///double-stranded RNA binding+++GO:0005515///protein binding+++GO:0005524///ATP binding+++GO:0005525///GTP binding+++GO:0016887///ATPase activity+++GO:0017098///sulfonylurea receptor binding+++GO:0019887///protein kinase regulator activity+++GO:0019900///kinase binding+++GO:0019901///protein kinase binding+++GO:0023026///MHC class II protein complex binding+++GO:0030235///nitric-oxide synthase regulator activity+++GO:0030911///TPR domain binding+++GO:0031072///heat shock protein binding+++GO:0031625///ubiquitin protein ligase binding+++GO:0032564///dATP binding+++GO:0042277///peptide binding+++GO:0042802///identical protein binding+++GO:0042803///protein homodimerization activity+++GO:0042826///histone deacetylase binding+++GO:0043008///ATP-dependent protein binding+++GO:0044183///protein binding involved in protein folding+++GO:0044325///ion channel binding+++GO:0045296///cadherin binding+++GO:0046983///protein dimerization activity+++GO:0048156///tau protein binding+++GO:0051082///unfolded protein binding+++GO:0070182///DNA polymerase binding+++GO:0097718///disordered domain specific binding+++GO:1990226///histone methyltransferase binding	GO:0001890///placenta development+++GO:0006457///protein folding+++GO:0006986///response to unfolded protein+++GO:0007004///telomere maintenance via telomerase+++GO:0009410///response to xenobiotic stimulus+++GO:0009651///response to salt stress+++GO:0010033///response to organic substance+++GO:0019062///virion attachment to host cell+++GO:0021955///central nervous system neuron axonogenesis+++GO:0030010///establishment of cell polarity+++GO:0030511///positive regulation of transforming growth factor beta receptor signaling pathway+++GO:0031396///regulation of protein ubiquitination+++GO:0032092///positive regulation of protein binding+++GO:0032435///negative regulation of proteasomal ubiquitin-dependent protein catabolic process+++GO:0032516///positive regulation of phosphoprotein phosphatase activity+++GO:0032880///regulation of protein localization+++GO:0033138///positive regulation of peptidyl-serine phosphorylation+++GO:0034605///cellular response to heat+++GO:0042220///response to cocaine+++GO:0042307///positive regulation of protein import into nucleus+++GO:0042493///response to drug+++GO:0043066///negative regulation of apoptotic process+++GO:0043524///negative regulation of neuron apoptotic process+++GO:0045429///positive regulation of nitric oxide biosynthetic process+++GO:0045597///positive regulation of cell differentiation+++GO:0045793///positive regulation of cell size+++GO:0048675///axon extension+++GO:0050821///protein stabilization+++GO:0051131///chaperone-mediated protein complex assembly+++GO:0051248///negative regulation of protein metabolic process+++GO:0051726///regulation of cell cycle+++GO:0051897///positive regulation of protein kinase B signaling+++GO:0051973///positive regulation of telomerase activity+++GO:0060334///regulation of interferon-gamma-mediated signaling pathway+++GO:0060338///regulation of type I interferon-mediated signaling pathway+++GO:0071353///cellular response to interleukin-4+++GO:0071407///cellular response to organic cyclic compound+++GO:0071902///positive regulation of protein serine/threonine kinase activity+++GO:0097435///supramolecular fiber organization+++GO:1901389///negative regulation of transforming growth factor beta activation+++GO:1901799///negative regulation of proteasomal protein catabolic process+++GO:1902949///positive regulation of tau-protein kinase activity+++GO:1903660///negative regulation of complement-dependent cytotoxicity+++GO:1903827///regulation of cellular protein localization+++GO:1904031///positive regulation of cyclin-dependent protein kinase activity+++GO:1905323///telomerase holoenzyme complex assembly+++GO:2000010///positive regulation of protein localization to cell surface	tissueType=Fetal kidney;cancerType=Normal;cellName=Natural killer T (NKT) cell+++tissueType=Kidney;cancerType=Normal;cellName=B cell		"Homo sapiens heat shock protein 90 alpha family class B member 1 (HSP90AB1), transcript variant 2, mRNA."		"PF00183///Hsp90 protein+++PF02518///Histidine kinase-, DNA gyrase B-, and HSP90-like ATPase"	"R-HSA-1266738///Developmental Biology+++R-HSA-1430728///Metabolism+++R-HSA-162582///Signal Transduction+++R-HSA-1640170///Cell Cycle+++R-HSA-1643685///Disease+++R-HSA-168249///Innate Immune System+++R-HSA-168256///Immune System+++R-HSA-168643///Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways+++R-HSA-168928///DDX58/IFIH1-mediated induction of interferon-alpha/beta+++R-HSA-194315///Signaling by Rho GTPases+++R-HSA-2029480///Fcgamma receptor (FCGR) dependent phagocytosis+++R-HSA-2029482///Regulation of actin dynamics for phagocytic cup formation+++R-HSA-211859///Biological oxidations+++R-HSA-211945///Phase I - Functionalization of compounds+++R-HSA-2262752///Cellular responses to stress+++R-HSA-3371497///HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand+++R-HSA-3371511///HSF1 activation+++R-HSA-3371556///Cellular response to heat stress+++R-HSA-3371568///Attenuation phase+++R-HSA-3371571///HSF1-dependent transactivation+++R-HSA-373755///Semaphorin interactions+++R-HSA-399954///Sema3A PAK dependent Axon repulsion+++R-HSA-422475///Axon guidance+++R-HSA-453274///Mitotic G2-G2/M phases+++R-HSA-5336415///Uptake and function of diphtheria toxin+++R-HSA-5339562///Uptake and actions of bacterial toxins+++R-HSA-5663205///Infectious disease+++R-HSA-622312///Inflammasomes+++R-HSA-6798695///Neutrophil degranulation+++R-HSA-69275///G2/M Transition+++R-HSA-69278///Cell Cycle, Mitotic+++R-HSA-844456///The NLRP3 inflammasome+++R-HSA-8852276///The role of GTSE1 in G2/M progression after G2 checkpoint+++R-HSA-8937144///Aryl hydrocarbon receptor signalling+++R-HSA-8939211///ESR-mediated signaling+++R-HSA-8953897///Cellular responses to stimuli+++R-HSA-9006931///Signaling by Nuclear Receptors+++R-HSA-9012999///RHO GTPase cycle+++R-HSA-9013418///RHOBTB2 GTPase cycle+++R-HSA-9018519///Estrogen-dependent gene expression+++R-HSA-9612973///Autophagy+++R-HSA-9613829///Chaperone Mediated Autophagy+++R-HSA-9658195///Leishmania infection+++R-HSA-9660826///Purinergic signaling in leishmaniasis infection+++R-HSA-9664424///Cell recruitment (pro-inflammatory response)+++R-HSA-9675108///Nervous system development+++R-HSA-9679191///Potential therapeutics for SARS+++R-HSA-9679506///SARS-CoV Infections+++R-HSA-9706574///RHOBTB GTPase Cycle+++R-HSA-9716542///Signaling by Rho GTPases, Miro GTPases and RHOBTB3"	COG0326///No_INFO	KOG0019///unfolded protein binding		"IPR001404///Heat shock protein Hsp90 family+++IPR003594///Histidine kinase/HSP90-like ATPase+++IPR019805///Heat shock protein Hsp90, conserved site+++IPR020568///Ribosomal protein S5 domain 2-type fold+++IPR020575///Heat shock protein Hsp90, N-terminal+++IPR036890///Histidine kinase/HSP90-like ATPase superfamily+++IPR037196///HSP90, C-terminal domain"	[HS90B_HUMAN|Reviewed]RecName: Full=Heat shock protein HSP 90-beta; Short=HSP 90; AltName: Full=Heat shock 84 kDa; Short=HSP 84; Short=HSP84;	chr6p21///Ensembl 103 genes in cytogenetic band chr6p21		KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION///Antigen processing and presentation+++KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY///NOD-like receptor signaling pathway+++KEGG_PATHWAYS_IN_CANCER///Pathways in cancer+++KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION///Progesterone-mediated oocyte maturation+++KEGG_PROSTATE_CANCER///Prostate cancer	"REACTOME_ARYL_HYDROCARBON_RECEPTOR_SIGNALLING///Aryl hydrocarbon receptor signalling+++REACTOME_ATTENUATION_PHASE///Attenuation phase+++REACTOME_AUTOPHAGY///Autophagy+++REACTOME_BIOLOGICAL_OXIDATIONS///Biological oxidations+++REACTOME_CELL_CYCLE///Cell Cycle+++REACTOME_CELL_CYCLE_MITOTIC///Cell Cycle, Mitotic+++REACTOME_CELLULAR_RESPONSES_TO_EXTERNAL_STIMULI///Cellular responses to external stimuli+++REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS///Cellular response to heat stress+++REACTOME_CHAPERONE_MEDIATED_AUTOPHAGY///Chaperone Mediated Autophagy+++REACTOME_DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA///DDX58/IFIH1-mediated induction of interferon-alpha/beta+++REACTOME_DEVELOPMENTAL_BIOLOGY///Developmental Biology+++REACTOME_ESR_MEDIATED_SIGNALING///ESR-mediated signaling+++REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION///Estrogen-dependent gene expression+++REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS///Fcgamma receptor (FCGR) dependent phagocytosis+++REACTOME_HSF1_ACTIVATION///HSF1 activation+++REACTOME_HSF1_DEPENDENT_TRANSACTIVATION///HSF1-dependent transactivation+++REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR///HSP90 chaperone cycle for steroid hormone receptors (SHR)+++REACTOME_INFECTIOUS_DISEASE///Infectious disease+++REACTOME_INFLAMMASOMES///Inflammasomes+++REACTOME_INNATE_IMMUNE_SYSTEM///Innate Immune System+++REACTOME_LEISHMANIA_INFECTION///Leishmania infection+++REACTOME_MITOTIC_G2_G2_M_PHASES///Mitotic G2-G2/M phases+++REACTOME_NERVOUS_SYSTEM_DEVELOPMENT///Nervous system development+++REACTOME_NEUTROPHIL_DEGRANULATION///Neutrophil degranulation+++REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS///Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways+++REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS///Phase I - Functionalization of compounds+++REACTOME_POTENTIAL_THERAPEUTICS_FOR_SARS///Potential therapeutics for SARS+++REACTOME_PURINERGIC_SIGNALING_IN_LEISHMANIASIS_INFECTION///Purinergic signaling in leishmaniasis infection+++REACTOME_RHOBTB2_GTPASE_CYCLE///RHOBTB2 GTPase cycle+++REACTOME_RHOBTB_GTPASE_CYCLE///RHOBTB GTPase Cycle+++REACTOME_RHO_GTPASE_CYCLE///RHO GTPase cycle+++REACTOME_SARS_COV_INFECTIONS///SARS-CoV Infections+++REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION///Sema3A PAK dependent Axon repulsion+++REACTOME_SEMAPHORIN_INTERACTIONS///Semaphorin interactions+++REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS///Signaling by Nuclear Receptors+++REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3///Signaling by Rho GTPases, Miro GTPases and RHOBTB3+++REACTOME_THE_NLRP3_INFLAMMASOME///The NLRP3 inflammasome+++REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT///The role of GTSE1 in G2/M progression after G2 checkpoint+++REACTOME_UPTAKE_AND_ACTIONS_OF_BACTERIAL_TOXINS///Uptake and actions of bacterial toxins+++REACTOME_UPTAKE_AND_FUNCTION_OF_DIPHTHERIA_TOXIN///Uptake and function of diphtheria toxin"			MIR3680_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3680-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4698///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4698 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR589_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-589-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6827_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6827-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).	ATCMNTCCGY_UNKNOWN///Genes having at least one occurence of the highly conserved motif M99 ATCMNTCCGY in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++ATF1_Q6///Genes having at least one occurence of the transcription factor binding site V$ATF1_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++ATF3_Q6///Genes having at least one occurence of the transcription factor binding site V$ATF3_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++ATF_B///Genes having at least one occurence of the transcription factor binding site V$ATF_B (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++CACGTG_MYC_Q2///Genes having at least one occurence of the highly conserved motif M2 CACGTG sites. The motif matches transcription factor binding site V$MYC_Q2 (v7.4 TRANSFAC).+++CREB_01///Genes having at least one occurence of the transcription factor binding site V$CREB_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++CREBP1CJUN_01///Genes having at least one occurence of the transcription factor binding site V$CREBP1CJUN_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++CTTTAAR_UNKNOWN///Genes having at least one occurence of the highly conserved motif M29 CTTTAAR in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++GCANCTGNY_MYOD_Q6///Genes having at least one occurence of the highly conserved motif M35 GCANCTGNY sites. The motif matches transcription factor binding site V$MYOD_Q6 (v7.4 TRANSFAC).+++HSF1_01///Genes having at least one occurence of the transcription factor binding site V$HSF1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++HSF_Q6///Genes having at least one occurence of the transcription factor binding site V$HSF_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++MGGAAGTG_GABP_B///Genes having at least one occurence of the highly conserved motif M11 MGGAAGTG sites. The motif matches transcription factor binding site V$GABP_B (v7.4 TRANSFAC).+++NRF2_Q4///Genes having at least one occurence of the transcription factor binding site V$NRF2_Q4 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++RNGTGGGC_UNKNOWN///Genes having at least one occurence of the highly conserved motif M140 RNGTGGGC in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++SCGGAAGY_ELK1_02///Genes having at least one occurence of the highly conserved motif M3 SCGGAAGY sites. The motif matches transcription factor binding site V$ELK1_02 (v7.4 TRANSFAC).+++TGACGTCA_ATF3_Q6///Genes having at least one occurence of the highly conserved motif M14 TGACGTCA sites. The motif matches transcription factor binding site V$ATF3_Q6 (v7.4 TRANSFAC).+++TGANNYRGCA_TCF11MAFG_01///Genes having at least one occurence of the highly conserved motif M67 TGANNYRGCA sites. The motif matches transcription factor binding site V$TCF11MAFG_01 (v7.4 TRANSFAC).+++TGAYRTCA_ATF3_Q6///Genes having at least one occurence of the highly conserved motif M9 TGAYRTCA sites. The motif matches transcription factor binding site V$ATF3_Q6 (v7.4 TRANSFAC).+++TTCNRGNNNNTTC_HSF_Q6///Genes having at least one occurence of the highly conserved motif M141 TTCNRGNNNNTTC sites. The motif matches transcription factor binding site V$HSF_Q6 (v7.4 TRANSFAC).+++TTCYRGAA_UNKNOWN///Genes having at least one occurence of the highly conserved motif M72 TTCYRGAA in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++USF_C///Genes having at least one occurence of the transcription factor binding site V$USF_C (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++WWTAAGGC_UNKNOWN///Genes having at least one occurence of the highly conserved motif M127 WWTAAGGC in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).	"ATF6_TARGET_GENES///Genes containing one or more binding sites for UniProt:P18850 (ATF6) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++BACH2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9BYV9 (BACH2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++BDP1_TARGET_GENES///Genes containing one or more binding sites for UniProt:A6H8Y1 (BDP1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++CHAF1B_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q13112 (CHAF1B) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++E2F2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q14209 (E2F2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++FEV_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q99581 (FEV) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++FOXD2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O60548 (FOXD2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++FOXE1_TARGET_GENES///Genes containing one or more binding sites for UniProt:O00358 (FOXE1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++FOXN3_TARGET_GENES///Genes containing one or more binding sites for UniProt:O00409 (FOXN3) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++GLI4_TARGET_GENES///Genes containing one or more binding sites for UniProt:P10075 (GLI4) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++GTF2A2_TARGET_GENES///Genes containing one or more binding sites for UniProt:P52657 (GTF2A2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++GTF2E2_TARGET_GENES///Genes containing one or more binding sites for UniProt:P29084 (GTF2E2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HOXB4_TARGET_GENES///Genes containing one or more binding sites for UniProt:P17483 (HOXB4) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++KAT5_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q92993 (KAT5) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++KDM7A_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6ZMT4 (KDM7A) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++LCORL_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8N3X6 (LCORL) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++MAFG_TARGET_GENES///Genes containing one or more binding sites for UniProt:O15525 (MAFG) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++MEF2C_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q06413 (MEF2C) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NFE2L1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q14494 (NFE2L1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NKX2_2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O95096 (NKX2_2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NR1I2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O75469 (NR1I2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++PAX6_TARGET_GENES///Genes containing one or more binding sites for UniProt:P26367 (PAX6) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++PPARGC1A_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9UBK2 (PPARGC1A) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++PRDM4_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9UKN5 (PRDM4) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++PSMB5_TARGET_GENES///Genes containing one or more binding sites for UniProt:P28074 (PSMB5) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++RUVBL1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9Y265 (RUVBL1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++RYBP_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8N488 (RYBP) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SALL4_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9UJQ4 (SALL4) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SNRNP70_TARGET_GENES///Genes containing one or more binding sites for UniProt:P08621 (SNRNP70) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++TAF9B_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9HBM6 (TAF9B) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++TEAD2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q15562 (TEAD2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++WRNIP1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96S55 (WRNIP1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZFP91_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96JP5 (ZFP91) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF146_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q15072 (ZNF146) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF184_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q99676 (ZNF184) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF236_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9UL36 (ZNF236) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF329_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q86UD4 (ZNF329) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF391_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9UJN7 (ZNF391) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF407_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9C0G0 (ZNF407) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF579_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8NAF0 (ZNF579) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF597_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96LX8 (ZNF597) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF740_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8NDX6 (ZNF740) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF84_TARGET_GENES///Genes containing one or more binding sites for UniProt:P51523 (ZNF84) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."	GCM_ACTG1///Neighborhood of ACTG1+++GCM_CSNK2B///Neighborhood of CSNK2B+++GCM_NPM1///Neighborhood of NPM1+++MORF_ACP1///Neighborhood of ACP1+++MORF_ACTG1///Neighborhood of ACTG1+++MORF_ANP32B///Neighborhood of ANP32B+++MORF_AP2M1///Neighborhood of AP2M1+++MORF_DAP3///Neighborhood of DAP3+++MORF_EIF3S6///Neighborhood of EIF3S6+++MORF_EIF4A2///Neighborhood of EIF4A2+++MORF_FBL///Neighborhood of FBL+++MORF_G22P1///Neighborhood of G22P1+++MORF_NME2///Neighborhood of NME2+++MORF_NPM1///Neighborhood of NPM1+++MORF_RAN///Neighborhood of RAN+++MORF_UBE2I///Neighborhood of UBE2I	MODULE_299///Genes in the cancer module 299.+++MODULE_355///Protein folding.		"FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_UP///Genes up-regulated in blood responders vs poor responders in adults (25-83) (responders) after exposure to Twinrix , time point 0D+++GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_ATOPIC_PATIENT_UP///Genes up-regulated in CD4 [GeneID=920] T cells from atopic patients: resting versus stimulated with allergen (house dust mite).+++GSE16385_MONOCYTE_VS_12H_IFNG_TNF_TREATED_MACROPHAGE_UP///Genes up-regulated in monocytes (12h) versus macrophages (12h) treated with IFNG and TNF [GeneID=3458;7124].+++GSE22611_NOD2_TRANSDUCED_VS_CTRL_HEK293T_STIMULATED_WITH_MDP_2H_DN///Genes down-regulated in HEK293 cells at 2h after stimulation by muramyl dipeptide [PubChem=11620162]: over-expressing wildtype NOD2 [GeneID=64127] versus control.+++GSE22886_DAY0_VS_DAY7_MONOCYTE_IN_CULTURE_DN///Genes down-regulated in comparison of monocytes cultured for 0 days versus those cultured for 7 days.+++GSE22886_IGM_MEMORY_BCELL_VS_BM_PLASMA_CELL_UP///Genes up-regulated in comparison of memory IgM B cells versus plasma cells from bone marrow and blood.+++GSE22886_NAIVE_BCELL_VS_NEUTROPHIL_UP///Genes up-regulated in comparison of naive B cells versus unstimulated neutrophils.+++GSE22886_NAIVE_VS_MEMORY_TCELL_UP///Genes up-regulated in comparison of naive CD4 [GeneID=920] CD8 T cells versus unstimulated memory CD4 [GeneID=920] CD8 T cells.+++GSE22886_NEUTROPHIL_VS_MONOCYTE_DN///Genes down-regulated in comparison of neutrophils versusl monocytes.+++GSE26156_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN///Genes down-regulated in thymocytes: double positive versus CD4 [GeneID=920] single positive.+++GSE27670_CTRL_VS_BLIMP1_TRANSDUCED_GC_BCELL_DN///Genes down-regulated in germinal center B lymphocytes: control versus over-expressing PRDM1 [GeneID=639].+++GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_48H_UP///Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 [GeneID=7040] and IL-12 (48h) versus untreated (48h).+++GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_48H_DN///Genes down-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 [GeneID=7040] and IL-12 (48h) versus IL4 [GeneID=3565] (48h).+++GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_48H_UP///Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 and IL4 [GeneID=7040;3565] (48h) versus untreated (48h).+++GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_48H_UP///Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 and IL4 [GeneID=7040;3565] (48h) versus IL4 [GeneID=3565] (48h).+++GSE2770_UNTREATED_VS_ACT_CD4_TCELL_48H_UP///Genes up-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 (48h).+++GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_DN///Genes down-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 and then stimulated by TGFB1 [GeneID=7040] and IL-12 (6h).+++GSE28726_ACT_CD4_TCELL_VS_ACT_NKTCELL_UP///Genes up-regulated in activated T cells: CD4 [GeneID=920] versus NKT.+++GSE28726_NAIVE_CD4_TCELL_VS_NAIVE_VA24NEG_NKTCELL_UP///Genes up-regulated in nave T cells: CD4 [GeneID=920] versus Va24- NKT.+++GSE28726_NAIVE_VS_ACTIVATED_VA24NEG_NKTCELL_UP///Genes up-regulated in Va24- NKT cells: nave versus activated.+++GSE32901_NAIVE_VS_TH17_ENRICHED_CD4_TCELL_DN///Genes down-regulated in CD4 [GeneID=920] nave versus Th17 enriched.+++GSE32901_NAIVE_VS_TH17_NEG_CD4_TCELL_UP///Genes up-regulated in CD4 [GeneID=920] T cells: nave versus Th17 negative.+++GSE34156_NOD2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_UP///Genes up-regulated in monocytes (6h): muramyl dipeptide [PubChem=11620162] versus muramyl dipeptide [PubChem=11620162] and M. tuberculosis 19 kDa lipopeptide.+++GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_DN///Genes down-regulated in monocytes (24h): muramyl dipeptide [PubChem=11620162] versus M. tuberculosis 19 kDa lipopeptide.+++GSE360_CTRL_VS_L_DONOVANI_MAC_DN///Genes down-regulated in comparison of macrophages versus macrophages exposed to L.donovani.+++GSE360_DC_VS_MAC_M_TUBERCULOSIS_UP///Genes up-regulated in comparison of dendritic cells (DC) exposed to M. tuberculosis versus macrophages exposed to L. major.+++GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_DC_DN///Genes down-regulated in comparison of dendritic cells (DC) exposed to L. donovani versus DCs exposed to M. tuberculosis.+++GSE360_L_MAJOR_VS_M_TUBERCULOSIS_DC_DN///Genes down-regulated in comparison of dendritic cells (DC) exposed to L. major versus DCs exposed to M. tuberculosis.+++GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_DN///Genes down-regulated in comparison of macrophages exposed to 5 worms/well B. malayi versus macrophages exposed to M. tuberculosis.+++GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_YOUNG_DN///Genes down-regulated in comparison of untreated CD4 [GeneID=920] memory T cells from young donors versus those treated with TSST at 16 h.+++GSE3982_MAST_CELL_VS_CENT_MEMORY_CD4_TCELL_UP///Genes up-regulated in comparison of mast cells versus central memory CD4 [GeneID=920] T cells.+++GSE3982_MEMORY_CD4_TCELL_VS_TH1_DN///Genes down-regulated in comparison of memory CD4 [GeneID=920] T cells versus Th1 cells.+++GSE3982_MEMORY_CD4_TCELL_VS_TH2_DN///Genes down-regulated in comparison of memory CD4 [GeneID=920] T cells versus Th2 cells.+++GSE42088_UNINF_VS_LEISHMANIA_INF_DC_2H_UP///Genes up-regulated in dendritic cells: untreated versus 2h after infection of Leishmania major.+++GSE42088_UNINF_VS_LEISHMANIA_INF_DC_4H_UP///Genes up-regulated in dendritic cells: untreated versus 4h after infection of Leishmania major.+++GSE4984_GALECTIN1_VS_LPS_STIM_DC_DN///Genes down-regulated in monocyte-derived dendritic cells: LGALS1 [GeneID=3956] versus LPS.+++GSE4984_UNTREATED_VS_GALECTIN1_TREATED_DC_DN///Genes down-regulated in monocyte-derived dendritic cells: control versus treated with LGALS1 [GeneID=3956].+++GSE7400_CTRL_VS_CSF3_IN_VIVO_TREATED_PBMC_UP///Genes up-regulated in comparison of untreated peripheral blood mononuclear cells (PBMC) versus PBMCs treated with CSF3 [GeneID=1440].+++GSE7509_FCGRIIB_VS_TNFA_IL1B_IL6_PGE_STIM_DC_UP///Genes up-regulated in dendritic cells: anti-FcgRIIB versus inflammatory cytokine cocktail.+++GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_UP///Genes up-regulated in monocytes: untreated versus anti- FcgRIIB.+++GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_12H_DN///Genes down-regulated in monocytes (12h): untreated versus M. tuberculosis 19 kDa lipopeptide.+++OCONNOR_PBMC_MENVEO_ACWYVAX_AGE_30_70YO_7DY_AFTER_SECOND_DOSE_VS_7DY_AFTER_FIRST_DOSE_UP///Genes up-regulated in peripheral blood mononuclear cell 7d after second dose vs 7d after first dose in adult (30-70) after exposure to Menveo/ACWYVax , time point 7D. Comment: second dose at 28 days"	HALLMARK_MYC_TARGETS_V1///A subgroup of genes regulated by MYC - version 1 (v1).	NM_007355	HSP90AB1				
P07737	sp|P07737|PROF1_HUMAN				Profilin-1 OS=Homo sapiens OX=9606 GN=PFN1 PE=1 SV=2								MAGWNAYIDNLMADGTCQDAAIVGYKDSPSVWAAVPGKTFVNITPAEVGVLVGKDRSSFYVNGLTLGGQKCSVIRDSLLQDGEFSMDLRTKSTGGAPTFNVTVTKTDKTLVLLMGKEGVHGGLINKKCYEMASHLRRSQY	0.4141902	-1.271634512	3.07E-04	7.3917201	8.7574734	8.2281	8.7891913	8.0729017	9.4392568	8.285887253	9.1045556	9.7955322	9.9191743	9.8360357	10.2253706	7.33089903	9.1127673	8.5217067	9.2962963	7.3445182	8.7357128	5.469460742	5.8375141	8.5585368	9.8711856	10.7237126	8.3479989	8.01577586	8.81310597	8.335647	12.130096	10.8316729	10.253231	10.2702725	9.040817	9.802824	10.7021058	9.7912126	9.8944503	10.4321101	8.991925	10.684073	10.2693392	9.53534423	10.7651891	9.2274923	9.04135957																																	C9606_78679					
P07108	sp|P07108|ACBP_HUMAN		DBI		Acyl-CoA-binding protein OS=Homo sapiens OX=9606 GN=DBI PE=1 SV=2	1622	NM_001079862	NP_001073331	ENST00000355857	K08762			MSQAEFEKAAEEVRHLKTKPSDEEMLFIYGHYKQATVGDINTERPGMLDFTGKAKWDAWNELKGTSKEDAMKAYINKVEELKKKYGI	0.6231497	-0.682349383	0.02573026	5.0122485	6.922919	6.359051	6.6559783	5.98854	7.5801021	6.687378731	7.7837796	7.2810255	7.0959912	7.4978371	7.7759751	7.14531177	7.1013211	6.7129667	7.2864308	7.6882347	7.3083666	6.306922306	7.5755106	7.977577	9.2788411	7.7536987	6.7732729	6.03910152	6.44955505	5.5987067	10.307415	8.8096376	8.570348	8.0082453	6.153158	7.4648462	7.8624443	8.3748347	7.3975552	7.8102308	7.4474352	9.00499	8.0741609	7.02856281	9.0814975	8.2274647	9.79683285	03320///PPAR signaling pathway				GO:0005788///endoplasmic reticulum lumen+++GO:0005794///Golgi apparatus+++GO:0032994///protein-lipid complex+++GO:0070062///extracellular exosome+++GO:0097038///perinuclear endoplasmic reticulum	GO:0008289///lipid binding+++GO:0030156///benzodiazepine receptor binding+++GO:0036042///long-chain fatty acyl-CoA binding+++GO:0042802///identical protein binding	GO:0006637///acyl-CoA metabolic process+++GO:0036151///phosphatidylcholine acyl-chain remodeling+++GO:1903060///negative regulation of protein lipidation+++GO:1905920///positive regulation of CoA-transferase activity+++GO:2001140///positive regulation of phospholipid transport	tissueType=Embryonic prefrontal cortex;cancerType=Normal;cellName=Oligodendrocyte progenitor cell+++tissueType=Fetal kidney;cancerType=Normal;cellName=Natural killer T (NKT) cell+++tissueType=Embryonic prefrontal cortex;cancerType=Normal;cellName=Astrocyte+++tissueType=Fetal gonad;cancerType=Normal;cellName=Migration phase fetal germ cell		"Homo sapiens diazepam binding inhibitor, acyl-CoA binding protein (DBI), transcript variant 3, mRNA."		PF00887///Acyl CoA binding protein	R-HSA-1430728///Metabolism+++R-HSA-556833///Metabolism of lipids+++R-HSA-77289///Mitochondrial Fatty Acid Beta-Oxidation+++R-HSA-8978868///Fatty acid metabolism		KOG0817///fatty-acyl-CoA binding		"IPR000582///Acyl-CoA-binding protein, ACBP+++IPR014352///FERM/acyl-CoA-binding protein superfamily+++IPR022408///Acyl-CoA-binding protein, ACBP, conserved site+++IPR035984///Acyl-CoA binding protein superfamily"	"[ACBP_HUMAN|Reviewed]RecName: Full=Acyl-CoA-binding protein; Short=ACBP; AltName: Full=Diazepam-binding inhibitor; Short=DBI; AltName: Full=Endozepine; Short=EP;+++[B8ZWD9_HUMAN|Unreviewed]SubName: Full=Diazepam binding inhibitor, splice form 1D(2) {ECO:0000313|EMBL:CAR82412.2};"	chr2q14///Ensembl 103 genes in cytogenetic band chr2q14		KEGG_PPAR_SIGNALING_PATHWAY///PPAR signaling pathway	REACTOME_FATTY_ACID_METABOLISM///Fatty acid metabolism+++REACTOME_METABOLISM_OF_LIPIDS///Metabolism of lipids+++REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION///Mitochondrial Fatty Acid Beta-Oxidation			"MIR3942_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3942-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AE_3P_MIR548AQ_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548ae-3p, hsa-miR-548aq-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AH_3P_MIR548AM_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548ah-3p, hsa-miR-548am-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AJ_3P_MIR548X_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548aj-3p, hsa-miR-548x-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548J_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548j-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6830_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6830-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7_1_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7-1-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7_2_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7-2-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets)."	ALPHACP1_01///Genes having at least one occurence of the transcription factor binding site V$ALPHACP1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++CAGGTA_AREB6_01///Genes having at least one occurence of the highly conserved motif M76 CAGGTA sites. The motif matches transcription factor binding site V$AREB6_01 (v7.4 TRANSFAC).+++GATTGGY_NFY_Q6_01///Genes having at least one occurence of the highly conserved motif M5 GATTGGY sites. The motif matches transcription factor binding site V$NFY_Q6_01 (v7.4 TRANSFAC).+++GGGYGTGNY_UNKNOWN///Genes having at least one occurence of the highly conserved motif M31 GGGYGTGNY in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++HSF1_01///Genes having at least one occurence of the transcription factor binding site V$HSF1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++RGAANNTTC_HSF1_01///Genes having at least one occurence of the highly conserved motif M68 RGAANNTTC sites. The motif matches transcription factor binding site V$HSF1_01 (v7.4 TRANSFAC).	"BARHL1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9BZE3 (BARHL1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++BPTF_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q12830 (BPTF) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++CREB3L4_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8TEY5 (CREB3L4) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++FEV_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q99581 (FEV) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++FOXD2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O60548 (FOXD2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HES2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9Y543 (HES2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++JDP2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8WYK2 (JDP2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++KDM7A_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6ZMT4 (KDM7A) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++KMT2D_TARGET_GENES///Genes containing one or more binding sites for UniProt:O14686 (KMT2D) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++MZF1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P28698 (MZF1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++PHF2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O75151 (PHF2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++PRKDC_TARGET_GENES///Genes containing one or more binding sites for UniProt:P78527 (PRKDC) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++RYBP_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8N488 (RYBP) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SFMBT1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9UHJ3 (SFMBT1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZBTB7B_TARGET_GENES///Genes containing one or more binding sites for UniProt:O15156 (ZBTB7B) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZFHX3_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q15911 (ZFHX3) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF224_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9NZL3 (ZNF224) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF257_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9Y2Q1 (ZNF257) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF669_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96BR6 (ZNF669) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZSCAN5DP_TARGET_GENES///Genes containing one or more binding sites for UniProt:P0CG00 (ZSCAN5DP) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."	MORF_PPP6C///Neighborhood of PPP6C			"ERWIN_COHEN_BLOOD_LIVE_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_14DY_UP///Genes up-regulated in blood vaccinated vs control in adults (23-48) after exposure to Live attenuated vaccine TC-83 , time point 14D+++GSE10240_IL22_VS_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP///Genes up-regulated in primary bronchial epithelial cells stimulated with: IL22 [GeneID=50616] versus IL17A [GeneID=3605].+++GSE11864_CSF1_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN///Genes down-regulated in comparison of macrophages cultured with M-CSF [GeneID=1435] versus macrophages cultured with M-CSF [GeneID=1435], IFNG [GeneID=3458] and Pam3Cyc.+++GSE11864_UNTREATED_VS_CSF1_IFNG_IN_MAC_DN///Genes down-regulated in comparison of untreated macrophages versus those cultured with M-CSF [GeneID=1435] and IFNG [GeneID=3458].+++GSE12366_GC_VS_MEMORY_BCELL_UP///Genes up-regulated in comparison of germinal center B cells versus memory B cells.+++GSE13738_RESTING_VS_BYSTANDER_ACTIVATED_CD4_TCELL_DN///Genes down-regulated in comparison of resting CD4 [GeneID=920] T cells versus bystander activated CD4 [GeneID=920] T cells.+++GSE13738_RESTING_VS_TCR_ACTIVATED_CD4_TCELL_DN///Genes down-regulated in comparison of resting CD4 [GeneID=920] T cells versus directly activated CD4 [GeneID=920] T cells.+++GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP///Genes up-regulated in comparison of CD4 [GeneID=920] CD8 thymocytes versus naive CD4 [GeneID=920] T cells from adult blood.+++GSE15215_CD2_POS_VS_NEG_PDC_DN///Genes down-regulated in comparison of CD2+ plasmacytoid dendritic cells (DC) versus CD2- cells.+++GSE16386_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_6H_UP///Genes up-regulated in macrophages (6h): IL4 [GeneID=3565] versus IL4 [GeneID=3565] and rosiglitazone [PubChem=77999].+++GSE17186_BLOOD_VS_CORD_BLOOD_CD21HIGH_TRANSITIONAL_BCELL_UP///Genes up-regulated in transitional CR2 [GeneID=1380] high B lymphocytes versus those from cord blood.+++GSE17974_0H_VS_72H_IN_VITRO_ACT_CD4_TCELL_DN///Genes down-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the untreated cells at 72 h.+++GSE17974_1.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_DN///Genes down-regulated in comparison of CD4 [GeneID=920] T cells treated with IL4 [GeneID=3565] and anti-IL12 at 1.5 h versus those at 72 h.+++GSE17974_2.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_DN///Genes down-regulated in comparison of CD4 [GeneID=920] T cells treated with IL4 [GeneID=3565] and anti-IL12 at 2 h versus those at 72 h.+++GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_72H_CD4_TCELL_DN///Genes down-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the cells treated with IL4 [GeneID=3565] and anti-IL12 at 72 h.+++GSE1925_CTRL_VS_24H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_DN///Genes down-regulated in macrophages primed by IFNG [GeneID=3458]: untreated versus stimulated by IFNG [GeneID=3458] for 24h.+++GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_24H_IFNG_STIM_DN///Genes down-regulated in macrophages stimulated by IFNG [GeneID=3458] for 24h: control versus primed by IFNG [GeneID=3458].+++GSE19772_HCMV_INFL_VS_HCMV_INF_MONOCYTES_AND_PI3K_INHIBITION_DN///Genes down-regulated in monocytes after HCMV infection: untreated versus pre-treated with Ly294002 [PubChem=3973].+++GSE19888_CTRL_VS_A3R_INHIBITOR_TREATED_MAST_CELL_UP///Genes up-regulated in HMC-1 (mast leukemia) cells: untreated versus incubated with the peptide ALL1.+++GSE22886_DAY0_VS_DAY7_MONOCYTE_IN_CULTURE_DN///Genes down-regulated in comparison of monocytes cultured for 0 days versus those cultured for 7 days.+++GSE26156_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN///Genes down-regulated in thymocytes: double positive versus CD4 [GeneID=920] single positive.+++GSE28726_ACT_CD4_TCELL_VS_ACT_NKTCELL_UP///Genes up-regulated in activated T cells: CD4 [GeneID=920] versus NKT.+++GSE28726_ACT_CD4_TCELL_VS_ACT_VA24NEG_NKTCELL_UP///Genes up-regulated in activated T cells: CD4 [GeneID=920] versus Va24- NKT.+++GSE28726_NAIVE_VS_ACTIVATED_CD4_TCELL_DN///Genes down-regulated in CD4 [GeneID=920] T cells: nave versus activated.+++GSE32164_ALTERNATIVELY_ACT_M2_VS_CMYC_INHIBITED_MACROPHAGE_DN///Genes down-regulated in macrophages: alternatively activated M2 versus MYC [GeneID=4609] inhibited.+++GSE33425_CD161_HIGH_VS_INT_CD8_TCELL_DN///Genes down-regulated in CD8 T cells: KLRB1 high [GeneID=3820] versus KLRB1 int [GeneID=3820].+++GSE33425_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_DN///Genes down-regulated in KLRB1 high [GeneID=3820] T cells: CD8A [GeneID=925] versus CD8A CD8B [GeneID=925;926].+++GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_DN///Genes down-regulated in comparison of dendritic cells (DC) exposed to 50 worms/well B. malayi versus DC exposed to M. tuberculosis+++GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_DN///Genes down-regulated in gamma delta T cells: Vd1 versus Vd2.+++GSE37416_0H_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_UP///Genes up-regulated in comparison of control polymorphonuclear leukocytes (PMN) at 0 h versus PMN treated with F. tularensis vaccine at 6 h.+++GSE37416_12H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_DN///Genes down-regulated in comparison of control polymorphonuclear leukocytes (PMN) at 12 h versus PMN treated with F. tularensis vaccine at 48 h.+++GSE3982_BASOPHIL_VS_EFF_MEMORY_CD4_TCELL_UP///Genes up-regulated in comparison of basophils versus effector memory CD4 [GeneID=920] T cells.+++GSE3982_BCELL_VS_BASOPHIL_DN///Genes down-regulated in comparison of B cells versus basophils.+++GSE3982_CTRL_VS_PMA_STIM_EOSINOPHIL_UP///Genes up-regulated in comparison of untreated eosinophils versus eosinophils treated with PMA [PubChem=4792] at 2 h.+++GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH2_DN///Genes down-regulated in comparison of effective memory CD4 [GeneID=920] T cells versus Th2 cells.+++GSE3982_MAC_VS_BCELL_UP///Genes up-regulated in comparison of macrophages versus B cells.+++GSE3982_MAC_VS_EFF_MEMORY_CD4_TCELL_UP///Genes up-regulated in comparison of macrophages versus effector memory CD4 [GeneID=920] T cells.+++GSE42724_B1_BCELL_VS_PLASMABLAST_UP///Genes up-regulated in B lymphocytes: B1 versus plasmablasts.+++GSE5099_MONOCYTE_VS_CLASSICAL_M1_MACROPHAGE_DN///Genes down-regulated in monocytes versus classically activated (M1) macrophages.+++GSE5542_UNTREATED_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_DN///Genes down-regulated in epithelial cells (24h): untreated versus interferon alpha and IFNG [GeneID=3458].+++GSE7509_FCGRIIB_VS_TNFA_IL1B_IL6_PGE_STIM_DC_UP///Genes up-regulated in dendritic cells: anti-FcgRIIB versus inflammatory cytokine cocktail.+++GSE7568_IL4_VS_IL4_AND_DEXAMETHASONE_TREATED_MACROPHAGE_UP///Genes up-regulated in macrophages differentiated for 5 days in the presence of: IL4 [GeneID=3565] versus IL4 [GeneID=3565] and dexamethasone [PubChem=5743].+++GSE8685_IL2_STARVED_VS_IL2_ACT_IL2_STARVED_CD4_TCELL_DN///Genes down-regulated in Sez-2 cells (T cell lymphoma): untreated versus IL2 [GeneID=3558].+++GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_6H_DN///Genes down-regulated in monocytes (6h): untreated versus M. tuberculosis 19 kDa lipopeptide.+++GSE9006_HEALTHY_VS_TYPE_2_DIABETES_PBMC_AT_DX_UP///Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMCs from patients with type 2 diabetes at the time of diagnosis.+++NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_UP///Genes up-regulated in peripheral blood mononuclear cell 3d vs 0d in adults (18-50) after exposure to Fluarix/Fluvirin , time point 3D. Comment: Supplementary Table 1a: All the differentially expressed genes identified in PBMCs of TIV vaccinees.+++THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_UP///Genes up-regulated in peripheral blood mononuclear cell 7d vs 0d in young adults (21-30) (responders) after exposure to Inactivated influenza vaccine , time point 7D"	HALLMARK_ANDROGEN_RESPONSE///Genes defining response to androgens.	NM_001079862	DBI				
P04792	sp|P04792|HSPB1_HUMAN		HSPB1		Heat shock protein beta-1 OS=Homo sapiens OX=9606 GN=HSPB1 PE=1 SV=2 >tr|V9HW43|V9HW43_HUMAN Heat shock 27 kDa protein OS=Homo sapiens OX=9606 GN=HEL-S-102 PE=2 SV=1	3315	NM_001540	NP_001531	ENST00000248553	K04455			MTERRVPFSLLRGPSWDPFRDWYPHSRLFDQAFGLPRLPEEWSQWLGGSSWPGYVRPLPPAAIESPAVAAPAYSRALSRQLSSGVSEIRHTADRWRVSLDVNHFAPDELTVKTKDGVVEITGKHEERQDEHGYISRCFTRKYTLPPGVDPTQVSSSLSPEGTLTVEAPMPKLATQSNEITIPVTFESRAQLGGPEAAKSDETAAK	0.5492087	-0.864573608	0.01349025	3.7170451	5.6338585	4.2082837	5.8335634	7.198255	5.1996643	5.70055887	4.9619469	5.7520717	8.1372026	5.2391645	6.8523391	4.23516617	6.3267738	6.2007046	7.2210462	6.2784583	6.5938028	3.846295745		5.0416779	6.1946101	6.9509899	5.5594177		4.33300454	5.1246812	8.541885	8.1303956	7.462094	7.0630354	5.138632	5.0106589	7.0322952	6.2917306	7.1140734	7.0485191	5.7893773	7.005581	6.7251887	6.67643912	6.8060223	6.6464491	8.07806629	04010///MAPK signaling pathway+++04370///VEGF signaling pathway+++05146///Amoebiasis	H00264///Charcot-Marie-Tooth disease+++H00856///Distal hereditary motor neuropathies			GO:0000502///proteasome complex+++GO:0005615///extracellular space+++GO:0005634///nucleus+++GO:0005737///cytoplasm+++GO:0005819///spindle+++GO:0005829///cytosol+++GO:0005856///cytoskeleton+++GO:0005886///plasma membrane+++GO:0005925///focal adhesion+++GO:0030018///Z disc+++GO:0043292///contractile fiber+++GO:0070062///extracellular exosome+++GO:1904115///axon cytoplasm	GO:0003723///RNA binding+++GO:0005080///protein kinase C binding+++GO:0005515///protein binding+++GO:0008426///protein kinase C inhibitor activity+++GO:0019901///protein kinase binding+++GO:0042802///identical protein binding+++GO:0042803///protein homodimerization activity+++GO:0043130///ubiquitin binding+++GO:0044183///protein binding involved in protein folding+++GO:0061629///RNA polymerase II sequence-specific DNA-binding transcription factor binding	GO:0001895///retina homeostasis+++GO:0001932///regulation of protein phosphorylation+++GO:0006446///regulation of translational initiation+++GO:0006469///negative regulation of protein kinase activity+++GO:0006986///response to unfolded protein+++GO:0009615///response to virus+++GO:0010506///regulation of autophagy+++GO:0016032///viral process+++GO:0032731///positive regulation of interleukin-1 beta production+++GO:0032760///positive regulation of tumor necrosis factor production+++GO:0035556///intracellular signal transduction+++GO:0035924///cellular response to vascular endothelial growth factor stimulus+++GO:0038033///positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway+++GO:0043066///negative regulation of apoptotic process+++GO:0043122///regulation of I-kappaB kinase/NF-kappaB signaling+++GO:0043488///regulation of mRNA stability+++GO:0043536///positive regulation of blood vessel endothelial cell migration+++GO:0045766///positive regulation of angiogenesis+++GO:0061077///chaperone-mediated protein folding+++GO:0070527///platelet aggregation+++GO:0099641///anterograde axonal protein transport+++GO:1902176///negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway+++GO:2001028///positive regulation of endothelial cell chemotaxis+++GO:2001234///negative regulation of apoptotic signaling pathway	tissueType=Fetal gonad;cancerType=Normal;cellName=Gonadal endothelial cell+++tissueType=Fetal gonad;cancerType=Normal;cellName=Endothelial cell+++tissueType=Liver;cancerType=Hepatocellular Cancer;cellName=Regulatory T (Treg) cell+++tissueType=Embryonic prefrontal cortex;cancerType=Normal;cellName=Astrocyte+++tissueType=Fetal gonad;cancerType=Normal;cellName=Mitotic arrest phase fetal germ cell+++tissueType=Liver;cancerType=Normal;cellName=Liver bud hepatic cell+++tissueType=Embryonic prefrontal cortex;cancerType=Normal;cellName=Neural progenitor cell+++tissueType=Lung;cancerType=Normal;cellName=Basal cell		"Homo sapiens heat shock protein family B (small) member 1 (HSPB1), mRNA."		PF00011///Hsp20/alpha crystallin family	R-HSA-162582///Signal Transduction+++R-HSA-194138///Signaling by VEGF+++R-HSA-4420097///VEGFA-VEGFR2 Pathway+++R-HSA-450408///AUF1 (hnRNP D0) binds and destabilizes mRNA+++R-HSA-450531///Regulation of mRNA stability by proteins that bind AU-rich elements+++R-HSA-5683057///MAPK family signaling cascades+++R-HSA-5687128///MAPK6/MAPK4 signaling+++R-HSA-8939211///ESR-mediated signaling+++R-HSA-8953854///Metabolism of RNA+++R-HSA-9006931///Signaling by Nuclear Receptors+++R-HSA-9006934///Signaling by Receptor Tyrosine Kinases+++R-HSA-9009391///Extra-nuclear estrogen signaling		KOG3591///structural constituent of eye lens		"IPR001436///Alpha crystallin/Small heat shock protein, animal type+++IPR002068///Alpha crystallin/Hsp20 domain+++IPR008978///HSP20-like chaperone+++IPR037876///Heat shock protein beta-1, ACD domain"	[HSPB1_HUMAN|Reviewed]RecName: Full=Heat shock protein beta-1; Short=HspB1; AltName: Full=28 kDa heat shock protein; AltName: Full=Estrogen-regulated 24 kDa protein; AltName: Full=Heat shock 27 kDa protein; Short=HSP 27; AltName: Full=Stress-responsive protein 27; Short=SRP27;	chr7q11///Ensembl 103 genes in cytogenetic band chr7q11	BIOCARTA_HSP27_PATHWAY///Stress Induction of HSP Regulation+++BIOCARTA_MTA3_PATHWAY///Downregulated of MTA-3 in ER-negative Breast Tumors+++BIOCARTA_P38MAPK_PATHWAY///p38 MAPK Signaling Pathway	KEGG_MAPK_SIGNALING_PATHWAY///MAPK signaling pathway+++KEGG_VEGF_SIGNALING_PATHWAY///VEGF signaling pathway	REACTOME_ATTENUATION_PHASE///Attenuation phase+++REACTOME_AUF1_HNRNP_D0_BINDS_AND_DESTABILIZES_MRNA///AUF1 (hnRNP D0) binds and destabilizes mRNA+++REACTOME_CELLULAR_RESPONSES_TO_EXTERNAL_STIMULI///Cellular responses to external stimuli+++REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS///Cellular response to heat stress+++REACTOME_ESR_MEDIATED_SIGNALING///ESR-mediated signaling+++REACTOME_EXTRA_NUCLEAR_ESTROGEN_SIGNALING///Extra-nuclear estrogen signaling+++REACTOME_HSF1_ACTIVATION///HSF1 activation+++REACTOME_HSF1_DEPENDENT_TRANSACTIVATION///HSF1-dependent transactivation+++REACTOME_MAPK6_MAPK4_SIGNALING///MAPK6/MAPK4 signaling+++REACTOME_MAPK_FAMILY_SIGNALING_CASCADES///MAPK family signaling cascades+++REACTOME_METABOLISM_OF_RNA///Metabolism of RNA+++REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE///Regulation of HSF1-mediated heat shock response+++REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS///Regulation of mRNA stability by proteins that bind AU-rich elements+++REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS///Signaling by Nuclear Receptors+++REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES///Signaling by Receptor Tyrosine Kinases+++REACTOME_SIGNALING_BY_VEGF///Signaling by VEGF			MIR539_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-539-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR580_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-580-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).	AACTTT_UNKNOWN///Genes having at least one occurence of the highly conserved motif M17 AACTTT in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++CTAWWWATA_RSRFC4_Q2///Genes having at least one occurence of the highly conserved motif M28 CTAWWWATA sites. The motif matches transcription factor binding site V$RSRFC4_Q2 (v7.4 TRANSFAC).+++HSF1_01///Genes having at least one occurence of the transcription factor binding site V$HSF1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++MMEF2_Q6///Genes having at least one occurence of the transcription factor binding site V$MMEF2_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++RGAANNTTC_HSF1_01///Genes having at least one occurence of the highly conserved motif M68 RGAANNTTC sites. The motif matches transcription factor binding site V$HSF1_01 (v7.4 TRANSFAC).+++TTCYRGAA_UNKNOWN///Genes having at least one occurence of the highly conserved motif M72 TTCYRGAA in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).	"BPTF_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q12830 (BPTF) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HSF2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q03933 (HSF2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++KDM5D_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9BY66 (KDM5D) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++KDM7A_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6ZMT4 (KDM7A) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++LCORL_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8N3X6 (LCORL) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++LHX9_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9NQ69 (LHX9) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++MEF2C_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q06413 (MEF2C) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++MEF2D_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q14814 (MEF2D) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NKX2_5_TARGET_GENES///Genes containing one or more binding sites for UniProt:P52952 (NKX2_5) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NR1H4_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96RI1 (NR1H4) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++PRDM4_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9UKN5 (PRDM4) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SETX_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q7Z333 (SETX) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SKIL_TARGET_GENES///Genes containing one or more binding sites for UniProt:P12757 (SKIL) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SUPT16H_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9Y5B9 (SUPT16H) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZSCAN29_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8IWY8 (ZSCAN29) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."		MODULE_105///Genes in the cancer module 105.+++MODULE_114///Protein biosynthesis and ribosomes.+++MODULE_115///Genes in the cancer module 115.+++MODULE_149///Translation factors.+++MODULE_299///Genes in the cancer module 299.+++MODULE_355///Protein folding.+++MODULE_81///Genes in the cancer module 81.+++MODULE_83///Genes in the cancer module 83.	SIRNA_EIF4GI_UP///Genes up-regulated in MCF10A cells vs knockdown of EIF4G1 [Gene ID=1981] gene by RNAi.	"GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_STIMULATED_VS_UNSTIMULATED_0DY_VACCINATION_INDEPENDENT_UP///Genes up-regulated in peripheral blood mononuclear cell stimulated vs unstimulated in young adults (18-25) after exposure to HPV-16 L1 VLP , time point 0D. Comment: List of Genes induced by VLP directly, independently of vaccination (p&lt;0.05 and FC&gt;1.30)+++GSE11057_CD4_CENT_MEM_VS_PBMC_UP///Genes up-regulated in comparison of central memory T cells versus peripheral blood mononuclear cells (PBMC).+++GSE11864_UNTREATED_VS_CSF1_PAM3CYS_IN_MAC_DN///Genes down-regulated in comparison of untreated macrophages versus those cultured with M-CSF [GeneID=1435] and Pam3Cys (TLR2 agonist).+++GSE12845_IGD_NEG_BLOOD_VS_PRE_GC_TONSIL_BCELL_UP///Genes up-regulated in comparison of IgD- peripheral blood B cells versus pre-germinal center B cells.+++GSE12845_IGD_POS_BLOOD_VS_PRE_GC_TONSIL_BCELL_UP///Genes up-regulated in comparison of IgD+ B cells from peripheral blood versus CD19 pre-germinal center tonsil B cell+++GSE13411_NAIVE_VS_IGM_MEMORY_BCELL_UP///Genes up-regulated in comparison of naive B cells versus IgM-memory B cells.+++GSE18893_TCONV_VS_TREG_24H_CULTURE_UP///Genes up-regulated in lymphocytes treated with medium for 24h: T conv versus T reg cells.+++GSE22025_UNTREATED_VS_PROGESTERONE_TREATED_CD4_TCELL_UP///Genes up-regulated in CD4 [GeneID=920] T cells: untreated versus progesterone [PubChem=5994].+++GSE22103_UNSTIM_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_DN///Genes down-regulated in neutrophils: untreated versus stimulated by CSF2 and IFNG [GeneID=1437;3458].+++GSE22103_UNSTIM_VS_LPS_STIM_NEUTROPHIL_DN///Genes down-regulated in neutrophils: untreated versus LPS.+++GSE22589_HEALTHY_VS_SIV_INFECTED_DC_UP///Genes up-regulated in monocyte-derived dendritic cells: control versus SIV infection.+++GSE22886_DAY0_VS_DAY7_MONOCYTE_IN_CULTURE_DN///Genes down-regulated in comparison of monocytes cultured for 0 days versus those cultured for 7 days.+++GSE22886_DAY1_VS_DAY7_MONOCYTE_IN_CULTURE_DN///Genes down-regulated in comparison of monocytes cultured for 1 day versus those cultured for 7 days.+++GSE22886_DC_VS_MONOCYTE_UP///Genes up-regulated in comparison of dendritic cells (DC) versus monocytes.+++GSE22886_IGM_MEMORY_BCELL_VS_BM_PLASMA_CELL_DN///Genes down-regulated in comparison of memory IgM B cells versus plasma cells from bone marrow and blood.+++GSE22886_NAIVE_CD4_TCELL_VS_MONOCYTE_UP///Genes up-regulated in comparison of naive CD4 [GeneID=920] T cells versus day 0 monocytes.+++GSE22886_NAIVE_CD4_TCELL_VS_NKCELL_UP///Genes up-regulated in comparison of naive CD4 [GeneID=920] T cells versus unstimulated NK cells.+++GSE22886_TH1_VS_TH2_48H_ACT_UP///Genes up-regulated in comparison of stimulated CD4 [GeneID=920] Th1 cells at 48 h versus stimulated CD4 [GeneID=920] Th2 cells at 48 h.+++GSE2405_S_AUREUS_VS_A_PHAGOCYTOPHILUM_NEUTROPHIL_UP///Genes up-regulated in polymorphonuclear leukocytes 9h after infection by: S. aureus versus A. phagocytophilum.+++GSE26351_UNSTIM_VS_WNT_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_DN///Genes down-regulated in CD34+ [GeneID=947] cells: control versus treated with GSK-3 Inhibitor IX (BIO) [PubChem=5287844].+++GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_2H_UP///Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 [GeneID=7040] and IL-12 (2h) versus untreated (2h).+++GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_6H_DN///Genes down-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: IL4 [GeneID=3565] (6h) versus untreated (6h).+++GSE360_CTRL_VS_L_MAJOR_DC_DN///Genes down-regulated in untreated dendritic cells (DC) versus DCs exposed to parasite L. major.+++GSE3982_EOSINOPHIL_VS_CENT_MEMORY_CD4_TCELL_DN///Genes down-regulated in comparison of eosinophils versus central memory CD4 [GeneID=920] T cells.+++GSE3982_EOSINOPHIL_VS_DC_DN///Genes down-regulated in comparison of eosinophils versus dendritic cells (DC).+++GSE3982_EOSINOPHIL_VS_EFF_MEMORY_CD4_TCELL_DN///Genes down-regulated in comparison of eosinophils versus effector memory CD4 [GeneID=920] T cells.+++GSE3982_MAC_VS_CENT_MEMORY_CD4_TCELL_UP///Genes up-regulated in comparison of macrophages versus central memory CD4 [GeneID=920] T cells.+++GSE3982_MAC_VS_EFF_MEMORY_CD4_TCELL_UP///Genes up-regulated in comparison of macrophages versus effector memory CD4 [GeneID=920] T cells.+++GSE3982_MAST_CELL_VS_EFF_MEMORY_CD4_TCELL_UP///Genes up-regulated in comparison of mast cells versus effector memory CD4 [GeneID=920] T cells.+++GSE42088_UNINF_VS_LEISHMANIA_INF_DC_4H_UP///Genes up-regulated in dendritic cells: untreated versus 4h after infection of Leishmania major.+++GSE4590_PRE_BCELL_VS_SMALL_PRE_BCELL_UP///Genes up-regulated during B lymphocyte differentiation: pre-B I versus small pre-B II.+++GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_DN///Genes down-regulated in monocyte-derived dendritic cells: untreated versus rosiglitazone and AM580 [PubChem=77999;2126].+++GSE9960_HEALTHY_VS_GRAM_POS_SEPSIS_PBMC_DN///Genes down-regulated in peripheral blood monocytes (PMBC):healthy versus Gram positive sepsis.+++GSE9960_HEALTHY_VS_SEPSIS_PBMC_DN///Genes down-regulated in peripheral blood monocytes (PMBC): healthy versus sepsis."	"HALLMARK_APICAL_SURFACE///Genes encoding proteins over-represented on the apical surface of epithelial cells, e.g., important for cell polarity (apical area).+++HALLMARK_APOPTOSIS///Genes mediating programmed cell death (apoptosis) by activation of caspases."	NM_001540	HSPB1				
P04075	sp|P04075|ALDOA_HUMAN				Fructose-bisphosphate aldolase A OS=Homo sapiens OX=9606 GN=ALDOA PE=1 SV=2 >tr|V9HWN7|V9HWN7_HUMAN Fructose-bisphosphate aldolase OS=Homo sapiens OX=9606 GN=HEL-S-87p PE=2 SV=1								MPYQYPALTPEQKKELSDIAHRIVAPGKGILAADESTGSIAKRLQSIGTENTEENRRFYRQLLLTADDRVNPCIGGVILFHETLYQKADDGRPFPQVIKSKGGVVGIKVDKGVVPLAGTNGETTTQGLDGLSERCAQYKKDGADFAKWRCVLKIGEHTPSALAIMENANVLARYASICQQNGIVPIVEPEILPDGDHDLKRCQYVTEKVLAAVYKALSDHHIYLEGTLLKPNMVTPGHACTQKFSHEEIAMATVTALRRTVPPAVTGITFLSGGQSEEEASINLNAINKCPLLKPWALTFSYGRALQASALKAWGGKKENLKAAQEEYVKRALANSLACQGKYTPSGQAGAAASESLFVSNHAY	0.6347501	-0.655739331	0.006271143		5.2346568	6.0036173	5.5040082	4.2970319	5.2122097	5.235844261	5.9274024	6.6636607	6.052471	5.7348136	7.0799068	4.4858295	5.5844404	6.710118	6.1913952	4.9993894	5.168206		5.7642036	6.166531	6.6188897	5.5344063	5.0465177		6.8055339	4.8857352	7.416603	7.3910925	7.205636	7.3473876	5.985926	6.15433	6.1546315	5.9700761	5.9741787	6.8770317	5.4547765	7.164796	7.0248124	6.04663967	6.6863184	6.104689	6.90576528																																	C9606_96098					
P02452	sp|P02452|CO1A1_HUMAN		COL1A1		Collagen alpha-1(I) chain OS=Homo sapiens OX=9606 GN=COL1A1 PE=1 SV=6	1277	NM_000088	NP_000079	ENST00000225964	K06236			MFSFVDLRLLLLLAATALLTHGQEEGQVEGQDEDIPPITCVQNGLRYHDRDVWKPEPCRICVCDNGKVLCDDVICDETKNCPGAEVPEGECCPVCPDGSESPTDQETTGVEGPKGDTGPRGPRGPAGPPGRDGIPGQPGLPGPPGPPGPPGPPGLGGNFAPQLSYGYDEKSTGGISVPGPMGPSGPRGLPGPPGAPGPQGFQGPPGEPGEPGASGPMGPRGPPGPPGKNGDDGEAGKPGRPGERGPPGPQGARGLPGTAGLPGMKGHRGFSGLDGAKGDAGPAGPKGEPGSPGENGAPGQMGPRGLPGERGRPGAPGPAGARGNDGATGAAGPPGPTGPAGPPGFPGAVGAKGEAGPQGPRGSEGPQGVRGEPGPPGPAGAAGPAGNPGADGQPGAKGANGAPGIAGAPGFPGARGPSGPQGPGGPPGPKGNSGEPGAPGSKGDTGAKGEPGPVGVQGPPGPAGEEGKRGARGEPGPTGLPGPPGERGGPGSRGFPGADGVAGPKGPAGERGSPGPAGPKGSPGEAGRPGEAGLPGAKGLTGSPGSPGPDGKTGPPGPAGQDGRPGPPGPPGARGQAGVMGFPGPKGAAGEPGKAGERGVPGPPGAVGPAGKDGEAGAQGPPGPAGPAGERGEQGPAGSPGFQGLPGPAGPPGEAGKPGEQGVPGDLGAPGPSGARGERGFPGERGVQGPPGPAGPRGANGAPGNDGAKGDAGAPGAPGSQGAPGLQGMPGERGAAGLPGPKGDRGDAGPKGADGSPGKDGVRGLTGPIGPPGPAGAPGDKGESGPSGPAGPTGARGAPGDRGEPGPPGPAGFAGPPGADGQPGAKGEPGDAGAKGDAGPPGPAGPAGPPGPIGNVGAPGAKGARGSAGPPGATGFPGAAGRVGPPGPSGNAGPPGPPGPAGKEGGKGPRGETGPAGRPGEVGPPGPPGPAGEKGSPGADGPAGAPGTPGPQGIAGQRGVVGLPGQRGERGFPGLPGPSGEPGKQGPSGASGERGPPGPMGPPGLAGPPGESGREGAPGAEGSPGRDGSPGAKGDRGETGPAGPPGAPGAPGAPGPVGPAGKSGDRGETGPAGPAGPVGPVGARGPAGPQGPRGDKGETGEQGDRGIKGHRGFSGLQGPPGPPGSPGEQGPSGASGPAGPRGPPGSAGAPGKDGLNGLPGPIGPPGPRGRTGDAGPVGPPGPPGPPGPPGPPSAGFDFSFLPQPPQEKAHDGGRYYRADDANVVRDRDLEVDTTLKSLSQQIENIRSPEGSRKNPARTCRDLKMCHSDWKSGEYWIDPNQGCNLDAIKVFCNMETGETCVYPTQPSVAQKNWYISKNPKDKRHVWFGESMTDGFQFEYGGQGSDPADVAIQLTFLRLMSTEASQNITYHCKNSVAYMDQQTGNLKKALLLQGSNEIEIRAEGNSRFTYSVTVDGCTSHTGAWGKTVIEYKTTKTSRLPIIDVAPLDVGAPDQEFGFDVGPVCFL	1.9988151	0.999145033	0.00112148		9.1368203	6.7852975	9.6135268	6.6353526	7.8497999	7.469744055	8.2349992	8.1589847	6.1175352	6.1715727	6.5235386	6.18767501	8.3060091	8.9023367	7.228081	7.1611399	6.0435524	5.808927836	7.5072231	5.9457539	6.6267781	5.9518423	6.2161282	5.3081851	7.16249593	5.9798341	5.43975	6.8471186	4.985041	6.5709848	5.713172	6.6607872		6.2198358	6.4351102	6.0163822	6.0926999	6.174688	6.1138998	6.49594174	6.0030186	6.4082362	8.63745093	04151///PI3K-Akt signaling pathway+++04510///Focal adhesion+++04512///ECM-receptor interaction+++04611///Platelet activation+++04926///Relaxin signaling pathway+++04933///AGE-RAGE signaling pathway in diabetic complications+++04974///Protein digestion and absorption+++05146///Amoebiasis+++05165///Human papillomavirus infection+++05205///Proteoglycans in cancer+++05415///Diabetic cardiomyopathy	H00506///Osteogenesis imperfecta+++H00613///Infantile cortical hyperostosis+++H01593///Osteoporosis+++H02241///Ehlers-Danlos syndrome cardiac valvular type+++H02243///Ehlers-Danlos syndrome arthrochalasia type			GO:0005576///extracellular region+++GO:0005581///collagen trimer+++GO:0005584///collagen type I trimer+++GO:0005615///extracellular space+++GO:0005737///cytoplasm+++GO:0005783///endoplasmic reticulum+++GO:0005788///endoplasmic reticulum lumen+++GO:0005794///Golgi apparatus+++GO:0016020///membrane+++GO:0016021///integral component of membrane+++GO:0030141///secretory granule+++GO:0031012///extracellular matrix+++GO:0062023///collagen-containing extracellular matrix	GO:0002020///protease binding+++GO:0005201///extracellular matrix structural constituent+++GO:0005515///protein binding+++GO:0030020///extracellular matrix structural constituent conferring tensile strength+++GO:0042802///identical protein binding+++GO:0046872///metal ion binding+++GO:0048407///platelet-derived growth factor binding	"GO:0001501///skeletal system development+++GO:0001503///ossification+++GO:0001568///blood vessel development+++GO:0001649///osteoblast differentiation+++GO:0001957///intramembranous ossification+++GO:0001958///endochondral ossification+++GO:0007155///cell adhesion+++GO:0007584///response to nutrient+++GO:0007596///blood coagulation+++GO:0007601///visual perception+++GO:0007605///sensory perception of sound+++GO:0009410///response to xenobiotic stimulus+++GO:0009612///response to mechanical stimulus+++GO:0010718///positive regulation of epithelial to mesenchymal transition+++GO:0010812///negative regulation of cell-substrate adhesion+++GO:0015031///protein transport+++GO:0030168///platelet activation+++GO:0030198///extracellular matrix organization+++GO:0030199///collagen fibril organization+++GO:0030335///positive regulation of cell migration+++GO:0031667///response to nutrient levels+++GO:0031960///response to corticosteroid+++GO:0032355///response to estradiol+++GO:0032964///collagen biosynthetic process+++GO:0034504///protein localization to nucleus+++GO:0034505///tooth mineralization+++GO:0038063///collagen-activated tyrosine kinase receptor signaling pathway+++GO:0042060///wound healing+++GO:0042493///response to drug+++GO:0042542///response to hydrogen peroxide+++GO:0043434///response to peptide hormone+++GO:0043588///skin development+++GO:0043589///skin morphogenesis+++GO:0044344///cellular response to fibroblast growth factor stimulus+++GO:0044691///tooth eruption+++GO:0045893///positive regulation of transcription, DNA-templated+++GO:0048545///response to steroid hormone+++GO:0048705///skeletal system morphogenesis+++GO:0048706///embryonic skeletal system development+++GO:0050776///regulation of immune response+++GO:0050900///leukocyte migration+++GO:0051591///response to cAMP+++GO:0055093///response to hyperoxia+++GO:0060325///face morphogenesis+++GO:0060346///bone trabecula formation+++GO:0060351///cartilage development involved in endochondral bone morphogenesis+++GO:0071230///cellular response to amino acid stimulus+++GO:0071260///cellular response to mechanical stimulus+++GO:0071300///cellular response to retinoic acid+++GO:0071306///cellular response to vitamin E+++GO:0071356///cellular response to tumor necrosis factor+++GO:0071364///cellular response to epidermal growth factor stimulus+++GO:0071560///cellular response to transforming growth factor beta stimulus+++GO:0090263///positive regulation of canonical Wnt signaling pathway+++GO:1902617///response to fluoride+++GO:1902618///cellular response to fluoride"	tissueType=Fetal gonad;cancerType=Normal;cellName=Granulosa cell+++tissueType=Fetal gonad;cancerType=Normal;cellName=Leydig precursor cell+++tissueType=Lung;cancerType=Normal;cellName=Idiopathic pulmonary fibrosis cell+++tissueType=Fetal kidney;cancerType=Normal;cellName=Natural killer T (NKT) cell+++tissueType=Peripheral blood;cancerType=Normal;cellName=Fibroblast+++tissueType=Large intestine;cancerType=Normal;cellName=DCLK1+ progenitor cell		"Homo sapiens collagen type I alpha 1 chain (COL1A1), mRNA."		PF00093///von Willebrand factor type C domain+++PF01391///Collagen triple helix repeat (20 copies)+++PF01410///Fibrillar collagen C-terminal domain	"R-HSA-109582///Hemostasis+++R-HSA-114604///GPVI-mediated activation cascade+++R-HSA-1280218///Adaptive Immune System+++R-HSA-1442490///Collagen degradation+++R-HSA-1474228///Degradation of the extracellular matrix+++R-HSA-1474244///Extracellular matrix organization+++R-HSA-1474290///Collagen formation+++R-HSA-162582///Signal Transduction+++R-HSA-1650814///Collagen biosynthesis and modifying enzymes+++R-HSA-168256///Immune System+++R-HSA-198933///Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell+++R-HSA-2022090///Assembly of collagen fibrils and other multimeric structures+++R-HSA-202733///Cell surface interactions at the vascular wall+++R-HSA-212436///Generic Transcription Pathway+++R-HSA-216083///Integrin cell surface interactions+++R-HSA-2173782///Binding and Uptake of Ligands by Scavenger Receptors+++R-HSA-2214320///Anchoring fibril formation+++R-HSA-2243919///Crosslinking of collagen fibrils+++R-HSA-3000170///Syndecan interactions+++R-HSA-3000171///Non-integrin membrane-ECM interactions+++R-HSA-3000178///ECM proteoglycans+++R-HSA-3000480///Scavenging by Class A Receptors+++R-HSA-430116///GP1b-IX-V activation signalling+++R-HSA-5653656///Vesicle-mediated transport+++R-HSA-6806834///Signaling by MET+++R-HSA-73857///RNA Polymerase II Transcription+++R-HSA-74160///Gene expression (Transcription)+++R-HSA-75892///Platelet Adhesion to exposed collagen+++R-HSA-76002///Platelet activation, signaling and aggregation+++R-HSA-76009///Platelet Aggregation (Plug Formation)+++R-HSA-8874081///MET activates PTK2 signaling+++R-HSA-8875878///MET promotes cell motility+++R-HSA-8878166///Transcriptional regulation by RUNX2+++R-HSA-8940973///RUNX2 regulates osteoblast differentiation+++R-HSA-8941326///RUNX2 regulates bone development+++R-HSA-8948216///Collagen chain trimerization+++R-HSA-9006934///Signaling by Receptor Tyrosine Kinases"		KOG3544///structural constituent of cuticle		"IPR000885///Fibrillar collagen, C-terminal+++IPR001007///VWFC domain+++IPR008160///Collagen triple helix repeat"	"[CO1A1_HUMAN|Reviewed]RecName: Full=Collagen alpha-1(I) chain; AltName: Full=Alpha-1 type I collagen; Flags: Precursor;+++[D3DTX7_HUMAN|Unreviewed]SubName: Full=Collagen, type I, alpha 1, isoform CRA_a {ECO:0000313|EMBL:EAW94631.1};+++[H9C5C5_HUMAN|Unreviewed]SubName: Full=Collagen alpha-1(I) chain preproprotein {ECO:0000313|EMBL:AFD28984.1};+++[L0R6F3_HUMAN|Unreviewed]SubName: Full=Alternative protein COL1A1 {ECO:0000313|EMBL:CCO13712.1};+++[O00604_HUMAN|Unreviewed]SubName: Full=Type I collagen alpha 1(I) chain {ECO:0000313|EMBL:AAB50780.2}; Flags: Fragment;+++[Q16053_HUMAN|Unreviewed]SubName: Full=Type I procollagen alpha 1 chain {ECO:0000313|EMBL:AAB27677.1}; Flags: Fragment;+++[Q6LAN8_HUMAN|Unreviewed]SubName: Full=Collagen type I alpha 1 {ECO:0000313|EMBL:CAA67261.1}; Flags: Fragment;+++[Q9UE86_HUMAN|Unreviewed]SubName: Full=Collagen alpha 1(I) chain {ECO:0000313|EMBL:AAB20361.1}; Flags: Fragment;+++[Q9UMA6_HUMAN|Unreviewed]SubName: Full=Type I collagen alpha 1 chain {ECO:0000313|EMBL:AAB26324.1}; Flags: Fragment;+++[Q9UNF2_HUMAN|Unreviewed]SubName: Full=Alpha 1 collagen {ECO:0000313|EMBL:AAD32608.1}; Flags: Fragment;+++[T1RTD8_HUMAN|Unreviewed]SubName: Full=COL1A1 {ECO:0000313|EMBL:AGO43920.1}; Flags: Fragment;"	chr17q21///Ensembl 103 genes in cytogenetic band chr17q21		KEGG_ECM_RECEPTOR_INTERACTION///ECM-receptor interaction+++KEGG_FOCAL_ADHESION///Focal adhesion	"REACTOME_ADAPTIVE_IMMUNE_SYSTEM///Adaptive Immune System+++REACTOME_ANCHORING_FIBRIL_FORMATION///Anchoring fibril formation+++REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES///Assembly of collagen fibrils and other multimeric structures+++REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS///Binding and Uptake of Ligands by Scavenger Receptors+++REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL///Cell surface interactions at the vascular wall+++REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES///Collagen biosynthesis and modifying enzymes+++REACTOME_COLLAGEN_CHAIN_TRIMERIZATION///Collagen chain trimerization+++REACTOME_COLLAGEN_DEGRADATION///Collagen degradation+++REACTOME_COLLAGEN_FORMATION///Collagen formation+++REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS///Crosslinking of collagen fibrils+++REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX///Degradation of the extracellular matrix+++REACTOME_ECM_PROTEOGLYCANS///ECM proteoglycans+++REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION///Extracellular matrix organization+++REACTOME_GP1B_IX_V_ACTIVATION_SIGNALLING///GP1b-IX-V activation signalling+++REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE///GPVI-mediated activation cascade+++REACTOME_HEMOSTASIS///Hemostasis+++REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL///Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell+++REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS///Integrin cell surface interactions+++REACTOME_MET_ACTIVATES_PTK2_SIGNALING///MET activates PTK2 signaling+++REACTOME_MET_PROMOTES_CELL_MOTILITY///MET promotes cell motility+++REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS///Non-integrin membrane-ECM interactions+++REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION///Platelet activation, signaling and aggregation+++REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN///Platelet Adhesion to exposed collagen+++REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION///Platelet Aggregation (Plug Formation)+++REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION///RNA Polymerase II Transcription+++REACTOME_RUNX2_REGULATES_BONE_DEVELOPMENT///RUNX2 regulates bone development+++REACTOME_RUNX2_REGULATES_OSTEOBLAST_DIFFERENTIATION///RUNX2 regulates osteoblast differentiation+++REACTOME_SCAVENGING_BY_CLASS_A_RECEPTORS///Scavenging by Class A Receptors+++REACTOME_SIGNALING_BY_MET///Signaling by MET+++REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES///Signaling by Receptor Tyrosine Kinases+++REACTOME_SYNDECAN_INTERACTIONS///Syndecan interactions+++REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX2///Transcriptional regulation by RUNX2+++REACTOME_VESICLE_MEDIATED_TRANSPORT///Vesicle-mediated transport"	"NABA_COLLAGENS///Genes encoding collagen proteins+++NABA_CORE_MATRISOME///Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans+++NABA_MATRISOME///Ensemble of genes encoding extracellular matrix and extracellular matrix-associated proteins "	"AAGCACA_MIR218///Genes having at least one occurence of the motif AAGCACA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-218 (v7.1 miRBase).+++ACTACCT_MIR196A_MIR196B///Genes having at least one occurence of the motif ACTACCT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-196a and hsa-miR-196b (v7.1 miRBase).+++AGGAAGC_MIR5163P///Genes having at least one occurence of the motif AGGAAGC in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-516-3p (v7.1 miRBase).+++CTACCTC_LET7A_LET7B_LET7C_LET7D_LET7E_LET7F_MIR98_LET7G_LET7I///Genes having at least one occurence of the motif CTACCTC in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-let-7a, hsa-let-7b, hsa-let-7c, hsa-let-7d, hsa-let-7e, hsa-let-7f, hsa-miR-98, hsa-let-7g and hsa-let-7i (v7.1 miRBase).+++CTTTGCA_MIR527///Genes having at least one occurence of the motif CTTTGCA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-527 (v7.1 miRBase).+++GCTTGAA_MIR498///Genes having at least one occurence of the motif GCTTGAA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-498 (v7.1 miRBase).+++TAATAAT_MIR126///Genes having at least one occurence of the motif TAATAAT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-126* (v7.1 miRBase).+++TGGTGCT_MIR29A_MIR29B_MIR29C///Genes having at least one occurence of the motif TGGTGCT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-29a, hsa-miR-29b and hsa-miR-29c (v7.1 miRBase)."	"MIR1275///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1275 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR129_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-129-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR143_3P_MIR4770///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-143-3p, hsa-miR-4770 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR29A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-29a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR29B_3P_MIR29C_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-29b-3p, hsa-miR-29c-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3184_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3184-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR372_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-372-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3940_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3940-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR423_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-423-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4492///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4492 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4507///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4507 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4789_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4789-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4789_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4789-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AC///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548ac in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AE_3P_MIR548AQ_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548ae-3p, hsa-miR-548aq-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AH_3P_MIR548AM_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548ah-3p, hsa-miR-548am-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AJ_3P_MIR548X_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548aj-3p, hsa-miR-548x-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AV_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548av-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548BB_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548bb-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548D_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548d-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548H_3P_MIR548Z///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548h-3p, hsa-miR-548z in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548J_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548j-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5587_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5587-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR561_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-561-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5682///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5682 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6088///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6088 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR651_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-651-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6734_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6734-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6751_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6751-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6803_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6803-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6830_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6830-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6871_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6871-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7109_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7109-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR92A_1_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-92a-1-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR9983_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-9983-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets)."	ALPHACP1_01///Genes having at least one occurence of the transcription factor binding site V$ALPHACP1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++ATF1_Q6///Genes having at least one occurence of the transcription factor binding site V$ATF1_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++CCAWNWWNNNGGC_UNKNOWN///Genes having at least one occurence of the highly conserved motif M165 CCAWNWWNNNGGC in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++COMP1_01///Genes having at least one occurence of the transcription factor binding site V$COMP1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++CP2_01///Genes having at least one occurence of the transcription factor binding site V$CP2_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++E2A_Q2///Genes having at least one occurence of the transcription factor binding site V$E2A_Q2 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++GATTGGY_NFY_Q6_01///Genes having at least one occurence of the highly conserved motif M5 GATTGGY sites. The motif matches transcription factor binding site V$NFY_Q6_01 (v7.4 TRANSFAC).+++GGGTGGRR_PAX4_03///Genes having at least one occurence of the highly conserved motif M56 GGGTGGRR sites. The motif matches transcription factor binding site V$PAX4_03 (v7.4 TRANSFAC).+++MAF_Q6///Genes having at least one occurence of the transcription factor binding site V$MAF_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++MEF2_Q6_01///Genes having at least one occurence of the transcription factor binding site V$MEF2_Q6_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++MYOGENIN_Q6///Genes having at least one occurence of the transcription factor binding site V$MYOGENIN_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++NFY_01///Genes having at least one occurence of the transcription factor binding site V$NFY_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++NFY_C///Genes having at least one occurence of the transcription factor binding site V$NFY_C (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++NFY_Q6_01///Genes having at least one occurence of the transcription factor binding site V$NFY_Q6_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++NFY_Q6///Genes having at least one occurence of the transcription factor binding site V$NFY_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++SRF_Q5_01///Genes having at least one occurence of the transcription factor binding site V$SRF_Q5_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++SRF_Q6///Genes having at least one occurence of the transcription factor binding site V$SRF_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++TAATTA_CHX10_01///Genes having at least one occurence of the highly conserved motif M23 TAATTA sites. The motif matches transcription factor binding site V$CHX10_01 (v7.4 TRANSFAC).+++TAAWWATAG_RSRFC4_Q2///Genes having at least one occurence of the highly conserved motif M54 TAAWWATAG sites. The motif matches transcription factor binding site V$RSRFC4_Q2 (v7.4 TRANSFAC).+++TATA_01///Genes having at least one occurence of the transcription factor binding site V$TATA_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++TATAAA_TATA_01///Genes having at least one occurence of the highly conserved motif M51 TATAAA sites. The motif matches transcription factor binding site V$TATA_01 (v7.4 TRANSFAC).+++TATA_C///Genes having at least one occurence of the transcription factor binding site V$TATA_C (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++TFIIA_Q6///Genes having at least one occurence of the transcription factor binding site V$TFIIA_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++TGANTCA_AP1_C///Genes having at least one occurence of the highly conserved motif M7 TGANTCA sites. The motif matches transcription factor binding site V$AP1_C (v7.4 TRANSFAC).+++WTTGKCTG_UNKNOWN///Genes having at least one occurence of the highly conserved motif M46 WTTGKCTG in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++YNGTTNNNATT_UNKNOWN///Genes having at least one occurence of the highly conserved motif M170 YNGTTNNNATT in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).	"BDP1_TARGET_GENES///Genes containing one or more binding sites for UniProt:A6H8Y1 (BDP1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++CREB3L4_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8TEY5 (CREB3L4) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++DYRK1A_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q13627 (DYRK1A) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++H1_6_TARGET_GENES///Genes containing one or more binding sites for UniProt:P22492 (H1_6) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++KLF7_TARGET_GENES///Genes containing one or more binding sites for UniProt:O75840 (KLF7) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++PSMB5_TARGET_GENES///Genes containing one or more binding sites for UniProt:P28074 (PSMB5) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SIX1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q15475 (SIX1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SNIP1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8TAD8 (SNIP1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SUPT16H_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9Y5B9 (SUPT16H) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZFP91_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96JP5 (ZFP91) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZMYND11_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q15326 (ZMYND11) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF391_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9UJN7 (ZNF391) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF597_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96LX8 (ZNF597) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF623_TARGET_GENES///Genes containing one or more binding sites for UniProt:O75123 (ZNF623) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."	GNF2_CDH11///Neighborhood of CDH11+++GNF2_PTX3///Neighborhood of PTX3	"MODULE_122///Adhesion molecules.+++MODULE_12///Spinal cord (neuro-development) genes.+++MODULE_13///Genes in the cancer module 12.+++MODULE_153///Genes in the cancer module 153.+++MODULE_1///Ovary genes.+++MODULE_220///Developmental processes.+++MODULE_234///Bone remodeling.+++MODULE_23///Liver genes - metabolism and xenobiotics.+++MODULE_24///Fetal liver genes - metabolism and xenobiotics.+++MODULE_38///Placenta genes.+++MODULE_41///Genes in the cancer module 41.+++MODULE_47///ECM and collagens.+++MODULE_55///Genes in the cancer module 55.+++MODULE_88///Heart, liver, kidney and pancreas metabolic and xenobiotic response genes."	"CSR_EARLY_UP.V1_DN///Genes down-regulated in early serum response of CRL 2091 cells (foreskin fibroblasts).+++PDGF_ERK_DN.V1_UP///Genes up-regulated in SH-SY5Y cells (neuroblastoma) in response to PDGF [Gene ID=] stimulation after pre-treatment with the ERK inhibitors U0126 and PD98059 [PubChem=3006531, 4713]."	"GSE12845_IGD_POS_BLOOD_VS_PRE_GC_TONSIL_BCELL_UP///Genes up-regulated in comparison of IgD+ B cells from peripheral blood versus CD19 pre-germinal center tonsil B cell+++GSE1460_CD4_THYMOCYTE_VS_THYMIC_STROMAL_CELL_DN///Genes down-regulated in comparison of CD4 [GeneID=920] thymocytes versus thymic stromal cells.+++GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_1H_ACT_CD4_TCELL_DN///Genes down-regulated in comparison of CD4 [GeneID=920] T cells treated with IL4 [GeneID=3565] and anti-IL12 at 1 h versus the untreated cells at 1 h.+++GSE22886_IGM_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_UP///Genes up-regulated in comparison of memory IgM B cells versus blood plasma cells.+++GSE22886_TH1_VS_TH2_12H_ACT_DN///Genes down-regulated in comparison of stimulated CD4 [GeneID=920] Th1 cells at 12 h versus stimulated CD4 [GeneID=920] Th2 cells at 12 h.+++GSE26928_NAIVE_VS_CENT_MEMORY_CD4_TCELL_DN///Genes down-regulated in comparison of naive CD4 [GeneID=920] T cells versus CD4 [GeneID=920] central memory T cells.+++GSE29618_PRE_VS_DAY7_FLU_VACCINE_BCELL_DN///Genes down-regulated in comparison of B cells from influenza vaccinee pre-vaccination versus those at day 7 post-vaccination.+++GSE3982_NEUTROPHIL_VS_TH1_UP///Genes up-regulated in comparison of neutrophils versus Th1 cells.+++GSE8835_HEALTHY_VS_CLL_CD8_TCELL_DN///Genes down-regulated in CD8 T cells: healthy versus CLL (chronic lymphocytic leukemia).+++GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_24H_UP///Genes up-regulated in monocytes: untreated versus M. tuberculosis 19 kDa lipopeptide (24h).+++NAKAYA_MONOCYTE_FLUMIST_AGE_18_50YO_7DY_DN///Genes down-regulated in monocyte 7d vs 0d in young adults (18-50) after exposure to FluMist , time point 7D"	"HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION///Genes defining epithelial-mesenchymal transition, as in wound healing, fibrosis and metastasis.+++HALLMARK_MYOGENESIS///Genes involved in development of skeletal muscle (myogenesis).+++HALLMARK_UV_RESPONSE_DN///Genes down-regulated in response to ultraviolet (UV) radiation."	NM_000088	COL1A1				
P01817	sp|P01817|HV205_HUMAN		IGHV2-5		Immunoglobulin heavy variable 2-5 OS=Homo sapiens OX=9606 GN=IGHV2-5 PE=1 SV=2	28457	id-IGHV2-5-2						MDTLCSTLLLLTIPSWVLSQITLKESGPTLVKPTQTLTLTCTFSGFSLSTSGVGVGWIRQPPGKALEWLALIYWDDDKRYSPSLKSRLTITKDTSKNQVVLTMTNMDPVDTATYYCAHR	0.5935043	-0.752669579	0.002730237	4.6057908	4.7747935	6.0054982	4.7246819	2.9587393	4.0197555	5.261586089	4.8186072	4.9031895	5.4836134	4.6640458	4.0980455	6.65201072	6.0396867	3.9033845	4.4363355	5.0413396	4.7142875	3.95063076	3.0920544	4.2949588	4.8689465	5.2991059	5.9654625	5.10308028	5.47887786	4.7808982	6.796346	4.8600618	6.55121	5.3827141	4.699143	5.2857621	3.8808288	6.2826048	5.2538556	5.2598697	4.4940908	6.709742	5.4187811	6.22623737	6.3846631	4.7161301	5.04124666																																	id-IGHV2-5-2	IGHV2-5				
P01721	sp|P01721|LV657_HUMAN		IGLV6-57		Immunoglobulin lambda variable 6-57 OS=Homo sapiens OX=9606 GN=IGLV6-57 PE=1 SV=2	28778	id-IGLV6-57						MAWAPLLLTLLAHCTGSWANFMLTQPHSVSESPGKTVTISCTGSSGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSSN	0.4742155	-1.076385232	0.01807142		5.4037153						5.9652966																6.7635101		6.84480244			7.0677624								6.3674897																																								id-IGLV6-57	IGLV6-57				
P01344	sp|P01344|IGF2_HUMAN		IGF2		Insulin-like growth factor II OS=Homo sapiens OX=9606 GN=IGF2 PE=1 SV=1	3481	URS0001A14C95						MGIPMGKSMLVLLTFLAFASCCIAAYRPSETLCGGELVDTLQFVCGDRGFYFSRPASRVSRRSRGIVEECCFRSCDLALLETYCATPAKSERDVSTPPTVLPDNFPRYPVGKFFQYDTWKQSTQRLRRGLPALLRARRGHVLAKELEAFREAKRHRPLIALPTQDPAHGGAPPEMASNRK	1.9079698	0.932038372	0.004342976	8.8337296	10.4467693	10.4109026	11.373037	12.7138679	11.5049249	10.09990473	11.4409939	11.1652152	10.3267117	10.6335245	10.851217	11.15966513	10.9030991	11.0397211	10.6148884	12.3115454	11.4676478	9.929911862	10.1010375	10.4540748	12.0621177	6.9237319	9.0401907	8.09366178	8.90587859	8.8107647	9.292283	9.5896816	8.818392	9.0262028	9.067662	10.1771495	10.4974051	11.1467846	10.6152245	11.2160491	11.3343462	11.05157	11.0382806	10.59388441	11.0460876	11.6933126	11.36111982																																	URS0001A14C95	IGF2				
O95810	sp|O95810|CAVN2_HUMAN		CAVIN2		Caveolae-associated protein 2 OS=Homo sapiens OX=9606 GN=CAVIN2 PE=1 SV=3	8436	NM_004657	NP_004648	ENST00000304141				MGEDAAQAEKFQHPGSDMRQEKPSSPSPMPSSTPSPSLNLGNTEEAIRDNSQVNAVTVLTLLDKLVNMLDAVQENQHKMEQRQISLEGSVKGIQNDLTKLSKYQASTSNTVSKLLEKSRKVSAHTRAVKERMDRQCAQVKRLENNHAQLLRRNHFKVLIFQEENEIPASVFVKQPVSGAVEGKEELPDENKSLEETLHTVDLSSDDDLPHDEEALEDSAEEKVEESRAEKIKRSSLKKVDSLKKAFSRQNIEKKMNKLGTKIVSVERREKIKKSLTSNHQKISSGKSSPFKVSPLTFGRKKVREGESHAENETKSEDLPSSEQMPNDQEEESFAEGHSEASLASALVEGEIAEEAAEKATSRGSNSGMDSNIDLTIVEDEEEESVALEQAQKVRYEGSYALTSEEAERSDGDPVQPAVLQVHQTS	0.5879518	-0.766230185	0.009320663					4.4751309	6.1938131		4.1228858	6.1976137	7.0564472	5.454072	6.3104196		5.451541	5.6150815	5.7731212		4.5913485			5.1450504	4.854513	7.1786787					6.430579	7.2112768	7.053157	7.399718	5.708024	4.2699363	5.8671275	5.042016	5.9191295	6.2083629	6.3630304	6.651185	6.5136249	6.13084452	6.5568448	5.2810477	6.64899774					GO:0005654///nucleoplasm+++GO:0005737///cytoplasm+++GO:0005829///cytosol+++GO:0005886///plasma membrane+++GO:0005901///caveola+++GO:0016020///membrane+++GO:0045121///membrane raft	GO:0001786///phosphatidylserine binding+++GO:0005080///protein kinase C binding+++GO:0005515///protein binding+++GO:0005543///phospholipid binding+++GO:0008289///lipid binding	GO:0097320///plasma membrane tubulation			"Homo sapiens caveolae associated protein 2 (CAVIN2), mRNA."		PF15237///PTRF/SDPR family			ENOG502QQCA///No_INFO		IPR026752///Cavin family+++IPR033298///Caveolae-associated protein 2	[CAVN2_HUMAN|Reviewed]RecName: Full=Caveolae-associated protein 2 {ECO:0000312|HGNC:HGNC:10690}; AltName: Full=Cavin-2; AltName: Full=PS-p68; AltName: Full=Phosphatidylserine-binding protein; AltName: Full=Serum deprivation-response protein;	chr2q32///Ensembl 103 genes in cytogenetic band chr2q32					"CTCCAAG_MIR432///Genes having at least one occurence of the motif CTCCAAG in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-432 (v7.1 miRBase)."	"MIR126_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-126-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1282///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1282 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR186_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-186-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR188_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-188-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR200C_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-200c-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR2053///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-2053 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR206///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-206 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR302B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-302b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR302D_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-302d-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3658///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3658 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3692_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3692-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR376A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-376a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3924///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3924 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4315///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4315 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR432_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-432-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4427///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4427 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4477A///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4477a in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4659A_3P_MIR4659B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4659a-3p, hsa-miR-4659b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4677_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4677-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4679///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4679 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4762_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4762-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4768_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4768-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4795_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4795-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AW///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548aw in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR550A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-550a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR613///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-613 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR618///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-618 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6515_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6515-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR656_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-656-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6832_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6832-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6833_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6833-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6866_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6866-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR8068///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-8068 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets)."	AACTTT_UNKNOWN///Genes having at least one occurence of the highly conserved motif M17 AACTTT in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++AFP1_Q6///Genes having at least one occurence of the transcription factor binding site V$AFP1_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++AREB6_02///Genes having at least one occurence of the transcription factor binding site V$AREB6_02 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++AREB6_03///Genes having at least one occurence of the transcription factor binding site V$AREB6_03 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++CAGCTG_AP4_Q5///Genes having at least one occurence of the highly conserved motif M15 CAGCTG sites. The motif matches transcription factor binding site V$AP4_Q5 (v7.4 TRANSFAC).+++CCAWWNAAGG_SRF_Q4///Genes having at least one occurence of the highly conserved motif M121 CCAWWNAAGG sites. The motif matches transcription factor binding site V$SRF_Q4 (v7.4 TRANSFAC).+++CEBPB_02///Genes having at least one occurence of the transcription factor binding site V$CEBPB_02 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++CEBPDELTA_Q6///Genes having at least one occurence of the transcription factor binding site V$CEBPDELTA_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++CEBP_Q2_01///Genes having at least one occurence of the transcription factor binding site V$CEBP_Q2_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++CTGCAGY_UNKNOWN///Genes having at least one occurence of the highly conserved motif M101 CTGCAGY in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++CTTTGA_LEF1_Q2///Genes having at least one occurence of the highly conserved motif M73 CTTTGA sites. The motif matches transcription factor binding site V$LEF1_Q2 (v7.4 TRANSFAC).+++E47_01///Genes having at least one occurence of the transcription factor binding site V$E47_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++E47_02///Genes having at least one occurence of the transcription factor binding site V$E47_02 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++GATA1_05///Genes having at least one occurence of the transcription factor binding site V$GATA1_05 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++ISRE_01///Genes having at least one occurence of the transcription factor binding site V$ISRE_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++LMO2COM_02///Genes having at least one occurence of the transcription factor binding site V$LMO2COM_02 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++NKX22_01///Genes having at least one occurence of the transcription factor binding site V$NKX22_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++NKX61_01///Genes having at least one occurence of the transcription factor binding site V$NKX61_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++NKX62_Q2///Genes having at least one occurence of the transcription factor binding site V$NKX62_Q2 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++PAX4_02///Genes having at least one occurence of the transcription factor binding site V$PAX4_02 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++PAX4_04///Genes having at least one occurence of the transcription factor binding site V$PAX4_04 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++PAX6_01///Genes having at least one occurence of the transcription factor binding site V$PAX6_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++RYTTCCTG_ETS2_B///Genes having at least one occurence of the highly conserved motif M16 RYTTCCTG sites. The motif matches transcription factor binding site V$ETS2_B (v7.4 TRANSFAC).+++SRF_Q4///Genes having at least one occurence of the transcription factor binding site V$SRF_Q4 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++SRF_Q5_01///Genes having at least one occurence of the transcription factor binding site V$SRF_Q5_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++SRF_Q6///Genes having at least one occurence of the transcription factor binding site V$SRF_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++TATA_C///Genes having at least one occurence of the transcription factor binding site V$TATA_C (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++TCF4_Q5///Genes having at least one occurence of the transcription factor binding site V$TCF4_Q5 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++TGACATY_UNKNOWN///Genes having at least one occurence of the highly conserved motif M42 TGACATY in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++TGANNYRGCA_TCF11MAFG_01///Genes having at least one occurence of the highly conserved motif M67 TGANNYRGCA sites. The motif matches transcription factor binding site V$TCF11MAFG_01 (v7.4 TRANSFAC).+++TGATTTRY_GFI1_01///Genes having at least one occurence of the highly conserved motif M94 TGATTTRY sites. The motif matches transcription factor binding site V$GFI1_01 (v7.4 TRANSFAC).+++TGCCAAR_NF1_Q6///Genes having at least one occurence of the highly conserved motif M47 TGCCAAR sites. The motif matches transcription factor binding site V$NF1_Q6 (v7.4 TRANSFAC).+++TGGNNNNNNKCCAR_UNKNOWN///Genes having at least one occurence of the highly conserved motif M27 TGGNNNNNNKCCAR in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++TNCATNTCCYR_UNKNOWN///Genes having at least one occurence of the highly conserved motif M75 TNCATNTCCYR in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++YKACATTT_UNKNOWN///Genes having at least one occurence of the highly conserved motif M145 YKACATTT in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++YNGTTNNNATT_UNKNOWN///Genes having at least one occurence of the highly conserved motif M170 YNGTTNNNATT in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).	"NCOA2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q15596 (NCOA2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZSCAN29_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8IWY8 (ZSCAN29) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."		MODULE_414///Genes in the cancer module 414.	"CORDENONSI_YAP_CONSERVED_SIGNATURE///YAP conserved signature.+++CSR_EARLY_UP.V1_DN///Genes down-regulated in early serum response of CRL 2091 cells (foreskin fibroblasts).+++CSR_LATE_UP.V1_DN///Genes down-regulated in late serum response of CRL 2091 cells (foreskin fibroblasts).+++NOTCH_DN.V1_UP///Genes up-regulated in MOLT4 cells (T-ALL) by DAPT [PubChem=16219261], an inhibitor of NOTCH signaling pathway.+++TBK1.DF_DN///Genes down-regulated in epithelial lung cancer cell lines upon over-expression of an oncogenic form of KRAS [Gene ID=3845] gene and knockdown of TBK1 [Gene ID=29110] gene by RNAi.+++TGFB_UP.V1_DN///Genes down-regulated in a panel of epithelial cell lines by TGFB1 [Gene ID=7040]."	"GSE13484_12H_VS_3H_YF17D_VACCINE_STIM_PBMC_DN///Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) cultured with YF17D vaccine for 12 h versus PBMC cultured for 3 h.+++GSE13484_UNSTIM_VS_12H_YF17D_VACCINE_STIM_PBMC_UP///Genes up-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) cultured for 0 h versus PBMC cultured for 12 h with YF17D vaccine.+++GSE18893_CTRL_VS_TNF_TREATED_TREG_24H_DN///Genes down-regulated in T reg cells: 2h versus 24h medium treatment.+++GSE19772_CTRL_VS_HCMV_INF_MONOCYTES_DN///Genes down-regulated in monocytes: control versus HCMV infection.+++GSE22229_UNTREATED_VS_IMMUNOSUPP_THERAPY_RENAL_TRANSPLANT_PATIENT_PBMC_DN///Genes down-regulated in periperal blood monocytes (PBMC) from kidney transplant recipients: tolerant versus immunosuppressive therapy.+++GSE23321_CD8_STEM_CELL_MEMORY_VS_CENTRAL_MEMORY_CD8_TCELL_UP///Genes up-regulated in CD8 T cells: stem cell memory versus central memory.+++GSE29615_CTRL_VS_DAY7_LAIV_FLU_VACCINE_PBMC_UP///Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from LAIV influenza vaccine pre-vaccination versus those at day 7 post-vaccination.+++GSE3982_MAST_CELL_VS_BCELL_UP///Genes up-regulated in comparison of mast cells versus B cells.+++GSE3982_MAST_CELL_VS_CENT_MEMORY_CD4_TCELL_UP///Genes up-regulated in comparison of mast cells versus central memory CD4 [GeneID=920] T cells.+++GSE3982_MAST_CELL_VS_MAC_UP///Genes up-regulated in comparison of mast cells versus macrophages.+++GSE7400_CTRL_VS_CSF3_IN_VIVO_TREATED_PBMC_UP///Genes up-regulated in comparison of untreated peripheral blood mononuclear cells (PBMC) versus PBMCs treated with CSF3 [GeneID=1440].+++GSE8685_IL2_ACT_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_DN///Genes down-regulated in Sez-2 cells (T cell lymphoma): untreated versus IL15 [GeneID=3600].+++GSE9601_NFKB_INHIBITOR_VS_PI3K_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_UP///Genes up-regulated in monocytes after HCMV infection: BAY 11-7082 [PubChem=5353431] versus Ly294002 [PubChem=3973].+++HOEK_NK_CELL_2011_2012_TIV_ADULT_3DY_UP///Genes up-regulated in natural killer cell 3d vs 0d in adults after exposure to 2011-2012 trivalent inactivated vaccine (A/California/7/09 (H1N1), A/Perth /16/2009 (H3N2), B/Brisbane/60/2008) , time point 3D. Comment: Up-regulated DE RNA transcripts (up &gt;= 1.5x) shared between both TIV-vaccinated donors+++HOEK_NK_CELL_2011_2012_TIV_ADULT_7DY_UP///Genes up-regulated in natural killer cell 7d vs 0d in adults after exposure to 2011-2012 trivalent inactivated vaccine (A/California/7/09 (H1N1), A/Perth /16/2009 (H3N2), B/Brisbane/60/2008) , time point 7D. Comment: Up-regulated DE RNA transcripts (up &gt;= 1.5x) shared between both TIV-vaccinated donors+++NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_NEGATIVE///Genes negatively correlated with HAI response at 28d in peripheral blood mononuclear cell in adults (18-50) after exposure to Fluarix/Fluvirin , time point 3D. Comment: Supplementary Table 5: All genes whose expression (d3/d0 or d7/d0) correlates to the fold increase in HAI titers (d28/d0).+++NAKAYA_PBMC_FLUMIST_AGE_18_50YO_7DY_DN///Genes down-regulated in peripheral blood mononuclear cell 7d vs 0d in adults (18-50) after exposure to FluMist , time point 7D. Comment: Supplementary Table 1a: All the differentially expressed genes identified in PBMCs of TIV vaccinees.+++THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_UP///Genes up-regulated in peripheral blood mononuclear cell 28d vs 0d in young adults (21-30) (responders) after exposure to Inactivated influenza vaccine , time point 28D"	HALLMARK_ADIPOGENESIS///Genes up-regulated during adipocyte differentiation (adipogenesis).	NM_004657	CAVIN2				
O95336	sp|O95336|6PGL_HUMAN		PGLS		6-phosphogluconolactonase OS=Homo sapiens OX=9606 GN=PGLS PE=1 SV=2 >tr|A0A0K0K1K7|A0A0K0K1K7_HUMAN 6-phosphogluconolactonase OS=Homo sapiens OX=9606 GN=HEL-S-304 PE=2 SV=1	25796	NM_012088	NP_036220	ENST00000252603	K01057			MAAPAPGLISVFSSSQELGAALAQLVAQRAACCLAGARARFALGLSGGSLVSMLARELPAAVAPAGPASLARWTLGFCDERLVPFDHAESTYGLYRTHLLSRLPIPESQVITINPELPVEEAAEDYAKKLRQAFQGDSIPVFDLLILGVGPDGHTCSLFPDHPLLQEREKIVAPISDSPKPPPQRVTLTLPVLNAARTVIFVATGEGKAAVLKRILEDQEENPLPAALVQPHTGKLCWFLDEAAARLLTVPFEKHSTL	0.5438764	-0.878649257	0.02054968					4.5268164	6.1210714	4.895830766		6.0154307	6.0841695	5.5316585	5.5510718			5.7085793	7.5388708		6.4946437		5.35396	6.3876813	6.4623847	6.1627111		5.65178106			9.285843	5.578443	6.471293	8.3417106	5.862062		7.7860099		5.0260318	6.5212395	5.979869	7.889035	5.7083882	6.76003476	8.0807644	6.4008788	7.69454842	00030///Pentose phosphate pathway+++01200///Carbon metabolism		"M00004///Pentose phosphate pathway (Pentose phosphate cycle)+++M00006///Pentose phosphate pathway, oxidative phase, glucose 6P => ribulose 5P+++M00008///Entner-Doudoroff pathway, glucose-6P => glyceraldehyde-3P + pyruvate"	"R02035///6-Phospho-D-glucono-1,5-lactone lactonohydrolase   D-Glucono-1,5-lactone 6-phosphate + H2O <=> 6-Phospho-D-gluconate"	GO:0005737///cytoplasm+++GO:0005829///cytosol+++GO:0070062///extracellular exosome	GO:0005515///protein binding+++GO:0016787///hydrolase activity+++GO:0017057///6-phosphogluconolactonase activity	"GO:0005975///carbohydrate metabolic process+++GO:0006098///pentose-phosphate shunt+++GO:0009051///pentose-phosphate shunt, oxidative branch"	tissueType=Fetal kidney;cancerType=Normal;cellName=Monocyte+++tissueType=Fetal kidney;cancerType=Normal;cellName=Natural killer T (NKT) cell		"Homo sapiens 6-phosphogluconolactonase (PGLS), mRNA."		PF01182///Glucosamine-6-phosphate isomerases/6-phosphogluconolactonase	R-HSA-1430728///Metabolism+++R-HSA-71336///Pentose phosphate pathway+++R-HSA-71387///Metabolism of carbohydrates	COG0363///No_INFO	KOG3147///6-phosphogluconolactonase activity		"IPR005900///6-phosphogluconolactonase, DevB-type+++IPR006148///Glucosamine/galactosamine-6-phosphate isomerase+++IPR037171///NagB/RpiA transferase-like+++IPR039104///6-Phosphogluconolactonase"	[6PGL_HUMAN|Reviewed]RecName: Full=6-phosphogluconolactonase; Short=6PGL; EC=3.1.1.31;	chr19p13///Ensembl 103 genes in cytogenetic band chr19p13		KEGG_PENTOSE_PHOSPHATE_PATHWAY///Pentose phosphate pathway	REACTOME_METABOLISM_OF_CARBOHYDRATES///Metabolism of carbohydrates+++REACTOME_PENTOSE_PHOSPHATE_PATHWAY///Pentose phosphate pathway				RCGCANGCGY_NRF1_Q6///Genes having at least one occurence of the highly conserved motif M1 RCGCANGCGY sites. The motif matches transcription factor binding site V$NRF1_Q6 (v7.4 TRANSFAC).	"CBX7_TARGET_GENES///Genes containing one or more binding sites for UniProt:O95931 (CBX7) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HMG20B_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9P0W2 (HMG20B) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++KAT2A_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q92830 (KAT2A) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++KDM5D_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9BY66 (KDM5D) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SETD7_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8WTS6 (SETD7) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++THAP1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9NVV9 (THAP1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZBTB7B_TARGET_GENES///Genes containing one or more binding sites for UniProt:O15156 (ZBTB7B) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF16_TARGET_GENES///Genes containing one or more binding sites for UniProt:P17020 (ZNF16) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF407_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9C0G0 (ZNF407) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF436_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9C0F3 (ZNF436) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF84_TARGET_GENES///Genes containing one or more binding sites for UniProt:P51523 (ZNF84) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF92_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q03936 (ZNF92) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."				"GSE12366_GC_BCELL_VS_PLASMA_CELL_UP///Genes up-regulated in comparison of germinal center B cells versus plasma cells.+++GSE13484_UNSTIM_VS_12H_YF17D_VACCINE_STIM_PBMC_UP///Genes up-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) cultured for 0 h versus PBMC cultured for 12 h with YF17D vaccine.+++GSE17186_BLOOD_VS_CORD_BLOOD_CD21HIGH_TRANSITIONAL_BCELL_UP///Genes up-regulated in transitional CR2 [GeneID=1380] high B lymphocytes versus those from cord blood.+++GSE17186_BLOOD_VS_CORD_BLOOD_NAIVE_BCELL_UP///Genes up-regulated in nave B lymphocytes versus those from cord blood.+++GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_1H_CD4_TCELL_UP///Genes up-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the cells treated with IL4 [GeneID=3565] and anti-IL12 at 1 h.+++GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_2H_CD4_TCELL_UP///Genes up-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the cells treated with IL4 [GeneID=3565] and anti-IL12 at 2 h.+++GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_4H_CD4_TCELL_UP///Genes up-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the cells treated with IL4 [GeneID=3565] and anti-IL12 at 4 h.+++GSE22103_UNSTIM_VS_LPS_STIM_NEUTROPHIL_DN///Genes down-regulated in neutrophils: untreated versus LPS.+++GSE22886_TH1_VS_TH2_48H_ACT_DN///Genes down-regulated in comparison of stimulated CD4 [GeneID=920] Th1 cells at 48 h versus stimulated CD4 [GeneID=920] Th2 cells at 48 h.+++GSE24081_CONTROLLER_VS_PROGRESSOR_HIV_SPECIFIC_CD8_TCELL_DN///Genes down-regulated in comparison of CD8 T cells with progressing HIV infection versus those with controlled HIV infection.+++GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_6H_DN///Genes down-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 and IL4 [GeneID=7040;3565] (6h) versus IL-12 (6h).+++GSE3720_LPS_VS_PMA_STIM_VD1_GAMMADELTA_TCELL_DN///Genes down-regulated in Vd1 gamma delta T cells: LPS versus phorbol myristate acetate and ionomycin [PubChem=4792;3733].+++GSE37416_0H_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_UP///Genes up-regulated in comparison of control polymorphonuclear leukocytes (PMN) at 0 h versus PMN treated with F. tularensis vaccine at 12 h.+++GSE37416_0H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP///Genes up-regulated in comparison of control polymorphonuclear leukocytes (PMN) at 0 h versus PMN treated with F. tularensis vaccine at 24 h.+++GSE37416_0H_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_UP///Genes up-regulated in comparison of control polymorphonuclear leukocytes (PMN) at 0 h versus PMN treated with F. tularensis vaccine at 3 h.+++GSE37416_0H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_UP///Genes up-regulated in comparison of control polymorphonuclear leukocytes (PMN) at 0 h versus PMN treated with F. tularensis vaccine at 48 h.+++GSE3982_BASOPHIL_VS_NKCELL_DN///Genes down-regulated in comparison of basophils versus NK cells.+++GSE3982_MAC_VS_TH1_UP///Genes up-regulated in comparison of macrophages versus Th1 cells.+++GSE3982_MAST_CELL_VS_BASOPHIL_UP///Genes up-regulated in comparison of mast cells versus basophils.+++GSE3982_MAST_CELL_VS_TH1_UP///Genes up-regulated in comparison of mast cells versus Th1 cells.+++GSE3982_NEUTROPHIL_VS_BASOPHIL_UP///Genes up-regulated in comparison of neutrophils versus basophils.+++GSE42088_UNINF_VS_LEISHMANIA_INF_DC_24H_UP///Genes up-regulated in dendritic cells: untreated versus 24h after infection of Leishmania major.+++GSE8921_3H_VS_24H_TLR1_2_STIM_MONOCYTE_DN///Genes down-regulated in monocytes in response to M. tuberculosis 19 kDa lipopeptide: 3h versus 24h.+++GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_24H_DN///Genes down-regulated in monocytes (24h): untreated versus M. tuberculosis 19 kDa lipopeptide.+++GSE9006_TYPE_1_VS_TYPE_2_DIABETES_PBMC_AT_DX_UP///Genes up-regulated in peripheral blood mononuclear cells (PBMC) from patients with type 1 diabetes at the time of diagnosis versus those with type 2 diabetes at the time of diagnosis.+++NAKAYA_B_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN///Genes down-regulated in B cell 7d vs 0d in young adults (18-50) after exposure to Fluarix/Fluvirin , time point 7D+++NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_UP///Genes up-regulated in peripheral blood mononuclear cell 3d vs 0d in adults (18-50) after exposure to Fluarix/Fluvirin , time point 3D. Comment: Supplementary Table 1a: All the differentially expressed genes identified in PBMCs of TIV vaccinees.+++NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_UP///Genes up-regulated in peripheral blood mononuclear cell 3d vs 0d in adults (18-50) after exposure to FluMist , time point 3D. Comment: Supplementary Table 1b: All the differentially expressed genes identified in PBMCs of TIV vaccinees."	HALLMARK_GLYCOLYSIS///Genes encoding proteins involved in glycolysis and gluconeogenesis.+++HALLMARK_HEME_METABOLISM///Genes involved in metabolism of heme (a cofactor consisting of iron and porphyrin) and erythroblast differentiation.	NM_012088	PGLS				
O75791	sp|O75791|GRAP2_HUMAN		GRAP2		GRB2-related adapter protein 2 OS=Homo sapiens OX=9606 GN=GRAP2 PE=1 SV=1 >tr|Q6FI14|Q6FI14_HUMAN GRAP2 protein OS=Homo sapiens OX=9606 GN=GRAP2 PE=2 SV=1	9402	NM_004810	NP_004801	ENST00000344138	K07366			MEAVAKFDFTASGEDELSFHTGDVLKILSNQEEWFKAELGSQEGYVPKNFIDIQFPKWFHEGLSRHQAENLLMGKEVGFFIIRASQSSPGDFSISVRHEDDVQHFKVMRDNKGNYFLWTEKFPSLNKLVDYYRTNSISRQKQIFLRDRTREDQGHRGNSLDRRSQGGPHLSGAVGEEIRPSMNRKLSDHPPTLPLQQHQHQPQPPQYAPAPQQLQQPPQQRYLQHHHFHQERRGGSLDINDGHCGTGLGSEMNAALMHRRHTDPVQLQAAGRVRWARALYDFEALEDDELGFHSGEVVEVLDSSNPSWWTGRLHNKLGLFPANYVAPMTR	0.5763197	-0.795058702	0.02326061						5.6031241			4.9133849	6.0683034	6.168279	6.6573231			5.5526997						4.5093344	6.1433156	6.5354102					8.063494	6.5866104	6.485003	6.9448528	4.756382		6.2431365	6.2378117	5.3001588	6.5198677		7.71277	6.5510716	5.65016364	7.222903	5.6197585	7.5230747	04660///T cell receptor signaling pathway				GO:0005634///nucleus+++GO:0005654///nucleoplasm+++GO:0005737///cytoplasm+++GO:0005768///endosome+++GO:0005829///cytosol+++GO:0005886///plasma membrane	GO:0005515///protein binding	GO:0007265///Ras protein signal transduction+++GO:0007267///cell-cell signaling+++GO:0019221///cytokine-mediated signaling pathway+++GO:0031295///T cell costimulation+++GO:0038095///Fc-epsilon receptor signaling pathway+++GO:0050852///T cell receptor signaling pathway	tissueType=Fetal kidney;cancerType=Normal;cellName=Natural killer T (NKT) cell		"Homo sapiens GRB2 related adaptor protein 2 (GRAP2), transcript variant 3, mRNA."		PF00017///SH2 domain+++PF00018///SH3 domain	R-HSA-1280215///Cytokine Signaling in Immune system+++R-HSA-1280218///Adaptive Immune System+++R-HSA-1433557///Signaling by SCF-KIT+++R-HSA-162582///Signal Transduction+++R-HSA-168249///Innate Immune System+++R-HSA-168256///Immune System+++R-HSA-202403///TCR signaling+++R-HSA-202433///Generation of second messenger molecules+++R-HSA-2172127///DAP12 interactions+++R-HSA-2424491///DAP12 signaling+++R-HSA-2454202///Fc epsilon receptor (FCERI) signaling+++R-HSA-2871796///FCERI mediated MAPK activation+++R-HSA-2871809///FCERI mediated Ca+2 mobilization+++R-HSA-388841///Costimulation by the CD28 family+++R-HSA-389356///CD28 co-stimulation+++R-HSA-9006934///Signaling by Receptor Tyrosine Kinases+++R-HSA-9607240///FLT3 Signaling		KOG3601///peptidyl-tyrosine autophosphorylation		"IPR000980///SH2 domain+++IPR001452///SH3 domain+++IPR035646///GRAP2, C-terminal SH3 domain+++IPR036028///SH3-like domain superfamily+++IPR036860///SH2 domain superfamily+++IPR043539///Grb2-like"	[GRAP2_HUMAN|Reviewed]RecName: Full=GRB2-related adapter protein 2; AltName: Full=Adapter protein GRID; AltName: Full=GRB-2-like protein; Short=GRB2L; AltName: Full=GRBLG; AltName: Full=GRBX; AltName: Full=Grf40 adapter protein; Short=Grf-40; AltName: Full=Growth factor receptor-binding protein; AltName: Full=Hematopoietic cell-associated adapter protein GrpL; AltName: Full=P38; AltName: Full=Protein GADS; AltName: Full=SH3-SH2-SH3 adapter Mona;+++[Q6FHA6_HUMAN|Unreviewed]SubName: Full=GRAP2 protein {ECO:0000313|EMBL:CAG46647.1}; Flags: Fragment;	chr22q13///Ensembl 103 genes in cytogenetic band chr22q13		KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY///T cell receptor signaling pathway	REACTOME_ADAPTIVE_IMMUNE_SYSTEM///Adaptive Immune System+++REACTOME_CD28_CO_STIMULATION///CD28 co-stimulation+++REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY///Costimulation by the CD28 family+++REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM///Cytokine Signaling in Immune system+++REACTOME_DAP12_INTERACTIONS///DAP12 interactions+++REACTOME_DAP12_SIGNALING///DAP12 signaling+++REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING///Fc epsilon receptor (FCERI) signaling+++REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION///FCERI mediated Ca+2 mobilization+++REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION///FCERI mediated MAPK activation+++REACTOME_FLT3_SIGNALING///FLT3 Signaling+++REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES///Generation of second messenger molecules+++REACTOME_INNATE_IMMUNE_SYSTEM///Innate Immune System+++REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES///Signaling by Receptor Tyrosine Kinases+++REACTOME_SIGNALING_BY_SCF_KIT///Signaling by SCF-KIT+++REACTOME_TCR_SIGNALING///TCR signaling			MIR192_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-192-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3059_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3059-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3119///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3119 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3177_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3177-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4271///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4271 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4422///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4422 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4667_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4667-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4675///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4675 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4725_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4725-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4741///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4741 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5702///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5702 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6728_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6728-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6752_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6752-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6780B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6780b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6787_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6787-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6814_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6814-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).	AML_Q6///Genes having at least one occurence of the transcription factor binding site V$AML_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++COMP1_01///Genes having at least one occurence of the transcription factor binding site V$COMP1_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++COREBINDINGFACTOR_Q6///Genes having at least one occurence of the transcription factor binding site V$COREBINDINGFACTOR_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++CTTTGA_LEF1_Q2///Genes having at least one occurence of the highly conserved motif M73 CTTTGA sites. The motif matches transcription factor binding site V$LEF1_Q2 (v7.4 TRANSFAC).+++FOXO1_02///Genes having at least one occurence of the transcription factor binding site V$FOXO1_02 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++FOXO4_02///Genes having at least one occurence of the transcription factor binding site V$FOXO4_02 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++MEF2_01///Genes having at least one occurence of the transcription factor binding site V$MEF2_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++PAX_Q6///Genes having at least one occurence of the transcription factor binding site V$PAX_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++STTTCRNTTT_IRF_Q6///Genes having at least one occurence of the highly conserved motif M85 STTTCRNTTT sites. The motif matches transcription factor binding site V$IRF_Q6 (v7.4 TRANSFAC).	"ARID5B_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q14865 (ARID5B) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++BDP1_TARGET_GENES///Genes containing one or more binding sites for UniProt:A6H8Y1 (BDP1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++CBFA2T2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O43439 (CBFA2T2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HMBOX1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6NT76 (HMBOX1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++IRF9_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q00978 (IRF9) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NFRKB_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6P4R8 (NFRKB) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NUP153_TARGET_GENES///Genes containing one or more binding sites for UniProt:P49790 (NUP153) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++RAG1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P15918 (RAG1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SOX10_TARGET_GENES///Genes containing one or more binding sites for UniProt:P56693 (SOX10) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SUPT20H_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8NEM7 (SUPT20H) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF436_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9C0F3 (ZNF436) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF589_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q86UQ0 (ZNF589) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF92_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q03936 (ZNF92) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."		MODULE_248///Genes in the cancer module 248.+++MODULE_46///Genes in the cancer module 46.+++MODULE_92///Secreted signaling molecules.	PGF_UP.V1_DN///Genes down-regulated in HUVEC cells (endothelium) by treatment with PGF [Gene ID=5228].	"GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_MYELOID_UP///Genes up-regulated in comparison of systemic lupus erythematosus CD4 [GeneID=920] T cells versus systemic lupus erythematosus myeloid cells.+++GSE12845_IGD_POS_BLOOD_VS_PRE_GC_TONSIL_BCELL_UP///Genes up-regulated in comparison of IgD+ B cells from peripheral blood versus CD19 pre-germinal center tonsil B cell+++GSE12963_UNINF_VS_ENV_AND_NEF_DEFICIENT_HIV1_INF_CD4_TCELL_UP///Genes up-regulated in control CD4 [GeneID=920] T cells versus those infected with HIV-1 viruses lacking Env and Nef.+++GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_DN///Genes down-regulated in immature neuron cell line: control versus interferon alpha (12h).+++GSE17974_0.5H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_DN///Genes down-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0.5 h versus the untreated cells at 72 h.+++GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_24H_ACT_CD4_TCELL_UP///Genes up-regulated in comparison of CD4 [GeneID=920] T cells treated with IL4 [GeneID=3565] and anti-IL12 at 24 h versus the untreated cells at 24 h.+++GSE18893_TCONV_VS_TREG_24H_CULTURE_DN///Genes down-regulated in lymphocytes treated with medium for 24h: T conv versus T reg cells.+++GSE19772_CTRL_VS_HCMV_INF_MONOCYTES_AND_PI3K_INHIBITION_DN///Genes down-regulated in monocytes pre-treated with Ly294002 [PubChem=3973]: control versus HCMV infection.+++GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_AND_A3R_INH_PRETREAT_IN_MAST_CELL_UP///Genes up-regulated in HMC-1 (mast leukemia) cells: Cl-IB-MECA [PubChem=3035850] versus incubated with the peptide ALL1 followed by stimulation with T cell membranes.+++GSE22886_CD8_TCELL_VS_BCELL_NAIVE_UP///Genes up-regulated in comparison of naive CD8 T cells versus naive B cells.+++GSE22886_NAIVE_CD4_TCELL_VS_MEMORY_TCELL_DN///Genes down-regulated in comparison of naive CD4 [GeneID=920] T cells versus unstimulated memory CD4 [GeneID=920] CD8 T cells.+++GSE22886_NAIVE_CD8_TCELL_VS_DC_UP///Genes up-regulated in comparison of naive CD8 T cells versus unstimulated dendritic cells (DC).+++GSE22886_NAIVE_CD8_TCELL_VS_MONOCYTE_UP///Genes up-regulated in comparison of naive CD8 T cells versus day 0 monocytes.+++GSE22886_NAIVE_TCELL_VS_MONOCYTE_UP///Genes up-regulated in comparison of naive CD4 [GeneID=920] CD8 T cells versus monocytes cultured for 0 days.+++GSE24634_NAIVE_CD4_TCELL_VS_DAY5_IL4_CONV_TREG_DN///Genes down-regulated in comparison of naive T cells at day 0 versus CD25+ regulatory T cell (Treg) treated with IL4 [GeneID=3565] at day 5.+++GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_DN///Genes down-regulated in AGS cells (gastric adenocarcinoma): control versus H. pylori LPS.+++GSE26928_CENTR_MEMORY_VS_CXCR5_POS_CD4_TCELL_UP///Genes up-regulated in comparison of CD4 [GeneID=920] central memory T cells versus CD4 [GeneID=920] CXCR5+ [GeneID=643] T cells.+++GSE26928_EFF_MEM_VS_CENTR_MEM_CD4_TCELL_DN///Genes down-regulated in comparison of CD4 [GeneID=920] effector memory T cells versus CD4 [GeneID=920] central memory T cells.+++GSE2770_UNTREATED_VS_ACT_CD4_TCELL_2H_UP///Genes up-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 (2h).+++GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_BCELL_DN///Genes down-regulated in comparison of B cells from LAIV influenza vaccinee pre-vaccination versus those at day 7 post-vaccination.+++GSE32901_NAIVE_VS_TH17_ENRICHED_CD4_TCELL_UP///Genes up-regulated in CD4 [GeneID=920] nave versus Th17 enriched.+++GSE32901_TH1_VS_TH17_ENRICHED_CD4_TCELL_UP///Genes up-regulated in CD4 [GeneID=920] T cells: Th1 versus Th17 enriched.+++GSE33374_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_UP///Genes up-regulated in KLRB1 high [GeneID=3820] T cells: CD8A [GeneID=925] versus CD8A CD8B [GeneID=925;926].+++GSE3982_BCELL_VS_CENT_MEMORY_CD4_TCELL_DN///Genes down-regulated in comparison of B cells versus central memory CD4 [GeneID=920] T cells.+++GSE3982_BCELL_VS_EFF_MEMORY_CD4_TCELL_DN///Genes down-regulated in comparison of B cells versus effector memory CD4 [GeneID=920] T cells.+++GSE3982_MEMORY_CD4_TCELL_VS_BCELL_UP///Genes up-regulated in comparison of memory CD4 [GeneID=920] T cells versus B cells.+++GSE4590_LARGE_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_UP///Genes up-regulated during B lymphocyte differentiation: large pre-B II versus VPREB1+ [GeneID=7441] pre-B Il.+++GSE5099_MONOCYTE_VS_CLASSICAL_M1_MACROPHAGE_UP///Genes up-regulated in monocytes versus classically activated (M1) macrophages.+++GSE7460_TCONV_VS_TREG_LN_UP///Genes up-regulated in comparison of TconvLN versus TregLN (see Fig. 1 in the paper for details).+++GSE7509_UNSTIM_VS_FCGRIIB_STIM_DC_DN///Genes down-regulated in dendritic cells: untreated versus anti-FcgRIIB.+++GSE7509_UNSTIM_VS_IFNA_STIM_IMMATURE_DC_DN///Genes down-regulated in immature dendritic cells: untreated versus interferon alpha.+++GSE8685_IL15_ACT_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_DN///Genes down-regulated in Sez-2 cells (T cell lymphoma): IL15 [GeneID=3600] versus IL21 [GeneID=3600].+++NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN///Genes down-regulated in plasmacytoid dendritic cell 7d vs 0d in young adults (18-50) after exposure to FluMist , time point 7D+++THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_UP///Genes up-regulated in peripheral blood mononuclear cell 7d vs 0d in young adults (21-30) (responders) after exposure to Inactivated influenza vaccine , time point 7D"		NM_004810	GRAP2				
O75608	sp|O75608|LYPA1_HUMAN		LYPLA1		Acyl-protein thioesterase 1 OS=Homo sapiens OX=9606 GN=LYPLA1 PE=1 SV=1 >tr|Q6IAQ1|Q6IAQ1_HUMAN LYPLA1 protein OS=Homo sapiens OX=9606 GN=LYPLA1 PE=1 SV=1	10434	NM_006330	NP_006321	ENST00000316963	K06128			MCGNNMSTPLPAIVPAARKATAAVIFLHGLGDTGHGWAEAFAGIRSSHIKYICPHAPVRPVTLNMNVAMPSWFDIIGLSPDSQEDESGIKQAAENIKALIDQEVKNGIPSNRIILGGFSQGGALSLYTALTTQQKLAGVTALSCWLPLRASFPQGPIGGANRDISILQCHGDCDPLVPLMFGSLTVEKLKTLVNPANVTFKTYEGMMHSSCQQEMMDVKQFIDKLLPPID	0.527735	-0.922114513	0.01482289		4.3901462		4.4812513	5.5677012	6.2508829		5.3156685	5.3079353	6.1998257	4.6082495	5.0110469		5.3123424				4.8084193			5.672793	6.9891067	5.8075275					8.297956	6.5158791	6.793276	7.3885863		5.4455385	6.1334059	6.9086023	4.021384	6.4269903	5.2759551	7.50585	5.9283655	4.54845722	8.0856374	4.9173779	7.10294796	00564///Glycerophospholipid metabolism+++05231///Choline metabolism in cancer			R02746///1-Acyl-sn-glycero-3-phosphocholine acylhydrolase   1-Acyl-sn-glycero-3-phosphocholine + H2O <=> sn-Glycero-3-phosphocholine + Fatty acid+++R03416///1-Acyl-sn-glycero-3-phosphoethanolamine aldehydohydrolase   1-Acyl-sn-glycero-3-phosphoethanolamine + H2O <=> Fatty acid + sn-Glycero-3-phosphoethanolamine	GO:0005634///nucleus+++GO:0005737///cytoplasm+++GO:0005783///endoplasmic reticulum+++GO:0005829///cytosol+++GO:0005886///plasma membrane+++GO:0016020///membrane+++GO:0016021///integral component of membrane+++GO:0031965///nuclear membrane+++GO:0070062///extracellular exosome	GO:0004620///phospholipase activity+++GO:0004622///lysophospholipase activity+++GO:0005515///protein binding+++GO:0008474///palmitoyl-(protein) hydrolase activity+++GO:0016298///lipase activity+++GO:0016787///hydrolase activity+++GO:0052689///carboxylic ester hydrolase activity	GO:0000165///MAPK cascade+++GO:0002084///protein depalmitoylation+++GO:0006629///lipid metabolic process+++GO:0006631///fatty acid metabolic process+++GO:0042997///negative regulation of Golgi to plasma membrane protein transport+++GO:0050999///regulation of nitric-oxide synthase activity	tissueType=Fetal kidney;cancerType=Normal;cellName=Natural killer T (NKT) cell+++tissueType=Kidney;cancerType=Normal;cellName=B cell+++tissueType=Embryo;cancerType=Normal;cellName=Morula cell (Blastomere)		"Homo sapiens lysophospholipase 1 (LYPLA1), transcript variant 1, mRNA."		PF02230///Phospholipase/Carboxylesterase	R-HSA-1430728///Metabolism+++R-HSA-162582///Signal Transduction+++R-HSA-202131///Metabolism of nitric oxide: NOS3 activation and regulation+++R-HSA-203615///eNOS activation+++R-HSA-5673001///RAF/MAP kinase cascade+++R-HSA-5683057///MAPK family signaling cascades+++R-HSA-5684996///MAPK1/MAPK3 signaling+++R-HSA-9648002///RAS processing		KOG2112///acyl-protein thioesterase		IPR003140///Phospholipase/carboxylesterase/thioesterase+++IPR029058///Alpha/Beta hydrolase fold	[LYPA1_HUMAN|Reviewed]RecName: Full=Acyl-protein thioesterase 1; Short=APT-1; Short=hAPT1; EC=3.1.2.-; AltName: Full=Lysophospholipase 1; AltName: Full=Lysophospholipase I; Short=LPL-I; Short=LysoPLA I;	chr8q11///Ensembl 103 genes in cytogenetic band chr8q11		KEGG_GLYCEROPHOSPHOLIPID_METABOLISM///Glycerophospholipid metabolism	REACTOME_ENOS_ACTIVATION///eNOS activation+++REACTOME_MAPK_FAMILY_SIGNALING_CASCADES///MAPK family signaling cascades+++REACTOME_METABOLISM_OF_NITRIC_OXIDE_NOS3_ACTIVATION_AND_REGULATION///Metabolism of nitric oxide: NOS3 activation and regulation+++REACTOME_RAS_PROCESSING///RAS processing		"ATTACAT_MIR3803P///Genes having at least one occurence of the motif ATTACAT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-380-3p (v7.1 miRBase).+++CACCAGC_MIR138///Genes having at least one occurence of the motif CACCAGC in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-138 (v7.1 miRBase).+++CAGTGTT_MIR141_MIR200A///Genes having at least one occurence of the motif CAGTGTT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-141 and hsa-miR-200a (v7.1 miRBase)."	"MIR135A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-135a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR135B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-135b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR138_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-138-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR141_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-141-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1468_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1468-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR200A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-200a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR205_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-205-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR2054///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-2054 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR221_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-221-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR222_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-222-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR22_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-22-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR23A_3P_MIR23B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-23a-3p, hsa-miR-23b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR23C///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-23c in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR29A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-29a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR29B_2_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-29b-2-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR29B_3P_MIR29C_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-29b-3p, hsa-miR-29c-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3121_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3121-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3150B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3150b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3606_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3606-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3609///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3609 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3671///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3671 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3674///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3674 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3924///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3924 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4422///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4422 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4445_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4445-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR450B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-450b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4784///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4784 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR513A_3P_MIR513C_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-513a-3p, hsa-miR-513c-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR526B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-526b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AH_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548ah-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AJ_5P_MIR548G_5P_MIR548X_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548aj-5p, hsa-miR-548g-5p, hsa-miR-548x-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AW///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548aw in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548F_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548f-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5590_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5590-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5682///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5682 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR607///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-607 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6835_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6835-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6871_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6871-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets)."		"FOXP2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O15409 (FOXP2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HOXA2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O43364 (HOXA2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++KDM7A_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6ZMT4 (KDM7A) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++MAFG_TARGET_GENES///Genes containing one or more binding sites for UniProt:O15525 (MAFG) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++MORC2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9Y6X9 (MORC2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++PHF2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O75151 (PHF2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SETX_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q7Z333 (SETX) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++TCF7_TARGET_GENES///Genes containing one or more binding sites for UniProt:P36402 (TCF7) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF175_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9Y473 (ZNF175) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF197_TARGET_GENES///Genes containing one or more binding sites for UniProt:O14709 (ZNF197) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF322_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6U7Q0 (ZNF322) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF589_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q86UQ0 (ZNF589) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF766_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q5HY98 (ZNF766) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZSCAN30_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q86W11 (ZSCAN30) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."	MORF_AATF///Neighborhood of AATF+++MORF_ACP1///Neighborhood of ACP1+++MORF_ANP32B///Neighborhood of ANP32B+++MORF_BUB3///Neighborhood of BUB3+++MORF_CSNK2B///Neighborhood of CSNK2B+++MORF_CTBP1///Neighborhood of CTBP1+++MORF_DAP3///Neighborhood of DAP3+++MORF_DEK///Neighborhood of DEK+++MORF_EI24///Neighborhood of EI24+++MORF_EIF3S2///Neighborhood of EIF3S2+++MORF_EIF3S6///Neighborhood of EIF3S6+++MORF_FBL///Neighborhood of FBL+++MORF_GNB1///Neighborhood of GNB1+++MORF_HAT1///Neighborhood of HAT1+++MORF_HDAC1///Neighborhood of HDAC1+++MORF_HDAC2///Neighborhood of HDAC2+++MORF_MAP2K2///Neighborhood of MAP2K2+++MORF_MTA1///Neighborhood of MTA1+++MORF_PAPSS1///Neighborhood of PAPSS1+++MORF_PPP1CA///Neighborhood of PPP1CA+++MORF_PPP2CA///Neighborhood of PPP2CA+++MORF_PRDX3///Neighborhood of PRDX3+++MORF_PRKAR1A///Neighborhood of PRKAR1A+++MORF_RAB6A///Neighborhood of RAB6A+++MORF_RAC1///Neighborhood of RAC1+++MORF_RAD21///Neighborhood of RAD21+++MORF_RAD23A///Neighborhood of RAD23A+++MORF_RAD23B///Neighborhood of RAD23B+++MORF_RAN///Neighborhood of RAN+++MORF_RFC4///Neighborhood of RFC4+++MORF_RPA1///Neighborhood of RPA1+++MORF_SKP1A///Neighborhood of SKP1A+++MORF_SOD1///Neighborhood of SOD1+++MORF_SP3///Neighborhood of SP3+++MORF_XRCC5///Neighborhood of XRCC5			"GSE10856_CTRL_VS_TNFRSF6B_IN_MACROPHAGE_DN///Genes down-regulated in comparison of macrophages treated with control (hIgG1) versus those treated with TNFRSF6B [GeneID=8771].+++GSE11864_UNTREATED_VS_CSF1_IFNG_IN_MAC_UP///Genes up-regulated in comparison of untreated macrophages versus those cultured with M-CSF [GeneID=1435] and IFNG [GeneID=3458].+++GSE11864_UNTREATED_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP///Genes up-regulated in comparison of untreated macrophages versus those cultured with M-CSF [GeneID=1435], IFNG [GeneID=3458] and Pam3Cys (TLR2 agonist).+++GSE13738_RESTING_VS_TCR_ACTIVATED_CD4_TCELL_DN///Genes down-regulated in comparison of resting CD4 [GeneID=920] T cells versus directly activated CD4 [GeneID=920] T cells.+++GSE1460_CORD_VS_ADULT_BLOOD_NAIVE_CD4_TCELL_UP///Genes up-regulated in CD4 [GeneID=920] T cells from cord blood versus those from adult blood.+++GSE18893_TCONV_VS_TREG_2H_CULTURE_UP///Genes up-regulated in lymphocytes treated with medium for 2h: T conv versus T reg cells.+++GSE19888_CTRL_VS_TCELL_MEMBRANES_ACT_MAST_CELL_PRETREAT_A3R_INH_UP///Genes up-regulated in HMC-1 (mast leukemia) cells: untreated versus incubated with the peptide ALL1 followed by stimulation with T cell membranes.+++GSE20198_IL12_VS_IFNA_TREATED_ACT_CD4_TCELL_UP///Genes up-regulated in the activated CD4 [GeneID=920] T cells (48h): IL-12 versus interferon alpha.+++GSE22025_UNTREATED_VS_PROGESTERONE_TREATED_CD4_TCELL_DN///Genes down-regulated in CD4 [GeneID=920] T cells: untreated versus progesterone [PubChem=5994].+++GSE23321_CD8_STEM_CELL_MEMORY_VS_EFFECTOR_MEMORY_CD8_TCELL_DN///Genes down-regulated in CD8 T cells: stem cell memory versus effector memory.+++GSE25147_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_MKN45_CELL_UP///Genes up-regulated in MKN45 cells (stomach cancer): control versus H. pylori LPS.+++GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_UP///Genes up-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 and then stimulated by TGFB1 [GeneID=7040] and IL-12 (48h).+++GSE29617_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_2008_DN///Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from TIV influenza vaccinee pre-vaccination versus those at day 3 post-vaccination.+++GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MDC_UP///Genes up-regulated in comparison of myeloid dendritic cells from LAIV influenza vaccinee at day 7 post-vaccination vesus those from TIV influenza vaccinee at day 7.+++GSE37416_0H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_UP///Genes up-regulated in comparison of control polymorphonuclear leukocytes (PMN) at 0 h versus PMN treated with F. tularensis vaccine at 48 h.+++GSE3982_MAST_CELL_VS_NEUTROPHIL_UP///Genes up-regulated in comparison of mast cells versus neutrophils.+++GSE4984_UNTREATED_VS_LPS_TREATED_DC_DN///Genes down-regulated in monocyte-derived dendritic cells: control versus LPS.+++GSE5542_UNTREATED_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_DN///Genes down-regulated in epithelial cells (24h): untreated versus interferon alpha and IFNG [GeneID=3458].+++GSE6092_CTRL_VS_BORRELIA_BIRGDOFERI_INF_ENDOTHELIAL_CELL_UP///Genes up-regulated in endothelial cells: untreated versus exposed to E. burgdoferi.+++GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_1MONTH_POST_DX_UP///Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMCs from patients with type 1 diabetes at 1 month after the diagnosis.+++GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_4MONTH_POST_DX_UP///Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMCs from patients with type 1 diabetes at 4 month after the diagnosis.+++GSE9601_UNTREATED_VS_NFKB_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_DN///Genes down-regulated in monocytes after HCMV infection: untreated versus BAY 11-7082 [PubChem=5353431].+++GSE9960_HEALTHY_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_DN///Genes down-regulated in peripheral blood monocytes (PMBC): healthy versus mixed infection sepsis.+++NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_UP///Genes up-regulated in peripheral blood mononuclear cell 3d vs 0d in adults (18-50) after exposure to Fluarix/Fluvirin , time point 3D. Comment: Supplementary Table 1a: All the differentially expressed genes identified in PBMCs of TIV vaccinees.+++THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_DN///Genes down-regulated in peripheral blood mononuclear cell 7d vs 0d in young adults (21-30) (responders) after exposure to Inactivated influenza vaccine , time point 7D. Comment: most (70-80%) of cohort were white"		NM_006330	LYPLA1				
O75563	sp|O75563|SKAP2_HUMAN		SKAP2		Src kinase-associated phosphoprotein 2 OS=Homo sapiens OX=9606 GN=SKAP2 PE=1 SV=1	8935	NM_003930	NP_003921	ENST00000345317	K23471			MPNPSSTSSPYPLPEEIRNLLADVETFVADILKGENLSKKAKEKRESLIKKIKDVKSIYLQEFQDKGDAEDGEEYDDPFAGPPDTISLASERYDKDDEAPSDGAQFPPIAAQDLPFVLKAGYLEKRRKDHSFLGFEWQKRWCALSKTVFYYYGSDKDKQQKGEFAIDGYSVRMNNTLRKDGKKDCCFEISAPDKRIYQFTAASPKDAEEWVQQLKFVLQDMESDIIPEDYDERGELYDDVDHPLPISNPLTSSQPIDDEIYEELPEEEEDSAPVKVEEQRKMSQDSVHHTSGDKSTDYANFYQGLWDCTGAFSDELSFKRGDVIYILSKEYNRYGWWVGEMKGAIGLVPKAYIMEMYDI	0.4738891	-1.077378526	0.003528366		4.4902387		5.6608071	5.4537603	8.0015484		6.3542628	7.9067672	8.0415776	6.9963906	7.9291624		6.8086915	6.1454254	7.0376368					6.6965165	7.203904	8.1698406					8.830916	9.1092766	8.778748	8.3252883	5.855472	7.1082727	7.8511539	8.0918154	7.1858983	8.5375254	7.437286	8.192976	8.067381	7.77218458	8.0340178	5.1253547	8.71086274	05135///Yersinia infection				GO:0005654///nucleoplasm+++GO:0005737///cytoplasm+++GO:0005829///cytosol+++GO:0005886///plasma membrane	GO:0005515///protein binding	GO:0007165///signal transduction+++GO:0008285///negative regulation of cell proliferation+++GO:0042113///B cell activation+++GO:0065003///protein-containing complex assembly	tissueType=Fetal gonad;cancerType=Normal;cellName=Retinoid acid signaling-responsive fetal germ cell+++tissueType=Lung;cancerType=Normal;cellName=Neuroendocrine cell+++tissueType=Lung;cancerType=Normal;cellName=Brush cell (Tuft cell)+++tissueType=Fetal gonad;cancerType=Normal;cellName=Gonadal endothelial cell		"Homo sapiens src kinase associated phosphoprotein 2 (SKAP2), transcript variant 1, mRNA."		PF00018///SH3 domain+++PF00169///PH domain	R-HSA-1500931///Cell-Cell communication+++R-HSA-391160///Signal regulatory protein family interactions		ENOG502QVFD///No_INFO		IPR001452///SH3 domain+++IPR001849///Pleckstrin homology domain+++IPR011993///PH-like domain superfamily+++IPR036028///SH3-like domain superfamily+++IPR037781///SKAP family	[SKAP2_HUMAN|Reviewed]RecName: Full=Src kinase-associated phosphoprotein 2; AltName: Full=Pyk2/RAFTK-associated protein; AltName: Full=Retinoic acid-induced protein 70; AltName: Full=SKAP55 homolog; Short=SKAP-55HOM; Short=SKAP-HOM; AltName: Full=Src family-associated phosphoprotein 2; AltName: Full=Src kinase-associated phosphoprotein 55-related protein; AltName: Full=Src-associated adapter protein with PH and SH3 domains;	chr7p15///Ensembl 103 genes in cytogenetic band chr7p15			REACTOME_CELL_CELL_COMMUNICATION///Cell-Cell communication+++REACTOME_SIGNAL_REGULATORY_PROTEIN_FAMILY_INTERACTIONS///Signal regulatory protein family interactions		"TAGCTTT_MIR9///Genes having at least one occurence of the motif TAGCTTT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-9* (v7.1 miRBase).+++TTGCCAA_MIR182///Genes having at least one occurence of the motif TTGCCAA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-182 (v7.1 miRBase)."	"MIR1179///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1179 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1224_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1224-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1251_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1251-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR132_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-132-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR212_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-212-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR219B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-219b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3156_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3156-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3689A_5P_MIR3689B_5P_MIR3689E_MIR3689F///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3689a-5p, hsa-miR-3689b-5p, hsa-miR-3689e, hsa-miR-3689f in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3942_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3942-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR411_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-411-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4288///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4288 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4506///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4506 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4703_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4703-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4735_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4735-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5197_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5197-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AE_3P_MIR548AQ_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548ae-3p, hsa-miR-548aq-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AH_3P_MIR548AM_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548ah-3p, hsa-miR-548am-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548AJ_3P_MIR548X_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548aj-3p, hsa-miR-548x-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548J_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548j-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR580_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-580-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR607///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-607 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6847_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6847-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6892_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6892-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7_1_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7-1-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7_2_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7-2-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets)."	GATTGGY_NFY_Q6_01///Genes having at least one occurence of the highly conserved motif M5 GATTGGY sites. The motif matches transcription factor binding site V$NFY_Q6_01 (v7.4 TRANSFAC).+++P300_01///Genes having at least one occurence of the transcription factor binding site V$P300_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++RYTTCCTG_ETS2_B///Genes having at least one occurence of the highly conserved motif M16 RYTTCCTG sites. The motif matches transcription factor binding site V$ETS2_B (v7.4 TRANSFAC).+++STAT6_02///Genes having at least one occurence of the transcription factor binding site V$STAT6_02 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++TATAAA_TATA_01///Genes having at least one occurence of the highly conserved motif M51 TATAAA sites. The motif matches transcription factor binding site V$TATA_01 (v7.4 TRANSFAC).+++WGTTNNNNNAAA_UNKNOWN///Genes having at least one occurence of the highly conserved motif M155 WGTTNNNNNAAA in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).	"CBFA2T2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O43439 (CBFA2T2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++CREB3_TARGET_GENES///Genes containing one or more binding sites for UniProt:O43889 (CREB3) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++EMX1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q04741 (EMX1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++FOXH1_TARGET_GENES///Genes containing one or more binding sites for UniProt:O75593 (FOXH1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++GCM2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O75603 (GCM2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HMBOX1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6NT76 (HMBOX1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HOXA2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O43364 (HOXA2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++JDP2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8WYK2 (JDP2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++MAFG_TARGET_GENES///Genes containing one or more binding sites for UniProt:O15525 (MAFG) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++MSX1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P28360 (MSX1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++MYOCD_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8IZQ8 (MYOCD) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NCOA4_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q13772 (NCOA4) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NFE2L1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q14494 (NFE2L1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NKX2_2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O95096 (NKX2_2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++PAX3_TARGET_GENES///Genes containing one or more binding sites for UniProt:P23760 (PAX3) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++RFX7_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q2KHR2 (RFX7) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SATB1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q01826 (SATB1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++TFEB_TARGET_GENES///Genes containing one or more binding sites for UniProt:P19484 (TFEB) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++THAP1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9NVV9 (THAP1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++TOP2B_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q02880 (TOP2B) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZBTB24_TARGET_GENES///Genes containing one or more binding sites for UniProt:O43167 (ZBTB24) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF134_TARGET_GENES///Genes containing one or more binding sites for UniProt:P52741 (ZNF134) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF322_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6U7Q0 (ZNF322) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF354B_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96LW1 (ZNF354B) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF410_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q86VK4 (ZNF410) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF507_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8TCN5 (ZNF507) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF680_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8NEM1 (ZNF680) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZSCAN29_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8IWY8 (ZSCAN29) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."	GNF2_CASP1///Neighborhood of CASP1+++GNF2_LYN///Neighborhood of LYN+++GNF2_MCL1///Neighborhood of MCL1+++GNF2_MYD88///Neighborhood of MYD88+++GNF2_SELL///Neighborhood of SELL	MODULE_163///Genes in the cancer module 163.+++MODULE_45///Whole blood genes.+++MODULE_95///Genes in the cancer module 95.	MEL18_DN.V1_DN///Genes down-regulated in DAOY cells (medulloblastoma) upon knockdown of PCGF2 [Gene ID=7703] gene by RNAi.+++RAF_UP.V1_UP///Genes up-regulated in MCF-7 cells (breast cancer) positive for ESR1 [Gene ID=2099] MCF-7 cells (breast cancer) stably over-expressing constitutively active RAF1 [Gene ID=5894] gene.	"FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_18HR_TO_48HR_EARLY_UP///Genes up-regulated in peripheral blood mononuclear cell (18 to 48)h vs 0h in adults (22-54) after exposure to F. tularensis vaccine LVS , time point 18 to 48H. Comment: Pattern 6, up early+++GSE10325_CD4_TCELL_VS_BCELL_DN///Genes down-regulated in comparison of healthy CD4 [GeneID=920] T cells versus healthy CD19 [GeneID=920] B cells. +++GSE10325_CD4_TCELL_VS_MYELOID_DN///Genes down-regulated in comparison of healthy CD4 [GeneID=920] T cells versus healthy myeloid cells.+++GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_BCELL_DN///Genes down-regulated in comparison of systemic lupus erythematosus CD4 [GeneID=920] T cells versus systemic lupus erythematosus B cells.+++GSE12198_NK_VS_NK_ACT_EXPANSION_SYSTEM_DERIVED_NK_CELL_UP///Genes up-regulated in NK cells: primary versus activated and expanded.+++GSE12366_GC_BCELL_VS_PLASMA_CELL_UP///Genes up-regulated in comparison of germinal center B cells versus plasma cells.+++GSE12366_PLASMA_CELL_VS_MEMORY_BCELL_DN///Genes down-regulated in plasma cells versus memory B cells.+++GSE13411_PLASMA_CELL_VS_MEMORY_BCELL_DN///Genes down-regulated in comparison of plasma cells versus memory B cells.+++GSE13484_UNSTIM_VS_3H_YF17D_VACCINE_STIM_PBMC_UP///Genes up-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) cultured for 0 h versus PBMC cultured for 3 h with YF17D vaccine.+++GSE14000_4H_VS_16H_LPS_DC_TRANSLATED_RNA_UP///Genes up-regulated in comparison of polysome bound (translated) mRNA in dendritic cells (DC) at 4 h after LPS (TLR4 agonist) stimulation versus those at 16 h after the stimulation.+++GSE14000_4H_VS_16H_LPS_DC_UP///Genes up-regulated in comparison of dendritic cells (DC) at 4 h after LPS (TLR4 agonist) stimulation versus those at 16 h after the stimulation.+++GSE14000_UNSTIM_VS_16H_LPS_DC_TRANSLATED_RNA_UP///Genes up-regulated in comparison of polysome bound (translated) mRNA before and 16 h after LPS (TLR4 agonist) stimulation.+++GSE14000_UNSTIM_VS_16H_LPS_DC_UP///Genes up-regulated in comparison of dendritic cells (DC) before and 16 h after LPS (TLR4 agonist) stimulation.+++GSE14386_UNTREATED_VS_IFNA_TREATED_ACT_PBMC_MS_PATIENT_DN///Genes down-regulated in peripheral blood mononclear cells (PBMC) from multiple sclerosis (MS) patient: untreated versus IFNB1 [GeneID=3456].+++GSE16385_IL4_VS_ROSIGLITAZONE_STIM_MACROPHAGE_UP///Genes up-regulated in macrophages (12h): IL4 [GeneID=3565] versus rosiglitazone [PubChem=77999].+++GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_UP///Genes up-regulated in immature neuron cell line: control versus interferon alpha (12h).+++GSE17186_NAIVE_VS_CD21LOW_TRANSITIONAL_BCELL_UP///Genes up-regulated in B lymphocytes: nave versus transitional CR2 [GeneID=1380] low.+++GSE19772_HCMV_INFL_VS_HCMV_INF_MONOCYTES_AND_PI3K_INHIBITION_DN///Genes down-regulated in monocytes after HCMV infection: untreated versus pre-treated with Ly294002 [PubChem=3973].+++GSE21774_CD62L_POS_CD56_DIM_VS_CD62L_NEG_CD56_DIM_NK_CELL_UP///Genes up-regulated in SELL dim [GeneID=6402] NK cells: NCAM1+ [GeneID=4684] versus NCAM1- [GeneID=4684].+++GSE22611_UNSTIM_VS_2H_MDP_STIM_NOD2_TRANSDUCED_HEK293T_CELL_UP///Genes up-regulated in HEK293 cells over-expressing wildtype NOD2 [GeneID=64127]: untreated versus muramyl dipeptide [PubChem=11620162] for 2h.+++GSE22886_NAIVE_CD8_TCELL_VS_NEUTROPHIL_DN///Genes down-regulated in comparison of naive CD8 T cells versus unstimulated neutrophils.+++GSE2405_0H_VS_3H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP///Genes up-regulated in polymorphonuclear leukocytes (3h): control versus infection by A. phagocytophilum.+++GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_24H_UP///Genes up-regulated in polymorphonuclear leukocytes (24h): treated by heat killed HC60 cell (promyelocytic leukemia) lysate versus A. phagocytophilum infection.+++GSE24634_TREG_VS_TCONV_POST_DAY3_IL4_CONVERSION_DN///Genes down-regulated in comparison of CD25+ regulatory T cell (Treg) treated with IL4 [GeneID=3565] at day 3 versus CD25- T cells incubated with IL4 [GeneID=3565] at day 3.+++GSE25087_TREG_VS_TCONV_ADULT_UP///Genes up-regulated in comparison of adult regulatory T cell (Treg) versus adult conventional T cells.+++GSE26156_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN///Genes down-regulated in thymocytes: double positive versus CD4 [GeneID=920] single positive.+++GSE27291_6H_VS_7D_STIM_GAMMADELTA_TCELL_DN///Genes down-regulated in gamma delta T cells activated by phosphoantigen BrHPP and IL2 [GeneID=3558]: 6h versus 7 days.+++GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_6H_UP///Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 and IL4 [GeneID=7040;3565] (6h) versus IL-12 (6h).+++GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MONOCYTE_UP///Genes up-regulated in comparison of monocytes from LAIV influenza vaccinee at day 7 post-vaccination vesus those from TIV influenza vaccinee at day 7.+++GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MONOCYTE_DN///Genes down-regulated in comparison of monocytes from LAIV influenza vaccinee pre-vaccination versus those at day 7 post-vaccination+++GSE33424_CD161_HIGH_VS_NEG_CD8_TCELL_UP///Genes up-regulated in CD8 T cells: KLRB1 high [GeneID=3820] versus KLRB1- [GeneID=3820].+++GSE33425_CD161_INT_VS_NEG_CD8_TCELL_UP///Genes up-regulated in CD8 T cells: KLRB1 int [GeneID=3820] versus KLRB1- [GeneID=3820].+++GSE35685_CD34POS_CD10NEG_CD62LPOS_VS_CD34POS_CD10POS_BONE_MARROW_DN///Genes down-regulated in the bone marrow CD34+ [GeneID=947] cells: MME- SELL+[GeneID=4311;6402] versus MME+ [GeneID=4311].+++GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_MAC_UP///Genes up-regulated in comparison of macrophages exposed to 50 worms/well B. malayi versus those exposed to 5 worms/well B. malayi.+++GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_MAC_DN///Genes down-regulated in comparison of macrophages exposed to L. major versus macrophages exposed to 50 worms/well B. malayi.+++GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_MAC_DN///Genes down-regulated in comparison of macrophages exposed to L. major versus macrophages exposed to 5 worms/well B. malayi.+++GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_MAC_DN///Genes down-regulated in comparison of macrophages exposed to T. gondii versus macrophages exposed to 50 worms/well B. malayi.+++GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_MAC_DN///Genes down-regulated in comparison of macrophages exposed to T. gondii versus macrophages exposed to 5 worms/well B. malayi.+++GSE3920_IFNB_VS_IFNG_TREATED_ENDOTHELIAL_CELL_DN///Genes down-regulated in endothelial cells: interferon beta versus IFNG [GeneID=3458].+++GSE3920_UNTREATED_VS_IFNA_TREATED_ENDOTHELIAL_CELL_UP///Genes up-regulated in ndothelial cells: untreated versus interferon alpha.+++GSE3982_MAC_VS_BCELL_UP///Genes up-regulated in comparison of macrophages versus B cells.+++GSE3982_MAC_VS_TH2_UP///Genes up-regulated in comparison of macrophages versus Th2 cells.+++GSE4590_LARGE_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_UP///Genes up-regulated during B lymphocyte differentiation: large pre-B II versus VPREB1+ [GeneID=7441] pre-B Il.+++GSE5679_PPARG_LIGAND_ROSIGLITAZONE_VS_RARA_AGONIST_AM580_TREATED_DC_DN///Genes down-regulated in monocyte-derived dendritic cells: rosiglitazone [PubChem=77999] versus AM580 [PubChem=2126].+++GSE7460_FOXP3_MUT_VS_WT_ACT_TCONV_UP///Genes up-regulated in comparsion of sfActCD4 versus ActCD4 (see Fig. 1 in the paper for details).+++GSE7460_FOXP3_MUT_VS_WT_ACT_WITH_TGFB_TCONV_UP///Genes up-regulated in comparsion of sfActCD4TGF versus ActCD4TGF (see Fig. 1 in the paper for details).+++GSE7460_TREG_VS_TCONV_ACT_WITH_TGFB_UP///Genes up-regulated in comparsion of ActTregTGF versus ActCD4TGF (see Fig. 1 in the paper for details).+++GSE7460_WT_VS_FOXP3_HET_ACT_WITH_TGFB_TCONV_DN///Genes down-regulated in comparison of ActCD4TGF versus WTActCD4TGF (see Fig. 1 in the paper for details).+++GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_AT_DX_UP///Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMCs from patients with type 1 diabetes at the time of diagnosis.+++GSE9960_GRAM_NEG_VS_GRAM_POS_SEPSIS_PBMC_DN///Genes down-regulated in peripheral blood monocytes (PMBC): Gram negative sepsis versus Gram positive sepsis.+++GSE9960_HEALTHY_VS_GRAM_NEG_SEPSIS_PBMC_UP///Genes up-regulated in peripheral blood monocytes (PMBC): healthy versus Gram negative sepsis.+++HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_POSITIVE///Genes positively correlated with memory B cell response at 28d in peripheral blood mononuclear cell in seniors (50-74) after exposure to Fluarix , time point 28D+++HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_DN///Genes down-regulated in peripheral blood mononuclear cell vaccinated vs unvaccinated in adolescent/young adults (11-22) after exposure to M-M-R II , time point 7Y+++NAKAYA_B_CELL_FLUMIST_AGE_18_50YO_7DY_DN///Genes down-regulated in B cell 7d vs 0d in young adults (18-50) after exposure to FluMist , time point 7D+++NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_POSITIVE///Genes positively correlated with HAI response at 28d in peripheral blood mononuclear cell in adults (18-50) after exposure to Fluarix/Fluvirin , time point 3D. Comment: Supplementary Table 5: All genes whose expression (d3/d0 or d7/d0) correlates to the fold increase in HAI titers (d28/d0).+++NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN///Genes down-regulated in plasmacytoid dendritic cell 7d vs 0d in young adults (18-50) after exposure to FluMist , time point 7D+++ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_UP///Genes up-regulated in peripheral blood mononuclear cell 1d vs 0d in adults (20-50) after exposure to MRKAd5 HIV-1 gag/pol/nef , time point 1D. Comment: Table includes specific cell types"	HALLMARK_APICAL_JUNCTION///Genes encoding components of apical junction complex.+++HALLMARK_MTORC1_SIGNALING///Genes up-regulated through activation of mTORC1 complex.	NM_003930	SKAP2				
O75396	sp|O75396|SC22B_HUMAN		SEC22B		Vesicle-trafficking protein SEC22b OS=Homo sapiens OX=9606 GN=SEC22B PE=1 SV=5	9554	NM_004892	NP_004883	ENST00000578049	K08517			MVLLTMIARVADGLPLAASMQEDEQSGRDLQQYQSQAKQLFRKLNEQSPTRCTLEAGAMTFHYIIEQGVCYLVLCEAAFPKKLAFAYLEDLHSEFDEQHGKKVPTVSRPYSFIEFDTFIQKTKKLYIDSRARRNLGSINTELQDVQRIMVANIEEVLQRGEALSALDSKANNLSSLSKKYRQDAKYLNMRSTYAKLAAVAVFFIMLIVYVRFWWL	0.4082769	-1.292379982	0.002336023									4.6742501	5.0091666	4.480108	5.1939044				3.0369136												6.827155	5.0780701	6.098349	5.9030205			4.3003517			6.3180253		6.001321	5.5250103		6.2428743		5.41830673	04130///SNARE interactions in vesicular transport+++04145///Phagosome+++05134///Legionellosis				GO:0000139///Golgi membrane+++GO:0005737///cytoplasm+++GO:0005783///endoplasmic reticulum+++GO:0005789///endoplasmic reticulum membrane+++GO:0005793///endoplasmic reticulum-Golgi intermediate compartment+++GO:0005794///Golgi apparatus+++GO:0008021///synaptic vesicle+++GO:0012507///ER to Golgi transport vesicle membrane+++GO:0016020///membrane+++GO:0016021///integral component of membrane+++GO:0030133///transport vesicle+++GO:0030137///COPI-coated vesicle+++GO:0030670///phagocytic vesicle membrane+++GO:0031201///SNARE complex+++GO:0033116///endoplasmic reticulum-Golgi intermediate compartment membrane+++GO:0042470///melanosome	GO:0005484///SNAP receptor activity+++GO:0005515///protein binding+++GO:0019905///syntaxin binding	"GO:0002479///antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent+++GO:0006888///ER to Golgi vesicle-mediated transport+++GO:0006890///retrograde vesicle-mediated transport, Golgi to ER+++GO:0015031///protein transport+++GO:0016192///vesicle-mediated transport+++GO:0045732///positive regulation of protein catabolic process+++GO:0048208///COPII vesicle coating+++GO:0048280///vesicle fusion with Golgi apparatus+++GO:0061025///membrane fusion+++GO:1902902///negative regulation of autophagosome assembly+++GO:1990668///vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane"			"Homo sapiens SEC22 homolog B, vesicle trafficking protein (SEC22B), mRNA."		PF00957///Synaptobrevin+++PF13774///Regulated-SNARE-like domain	R-HSA-1236974///ER-Phagosome pathway+++R-HSA-1236975///Antigen processing-Cross presentation+++R-HSA-1280218///Adaptive Immune System+++R-HSA-168256///Immune System+++R-HSA-199977///ER to Golgi Anterograde Transport+++R-HSA-199991///Membrane Trafficking+++R-HSA-204005///COPII-mediated vesicle transport+++R-HSA-392499///Metabolism of proteins+++R-HSA-446203///Asparagine N-linked glycosylation+++R-HSA-5653656///Vesicle-mediated transport+++R-HSA-5694530///Cargo concentration in the ER+++R-HSA-597592///Post-translational protein modification+++R-HSA-6811434///COPI-dependent Golgi-to-ER retrograde traffic+++R-HSA-6811442///Intra-Golgi and retrograde Golgi-to-ER traffic+++R-HSA-8856688///Golgi-to-ER retrograde transport+++R-HSA-948021///Transport to the Golgi and subsequent modification+++R-HSA-983169///Class I MHC mediated antigen processing & presentation		KOG0862///vesicle fusion with Golgi apparatus		"IPR001388///Synaptobrevin+++IPR010908///Longin domain+++IPR011012///Longin-like domain superfamily+++IPR042855///v-SNARE, coiled-coil homology domain+++IPR044565///Vesicle-trafficking protein Sec22"	[SC22B_HUMAN|Reviewed]RecName: Full=Vesicle-trafficking protein SEC22b; AltName: Full=ER-Golgi SNARE of 24 kDa; Short=ERS-24; Short=ERS24; AltName: Full=SEC22 vesicle-trafficking protein homolog B; AltName: Full=SEC22 vesicle-trafficking protein-like 1;+++[I1VE16_HUMAN|Unreviewed]SubName: Full=SEC22 vesicle trafficking protein B {ECO:0000313|EMBL:AFI41826.1}; Flags: Fragment;+++[I1VE17_HUMAN|Unreviewed]SubName: Full=SEC22 vesicle trafficking protein B {ECO:0000313|EMBL:AFI41827.1}; Flags: Fragment;+++[I1VE18_HUMAN|Unreviewed]SubName: Full=SEC22 vesicle trafficking protein B {ECO:0000313|EMBL:AFI41828.1}; Flags: Fragment;+++[I1VE19_HUMAN|Unreviewed]SubName: Full=SEC22 vesicle trafficking protein B {ECO:0000313|EMBL:AFI41829.1}; Flags: Fragment;+++[I1VE20_HUMAN|Unreviewed]SubName: Full=SEC22 vesicle trafficking protein B {ECO:0000313|EMBL:AFI41830.1}; Flags: Fragment;	chr1p12///Ensembl 103 genes in cytogenetic band chr1p12		KEGG_SNARE_INTERACTIONS_IN_VESICULAR_TRANSPORT///SNARE interactions in vesicular transport	REACTOME_ADAPTIVE_IMMUNE_SYSTEM///Adaptive Immune System+++REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION///Antigen processing-Cross presentation+++REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION///Asparagine N-linked glycosylation+++REACTOME_CARGO_CONCENTRATION_IN_THE_ER///Cargo concentration in the ER+++REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION///Class I MHC mediated antigen processing &amp; presentation+++REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC///COPI-dependent Golgi-to-ER retrograde traffic+++REACTOME_COPII_MEDIATED_VESICLE_TRANSPORT///COPII-mediated vesicle transport+++REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT///ER to Golgi Anterograde Transport+++REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT///Golgi-to-ER retrograde transport+++REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC///Intra-Golgi and retrograde Golgi-to-ER traffic+++REACTOME_MEMBRANE_TRAFFICKING///Membrane Trafficking+++REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION///Post-translational protein modification+++REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION///Transport to the Golgi and subsequent modification+++REACTOME_VESICLE_MEDIATED_TRANSPORT///Vesicle-mediated transport		"ACATTCC_MIR1_MIR206///Genes having at least one occurence of the motif ACATTCC in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-1 and hsa-miR-206 (v7.1 miRBase).+++TAGAACC_MIR182///Genes having at least one occurence of the motif TAGAACC in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-182* (v7.1 miRBase)."	MIR10527_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-10527-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1468_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1468-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR149_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-149-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR206///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-206 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3125///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3125 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3140_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3140-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3916///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3916 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3919///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3919 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3938///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3938 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR409_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-409-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4287///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4287 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4320///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4320 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4451///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4451 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4477B///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4477b in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4536_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4536-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4685_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4685-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4712_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4712-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4728_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4728-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR548N///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-548n in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR613///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-613 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR621///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-621 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6785_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6785-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6859_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6859-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6866_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6866-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6867_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6867-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6883_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6883-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6883_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6883-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7152_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7152-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).	COUP_DR1_Q6///Genes having at least one occurence of the transcription factor binding site V$COUP_DR1_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++DR1_Q3///Genes having at least one occurence of the transcription factor binding site V$DR1_Q3 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++HNF4_01///Genes having at least one occurence of the transcription factor binding site V$HNF4_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++HNF4_DR1_Q3///Genes having at least one occurence of the transcription factor binding site V$HNF4_DR1_Q3 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.	"ADA2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9NZK5 (ADA2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++AHRR_TARGET_GENES///Genes containing one or more binding sites for UniProt:A9YTQ3 (AHRR) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ALKBH3_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96Q83 (ALKBH3) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++CASP8AP2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9UKL3 (CASP8AP2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++CC2D1A_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6P1N0 (CC2D1A) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++CDC73_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6P1J9 (CDC73) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++CHAMP1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96JM3 (CHAMP1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++DIDO1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9BTC0 (DIDO1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++DLX4_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q92988 (DLX4) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++FEV_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q99581 (FEV) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++GLI4_TARGET_GENES///Genes containing one or more binding sites for UniProt:P10075 (GLI4) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++GTF2E2_TARGET_GENES///Genes containing one or more binding sites for UniProt:P29084 (GTF2E2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HHEX_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q03014 (HHEX) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HMBOX1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6NT76 (HMBOX1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HMG20B_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9P0W2 (HMG20B) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HOXA2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O43364 (HOXA2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++INSM2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96T92 (INSM2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++MORC2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9Y6X9 (MORC2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++MZF1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P28698 (MZF1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NFRKB_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6P4R8 (NFRKB) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NUP153_TARGET_GENES///Genes containing one or more binding sites for UniProt:P49790 (NUP153) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++OVOL3_TARGET_GENES///Genes containing one or more binding sites for UniProt:O00110 (OVOL3) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++PAX7_TARGET_GENES///Genes containing one or more binding sites for UniProt:P23759 (PAX7) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++PCGF2_TARGET_GENES///Genes containing one or more binding sites for UniProt:P35227 (PCGF2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++RYBP_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8N488 (RYBP) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SETX_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q7Z333 (SETX) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SKIL_TARGET_GENES///Genes containing one or more binding sites for UniProt:P12757 (SKIL) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SNAI1_TARGET_GENES///Genes containing one or more binding sites for UniProt:O95863 (SNAI1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SUMO1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P63165 (SUMO1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SUPT20H_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8NEM7 (SUPT20H) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++TAF9B_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9HBM6 (TAF9B) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++TBX1_TARGET_GENES///Genes containing one or more binding sites for UniProt:O43435 (TBX1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++TOP2B_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q02880 (TOP2B) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++TP73_TARGET_GENES///Genes containing one or more binding sites for UniProt:O15350 (TP73) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++UBN1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9NPG3 (UBN1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++WRNIP1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96S55 (WRNIP1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZBTB18_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q99592 (ZBTB18) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZBTB24_TARGET_GENES///Genes containing one or more binding sites for UniProt:O43167 (ZBTB24) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZC3H11A_TARGET_GENES///Genes containing one or more binding sites for UniProt:O75152 (ZC3H11A) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZIM3_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96PE6 (ZIM3) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF134_TARGET_GENES///Genes containing one or more binding sites for UniProt:P52741 (ZNF134) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF260_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q3ZCT1 (ZNF260) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9BSG1 (ZNF2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF30_TARGET_GENES///Genes containing one or more binding sites for UniProt:P17039 (ZNF30) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF318_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q5VUA4 (ZNF318) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF329_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q86UD4 (ZNF329) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF331_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9NQX6 (ZNF331) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF34_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8IZ26 (ZNF34) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF391_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9UJN7 (ZNF391) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF394_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q53GI3 (ZNF394) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF41_TARGET_GENES///Genes containing one or more binding sites for UniProt:P51814 (ZNF41) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF549_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6P9A3 (ZNF549) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF558_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96NG5 (ZNF558) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF561_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8N587 (ZNF561) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF595_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8IYB9 (ZNF595) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF660_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6AZW8 (ZNF660) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF664_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8N3J9 (ZNF664) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF711_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9Y462 (ZNF711) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF784_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8NCA9 (ZNF784) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF85_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q03923 (ZNF85) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZSCAN4_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8NAM6 (ZSCAN4) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."	MORF_PPP2R5E///Neighborhood of PPP2R5E+++MORF_RAB11A///Neighborhood of RAB11A+++MORF_RAB1A///Neighborhood of RAB1A+++MORF_UBE2A///Neighborhood of UBE2A	MODULE_15///Genes in the cancer module 14.+++MODULE_16///Genes in the cancer module 15.		"GSE10325_MYELOID_VS_LUPUS_MYELOID_DN///Genes down-regulated in comparison of healthy myeloid cells versus systemic lupus erythematosus myeloid cells.+++GSE13484_12H_VS_3H_YF17D_VACCINE_STIM_PBMC_UP///Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) cultured with YF17D vaccine for 12 h versus PBMC cultured for 3 h.+++GSE13485_DAY1_VS_DAY21_YF17D_VACCINE_PBMC_DN///Genes down-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) 1 day after stimulation with YF17D vaccine versus PBMC 21 days after the stimulation.+++GSE14908_ATOPIC_VS_NONATOPIC_PATIENT_RESTING_CD4_TCELL_UP///Genes up-regulated in resting CD4 [GeneID=920] T cells: atopy versus healthy.+++GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA2_STIM_CD8_TCELL_UP///Genes up-regulated in CD8 T cells: control versus stimulated by IFNA2 [GeneID=3440] and activated by anti-CD3 and anti-CD28.+++GSE18893_CTRL_VS_TNF_TREATED_TCONV_2H_UP///Genes up-regulated in T conv cells (2h): medium versus TNF [GeneID=7124].+++GSE22601_DOUBLE_NEGATIVE_VS_IMMATURE_CD4_SP_THYMOCYTE_UP///Genes up-regulated in double negative thymocyte versus immature CD4 [GeneID=920] single positive cells.+++GSE29618_PRE_VS_DAY7_FLU_VACCINE_PDC_DN///Genes down-regulated in comparison of plasmacytoid dendritic cells (pDC) from influenza vaccinee pre-vaccination versus those at day 7 post-vaccination.+++GSE360_CTRL_VS_M_TUBERCULOSIS_MAC_DN///Genes down-regulated in comparison of macrophages versus macrophages exposed to M. tuberculosis.+++GSE360_CTRL_VS_T_GONDII_MAC_DN///Genes down-regulated in comparison of macrophages versus macrophages exposed to T. gondii.+++GSE360_T_GONDII_VS_M_TUBERCULOSIS_MAC_DN///Genes down-regulated in comparison of macrophages exposed to T. gondii versus macrophages exposed to M. tuberculosis.+++GSE37416_0H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_DN///Genes down-regulated in comparison of control polymorphonuclear leukocytes (PMN) at 0 h versus PMN treated with F. tularensis vaccine at 24 h.+++GSE37416_0H_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_DN///Genes down-regulated in comparison of control polymorphonuclear leukocytes (PMN) at 0 h versus PMN treated with F. tularensis vaccine at 3 h.+++GSE37416_0H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_DN///Genes down-regulated in comparison of control polymorphonuclear leukocytes (PMN) at 0 h versus PMN treated with F. tularensis vaccine at 48 h.+++NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_UP///Genes up-regulated in peripheral blood mononuclear cell 3d vs 0d in adults (18-50) after exposure to Fluarix/Fluvirin , time point 3D. Comment: Supplementary Table 1a: All the differentially expressed genes identified in PBMCs of TIV vaccinees.+++NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_UP///Genes up-regulated in peripheral blood mononuclear cell 3d vs 0d in adults (18-50) after exposure to FluMist , time point 3D. Comment: Supplementary Table 1b: All the differentially expressed genes identified in PBMCs of TIV vaccinees.+++NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP///Genes up-regulated in plasmacytoid dendritic cell 7d vs 0d in young adults (18-50) after exposure to FluMist , time point 7D"	HALLMARK_PROTEIN_SECRETION///Genes involved in protein secretion pathway.	NM_004892	SEC22B				
O60844	sp|O60844|ZG16_HUMAN		ZG16		Zymogen granule membrane protein 16 OS=Homo sapiens OX=9606 GN=ZG16 PE=1 SV=3	653808	XM_011545921	XP_011544223					MLTVALLALLCASASGNAIQARSSSYSGEYGGGGGKRFSHSGNQLDGPITALRVRVNTYYIVGLQVRYGKVWSDYVGGRNGDLEEIFLHPGESVIQVSGKYKWYLKKLVFVTDKGRYLSFGKDSGTSFNAVPLHPNTVLRFISGRSGSLIDAIGLHWDVYPSSCSRC	1.5719478	0.652553287	0.008373539	5.2558234	4.1671767	3.5321354	3.5266119		4.0678434	3.826450512	4.2666602	5.3656425	4.2403529	4.8453928	4.6598839	4.85251459	4.9426509	5.1342113	4.9670601	4.4736403	4.150982	6.342412368	6.760924	4.8313964	5.9741566	5.1857195	5.2641065	3.89315923	4.20506818	3.5659381	2.49822	2.712031	4.22543	3.4659707		5.4498573	4.515534	4.8371728	4.5215525	3.7952972	4.3540844	3.682113	3.6714173	3.73242111	4.5569397	3.8605513	4.48771906					GO:0005576///extracellular region+++GO:0005615///extracellular space+++GO:0005794///Golgi apparatus+++GO:0005796///Golgi lumen+++GO:0031410///cytoplasmic vesicle+++GO:0042589///zymogen granule membrane+++GO:0062023///collagen-containing extracellular matrix+++GO:0070701///mucus layer	GO:0005515///protein binding+++GO:0030246///carbohydrate binding+++GO:0042834///peptidoglycan binding	GO:0015031///protein transport+++GO:0050830///defense response to Gram-positive bacterium+++GO:0052373///negative regulation by organism of entry into other organism involved in symbiotic interaction	tissueType=Large intestine;cancerType=Normal;cellName=Goblet cell		"PREDICTED: Homo sapiens zymogen granule protein 16 (ZG16), transcript variant X1, mRNA."									chr16p11///Ensembl 103 genes in cytogenetic band chr16p11						MIR324_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-324-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4707_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4707-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6807_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6807-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR8078///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-8078 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).	GATAAGR_GATA_C///Genes having at least one occurence of the highly conserved motif M131 GATAAGR sites. The motif matches transcription factor binding site V$GATA_C (v7.4 TRANSFAC).+++HNF3ALPHA_Q6///Genes having at least one occurence of the transcription factor binding site V$HNF3ALPHA_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++TATAAA_TATA_01///Genes having at least one occurence of the highly conserved motif M51 TATAAA sites. The motif matches transcription factor binding site V$TATA_01 (v7.4 TRANSFAC).		GNF2_HPN///Neighborhood of HPN+++GNF2_HPX///Neighborhood of HPX+++GNF2_LCAT///Neighborhood of LCAT			GSE10147_IL3_VS_IL3_AND_CPG_STIM_PDC_UP///Genes up-regulated in plasmacytoid dendritic cells: IL3 [GeneID=3562] versus IL3 [GeneID=3562] and CpG.+++GSE22886_NAIVE_VS_MEMORY_TCELL_UP///Genes up-regulated in comparison of naive CD4 [GeneID=920] CD8 T cells versus unstimulated memory CD4 [GeneID=920] CD8 T cells.+++GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_DN///Genes down-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 and then stimulated by TGFB1 [GeneID=7040] and IL-12 (6h).+++GSE28726_NAIVE_VS_ACTIVATED_VA24NEG_NKTCELL_DN///Genes down-regulated in Va24- NKT cells: nave versus activated.+++GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_DC_UP///Genes up-regulated in comparison of dendritic cells (DC) versus DCs exposed to B. malayi (5 worms/well).+++GSE360_DC_VS_MAC_B_MALAYI_LOW_DOSE_UP///Genes up-regulated in comparison of dendritic cells (DC) exposed to 5 worm/well B. malayi versus macrophages exposed to 5 worms/well B. malayi.+++GSE360_DC_VS_MAC_L_MAJOR_DN///Genes down-regulated in comparison of dendritic cells exposed to L. major versus macrophages exposed to L. major.+++GSE360_DC_VS_MAC_M_TUBERCULOSIS_UP///Genes up-regulated in comparison of dendritic cells (DC) exposed to M. tuberculosis versus macrophages exposed to L. major.+++GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_UP///Genes up-regulated in comparison of macrophages exposed to 50 worms/well B. malayi versus macrophages exposed to M. tuberculosis.+++GSE360_L_MAJOR_VS_M_TUBERCULOSIS_MAC_UP///Genes up-regulated in comparison of macrophages exposed to L. major versus macrophages exposed to M. tuberculosis.+++GSE6566_STRONG_VS_WEAK_DC_STIMULATED_CD4_TCELL_UP///Genes up-regulated in CD4 [GeneID=920] cells stimulated with strong dendritic cells (DC) versus CD4 [GeneID=920] T cells stimulated with weak DCs.+++GSE7509_UNSTIM_VS_FCGRIIB_STIM_DC_UP///Genes up-regulated in dendritic cells: untreated versus anti-FcgRIIB.+++GSE9960_GRAM_POS_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_DN///Genes down-regulated in peripheral blood monocytes (PMBC): Gram positive sepsis versus mixed infection sepsis.		XM_011545921	ZG16				
O43665	sp|O43665|RGS10_HUMAN		RGS10		Regulator of G-protein signaling 10 OS=Homo sapiens OX=9606 GN=RGS10 PE=1 SV=3	6001	NM_001005339	NP_001005339	ENST00000369103				MFNRAVSRLSRKRPPSDIHDSDGSSSSSHQSLKSTAKWAASLENLLEDPEGVKRFREFLKKEFSEENVLFWLACEDFKKMQDKTQMQEKAKEIYMTFLSSKASSQVNVEGQSRLNEKILEEPHPLMFQKLQDQIFNLMKYDSYSRFLKSDLFLKHKRTEEEEEDLPDAQTAAKRASRIYNT	0.3990506	-1.325356552	0.04260431		4.1150876				4.5728245				5.3382742	4.4177248											4.4617747	6.2977685					7.989432	8.1531486	7.908306	5.9738436	4.278908	4.8350193	5.5155303	4.6388011	5.2753326	6.9624699	4.1630732	6.810326			6.1293709		3.6660757					GO:0005634///nucleus+++GO:0005737///cytoplasm+++GO:0005829///cytosol+++GO:0005886///plasma membrane+++GO:0043025///neuronal cell body+++GO:0043197///dendritic spine+++GO:0043679///axon terminus	GO:0001965///G-protein alpha-subunit binding+++GO:0003924///GTPase activity+++GO:0005096///GTPase activator activity+++GO:0005515///protein binding	GO:0001975///response to amphetamine+++GO:0007186///G protein-coupled receptor signaling pathway+++GO:0007213///G protein-coupled acetylcholine receptor signaling pathway+++GO:0008277///regulation of G protein-coupled receptor signaling pathway+++GO:0009968///negative regulation of signal transduction+++GO:0043547///positive regulation of GTPase activity	tissueType=Fetal kidney;cancerType=Normal;cellName=Monocyte+++tissueType=Embryonic prefrontal cortex;cancerType=Normal;cellName=Microglial cell+++tissueType=Fetal gonad;cancerType=Normal;cellName=Mitotic fetal germ cell+++tissueType=Blood;cancerType=Normal;cellName=CD141+CLEC9A+ dendritic cell		"Homo sapiens regulator of G protein signaling 10 (RGS10), transcript variant 1, mRNA."		PF00615///Regulator of G protein signaling domain	R-HSA-162582///Signal Transduction+++R-HSA-372790///Signaling by GPCR+++R-HSA-388396///GPCR downstream signalling+++R-HSA-418594///G alpha (i) signalling events		KOG3589///positive regulation of GTPase activity		"IPR016137///RGS domain+++IPR024066///RGS, subdomain 1/3+++IPR036305///RGS domain superfamily+++IPR037879///RGS10, RGS domain+++IPR044926///RGS, subdomain 2"	[RGS10_HUMAN|Reviewed]RecName: Full=Regulator of G-protein signaling 10; Short=RGS10;	chr10q26///Ensembl 103 genes in cytogenetic band chr10q26			REACTOME_G_ALPHA_I_SIGNALLING_EVENTS///G alpha (i) signalling events+++REACTOME_SIGNALING_BY_GPCR///Signaling by GPCR			MIR1910_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1910-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR330_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-330-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3908///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3908 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4795_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4795-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR493_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-493-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6864_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6864-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).		"GREB1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q4ZG55 (GREB1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NFXL1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6ZNB6 (NFXL1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++RAG1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P15918 (RAG1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SUPT16H_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9Y5B9 (SUPT16H) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZFP91_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96JP5 (ZFP91) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF513_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8N8E2 (ZNF513) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF592_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q92610 (ZNF592) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF664_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8N3J9 (ZNF664) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."		"MODULE_118///cell line expressed genes.+++MODULE_15///Genes in the cancer module 14.+++MODULE_16///Genes in the cancer module 15.+++MODULE_17///Genes in the cancer module 17.+++MODULE_23///Liver genes - metabolism and xenobiotics.+++MODULE_24///Fetal liver genes - metabolism and xenobiotics.+++MODULE_38///Placenta genes.+++MODULE_44///Thymus genes.+++MODULE_45///Whole blood genes.+++MODULE_53///Cell line expressed genes.+++MODULE_55///Genes in the cancer module 55.+++MODULE_84///Immune (humoral) and inflammatory response.+++MODULE_88///Heart, liver, kidney and pancreas metabolic and xenobiotic response genes."		"ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_6HR_DN///Genes down-regulated in blood 6hr vs 0hr in adults (18-45) after exposure to CN54gp140 adjuvanted with GLA-AF , time point 6H , administered i.m.+++GSE10325_CD4_TCELL_VS_BCELL_UP///Genes up-regulated in comparison of healthy CD4 [GeneID=920] T cells versus healthy CD19 [GeneID=920] B cells. +++GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_BCELL_UP///Genes up-regulated in comparison of systemic lupus erythematosus CD4 [GeneID=920] T cells versus systemic lupus erythematosus B cells.+++GSE11057_NAIVE_VS_EFF_MEMORY_CD4_TCELL_UP///Genes up-regulated in comparison of naive T cells versus effector memory T cells.+++GSE11057_NAIVE_VS_MEMORY_CD4_TCELL_UP///Genes up-regulated in comparison of naive T cells versus memory T cells.+++GSE11864_UNTREATED_VS_CSF1_IFNG_IN_MAC_DN///Genes down-regulated in comparison of untreated macrophages versus those cultured with M-CSF [GeneID=1435] and IFNG [GeneID=3458].+++GSE12845_IGD_NEG_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_DN///Genes down-regulated in comparison of IgD- peripheral blood B cells versus dark zone germinal center B cells.+++GSE14000_4H_VS_16H_LPS_DC_TRANSLATED_RNA_UP///Genes up-regulated in comparison of polysome bound (translated) mRNA in dendritic cells (DC) at 4 h after LPS (TLR4 agonist) stimulation versus those at 16 h after the stimulation.+++GSE14000_TRANSLATED_RNA_VS_MRNA_4H_LPS_DC_DN///Genes down-regulated in comparison of polysome bound (translated) mRNA versus total mRNA 4 h after LPS (TLR4 agonist) stimulation.+++GSE16385_MONOCYTE_VS_MACROPHAGE_UP///Genes up-regulated in monocytes versus macrophages.+++GSE17186_BLOOD_VS_CORD_BLOOD_NAIVE_BCELL_DN///Genes down-regulated in nave B lymphocytes versus those from cord blood.+++GSE17186_NAIVE_VS_CD21LOW_TRANSITIONAL_BCELL_CORD_BLOOD_UP///Genes up-regulated in B lymphocytes from cord blood: nave versus transitional CR2 [GeneID=1380].+++GSE17301_IFNA2_VS_IFNA5_STIM_ACD3_ACD28_ACT_CD8_TCELL_UP///Genes up-regulated in CD8 T cells stimulated by IFNA2 [GeneID=3440] versus CD8 T cells stimulated by IFNA5 [GeneID=3442] and activated by anti-CD3 and anti-CD28.+++GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_3H_IFNG_STIM_UP///Genes up-regulated in macrophages stimulated by IFNG [GeneID=3458] for 3h: control versus primed by IFNG [GeneID=3458].+++GSE22589_SIV_VS_HIV_AND_SIV_INFECTED_DC_DN///Genes down-regulated in monocyte-derived dendritic cells infected by: SIV versus HIV and SIV.+++GSE22601_DOUBLE_NEGATIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_UP///Genes up-regulated in thymocytes: double negative versus CD4 [GeneID=920] single positive.+++GSE22601_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN///Genes down-regulated in thymocytes: double positive versus CD4 [GeneID=920] single positive.+++GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_DN///Genes down-regulated in immature CD4 [GeneID=920] single positive cells versus double positive thymocytes.+++GSE22886_CD4_TCELL_VS_BCELL_NAIVE_UP///Genes up-regulated in comparison of naive CD4 [GeneID=920] T cells versus naive B cells.+++GSE22886_CD8_TCELL_VS_BCELL_NAIVE_UP///Genes up-regulated in comparison of naive CD8 T cells versus naive B cells.+++GSE22886_IGM_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_DN///Genes down-regulated in comparison of memory IgM B cells versus blood plasma cells.+++GSE22886_NAIVE_CD8_TCELL_VS_NEUTROPHIL_UP///Genes up-regulated in comparison of naive CD8 T cells versus unstimulated neutrophils.+++GSE22886_NAIVE_CD8_TCELL_VS_NKCELL_UP///Genes up-regulated in comparison of naive CD8 T cells versus unstimulated NK cells.+++GSE22886_NAIVE_TCELL_VS_NKCELL_UP///Genes up-regulated in comparison of naive CD4 [GeneID=920] CD8 T cells versus unstimulated NK cells.+++GSE22886_NAIVE_VS_IGG_IGA_MEMORY_BCELL_DN///Genes down-regulated in comparison of naive B cells versus memory IgG IgA B cells.+++GSE22886_NAIVE_VS_IGM_MEMORY_BCELL_DN///Genes down-regulated in comparison of naive B cells versus memory IgM B cells.+++GSE22886_TCELL_VS_BCELL_NAIVE_UP///Genes up-regulated in comparison of naive CD4 [GeneID=920] CD8 T cells versus naive B cells.+++GSE25085_FETAL_LIVER_VS_FETAL_BM_SP4_THYMIC_IMPLANT_UP///Genes up-regulated in thymic implants from fetal liver versus those from fetal bone marrow.+++GSE26156_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_UP///Genes up-regulated in thymocytes: double positive versus CD4 [GeneID=920] single positive.+++GSE26495_NAIVE_VS_PD1LOW_CD8_TCELL_UP///Genes up-regulated in comparison of naive CD8 T cells versus PD-1 low CD8 T cells.+++GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_6H_UP///Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 [GeneID=7040] and IL-12 (6h) versus untreated (6h).+++GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_DN///Genes down-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: IL-12 (48h) versus TGFB1 [GeneID=7040] and IL-12 (48h).+++GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_2H_UP///Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: IL4 [GeneID=3565] (2h) versus untreated (2h).+++GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_6H_UP///Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 and IL4 [GeneID=7040;3565] (6h) versus IL-12 (6h).+++GSE28726_ACT_CD4_TCELL_VS_ACT_NKTCELL_UP///Genes up-regulated in activated T cells: CD4 [GeneID=920] versus NKT.+++GSE28726_NAIVE_CD4_TCELL_VS_NAIVE_NKTCELL_UP///Genes up-regulated in nave T cells: CD4 [GeneID=920] versus NK.+++GSE28726_NAIVE_VS_ACTIVATED_NKTCELL_DN///Genes down-regulated in NKT cells: nave versus activated.+++GSE29618_BCELL_VS_MDC_DAY7_FLU_VACCINE_DN///Genes down-regulated in comparison of B cells from influenza vaccinee at day 7 post-vaccination versus myeloid dendritic cells (mDC) at day 7 post-vaccination.+++GSE29618_BCELL_VS_MDC_DN///Genes down-regulated in comparison of B cells versus myeloid dendritic cells (mDC).+++GSE29618_BCELL_VS_MONOCYTE_DAY7_FLU_VACCINE_DN///Genes down-regulated in comparison of B cells from influenza vaccinee at day 7 versus monocytes from influenza vaccinee at day 7.+++GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_BCELL_DN///Genes down-regulated in comparison of B cells from LAIV influenza vaccinee at day 7 post-vaccination versus those from TIV influenza vaccinee at day 7 post-vaccination.+++GSE29618_MONOCYTE_VS_MDC_DAY7_FLU_VACCINE_DN///Genes down-regulated in comparison of monocytes from influenza vaccinee at day 7 post-vaccination versus myeloid dendritic cells at day 7 post-vaccination.+++GSE29618_MONOCYTE_VS_MDC_DN///Genes down-regulated in comparison of monocytes versus myeloid dendritic cells (mDC).+++GSE29618_PDC_VS_MDC_DAY7_FLU_VACCINE_DN///Genes down-regulated in comparison of plasmacytoid dendritic cells (DC) from influenza vaccinee at day 7 post-vaccination versus myeloid DCs at day 7 post-vaccination.+++GSE29618_PDC_VS_MDC_DN///Genes down-regulated in comparison of plasmacytoid dendritic cells (DC) versus myeloid DCs.+++GSE29618_PRE_VS_DAY7_FLU_VACCINE_MDC_DN///Genes down-regulated in comparison of plasmacytoid dendritic cells (DC) from influenza vaccinee at day 0 versus myeloid DCs at day 7 post-vaccination.+++GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MDC_DN///Genes down-regulated in comparison of myeloid dendritic cells (mDC) from LAIV influenza vaccinee pre-vaccination versus those at day 7 post-vaccination.+++GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MDC_DN///Genes down-regulated in comparison of myeloid dendritic cells (mDC) from TIV influenza vaccinee pre-vaccination versus those at day 7 post-vaccination.+++GSE32164_ALTERNATIVELY_ACT_M2_VS_CMYC_INHIBITED_MACROPHAGE_DN///Genes down-regulated in macrophages: alternatively activated M2 versus MYC [GeneID=4609] inhibited.+++GSE32164_RESTING_DIFFERENTIATED_VS_ALTERNATIVELY_ACT_M2_MACROPHAGE_UP///Genes up-regulated in macrophages: resting differentiated versus alternatively activated M2.+++GSE33424_CD161_HIGH_VS_INT_CD8_TCELL_DN///Genes down-regulated in CD8 T cells: KLRB1 high [GeneID=3820] versus KLRB1 int [GeneID=3820].+++GSE33424_CD161_HIGH_VS_NEG_CD8_TCELL_DN///Genes down-regulated in CD8 T cells: KLRB1 high [GeneID=3820] versus KLRB1- [GeneID=3820].+++GSE33425_CD161_HIGH_VS_INT_CD8_TCELL_DN///Genes down-regulated in CD8 T cells: KLRB1 high [GeneID=3820] versus KLRB1 int [GeneID=3820].+++GSE33425_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_DN///Genes down-regulated in KLRB1 high [GeneID=3820] T cells: CD8A [GeneID=925] versus CD8A CD8B [GeneID=925;926].+++GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10NEG_CD62LPOS_BONE_MARROW_UP///Genes up-regulated in the bone marrow CD34+ [GeneID=947] cells: CD38- [GeneID=952] versus MME- SELL+ [GeneID=4311;6402].+++GSE360_CTRL_VS_L_MAJOR_DC_UP///Genes up-regulated in untreated dendritic cells (DC) versus DCs exposed to parasite L. major.+++GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_UP///Genes up-regulated in comparison of dendritic cells (DC) exposed to 50 worms/well B. malayi versus DC exposed to M. tuberculosis+++GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_UP///Genes up-regulated in comparison of dendritic cells (DC) exposed to 5 worms/well B. malayi versus DC exposed to M. tuberculosis+++GSE360_T_GONDII_VS_M_TUBERCULOSIS_DC_UP///Genes up-regulated in comparison of dendritic cells (DC) exposed to T. gondii versus DCs exposed to M. tuberculosis.+++GSE3720_UNSTIM_VS_LPS_STIM_VD2_GAMMADELTA_TCELL_UP///Genes up-regulated in Vd2 gamma delta T cells: untreated versus LPS.+++GSE3720_UNSTIM_VS_PMA_STIM_VD2_GAMMADELTA_TCELL_UP///Genes up-regulated in Vd2 gamma delta T cells: untreated versus phorbol myristate acetate and ionomycin [PubChem=4792;3733].+++GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_DN///Genes down-regulated in gamma delta T cells: Vd1 versus Vd2.+++GSE3920_IFNA_VS_IFNB_TREATED_ENDOTHELIAL_CELL_UP///Genes up-regulated in endothelial cells: interferon alpha versus interferon beta.+++GSE3920_IFNA_VS_IFNG_TREATED_FIBROBLAST_DN///Genes down-regulated in fibroblasts: interferon alpha versus IFNG [GeneID=3458].+++GSE3920_IFNB_VS_IFNG_TREATED_ENDOTHELIAL_CELL_UP///Genes up-regulated in endothelial cells: interferon beta versus IFNG [GeneID=3458].+++GSE3920_UNTREATED_VS_IFNG_TREATED_FIBROBLAST_DN///Genes down-regulated in fibroblasts: untreated versus IFNG [GeneID=3458].+++GSE3982_MAC_VS_NEUTROPHIL_UP///Genes up-regulated in comparison of macrophages versus neutrophils.+++GSE3982_MAST_CELL_VS_BCELL_UP///Genes up-regulated in comparison of mast cells versus B cells.+++GSE3982_MAST_CELL_VS_MAC_UP///Genes up-regulated in comparison of mast cells versus macrophages.+++GSE3982_MAST_CELL_VS_NKCELL_UP///Genes up-regulated in comparison of mast cells versus NK cells.+++GSE3982_NEUTROPHIL_VS_NKCELL_DN///Genes down-regulated in comparison of neutrophils versus NK cells.+++GSE3982_NEUTROPHIL_VS_TH1_DN///Genes down-regulated in comparison of neutrophils versus Th1 cells.+++GSE4590_LARGE_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_DN///Genes down-regulated during B lymphocyte differentiation: large pre-B II versus VPREB1+ [GeneID=7441] pre-B Il.+++GSE4590_SMALL_VS_LARGE_PRE_BCELL_UP///Genes up-regulated during B lymphocyte differentiation: small pre-B II versus large pre-B II.+++GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY3_UP///Genes up-regulated in monocytes: untreated versus CSF1 [GeneID=1435].+++GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_DN///Genes down-regulated in monocyte-derived dendritic cells: untreated versus rosiglitazone and AM580 [PubChem=77999;2126].+++GSE6092_IFNG_VS_IFNG_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_UP///Genes up-regulated in endothelial cells: IFNG [GeneID=3459] versus IFNG [GeneID=3459] and B. burgdoferi.+++GSE9006_TYPE_1_DIABETES_AT_DX_VS_4MONTH_POST_DX_PBMC_DN///Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from patients with type 1 diabetes at the time of the diagnosis versus those at 4 months later.+++GSE9601_NFKB_INHIBITOR_VS_PI3K_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_UP///Genes up-regulated in monocytes after HCMV infection: BAY 11-7082 [PubChem=5353431] versus Ly294002 [PubChem=3973].+++NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP///Genes up-regulated in plasmacytoid dendritic cell 7d vs 0d in young adults (18-50) after exposure to FluMist , time point 7D+++THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_UP///Genes up-regulated in peripheral blood mononuclear cell 28d vs 0d in young adults (21-30) (responders) after exposure to Inactivated influenza vaccine , time point 28D"		NM_001005339	RGS10				
O43516	sp|O43516|WIPF1_HUMAN		WIPF1		WAS/WASL-interacting protein family member 1 OS=Homo sapiens OX=9606 GN=WIPF1 PE=1 SV=3 >tr|A0A140VJZ9|A0A140VJZ9_HUMAN Testicular tissue protein Li 226 OS=Homo sapiens OX=9606 PE=2 SV=1	7456	NM_003387	NP_003378	ENST00000392547	K19475			MPVPPPPAPPPPPTFALANTEKPTLNKTEQAGRNALLSDISKGKKLKKTVTNDRSAPILDKPKGAGAGGGGGGFGGGGGFGGGGGGGGGGSFGGGGPPGLGGLFQAGMPKLRSTANRDNDSGGSRPPLLPPGGRSTSAKPFSPPSGPGRFPVPSPGHRSGPPEPQRNRMPPPRPDVGSKPDSIPPPVPSTPRPIQSSPHNRGSPPVPGGPRQPSPGPTPPPFPGNRGTALGGGSIRQSPLSSSSPFSNRPPLPPTPSRALDDKPPPPPPPVGNRPSIHREAVPPPPPQNNKPPVPSTPRPSASSQAPPPPPPPSRPGPPPLPPSSSGNDETPRLPQRNLSLSSSTPPLPSPGRSGPLPPPPSERPPPPVRDPPGRSGPLPPPPPVSRNGSTSRALPATPQLPSRSGVDSPRSGPRPPLPPDRPSAGAPPPPPPSTSIRNGFQDSPCEDEWESRFYFHPISDLPPPEPYVQTTKSYPSKLARNESRSGSNRRERGAPPLPPIPR	0.447074	-1.161414576	0.006042251		4.9463732				6.8393262	4.576094243	6.389832	7.1230185	7.4180125	7.7348687	6.9451183		4.8828036	6.9736662	6.9542581	3.0079506	6.917468			7.0917206	7.3972774	8.214244					8.026578	7.8104186	8.304532	8.449051	4.796996	5.872098	8.0999206	6.52279	8.1113698	6.3661527	7.5404636	8.596069	7.726279	6.83506888	8.2782213	6.5788841	9.01367194	04144///Endocytosis+++05130///Pathogenic Escherichia coli infection+++05135///Yersinia infection	H01523///Wiskott-Aldrich syndrome			GO:0001726///ruffle+++GO:0005737///cytoplasm+++GO:0005829///cytosol+++GO:0005856///cytoskeleton+++GO:0005884///actin filament+++GO:0015629///actin cytoskeleton+++GO:0031410///cytoplasmic vesicle+++GO:0042995///cell projection	GO:0003779///actin binding+++GO:0005515///protein binding+++GO:0005522///profilin binding+++GO:0017124///SH3 domain binding	GO:0008154///actin polymerization or depolymerization+++GO:0030048///actin filament-based movement+++GO:0038096///Fc-gamma receptor signaling pathway involved in phagocytosis+++GO:0051707///response to other organism+++GO:0065003///protein-containing complex assembly	tissueType=Fetal kidney;cancerType=Normal;cellName=Monocyte+++tissueType=Fetal kidney;cancerType=Normal;cellName=Natural killer T (NKT) cell+++tissueType=Fetal gonad;cancerType=Normal;cellName=Gonadal endothelial cell+++tissueType=Large intestine;cancerType=Normal;cellName=Paneth cell		"Homo sapiens WAS/WASL interacting protein family member 1 (WIPF1), transcript variant 1, mRNA."		PF02205///WH2 motif	"R-HSA-162582///Signal Transduction+++R-HSA-1643685///Disease+++R-HSA-168249///Innate Immune System+++R-HSA-168256///Immune System+++R-HSA-194315///Signaling by Rho GTPases+++R-HSA-195258///RHO GTPase Effectors+++R-HSA-2029480///Fcgamma receptor (FCGR) dependent phagocytosis+++R-HSA-2029482///Regulation of actin dynamics for phagocytic cup formation+++R-HSA-5663205///Infectious disease+++R-HSA-5663213///RHO GTPases Activate WASPs and WAVEs+++R-HSA-9012999///RHO GTPase cycle+++R-HSA-9013148///CDC42 GTPase cycle+++R-HSA-9013149///RAC1 GTPase cycle+++R-HSA-9658195///Leishmania infection+++R-HSA-9664407///Parasite infection+++R-HSA-9664417///Leishmania phagocytosis+++R-HSA-9664422///FCGR3A-mediated phagocytosis+++R-HSA-9716542///Signaling by Rho GTPases, Miro GTPases and RHOBTB3"		KOG4462///actin binding		IPR003124///WH2 domain+++IPR011993///PH-like domain superfamily+++IPR028295///WAS/WASL-interacting protein family member 1	"[WIPF1_HUMAN|Reviewed]RecName: Full=WAS/WASL-interacting protein family member 1; AltName: Full=Protein PRPL-2; AltName: Full=Wiskott-Aldrich syndrome protein-interacting protein; Short=WASP-interacting protein;+++[D3DPE6_HUMAN|Unreviewed]SubName: Full=Wiskott-Aldrich syndrome protein interacting protein, isoform CRA_a {ECO:0000313|EMBL:EAX11134.1};"	chr2q31///Ensembl 103 genes in cytogenetic band chr2q31			"REACTOME_CDC42_GTPASE_CYCLE///CDC42 GTPase cycle+++REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS///Fcgamma receptor (FCGR) dependent phagocytosis+++REACTOME_INFECTIOUS_DISEASE///Infectious disease+++REACTOME_INNATE_IMMUNE_SYSTEM///Innate Immune System+++REACTOME_LEISHMANIA_INFECTION///Leishmania infection+++REACTOME_PARASITE_INFECTION///Parasite infection+++REACTOME_RAC1_GTPASE_CYCLE///RAC1 GTPase cycle+++REACTOME_RHO_GTPASE_CYCLE///RHO GTPase cycle+++REACTOME_RHO_GTPASE_EFFECTORS///RHO GTPase Effectors+++REACTOME_RHO_GTPASES_ACTIVATE_WASPS_AND_WAVES///RHO GTPases Activate WASPs and WAVEs+++REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3///Signaling by Rho GTPases, Miro GTPases and RHOBTB3"		"ATTCTTT_MIR186///Genes having at least one occurence of the motif ATTCTTT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-186 (v7.1 miRBase).+++CAGTATT_MIR200B_MIR200C_MIR429///Genes having at least one occurence of the motif CAGTATT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-200b, hsa-miR-200c and hsa-miR-429 (v7.1 miRBase).+++CAGTGTT_MIR141_MIR200A///Genes having at least one occurence of the motif CAGTGTT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-141 and hsa-miR-200a (v7.1 miRBase).+++CTATGCA_MIR153///Genes having at least one occurence of the motif CTATGCA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-153 (v7.1 miRBase).+++GTGCCTT_MIR506///Genes having at least one occurence of the motif GTGCCTT in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-506 (v7.1 miRBase).+++TGCCTTA_MIR124A///Genes having at least one occurence of the motif TGCCTTA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-124a (v7.1 miRBase).+++TGTTTAC_MIR30A5P_MIR30C_MIR30D_MIR30B_MIR30E5P///Genes having at least one occurence of the motif TGTTTAC in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-30a-5p, hsa-miR-30c, hsa-miR-30d, hsa-miR-30b and hsa-miR-30e-5p (v7.1 miRBase).+++TTGCCAA_MIR182///Genes having at least one occurence of the motif TTGCCAA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-182 (v7.1 miRBase)."	"MIR10399_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-10399-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR12117///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-12117 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR12128///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-12128 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1229_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1229-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1231///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1231 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR124_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-124-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1249_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1249-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1266_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1266-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1277_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1277-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR153_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-153-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR200B_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-200b-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR200C_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-200c-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR203A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-203a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR203A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-203a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR2681_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-2681-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR30A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-30a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR30B_5P_MIR30C_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-30b-5p, hsa-miR-30c-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR30D_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-30d-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR30E_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-30e-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3119///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3119 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3121_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3121-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3646///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3646 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3675_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3675-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR374C_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-374c-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3942_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3942-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4283///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4283 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR429///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-429 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4480///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4480 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4518///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4518 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4519///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4519 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4668_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4668-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4779///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4779 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4790_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4790-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR494_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-494-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR495_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-495-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR506_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-506-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR520D_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-520d-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR524_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-524-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5680///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5680 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5688///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5688 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR5700///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-5700 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR593_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-593-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR607///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-607 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6500_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6500-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6504_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6504-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR655_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-655-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6797_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6797-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6809_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6809-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7_1_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7-1-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7_2_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7-2-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR9851_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-9851-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets)."	CHOP_01///Genes having at least one occurence of the transcription factor binding site V$CHOP_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++MGGAAGTG_GABP_B///Genes having at least one occurence of the highly conserved motif M11 MGGAAGTG sites. The motif matches transcription factor binding site V$GABP_B (v7.4 TRANSFAC).+++RYTTCCTG_ETS2_B///Genes having at least one occurence of the highly conserved motif M16 RYTTCCTG sites. The motif matches transcription factor binding site V$ETS2_B (v7.4 TRANSFAC).+++STAT5A_01///Genes having at least one occurence of the transcription factor binding site V$STAT5A_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++STAT5B_01///Genes having at least one occurence of the transcription factor binding site V$STAT5B_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++TGACAGNY_MEIS1_01///Genes having at least one occurence of the highly conserved motif M41 TGACAGNY sites. The motif matches transcription factor binding site V$MEIS1_01 (v7.4 TRANSFAC).+++TGACATY_UNKNOWN///Genes having at least one occurence of the highly conserved motif M42 TGACATY in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).+++TGGAAA_NFAT_Q4_01///Genes having at least one occurence of the highly conserved motif M55 TGGAAA sites. The motif matches transcription factor binding site V$NFAT_Q4_01 (v7.4 TRANSFAC).+++TTCYNRGAA_STAT5B_01///Genes having at least one occurence of the highly conserved motif M40 TTCYNRGAA sites. The motif matches transcription factor binding site V$STAT5B_01 (v7.4 TRANSFAC).+++WTGAAAT_UNKNOWN///Genes having at least one occurence of the highly conserved motif M174 WTGAAAT in the region spanning up to 4 kb around their transcription start sites. The motif does not match any known transcription factor binding site (v7.4 TRANSFAC).	"BACH2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9BYV9 (BACH2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++CREB3_TARGET_GENES///Genes containing one or more binding sites for UniProt:O43889 (CREB3) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HMBOX1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6NT76 (HMBOX1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++MAFG_TARGET_GENES///Genes containing one or more binding sites for UniProt:O15525 (MAFG) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NFE2L1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q14494 (NFE2L1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NFKBIA_TARGET_GENES///Genes containing one or more binding sites for UniProt:P25963 (NFKBIA) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NOTCH3_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9UM47 (NOTCH3) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SKIL_TARGET_GENES///Genes containing one or more binding sites for UniProt:P12757 (SKIL) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++WRNIP1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96S55 (WRNIP1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF584_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8IVC4 (ZNF584) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."	GNF2_CD53///Neighborhood of CD53+++GNF2_INPP5D///Neighborhood of INPP5D+++GNF2_PTPRC///Neighborhood of PTPRC+++MORF_BMPR2///Neighborhood of BMPR2+++MORF_DCC///Neighborhood of DCC+++MORF_EPHA7///Neighborhood of EPHA7+++MORF_FRK///Neighborhood of FRK+++MORF_IL9///Neighborhood of IL9+++MORF_ZNF10///Neighborhood of ZNF10		EGFR_UP.V1_DN///Genes down-regulated in MCF-7 cells (breast cancer) positive for ESR1 [Gene ID=2099] and engineered to express ligand-activatable EGFR [Gene ID=1956].+++ERBB2_UP.V1_DN///Genes down-regulated in MCF-7 cells (breast cancer) positive for ESR1 [Gene ID=2099] and engineered to express ligand-activatable ERBB2 [Gene ID=2064].+++JNK_DN.V1_DN///Genes down-regulated in JNK inhibitor-treated (SP600125[PubChem=8515]) keratinocytes.+++LTE2_UP.V1_DN///Genes down-regulated in MCF-7 cells (breast cancer) positive for ESR1 [Gene ID=2099] MCF-7 cells (breast cancer) and long-term adapted for estrogen-independent growth.+++MEK_UP.V1_DN///Genes down-regulated in MCF-7 cells (breast cancer) positive for ESR1 [Gene ID=2099] MCF-7 cells (breast cancer) stably over-expressing constitutively active MAP2K1 [Gene ID=5604] gene.+++PTEN_DN.V2_DN///Genes down-regulated in HCT116 cells (colon carcinoma) upon knockdown of PTEN [Gene ID=5728] by RNAi.	"GSE11864_CSF1_IFNG_VS_CSF1_PAM3CYS_IN_MAC_UP///Genes up-regulated in comparison of macrophages cultured with M-CSF [GeneID=1435] and IFNG [GeneID=3458] versus macrophages cultured with M-CSF [GeneID=1435] and Pam3Cyc.+++GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_NONATOPIC_PATIENT_UP///Genes up-regulated in CD4 [GeneID=920] T cells from non-atopic donors: resting versus stimulated with allergen (house dust mite).+++GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA5_STIM_CD8_TCELL_DN///Genes down-regulated in CD8 T cells activated by anti-CD3 and anti-CD28 versus those stimulated by IFNA5 [GeneID=3442].+++GSE17301_IFNA2_VS_IFNA2_AND_ACD3_ACD28_STIM_CD8_TCELL_UP///Genes up-regulated in CD8 T cells stimulated by IFNA2 [GeneID=3440] versus those activated by anti-CD3 and anti-CD28.+++GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_72H_ACT_CD4_TCELL_DN///Genes down-regulated in comparison of CD4 [GeneID=920] T cells treated with IL4 [GeneID=3565] and anti-IL12 at 72 h versus the untreated cells at 72 h.+++GSE22103_LPS_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_UP///Genes up-regulated in neutrophils: LPS versus stimulated by CSF2 and IFNG [GeneID=1437;3458].+++GSE22886_NAIVE_CD4_TCELL_VS_NKCELL_DN///Genes down-regulated in comparison of naive CD4 [GeneID=920] T cells versus unstimulated NK cells.+++GSE23984_CTRL_VS_HYPOCALEMIC_VITAMIND_ANALOG_TCELL_DN///Genes down-regulated in T cells: control versus TX527 (hypocalemic analog of 25-hydroxyvitamin D3 [PubChem=1593]).+++GSE27291_0H_VS_7D_STIM_GAMMADELTA_TCELL_UP///Genes up-regulated in gamma delta T cells activated by phophoantigen BrHPP and IL2 [GeneID=3558]: 0h versus 7 days.+++GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_6H_UP///Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 and IL4 [GeneID=7040;3565] (6h) versus IL-12 (6h).+++GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_6H_DN///Genes down-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 and then stimulated by IL4 [GeneID=3565] (6h).+++GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_2H_DN///Genes down-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 and then stimulated by TGFB1 and IL4 [GeneID=7040;3565] (2h).+++GSE32164_ALTERNATIVELY_ACT_M2_VS_CMYC_INHIBITED_MACROPHAGE_UP///Genes up-regulated in macrophages: alternatively activated M2 versus MYC [GeneID=4609] inhibited.+++GSE32164_RESTING_DIFFERENTIATED_VS_ALTERNATIVELY_ACT_M2_MACROPHAGE_DN///Genes down-regulated in macrophages: resting differentiated versus alternatively activated M2.+++GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_MAC_UP///Genes up-regulated in comparison of macrophages exposed to L. major versus macrophages exposed to 50 worms/well B. malayi.+++GSE360_L_MAJOR_VS_M_TUBERCULOSIS_MAC_UP///Genes up-regulated in comparison of macrophages exposed to L. major versus macrophages exposed to M. tuberculosis.+++GSE37416_0H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_UP///Genes up-regulated in comparison of control polymorphonuclear leukocytes (PMN) at 0 h versus PMN treated with F. tularensis vaccine at 48 h.+++GSE3982_BASOPHIL_VS_TH1_UP///Genes up-regulated in comparison of basophils versus Th1 cells.+++GSE6269_FLU_VS_E_COLI_INF_PBMC_UP///Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from patients with acute influenza infection versus PBMC from patients with acute E. coli infection.+++GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_24H_UP///Genes up-regulated in monocytes (24h): untreated versus M. tuberculosis 19 kDa lipopeptide.+++NAKAYA_MONOCYTE_FLUMIST_AGE_18_50YO_7DY_UP///Genes up-regulated in monocyte 7d vs 0d in young adults (18-50) after exposure to FluMist , time point 7D+++NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN///Genes down-regulated in peripheral blood mononuclear cell 3d vs 0d in adults (18-50) after exposure to FluMist , time point 3D. Comment: Supplementary Table 1b: All the differentially expressed genes identified in PBMCs of TIV vaccinees.+++OCONNOR_PBMC_MENVEO_ACWYVAX_AGE_30_70YO_7DY_AFTER_SECOND_DOSE_VS_7DY_AFTER_FIRST_DOSE_DN///Genes down-regulated in peripheral blood mononuclear cell 7d after second dose vs 7d after first dose in adult (30-70) after exposure to Menveo/ACWYVax , time point 7D. Comment: second dose at 28 days"	"HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION///Genes defining epithelial-mesenchymal transition, as in wound healing, fibrosis and metastasis."	NM_003387	WIPF1				
O15511	sp|O15511|ARPC5_HUMAN		ARPC5		Actin-related protein 2/3 complex subunit 5 OS=Homo sapiens OX=9606 GN=ARPC5 PE=1 SV=3	10092	URS0001A0CDB4						MSKNTVSSARFRKVDVDEYDENKFVDEEDGGDGQAGPDEGEVDSCLRQGNMTAALQAALKNPPINTKSQAVKDRAGSIVLKVLISFKANDIEKAVQSLDKNGVDLLMKYIYKGFESPSDNSSAMLLQWHEKALAAGGVGSIVRVLTARKTV	0.5223363	-0.936949113	0.03569803								4.7163688	5.8130889			4.9541386					4.3034637					6.4570909							5.7186157				5.9657491						6.47761			6.316617	6.5323789	6.10370489																																	URS0001A0CDB4	ARPC5				
O15400	sp|O15400|STX7_HUMAN		STX7		Syntaxin-7 OS=Homo sapiens OX=9606 GN=STX7 PE=1 SV=4	8417	NM_001326578	NP_001313507		K08488			MSYTPGVGGDPAQLAQRISSNIQKITQCSVEIQRTLNQLGTPQDSPELRQQLQQKQQYTNQLAKETDKYIKEFGSLPTTPSEQRQRKIQKDRLVAEFTTSLTNFQKVQRQAAEREKEFVARVRASSRVSGSFPEDSSKERNLVSWESQTQPQVQVQDEEITEDDLRLIHERESSIRQLEADIMDINEIFKDLGMMIHEQGDVIDSIEANVENAEVHVQQANQQLSRAADYQRKSRKTLCIIILILVIGVAIISLIIWGLNH	0.5189524	-0.946325758	0.02331142					5.532525	6.2215109		6.2998534	6.0782474	6.4752087	5.2843929	6.4145898			5.7831047	7.268841					7.208841	9.008087	7.5173554					9.214713	8.4701367	8.713691	8.0067586	5.884643	7.6369267	7.5749463	7.2440583	6.1309239	6.2216815	6.0370278	8.218071	6.6879196	6.21769366	8.9120666	6.7700828	8.69822464	04130///SNARE interactions in vesicular transport+++04145///Phagosome				GO:0001772///immunological synapse+++GO:0005764///lysosome+++GO:0005765///lysosomal membrane+++GO:0005768///endosome+++GO:0005769///early endosome+++GO:0005770///late endosome+++GO:0005886///plasma membrane+++GO:0008021///synaptic vesicle+++GO:0012505///endomembrane system+++GO:0016020///membrane+++GO:0016021///integral component of membrane+++GO:0030139///endocytic vesicle+++GO:0031201///SNARE complex+++GO:0031901///early endosome membrane+++GO:0031982///vesicle+++GO:0042582///azurophil granule+++GO:0048471///perinuclear region of cytoplasm+++GO:0055037///recycling endosome+++GO:0070062///extracellular exosome+++GO:0070820///tertiary granule	GO:0000149///SNARE binding+++GO:0005484///SNAP receptor activity+++GO:0005515///protein binding+++GO:0019869///chloride channel inhibitor activity+++GO:0019905///syntaxin binding	GO:0001916///positive regulation of T cell mediated cytotoxicity+++GO:0006886///intracellular protein transport+++GO:0006906///vesicle fusion+++GO:0016192///vesicle-mediated transport+++GO:0048278///vesicle docking+++GO:0051640///organelle localization+++GO:0070925///organelle assembly+++GO:1902685///positive regulation of receptor localization to synapse+++GO:1903076///regulation of protein localization to plasma membrane	tissueType=Kidney;cancerType=Normal;cellName=B cell+++tissueType=Fetal gonad;cancerType=Normal;cellName=Endothelial cell+++tissueType=Kidney;cancerType=Renal Cell Carcinoma;cellName=B cell+++tissueType=Esophagus;cancerType=Normal;cellName=Ciliated epithelial cell		"Homo sapiens syntaxin 7 (STX7), transcript variant 1, mRNA."		PF05739///SNARE domain+++PF14523///Syntaxin-like protein			KOG0811///SNAP receptor activity		"IPR000727///Target SNARE coiled-coil homology domain+++IPR006011///Syntaxin, N-terminal domain+++IPR006012///Syntaxin/epimorphin, conserved site+++IPR010989///SNARE+++IPR045242///Syntaxin"	[STX7_HUMAN|Reviewed]RecName: Full=Syntaxin-7;	chr6q23///Ensembl 103 genes in cytogenetic band chr6q23		KEGG_SNARE_INTERACTIONS_IN_VESICULAR_TRANSPORT///SNARE interactions in vesicular transport			"TCTGATA_MIR361///Genes having at least one occurence of the motif TCTGATA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-361 (v7.1 miRBase)."	MIR10398_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-10398-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR1279///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-1279 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR128_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-128-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR16_1_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-16-1-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR192_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-192-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR215_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-215-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR216A_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-216a-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR302A_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-302a-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3074_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3074-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR32_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-32-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3646///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3646 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR3681_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-3681-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4671_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4671-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4672///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4672 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR497_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-497-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR499B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-499b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR580_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-580-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6502_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6502-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6510_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6510-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6833_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6833-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7844_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7844-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).	AFP1_Q6///Genes having at least one occurence of the transcription factor binding site V$AFP1_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++CHX10_01///Genes having at least one occurence of the transcription factor binding site V$CHX10_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++LHX3_01///Genes having at least one occurence of the transcription factor binding site V$LHX3_01 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++NKX62_Q2///Genes having at least one occurence of the transcription factor binding site V$NKX62_Q2 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.+++TAATTA_CHX10_01///Genes having at least one occurence of the highly conserved motif M23 TAATTA sites. The motif matches transcription factor binding site V$CHX10_01 (v7.4 TRANSFAC).+++TGGAAA_NFAT_Q4_01///Genes having at least one occurence of the highly conserved motif M55 TGGAAA sites. The motif matches transcription factor binding site V$NFAT_Q4_01 (v7.4 TRANSFAC).+++YTAATTAA_LHX3_01///Genes having at least one occurence of the highly conserved motif M61 YTAATTAA sites. The motif matches transcription factor binding site V$LHX3_01 (v7.4 TRANSFAC).	"DACH1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9UI36 (DACH1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++FEV_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q99581 (FEV) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HOXA2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O43364 (HOXA2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++MAFG_TARGET_GENES///Genes containing one or more binding sites for UniProt:O15525 (MAFG) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NR2E3_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9Y5X4 (NR2E3) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NUP153_TARGET_GENES///Genes containing one or more binding sites for UniProt:P49790 (NUP153) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++PRKDC_TARGET_GENES///Genes containing one or more binding sites for UniProt:P78527 (PRKDC) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."		MODULE_491///Genes in the cancer module 491.+++MODULE_568///Genes in the cancer module 568.		"GSE10325_CD4_TCELL_VS_BCELL_DN///Genes down-regulated in comparison of healthy CD4 [GeneID=920] T cells versus healthy CD19 [GeneID=920] B cells. +++GSE10325_CD4_TCELL_VS_MYELOID_DN///Genes down-regulated in comparison of healthy CD4 [GeneID=920] T cells versus healthy myeloid cells.+++GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_BCELL_DN///Genes down-regulated in comparison of systemic lupus erythematosus CD4 [GeneID=920] T cells versus systemic lupus erythematosus B cells.+++GSE11057_CD4_EFF_MEM_VS_PBMC_DN///Genes down-regulated in comarison of effector memory T cells versus peripheral blood mononuclear cells (PBMC).+++GSE11864_UNTREATED_VS_CSF1_IFNG_IN_MAC_DN///Genes down-regulated in comparison of untreated macrophages versus those cultured with M-CSF [GeneID=1435] and IFNG [GeneID=3458].+++GSE12845_NAIVE_VS_PRE_GC_TONSIL_BCELL_DN///Genes down-regulated in comparison of naive B cell versus pre-germinal tonsil B cells.+++GSE12845_PRE_GC_VS_DARKZONE_GC_TONSIL_BCELL_DN///Genes down-regulated in comparison of pre-germinal center B cells versus dark zone germinal center B cells.+++GSE13484_12H_VS_3H_YF17D_VACCINE_STIM_PBMC_UP///Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) cultured with YF17D vaccine for 12 h versus PBMC cultured for 3 h.+++GSE1460_INTRATHYMIC_T_PROGENITOR_VS_THYMIC_STROMAL_CELL_DN///Genes down-regulated in comparison of intrathymic T progenitor cells (ITTP) versus thymic stromal cells.+++GSE16450_CTRL_VS_IFNA_12H_STIM_MATURE_NEURON_CELL_LINE_DN///Genes down-regulated in mature neuron cell line: control versus interferon alpha (12h).+++GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA5_STIM_CD8_TCELL_DN///Genes down-regulated in CD8 T cells activated by anti-CD3 and anti-CD28 versus those stimulated by IFNA5 [GeneID=3442].+++GSE18893_TCONV_VS_TREG_24H_CULTURE_UP///Genes up-regulated in lymphocytes treated with medium for 24h: T conv versus T reg cells.+++GSE1925_3H_VS_24H_IFNG_STIM_MACROPHAGE_DN///Genes down-regulated in macrophages stimulated by IFNG [GeneID=3458]: 3h versus 24h.+++GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_TCELL_MEMBRANES_ACT_MAST_CELL_UP///Genes up-regulated in HMC-1 (mast leukemia) cells: incubated with the peptide ALL1 and then treated with Cl-IB-MECA [PubChem=3035850] versus stimulation by T cell membranes.+++GSE21774_CD62L_POS_CD56_DIM_VS_CD62L_NEG_CD56_DIM_NK_CELL_DN///Genes down-regulated in SELL dim [GeneID=6402] NK cells: NCAM1+ [GeneID=4684] versus NCAM1- [GeneID=4684].+++GSE22229_RENAL_TRANSPLANT_IMMUNOSUPP_THERAPY_VS_HEALTHY_PBMC_UP///Genes up-regulated in periperal blood monocytes (PBMC): kidney transplant recipients receiving immunosuppression therapy versus healthy controls.+++GSE22886_IGG_IGA_MEMORY_BCELL_VS_BM_PLASMA_CELL_UP///Genes up-regulated in comparison of memory IgG IgA B cells versus plasma cells from bone marrow and blood.+++GSE22886_NAIVE_CD4_TCELL_VS_DC_DN///Genes down-regulated in comparison of naive CD4 [GeneID=920] T cells versus unstimulatd dendritic cells (DC).+++GSE22886_NAIVE_CD4_TCELL_VS_MONOCYTE_DN///Genes down-regulated in comparison of naive CD4 [GeneID=920] T cells versus day 0 monocytes.+++GSE22886_NAIVE_CD4_TCELL_VS_NKCELL_DN///Genes down-regulated in comparison of naive CD4 [GeneID=920] T cells versus unstimulated NK cells.+++GSE22886_NAIVE_CD8_TCELL_VS_NKCELL_DN///Genes down-regulated in comparison of naive CD8 T cells versus unstimulated NK cells.+++GSE22886_NAIVE_TCELL_VS_MONOCYTE_DN///Genes down-regulated in comparison of naive CD4 [GeneID=920] CD8 T cells versus monocytes cultured for 0 days.+++GSE22886_NAIVE_TCELL_VS_NKCELL_DN///Genes down-regulated in comparison of naive CD4 [GeneID=920] CD8 T cells versus unstimulated NK cells.+++GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_24H_UP///Genes up-regulated in polymorphonuclear leukocytes (24h): treated by heat killed HC60 cell (promyelocytic leukemia) lysate versus A. phagocytophilum infection.+++GSE2405_S_AUREUS_VS_A_PHAGOCYTOPHILUM_NEUTROPHIL_UP///Genes up-regulated in polymorphonuclear leukocytes 9h after infection by: S. aureus versus A. phagocytophilum.+++GSE24081_CONTROLLER_VS_PROGRESSOR_HIV_SPECIFIC_CD8_TCELL_DN///Genes down-regulated in comparison of CD8 T cells with progressing HIV infection versus those with controlled HIV infection.+++GSE26351_UNSTIM_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_UP///Genes up-regulated in CD34+ [GeneID=947] cells: control versus stimulated by BMP4 [GeneID=652].+++GSE2706_LPS_VS_R848_AND_LPS_8H_STIM_DC_UP///Genes up-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 8 h versus DCs stimulated with LPS (TLR4 agonist) and R848 for 8 h.+++GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_48H_DN///Genes down-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 and then stimulated by TGFB1 and IL4 [GeneID=7040;3565] (48h).+++GSE33425_CD161_HIGH_VS_INT_CD8_TCELL_UP///Genes up-regulated in CD8 T cells: KLRB1 high [GeneID=3820] versus KLRB1 int [GeneID=3820].+++GSE33425_CD161_INT_VS_NEG_CD8_TCELL_DN///Genes down-regulated in CD8 T cells: KLRB1 int [GeneID=3820] versus KLRB1- [GeneID=3820].+++GSE360_DC_VS_MAC_B_MALAYI_HIGH_DOSE_DN///Genes down-regulated in comparison of dendritic cells (DC) exposed to 50 worm/well B. malayi versus macrophages exposed to 50 worms/well B. malayi.+++GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_UP///Genes up-regulated in comparison of macrophages exposed to 50 worms/well B. malayi versus macrophages exposed to M. tuberculosis.+++GSE3982_BASOPHIL_VS_CENT_MEMORY_CD4_TCELL_UP///Genes up-regulated in comparison of basophils versus central memory CD4 [GeneID=920] T cells.+++GSE3982_BCELL_VS_EFF_MEMORY_CD4_TCELL_UP///Genes up-regulated in comparison of B cells versus effector memory CD4 [GeneID=920] T cells.+++GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH2_UP///Genes up-regulated in comparison of central memory CD4 [GeneID=920] T cells versus Th2 cells.+++GSE3982_MAC_VS_BASOPHIL_UP///Genes up-regulated in comparison of macrophages versus basophils.+++GSE3982_MAC_VS_EFF_MEMORY_CD4_TCELL_UP///Genes up-regulated in comparison of macrophages versus effector memory CD4 [GeneID=920] T cells.+++GSE3982_MEMORY_CD4_TCELL_VS_BCELL_DN///Genes down-regulated in comparison of memory CD4 [GeneID=920] T cells versus B cells.+++GSE43260_BTLA_POS_VS_NEG_INTRATUMORAL_CD8_TCELL_DN///Genes down-regulated in tumor-infiltrating CD8 T cells: BTLA+ [GeneID=151888] versus BTLA- [GeneID=151888].+++GSE7460_CTRL_VS_TGFB_TREATED_ACT_FOXP3_HET_TCONV_UP///Genes up-regulated in comparsion of WTActCD4 versus WTActCD4TGF (see Fig. 1 in the paper for details).+++GSE7460_CTRL_VS_TGFB_TREATED_ACT_TREG_UP///Genes up-regulated in comparsion of ActTreg versus ActTregTGF (see Fig. 1 in the paper for details).+++GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_3H_DN///Genes down-regulated in monocytes (3h): untreated versus M. tuberculosis 19 kDa lipopeptide.+++GSE9988_LPS_VS_VEHICLE_TREATED_MONOCYTE_DN///Genes down-regulated in comparison of monocytes treated with 1 ng/ml LPS (TLR4 agonist) versus untreated monocytes.+++NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_UP///Genes up-regulated in peripheral blood mononuclear cell 3d vs 0d in adults (18-50) after exposure to Fluarix/Fluvirin , time point 3D. Comment: Supplementary Table 1a: All the differentially expressed genes identified in PBMCs of TIV vaccinees.+++NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_UP///Genes up-regulated in peripheral blood mononuclear cell 3d vs 0d in adults (18-50) after exposure to FluMist , time point 3D. Comment: Supplementary Table 1b: All the differentially expressed genes identified in PBMCs of TIV vaccinees.+++NAKAYA_PBMC_FLUMIST_AGE_18_50YO_7DY_UP///Genes up-regulated in peripheral blood mononuclear cell 7d vs 0d in adults (18-50) after exposure to FluMist , time point 7D. Comment: Supplementary Table 1b: All the differentially expressed genes identified in PBMCs of TIV vaccinees."	HALLMARK_PROTEIN_SECRETION///Genes involved in protein secretion pathway.	NM_001326578	STX7				
O00244	sp|O00244|ATOX1_HUMAN				Copper transport protein ATOX1 OS=Homo sapiens OX=9606 GN=ATOX1 PE=1 SV=1								MPKHEFSVDMTCGGCAEAVSRVLNKLGGVKYDIDLPNKKVCIESEHSMDTLLATLKKTGKTVSYLGLE	0.4777936	-1.065540489	0.004466055	4.4154811	5.3134982	5.2604578	5.1137826	6.7770657	5.1515164	4.11960986	5.819587	7.0079186	6.8297861	4.663532	6.4989102	4.58387507	6.0007139		5.6339101	4.9661981	5.9885964			4.5914727	6.3861473	8.2086685	5.4787922	4.24078461	5.55756818	4.6443904	9.482752	7.8881579	7.824818	7.4401405	4.2756	5.6227581	6.8503777	6.6909945	5.7719114	5.8950072	6.0865065	7.986949	7.9756624	6.55525938	8.2377344	5.8802947	6.5670423																																	C9606_51593					
O00233	sp|O00233|PSMD9_HUMAN		PSMD9		26S proteasome non-ATPase regulatory subunit 9 OS=Homo sapiens OX=9606 GN=PSMD9 PE=1 SV=3	5715	NM_002813	NP_002804	ENST00000541212	K06693			MSDEEARQSGGSSQAGVVTVSDVQELMRRKEEIEAQIKANYDVLESQKGIGMNEPLVDCEGYPRSDVDLYQVRTARHNIICLQNDHKAVMKQVEEALHQLHARDKEKQARDMAEAHKEAMSRKLGQSESQGPPRAFAKVNSISPGSPASIAGLQVDDEIVEFGSVNTQNFQSLHNIGSVVQHSEGKPLNVTVIRRGEKHQLRLVPTRWAGKGLLGCNIIPLQR	0.4837512	-1.047662831	0.004697087									5.2872949	5.0464819	4.9132205	4.9846788			6.4079581	3.8379765						4.6159334	5.738994		4.58964573			7.14733	7.2851729	6.395337	7.1114459			5.9929689	6.5652653	5.3954192	4.9281887		6.57857	6.1673923	5.43871908	6.0221617	5.2510461	6.36876388	03050///Proteasome+++05010///Alzheimer disease+++05012///Parkinson disease+++05014///Amyotrophic lateral sclerosis+++05016///Huntington disease+++05017///Spinocerebellar ataxia+++05020///Prion disease+++05022///Pathways of neurodegeneration - multiple diseases				"GO:0005634///nucleus+++GO:0005654///nucleoplasm+++GO:0005737///cytoplasm+++GO:0005829///cytosol+++GO:0005838///proteasome regulatory particle+++GO:0008540///proteasome regulatory particle, base subcomplex"	GO:0003713///transcription coactivator activity+++GO:0005515///protein binding+++GO:0043425///bHLH transcription factor binding	"GO:0000165///MAPK cascade+++GO:0000209///protein polyubiquitination+++GO:0002223///stimulatory C-type lectin receptor signaling pathway+++GO:0002479///antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent+++GO:0006511///ubiquitin-dependent protein catabolic process+++GO:0006521///regulation of cellular amino acid metabolic process+++GO:0010972///negative regulation of G2/M transition of mitotic cell cycle+++GO:0016579///protein deubiquitination+++GO:0031145///anaphase-promoting complex-dependent catabolic process+++GO:0031146///SCF-dependent proteasomal ubiquitin-dependent protein catabolic process+++GO:0032024///positive regulation of insulin secretion+++GO:0033209///tumor necrosis factor-mediated signaling pathway+++GO:0036388///pre-replicative complex assembly+++GO:0038061///NIK/NF-kappaB signaling+++GO:0038095///Fc-epsilon receptor signaling pathway+++GO:0043161///proteasome-mediated ubiquitin-dependent protein catabolic process+++GO:0043488///regulation of mRNA stability+++GO:0043687///post-translational protein modification+++GO:0045893///positive regulation of transcription, DNA-templated+++GO:0046676///negative regulation of insulin secretion+++GO:0050852///T cell receptor signaling pathway+++GO:0055085///transmembrane transport+++GO:0060071///Wnt signaling pathway, planar cell polarity pathway+++GO:0061418///regulation of transcription from RNA polymerase II promoter in response to hypoxia+++GO:0070498///interleukin-1-mediated signaling pathway+++GO:0070682///proteasome regulatory particle assembly+++GO:0090090///negative regulation of canonical Wnt signaling pathway+++GO:0090263///positive regulation of canonical Wnt signaling pathway+++GO:1901990///regulation of mitotic cell cycle phase transition+++GO:1902036///regulation of hematopoietic stem cell differentiation"	tissueType=Fetal gonad;cancerType=Normal;cellName=Granulosa cell+++tissueType=Fetal kidney;cancerType=Normal;cellName=Natural killer T (NKT) cell		"Homo sapiens proteasome 26S subunit, non-ATPase 9 (PSMD9), transcript variant 1, mRNA."		PF17820///PDZ domain+++PF18265///Nas2 N_terminal domain	"R-HSA-109581///Apoptosis+++R-HSA-1168372///Downstream signaling events of B Cell Receptor (BCR)+++R-HSA-1169091///Activation of NF-kappaB in B cells+++R-HSA-1234174///Cellular response to hypoxia+++R-HSA-1234176///Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha+++R-HSA-1236974///ER-Phagosome pathway+++R-HSA-1236975///Antigen processing-Cross presentation+++R-HSA-1236978///Cross-presentation of soluble exogenous antigens (endosomes)+++R-HSA-1257604///PIP3 activates AKT signaling+++R-HSA-1266738///Developmental Biology+++R-HSA-1280215///Cytokine Signaling in Immune system+++R-HSA-1280218///Adaptive Immune System+++R-HSA-1430728///Metabolism+++R-HSA-157118///Signaling by NOTCH+++R-HSA-162582///Signal Transduction+++R-HSA-162906///HIV Infection+++R-HSA-162909///Host Interactions of HIV factors+++R-HSA-1640170///Cell Cycle+++R-HSA-1643685///Disease+++R-HSA-168249///Innate Immune System+++R-HSA-168256///Immune System+++R-HSA-169911///Regulation of Apoptosis+++R-HSA-174084///Autodegradation of Cdh1 by Cdh1:APC/C+++R-HSA-174113///SCF-beta-TrCP mediated degradation of Emi1+++R-HSA-174143///APC/C-mediated degradation of cell cycle proteins+++R-HSA-174154///APC/C:Cdc20 mediated degradation of Securin+++R-HSA-174178///APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1+++R-HSA-174184///Cdc20:Phospho-APC/C mediated degradation of Cyclin A+++R-HSA-176408///Regulation of APC/C activators between G1/S and early anaphase+++R-HSA-176409///APC/C:Cdc20 mediated degradation of mitotic proteins+++R-HSA-176814///Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins+++R-HSA-179419///APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint+++R-HSA-180534///Vpu mediated degradation of CD4+++R-HSA-180585///Vif-mediated degradation of APOBEC3G+++R-HSA-187577///SCF(Skp2)-mediated degradation of p27/p21+++R-HSA-195253///Degradation of beta-catenin by the destruction complex+++R-HSA-195721///Signaling by WNT+++R-HSA-201681///TCF dependent signaling in response to WNT+++R-HSA-202403///TCR signaling+++R-HSA-202424///Downstream TCR signaling+++R-HSA-211733///Regulation of activated PAK-2p34 by proteasome mediated degradation+++R-HSA-212436///Generic Transcription Pathway+++R-HSA-2262752///Cellular responses to stress+++R-HSA-2454202///Fc epsilon receptor (FCERI) signaling+++R-HSA-2467813///Separation of Sister Chromatids+++R-HSA-2555396///Mitotic Metaphase and Anaphase+++R-HSA-2871837///FCERI mediated NF-kB activation+++R-HSA-349425///Autodegradation of the E3 ubiquitin ligase COP1+++R-HSA-350562///Regulation of ornithine decarboxylase (ODC)+++R-HSA-351202///Metabolism of polyamines+++R-HSA-376176///Signaling by ROBO receptors+++R-HSA-382551///Transport of small molecules+++R-HSA-382556///ABC-family proteins mediated transport+++R-HSA-3858494///Beta-catenin independent WNT signaling+++R-HSA-392499///Metabolism of proteins+++R-HSA-4086400///PCP/CE pathway+++R-HSA-422475///Axon guidance+++R-HSA-446652///Interleukin-1 family signaling+++R-HSA-449147///Signaling by Interleukins+++R-HSA-450408///AUF1 (hnRNP D0) binds and destabilizes mRNA+++R-HSA-450531///Regulation of mRNA stability by proteins that bind AU-rich elements+++R-HSA-453274///Mitotic G2-G2/M phases+++R-HSA-453276///Regulation of mitotic cell cycle+++R-HSA-453279///Mitotic G1 phase and G1/S transition+++R-HSA-4608870///Asymmetric localization of PCP proteins+++R-HSA-4641257///Degradation of AXIN+++R-HSA-4641258///Degradation of DVL+++R-HSA-5357801///Programmed Cell Death+++R-HSA-5358346///Hedgehog ligand biogenesis+++R-HSA-5358351///Signaling by Hedgehog+++R-HSA-5362768///Hh mutants are degraded by ERAD+++R-HSA-5387390///Hh mutants abrogate ligand secretion+++R-HSA-5607761///Dectin-1 mediated noncanonical NF-kB signaling+++R-HSA-5607764///CLEC7A (Dectin-1) signaling+++R-HSA-5610780///Degradation of GLI1 by the proteasome+++R-HSA-5610783///Degradation of GLI2 by the proteasome+++R-HSA-5610785///GLI3 is processed to GLI3R by the proteasome+++R-HSA-5610787///Hedgehog 'off' state+++R-HSA-5619084///ABC transporter disorders+++R-HSA-5619115///Disorders of transmembrane transporters+++R-HSA-5621481///C-type lectin receptors (CLRs)+++R-HSA-5632684///Hedgehog 'on' state+++R-HSA-5658442///Regulation of RAS by GAPs+++R-HSA-5663202///Diseases of signal transduction by growth factor receptors and second messengers+++R-HSA-5663205///Infectious disease+++R-HSA-5668541///TNFR2 non-canonical NF-kB pathway+++R-HSA-5673001///RAF/MAP kinase cascade+++R-HSA-5676590///NIK-->noncanonical NF-kB signaling+++R-HSA-5678895///Defective CFTR causes cystic fibrosis+++R-HSA-5683057///MAPK family signaling cascades+++R-HSA-5684996///MAPK1/MAPK3 signaling+++R-HSA-5687128///MAPK6/MAPK4 signaling+++R-HSA-5688426///Deubiquitination+++R-HSA-5689603///UCH proteinases+++R-HSA-5689880///Ub-specific processing proteases+++R-HSA-597592///Post-translational protein modification+++R-HSA-6807070///PTEN Regulation+++R-HSA-68827///CDT1 association with the CDC6:ORC:origin complex+++R-HSA-68867///Assembly of the pre-replicative complex+++R-HSA-68882///Mitotic Anaphase+++R-HSA-68886///M Phase+++R-HSA-68949///Orc1 removal from chromatin+++R-HSA-69002///DNA Replication Pre-Initiation+++R-HSA-69017///CDK-mediated phosphorylation and removal of Cdc6+++R-HSA-69052///Switching of origins to a post-replicative state+++R-HSA-69202///Cyclin E associated events during G1/S transition +++R-HSA-69206///G1/S Transition+++R-HSA-69239///Synthesis of DNA+++R-HSA-69242///S Phase+++R-HSA-69275///G2/M Transition+++R-HSA-69278///Cell Cycle, Mitotic+++R-HSA-69306///DNA Replication+++R-HSA-69481///G2/M Checkpoints+++R-HSA-69541///Stabilization of p53+++R-HSA-69563///p53-Dependent G1 DNA Damage Response+++R-HSA-69580///p53-Dependent G1/S DNA damage checkpoint+++R-HSA-69601///Ubiquitin Mediated Degradation of Phosphorylated Cdc25A+++R-HSA-69610///p53-Independent DNA Damage Response+++R-HSA-69613///p53-Independent G1/S DNA damage checkpoint+++R-HSA-69615///G1/S DNA Damage Checkpoints+++R-HSA-69620///Cell Cycle Checkpoints+++R-HSA-69656///Cyclin A:Cdk2-associated events at S phase entry+++R-HSA-71291///Metabolism of amino acids and derivatives+++R-HSA-73857///RNA Polymerase II Transcription+++R-HSA-74160///Gene expression (Transcription)+++R-HSA-75815///Ubiquitin-dependent degradation of Cyclin D+++R-HSA-8852276///The role of GTSE1 in G2/M progression after G2 checkpoint+++R-HSA-8854050///FBXL7 down-regulates AURKA during mitotic entry and in early mitosis+++R-HSA-8878159///Transcriptional regulation by RUNX3+++R-HSA-8878166///Transcriptional regulation by RUNX2+++R-HSA-8878171///Transcriptional regulation by RUNX1+++R-HSA-8932339///ROS sensing by NFE2L2+++R-HSA-8939236///RUNX1 regulates transcription of genes involved in differentiation of HSCs+++R-HSA-8939902///Regulation of RUNX2 expression and activity+++R-HSA-8941858///Regulation of RUNX3 expression and activity+++R-HSA-8948751///Regulation of PTEN stability and activity+++R-HSA-8951664///Neddylation+++R-HSA-8953854///Metabolism of RNA+++R-HSA-8953897///Cellular responses to stimuli+++R-HSA-9006925///Intracellular signaling by second messengers+++R-HSA-9010553///Regulation of expression of SLITs and ROBOs+++R-HSA-9013694///Signaling by NOTCH4+++R-HSA-9020702///Interleukin-1 signaling+++R-HSA-9604323///Negative regulation of NOTCH4 signaling+++R-HSA-9675108///Nervous system development+++R-HSA-9707564///Cytoprotection by HMOX1+++R-HSA-9707587///Regulation of HMOX1 expression and activity+++R-HSA-9711123///Cellular response to chemical stress+++R-HSA-983168///Antigen processing: Ubiquitination & Proteasome degradation+++R-HSA-983169///Class I MHC mediated antigen processing & presentation+++R-HSA-983705///Signaling by the B Cell Receptor (BCR)"		KOG3129///26S Proteasome non-ATPase regulatory subunit		"IPR001478///PDZ domain+++IPR035269///26S Proteasome non-ATPase regulatory subunit 9+++IPR036034///PDZ superfamily+++IPR040815///Nas2, N-terminal+++IPR041489///PDZ domain 6"	[PSMD9_HUMAN|Reviewed]RecName: Full=26S proteasome non-ATPase regulatory subunit 9; AltName: Full=26S proteasome regulatory subunit p27;	chr12q24///Ensembl 103 genes in cytogenetic band chr12q24			"REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT///ABC-family proteins mediated transport+++REACTOME_ABC_TRANSPORTER_DISORDERS///ABC transporter disorders+++REACTOME_ADAPTIVE_IMMUNE_SYSTEM///Adaptive Immune System+++REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION///Antigen processing-Cross presentation+++REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION///Antigen processing: Ubiquitination &amp; Proteasome degradation+++REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1///APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1+++REACTOME_APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS///APC/C-mediated degradation of cell cycle proteins+++REACTOME_APOPTOSIS///Apoptosis+++REACTOME_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX///Assembly of the pre-replicative complex+++REACTOME_ASYMMETRIC_LOCALIZATION_OF_PCP_PROTEINS///Asymmetric localization of PCP proteins+++REACTOME_AUF1_HNRNP_D0_BINDS_AND_DESTABILIZES_MRNA///AUF1 (hnRNP D0) binds and destabilizes mRNA+++REACTOME_BETA_CATENIN_INDEPENDENT_WNT_SIGNALING///Beta-catenin independent WNT signaling+++REACTOME_CELL_CYCLE///Cell Cycle+++REACTOME_CELL_CYCLE_CHECKPOINTS///Cell Cycle Checkpoints+++REACTOME_CELL_CYCLE_MITOTIC///Cell Cycle, Mitotic+++REACTOME_CELLULAR_RESPONSES_TO_EXTERNAL_STIMULI///Cellular responses to external stimuli+++REACTOME_CELLULAR_RESPONSE_TO_CHEMICAL_STRESS///Cellular response to chemical stress+++REACTOME_CELLULAR_RESPONSE_TO_HYPOXIA///Cellular response to hypoxia+++REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION///Class I MHC mediated antigen processing &amp; presentation+++REACTOME_CLEC7A_DECTIN_1_SIGNALING///CLEC7A (Dectin-1) signaling+++REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES///Cross-presentation of soluble exogenous antigens (endosomes)+++REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS///C-type lectin receptors (CLRs)+++REACTOME_CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY///Cyclin A:Cdk2-associated events at S phase entry+++REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM///Cytokine Signaling in Immune system+++REACTOME_CYTOPROTECTION_BY_HMOX1///Cytoprotection by HMOX1+++REACTOME_DECTIN_1_MEDIATED_NONCANONICAL_NF_KB_SIGNALING///Dectin-1 mediated noncanonical NF-kB signaling+++REACTOME_DEFECTIVE_CFTR_CAUSES_CYSTIC_FIBROSIS///Defective CFTR causes cystic fibrosis+++REACTOME_DEGRADATION_OF_AXIN///Degradation of AXIN+++REACTOME_DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX///Degradation of beta-catenin by the destruction complex+++REACTOME_DEGRADATION_OF_DVL///Degradation of DVL+++REACTOME_DEGRADATION_OF_GLI1_BY_THE_PROTEASOME///Degradation of GLI1 by the proteasome+++REACTOME_DEUBIQUITINATION///Deubiquitination+++REACTOME_DEVELOPMENTAL_BIOLOGY///Developmental Biology+++REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS///Diseases of signal transduction by growth factor receptors and second messengers+++REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS///Disorders of transmembrane transporters+++REACTOME_DNA_REPLICATION///DNA Replication+++REACTOME_DNA_REPLICATION_PRE_INITIATION///DNA Replication Pre-Initiation+++REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR///Downstream signaling events of B Cell Receptor (BCR)+++REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING///Fc epsilon receptor (FCERI) signaling+++REACTOME_FCERI_MEDIATED_NF_KB_ACTIVATION///FCERI mediated NF-kB activation+++REACTOME_G1_S_DNA_DAMAGE_CHECKPOINTS///G1/S DNA Damage Checkpoints+++REACTOME_G2_M_CHECKPOINTS///G2/M Checkpoints+++REACTOME_HEDGEHOG_LIGAND_BIOGENESIS///Hedgehog ligand biogenesis+++REACTOME_HEDGEHOG_OFF_STATE///Hedgehog 'off' state+++REACTOME_HEDGEHOG_ON_STATE///Hedgehog 'on' state+++REACTOME_HIV_INFECTION///HIV Infection+++REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS///Host Interactions of HIV factors+++REACTOME_INFECTIOUS_DISEASE///Infectious disease+++REACTOME_INNATE_IMMUNE_SYSTEM///Innate Immune System+++REACTOME_INTERLEUKIN_1_FAMILY_SIGNALING///Interleukin-1 family signaling+++REACTOME_INTERLEUKIN_1_SIGNALING///Interleukin-1 signaling+++REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS///Intracellular signaling by second messengers+++REACTOME_MAPK6_MAPK4_SIGNALING///MAPK6/MAPK4 signaling+++REACTOME_MAPK_FAMILY_SIGNALING_CASCADES///MAPK family signaling cascades+++REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES///Metabolism of amino acids and derivatives+++REACTOME_METABOLISM_OF_POLYAMINES///Metabolism of polyamines+++REACTOME_METABOLISM_OF_RNA///Metabolism of RNA+++REACTOME_MITOTIC_G1_PHASE_AND_G1_S_TRANSITION///Mitotic G1 phase and G1/S transition+++REACTOME_MITOTIC_G2_G2_M_PHASES///Mitotic G2-G2/M phases+++REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE///Mitotic Metaphase and Anaphase+++REACTOME_M_PHASE///M Phase+++REACTOME_NEDDYLATION///Neddylation+++REACTOME_NEGATIVE_REGULATION_OF_NOTCH4_SIGNALING///Negative regulation of NOTCH4 signaling+++REACTOME_NERVOUS_SYSTEM_DEVELOPMENT///Nervous system development+++REACTOME_ORC1_REMOVAL_FROM_CHROMATIN///Orc1 removal from chromatin+++REACTOME_PCP_CE_PATHWAY///PCP/CE pathway+++REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION///Post-translational protein modification+++REACTOME_PROGRAMMED_CELL_DEATH///Programmed Cell Death+++REACTOME_PTEN_REGULATION///PTEN Regulation+++REACTOME_REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS///Regulation of expression of SLITs and ROBOs+++REACTOME_REGULATION_OF_HMOX1_EXPRESSION_AND_ACTIVITY///Regulation of HMOX1 expression and activity+++REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS///Regulation of mRNA stability by proteins that bind AU-rich elements+++REACTOME_REGULATION_OF_PTEN_STABILITY_AND_ACTIVITY///Regulation of PTEN stability and activity+++REACTOME_REGULATION_OF_RAS_BY_GAPS///Regulation of RAS by GAPs+++REACTOME_REGULATION_OF_RUNX2_EXPRESSION_AND_ACTIVITY///Regulation of RUNX2 expression and activity+++REACTOME_REGULATION_OF_RUNX3_EXPRESSION_AND_ACTIVITY///Regulation of RUNX3 expression and activity+++REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION///RNA Polymerase II Transcription+++REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_HSCS///RUNX1 regulates transcription of genes involved in differentiation of HSCs+++REACTOME_SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21///SCF(Skp2)-mediated degradation of p27/p21+++REACTOME_SEPARATION_OF_SISTER_CHROMATIDS///Separation of Sister Chromatids+++REACTOME_SIGNALING_BY_HEDGEHOG///Signaling by Hedgehog+++REACTOME_SIGNALING_BY_INTERLEUKINS///Signaling by Interleukins+++REACTOME_SIGNALING_BY_NOTCH4///Signaling by NOTCH4+++REACTOME_SIGNALING_BY_NOTCH///Signaling by NOTCH+++REACTOME_SIGNALING_BY_ROBO_RECEPTORS///Signaling by ROBO receptors+++REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR///Signaling by the B Cell Receptor (BCR)+++REACTOME_SIGNALING_BY_WNT///Signaling by WNT+++REACTOME_S_PHASE///S Phase+++REACTOME_STABILIZATION_OF_P53///Stabilization of p53+++REACTOME_SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE///Switching of origins to a post-replicative state+++REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT///TCF dependent signaling in response to WNT+++REACTOME_TCR_SIGNALING///TCR signaling+++REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT///The role of GTSE1 in G2/M progression after G2 checkpoint+++REACTOME_TNFR2_NON_CANONICAL_NF_KB_PATHWAY///TNFR2 non-canonical NF-kB pathway+++REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1///Transcriptional regulation by RUNX1+++REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX2///Transcriptional regulation by RUNX2+++REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3///Transcriptional regulation by RUNX3+++REACTOME_TRANSPORT_OF_SMALL_MOLECULES///Transport of small molecules+++REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES///Ub-specific processing proteases+++REACTOME_UCH_PROTEINASES///UCH proteinases"			"MIR4270///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4270 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4441///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4441 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR4685_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-4685-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR519A_2_5P_MIR520B_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-519a-2-5p, hsa-miR-520b-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR589_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-589-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6754_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6754-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR6837_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-6837-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7113_5P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7113-5p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR7153_3P///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-7153-3p in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets).+++MIR9902///Genes predicted to be targets of miRBase v22 microRNA hsa-miR-9902 in miRDB v6.0 with MirTarget v4 prediction scores &gt; 80 (high confidence targets)."	PU1_Q6///Genes having at least one occurence of the transcription factor binding site V$PU1_Q6 (v7.4 TRANSFAC) in the regions spanning up to 4 kb around their transcription starting sites.	"AHRR_TARGET_GENES///Genes containing one or more binding sites for UniProt:A9YTQ3 (AHRR) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ARNT2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9HBZ2 (ARNT2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++BACH2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9BYV9 (BACH2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++BANP_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q8N9N5 (BANP) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++CHAF1B_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q13112 (CHAF1B) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++EWSR1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q01844 (EWSR1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++FOXR2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6PJQ5 (FOXR2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++GLI3_TARGET_GENES///Genes containing one or more binding sites for UniProt:P10071 (GLI3) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++HSF2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q03933 (HSF2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ID1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P41134 (ID1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++KDM5D_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9BY66 (KDM5D) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++KLF7_TARGET_GENES///Genes containing one or more binding sites for UniProt:O75840 (KLF7) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++MAFG_TARGET_GENES///Genes containing one or more binding sites for UniProt:O15525 (MAFG) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++METHYLCYTOSINE_DIOXYGENASE_TET_UNIPROT_A0A023HHK9_UNREVIEWED_TARGET_GENES///Genes containing one or more binding sites for UniProt:A0A023HHK9 (METHYLCYTOSINE_DIOXYGENASE_TET_UNIPROT_A0A023HHK9_UNREVIEWED) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++MZF1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P28698 (MZF1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NCOA2_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q15596 (NCOA2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NFE2L1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q14494 (NFE2L1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NKX2_2_TARGET_GENES///Genes containing one or more binding sites for UniProt:O95096 (NKX2_2) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++NKX6_1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P78426 (NKX6_1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++PITX1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P78337 (PITX1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++RAG1_TARGET_GENES///Genes containing one or more binding sites for UniProt:P15918 (RAG1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SETD1A_TARGET_GENES///Genes containing one or more binding sites for UniProt:O15047 (SETD1A) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SETX_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q7Z333 (SETX) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++SFMBT1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9UHJ3 (SFMBT1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++TBX3_TARGET_GENES///Genes containing one or more binding sites for UniProt:O15119 (TBX3) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++TFEB_TARGET_GENES///Genes containing one or more binding sites for UniProt:P19484 (TFEB) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++UBP1_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9NZI7 (UBP1) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZBTB49_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q6ZSB9 (ZBTB49) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZFP91_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q96JP5 (ZFP91) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF146_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q15072 (ZNF146) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF184_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q99676 (ZNF184) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF407_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9C0G0 (ZNF407) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF581_TARGET_GENES///Genes containing one or more binding sites for UniProt:Q9P0T4 (ZNF581) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization.+++ZNF8_TARGET_GENES///Genes containing one or more binding sites for UniProt:P17098 (ZNF8) in their promoter regions (TSS -1000,+100 bp) as identified by GTRD version 20.06 ChIP-seq harmonization."	GNF2_CDC27///Neighborhood of CDC27+++GNF2_MAP2K3///Neighborhood of MAP2K3+++MORF_CSNK2B///Neighborhood of CSNK2B+++MORF_DAP///Neighborhood of DAP+++MORF_GSPT1///Neighborhood of GSPT1+++MORF_PPP1CA///Neighborhood of PPP1CA+++MORF_PPP6C///Neighborhood of PPP6C+++MORF_PSMC1///Neighborhood of PSMC1+++MORF_RAD23B///Neighborhood of RAD23B+++MORF_SKP1A///Neighborhood of SKP1A+++MORF_SOD1///Neighborhood of SOD1	MODULE_28///Genes in the cancer module 28.+++MODULE_91///Proteasome.		"GSE12198_NK_VS_NK_ACT_EXPANSION_SYSTEM_DERIVED_NK_CELL_DN///Genes down-regulated in NK cells: primary versus activated and expanded.+++GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP///Genes up-regulated in comparison of CD4 [GeneID=920] CD8 thymocytes versus naive CD4 [GeneID=920] T cells from adult blood.+++GSE1460_DP_VS_CD4_THYMOCYTE_UP///Genes up-regulated in comparison of CD4 [GeneID=920] CD8 thymocytes versus T cells from cord blood.+++GSE17186_NAIVE_VS_CD21LOW_TRANSITIONAL_BCELL_UP///Genes up-regulated in B lymphocytes: nave versus transitional CR2 [GeneID=1380] low.+++GSE22611_UNSTIM_VS_2H_MDP_STIM_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_UP///Genes up-regulated in HEK293 cells expressing mutant NOD2 [GeneID=64127]: untreated versus muramyl dipeptide [PubChem=11620162] for 2h.+++GSE26928_CENTR_MEMORY_VS_CXCR5_POS_CD4_TCELL_UP///Genes up-regulated in comparison of CD4 [GeneID=920] central memory T cells versus CD4 [GeneID=920] CXCR5+ [GeneID=643] T cells.+++GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_2H_DN///Genes down-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 and then stimulated by IL4 [GeneID=3565] (2h).+++GSE28726_NAIVE_VS_ACTIVATED_NKTCELL_DN///Genes down-regulated in NKT cells: nave versus activated.+++GSE32901_TH1_VS_TH17_ENRICHED_CD4_TCELL_DN///Genes down-regulated in CD4 [GeneID=920] T cells: Th1 versus Th17 enriched.+++GSE33374_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_DN///Genes down-regulated in KLRB1 high [GeneID=3820] T cells: CD8A [GeneID=925] versus CD8A CD8B [GeneID=925;926].+++GSE360_CTRL_VS_L_MAJOR_DC_UP///Genes up-regulated in untreated dendritic cells (DC) versus DCs exposed to parasite L. major.+++GSE360_CTRL_VS_T_GONDII_MAC_UP///Genes up-regulated in comparison of macrophages versus macrophages exposed to T. gondii.+++GSE360_DC_VS_MAC_UP///Genes up-regulated in comparison of dendritic cells (DC) versus untreated macrophages.+++GSE360_L_MAJOR_VS_T_GONDII_MAC_UP///Genes up-regulated in comparison of macrophages exposed to L. major versus macrophages exposed to T. gondii.+++GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_MAC_DN///Genes down-regulated in comparison of macrophages exposed to T. gondii versus macrophages exposed to 50 worms/well B. malayi.+++GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_MAC_DN///Genes down-regulated in comparison of macrophages exposed to T. gondii versus macrophages exposed to 5 worms/well B. malayi.+++GSE37416_0H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP///Genes up-regulated in comparison of control polymorphonuclear leukocytes (PMN) at 0 h versus PMN treated with F. tularensis vaccine at 24 h.+++GSE7400_CTRL_VS_CSF3_IN_VIVO_TREATED_PBMC_DN///Genes down-regulated in comparison of untreated peripheral blood mononuclear cells (PBMC) versus PBMCs treated with CSF3 [GeneID=1440].+++HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_0DY_POSITIVE///Genes positively correlated with memory B cell response at 28d in peripheral blood mononuclear cell in seniors(50-74) after exposure to Fluarix , time point 0D"	HALLMARK_HEME_METABOLISM///Genes involved in metabolism of heme (a cofactor consisting of iron and porphyrin) and erythroblast differentiation.	NM_002813	PSMD9				
O00194	sp|O00194|RB27B_HUMAN		RAB27B		Ras-related protein Rab-27B OS=Homo sapiens OX=9606 GN=RAB27B PE=1 SV=4	5874	XR_935245						MTDGDYDYLIKLLALGDSGVGKTTFLYRYTDNKFNPKFITTVGIDFREKRVVYNAQGPNGSSGKAFKVHLQLWDTAGQERFRSLTTAFFRDAMGFLLMFDLTSQQSFLNVRNWMSQLQANAYCENPDIVLIGNKADLPDQREVNERQARELADKYGIPYFETSAATGQNVEKAVETLLDLIMKRMEQCVEKTQIPDTVNGGNSGNLDGEKPPEKKCIC	0.4391924	-1.187075139	0.01116096		6.478224	6.2302582	7.2426481	8.1380914	8.3852439	5.964734653	7.8510398	8.8137815	9.2882133	8.3013322	9.8018211	5.25154403	7.7752809	7.4772378	7.770267		6.6281199			7.9442197	9.9196751	9.4756994	5.7327932		5.63329187	6.3253404	11.953288	10.5282724	10.003913	9.1464926	6.878152	8.9283636	9.9719405	9.3105684	8.9375371	9.2852868	8.4695402	10.581465	9.3895205	8.67919257	10.2967325	8.1299305	9.74327896										"PREDICTED: Homo sapiens RAB27B, member RAS oncogene family (RAB27B), transcript variant X5, misc_RNA."																							XR_935245	RAB27B				
O00151	sp|O00151|PDLI1_HUMAN				PDZ and LIM domain protein 1 OS=Homo sapiens OX=9606 GN=PDLIM1 PE=1 SV=4 >tr|V9HW92|V9HW92_HUMAN Epididymis secretory protein Li 112 OS=Homo sapiens OX=9606 GN=HEL-S-112 PE=2 SV=1								MTTQQIDLQGPGPWGFRLVGGKDFEQPLAISRVTPGSKAALANLCIGDVITAIDGENTSNMTHLEAQNRIKGCTDNLTLTVARSEHKVWSPLVTEEGKRHPYKMNLASEPQEVLHIGSAHNRSAMPFTASPASSTTARVITNQYNNPAGLYSSENISNFNNALESKTAASGVEANSRPLDHAQPPSSLVIDKESEVYKMLQEKQELNEPPKQSTSFLVLQEILESEEKGDPNKPSGFRSVKAPVTKVAASIGNAQKLPMCDKCGTGIVGVFVKLRDRHRHPECYVCTDCGTNLKQKGHFFVEDQIYCEKHARERVTPPEGYEVVTVFPK	0.3499625	-1.514727703	0.002494621	4.9346517	7.8075466	6.3192542	6.87296	7.2895625	9.9226651	7.166282463	9.0052775	8.399491	9.6874566	8.9538267	9.606026	6.21644521	8.3707542	7.514532	8.1278372		7.49776	4.331484747		8.7911401	9.6261535	10.1750329	7.7230418	5.60475394	6.83032727	6.4298312	12.055305	10.80893	10.518505	10.6629338	7.185426	8.3627426	9.3800165	10.0140596	9.7740882	9.9977144	8.5549386	10.972526	10.3946287	9.63251826	10.968316	9.1015844	10.26200714																																	C9606_121904					
A0A0J9YVY3	sp|A0A0J9YVY3|HV741_HUMAN		IGHV7-4-1		Immunoglobulin heavy variable 7-4-1 OS=Homo sapiens OX=9606 GN=IGHV7-4-1 PE=3 SV=1	57289	id-IGHV7-4-1-2						MDWTWRILFLVAAATGAHSQVQLVQSGSELKKPGASVKVSCKASGYTFTSYAMNWVRQAPGQGLEWMGWINTNTGNPTYAQGFTGRFVFSLDTSVSTAYLQICSLKAEDTAVYYCAR	0.6269093	-0.673671408	0.04692646	5.3334022				3.469057	4.5240678	4.894119325					4.4093318		4.7937599	4.8998794	3.0896342	3.2802439		2.619769371				4.2223859	4.356111			5.2492947	5.114667		5.02338					4.2912577	5.1746197	5.5834656					4.6341647		4.40063314																																	id-IGHV7-4-1-2	IGHV7-4-1				
A0A0A0MS15	sp|A0A0A0MS15|HV349_HUMAN		IGHV3-49		Immunoglobulin heavy variable 3-49 OS=Homo sapiens OX=9606 GN=IGHV3-49 PE=3 SV=1	28423	id-IGHV3-49-2						MEFGLSWVFLVAILKGVQCEVQLVESGGGLVQPGRSLRLSCTASGFTFGDYAMSWVRQAPGKGLEWVGFIRSKAYGGTTEYAASVKGRFTISRDDSKSIAYLQMNSLKTEDTAVYYCTR	1.724712	0.786355436	0.008558765		6.1627421				5.0664889	6.961056352	6.6826453	5.1215056		5.7450323	5.8034349			4.9999699									4.2719833	4.5324744		4.7615909	5.057359	5.8230803		5.5269014			5.5232667	4.4363583				4.496149	5.7415148	5.51379766	4.7678238	4.9572521																																		id-IGHV3-49-2	IGHV3-49				
